PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Luo, ZX; Ji, Q; Wible, JR; Yuan, CX				Luo, ZX; Ji, Q; Wible, JR; Yuan, CX			An early Cretaceous tribosphenic mammal and metatherian evolution	SCIENCE			English	Article							EUTHERIAN MAMMALS; ORIGIN; MARSUPIALS; PHYLOGENY	Derived features of a new boreosphenidan mammal from the Lower Cretaceous Yixian Formation of China suggest that it has a closer relationship to metatherians (including extant marsupials) than to eutherians (including extant placentals). This fossil dates to 125 million years ago and extends the record of marsupial relatives with skeletal remains by 50 million years. It also has many foot structures known only from climbing and tree-living extant mammals, suggesting that early crown therians exploited diverse niches. New data from this fossil support the view that Asia was likely the center for the diversification of the earliest metatherians and eutherians during the Early Cretaceous.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Nanjing Univ, Dept Earth Sci, Nanjing 200017, Peoples R China; Chinese Acad Geol Sci, Beijing 100037, Peoples R China; China Univ Geosci, Beijing 100083, Peoples R China	Nanjing University; Chinese Academy of Geological Sciences; China University of Geosciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemuseums.org	Luo, Zhe-XI/AAU-2263-2021					Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Averianov A, 1999, ACTA PALAEONTOL POL, V44, P71; BEARD KC, 1992, PRIMATES THEIR RELAT, P63; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; Cifelli RL, 1996, NATURE, V379, P715, DOI 10.1038/379715a0; Clemens W. A., 1966, U CALIFORNIA PUBLICA, V62, P1; de Muizon Christian, 1998, Geodiversitas, V20, P19; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Horovitz I, 2003, CLADISTICS, V19, P181, DOI 10.1016/S0748-3007(03)00045-8; Horovitz I, 2000, J VERTEBR PALEONTOL, V20, P547, DOI 10.1671/0272-4634(2000)020[0547:TTOUNE]2.0.CO;2; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hu YM, 2002, CHINESE SCI BULL, V47, P933, DOI 10.1360/02tb9209; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z., 1979, Palaeontologia Polonica, V38, P5; Kielan-Jaworowska Z, 2001, ACTA PALAEONTOL POL, V46, P377; KIELAN-JAWOROWSKA Z, 1975, Palaeontologia Polonica, V33, P103; KIELANJAWOROWSK.Z, IN PRESS MAMMALS AGE; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Lillegraven J.A., 1974, Annual Rev Ecol Syst, V5, P263, DOI 10.1146/annurev.es.05.110174.001403; LILLEGRAVEN JA, 1984, U TENN STUD GEOL, V8, P1; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Marshall Larry G., 1995, Memoires du Museum National d'Histoire Naturelle, V165, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Reig O.A., 1987, P1; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Rougier G.W., 1993, THESIS U NACL BUENOS; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Sanchez-Villagra Marcelo R., 1997, Journal of Mammalian Evolution, V4, P119, DOI 10.1023/A:1027318213347; SIGOGNEAURUSSELL D, 1992, ZOOL SCR, V21, P205, DOI 10.1111/j.1463-6409.1992.tb00322.x; Springer Mark S., 1997, Journal of Mammalian Evolution, V4, P285, DOI 10.1023/A:1027378615412; Springer Mark S., 1997, P129; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Swofford D, 2000, PAUP PHYLOGENETIC AN; Szalay F.S., 1994, EVOLUTIONARY HIST MA; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Szalay FS, 1996, J VERTEBR PALEONTOL, V16, P474, DOI 10.1080/02724634.1996.10011335; Tyndale-Biscoe CH., 1987, REPROD PHYSL MARSUPI; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Weil A, 2002, NATURE, V416, P798, DOI 10.1038/416798a; [No title captured]	46	296	333	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1934	1940		10.1126/science.1090718	http://dx.doi.org/10.1126/science.1090718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671295				2022-12-01	WOS:000187174000052
J	Malin, MC; Edgett, KS				Malin, MC; Edgett, KS			Evidence for persistent flow and aqueous sedimentation on early Mars	SCIENCE			English	Article							CHANNELS; WATER; MORPHOLOGY; SCALE	Landforms representative of sedimentary processes and environments that occurred early in martian history have been recognized in Mars Global Surveyor Mars Orbiter Camera and Mars Odyssey Thermal Emission Imaging System images. Evidence of distributary, channelized flow (in particular, flow that lasted long enough to foster meandering) and the resulting deposition of a fan-shaped apron of debris indicate persistent flow conditions and formation of at least some large intracrater layered sedimentary sequences within fluvial, and potentially lacustrine, environments.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.			Edgett, Kenneth/0000-0001-7197-5751				[Anonymous], 1983, GEOL SOC AM BULL, V94, P1035; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; BLAIR TC, 1994, J SEDIMENT RES A, V64, P450; Cabrol NA, 2001, ICARUS, V149, P291, DOI 10.1006/icar.2000.6530; Carr M.H, 1996, WATER MARS; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; Christensen PR, 2003, SCIENCE, V300, P2056, DOI 10.1126/science.1080885; Galloway W E, 1975, DELTAS MODELS EXPLOR, P87; KOMAR PD, 1979, ICARUS, V37, P156, DOI 10.1016/0019-1035(79)90123-4; MAIZELS J, 1990, PALAEOGEOGR PALAEOCL, V76, P241, DOI 10.1016/0031-0182(90)90115-N; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Miller RP, 1937, J GEOL, V45, P432, DOI 10.1086/624550; MILTON DJ, 1973, J GEOPHYS RES, V78, P4037, DOI 10.1029/JB078i020p04037; MILTON DJ, 1974, ICARUS, V23, P27; Nemec W., 1990, SPECIAL PUBLICATION, V10, P3; Ori GG, 2000, J GEOPHYS RES-PLANET, V105, P17629, DOI 10.1029/1999JE001219; SHARP RP, 1975, GEOL SOC AM BULL, V86, P593, DOI 10.1130/0016-7606(1975)86<593:COM>2.0.CO;2; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; WEIHAUPT JG, 1974, J GEOPHYS RES, V79, P2073, DOI 10.1029/JB079i014p02073; Wessel P., 1991, EOS T AM GEOPHYS UN, V72, P441, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	23	349	356	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1931	1934		10.1126/science.1090544	http://dx.doi.org/10.1126/science.1090544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14615547				2022-12-01	WOS:000187174000051
J	Zhang, FX; Su, KH; Yang, XY; Bowe, DB; Paterson, AJ; Kudlow, JE				Zhang, FX; Su, KH; Yang, XY; Bowe, DB; Paterson, AJ; Kudlow, JE			O-GIcNAc modification is an endogenous inhibitor of the proteasome	CELL			English	Article							PANCREATIC BETA-CELLS; N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; CYTOSOLIC PROTEINS; TETRATRICOPEPTIDE REPEATS; DEPENDENT DEGRADATION; PROTEOLYTIC PATHWAY; GENE-TRANSCRIPTION; RESEARCH TOOLS; LINKED GLCNAC	The ubiquitin proteasome system classically selects its substrates for degradation by tagging them with ubiquitin. Here, we describe another means of controlling proteasome function in a global manner. The 26S proteasome can be inhibited by modification with the enzyme, O-GlcNAc transferase (OGT). This reversible modification of the proteasome inhibits the proteolysis of the transcription factor Sp1 and a hydrophobic peptide through inhibition of the ATPase activity of 26S proteasomes. The Rpt2 ATPase in the mammalian proteasome 19S cap is modified by O-GlcNAc in vitro and in vivo and as its modification increases, proteasome function decreases. This mechanism may couple proteasomes to the general metabolic state of the cell. The O-GlcNAc modification of proteasomes may allow the organism to respond to its metabolic needs by controlling the availability of amino acids and regulatory proteins.	Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama, Dept Pharmacol, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Div Endocrinol Diabet & Metabolism, Birmingham, AL 35294 USA; Gene Express Lab, Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Salk Institute	Kudlow, JE (corresponding author), Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.				NATIONAL CANCER INSTITUTE [R01CA095021] Funding Source: NIH RePORTER; NCI NIH HHS [CA095021] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams J, 1999, CANCER RES, V59, P2615; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen F, 2000, CELL GROWTH DIFFER, V11, P239; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, NAT MED, V8, P338, DOI 10.1038/nm0402-338; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Han I, 2000, BIOCHEM J, V350, P109, DOI 10.1042/0264-6021:3500109; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hideshima T, 2001, CANCER RES, V61, P3071; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; LECKER SH, 2002, J PHYSL, V545, P819; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Pasquini LA, 2000, J NEUROSCI RES, V59, P601, DOI 10.1002/(SICI)1097-4547(20000301)59:5<601::AID-JNR3>3.0.CO;2-1; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Roos MD, 1998, P ASSOC AM PHYSICIAN, V110, P422; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Russell SJ, 2001, CHEM BIOL, V8, P941, DOI 10.1016/S1074-5521(01)00060-6; Sayeski PP, 1996, J BIOL CHEM, V271, P15237, DOI 10.1074/jbc.271.25.15237; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WING SS, 1993, AM J PHYSIOL, V264, P668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998	53	329	355	4	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					715	725		10.1016/S0092-8674(03)00974-7	http://dx.doi.org/10.1016/S0092-8674(03)00974-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675536	Bronze			2022-12-01	WOS:000187366100011
J	McNab, BK				McNab, BK			Metabolism - Ecology shapes bird bioenergetics	NATURE			English	Editorial Material							ENERGY-EXPENDITURE; MAMMALS; ENERGETICS; BASAL; RATES		Univ Florida, Dept Zool, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	McNab, BK (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.							BARTHOLOMEW GA, 1983, PHYSIOL ZOOL, V56, P370, DOI 10.1086/physzool.56.3.30152601; Beehler B.M., 1989, ACT 19 C INT ORN, P816, DOI 10.1515/9781400880713; FRITH CB, 1998, BRIDS PARADISE; GLAZIER DS, 1985, COMP BIOCHEM PHYS A, V80, P587, DOI 10.1016/0300-9629(85)90417-7; KOTEJA P, 1991, FUNCT ECOL, V5, P56, DOI 10.2307/2389555; McNab B.K., 2002, PHYSL ECOLOGY VERTEB; MCNAB BK, 1980, AM NAT, V116, P106, DOI 10.1086/283614; McNab BK, 2001, AUK, V118, P916, DOI 10.1642/0004-8038(2001)118[0916:EOTABA]2.0.CO;2; McNab BK, 2000, COMP BIOCHEM PHYS A, V127, P309, DOI 10.1016/S1095-6433(00)00268-3; NAGY KA, 1994, AUST J ZOOL, V42, P43, DOI 10.1071/ZO9940043; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Reynolds PS, 1996, AM NAT, V147, P735, DOI 10.1086/285877; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892	13	38	39	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					620	621		10.1038/426620b	http://dx.doi.org/10.1038/426620b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668851				2022-12-01	WOS:000187132800028
J	Shaevitz, JW; Abbondanzieri, EA; Landick, R; Block, SM				Shaevitz, JW; Abbondanzieri, EA; Landick, R; Block, SM			Backtracking by single RNA polymerase molecules observed at near-base-pair resolution	NATURE			English	Article							ESCHERICHIA-COLI; TRANSCRIPT CLEAVAGE; ELONGATION; DNA; FIDELITY; FORCE; GREA; MECHANISM; COMPLEXES; ARREST	Escherichia coli RNA polymerase ( RNAP) synthesizes RNA with remarkable fidelity in vivo(1). Its low error rate may be achieved by means of a ' proofreading' mechanism comprised of two sequential events. The first event ( backtracking) involves a transcriptionally upstream motion of RNAP through several base pairs, which carries the 30 end of the nascent RNA transcript away from the enzyme active site. The second event ( endonucleolytic cleavage) occurs after a variable delay and results in the scission and release of the most recently incorporated ribonucleotides, freeing up the active site. Here, by combining ultrastable optical trapping apparatus with a novel two- bead assay to monitor transcriptional elongation with near- base- pair precision, we observed backtracking and recovery by single molecules of RNAP. Backtracking events (similar to 5 bp) occurred infrequently at locations throughout the DNA template and were associated with pauses lasting 20 s to > 30 min. Inosine triphosphate increased the frequency of backtracking pauses, whereas the accessory proteins GreA and GreB, which stimulate the cleavage of nascent RNA, decreased the duration of such pauses.	Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Stanford University; Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.				NIGMS NIH HHS [R01 GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; FENG GH, 1994, J BIOL CHEM, V269, P22282; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0	28	288	302	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					684	687		10.1038/nature02191	http://dx.doi.org/10.1038/nature02191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14634670	Green Accepted			2022-12-01	WOS:000187132800047
J	Journet, L; Agrain, C; Broz, P; Cornelis, GR				Journet, L; Agrain, C; Broz, P; Cornelis, GR			The needle length of bacterial injectisomes is determined by a molecular ruler	SCIENCE			English	Article							FLAGELLAR HOOK LENGTH; III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; SUBSTRATE-SPECIFICITY; SHIGELLA-FLEXNERI; YOP SECRETION; TAIL LENGTH; PROTEIN; COMPLEX; YSCP	Size determination represents a fundamental requirement for multicomponent biological structures. Some pathogenic bacteria possess a weapon derived from the flagellum. Like the flagellum, this type-III secretion apparatus, called the injectisome, has a transmembrane basal body, but the external component is a needle-like structure instead of a hook and a. lament. Here, we provide evidence that the length of this needle is determined by the size of a protein, YscP, acting as a molecular ruler.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.		Broz, Petr/AAC-7940-2019	Broz, Petr/0000-0002-2334-7790; Journet, Laure/0000-0002-5847-2962				ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; DUDA RL, 1986, VIROLOGY, V151, P296, DOI 10.1016/0042-6822(86)90051-6; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002	23	235	246	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1757	1760		10.1126/science.1091422	http://dx.doi.org/10.1126/science.1091422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657497				2022-12-01	WOS:000186970100046
J	Monje, ML; Toda, H; Palmer, TD				Monje, ML; Toda, H; Palmer, TD			Inflammatory blockade restores adult hippocampal neurogenesis	SCIENCE			English	Article							NEURAL STEM-CELLS; DENTATE GYRUS; RAT-BRAIN; RECEPTOR ACTIVATION; MAMMALIAN FOREBRAIN; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; EXPRESSION; INTERLEUKIN-6; DIFFERENTIATION	Cranial radiation therapy causes a progressive decline in cognitive function that is linked to impaired neurogenesis. Chronic inflammation accompanies radiation injury, suggesting that inflammatory processes may contribute to neural stem cell dysfunction. Here, we show that neuroinflammation alone inhibits neurogenesis and that inflammatory blockade with indomethacin, a common nonsteroidal anti-inflammatory drug, restores neurogenesis after endotoxin-induced inflammation and augments neurogenesis after cranial irradiation.	Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University	Palmer, TD (corresponding author), Stanford Univ, Dept Neurosurg, MSLS P309,Mail Code 5487,1201 Welche Rd, Stanford, CA 94305 USA.		Toda, Hiroki/C-6932-2016; Palmer, Theo/GSI-6635-2022	Toda, Hiroki/0000-0002-1596-4131; Palmer, Theo/0000-0002-6266-1862	NIMH NIH HHS [MH20016-05] Funding Source: Medline; NINDS NIH HHS [F30 NS04696701] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brew BJ, 1999, NEUROL CLIN, V17, P861, DOI 10.1016/S0733-8619(05)70170-5; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; CALVO W, 1988, BRIT J RADIOL, V61, P1043, DOI 10.1259/0007-1285-61-731-1043; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; Cameron HA, 1998, NEUROSCIENCE, V82, P349; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Dickson DW, 2001, CLIN GERIATR MED, V17, P209, DOI 10.1016/S0749-0690(05)70066-5; EKDAHL CT, 2003, P NATL ACAD SCI US; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gould E, 1997, J NEUROSCI, V17, P2492; Hodges H, 1998, BEHAV BRAIN RES, V91, P99, DOI 10.1016/S0166-4328(97)00108-3; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luskin MB, 1998, J NEUROBIOL, V36, P221; Mackenzie IRA, 2000, NEUROLOGY, V55, P132, DOI 10.1212/WNL.55.1.132; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MARKS JE, 1981, INT J RADIAT ONCOL, V7, P243, DOI 10.1016/0360-3016(81)90443-0; Marz P, 1999, GLIA, V26, P191, DOI 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nakashima K, 2002, MOL NEUROBIOL, V25, P233; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; REICHMAN HR, 1986, J NEUROSURG, V65, P233, DOI 10.3171/jns.1986.65.2.0233; Reyes TM, 1998, AM J PHYSIOL-REG I, V274, pR139, DOI 10.1152/ajpregu.1998.274.1.R139; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Shaw KN, 2001, BEHAV BRAIN RES, V124, P47, DOI 10.1016/S0166-4328(01)00232-7; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; SHINTANI F, 1995, J NEUROSCI, V15, P1961, DOI 10.1523/JNEUROSCI.15-03-01961.1995; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; Terrazzino S, 2002, J NEUROIMMUNOL, V124, P45, DOI 10.1016/S0165-5728(02)00013-9; Turrin NP, 2001, BRAIN RES BULL, V54, P443, DOI 10.1016/S0361-9230(01)00445-2; Valerio A, 2002, MOL CELL NEUROSCI, V21, P602, DOI 10.1006/mcne.2002.1208; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Watanabe D, 1996, EUR J NEUROSCI, V8, P1630, DOI 10.1111/j.1460-9568.1996.tb01307.x; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x	51	1803	1876	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1760	1765		10.1126/science.1088417	http://dx.doi.org/10.1126/science.1088417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14615545				2022-12-01	WOS:000186970100047
J	Hull, MC; Morris, CG; Pepine, CJ; Mendenhall, NP				Hull, MC; Morris, CG; Pepine, CJ; Mendenhall, NP			Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NASOPHARYNGEAL CARCINOMA; HEART-DISEASE; RADIOTHERAPY; IRRADIATION; STENOSIS; REGURGITATION; PERICARDITIS; MORTALITY; EFFUSION; RISK	Context The majority of patients with Hodgkin lymphoma are young and highly curable. This necessitates concern for prevention, diagnosis, and optimal management of potential treatment-related complications. Objective To identify and quantify the incidence of and factors contributing to long-term cardiac and vascular complications after radiation therapy for Hodgkin lymphoma. Design and Setting Retrospective study comparing patients treated from 1962 to 1998 at a university-based referral center with a matched general population. Patients Four hundred fifteen consecutive patients who fulfilled the inclusion criteria of a minimum 2-year follow-up (median, 11.2 years) and whose radiation fields included the heart or carotid or subclavian arteries. Main Outcome Measures Multivariable analyses of potential risk factors and observed-to-expected ratios for cardiac valve surgery, coronary artery bypass graft surgery, percutaneous coronary intervention, or both based on Surveillance, Epidemiology, and End Results (SEER) and National Hospital Discharge Survey (NHDS) data. Results Forty-two patients (10.4%) developed coronary artery disease at a median of 9 years after treatment, 30 patients (7.4%) developed carotid and/or subclavian artery disease at a median of 17 years after treatment, and 25 patients (6.2%) developed clinically significant valvular dysfunction at a median of 22 years. The most common valve lesion was aortic stenosis, which occurred in 14 valves. The observed-to-expected ratio for valve surgery was 8.42 (95% confidence interval [CI], 3.20-13.65) and the observed-to-expected ratio for coronary artery bypass graft surgery or percutaneous coronary intervention was 1.63 (95% Cl, 0.98-2.28). At least 1 cardiac risk factor was present in all patients who developed coronary artery disease. The only treatment-related factor associated with the development of coronary artery disease was utilization of a radiation technique that resulted in a higher total dose to a portion of the heart (relative risk, 7.8; 95% Cl, 1.1-53.2; P=.04). No specific treatment-related factor was associated with carotid or subclavian artery disease or valvular dysfunction., Freedom from any cardiovascular morbidity was 88% at 15 years and 84% at 20 years. Conclusions Among patients treated with radiation therapy for Hodgkin lymphoma, there are statistically higher than expected rates of valve surgery and coronary revascularization procedures over the next 10 to 20 years. Coronary vascular disease is associated with higher radiation doses and traditional coronary heart disease risk factors. Noncoronary vascular disease and clinically important valvular dysfunction are less well understood complications at 15 to 20 years after radiation, requiring surveillance and further study.	Univ Florida, Coll Med, Dept Radiat Oncol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mendenhall, NP (corresponding author), 2000 SW Archer Rd, Gainesville, FL 32608 USA.							Achenbach S, 1998, NEW ENGL J MED, V339, P1964, DOI 10.1056/NEJM199812313392702; AHUJA A, 1995, NEUROSURGERY, V36, P399, DOI 10.1227/00006123-199502000-00023; BOIVIN JF, 1992, CANCER, V69, P1241; BYHARDT R, 1975, CANCER-AM CANCER SOC, V35, P795, DOI 10.1002/1097-0142(197503)35:3<795::AID-CNCR2820350335>3.0.CO;2-M; *CDCP NAT CTR HLTH, 2002, CDCP NAT CTR HLTH ST, V13; Cheng SWK, 2000, ARCH OTOLARYNGOL, V126, P517, DOI 10.1001/archotol.126.4.517; COHN KE, 1967, MEDICINE, V46, P281, DOI 10.1097/00005792-196705000-00003; CONOMY JP, 1975, CANCER, V36, P1702, DOI 10.1002/1097-0142(197511)36:5<1702::AID-CNCR2820360525>3.0.CO;2-V; COSSET JM, 1991, INT J RADIAT ONCOL, V21, P447, DOI 10.1016/0360-3016(91)90794-5; COX DR, 1972, J R STAT SOC B, V34, P187; Dubec JJ, 1998, BRIT J RADIOL, V71, P872, DOI 10.1259/bjr.71.848.9828801; ELERDING SC, 1981, ANN SURG, V194, P609, DOI 10.1097/00000658-198111000-00009; Fletcher GH., 1980, TXB RADIOTHERAPY, V3rd ed.; Glanzmann C, 1998, RADIOTHER ONCOL, V46, P51, DOI 10.1016/S0167-8140(97)00125-4; GUSTAVSSON A, 1990, ANN ONCOL, V1, P355, DOI 10.1093/oxfordjournals.annonc.a057774; Hancock SL, 1999, HODGKIN'S DISEASE, P647; HENRYAMAR M, 1990, INT J RADIAT ONCOL, V19, P1155, DOI 10.1016/0360-3016(90)90221-5; Hoppe RT, 1997, ANN ONCOL, V8, P115, DOI 10.1023/A:1008238908676; Houdart E, 2001, STROKE, V32, P118, DOI 10.1161/01.STR.32.1.118; HUDSON BV, 1994, ANN ONCOL         S2, V5, P65; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; King LJ, 1999, RADIOLOGY, V213, P167, DOI 10.1148/radiology.213.1.r99oc07167; King V, 1996, INT J RADIAT ONCOL, V36, P881, DOI 10.1016/S0360-3016(96)00295-7; KREUSER ED, 1993, BRIT J HAEMATOL, V84, P615, DOI 10.1111/j.1365-2141.1993.tb03136.x; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lee CKK, 2000, INT J RADIAT ONCOL, V48, P169, DOI 10.1016/S0360-3016(00)00647-7; Lund MB, 1996, HEART, V75, P591, DOI 10.1136/hrt.75.6.591; Mauch P M, 1995, Cancer J Sci Am, V1, P33; Mendenhall NP, 1999, INT J RADIAT ONCOL, V44, P551, DOI 10.1016/S0360-3016(99)00087-5; MENDENHALL NP, 2000, CLIN RAD ONCOLOGY, P1123; MORTON DL, 1973, CHEST, V64, P291, DOI 10.1378/chest.64.3.291; *NCI DCCPS SURV RE, 2002, SURV EP END RES SEER; PERRAULT DJ, 1985, J CLIN ONCOL, V3, P546, DOI 10.1200/JCO.1985.3.4.546; POHJOLASINTONEN S, 1987, CANCER-AM CANCER SOC, V60, P31, DOI 10.1002/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO;2-D; PRENTICE RT, 1965, LANCET, V2, P388; Reinders JG, 1999, RADIOTHER ONCOL, V51, P35, DOI 10.1016/S0167-8140(99)00026-2; Santoro A, 2000, J Neurosurg Sci, V44, P159; *SAS I INC, 1999, SAS ONL COMP PROGR V	39	421	445	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2831	2837		10.1001/jama.290.21.2831	http://dx.doi.org/10.1001/jama.290.21.2831			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657067	Bronze			2022-12-01	WOS:000186872800025
J	Le Marchand, L; Seifried, A; Lum-Jones, A; Donlon, T; Wilkens, LR				Le Marchand, L; Seifried, A; Lum-Jones, A; Donlon, T; Wilkens, LR			Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SQUAMOUS-CELL CARCINOMA; D1 POLYMORPHISM; GENE POLYMORPHISM; INCREASED RISK; EXPRESSION; SURVIVAL; HAWAII; HEAD; AGE	Context Cyclin D1 (CCND1) is a key cell cycle regulatory, protein, the overexpression of which is often found in human tumors and is associated with cell proliferation and poor prognosis. A common adenine-to-guanine substitution polymorphism (A870G) in the CCND1 gene results in an altered messenger RNA transcript and a longer-life protein, which are preferentially encoded by the A allele. Objective To test the overall and stage-specific associations of the CCND1 870A allele with colorectal cancer. Design, Setting, and Participants A population-based case-control study conducted in the multiethnic population of Hawaii between January 1, 1994, and August 31,1998, which included 504 patients with incident colorectal cancer and 624 population-based participants of Japanese, white, or Native Hawaiian origin. Participation rates were 58% for cases and 52% for controls. Main Outcome Measurement Ethnicity, gene-dosage effects, and stage (regional/ distant) and subsite (colon vs rectal) of cancer. Results The odds ratio (OR) for the CCND1 870 GA and AA genotypes compared with the GG genotype was 1.2 (95% confidence interval [01, 0.9-1.7) and 1.5 (95% Cl, 1.0-2.1), respectively (P=.03 for gene-dosage effect). These risk estimates were significantly greater for patients diagnosed at a regional or distant stage (GA vs GG: OR, 1.7; 95% Cl, 1.1 -2.5 and AA vs GG: OR, 1.9; 95% Cl, 1.2-3.1; P=.008 for gene-dosage effect) compared with those estimates for patients diagnosed at an earlier stage (P=.048). In subset analyses, the association between the A allele and advanced colorectal cancer was statistically significant in white and Hawaiian participants but not in Japanese, and was stronger for rectal cancer. Conclusion The CCND1 870A allele may be Associated with colorectal cancer, and particularly with forms of the disease that result in severe morbidity and mortality.	Univ Hawaii, Canc Res Ctr Hawaii, Etiol Program, Honolulu, HI 96813 USA	Cancer Research Center of Hawaii; University of Hawaii System	Le Marchand, L (corresponding author), Univ Hawaii, Canc Res Ctr Hawaii, Etiol Program, 1236 Lauhala St,Suite 407, Honolulu, HI 96813 USA.				NCI NIH HHS [CA72520, R01 CA60987, N01-CN55424] Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA072520, R01CA060987] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 1997, CANCER RES, V57, P1569; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bala S, 2001, CANCER RES, V61, P6042; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Holley SL, 2001, AM J PATHOL, V159, P1917, DOI 10.1016/S0002-9440(10)63038-6; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Izzo JG, 2003, JNCI-J NATL CANCER I, V95, P198, DOI 10.1093/jnci/95.3.198; Kong SM, 2001, JNCI-J NATL CANCER I, V93, P1106, DOI 10.1093/jnci/93.14.1106; Kong SM, 2000, CANCER RES, V60, P249; Le Marchand L, 2002, JNCI-J NATL CANCER I, V94, P454, DOI 10.1093/jnci/94.6.454; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P1259; Maohua Le, 2002, Smarandache Notions Journal, V13, P239; McKay JA, 2000, INT J CANCER, V88, P77, DOI 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; OYAMA N, 1986, 54 HAW STAT DEP HLTH; Pagano IS, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-5; Porter TR, 2002, ONCOGENE, V21, P1928, DOI 10.1038/sj.onc.1205245; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Wang LZ, 2002, CARCINOGENESIS, V23, P257, DOI 10.1093/carcin/23.2.257; WEGNER EL, 1982, CANCER, V49, P2208, DOI 10.1002/1097-0142(19820515)49:10<2208::AID-CNCR2820491038>3.0.CO;2-6; Zheng YX, 2001, CARCINOGENESIS, V22, P1195, DOI 10.1093/carcin/22.8.1195	21	80	81	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2843	2848						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657069	Bronze			2022-12-01	WOS:000186872800027
J	Wehr, M; Zador, AM				Wehr, M; Zador, AM			Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex	NATURE			English	Article							VISUAL CORTICAL-NEURONS; DIRECTION SELECTIVITY; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; SIMPLE CELLS; IN-VIVO; CAT; INPUT; ORIENTATION; SENSITIVITY	Neurons in the primary auditory cortex are tuned to the intensity and specific frequencies of sounds, but the synaptic mechanisms underlying this tuning remain uncertain. Inhibition seems to have a functional role in the formation of cortical receptive fields, because stimuli often suppress similar or neighbouring responses(1-3), and pharmacological blockade of inhibition broadens tuning curves(4,5). Here we use whole-cell recordings in vivo to disentangle the roles of excitatory and inhibitory activity in the tone-evoked responses of single neurons in the auditory cortex. The excitatory and inhibitory receptive fields cover almost exactly the same areas, in contrast to the predictions of classical lateral inhibition models. Thus, although inhibition is typically as strong as excitation, it is not necessary to establish tuning, even in the receptive field surround. However, inhibition and excitation occurred in a precise and stereotyped temporal sequence: an initial barrage of excitatory input was rapidly quenched by inhibition, truncating the spiking response within a few (1-4) milliseconds. Balanced inhibition might thus serve to increase the temporal precision(6) and thereby reduce the randomness of cortical operation, rather than to increase noise as has been proposed previously(7).	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Zador, Anthony/0000-0002-8431-9136				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen QC, 2000, HEARING RES, V150, P161, DOI 10.1016/S0378-5955(00)00197-0; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Covey E, 1996, J NEUROSCI, V16, P3009; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; DeWeese MR, 2003, J NEUROSCI, V23, P7940; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; MITANI A, 1985, J COMP NEUROL, V235, P417, DOI 10.1002/cne.902350402; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; PHILLIPS DP, 1988, J NEUROPHYSIOL, V59, P1524, DOI 10.1152/jn.1988.59.5.1524; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; VOLKOV IO, 1992, EXP BRAIN RES, V91, P115; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	30	973	983	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					442	446		10.1038/nature02116	http://dx.doi.org/10.1038/nature02116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647382				2022-12-01	WOS:000186800800038
J	Lynch, M; Conery, JS				Lynch, M; Conery, JS			The origins of genome complexity	SCIENCE			English	Article							DUPLICATE GENES; INTRON; EVOLUTION; SIZE; RECOMBINATION; PRESERVATION; COMMUNITIES; DROSOPHILA; MUTATION; DENSITY	Complete genomic sequences from diverse phylogenetic lineages reveal notable increases in genome complexity from prokaryotes to multicellular eukaryotes. The changes include gradual increases in gene number, resulting from the retention of duplicate genes, and more abrupt increases in the abundance of spliceosomal introns and mobile genetic elements. We argue that many of these modi. cations emerged passively in response to the long-term population-size reductions that accompanied increases in organism size. According to this model, much of the restructuring of eukaryotic genomes was initiated by nonadaptive processes, and this in turn provided novel substrates for the secondary evolution of phenotypic complexity by natural selection. The enormous long-term effective population sizes of prokaryotes may impose a substantial barrier to the evolution of complex genomes and morphologies.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA	Indiana University System; Indiana University Bloomington; University of Oregon	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.							Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Charlesworth B., 1985, POPULATION GENETICS, P213; Comeron JM, 2000, GENETICS, V156, P1175; CRAIG NL, 2002, MOBILE DNA, V2; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Drake JW, 1998, GENETICS, V148, P1667; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Force A, 1999, GENETICS, V151, P1531; Gillespie J.H., 1991, CAUSES MOL EVOLUTION; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Kimura M., 1983, NEUTRAL THEORY MOL E; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Schmid PE, 2000, SCIENCE, V289, P1557, DOI 10.1126/science.289.5484.1557; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561	30	1107	1129	4	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1401	1404		10.1126/science.1089370	http://dx.doi.org/10.1126/science.1089370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631042				2022-12-01	WOS:000186683500054
J	Ravizza, G; Peucker-Ehrenbrink, B				Ravizza, G; Peucker-Ehrenbrink, B			Chemostratigraphic evidence of Deccan volcanism from the marine osmium isotope record	SCIENCE			English	Article							GLOBAL CLIMATE; TRAPS; AGE; GEOCHEMISTRY; INFERENCES; DURATION; ROCKS	Continental flood basalt (CFB) volcanism is hypothesized to have played a causative role in global climate change and mass extinctions. Uncertainties associated with radiometric dating preclude a clear chronological assessment of the environmental consequences of CFB volcanism. Our results document a 25% decline in the marine Os-187/Os-188 record that predates the Cretaceous-Tertiary boundary (KTB) and coincides with late Maastrichtian warming. We argue that this decline provides a chemostratigraphic marker of Deccan volcanism and thus constitutes compelling evidence that the main environmental consequence of Deccan volcanism was a transient global warming event of 3degrees to 5degreesC that is fully resolved from the KTB mass extinction.	Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	University of Hawaii System; Woods Hole Oceanographic Institution	Ravizza, G (corresponding author), Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA.	ravizza@hawaii.edu	Ravizza, Greg/J-5104-2013	Peucker-Ehrenbrink, Bernhard/0000-0002-3819-992X				Allegre CJ, 1999, EARTH PLANET SC LETT, V170, P197, DOI 10.1016/S0012-821X(99)00110-7; Banerjee AC, 2000, J GEOL SOC INDIA, V56, P625; Barrera E, 1999, GEOL S AM S, P245; CALDEIRA K, 1990, GEOPHYS RES LETT, V17, P1299, DOI 10.1029/GL017i009p01299; Cohen AS, 2002, GEOLOGY, V30, P267, DOI 10.1130/0091-7613(2002)030<0267:NGEFTO>2.0.CO;2; Courtillot V, 2000, EARTH PLANET SC LETT, V182, P137, DOI 10.1016/S0012-821X(00)00238-7; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Dessert C, 2001, EARTH PLANET SC LETT, V188, P459, DOI 10.1016/S0012-821X(01)00317-X; Hassler DR, 2000, CHEM GEOL, V166, P1, DOI 10.1016/S0009-2541(99)00180-1; Hicks JF, 2002, GEOL S AM S, P35; Hofmann C, 2000, EARTH PLANET SC LETT, V180, P13, DOI 10.1016/S0012-821X(00)00159-X; KYTE FT, 1993, GEOCHIM COSMOCHIM AC, V57, P1719, DOI 10.1016/0016-7037(93)90109-A; Li LQ, 1999, MAR GEOL, V161, P171, DOI 10.1016/S0025-3227(99)00078-X; Li LQ, 1998, GEOLOGY, V26, P995, DOI 10.1130/0091-7613(1998)026<0995:ADSWAT>2.3.CO;2; Mahoney JJ, 2002, EARTH PLANET SC LETT, V203, P295, DOI 10.1016/S0012-821X(02)00840-3; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Mukhopadhyay S, 2001, GEOCHIM COSMOCHIM AC, V65, P653, DOI 10.1016/S0016-7037(00)00555-X; Nordt L, 2002, GEOLOGY, V30, P703, DOI 10.1130/0091-7613(2002)030<0703:PBIEFI>2.0.CO;2; Olsson RK, 2001, J FORAMIN RES, V31, P275, DOI 10.2113/31.3.275; Pande K, 2002, P INDIAN AS-EARTH, V111, P115, DOI 10.1007/BF02981139; Pegram WJ, 1999, GEOCHIM COSMOCHIM AC, V63, P4053, DOI 10.1016/S0016-7037(99)00308-7; Peucker-Ehrenbrink B, 2000, TERRA NOVA, V12, P205, DOI 10.1046/j.1365-3121.2000.00295.x; Ravizza G, 2001, PALEOCEANOGRAPHY, V16, P155, DOI 10.1029/2000PA000541; SUGARMAN PJ, 1995, GEOL SOC AM BULL, V107, P19, DOI 10.1130/0016-7606(1995)107<0019:UCMSIB>2.3.CO;2; Taylor AS, 1999, CHEM GEOL, V161, P199, DOI 10.1016/S0009-2541(99)00087-X; Vonhof HB, 1997, GEOLOGY, V25, P347, DOI 10.1130/0091-7613(1997)025<0347:HRLMED>2.3.CO;2; WARNER TB, 1974, INITIAL REPORTS DEEP, V25, P395; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Zachos JC, 1986, PALEOCEANOGRAPHY, V1, P5, DOI 10.1029/PA001i001p00005	30	119	127	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1392	1395		10.1126/science.1089209	http://dx.doi.org/10.1126/science.1089209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631039				2022-12-01	WOS:000186683500051
J	Lee, DS; Austin, PC; Rouleau, JL; Liu, PP; Naimark, D; Tu, JV				Lee, DS; Austin, PC; Rouleau, JL; Liu, PP; Naimark, D; Tu, JV			Predicting mortality among patients hospitalized for heart failure - Derivation and validation of a clinical model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOGISTIC-REGRESSION ANALYSIS; ACUTE MYOCARDIAL-INFARCTION; CARDIAC-SURGERY; CARE; COMMUNITY; RULES; INDEX; PROGNOSIS; SURVIVAL; MULTICENTER	Context A predictive model of mortality in heart failure may be useful for clinicians to improve communication with and care of hospitalized patients. Objectives To identify predictors of mortality and to develop and to validate a model using information available at hospital presentation. Design, Setting, and Participants Retrospective study of 4031 community-based patients presenting with heart failure at multiple hospitals in Ontario, Canada (2624 patients in the derivation cohort from 1999-2001 and 1407 patients in the validation cohort from 1997-1999), who had been identitifed as part of the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study. Main Outcome Measures All-cause 30-day and 1-year mortality. Results The mortality rates for the derivation cohort and validation cohort, respectively, were 8.9% and 8.2% in hospital, 10.7% and 10.4% at 30 days, and 32.9% and 30.5% at 1 year. Multivariable predictors of mortality at both 30 days and 1 year included older age, lower systolic blood pressure, higher respiratory rate, higher urea nitrogen level (all P<.001), and hyponatremia (P<.01). Comorbid conditions associated with mortality included cerebrovascular disease (30-day mortality odds ratio [OR], 1.43; 95% confidence interval [CI], 1.03-1.98; P=.03), chronic obstructive pulmonary disease (OR, 1.66; 95 % CI, 1.22-2.27; P=.002), hepatic cirrhosis (OR, 3.22; 95% CI, 1.08-9.65; P=.04), dementia (OR, 2.54; 95% CI, 1.77-3.65; P<.001), and cancer (OR, 1.86; 95% CI, 1.28-2.70; P=.001). A risk index stratified the risk of death and identified low- and high-risk individuals. Patients with very low-risk scores (:560) had a mortality rate of 0.4% at 30 days and 7.8% at 1 year. Patients with very high-risk scores (>150) had a mortality rate of 59.0% at 30 days and 78.8% at 1 year. Patients with higher 1-year risk scores had reduced survival at all times up to 1 year (log-rank, P<.001). For the derivation cohort, the area under the receiver operating characteristic curve for the model was 0.80 for 30-day mortality and 0.77 for 1-year mortality. Predicted mortality rates in the validation cohort closely matched observed rates across the entire spectrum of risk. Conclusions Among community-based heart failure patients, factors identifiable Within hours of hospital presentation predicted mortality risk at 30 days and 1 year. The externally validated predictive index may assist clinicians in estimating heart failure mortality risk and in providing quantitative guidance for decision making in heart failure care.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto Gen Hosp, Toronto, ON M5G 1L7, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Hlth Policy, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Management, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Evaluat Clin Epidemiol, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Publ Hlth Sci, Toronto, ON, Canada; Mt Sinai Hosp, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1X5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Tu, JV (corresponding author), Inst Clin Evaluat Sci, Room G-106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	tu@ices.on.ca		Lee, Douglas/0000-0001-7078-745X; Tu, Jack/0000-0003-0111-722X; Austin, Peter/0000-0003-3337-233X; Naimark, David Malcolm Joseph/0000-0002-0621-0637				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; Cleland JGF, 2002, LANCET, V360, P1631, DOI 10.1016/S0140-6736(02)11601-1; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Efron B., 1998, INTRO BOOTSTRAP; Eichhorn Eric J., 2001, American Journal of Medicine, V110, p14S; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fried Terri R, 2003, J Palliat Med, V6, P237, DOI 10.1089/109662103764978489; GOLDBERGER JJ, 1986, ARCH INTERN MED, V146, P489, DOI 10.1001/archinte.146.3.489; Graff L, 1999, ANN EMERG MED, V34, P429, DOI 10.1016/S0196-0644(99)80043-2; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hanratty B, 2002, BRIT MED J, V325, P581, DOI 10.1136/bmj.325.7364.581; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; KEELER EB, 1990, JAMA-J AM MED ASSOC, V264, P1962, DOI 10.1001/jama.264.15.1962; KONSTAM M, 2001, 940612 AHCPR; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lee DS, 2003, CAN J CARDIOL, V19, P357; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Polanczyk CA, 1998, MED CARE, V36, P1489, DOI 10.1097/00005650-199810000-00007; Poses RM, 2000, ANN INTERN MED, V133, P10, DOI 10.7326/0003-4819-133-1-200007040-00003; Reilly BM, 2002, JAMA-J AM MED ASSOC, V288, P342, DOI 10.1001/jama.288.3.342; Rosenthal GE, 2000, HEALTH SERV RES, V34, P1449; Seamark DA, 2002, PALLIATIVE MED, V16, P495, DOI 10.1191/0269216302pm596oa; SELKER HP, 1994, MED CARE, V32, P1040, DOI 10.1097/00005650-199410000-00005; Senni M, 1999, J AM COLL CARDIOL, V33, P164, DOI 10.1016/S0735-1097(98)00523-3; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Sharpe N, 1998, PROG CARDIOVASC DIS, V41, P73, DOI 10.1016/S0033-0620(98)80034-0; Southard P, 1989, J Emerg Nurs, V15, P393; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV, 1997, J CLIN EPIDEMIOL, V50, P743, DOI 10.1016/S0895-4356(97)89028-2; TU JV, 1994, CAN MED ASSOC J, V151, P177; TU JV, 1995, CIRCULATION, V91, P677, DOI 10.1161/01.CIR.91.3.677; TU JV, 1999, CARDIOVASCULAR HLTH, P111; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Zannad F, 1999, J AM COLL CARDIOL, V33, P734, DOI 10.1016/S0735-1097(98)00634-2	53	998	1051	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2581	2587		10.1001/jama.290.19.2581	http://dx.doi.org/10.1001/jama.290.19.2581			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744DQ	14625335	Bronze			2022-12-01	WOS:000186613000028
J	Sedkov, Y; Cho, E; Petruk, S; Cherbas, L; Smith, ST; Jones, RS; Cherbas, P; Canaani, E; Jaynes, JB; Mazo, A				Sedkov, Y; Cho, E; Petruk, S; Cherbas, L; Smith, ST; Jones, RS; Cherbas, P; Canaani, E; Jaynes, JB; Mazo, A			Methylation at lysine 4 of histone H3 in ecdysone-dependent development of Drosophila	NATURE			English	Article							MORPHOGENETIC FURROW MOVEMENT; POLARITY GENE HEDGEHOG; RETINOID-X-RECEPTOR; NUCLEAR RECEPTOR; ULTRASPIRACLE; PROTEIN; EYE; ECR; PROGRESSION; ENCODES	Steroid hormones fulfil important functions in animal development. In Drosophila, ecdysone triggers moulting and metamorphosis through its effects on gene expression(1). Ecdysone works by binding to a nuclear receptor, EcR, which heterodimerizes with the retinoid X receptor homologue Ultraspiracle(2,3). Both partners are required for binding to ligand or DNA(4-6). Like most DNA-binding transcription factors, nuclear receptors activate or repress gene expression by recruiting co-regulators, some of which function as chromatin-modifying complexes(7,8). For example, p160 class coactivators associate with histone acetyltransferases and arginine histone methyltransferases(9). The Trithorax-related gene of Drosophila encodes the SET domain protein TRR. Here we report that TRR is a histone methyltransferases capable of trimethylating lysine 4 of histone H3 (H3-K4). trr acts upstream of hedgehog (hh) in progression of the morphogenetic furrow, and is required for retinal differentiation. Mutations in trr interact in eye development with EcR, and EcR and TRR can be co-immunoprecipitated on ecdysone treatment. TRR, EcR and trimethylated H3-K4 are detected at the ecdysone-inducible promoters of hh and BR-C in cultured cells, and H3-K4 trimethylation at these promoters is decreased in embryos lacking a functional copy of trr. We propose that TRR functions as a coactivator of EcR by altering the chromatin structure at ecdysone-responsive promoters.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Indiana University System; Indiana University Bloomington; Southern Methodist University; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.			Jaynes, James/0000-0001-7943-794X	NIGMS NIH HHS [R01 GM050231-05A2, R01 GM050231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chanut F, 2000, GENETICS, V156, P1203; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Ghbeish N, 2002, MECH DEVELOP, V111, P89, DOI 10.1016/S0925-4773(01)00610-4; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sedkov Y, 1999, MECH DEVELOP, V82, P171, DOI 10.1016/S0925-4773(98)00246-9; SMITH ST, UNPUB NATURE CELL BI; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zelhof AC, 1997, DEVELOPMENT, V124, P2499	29	126	136	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					78	83		10.1038/nature02080	http://dx.doi.org/10.1038/nature02080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603321	Green Accepted			2022-12-01	WOS:000186370800045
J	Orlova, M; Yueh, A; Leung, J; Goff, SP				Orlova, M; Yueh, A; Leung, J; Goff, SP			Reverse transcriptase of Moloney murine leukemia virus binds to eukarvotic release factor 1 to modulate suppression of translational termination	CELL			English	Article							STOP CODON RECOGNITION; PEPTIDYL-TRANSFER-RNA; POL FUSION PROTEIN; GENE AMBER CODON; MESSENGER-RNA; DNA-POLYMERASE; READ-THROUGH; FACTOR ERF1; PRECURSOR POLYPROTEINS; MUTATIONAL ANALYSIS	The pol (for polymerase) gene of the murine leukemia viruses (MuLVs) is expressed in the form of a large Gag-Pol precursor protein by the suppression of translational termination, or enhanced readthrough, of a UAG stop codon at the end of gag. A search for cellular proteins that interact with the reverse transcriptase of Moloney MuLV resulted in the identification of eRF1, the eukaryotic translation release factor 1. The proteins bound strongly in vitro, and the overexpression of eRF1 resulted in the RT-dependent incorporation of the protein into assembling virion particles. The overexpression of RT in trans enhanced the translational readthrough of a reporter construct containing the Gag-Pol boundary region. Noninteracting mutants of RT failed to synthesize adequate levels of Gag-Pol and could not replicate. These results suggest that RT enhances suppression of termination and that the interaction of RT with eRF1 is required for an appropriate level of translational readthrough.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Integrated Program Cell & Mol Biol, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Integrated Program Cell & Mol Biol, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	goff@cancercenter.columbia.edu	Goff, Stephen P/K-6337-2014; Yueh, Andrew/D-2079-2010	Goff, Stephen P/0000-0003-0693-5547; 	NATIONAL CANCER INSTITUTE [R37CA030488, R01CA030488] Funding Source: NIH RePORTER; NCI NIH HHS [CA30488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alam SL, 1999, J MOL BIOL, V288, P837, DOI 10.1006/jmbi.1999.2713; Alderete JP, 2001, J VIROL, V75, P7188, DOI 10.1128/JVI.75.15.7188-7192.2001; ATKINS JF, 1990, CELL, V62, P413, DOI 10.1016/0092-8674(90)90007-2; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; BERTEAUX V, 1991, BIOCHIMIE, V73, P1291, DOI 10.1016/0300-9084(91)90091-E; Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; BLAIN SW, 1993, J BIOL CHEM, V268, P23585; Carnes J, 2000, RNA, V6, P1468, DOI 10.1017/S1355838200001242; COLICELLI J, 1988, J MOL BIOL, V199, P47, DOI 10.1016/0022-2836(88)90378-6; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; Drugeon G, 1997, NUCLEIC ACIDS RES, V25, P2254, DOI 10.1093/nar/25.12.2254; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; FELSENSTEIN KM, 1992, J VIROL, V66, P6601, DOI 10.1128/JVI.66.11.6601-6608.1992; FENG YX, 1989, J VIROL, V63, P2870, DOI 10.1128/JVI.63.6.2870-2873.1989; FENG YX, 1989, J VIROL, V63, P2405, DOI 10.1128/JVI.63.5.2405-2410.1989; FENG YX, 1992, J VIROL, V66, P5127, DOI 10.1128/JVI.66.8.5127-5132.1992; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; Grentzmann G, 1998, RNA, V4, P479; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HATFIELD DL, 1992, ADV VIRUS RES, V41, P193, DOI 10.1016/S0065-3527(08)60037-8; HONIGMAN A, 1991, VIROLOGY, V183, P313, DOI 10.1016/0042-6822(91)90144-Z; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; JAMJOOM GA, 1977, VIROLOGY, V78, P11, DOI 10.1016/0042-6822(77)90075-7; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; JONES DS, 1989, NUCLEIC ACIDS RES, V17, P5933, DOI 10.1093/nar/17.15.5933; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; KUCHINO Y, 1987, P NATL ACAD SCI USA, V84, P2668, DOI 10.1073/pnas.84.9.2668; LeGoff X, 1997, MOL CELL BIOL, V17, P3164, DOI 10.1128/MCB.17.6.3164; Leung DW, 1989, TECHNIQUE, V1, P11; Levin J. G., 1993, REVERSE TRANSCRIPTAS, P5; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; MURPHY EC, 1978, VIROLOGY, V86, P329, DOI 10.1016/0042-6822(78)90074-0; MURPHY EC, 1978, J VIROL, V13, P359; PANET A, 1975, P NATL ACAD SCI USA, V72, P2535, DOI 10.1073/pnas.72.7.2535; PANET A, 1978, J VIROL, V26, P214, DOI 10.1128/JVI.26.2.214-220.1978; PANGANIBAN AT, 1988, J VIROL, V62, P3574, DOI 10.1128/JVI.62.10.3574-3580.1988; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; SKALKA A, 1993, REVERSE TRANSCRIPTAS; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Stansfield I, 1996, MOL MICROBIOL, V20, P1135, DOI 10.1111/j.1365-2958.1996.tb02634.x; Tachedjian G, 2000, P NATL ACAD SCI USA, V97, P6334, DOI 10.1073/pnas.97.12.6334; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; TELESNITSKY A, 1993, EMBO J, V12, P4433, DOI 10.1002/j.1460-2075.1993.tb06128.x; Telesnitsky A., 1997, P121; TENDAM EB, 1990, VIRUS GENES, V2, P121; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; YOSHINAKA Y, 1985, P NATL ACAD SCI USA, V82, P1618, DOI 10.1073/pnas.82.6.1618; YOSHINAKA Y, 1985, J VIROL, V55, P870, DOI 10.1128/JVI.55.3.870-873.1985; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	64	49	54	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					319	331		10.1016/S0092-8674(03)00805-5	http://dx.doi.org/10.1016/S0092-8674(03)00805-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636559	Bronze			2022-12-01	WOS:000186415000011
J	Ying, QL; Nichols, J; Chambers, I; Smith, A				Ying, QL; Nichols, J; Chambers, I; Smith, A			BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3	CELL			English	Article							BONE MORPHOGENETIC PROTEIN-4; SIGNAL-TRANSDUCTION; NEURAL FATE; ES CELLS; ACTIVATION; EXPRESSION; PATHWAY; NEUROGENESIS; RECEPTOR; LINE	The cytokine leukemia inhibitory factor (LIF) drives self-renewal of mouse embryonic stem (ES) cells by activating the transcription factor STAT3. In serum-free cultures, however, LIF is insufficient to block neural differentiation and maintain pluripotency. Here, we report that bone morphogenetic proteins (BMPs) act in combination with LIF to sustain self-renewal and preserve multilineage differentiation, chimera colonization, and germline transmission properties. ES cells can be propagated from single cells and derived de novo without serum or feeders using LIF plus BMP. The critical contribution of BMP is to induce expression of Id genes via the Smad pathway. Forced expression of Id liberates ES cells from BMP or serum dependence and allows self-renewal in LIF alone. Upon LIF withdrawal, Id-expressing ES cells differentiate but do not give rise to neural lineages. We conclude that blockade of lineage-specific transcription factors by Id proteins enables the self-renewal response to LIF/STAT3.	Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh	Ying, QL (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	qilong.ying@ed.ac.uk; austin.smith@ed.ac.uk		Nichols, Jennifer/0000-0002-8650-1388; Chambers, Ian/0000-0003-2605-1597; Smith, Austin/0000-0002-3029-4682				Adelman CA, 2002, DEVELOPMENT, V129, P539; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baonza A, 2000, DEVELOPMENT, V127, P2383; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Benezra R, 2001, TRENDS CARDIOVAS MED, V11, P237, DOI 10.1016/S1050-1738(01)00117-7; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 1997, FEBS LETT, V401, P49, DOI 10.1016/S0014-5793(96)01430-5; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nishinakamura R, 1999, DEV BIOL, V216, P481, DOI 10.1006/dbio.1999.9518; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Norton JD, 2000, J CELL SCI, V113, P3897; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Ying QL, 2003, METHOD ENZYMOL, V365, P327	62	1577	1745	4	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					281	292		10.1016/S0092-8674(03)00847-X	http://dx.doi.org/10.1016/S0092-8674(03)00847-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636556	Bronze			2022-12-01	WOS:000186415000008
J	Talbot, L				Talbot, L			"Failed back surgery syndrome"	BRITISH MEDICAL JOURNAL			English	Article								An inappropriate diagnostic label may exacerbate the discomfort of patients who develop persistent and disabling symptoms after back surgery.										HELTHOFF KB, 1985, ORTHOP CLIN N AM, V16, P417; Porter RW, 1997, J ROY COLL SURG EDIN, V42, P376; RESNICK D, MEDCYCLOPAEDIA	3	26	30	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2003	327	7421					985	986		10.1136/bmj.327.7421.985	http://dx.doi.org/10.1136/bmj.327.7421.985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	736AL	14576254	Green Published			2022-12-01	WOS:000186147800024
J	Mazumder, B; Sampath, P; Seshadri, V; Maitra, RK; DiCorleto, PE; Fox, PL				Mazumder, B; Sampath, P; Seshadri, V; Maitra, RK; DiCorleto, PE; Fox, PL			Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control	CELL			English	Article							BINDING-PROTEIN; MESSENGER-RNAS; TYROSINE PHOSPHORYLATION; TRANSPLANTATION ANTIGEN; GAMMA-INTERFERON; CERULOPLASMIN; YEAST; EXPRESSION; COMPLEX; GENE	Transcript-specific translational control is generally directed by binding of trans-acting proteins to structural elements in the untranslated region (UTR) of the target mRNA. Here, we elucidate a translational silencing mechanism involving regulated release of an integral ribosomal protein and subsequent binding to its target mRNA. Human ribosomal protein L13a was identified as a candidate interferon-Gamma-Activated Inhibitor of Translation (GAIT) of ceruloplasmin (Cp) mRNA by a genetic screen for Cp 3' -UTR binding proteins. In vitro activity of L13a was shown by inhibition of target mRNA translation by recombinant protein. In response to interferon-gamma in vivo, the entire cellular pool of L13a was phosphorylated and released from the 60S ribosomal subunit. Released L13a specifically bound the 3'-UTR GAIT element of Cp mRNA and silenced translation. We propose a model in which the ribosome functions not only as a protein synthesis machine, but also as a depot for regulatory proteins that modulate translation.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Virus Core Facil, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Biol, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Fox, PL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org		Mazumder, Barsanjit/0000-0003-3069-7833	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067725, P01HL029582] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL67725, HL29582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnold RJ, 1999, J BIOL CHEM, V274, P37035, DOI 10.1074/jbc.274.52.37035; Ballesta JPG, 1999, FEMS MICROBIOL REV, V23, P537, DOI 10.1111/j.1574-6976.1999.tb00412.x; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; CAMPOS F, 1990, BIOCHIM BIOPHYS ACTA, V1087, P142, DOI 10.1016/0167-4781(90)90198-B; CHAN YL, 1994, J BIOL CHEM, V269, P5589; Diaz JJ, 2002, J CHROMATOGR B, V771, P237, DOI 10.1016/S1570-0232(02)00038-7; Dominski Z, 2002, MOL CELL BIOL, V22, P6648, DOI 10.1128/MCB.22.18.6648-6660.2002; Ehrenwald E, 1996, J CLIN INVEST, V97, P884, DOI 10.1172/JCI118491; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FLEMING RE, 1991, AM J PHYSIOL, V260, pL68, DOI 10.1152/ajplung.1991.260.2.L68; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kirkpatrick P, 2002, NAT REV DRUG DISCOV, V1, P99, DOI 10.1038/nrd738; KLEBANOFF SJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P302, DOI 10.1016/0003-9861(92)90522-X; Kritzik MR, 2000, J ENDOCRINOL, V165, P67, DOI 10.1677/joe.0.1650067; Law LMJ, 2003, J VIROL, V77, P1764, DOI 10.1128/JVI.77.3.1764-1771.2003; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; Li J, 2001, J IMMUNOL, V166, P432, DOI 10.4049/jimmunol.166.1.432; Li JX, 2002, NATURE, V418, P793, DOI 10.1038/nature00936; MADEN BEH, 1968, J MOL BIOL, V35, P333, DOI 10.1016/S0022-2836(68)80028-2; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; MARZOUKI A, 1990, BIOCHIM BIOPHYS ACTA, V1048, P238, DOI 10.1016/0167-4781(90)90062-7; MASSE T, 1990, MOL GEN GENET, V220, P377, DOI 10.1007/BF00391742; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Mazumder B, 1997, J IMMUNOL, V159, P1938; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Mezzetti A, 1999, ARTERIOSCL THROM VAS, V19, P2659, DOI 10.1161/01.ATV.19.11.2659; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Mukhopadhyay CK, 1997, P NATL ACAD SCI USA, V94, P11546, DOI 10.1073/pnas.94.21.11546; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; PRICE SR, 1992, GENOMICS, V14, P959, DOI 10.1016/S0888-7543(05)80117-X; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; SAENZROBLES MT, 1988, EUR J BIOCHEM, V177, P531, DOI 10.1111/j.1432-1033.1988.tb14405.x; SALONEN JT, 1991, BRIT MED J, V302, P756, DOI 10.1136/bmj.302.6779.756; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; SIBILLE C, 1990, J EXP MED, V172, P35, DOI 10.1084/jem.172.1.35; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Vilardell J, 2000, MOL CELL, V5, P761, DOI 10.1016/S1097-2765(00)80255-5; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; WOOL IG, 1996, TRANSLATIONAL CONTRO, P481; WORMINGTON M, 1991, METHOD CELL BIOL, V36, P167; Yoo JY, 1999, GENE, V229, P215, DOI 10.1016/S0378-1119(98)00604-0; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171	62	246	263	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2003	115	2					187	198		10.1016/S0092-8674(03)00773-6	http://dx.doi.org/10.1016/S0092-8674(03)00773-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567916	Bronze, Green Submitted			2022-12-01	WOS:000186039200010
J	Sawaya, GF; McConnell, KJ; Kulasingam, SL; Lawson, HW; Kerlikowske, K; Melnikow, J; Lee, NC; Gildengorin, G; Myers, ER; Washington, AE				Sawaya, GF; McConnell, KJ; Kulasingam, SL; Lawson, HW; Kerlikowske, K; Melnikow, J; Lee, NC; Gildengorin, G; Myers, ER; Washington, AE			Risk of cervical cancer associated with extending the interval between cervical-cancer screenings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATURAL-HISTORY; PAPILLOMAVIRUS INFECTION; RANDOMIZED TRIAL; COSTA-RICA; WOMEN; ABNORMALITIES; CYTOLOGY; GUIDELINES; MANAGEMENT; NEOPLASIA	BACKGROUND: Although contemporary guidelines suggest that the intervals between Papanicolaou tests can be extended to three years among low-risk women with previous negative tests, the excess risk of cervical cancer associated with less frequent than annual screening is uncertain. METHODS: We determined the prevalence of biopsy-proven cervical neoplasia among 938,576 women younger than 65 years of age, stratified according to the number of previous consecutive negative Papanicolaou tests. Using a Markov model that estimates the rate at which dysplasia will progress to cancer, we estimated the risk of cancer within three years after one or more negative Papanicolaou tests, as well as the number of additional Papanicolaou tests and colposcopic examinations that would be required to avert one case of cancer given a particular interval between screenings. RESULTS: Among 31,728 women 30 to 64 years of age who had had three or more consecutive negative tests, the prevalence of biopsy-proven cervical intraepithelial neoplasia of grade 2 was 0.028 percent and the prevalence of grade 3 neoplasia was 0.019 percent; none of the women had invasive cervical cancer. According to our model, the estimated risk of cancer with annual Papanicolaou tests for three years was 2 in 100,000 among women 30 to 44 years of age, 1 in 100,000 among women 45 to 59 years of age, and 1 in 100,000 among women 60 to 64 years of age; these risks would be 5 in 100,000, 2 in 100,000, and 1 in 100,000, respectively, if screening were performed once three years after the last negative test. To avert one additional case of cancer by screening 100,000 women annually for three years rather than once three years after the last negative test, an average of 69,665 additional Papanicolaou tests and 3861 colposcopic examinations would be needed in women 30 to 44 years of age and an average of 209,324 additional Papanicolaou tests and 11,502 colposcopic examinations in women 45 to 59 years of age. CONCLUSIONS: As compared with annual screening for three years, screening performed once three years after the last negative test in women 30 to 64 years of age who have had three or more consecutive negative Papanicolaou tests is associated with an average excess risk of cervical cancer of approximately 3 in 100,000.	Dept Vet Affairs, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94121 USA; Dept Vet Affairs, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA; Dept Vet Affairs, Dept Med, San Francisco, CA 94121 USA; Dept Vet Affairs, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Oregon Hlth Sci Univ, Dept Emergency Med Publ Hlth & Prevent Med, Portland, OR 97201 USA; Duke Univ, Dept Obstet & Gynecol, Durham, NC 27710 USA; Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA	University of California System; University of California San Francisco; Oregon Health & Science University; Duke University; Centers for Disease Control & Prevention - USA; University of California System; University of California Davis	Sawaya, GF (corresponding author), Dept Vet Affairs, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94121 USA.			Kulasingam, Shalini/0000-0002-0932-9166	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS007373] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA074973] Funding Source: NIH RePORTER; AHRQ HHS [HS07373] Funding Source: Medline; NCI NIH HHS [K08 CA 74973-02] Funding Source: Medline; PHS HHS [282-98-0026] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AG HLTH CAR POL R, 1999, AHCPR PUBL; BEARMAN DM, 1987, OBSTET GYNECOL, V69, P660; Belinson J, 2002, GYNECOL ONCOL, V84, P355, DOI 10.1006/gyno.2001.6554; CHAN PG, IN PRESS OBSTET GYNE; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; DEVESA SS, 1989, CANCER, V64, P2184, DOI 10.1002/1097-0142(19891115)64:10<2184::AID-CNCR2820641034>3.0.CO;2-8; Duggan MA, 1998, EUR J GYNAECOL ONCOL, V19, P338; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; FINK DJ, 1988, CA-CANCER J CLIN, V38, P127, DOI 10.3322/canjclin.38.2.127; FLEISS JL, 1981, STATISTICAL METHODS, P64; Freeman-Wang T, 2001, BRIT J OBSTET GYNAEC, V108, P482, DOI 10.1111/j.1471-0528.2001.00121.x; Henson R M, 1996, J Public Health Manag Pract, V2, P36; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Hutchinson ML, 1999, CANCER CYTOPATHOL, V87, P48, DOI 10.1002/(SICI)1097-0142(19990425)87:2&lt;48::AID-CNCR2&gt;3.0.CO;2-D; JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; KURMAN RJ, 1994, JAMA-J AM MED ASSOC, V271, P1866, DOI 10.1001/jama.271.23.1866; Lawson HW, 1998, OBSTET GYNECOL, V92, P745, DOI 10.1016/S0029-7844(98)00257-9; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Munoz N, 1996, SEX TRANSM DIS, V23, P504, DOI 10.1097/00007435-199611000-00012; Myers ER, 2000, OBSTET GYNECOL, V96, P645, DOI 10.1016/S0029-7844(00)00979-0; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; National Institutes of Health, 1996, CERV CANC NIH CONS S; PAYNE N, 2000, LIQUID BASED CYTOLOG; PRETORIUS R, 1991, GYNECOL ONCOL, V42, P48, DOI 10.1016/0090-8258(91)90229-X; *PREV SERV TASK FO, 2003, CERV CANC SCREEN; Ries LAG, 2003, SEER CANC STAT REV 1; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Sawaya GF, 2001, NEW ENGL J MED, V344, P1603, DOI 10.1056/NEJM200105243442107; Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6; Sawaya GF, 2000, ANN INTERN MED, V133, P942, DOI 10.7326/0003-4819-133-12-200012190-00009; Sawaya GF, 2000, OBSTET GYNECOL, V96, P219, DOI 10.1016/S0029-7844(00)00882-6; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; Schwartz PE, 1996, AM J OBSTET GYNECOL, V175, P1105, DOI 10.1016/S0002-9378(96)70012-1; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Stenkvist B, 1996, J Med Screen, V3, P204; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178	45	86	107	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2003	349	16					1501	1509		10.1056/NEJMoa035419	http://dx.doi.org/10.1056/NEJMoa035419			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731ZM	14561792				2022-12-01	WOS:000185916400004
J	Ho, DG; Gao, RM; Celaje, J; Chung, HY; Selke, M				Ho, DG; Gao, RM; Celaje, J; Chung, HY; Selke, M			Phosphadioxirane: A peroxide from an ortho-substituted arylphosphine and singlet dioxygen	SCIENCE			English	Article							OXYGEN; SULFIDES; PHOSPHINES; CHEMISTRY; MECHANISM	We prepared the primary adduct for the reaction of singlet dioxygen (O-1(2)) with an arylphosphine by using the sterically hindered arylphosphine tris(omethoxyphenyl) phosphine. The resulting phosphadioxirane has a dioxygen molecule triangularly bound to the phosphorus atom. Olefin trapping experiments show that the phosphadioxirane can undergo nonradical oxygen atom-transfer reactions. Under protic conditions, two different intermediates are formed during the reaction of singlet dioxygen with tris(o-methoxyphenyl) phosphine, namely, the corresponding hydroperoxy arylphosphine and a hydroxy phosphorane. Experiments with other arylphosphines possessing different electronic and steric properties demonstrate that the relative stability of the tris(o-methoxyphenyl) phosphadioxirane is due to both steric and electronic effects.	Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Selke, M (corresponding author), Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA.	mselke@calstatela.edu			NIGMS NIH HHS [GM 64104, GM 08101] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064104] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], COMMUNICATION; BOLDUC PR, 1974, J ORG CHEM, V39, P3178; Clennan EL, 2001, ACCOUNTS CHEM RES, V34, P875, DOI 10.1021/ar0100879; EAPEN KC, 1980, J FLUORINE CHEM, V15, P239, DOI 10.1016/S0022-1139(00)82580-4; Gao RM, 2001, ORG LETT, V3, P3719, DOI 10.1021/ol010195v; GORENSTEINDG, 1984, PHOSPHORUS 31 NMR PR, P14; GU CL, 1981, J AM CHEM SOC, V103, P5949, DOI 10.1021/ja00409a073; Jensen F, 1998, J AM CHEM SOC, V120, P4439, DOI 10.1021/ja973782d; LIANG JJ, 1983, J AM CHEM SOC, V105, P4717, DOI 10.1021/ja00352a033; NAHM K, 1993, J AM CHEM SOC, V115, P4879, DOI 10.1021/ja00064a057; NAHM K, 1989, J AM CHEM SOC, V111, P909; Reynolds MS, 1996, INORG CHEM, V35, P2378, DOI 10.1021/ic951212d; TSUJI S, 1993, J ORG CHEM, V58, P5055, DOI 10.1021/jo00071a012; VONITZSTEIN M, 1983, J CHEM SOC CHEM COMM, V164	14	58	59	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					259	262		10.1126/science.1089145	http://dx.doi.org/10.1126/science.1089145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	730HT	14551430				2022-12-01	WOS:000185825900034
J	Bloom, J; Amador, V; Bartolini, F; DeMartino, G; Pagano, M				Bloom, J; Amador, V; Bartolini, F; DeMartino, G; Pagano, M			Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation	CELL			English	Article							S-PHASE; IN-VIVO; UBIQUITINATION; PROTEIN; PROGRESSION; RESIDUE; CYCLIN; P53; INHIBITOR; P21(CIP1)	We examined the mechanism responsible for the degradation of p21, a negative regulator of the cell division cycle. We found that p21 proteolysis requires functional ubiquitin and Nedd8 systems. Ubiquitinylated forms of p21 and p21(K0), a p21 mutant missing all lysines, are detected in vivo and in vitro, showing that the presence of lysines is dispensable for p21 ubiquitinylation. Instead, the free amino group of the N-terminal methionine of p21 is a site for ubiquitinylation in vivo. Although wild-type p21 is more abundantly ubiquitinylated than p21(K0) mutant due to the presence of internal lysine residues, their rates of proteolysis are indistinguishable. These results demonstrate that proteasomal degradation of p21 is regulated by the ubiquitin pathway and suggest that the site of the ubiquitin chain is critical in making p21 a competent substrate for the proteasome.	NYU, Inst Canc, New York, NY 10016 USA; NYU, Sch Med, New York, NY 10016 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	New York University; New York University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Pagano, M (corresponding author), NYU, Inst Canc, 550 1St Ave, New York, NY 10016 USA.			pagano, michele/0000-0003-3210-2442	NCI NIH HHS [R01-CA76584] Funding Source: Medline; NIGMS NIH HHS [R01-GM57587] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Cayrol C, 1998, ONCOGENE, V17, P2437, DOI 10.1038/sj.onc.1202189; Fukuchi K, 2002, BIOCHEM BIOPH RES CO, V293, P120, DOI 10.1016/S0006-291X(02)00198-5; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Maki CG, 1996, CANCER RES, V56, P2649; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; NISHIMOTO T, 1980, SOMAT CELL GENET, V6, P465, DOI 10.1007/BF01539150; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367	25	261	269	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 3	2003	115	1					71	82		10.1016/S0092-8674(03)00755-4	http://dx.doi.org/10.1016/S0092-8674(03)00755-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532004	Bronze			2022-12-01	WOS:000185815500010
J	Pretty, J				Pretty, J			Social capital and the collective management of resources	SCIENCE			English	Article								The proposition that natural resources need protection from the destructive actions of people is widely accepted. Yet communities have shown in the past and increasingly today that they can collaborate for long-term resource management. The term social capital captures the idea that social bonds and norms are critical for sustainability. Where social capital is high in formalized groups, people have the confidence to invest in collective activities, knowing that others will do so too. Some 0.4 to 0.5 million groups have been established since the early 1990s for watershed, forest, irrigation, pest, wildlife, fishery, and microfinance management. These offer a route to sustainable management and governance of common resources.	Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Pretty, J (corresponding author), Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England.	jpretty@essex.ac.uk	Pretty, Jules/D-4071-2012	Nedanov, Aleksandar/0000-0002-4238-9275; Pretty, Jules/0000-0002-3897-6581				[Anonymous], 2002, DRAMA COMMONS; Beck T, 2001, WORLD DEV, V29, P119, DOI 10.1016/S0305-750X(00)00089-9; Callicott J. Baird, 1998, GREAT NEW WILDERNESS; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; DONNELLYROARK P, 2002, GROWTH EQUITY SOCIAL; Dryzek JS., 2000, DELIBERATIVE DEMOCRA; FLORA CB, 1993, ANN AM ACAD POLIT SS, V529, P48, DOI 10.1177/0002716293529001005; Gadgil M., 1992, THIS FISSURED LAND E; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Keohane R. O., 1993, I EARTH; Krishna A., 2002, ACTIVE SOCIAL CAPITA; Murali K. S., 2002, Environmental Management and Health, V13, P512, DOI 10.1108/09566160210441807; Murali K. S., 2003, International Journal of Environment and Sustainable Development, V2, P19, DOI 10.1504/IJESD.2003.002361; Narayan D., 1997, 1796 WORLD BANK; Nash Roderick, 1973, WILDERNESS AM MIND; ORiordan T., 2002, BIODIVERSITY SUSTAIN; OSTROM E, 1990, GOVT COMMONS; Ostrom E., 2002, DRAMA COMMONS, DOI 10.17226/10287; PONTIUS J, 2001, FARMER FIELD SCH COM; Portes A., 1996, AM PROSPECT, V26, P18; Posey DA, 1999, CULTURAL SPIRITUAL V; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Pretty J., 2002, AGRICULTURE RECONNEC; Pretty JN, 2003, AGR ECOSYST ENVIRON, V95, P217, DOI 10.1016/S0167-8809(02)00087-7; Putnam R. D., 2000, BOWLING ALONE COLLAP; Putnam Robert D., 1994, MAKING DEMOCRACY WOR; SINGLETON S, 1992, J THEORETICAL POLITI, V4, P309, DOI DOI 10.1177/0951692892004003004; Stern P.C., 2002, DRAMA COMMONS, P443; Taylor M., 1982, COMMUNITY ANARCHY LI; Uphoff N., 2002, AGROECOLOGICAL INNOV; Wade R., 1994, VILLAGE REPUBLICS; Wilkinson RG, 1999, ANN NY ACAD SCI, V896, P48, DOI 10.1111/j.1749-6632.1999.tb08104.x; WOOLCOCK M, 2001, ISUMA CANADIAN J POL, V0002	34	833	871	7	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1912	1914		10.1126/science.1090847	http://dx.doi.org/10.1126/science.1090847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671287	Green Submitted			2022-12-01	WOS:000187174000042
J	Boerma, JT; Ghys, PD; Walker, N				Boerma, JT; Ghys, PD; Walker, N			Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard	LANCET			English	Editorial Material							GENERAL-POPULATION; INFECTION; RISK; SURVEILLANCE; MIGRATION; EPIDEMIC		WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; Joint UN Programme HIV AIDS, Geneva, Switzerland	World Health Organization	Boerma, JT (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	boermat@who.int						Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Boerma JT, 2001, POPUL DEV REV, V27, P303, DOI 10.1111/j.1728-4457.2001.00303.x; *CDCP, 2001, ET INT PREV IST COMP; *CELL PLAN STAT MI, 2002, HIV TEST MAL FIND 20; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; Hodes R, 2002, AIDS, V16, P1, DOI 10.1097/00002030-200201040-00001; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Kwesigabo G, 2000, J ACQ IMMUN DEF SYND, V23, P410; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; Shisana O, 2002, S AFRICAN NATL HIV P; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *UNAIDS WHO, 2002, AIDS EP UPD; WALKER N, IN PRESS AIDS; Zaba B, 1998, AIDS, V12, pS41; [No title captured]	20	100	100	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1929	1931		10.1016/S0140-6736(03)14967-7	http://dx.doi.org/10.1016/S0140-6736(03)14967-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667753				2022-12-01	WOS:000187011600027
J	Venstrom, JM; McBride, MA; Rother, KI; Hirshberg, B; Orchard, TJ; Harlan, DM				Venstrom, JM; McBride, MA; Rother, KI; Hirshberg, B; Orchard, TJ; Harlan, DM			Survival after pancreas transplantation in patients with diabetes and preserved kidney function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; COMPLICATIONS; MELLITUS; RECIPIENTS; REGISTRY; PROGNOSIS; MORTALITY; IMPACT; ONSET; ERA	Context Solitary pancreas transplantation (ie, pancreas alone or pancreas-after-kidney) for diabetes mellitus remains controversial due to procedure-associated morbidity/ mortality, toxicity of immunosuppression, expense, and unproven effects on the secondary complications of diabetes. Whether transplantation offers a survival advantage over conventional therapies for diabetes is unknown. Objective To determine the association between solitary pancreas transplantation and survival in patients with diabetes and preserved kidney function. Design, Setting, and Patients Retrospective observational cohort study conducted at 124 transplant centers in the United States, in 11572 patients with diabetes mellitus on the waiting list for pancreas transplantation (pancreas alone, pancreas-after-kidney, or simultaneous pancreas-kidney) at the United Network for Organ Sharing/ Organ Procurement and Transplantation Network between January 1, 1995, and December 31, 2000. All patients receiving a multiorgan (other than simultaneous pancreas-kidney) transplant were excluded, as were those listed for solitary pancreas transplantation who had a serum creatinine level greater than 2 mg/dL (176.8 mumol/L) at time of listing, or who ultimately received a simultaneous pancreas-kidney transplant. Main Outcome Measure All-cause mortality Within 4 years following transplantation (or within a comparable time on the waiting list for the group not undergoing transplantation). Results Overall relative risk of all-cause mortality for transplant recipients (compared with patients awaiting the same procedure) over 4 years of follow-up was 1.57 (95% confidence interval [CI], 0.98-2.53; P=.06) for pancreas transplant alone, 1.42 (95% Cl, 1.03-1.94; P=.03) for pancreas-after-kidney transplant, and 0.43 (95% Cl, 0.39-0.48) for simultaneous pancreas-kidney transplant. Transplant patient 1 - and 4-year survival rates were 96.5% and 85.2% for pancreas transplant alone, respectively, and 95.3% and 84.5% for pancreas-after-kidney transplant, while 1 - and 4-year survival rates for patients on the waiting list were 97.6% and 92.1% for pancreas transplant alone, respectively, and 97.1% and 88.1% for pancreas-after-kidney transplant. Conclusion From 1995-2000, survival for those with diabetes and preserved kidney function and receiving a solitary pancreas transplant was significantly worse compared with the survival of waiting-list patients receiving conventional therapy.	NIDDKD, Transplantat & Autoimmun Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; United Network Organ Sharing, Richmond, VA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; United Network for Organ Sharing; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uniformed Services University of the Health Sciences - USA	Harlan, DM (corresponding author), NIDDKD, Transplantat & Autoimmun Branch, NIH, US Dept HHS, 10 Ctr Dr,Bldg 10,Room 8N307, Bethesda, MD 20892 USA.			orchard, trevor/0000-0001-9552-3215	PHS HHS [231-00-0115] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK062000] Funding Source: NIH RePORTER	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P208, DOI 10.1097/01.ASN.0000037678.54984.41; DECKERT T, 1978, DIABETOLOGIA, V14, P363, DOI 10.1007/BF01228130; DECKERT T, 1978, DIABETOLOGIA, V14, P371, DOI 10.1007/BF01228131; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; GROSS CR, 1992, CLIN TRANSPLANT, V6, P165; Gross CR, 1998, CLIN TRANSPLANT, V12, P351; Gruessner AC, 2001, TRANSPLANT P, V33, P1643, DOI 10.1016/S0041-1345(00)02625-7; Gruessner RWG, 1997, TRANSPLANTATION, V64, P1572, DOI 10.1097/00007890-199712150-00011; Gruessner RWG, 1997, J AM COLL SURGEONS, V185, P128, DOI 10.1016/S1072-7515(01)00895-X; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; Humar A, 2000, ANN SURG, V231, P269, DOI 10.1097/00000658-200002000-00017; KATZ H, 1991, NEW ENGL J MED, V325, P1278, DOI 10.1056/NEJM199110313251804; Landgraf R, 1996, DIABETOLOGIA, V39, P1415, DOI 10.1007/s001250050593; Luzi L, 1998, NEW ENGL J MED, V339, P115, DOI 10.1056/NEJM199807093390210; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Ojo AO, 2001, TRANSPLANTATION, V71, P82, DOI 10.1097/00007890-200101150-00014; Piehlmeier W, 1996, EUR J SURG, V162, P933; PIEHLMEIER W, 1991, DIABETOLOGIA S1, V34, P150; Reddy KS, 2003, AM J KIDNEY DIS, V41, P464, DOI 10.1053/ajkd.2003.50057; Robertson R Paul, 2003, Diabetes Care, V26 Suppl 1, pS120; Robertson RP, 1998, J CLIN ENDOCR METAB, V83, P1868, DOI 10.1210/jc.83.6.1868; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sutherland DER, 1999, TRANSPLANT P, V31, P597, DOI 10.1016/S0041-1345(98)01573-5; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	25	217	225	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2817	2823		10.1001/jama.290.21.2817	http://dx.doi.org/10.1001/jama.290.21.2817			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657065	Bronze			2022-12-01	WOS:000186872800023
J	Lingel, A; Simon, B; Izaurralde, E; Sattler, M				Lingel, A; Simon, B; Izaurralde, E; Sattler, M			Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain	NATURE			English	Article							RNA INTERFERENCE; PROTEIN STRUCTURES; GENE; NMR; ATP; RECOGNITION; CLEAVAGE; PROGRAM; HOMOLOG; SYSTEM	RNA interference is a conserved mechanism that regulates gene expression in response to the presence of double-stranded (ds) RNAs1,2. The RNase III-like enzyme Dicer first cleaves dsRNA into 21-23-nucleotide small interfering RNAs (siR-NAs)(3-6). In the effector step, the multimeric RNA-induced silencing complex ( RISC) identifies messenger RNAs homologous to the siRNAs and promotes their degradation(3,7). The Argonaute 2 protein (Ago2) is a critical component of RISC8,9. Both Argonaute and Dicer family proteins contain a common PAZ domain whose function is unknown(10). Here we present the three-dimensional nuclear magnetic resonance structure of the Drosophila melanogaster Ago2 PAZ domain. This domain adopts a nucleic-acid-binding fold that is stabilized by conserved hydrophobic residues. The nucleic-acid-binding patch is located in a cleft between the surface of a central beta-barrel and a conserved module comprising strands beta3, beta4 and helix alpha3. Because critical structural residues and the binding surface are conserved, we suggest that PAZ domains in all members of the Argonaute and Dicer families adopt a similar fold with nucleic-acid binding function, and that this plays an important part in gene silencing.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Izaurralde, E (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Sattler, Michael/C-1169-2010; Lingel, Andreas/AAP-5078-2021; Sattler, Michael/A-2407-2012; Izaurralde, Elisa/G-3239-2012	Sattler, Michael/0000-0002-1594-0527; Simon, Bernd/0000-0003-0164-5516; Izaurralde, Elisa/0000-0001-7365-2649				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; YAN KS, 2003, NATURE          1116; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	30	325	361	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					465	469		10.1038/nature02123	http://dx.doi.org/10.1038/nature02123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14615801				2022-12-01	WOS:000186800800043
J	Xiong, W; Ferrell, JE				Xiong, W; Ferrell, JE			A positive-feedback-based bistable 'memory module' that governs a cell fate decision	NATURE			English	Article							XENOPUS OOCYTE MATURATION; RANA PIPIENS OOCYTES; MAP KINASE; INHIBITORY KINASE; CYCLIN-B; ACTIVATION; PROTEIN; MOS; DIFFERENTIATION; INITIATION	The maturation of Xenopus oocytes can be thought of as a process of cell fate induction, with the immature oocyte representing the default fate and the mature oocyte representing the induced fate(1,2). Crucial mediators of Xenopus oocyte maturation, including the p42 mitogen-activated protein kinase (MAPK) and the cell-division cycle protein kinase Cdc2, are known to be organized into positive feedback loops(3). In principle, such positive feedback loops could produce an actively maintained 'memory' of a transient inductive stimulus and could explain the irreversibility of maturation(3-6). Here we show that the p42 MAPK and Cdc2 system normally generates an irreversible biochemical response from a transient stimulus, but the response becomes transient when positive feedback is blocked. Our results explain how a group of intrinsically reversible signal transducers can generate an irreversible response at a systems level, and show how a cell fate can be maintained by a self-sustaining pattern of protein kinase activation.	Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA.							Abrieu A, 2001, J CELL SCI, V114, P257; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bosch E, 1997, ONCOGENE, V15, P1021, DOI 10.1038/sj.onc.1201270; DETTLAFF TA, 1966, J EMBRYOL EXP MORPH, V16, P183; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; Roy LM, 1996, ONCOGENE, V12, P2203; SCHUETZ AW, 1967, J EXP ZOOL, V166, P347, DOI 10.1002/jez.1401660307; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SMITH LD, 1968, DEV BIOL, V17, P627, DOI 10.1016/0012-1606(68)90010-9; Sohaskey ML, 1999, MOL BIOL CELL, V10, P3729, DOI 10.1091/mbc.10.11.3729; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	30	553	567	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					460	465		10.1038/nature02089	http://dx.doi.org/10.1038/nature02089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647386				2022-12-01	WOS:000186800800042
J	Mootha, VK; Bunkenborg, J; Olsen, JV; Hjerrild, M; Wisniewski, JR; Stahl, E; Bolouri, MS; Ray, HN; Sihag, S; Kamal, M; Patterson, N; Lander, ES; Mann, M				Mootha, VK; Bunkenborg, J; Olsen, JV; Hjerrild, M; Wisniewski, JR; Stahl, E; Bolouri, MS; Ray, HN; Sihag, S; Kamal, M; Patterson, N; Lander, ES; Mann, M			Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria	CELL			English	Article							MASS-SPECTROMETRY; CYTOCHROME-C; SEQUENCE DATABASES; PROTEOMIC ANALYSIS; IDENTIFICATION; EXPRESSION; APOPTOSIS; SUBUNIT; COMPLEX; ORIGIN	Mitochondria are tailored to meet the metabolic and signaling needs of each cell. To explore its molecular composition, we performed a proteomic survey of mitochondria from mouse brain, heart, kidney, and liver and combined the results with existing gene annotations to produce a list of 591 mitochondrial proteins, including 163 proteins not previously associated with this organelle. The protein expression data were largely concordant with large-scale surveys of RNA abundance and both measures indicate tissue-specific differences in organelle composition. RNA expression profiles across tissues revealed networks of mitochondrial genes that share functional and regulatory mechanisms. We also determined a larger "neighborhood" of genes whose expression is closely correlated to the mitochondrial genes. The combined analysis identifies specific genes of biological interest, such as candidates for mtDNA repair enzymes, offers new insights into the biogenesis and ancestry of mammalian mitochondria, and provides a framework for understanding the organelle's contribution to human disease.	MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; MDS Proteom, DK-5230 Odense, Denmark; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Univ So Denmark, Ctr Expt Bioinformat, DK-5230 Odense, Denmark; MIT, Dept Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southern Denmark; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Ctr Genome Res, Whitehead Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lander@genome.wi.mit.edu; mann@bmb.sdu.dk	Olsen, Jesper/ABH-4638-2020; Olsen, Jesper/C-4738-2008; Mann, Matthias/A-3454-2013	Olsen, Jesper/0000-0002-4747-4938; Mann, Matthias/0000-0003-1292-4799; Bunkenborg, Jakob/0000-0002-2908-9323				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; CHI NW, 1994, J BIOL CHEM, V269, P29984; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; GHADIALLY FN, 1997, ULTRASTRUCTURAL PATH, V1; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hardman RA, 2001, CANCER RES, V61, P1392; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PULGSERVER P, 2003, ENDOCR REV, V24, P78; Rabilloud T, 1998, ELECTROPHORESIS, V19, P1006, DOI 10.1002/elps.1150190616; Samuel SJ, 1997, HEPATOLOGY, V25, P1213, DOI 10.1002/hep.510250525; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Scharfe C, 2000, NUCLEIC ACIDS RES, V28, P155, DOI 10.1093/nar/28.1.155; STREYER L, 1988, BIOCHEMISTRY; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; Vijayasarathy C, 1998, BBA-BIOMEMBRANES, V1371, P71, DOI 10.1016/S0005-2736(97)00278-2; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Westermann B, 2003, NAT BIOTECHNOL, V21, P239, DOI 10.1038/nbt0303-239	49	683	728	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					629	640		10.1016/S0092-8674(03)00926-7	http://dx.doi.org/10.1016/S0092-8674(03)00926-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651853	Bronze			2022-12-01	WOS:000186885600012
J	Rayapureddi, JP; Kattamuri, C; Steinmetz, BD; Frankfort, BJ; Ostrin, EJ; Mardon, G; Hegde, RS				Rayapureddi, JP; Kattamuri, C; Steinmetz, BD; Frankfort, BJ; Ostrin, EJ; Mardon, G; Hegde, RS			Eyes absent represents a class of protein tyrosine phosphatases	NATURE			English	Article							P-TYPE ATPASE; DROSOPHILA EYE; GENE; DEHALOGENASE; SUBSTRATE; MUTATIONS; EYA1; SUPERFAMILY; ACTIVATION; COMPLEX	The Eyes absent proteins are members of a conserved regulatory network implicated in the development of the eye, muscle, kidney and ear(1-7). Mutations in the Eyes absent genes have been associated with several congenital disorders including the multi-organ disease bronchio-oto-renal syndrome(8), congenital cataracts(9) and late-onset deafness(10). On the basis of previous analyses it has been shown that Eyes absent is a nuclear transcription factor, acting through interaction with homeodomain-containing Sine oculis (also known as Six) proteins(11). Here we show that Eyes absent is also a protein tyrosine phosphatase. It does not resemble the classical tyrosine phosphatases that use cysteine as a nucleophile and proceed by means of a thiol-phosphate intermediate(12). Rather, Eyes absent is the prototype for a class of protein tyrosine phosphatases that use a nucleophilic aspartic acid in a metal-dependent reaction. Furthermore, the phosphatase activity of Eyes absent contributes to its ability to induce eye formation in Drosophila.	Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Neurosci & Program Dev Biol, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hegde, RS (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				NEI NIH HHS [R01 EY014648] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011232, R01EY014648] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Bui QT, 2000, GENETICS, V155, P709; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; DAUM G, 1993, ANAL BIOCHEM, V211, P50, DOI 10.1006/abio.1993.1231; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; Desplan C, 1997, CELL, V91, P861, DOI 10.1016/S0092-8674(00)80475-4; Fan XM, 2000, J BIOL CHEM, V275, P32129, DOI 10.1074/jbc.M004577200; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Ridder IS, 1997, J BIOL CHEM, V272, P33015, DOI 10.1074/jbc.272.52.33015; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 1997, DEVELOPMENT, V124, P219; Xu PX, 2002, DEVELOPMENT, V129, P3033; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446	30	188	210	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					295	298		10.1038/nature02093	http://dx.doi.org/10.1038/nature02093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628052				2022-12-01	WOS:000186660800045
J	Kodama, S; Kuhtreiber, W; Fujimura, S; Dale, EA; Faustman, DL				Kodama, S; Kuhtreiber, W; Fujimura, S; Dale, EA; Faustman, DL			Islet regeneration during the reversal of autoimmune diabetes in NOD mice	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW CELLS; IN-VIVO; ADULT MICE; DIFFERENTIATE; FUSION; HEPATOCYTES; BRAIN; PROGENITORS; EXPRESSION	Nonobese diabetic (NOD) mice are a model for type 1 diabetes in humans. Treatment of NOD mice with end-stage disease by injection of donor splenocytes and complete Freund's adjuvant eliminates autoimmunity and permanently restores normoglycemia. The return of endogenous insulin secretion is accompanied by the reappearance of pancreatic beta cells. We now show that live donor male or labeled splenocytes administered to diabetic NOD females contain cells that rapidly differentiate into islet and ductal epithelial cells within the pancreas. Treatment with irradiated splenocytes is also followed by islet regeneration, but at a slower rate. The islets generated in both instances are persistent, functional, and apparent in all NOD hosts with permanent disease reversal.	Massachusetts Gen Hosp, Immunobiol Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Faustman, DL (corresponding author), Massachusetts Gen Hosp, Immunobiol Lab, Bldg 149,13th St,Room 3602, Charlestown, MA 02129 USA.	faustman@helix.mgh.harvard.edu		Kuhtreiber, Willem/0000-0002-5717-5915	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK57521-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; FAUSTMAN D, 1991, SCIENCE, V254, P1756, DOI 10.1126/science.1763324; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayashi T, 2000, NAT MED, V6, P1065, DOI 10.1038/80353; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI12335; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Yang G, 1997, J IMMUNOL, V159, P3068; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	36	281	313	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2003	302	5648					1223	1227		10.1126/science.1088949	http://dx.doi.org/10.1126/science.1088949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615542				2022-12-01	WOS:000186544300058
J	Zhou, Y; Su, Y; Li, BL; Liu, F; Ryder, JW; Wu, X; Gonzalez-DeWhitt, PA; Gelfanova, V; Hale, JE; May, PC; Paul, SM; Ni, BH				Zhou, Y; Su, Y; Li, BL; Liu, F; Ryder, JW; Wu, X; Gonzalez-DeWhitt, PA; Gelfanova, V; Hale, JE; May, PC; Paul, SM; Ni, BH			Nonsteroidal anti-inflammatory drugs can lower amyloidogenic A beta(42) by inhibiting Rho	SCIENCE			English	Article							ALZHEIMERS-DISEASE; SULINDAC SULFIDE; RAS; PROTEIN	A subset of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to preferentially reduce the secretion of the highly amyloidogenic, 42-residue amyloid-beta peptide Abeta(42). We found that Rho and its effector, Rho-associated kinase, preferentially regulated the amount of Abeta(42) produced in vitro and that only those NSAIDs effective as Rho inhibitors lowered Abeta(42). Administration of Y-27632, a selective Rock inhibitor, also preferentially lowered brain levels of Abeta(42) in a transgenic mouse model of Alzheimer's disease. Thus, the Rho-Rock pathway may regulate amyloid precursor protein processing, and a subset of NSAIDs can reduce Abeta(42) through inhibition of Rho activity.	Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res & Biores Technol & Prot, Indianapolis, IN 46285 USA	Eli Lilly	Zhou, Y (corresponding author), Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res & Biores Technol & Prot, Indianapolis, IN 46285 USA.	zhou_yan_yz@lilly.com; paul_steven_m@lilly.com	Paul, Steve/ABE-5400-2020					CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gala M, 2002, CANCER LETT, V175, P89, DOI 10.1016/S0304-3835(01)00716-9; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrmann C, 1998, ONCOGENE, V17, P1769, DOI 10.1038/sj.onc.1202085; Holstein SA, 2002, BIOCHEMISTRY-US, V41, P13698, DOI 10.1021/bi026251x; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; Morihara T, 2002, J NEUROCHEM, V83, P1009, DOI 10.1046/j.1471-4159.2002.01195.x; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591	15	272	318	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2003	302	5648					1215	1217		10.1126/science.1090154	http://dx.doi.org/10.1126/science.1090154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615541				2022-12-01	WOS:000186544300056
J	di Fagagna, FD; Reaper, PM; Clay-Farrace, L; Fiegler, H; Carr, P; von Zglinicki, T; Saretzki, G; Carter, NP; Jackson, SP				di Fagagna, FD; Reaper, PM; Clay-Farrace, L; Fiegler, H; Carr, P; von Zglinicki, T; Saretzki, G; Carter, NP; Jackson, SP			A DNA damage checkpoint response in telomere-initiated senescence	NATURE			English	Article							IONIZING-RADIATION; S-CHECKPOINT; LIFE-SPAN; SENSITIVITY; GENOME; MDC1; ATM; APOPTOSIS; DISTINCT; KINASE	Most human somatic cells can undergo only a limited number of population doublings in vitro(1). This exhaustion of proliferative potential, called senescence, can be triggered when telomeres the ends of linear chromosomes-cannot fulfil their normal protective functions. Here we show that senescent human fibroblasts display molecular markers characteristic of cells bearing DNA double-strand breaks. These markers include nuclear foci of phosphorylated histone H2AX and their co-localization with DNA repair and DNA damage checkpoint factors such as 53BP1, MDC1 and NBS1. We also show that senescent cells contain activated forms of the DNA damage checkpoint kinases CHK1 and CHK2. Furthermore, by chromatin immunoprecipitation and whole-genome scanning approaches, we show that the chromosome ends of senescent cells directly contribute to the DNA damage response, and that uncapped telomeres directly associate with many, but not all, DNA damage response proteins. Finally, we show that inactivation of DNA damage checkpoint kinases in senescent cells can restore cell-cycle progression into S phase. Thus, we propose that telomere-initiated senescence reflects a DNA damage checkpoint response that is activated with a direct contribution from dysfunctional telomeres.	Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	University of Cambridge; Wellcome Trust Sanger Institute; Newcastle University - UK	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England.	dadda@ifom-firc.it; spj13@mole.bio.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Saretzki, Gabriele Christine/I-7175-2019; d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Saretzki, Gabriele Christine/0000-0003-2100-8223; d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; von Zglinicki, Thomas/0000-0002-5939-0248				Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 2000, GENE DEV, V14, P278; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stoeber K, 2001, J CELL SCI, V114, P2027; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	30	1182	1214	8	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					194	198		10.1038/nature02118	http://dx.doi.org/10.1038/nature02118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14608368				2022-12-01	WOS:000186517200047
J	Wentworth, P; Nieva, J; Takeuchi, C; Galve, R; Wentworth, AD; Dilley, RB; DeLaria, GA; Saven, A; Babior, BM; Janda, KD; Eschenmoser, A; Lerner, RA				Wentworth, P; Nieva, J; Takeuchi, C; Galve, R; Wentworth, AD; Dilley, RB; DeLaria, GA; Saven, A; Babior, BM; Janda, KD; Eschenmoser, A; Lerner, RA			Evidence for ozone formation in human atherosclerotic arteries	SCIENCE			English	Article							LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL; OZONIZATION; OXIDATION	Here, we report evidence for the production of ozone in human disease. Signature products unique to cholesterol ozonolysis are present within atherosclerotic tissue at the time of carotid endarterectomy, suggesting that ozone production occurred during lesion development. Furthermore, advanced atherosclerotic plaques generate ozone when the leukocytes within the diseased arteries are activated in vitro. The steroids produced by cholesterol ozonolysis cause effects that are thought to be critical to the pathogenesis of atherosclerosis, including cytotoxicity, lipid-loading in macrophages, and deformation of the apolipoprotein B-100 secondary structure. We propose the trivial designation "atheronals" for this previously unrecognized class of steroids.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Clin, Div Hematol & Oncol, La Jolla, CA 92037 USA; Scripps Clin, Div Cardiothorac & Vasc Surg, La Jolla, CA 92037 USA; ETH Honggerberg, Organ Chem Lab, CH-8093 Zurich, Switzerland; Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford	Wentworth, P (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Galve, Roger/I-3443-2017	Galve, Roger/0000-0001-6189-5037	NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043858, R29GM043858] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA27489] Funding Source: Medline; NIAID NIH HHS [5T32AI07606] Funding Source: Medline; NIGMS NIH HHS [GM 43858] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babior BM, 2003, P NATL ACAD SCI USA, V100, P3031, DOI 10.1073/pnas.0530251100; CORNFORTH JW, 1953, BIOCHEM J, V54, P590, DOI 10.1042/bj0540590; GUMULKA J, 1983, J AM CHEM SOC, V105, P1972, DOI 10.1021/ja00345a052; GUMULKA J, 1982, LIPIDS, V17, P197, DOI 10.1007/BF02535103; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; HIETTER H, 1986, CANCER BIOCHEM BIOPH, V9, P75; JAWORSKI K, 1988, J ORG CHEM, V53, P545, DOI 10.1021/jo00238a014; LORENZO JL, 1987, FEBS LETT, V218, P77, DOI 10.1016/0014-5793(87)81022-0; LUND E, 1995, ACCOUNTS CHEM RES, V28, P241, DOI 10.1021/ar00054a001; PARYZEK Z, 1990, J CHEM SOC PERK T 1, P1222, DOI 10.1039/p19900001222; REYMOND JL, 1995, J ORG CHEM, V60, P6970, DOI 10.1021/jo00126a057; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SEVANIAN A, 1984, P NATL ACAD SCI-BIOL, V81, P4198, DOI 10.1073/pnas.81.13.4198; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; TAKEUCHI K, 1990, ANAL CHIM ACTA, V230, P183, DOI 10.1016/S0003-2670(00)82779-8; TAKEUCHI K, 1989, ANAL CHEM, V61, P619, DOI 10.1021/ac00181a025; WANG KY, 1993, STEROIDS, V58, P225, DOI 10.1016/0039-128X(93)90023-G; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; Wentworth P, 2003, P NATL ACAD SCI USA, V100, P1490, DOI 10.1073/pnas.0437831100	24	230	249	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1053	1056		10.1126/science.1089525	http://dx.doi.org/10.1126/science.1089525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605372				2022-12-01	WOS:000186396300051
J	Changelian, PS; Flanagan, ME; Ball, DJ; Kent, CR; Magnuson, KS; Martin, WH; Rizzuti, BJ; Sawyer, PS; Perry, BD; Brissette, WH; McCurdy, SP; Kudlacz, EM; Conklyn, MJ; Elliott, EA; Koslov, ER; Fisher, MB; Strelevitz, TJ; Yoon, K; Whipple, DA; Sun, JM; Munchhof, MJ; Doty, JL; Casavant, JM; Blumenkopf, TA; Hines, M; Brown, MF; Lillie, BM; Subramanyam, C; Shang-Poa, C; Milici, AJ; Beckius, GE; Moyer, JD; Su, CY; Woodworth, TG; Gaweco, AS; Beals, CR; Littman, BH; Fisher, DA; Smith, JF; Zagouras, P; Magna, HA; Saltarelli, MJ; Johnson, KS; Nelms, LF; Des Etages, SG; Hayes, LS; Kawabata, TT; Finco-Kent, D; Baker, DL; Larson, M; Si, MS; Paniagua, R; Higgins, J; Holm, B; Reitz, B; Zhou, YJ; Morris, RE; O'Shea, JJ; Borie, DC				Changelian, PS; Flanagan, ME; Ball, DJ; Kent, CR; Magnuson, KS; Martin, WH; Rizzuti, BJ; Sawyer, PS; Perry, BD; Brissette, WH; McCurdy, SP; Kudlacz, EM; Conklyn, MJ; Elliott, EA; Koslov, ER; Fisher, MB; Strelevitz, TJ; Yoon, K; Whipple, DA; Sun, JM; Munchhof, MJ; Doty, JL; Casavant, JM; Blumenkopf, TA; Hines, M; Brown, MF; Lillie, BM; Subramanyam, C; Shang-Poa, C; Milici, AJ; Beckius, GE; Moyer, JD; Su, CY; Woodworth, TG; Gaweco, AS; Beals, CR; Littman, BH; Fisher, DA; Smith, JF; Zagouras, P; Magna, HA; Saltarelli, MJ; Johnson, KS; Nelms, LF; Des Etages, SG; Hayes, LS; Kawabata, TT; Finco-Kent, D; Baker, DL; Larson, M; Si, MS; Paniagua, R; Higgins, J; Holm, B; Reitz, B; Zhou, YJ; Morris, RE; O'Shea, JJ; Borie, DC			Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor	SCIENCE			English	Article							T-CELL HOMEOSTASIS; TRANSPLANTATION; LEUKEMIA; SURVIVAL; MICE; GENE; JAK3	Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clinical immunosuppression. We report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolonged survival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants. CP-690,550 treatment was not associated with hypertension, hyperlipidemia, or lymphoproliferative disease. On the basis of these preclinical results, we believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation and in other clinical settings.	Pfizer Global Res & Dev, Dept Antibacterials & Immunol, Immunol Grp, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Drug Safety Evaluat, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Pharmacokinet Dynam & Metab, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Genom & Proteom Sci, Groton, CT 06340 USA; Stanford Univ, Sch Med, Transplantat Immunol Lab, Stanford, CA 94305 USA; NIH, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA	Pfizer; Pfizer; Pfizer; Pfizer; Stanford University; National Institutes of Health (NIH) - USA	Changelian, PS (corresponding author), Pfizer Global Res & Dev, Dept Antibacterials & Immunol, Immunol Grp, Groton, CT 06340 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, ZIAAR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Behbod F, 2001, J IMMUNOL, V166, P3724, DOI 10.4049/jimmunol.166.6.3724; Borie DC, 2002, J SURG RES, V107, P64, DOI 10.1006/jsre.2002.6499; CHANGELIAN PS, UNPUB; Christopher K, 2002, J IMMUNOL, V169, P522, DOI 10.4049/jimmunol.169.1.522; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; COPELAND RA, ENZYMES PRACTICAL IN; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; El-Sawy T, 2002, CURR OPIN IMMUNOL, V14, P562, DOI 10.1016/S0952-7915(02)00382-5; Gozalo-Sanmillan S, 2001, J IMMUNOL, V166, P727, DOI 10.4049/jimmunol.166.2.727; Hausen B, 2001, TRANSPLANTATION, V72, P1128, DOI 10.1097/00007890-200109270-00025; Hong JC, 2000, SEMIN NEPHROL, V20, P108; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saemann MD, 2003, TRANSPLANTATION, V75, P1864, DOI 10.1097/01.TP.0000065738.58742.A9; Saiura A, 2001, TRANSPLANTATION, V72, P320, DOI 10.1097/00007890-200107270-00027; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Sohn SJ, 1998, J IMMUNOL, V160, P2130; Stock PG, 2003, AM J TRANSPLANT, V3, P373, DOI 10.1034/j.1600-6143.2003.00115.x; Uckun FM, 2002, BLOOD, V99, P4192, DOI 10.1182/blood.V99.11.4192	24	528	644	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					875	878		10.1126/science.1087061	http://dx.doi.org/10.1126/science.1087061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593182				2022-12-01	WOS:000186258000052
J	Calvi, LM; Adams, GB; Weibrecht, KW; Weber, JM; Olson, DP; Knight, MC; Martin, RP; Schipani, E; Divieti, P; Bringhurst, FR; Milner, LA; Kronenberg, HM; Scadden, DT				Calvi, LM; Adams, GB; Weibrecht, KW; Weber, JM; Olson, DP; Knight, MC; Martin, RP; Schipani, E; Divieti, P; Bringhurst, FR; Milner, LA; Kronenberg, HM; Scadden, DT			Osteoblastic cells regulate the haematopoietic stem cell niche	NATURE			English	Article							BONE-MARROW; GROWTH-FACTOR; SELF-RENEWAL; NOTCH; LINEAGE	Stem cell fate is influenced by specialized microenvironments that remain poorly defined in mammals(1-3). To explore the possibility that haematopoietic stem cells derive regulatory information from bone, accounting for the localization of haematopoiesis in bone marrow, we assessed mice that were genetically altered to produce osteoblast-specific, activated PTH/PTHrP receptors (PPRs)(4). Here we show that PPR-stimulated osteoblastic cells that are increased in number produce high levels of the Notch ligand jagged 1 and support an increase in the number of haematopoietic stem cells with evidence of Notch1 activation in vivo. Furthermore, ligand-dependent activation of PPR with parathyroid hormone (PTH) increased the number of osteoblasts in stromal cultures, and augmented ex vivo primitive haematopoietic cell growth that was abrogated by gamma-secretase inhibition of Notch activation. An increase in the number of stem cells was observed in wild-type animals after PTH injection, and survival after bone marrow transplantation was markedly improved. Therefore, osteoblastic cells are a regulatory component of the haematopoietic stem cell niche in vivo that influences stem cell function through Notch activation. Niche constituent cells or signalling pathways provide pharmacological targets with therapeutic potential for stem-cell-based therapies.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Canc Ctr, Partners AIDS Res Ctr,Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA; Univ Rochester, Sch Med, Dept Med, Endocrine Unit, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Pediat, Ctr Human Genet & Mol Pediat Dis, Rochester, NY 14642 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Rochester; University of Rochester	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Canc Ctr, Partners AIDS Res Ctr,Ctr Regenerat Med & Technol, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu	Calvi, Laura/P-6988-2019	Calvi, Laura/0000-0001-6969-239X; Weber, Jonathan/0000-0002-6015-8454; Divieti Pajevic, Paola/0000-0001-9853-9837	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064381] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK064381, K08 DK064381-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cui YF, 1996, CELL PROLIFERAT, V29, P243, DOI 10.1046/j.1365-2184.1996.00999.x; Giri N, 2001, EXP HEMATOL, V29, P779, DOI 10.1016/S0301-472X(01)00646-4; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; LORD BI, 1990, INT J CELL CLONING, V8, P317, DOI 10.1002/stem.5530080501; LORD BI, 1975, BLOOD, V46, P65; Pereira RMR, 2002, J CELL BIOCHEM, V85, P252, DOI 10.1002/jcb.10125; PLOEMACHER RE, 1991, BLOOD, V78, P2527; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Taichman RS, 2001, BRIT J HAEMATOL, V112, P438, DOI 10.1046/j.1365-2141.2001.02568.x; Taichman RUSSELL S., 2000, Hematology, V4, P421; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	26	2585	2741	5	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2003	425	6960					841	846		10.1038/nature02040	http://dx.doi.org/10.1038/nature02040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574413	Bronze			2022-12-01	WOS:000186118500046
J	Elia, AEH; Rellos, P; Haire, LF; Chao, JW; Ivins, FJ; Hoepker, K; Mohammad, D; Cantley, LC; Smerdon, SJ; Yaffe, MB				Elia, AEH; Rellos, P; Haire, LF; Chao, JW; Ivins, FJ; Hoepker, K; Mohammad, D; Cantley, LC; Smerdon, SJ; Yaffe, MB			The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain	CELL			English	Article							PHOSPHOSERINE/THREONINE-BINDING DOMAINS; SACCHAROMYCES-CEREVISIAE CDC5; TYROSINE KINASE HCK; CELL-CYCLE; STRUCTURAL BASIS; PROTEIN-KINASE; M-PHASE; CRYSTAL-STRUCTURE; UBIQUITIN LIGASE; MAMMALIAN-CELLS	Polo-like kinases (Plks) perform crucial functions in cell-cycle progression and multiple stages of mitosis. Plks are characterized by a C-terminal noncatalytic region containing two tandem Polo boxes, termed the Polo-box domain (PBD), which has recently been implicated in phosphodependent substrate targeting. We show that the PBDs of human, Xenopus, and yeast Plks all recognize similar phosphoserine/threonine-containing motifs. The 1.9 Angstrom X-ray structure of a human Plk1 PBD-phosphopeptide complex shows that the Polo boxes each comprise beta(6)alpha structures that associate to form a 12-stranded beta sandwich domain. The phosphopeptide binds along a conserved, positively charged cleft located at the edge of the Polo-box interface. Mutations that specifically disrupt phosphodependent interactions abolish cell-cycle-dependent localization and provide compelling phenotypic evidence that PBD-phospholigand binding is necessary for proper mitotic progression. In addition, phosphopeptide binding to the PBD stimulates kinase activity in full-length Plk1, suggesting a conformational switching mechanism for Plk regulation and a dual functionality for the PBD.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Beth Israel Deaconess Hosp, Sch Med, Dept Cell Biol,Div Signal Transduct, Boston, MA 02215 USA	MRC National Institute for Medical Research; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Smerdon, SJ (corresponding author), Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Smerdon, Stephen/0000-0001-5688-8465	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, R01GM060594] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056203, GM60594] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 1998, J CELL SCI, V111, P1751; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Conn CW, 2000, CANCER RES, V60, P6826; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elez R, 2000, BIOCHEM BIOPH RES CO, V269, P352, DOI 10.1006/bbrc.2000.2291; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Grallert A, 2002, EMBO J, V21, P3096, DOI 10.1093/emboj/cdf294; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee KS, 1999, P NATL ACAD SCI USA, V96, P14360, DOI 10.1073/pnas.96.25.14360; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; LIU XQ, 1993, ONCOGENE, V8, P1119; Ma S, 2003, MOL CANCER RES, V1, P376; May KM, 2002, J CELL BIOL, V156, P23, DOI 10.1083/jcb.200106150; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7	50	588	605	1	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 3	2003	115	1					83	95		10.1016/S0092-8674(03)00725-6	http://dx.doi.org/10.1016/S0092-8674(03)00725-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532005	Bronze			2022-12-01	WOS:000185815500011
J	Mizuguchi, G; Shen, XT; Landry, J; Wu, WH; Sen, S; Wu, C				Mizuguchi, G; Shen, XT; Landry, J; Wu, WH; Sen, S; Wu, C			ATP-Driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex	SCIENCE			English	Article							ACTIN-RELATED PROTEINS; NUCLEOSOME CORE PARTICLE; NUCLEAR ACTIN; SACCHAROMYCES-CEREVISIAE; RSC	The conserved histone variant H2AZ has an important role in the regulation of gene expression and the establishment of a buffer to the spread of silent heterochromatin. How histone variants such as H2AZ are incorporated into nucleosomes has been obscure. We have found that Swr1, a Swi2/Snf2-related adenosine triphosphatase, is the catalytic core of a multisubunit, histone-variant exchanger that efficiently replaces conventional histone H2A with histone H2AZ in nucleosome arrays. Swr1 is required for the deposition of histone H2AZ at specific chromosome locations in vivo, and Swr1 and H2AZ commonly regulate a subset of yeast genes. These findings de. ne a previously unknown role for the adenosine triphosphate - dependent chromatin remodeling machinery.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wu, C (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bldg 37,Room 6068, Bethesda, MD 20892 USA.	carlwu@helix.nih.gov	Sen, Subhojit/I-9033-2012	Sen, Subhojit/0000-0001-8457-915X; Shen, Xuetong/0000-0002-4267-5298	NATIONAL CANCER INSTITUTE [Z01BC005263, ZIABC005263] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; [Anonymous], COMMUNICATION; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Begley TJ, 2002, MOL CANCER RES, V1, P103; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Goodson HV, 2002, J CELL SCI, V115, P2619; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; HATCH CL, 1983, SCIENCE, V221, P468, DOI 10.1126/science.6306766; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Luger K, 1999, METHOD ENZYMOL, V304, P3; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; MIZUGUCHI G, UNPUB; NAKATANI Y, COMMUNICATION; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Richmond T. J., 2000, CHROMATIN STRUCTURE; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; van Holde K.E., 1989, CHROMATIN; VANHOLDE KE, 1995, CHROMATIN STRUCTURE; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003	39	948	994	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					343	348		10.1126/science.1090701	http://dx.doi.org/10.1126/science.1090701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14645854	Green Published			2022-12-01	WOS:000188111800035
J	Ben-Shem, A; Frolow, F; Nelson, N				Ben-Shem, A; Frolow, F; Nelson, N			Crystal structure of plant photosystem I	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; FAST-ELECTRON TRANSFER; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; ANGSTROM RESOLUTION; THYLAKOID MEMBRANES; CYTOCHROME C(6); IRON-DEFICIENCY; ENERGY-TRANSFER; ANTENNA RING	Oxygenic photosynthesis is the principal producer of both oxygen and organic matter on Earth. The conversion of sunlight into chemical energy is driven by two multisubunit membrane protein complexes named photosystem I and II. We determined the crystal structure of the complete photosystem I ( PSI) from a higher plant ( Pisum sativum var. alaska) to 4.4 Angstrom resolution. Its intricate structure shows 12 core subunits, 4 different light- harvesting membrane proteins ( LHCI) assembled in a half- moon shape on one side of the core, 45 transmembrane helices, 167 chlorophylls, 3 Fe - S clusters and 2 phylloquinones. About 20 chlorophylls are positioned in strategic locations in the cleft between LHCI and the core. This structure provides a framework for exploration not only of energy and electron transfer but also of the evolutionary forces that shaped the photosynthetic apparatus of terrestrial plants after the divergence of chloroplasts from marine cyanobacteria one billion years ago.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Frolow, Felix/A-1760-2013	Ben-Shem, Adam/0000-0003-0297-8662; Nelson, Nathan/0000-0003-3588-7265				Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Barber J, 2002, CURR OPIN STRUC BIOL, V12, P523, DOI 10.1016/S0959-440X(02)00357-3; Ben-Shem A, 2003, ACTA CRYSTALLOGR D, V59, P1824, DOI 10.1107/S0907444903016056; BENGIS C, 1977, J BIOL CHEM, V252, P4564; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CHITNIS PR, 1991, J BIOL CHEM, V266, P20146; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; Herrmann RG, 1999, BIOSCIENCE REP, V19, P355, DOI 10.1023/A:1020251903707; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jennings RC, 2003, BBA-BIOENERGETICS, V1557, P91, DOI 10.1016/S0005-2728(02)00399-7; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Junge W, 1999, P NATL ACAD SCI USA, V96, P4735, DOI 10.1073/pnas.96.9.4735; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Knoetzel H, 2002, FEBS LETT, V510, P145, DOI 10.1016/S0014-5793(01)03253-7; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Nelson N, 2002, PHOTOSYNTH RES, V73, P193, DOI 10.1023/A:1020403231100; Nield J, 2003, BIOCHEMISTRY-US, V42, P3180, DOI 10.1021/bi026933k; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 2002, BIOCHEMISTRY-US, V41, P9126, DOI 10.1021/bi016042x; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Xiong J, 2002, ANNU REV PLANT BIOL, V53, P503, DOI 10.1146/annurev.arplant.53.100301.135212; Xue YF, 1998, PROTEIN SCI, V7, P2099, DOI 10.1002/pro.5560071006	40	628	682	7	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					630	635		10.1038/nature02200	http://dx.doi.org/10.1038/nature02200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668855				2022-12-01	WOS:000187132800032
J	Moore, P; Clayton, J				Moore, P; Clayton, J			To affinity and beyond	NATURE			English	Article																			0	6	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					725	+		10.1038/426725a	http://dx.doi.org/10.1038/426725a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668881	Bronze			2022-12-01	WOS:000187132800058
J	Renault, L; Guibert, B; Cherfils, J				Renault, L; Guibert, B; Cherfils, J			Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor	NATURE			English	Article							ADP-RIBOSYLATION FACTOR-1; BREFELDIN-A; SEC7 DOMAIN; ARF; PROTEIN; BINDING; RAS; FAMILY; GDP; ACTIVATION	Small GTP-binding (G) proteins are activated by GDP/GTP nucleotide exchange stimulated by guanine nucleotide exchange factors ( GEFs). Nucleotide dissociation from small G protein - GEF complexes involves transient GDP-bound intermediates whose structures have never been described. In the case of Arf proteins, small G proteins that regulate membrane traffic in eukaryotic cells, such intermediates can be trapped either by the natural inhibitor brefeldin A or by charge reversal at the catalytic glutamate of the Sec7 domain of their GEFs. Here we report the crystal structures of these intermediates that show that membrane recruitment of Arf and nucleotide dissociation are separate reactions stimulated by Sec7. The reactions proceed through sequential rotations of the Arf.GDP core towards the Sec7 catalytic site, and are blocked by interfacial binding of brefeldin A and unproductive stabilization of GDP by charge reversal. The structural characteristics of the reaction and its modes of inhibition reveal unexplored ways in which to inhibit the activation of small G proteins.	CNRS, UPR 9063, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cherfils, J (corresponding author), CNRS, UPR 9063, Lab Enzymol & Biochim Struct, Ave Terrasse, F-91198 Gif Sur Yvette, France.	cherfils@lebs.cnrs-gif.fr						AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Baumgartner F, 2001, MOL MICROBIOL, V41, P1151, DOI 10.1046/j.1365-2958.2001.02572.x; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cherfils J, 2001, FEBS LETT, V507, P280, DOI 10.1016/S0014-5793(01)02970-2; Choi Jai-Pil, 1996, EUROPEAN J POLITICAL, V12, P273, DOI DOI 10.1016/0176-2680(95)00017-8; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson C L, 2000, Subcell Biochem, V34, P233; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; McCormick F, 2000, CURR OPIN BIOTECH, V11, P593, DOI 10.1016/S0958-1669(00)00149-X; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; PASQUALATO S, IN PRESS ARF BOOK, pCH3; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; Schmidt S, 2002, FEBS LETT, V523, P35, DOI 10.1016/S0014-5793(02)02928-9; TORII S, 1995, J BIOL CHEM, V270, P11574, DOI 10.1074/jbc.270.19.11574; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WEBER HP, 1971, HELV CHIM ACTA, V54, P2763, DOI 10.1002/hlca.19710540839; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Zhu JW, 2000, BIOORGAN MED CHEM, V8, P455, DOI 10.1016/S0968-0896(99)00297-7	45	244	251	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					525	530		10.1038/nature02197	http://dx.doi.org/10.1038/nature02197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654833				2022-12-01	WOS:000186944300030
J	Mills, EM; Banks, ML; Sprague, JE; Finkel, T				Mills, EM; Banks, ML; Sprague, JE; Finkel, T			Pharmacology: Uncoupling the agony from ecstasy - A mitochondrial protein may mediate a dangerous side-effect of some recreational drugs	NATURE			English	Editorial Material							MDMA		NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; Ohio No Univ, Dept Pharmaceut & Biomed Sci, Ada, OH 45810 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ohio Northern University	Mills, EM (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	j-sprague@onu.edu	Banks, Matthew L/CAF-1091-2022; Sprague, Jon/AAE-6346-2021; Banks, Matthew L/K-4429-2014	Banks, Matthew L/0000-0003-4949-5246; Banks, Matthew L/0000-0003-4949-5246	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dar KJ, 1996, INTENS CARE MED, V22, P995; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; GONG DW, 1997, J BIOL CHEM, V272; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Landry MJ, 2002, J PSYCHOACTIVE DRUGS, V34, P163, DOI 10.1080/02791072.2002.10399950; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Sprague JE, 2003, J PHARMACOL EXP THER, V305, P159, DOI 10.1124/jpet.102.044982; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; 1964, NATURE, V204, P387; 2003, PSYCHOPHARMACOLOGY, V166, P202	11	117	118	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					403	404		10.1038/426403a	http://dx.doi.org/10.1038/426403a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647371				2022-12-01	WOS:000186800800027
J	Salonen, JT				Salonen, JT			Liver damage and protective effect of high density lipoprotein cholesterol	BRITISH MEDICAL JOURNAL			English	Article									Univ Kuopio, Publ Hlth Res Inst, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland	University of Eastern Finland	Salonen, JT (corresponding author), Univ Kuopio, Publ Hlth Res Inst, Dept Publ Hlth & Gen Practice, Box 1627, FIN-70211 Kuopio, Finland.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044199] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 44199] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Liinamaa MJ, 1997, ARTERIOSCL THROM VAS, V17, P2940, DOI 10.1161/01.ATV.17.11.2940; Perova Natalia V., 1995, Annals of Epidemiology, V5, P179, DOI 10.1016/1047-2797(94)00104-2; SALONEN JT, 1991, CIRCULATION, V84, P129, DOI 10.1161/01.CIR.84.1.129; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; *SOC CLIN CHEM CLI, 1976, SCAND J CLIN LAB INV, V36, P119	5	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 8	2003	327	7423					1082	1083		10.1136/bmj.327.7423.1082	http://dx.doi.org/10.1136/bmj.327.7423.1082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742QW	14604929	Green Published, Bronze			2022-12-01	WOS:000186530400018
J	Inatani, M; Irie, F; Plump, AS; Tessier-Lavigne, M; Yamaguchi, Y				Inatani, M; Irie, F; Plump, AS; Tessier-Lavigne, M; Yamaguchi, Y			Mammalian brain morphogenesis and midline axon guidance require heparan sulfate	SCIENCE			English	Article							NERVOUS-SYSTEM; PROTEOGLYCANS; GENE; NEUROGENESIS; DISRUPTION; EXPRESSION; RECEPTOR; EXT1; MICE	Heparan sulfate (HS) is required for morphogen signaling during Drosophila pattern formation, but little is known about its physiological importance in mammalian development. To de. ne the developmental role of HS in mammalian species, we conditionally disrupted the HS-polymerizing enzyme EXT1 in the embryonic mouse brain. The EXT1-null brain exhibited patterning defects that are composites of those caused by mutations of multiple HS-binding morphogens. Furthermore, the EXT1-null brain displayed severe guidance errors in major commissural tracts, revealing a pivotal role of HS in midline axon guidance. These findings demonstrate that HS is essential for mammalian brain development.	Burnham Inst, La Jolla, CA 92037 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94035 USA	Sanford Burnham Prebys Medical Discovery Institute; Howard Hughes Medical Institute; Stanford University	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NICHD NIH HHS [P01 HD25938] Funding Source: Medline; NINDS NIH HHS [R01 NS33117] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033117] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; IRIE F, UNPUB; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin X, 1998, BIOCHEM BIOPH RES CO, V248, P738, DOI 10.1006/bbrc.1998.9050; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238	19	331	339	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1044	1046		10.1126/science.1090497	http://dx.doi.org/10.1126/science.1090497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605369				2022-12-01	WOS:000186396300048
J	Biteau, B; Labarre, J; Toledano, MB				Biteau, B; Labarre, J; Toledano, MB			ATP-dependent reduction of cysteine-sulphinic acid by S-cerevisiae sulphiredoxin	NATURE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; OXIDATIVE STRESS; THIOREDOXIN PEROXIDASE; 2-CYS PEROXIREDOXIN; CRYSTAL-STRUCTURE; SULFENIC ACID; YEAST; IDENTIFICATION; CATALYSIS; SITE	Proteins contain thiol-bearing cysteine residues that are sensitive to oxidation, and this may interfere with biological function either as 'damage' or in the context of oxidant-dependent signal transduction. Cysteine thiols oxidized to sulphenic acid are generally unstable, either forming a disulphide with a nearby thiol or being further oxidized to a stable sulphinic acid(1,2). Cysteine - sulphenic acids and disulphides are known to be reduced by glutathione or thioredoxin in biological systems, but cysteine - sulphinic acid derivatives have been viewed as irreversible protein modifications. Here we identify a yeast protein of relative molecular mass M-r = 13,000, which we have named sulphiredoxin ( identified by the US spelling 'sulfiredoxin', in the Saccharomyces Genome Database), that is conserved in higher eukaryotes and reduces cysteine - sulphinic acid in the yeast peroxiredoxin Tsa1. Peroxiredoxins are ubiquitous thiol-containing antioxidants that reduce hydroperoxides(3-5) and control hydroperoxide-mediated signalling in mammals(6-8). The reduction reaction catalysed by sulphiredoxin requires ATP hydrolysis and magnesium, involving a conserved active-site cysteine residue which forms a transient disulphide linkage with Tsa1. We propose that reduction of cysteine - sulphinic acids by sulphiredoxin involves activation by phosphorylation followed by a thiol-mediated reduction step. Sulphiredoxin is important for the antioxidant function of peroxiredoxins, and is likely to be involved in the repair of proteins containing cysteine sulphinic acid modifications, and in signalling pathways involving protein oxidation.	CEA Saclay, DBJC, SBGM, Lab Stress Oxydants & Canc, F-91191 Gif Sur Yvette, France; CEA Saclay, DBJC, SBGM, Lab Physiogenom, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Toledano, MB (corresponding author), CEA Saclay, DBJC, SBGM, Lab Stress Oxydants & Canc, F-91191 Gif Sur Yvette, France.							CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; FURUKAWA M, 1980, SYNTHESIS-STUTTGART, P937; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KICE JL, 1979, J ORG CHEM, V44, P1918, DOI 10.1021/jo01326a005; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Maillet I, 1996, J BIOL CHEM, V271, P10263, DOI 10.1074/jbc.271.17.10263; NOGUCHI Y, 1983, B CHEM SOC JPN, V56, P349, DOI 10.1246/bcsj.56.349; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Poole LB, 2002, METHOD ENZYMOL, V348, P122, DOI 10.1016/S0076-6879(02)48632-6; Prouzet-Mauleon V, 2002, J BIOL CHEM, V277, P4823, DOI 10.1074/jbc.M109614200; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	30	745	781	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					980	984		10.1038/nature02075	http://dx.doi.org/10.1038/nature02075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586471				2022-12-01	WOS:000186230600046
J	Grakoui, A; Shoukry, NH; Woollard, DJ; Han, JH; Hanson, HL; Ghrayeb, J; Murthy, KK; Rice, CM; Walker, CM				Grakoui, A; Shoukry, NH; Woollard, DJ; Han, JH; Hanson, HL; Ghrayeb, J; Murthy, KK; Rice, CM; Walker, CM			HCV persistence and immune evasion in the absence of memory T cell help	SCIENCE			English	Article							HEPATITIS-C VIRUS; PROTECTIVE IMMUNITY; CD8-T-CELL MEMORY; VIRAL CLEARANCE; CD4-T-CELL HELP; INFECTION; RESPONSES; CHIMPANZEES; CD8(+); DETERMINANTS	Spontaneous resolution of hepatitis C virus (HCV) infection in humans usually affords long-term immunity to persistent viremia and associated liver diseases. Here, we report that memory CD4+ T cells are essential for this protection. Antibody-mediated depletion of CD4+ T cells before reinfection of two immune chimpanzees resulted in persistent, low-level viremia despite functional intrahepatic memory CD8+ T cell responses. Incomplete control of HCV replication by memory CD8+ T cells in the absence of adequate CD4+ T cell help was associated with emergence of viral escape mutations in class I major histocompatibility complex-restricted epitopes and failure to resolve HCV infection.	Cilumbus Childrens Res Inst, Ctr Vaccines & Immun, Columbus, OH 43205 USA; Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; Centocor Inc, Malvern, PA 19355 USA; SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX 78227 USA; Ohio State Univ, Coll Med & Publ Hlth, Dept Pediat, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Rockefeller University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Texas Biomedical Research Institute; University System of Ohio; Ohio State University	Walker, CM (corresponding author), Cilumbus Childrens Res Inst, Ctr Vaccines & Immun, 700 Childrens Dr,W503, Columbus, OH 43205 USA.		Yang, Chen/G-1379-2010		NCI NIH HHS [CA85883, CA57973] Funding Source: Medline; NHLBI NIH HHS [N01 HB27091] Funding Source: Medline; NIAID NIH HHS [AI40034, AI48231] Funding Source: Medline; PHS HHS [A14736] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB027091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085883, R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI048231] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JONKER M, 1993, CLIN EXP IMMUNOL, V93, P301, DOI 10.1111/j.1365-2249.1993.tb08176.x; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Looney James E., 1992, Human Antibodies and Hybridomas, V3, P191; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; PRINCE AM, 1992, J INFECT DIS, V165, P438, DOI 10.1093/infdis/165.3.438; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; WALKER CM, UNPUB; Weiner AJ, 2001, J VIROL, V75, P7142, DOI 10.1128/JVI.75.15.7142-7148.2001	28	651	679	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					659	662		10.1126/science.1088774	http://dx.doi.org/10.1126/science.1088774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576438				2022-12-01	WOS:000186119900063
J	Pellino, JL; Sontheimer, EJ				Pellino, JL; Sontheimer, EJ			R2D2 leads the silencing trigger to mRNA's death star	CELL			English	Editorial Material							REQUIREMENTS; INTERFERENCE; RDE-1; GENE	During RNA interference (RNAi), Dicer generates short interfering RNAs (siRNAs), which then guide target mRNA cleavage by the RISC complex. Now, Liu et al. identify R2D2, a Dicer-associated protein that is important for siRNA incorporation into RISC, thus linking the initiation and execution phases of RNAi.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Pellino, JL (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.			Sontheimer, Erik/0000-0002-0881-0310				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	10	6	12	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2003	115	2					132	133		10.1016/S0092-8674(03)00806-7	http://dx.doi.org/10.1016/S0092-8674(03)00806-7			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567910	Bronze			2022-12-01	WOS:000186039200004
J	Barzilai, N; Atzmon, G; Schechter, C; Schaefer, EJ; Cupples, AL; Lipton, R; Cheng, S; Shuldiner, AR				Barzilai, N; Atzmon, G; Schechter, C; Schaefer, EJ; Cupples, AL; Lipton, R; Cheng, S; Shuldiner, AR			Unique lipoprotein phenotype and genotype associated with exceptional longevity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEINS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PARTICLE-SIZE; GENE POLYMORPHISMS; HEPATIC LIPASE; HDL; ATHEROSCLEROSIS; CHOLESTEROL	Context Individuals with exceptional longevity have a lower incidence and/or significant delay in the onset of age-related disease, and their family members may inherit biological factors that modulate aging processes and disease susceptibility. Objective To identify specific biological and genetic factors that are associated with or reliably define a human longevity phenotype. Design, Setting, and Participants In a case-control design, 213 Ashkenazi Jewish probands with exceptional longevity (mean [SDI age, 98.2 [5.3] years) and their offspring (n=216; mean [SD] age, 68.3 [6.7] years) were recruited from 1998 to 2002, while an age-matched control group of Ashkenazi Jews (n=258) and participants from the Framingham Offspring Study (n = 589) were accepted as control groups. Main Outcome Measures Detailed questionnaires, physical examination, and blood samples were taken, including assessment of lipids and lipoprotein subclass levels and particle sizes by proton nuclear magnetic resonance. Samples were also genotyped for the codon 405 isoleucine to valine (1405V) variation in the cholesteryl ester transfer protein (CETP) gene, which is involved in regulation of lipoprotein and its particle sizes. Results High-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes were significantly higher in probands compared with both control groups (P=.001 for both), independent of plasma levels of HDL and LDL cholesterol and apolipoprotein A1 and B. This phenotype was also typical of the proband's offspring but not of the age-matched controls. The HDL and LDL particle sizes were significantly larger in offspring and controls without hypertension or cardiovascular disease, (P=.001 and P=.008, respectively). Furthermore, lipoprotein particle sizes, but not plasma LDL levels, were significantly higher in offspring and controls without the metabolic syndrome (P<.001). Probands and offspring had a 2.9- and 3.6-fold (in men) and 2.7- and 1.5-fold (in women) increased frequency, respectively, of homozygosity for the 405 valine allele of CETP (VV genotype), respectively, compared with controls (P<.001 for both). Those probands with the VV genotype had increased lipoprotein sizes and lower serum CETP concentrations. Conclusions Individuals with exceptional longevity and their offspring have significantly larger HDL and LDL particle sizes. This phenotype is associated with a lower prevalence of hypertension, cardiovascular disease, the metabolic syndrome, and increased homozygosity for the 1405V variant in CETP. These findings suggest that lipoprotein particle sizes are heritable and promote a healthy aging phenotype.	Yeshiva Univ Albert Einstein Coll Med, Inst Aging Res, Ctr Diabet Res & Training, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Community & Family Med, Bronx, NY 10461 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Baltimore Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD USA; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Roche Mol Syst Inc, Dept Human Genet, Alameda, CA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Tufts University; United States Department of Agriculture (USDA); Boston University; Roche Holding	Barzilai, N (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Inst Aging Res, Ctr Diabet Res & Training, Belfer Bldg 701,1300 Morris Pk Ave, Bronx, NY 10461 USA.	barzilai@aecom.yu.edu		Cupples, L. Adrienne/0000-0003-0273-7965; Shuldiner, Alan/0000-0001-9921-4305	NCRR NIH HHS [M01-RR12248] Funding Source: Medline; NIA NIH HHS [R01 AG-18728-01A1] Funding Source: Medline; NIDDK NIH HHS [DK 20541] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR012248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arai T, 2000, CLIN CHIM ACTA, V301, P103, DOI 10.1016/S0009-8981(00)00328-4; Arai Y, 2003, J MOL MED, V81, P102, DOI 10.1007/s00109-002-0407-6; Asztalos BF, 2002, J LIPID RES, V43, P1701, DOI 10.1194/jlr.M200037-JLR200; Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712; ATZMON G, IN PRESS J AM GERIAT; Austin M A, 2000, Curr Atheroscler Rep, V2, P200, DOI 10.1007/s11883-000-0021-4; AUSTIN MA, 1993, GENET EPIDEMIOL, V10, P599, DOI 10.1002/gepi.1370100645; Barzilai N, 1999, J GERONTOL A-BIOL, V54, pB89, DOI 10.1093/gerona/54.3.B89; Barzilai N, 2001, J AM GERIATR SOC, V49, P76, DOI 10.1046/j.1532-5415.2001.49013.x; Barzilai N, 2001, J GERONTOL A-BIOL, V56, pM83, DOI 10.1093/gerona/56.2.M83; Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9; Boekholdt SM, 2003, J LIPID RES, V44, P1080, DOI 10.1194/jlr.R200018-JLR200; Bruce C, 1998, J LIPID RES, V39, P1071; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Falconer D. S., 1996, INTRO QUANTATIVE GEN; FUNKE H, 1994, CIRCULATION, V90, P241; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Goto A, 2001, ATHEROSCLEROSIS, V159, P153, DOI 10.1016/S0021-9150(01)00476-2; Grundy SM, 1999, J LIPID RES, V40, P229; Gudnason V, 1999, EUR J CLIN INVEST, V29, P116, DOI 10.1046/j.1365-2362.1999.00412.x; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; IKEWAKI K, 1995, J CLIN INVEST, V96, P1573, DOI 10.1172/JCI118196; Kakko S, 2000, EUR J CLIN INVEST, V30, P18; Kakko S, 2001, EUR J CLIN INVEST, V31, P593, DOI 10.1046/j.1365-2362.2001.00859.x; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Kuivenhoven JA, 1997, ARTERIOSCL THROM VAS, V17, P560, DOI 10.1161/01.ATV.17.3.560; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Lancaster, 1997, Medscape Womens Health, V2, P7; Libby P, 2001, AM J CARDIOL, V88, p3N; Okumura K, 2002, ATHEROSCLEROSIS, V161, P425, DOI 10.1016/S0021-9150(01)00653-0; Otvos James D, 2002, Clin Lab, V48, P171; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Pascot A, 2002, ATHEROSCLEROSIS, V160, P399, DOI 10.1016/S0021-9150(01)00579-2; Perls T, 2002, MECH AGEING DEV, V123, P231, DOI 10.1016/S0047-6374(01)00348-7; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Rader DJ, 2000, MOL MED TODAY, V6, P170, DOI 10.1016/S1357-4310(00)01673-7; SAKAI N, 1995, EUR J CLIN INVEST, V25, P332, DOI 10.1111/j.1365-2362.1995.tb01710.x; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; YAMASHITA S, 1990, J CLIN INVEST, V86, P688, DOI 10.1172/JCI114764	43	428	451	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2003	290	15					2030	2040		10.1001/jama.290.15.2030	http://dx.doi.org/10.1001/jama.290.15.2030			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CX	14559957				2022-12-01	WOS:000185924200027
J	Kannus, P; Parkkari, J; Khan, K				Kannus, P; Parkkari, J; Khan, K			Hip protectors need an evidence base	LANCET			English	Editorial Material							OSTEOPOROTIC FRACTURES; FALLING CONDITIONS; IMPACT; PREVENTION; FORCE		Tampere Univ, Sch Med, Dept Surg, FIN-33520 Tampere, Finland; Univ Hosp, FIN-33520 Tampere, Finland; Tampere Res Ctr Sports Med, UKK Inst Hlth Promot Res, Tampere, Finland; Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, BC Womens Hosp Osteoporosis Program, Vancouver, BC V5Z 1M9, Canada	Tampere University; UKK Institute; University of British Columbia; University of British Columbia	Kannus, P (corresponding author), Tampere Univ, Sch Med, Dept Surg, FIN-33520 Tampere, Finland.							Birks YF, 2003, AGE AGEING, V32, P442, DOI 10.1093/ageing/32.4.442; Colon-Emeric CS, 2003, AGE AGEING, V32, P47, DOI 10.1093/ageing/32.1.47; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000063449; Dolan P, 1998, OSTEOPOROSIS INT, V8, P611, DOI 10.1007/s001980050107; Ekman A, 1997, LANCET, V350, P563, DOI 10.1016/S0140-6736(05)63140-6; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; Kannus P, 1999, LANCET, V353, P802, DOI 10.1016/S0140-6736(98)04235-4; Kannus P, 1999, BONE, V25, P229, DOI 10.1016/S8756-3282(99)00154-4; LAURITZEN JB, 1993, LANCET, V341, P11, DOI 10.1016/0140-6736(93)92480-H; McColl A, 1998, J PUBLIC HEALTH MED, V20, P196, DOI 10.1093/oxfordjournals.pubmed.a024743; PARKKARI J, 1995, J BONE MINER RES, V10, P1437; Parkkari J, 1997, CALCIFIED TISSUE INT, V60, P354, DOI 10.1007/s002239900242; Parkkari J, 1998, AGE AGEING, V27, P225, DOI 10.1093/ageing/27.2.225; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Wei TS, 2001, OSTEOPOROSIS INT, V12, P1050, DOI 10.1007/PL00004184	15	15	15	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 11	2003	362	9391					1168	1169		10.1016/S0140-6736(03)14554-0	http://dx.doi.org/10.1016/S0140-6736(03)14554-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CW	14568734				2022-12-01	WOS:000185924100004
J	Konje, JC; Huppertz, B; Bell, SC; Taylor, DJ; Kaufmann, P				Konje, JC; Huppertz, B; Bell, SC; Taylor, DJ; Kaufmann, P			3-dimensional colour power angiography for staging human placental development	LANCET			English	Article							ANGIOGENESIS	Maldevelopment of placental villous trees and their blood vessels results in impaired fetal growth, which can greatly compromise fetal, neonatal, childhood, and adulthood health. There are no means of directly assessing such maldevelopment. We have applied a new technique of imaging (colour power angiography [CPA]) with 3-dimensional reconstruction to assess directly villous development in human pregnancy in vivo in 20 uncomplicated pregnancies from 13 to 38 weeks' gestation. The chronology of villous trees was much the same in 3-dimensional CPA, scanning electron micrography, and classical histology from controls matched by age. This approach provides a unique opportunity to examine normal placental development directly, and should provide the bases for real-time investigation of placental pathology and a robust method for diagnosis and surveillance during pregnancy.	Univ Leicester, Dept Obstet & Gynaecol, Fetal Growth & Dev Res Grp, Leicester, Leics, England; Univ Technol, Univ Hosp, Inst Anat 2, Aachen, Germany	University of Leicester; RWTH Aachen University; RWTH Aachen University Hospital	Konje, JC (corresponding author), Univ Leicester, Dept Obstet & Gynaecol, Fetal Growth & Dev Res Grp, Leicester, Leics, England.	jck4@le.ac.uk	Huppertz, Berthold/I-2331-2019	Huppertz, Berthold/0000-0003-4814-2158				BERNISCHKE K, 2000, PATHOLOGY HUMAN PLAC; GRANNUM PAT, 1979, AM J OBSTET GYNECOL, V133, P915, DOI 10.1016/0002-9378(79)90312-0; Kadyrov M, 1998, LANCET, V352, P1747, DOI 10.1016/S0140-6736(98)02069-8; KAUFMANN P, 1987, PLACENTA, V8, P235, DOI 10.1016/0143-4004(87)90047-6; Todros T, 1999, OBSTET GYNECOL, V93, P499, DOI 10.1016/S0029-7844(98)00440-2	5	36	36	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2003	362	9391					1199	1201		10.1016/S0140-6736(03)14514-X	http://dx.doi.org/10.1016/S0140-6736(03)14514-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CW	14568743				2022-12-01	WOS:000185924100013
J	Binswanger, HP				Binswanger, HP			Willingness to pay for AIDS treatment: myths and realities	LANCET			English	Editorial Material									World Bank, Africa Reg, Washington, DC 20433 USA	The World Bank	Binswanger, HP (corresponding author), World Bank, Africa Reg, 1818 H St NW, Washington, DC 20433 USA.		Binswanger, Hans/M-6883-2013	Binswanger, Hans/0000-0002-6323-1418				BINSWANGER H, 2002, 14 C AIDS BARC JUL 7; Binswanger HP, 2001, SCIENCE, V292, P221, DOI 10.1126/science.1057504; DESCLAUX A, 2001, INITIATIVE SENEGALAI; DO M, 14 INT HIV AIDS C 20; DONNELLY J, 2001, BOSTON GLOBE BO 0607, P8; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; MSELLATI P, 2002, ACCES TRAITEMENTS VI; RIVERS B, FILLING FUNDING GAP; ROSEN S, 2003, HARVARD BUSINESS FEB, P80; SIMON J, 2000, HIV AIDS COMMONWEALT, P4; *UNAIDS, FACT SHEET IMPACT HI; *UNAIDS, 2002, GLOB AIDS EP BARC JU; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; World Health Organization, 2002, SCAL ANT THER RES LT	14	9	9	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 4	2003	362	9390					1152	1153		10.1016/S0140-6736(03)14473-X	http://dx.doi.org/10.1016/S0140-6736(03)14473-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728HA	14550705				2022-12-01	WOS:000185710700026
J	Unger, DL				Unger, DL			One should never forget about heredity	LANCET			English	Editorial Material									Diplomate Amer Board Allergy & Immunol, Thousand Oaks, CA 91362 USA		Unger, DL (corresponding author), Diplomate Amer Board Allergy & Immunol, 1459 Thousand Oaks Blvd, Thousand Oaks, CA 91362 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1934	1934		10.1016/S0140-6736(03)14969-0	http://dx.doi.org/10.1016/S0140-6736(03)14969-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667755				2022-12-01	WOS:000187011600029
J	Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ				Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ			An ostracode crustacean with soft parts from the lower silurian	SCIENCE			English	Article							FUNCTIONAL-MORPHOLOGY; HEREFORDSHIRE; ARTHROPOD; ENGLAND; MYODOCOPES; APPENDAGES	An exceptionally well-preserved ostracode from the Silurian of Herefordshire, United Kingdom, provides a rare view of the fossilized soft-part anatomy of this important group of living crustaceans and confirms that Ostracoda were extant in the Paleozoic. The fossil has striking similarity to the extant myodocopid family Cylindroleberididae, to which it is assigned, and demonstrates remarkable evolutionary stasis over 425 million years. The fossil is identified as a male on the basis of its copulatory organ.	Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Museum Nat Hist, Geol Collect, Oxford OX1 3PW, England	University of Leicester; University of Oxford; Yale University; University of Oxford	Siveter, DJ (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	djs@leicester.ac.uk	Sutton, Mark/A-4189-2010					Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Gabbott SE, 2003, LETHAIA, V36, P151, DOI 10.1080/00241160310004620; HIRUTA S, 1979, J FS HOKKAIDO U, V22, P9; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Hou XG, 1996, PHILOS T ROY SOC B, V351, P1131; KORNICKER LS, 1981, SMITHSON CONTRIB ZOO, V319, P1548; Muller K. J, 1979, P 7 INT S OSTR BEOGR, P5; Orr PJ, 2000, J GEOL SOC LONDON, V157, P173, DOI 10.1144/jgs.157.1.173; Parker AR, 1997, J MAR BIOL ASSOC UK, V77, P1223, DOI 10.1017/S002531540003873X; Parker AR, 1997, J CRUSTACEAN BIOL, V17, P632, DOI 10.2307/1549366; Siveter D.J., 1991, Journal of Micropalaeontology, V10, P151; SIVETER D. J, 1989, NATL MUSEUM WALES GE, V9, P252; SIVETER DJ, 1990, T ROY SOC EDIN-EARTH, V81, P45, DOI 10.1017/S0263593300005125; Smith RJ, 2000, PALAEONTOLOGY, V43, P63, DOI 10.1111/1475-4983.00119; Sutton MD, 2002, P ROY SOC B-BIOL SCI, V269, P1195, DOI 10.1098/rspb.2002.1986; Sutton MD, 2001, P ROY SOC B-BIOL SCI, V268, P2355, DOI 10.1098/rspb.2001.1788; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; SUTTON MD, 2001, PALEONTOL ELECT, V4; Vannier J, 1998, MAR BIOL, V132, P391, DOI 10.1007/s002270050406; Vannier J, 1996, J CRUSTACEAN BIOL, V16, P453, DOI 10.2307/1548735; Walossek Dieter, 1993, Fossils and Strata, V32, P1; Yamaguchi S, 2003, MAR BIOL, V143, P23, DOI 10.1007/s00227-003-1062-3	22	106	115	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1749	1751		10.1126/science.1091376	http://dx.doi.org/10.1126/science.1091376			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657495				2022-12-01	WOS:000186970100043
J	Papa, FR; Zhang, C; Shokat, K; Walter, P				Papa, FR; Zhang, C; Shokat, K; Walter, P			Bypassing a kinase activity with an ATP-competitive drug	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; RNASE-L; TRANSMEMBRANE PROTEIN; TYROSINE KINASES; NUCLEUS; IRE1P; ER; PHOSPHORYLATION; DIMERIZATION	Unfolded proteins in the endoplasmic reticulum cause trans-autophosphorylation of the bifunctional transmembrane kinase Ire1, which induces its endoribonuclease activity. The endoribonuclease initiates nonconventional splicing of HAC1 messenger RNA to trigger the unfolded-protein response (UPR). We explored the role of Ire1's kinase domain by sensitizing it through site-directed mutagenesis to the ATP-competitive inhibitor 1NM-PP1. Paradoxically, rather than being inhibited by 1NM-PP1, drug-sensitized Ire1 mutants required 1NM-PP1 as a cofactor for activation. In the presence of 1NM-PP1, drug-sensitized Ire1 bypassed mutations that inactivate its kinase activity and induced a full UPR. Thus, rather than through phosphorylation per se, a conformational change in the kinase domain triggered by occupancy of the active site with a ligand leads to activation of all known downstream functions.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.		Longo, Kenneth A/A-5631-2010	Papa, Feroz/0000-0002-3684-9108	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384, R37GM032384] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44009] Funding Source: Medline; NIGMS NIH HHS [GM32384] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Carroll AS, 2001, P NATL ACAD SCI USA, V98, P12578, DOI 10.1073/pnas.211195798; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.0.CO;2-K; MORI K, 1993, CELL, V74, P743; Naik S, 1998, NUCLEIC ACIDS RES, V26, P1522, DOI 10.1093/nar/26.6.1522; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schuit F, 1999, J BIOL CHEM, V274, P32803, DOI 10.1074/jbc.274.46.32803; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, J CELL SCI, V113, P3697; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300	29	193	203	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1533	1537		10.1126/science.1090031	http://dx.doi.org/10.1126/science.1090031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14564015				2022-12-01	WOS:000186802200033
J	Ariyo, AA; Thach, C; Tracy, R				Ariyo, AA; Thach, C; Tracy, R		Cardiovascular Hlth Study Investig	Lp(a) lipoprotein, vascular disease, and mortality in the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; INDEPENDENT RISK-FACTOR; ELEVATED LIPOPROTEIN(A); ATHEROTHROMBOTIC DISEASE; CEREBROVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CEREBRAL INFARCTION; MEN; WOMEN; JAPANESE	Background: As compared with what is known about predictors of vascular events in middle-aged persons, less is known about these events in the elderly. Lp(a) lipoprotein, which plays an important part in atherothrombogenesis, has been associated with an increased risk of vascular disease. We investigated this relation among older U.S. adults. Methods: In a prospective study of 5888 community-dwelling older adults (65 years of age or older) in the United States, 2375 women and 1597 men who were free of vascular disease provided base-line serum samples for analysis for levels of Lp(a) lipoprotein. These 3972 subjects were followed for a median of 7.4 years to evaluate the development of stroke and to track deaths from vascular causes and all causes. The men and women were divided into quintile groups according to the Lp(a) lipoprotein level at base line. Results: Using Cox proportional-hazards models, we determined the risk associated with each quintile level of Lp(a) lipoprotein, with the lowest quintile serving as the reference group. As compared with those in the lowest quintile, men in the highest quintile had three times the unadjusted risk of stroke (relative risk, 3.00; 95 percent confidence interval, 1.59 to 5.65), almost three times the risk of death associated with vascular events (relative risk, 2.54; 95 percent confidence interval, 1.59 to 4.08), and nearly twice the risk of death from all causes (relative risk, 1.76; 95 percent confidence interval, 1.31 to 2.36). Adjustment for age; sex; the levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides; carotid-wall thickness; smoking status; the presence or absence of diabetes and systolic and diastolic hypertension; body-mass index; and other traditional risk factors had little effect on the final assessments. Similar analyses for women, which also included adjustment for estrogen use or nonuse, revealed no such relation. Conclusions: Among older adults in the United States, an elevated level of Lp(a) lipoprotein is an independent predictor of stroke, death from vascular disease, and death from any cause in men but not in women. These data support the use of Lp(a) lipoprotein levels in predicting the risk of these events in older men.	HeartMasters, Ctr Cardiovasc Dis Prevent & Intervent, Dallas, TX 75212 USA; Johns Hopkins Univ Hosp, Div Cardiol, Baltimore, MD 21287 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle; University of Vermont	Ariyo, AA (corresponding author), HeartMasters, Ctr Cardiovasc Dis Prevent & Intervent, 2411 Poinciana Pl, Dallas, TX 75212 USA.				NHLBI NIH HHS [N01-HC-15103, N01-HC-850079-85086] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ariyo A, 1998, J Cardiovasc Risk, V5, P273, DOI 10.1097/00043798-199808000-00010; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; CAMBILLAU M, 1992, ARTERIOSCLER THROMB, V12, P1346, DOI 10.1161/01.ATV.12.11.1346; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; COLEMAN MP, 1992, ATHEROSCLEROSIS, V92, P177, DOI 10.1016/0021-9150(92)90276-M; COX DR, 1972, J R STAT SOC B, V34, P187; Craig WY, 1998, CLIN CHEM, V44, P2301; Dahlen GH, 1998, J INTERN MED, V244, P425; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; *DEP HLTH HHS, 1980, DHHS PUBL PHS; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; KANNEL WB, 1986, CORONARY HEART DISEA, P60; Kario K, 1996, ARTERIOSCL THROM VAS, V16, P734, DOI 10.1161/01.ATV.16.6.734; KARIO K, 1994, AM J CARDIOL, V73, P1187, DOI 10.1016/0002-9149(94)90179-1; Klausen IC, 1997, ATHEROSCLEROSIS, V132, P77, DOI 10.1016/S0021-9150(97)00071-3; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P672, DOI 10.1161/01.ATV.10.5.672; *MATHS, 1998, S PLUS WIND SYST REL; Nguyen TT, 1997, CIRCULATION, V96, P1390, DOI 10.1161/01.CIR.96.5.1390; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; RIDKER PM, 1995, JAMA-J AM MED ASSOC, V273, P1269, DOI 10.1001/jama.273.16.1269; *SAS I, 1996, SAS WIND SYST REL 6; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Schlaich MP, 1998, J AM COLL CARDIOL, V31, P359, DOI 10.1016/S0735-1097(97)00497-X; SHINTANI S, 1993, STROKE, V24, P965, DOI 10.1161/01.STR.24.7.965; SPENCER G, 1989, CURRENT POPULATI P25, V1018; Sunayama S, 1996, CIRCULATION, V94, P1263, DOI 10.1161/01.CIR.94.6.1263; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P1010, DOI 10.1161/01.ATV.17.5.1010; WONG WLT, 1990, CLIN CHEM, V36, P192; ZENKER G, 1986, STROKE, V17, P942, DOI 10.1161/01.STR.17.5.942	36	180	193	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2108	2115		10.1056/NEJMoa001066	http://dx.doi.org/10.1056/NEJMoa001066			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645638				2022-12-01	WOS:000186779700005
J	Varma, JK; Greene, KD; Reller, ME; DeLong, SM; Trottier, J; Nowicki, SF; DiOrio, M; Koch, EM; Bannerman, TL; York, ST; Lambert-Fair, MA; Wells, JG; Mead, PS				Varma, JK; Greene, KD; Reller, ME; DeLong, SM; Trottier, J; Nowicki, SF; DiOrio, M; Koch, EM; Bannerman, TL; York, ST; Lambert-Fair, MA; Wells, JG; Mead, PS			An outbreak of Escherichia coli O157 infection following exposure to a contaminated building	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAIRY FARM FAMILIES; UNITED-STATES; RISK-FACTORS; SURVIVAL; CONTACT	Context Infection with Escherichia coli O157 causes an estimated 70000 diarrheal illnesses per year in the United States and can result in hemolytic-uremic syndrome and death. Environmental contamination with E coli O157 may be a public health problem. Objectives To determine risk factors for E coli O157 infection during an outbreak investigation at a county fair and to evaluate environmental contamination as a possible cause of the outbreak. Design, Setting, and Participants Case-control study of 23 patients (median age, 15 years) and 53 age-matched controls who had attended the Lorain County, Ohio, fair between August 20 and August 26, 2001. Case-patients had laboratory-confirmed E coli O157 infection, hemolytic-uremic syndrome, or bloody diarrhea within 7 days of attending the fair; controls attended the fair and did not have diarrhea. Main Outcome Measures Risk factors for infection and isolates of E coli O157 from environmental specimens. Results Six (26%) case-patients were hospitalized and 2 (9%) developed hemolyticuremic syndrome. Case-patients were more likely than controls to have visited building A (a multipurpose community facility on the fairgrounds; matched odds ratio [MOR], 21.4 [95% confidence interval {CI), 2.7-170.7]). Among visitors to building A, illness was independently associated with attending a dance in the building (MOR, 7.5; 95% CI, 1.4-41.2), handling sawdust from the floor (MOR, 4.6; 95% CI, 1.1-20.0), or eating and/or drinking in the building (MOR, 4.5; 95% CI, 1.2-16.6). Twenty-four (44%) of 54 specimens collected from building A 6 weeks after the fair grew Shiga toxin-producing E coli O157. Isolates from sawdust, the rafters, and other surfaces were identical by molecular fingerprinting to patient isolates. Sawdust specimens collected 42 weeks after the fair also grew the same E coli O157 strain. Conclusions Absence of evidence implicating specific food or beverage sources and the recovery of E coli O157 from the rafters suggest that airborne dispersion of bacteria contributed to the contamination. Because E coli O157 can survive in the environment for more than 10 months, humans may be at risk of infection long after an environment is initially contaminated.	Ctr Dis Control & Prevent, Food & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ohio Dept Hlth, Elyria, OH USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Varma, JK (corresponding author), CDC HIV, TB Prevent & Control Sect, Box 68,Amer Embassy, APO, AP 96546 USA.		Bannerman, Tammy/E-2694-2011					Browning N.D., 2000, REV ADV MATER SCI, V1, P1; *CDCP, 2000, STAND MOL SUBT FOODB; *CDCP, 2000, FOODB DIS ACT SURV N, P19; Crampin M, 1999, EUR J CLIN MICROBIOL, V18, P286, DOI 10.1007/s100960050278; Crump JA, 2002, NEW ENGL J MED, V347, P555, DOI 10.1056/NEJMoa020524; CRUMP JA, IN PRESS EPIDEMIOL I; DOYLE MP, 1987, APPL ENVIRON MICROB, V53, P2394, DOI 10.1128/AEM.53.10.2394-2396.1987; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Locking ME, 2001, EPIDEMIOL INFECT, V127, P215, DOI 10.1017/S0950268801006045; Mead PS, 1997, ARCH INTERN MED, V157, P204, DOI 10.1001/archinte.157.2.204; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; O'Brien SJ, 2001, EMERG INFECT DIS, V7, P1049, DOI 10.3201/eid0706.010626; Ogden ID, 2002, LETT APPL MICROBIOL, V34, P100, DOI 10.1046/j.1472-765x.2002.01052.x; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; Rahn K, 1998, J INFECT DIS, V177, P1139, DOI 10.1086/517394; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; WELLS JG, 1999, 99 GEN M AM SOC MICR; Wilson JB, 1996, J INFECT DIS, V174, P1021, DOI 10.1093/infdis/174.5.1021; 2001, MMWR MORB MORTAL WKL, V50, P293	22	112	122	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2709	2712		10.1001/jama.290.20.2709	http://dx.doi.org/10.1001/jama.290.20.2709			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645313	Bronze			2022-12-01	WOS:000186788100023
J	Pak, DTS; Sheng, M				Pak, DTS; Sheng, M			Targeted protein degradation and synapse remodeling by an inducible protein kinase	SCIENCE			English	Article							LONG-TERM POTENTIATION; POLO-LIKE KINASES; DENDRITIC SPINES; EXCITATORY SYNAPSES; PLASTICITY; ACTIN; UBIQUITIN; MITOSIS	Synaptic plasticity involves the reorganization of synapses at the protein and the morphological levels. Here, we report activity-dependent remodeling of synapses by serum-inducible kinase (SNK). SNK was induced in hippocampal neurons by synaptic activity and was targeted to dendritic spines. SNK bound to and phosphorylated spine-associated Rap guanosine triphosphatase activating protein (SPAR), a postsynaptic actin regulatory protein, leading to degradation of SPAR. Induction of SNK in hippocampal neurons eliminated SPAR protein, depleted postsynaptic density-95 and Bassoon clusters, and caused loss of mature dendritic spines. These results implicate SNK as a mediator of activity-dependent change in the molecular composition and morphology of synapses.	MIT, Howard Hughes Med Inst, Neurosci Res Ctr, RIKEN,Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Pak, DTS (corresponding author), MIT, Howard Hughes Med Inst, Neurosci Res Ctr, RIKEN,Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.			Sheng, Morgan/0000-0002-8703-5366				BAILEY CH, 1989, J NEUROBIOL, V20, P356, DOI 10.1002/neu.480200508; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; El-Hussein AE, 2000, SCIENCE, V290, P1364; Feng Y, 2001, CELL GROWTH DIFFER, V12, P29; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Gao QS, 1999, MOL CELL BIOL, V19, P733; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim CH, 1999, J NEUROSCI, V19, P4314; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	28	233	244	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1368	1373		10.1126/science.1082475	http://dx.doi.org/10.1126/science.1082475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14576440				2022-12-01	WOS:000186683500044
J	Dacey, MJ				Dacey, MJ			Tragedy and response - The Rhode Island nightclub fire	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kent Cty Hosp, Dept Crit Care Med, Warwick, RI 02886 USA		Dacey, MJ (corresponding author), Kent Cty Hosp, Dept Crit Care Med, Warwick, RI 02886 USA.								0	27	27	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2003	349	21					1990	1992		10.1056/NEJMp038179	http://dx.doi.org/10.1056/NEJMp038179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744QE	14627783				2022-12-01	WOS:000186642900002
J	Friml, J; Vieten, A; Sauer, M; Weijers, D; Schwarz, H; Hamann, T; Offringa, R; Jurgens, G				Friml, J; Vieten, A; Sauer, M; Weijers, D; Schwarz, H; Hamann, T; Offringa, R; Jurgens, G			Efflux-dependent auxin gradients establish the apical-basal axis of Arabidopsis	NATURE			English	Article							GNOM ARF-GEF; PATTERN-FORMATION; MORPHOGEN GRADIENTS; POLAR TRANSPORT; PLANT; EMBRYO; GENE; CELLS; ROOT; EMBRYOGENESIS	Axis formation occurs in plants, as in animals, during early embryogenesis. However, the underlying mechanism is not known. Here we show that the first manifestation of the apical-basal axis in plants, the asymmetric division of the zygote, produces a basal cell that transports and an apical cell that responds to the signalling molecule auxin. This apical-basal auxin activity gradient triggers the specification of apical embryo structures and is actively maintained by a novel component of auxin efflux, PIN7, which is located apically in the basal cell. Later, the developmentally regulated reversal of PIN7 and onset of PIN1 polar localization reorganize the auxin gradient for specification of the basal root pole. An analysis of pin quadruple mutants identifies PIN-dependent transport as an essential part of the mechanism for embryo axis formation. Our results indicate how the establishment of cell polarity, polar auxin efflux and local auxin response result in apical-basal axis formation of the embryo, and thus determine the axiality of the adult plant.	Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Leiden Univ, Clusius Lab, Inst Biol, NL-2333 AL Leiden, Netherlands; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Leiden University; Leiden University - Excl LUMC; Max Planck Society	Friml, J (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 3, D-72076 Tubingen, Germany.		Sauer, Michael/G-3424-2011; Friml, Jiri/D-9511-2012; Sauer, Michael/F-6519-2014; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010	Friml, Jiri/0000-0002-8302-7596; Sauer, Michael/0000-0002-4014-9825; Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X				Braselton JP, 1996, BIOTECH HISTOCHEM, V71, P84, DOI 10.3109/10520299609117139; CARUSO JL, 1995, PLANT HORMONES PHYSL, P43; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Fischer-Iglesias C, 2001, PLANT J, V26, P115, DOI 10.1046/j.1365-313x.2001.01013.x; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Hadfi K, 1998, DEVELOPMENT, V125, P879; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; MAYER U, 1993, DEVELOPMENT, V117, P149; Moctezuma E, 1999, ANN BOT-LONDON, V83, P235, DOI 10.1006/anbo.1998.0814; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; RAVEN JA, 1975, NEW PHYTOL, V74, P163, DOI 10.1111/j.1469-8137.1975.tb02602.x; Ribnicky DM, 2002, PLANTA, V214, P505, DOI 10.1007/s004250100639; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Steeves TA, 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; STJOHNSTON D, 1992, CELL, V68, P201; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; WEIJERS D, 2002, THESIS U LEIDEN; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	39	1334	1418	17	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					147	153		10.1038/nature02085	http://dx.doi.org/10.1038/nature02085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614497				2022-12-01	WOS:000186517200034
J	Lane, AA; Ley, TJ				Lane, AA; Ley, TJ			Neutrophil elastase cleaves PML-RAR alpha and is important for the development of acute promyelocytic leukemia in mice	CELL			English	Article							DIPEPTIDYL PEPTIDASE-I; RECURRING CHROMOSOMAL-ABNORMALITIES; TRANS-RETINOIC ACID; CATHEPSIN-G; PML/RAR-ALPHA; SERINE PROTEASES; FUSION PROTEIN; MOUSE MODEL; GRANZYME-B; CELL	The fusion protein PML-RARalpha, generated by the t(15;17)(q22;q11.2) translocation associated with acute promyelocytic leukemia (APL), initiates APL when expressed in the early myeloid compartment of transgenic mice. PML-RARalpha is cleaved in several positions by a neutral serine protease in a human myeloid cell line; purification revealed that the protease is neutrophil elastase (NE). Immunofluorescence localization studies suggested that the cleavage of PML-RARalpha must occur within the cell, and perhaps, within the nucleus. The functional importance of NE for APL development was assessed in NE deficient mice. Greater than 90% of bone marrow PML-RARalpha cleaving activity was lost in the absence of NE, and NE (but not Cathepsin G) deficient animals were protected from APL development. Primary mouse and human APL cells also contain NE-dependent PML-RARalpha cleaving activity. Since NE is maximally produced in promyelocytes, this protease may play a role in APL pathogenesis by facilitating the leukemogenic potential of PML-RARalpha.	Washington Univ, Sch Med, Siteman Canc Ctr, Dept Med,Div Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, Dept Genet,Div Oncol, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, Dept Med,Div Oncol, St Louis, MO 63110 USA.	tley@im.wustl.edu		Lane, Andrew/0000-0001-7380-0226	NATIONAL CANCER INSTITUTE [R01CA083962] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NCI NIH HHS [CA83962] Funding Source: Medline; NHLBI NIH HHS [T32 HLO 7088] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI200213462; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; CAMPBELL EJ, 1989, J IMMUNOL, V143, P2961; Early E, 1996, P NATL ACAD SCI USA, V93, P7900, DOI 10.1073/pnas.93.15.7900; Fanelli M, 1999, BLOOD, V93, P1477, DOI 10.1182/blood.V93.5.1477.405a33_1477_1481; Ferrucci PF, 1997, P NATL ACAD SCI USA, V94, P10901, DOI 10.1073/pnas.94.20.10901; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; GALLAGHER RE, 1995, BLOOD, V86, P1540, DOI 10.1182/blood.V86.4.1540.bloodjournal8641540; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Horwitz M, 2003, CURR OPIN HEMATOL, V10, P49, DOI 10.1097/00062752-200301000-00008; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jans DA, 1998, J CELL SCI, V111, P2645; Jans DA, 1996, J BIOL CHEM, V271, P30781, DOI 10.1074/jbc.271.48.30781; Jing Y, 2003, ONCOGENE, V22, P4083, DOI 10.1038/sj.onc.1206568; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; Le Beau MM, 2003, BLOOD, V102, P1072, DOI 10.1182/blood-2003-01-0155; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Mcdonold SJF, 2001, BIOORG MED CHEM LETT, V11, P895, DOI 10.1016/S0960-894X(01)00078-6; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Pollock JL, 2001, CURR OPIN HEMATOL, V8, P206, DOI 10.1097/00062752-200107000-00005; Sohal J, 2003, BLOOD, V101, P3188, DOI 10.1182/blood-2002-06-1800; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Trapani JA, 1996, J BIOL CHEM, V271, P4127; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; WELGUS HG, 1986, J CLIN INVEST, V77, P1675, DOI 10.1172/JCI112485; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Westervelt P, 1999, BLOOD, V93, P2143, DOI 10.1182/blood.V93.7.2143.407a32_2143_2148; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215; Zimonjic DB, 2000, P NATL ACAD SCI USA, V97, P13306, DOI 10.1073/pnas.97.24.13306	45	103	125	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					305	318		10.1016/S0092-8674(03)00852-3	http://dx.doi.org/10.1016/S0092-8674(03)00852-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636558	Bronze			2022-12-01	WOS:000186415000010
J	Huxter, J; Burgess, N; O'Keefe, J				Huxter, J; Burgess, N; O'Keefe, J			Independent rate and temporal coding in hippocampal pyramidal cells	NATURE			English	Article							THETA-PHASE PRECESSION; PLACE CELLS; NEURONAL-ACTIVITY; OSCILLATIONS; MEMORY; EXPERIENCE; EXPANSION; SEQUENCES; DYNAMICS; POSITION	In the brain, hippocampal pyramidal cells use temporal(1) as well as rate(2) coding to signal spatial aspects of the animal's environment or behaviour. The temporal code takes the form of a phase relationship to the concurrent cycle of the hippocampal electroencephalogram theta rhythm(1). These two codes could each represent a different variable(3,4). However, this requires the rate and phase to vary independently, in contrast to recent suggestions(5,6) that they are tightly coupled, both reflecting the amplitude of the cell's input. Here we show that the time of firing and firing rate are dissociable, and can represent two independent variables: respectively the animal's location within the place field, and its speed of movement through the field. Independent encoding of location together with actions and stimuli occurring there may help to explain the dual roles of the hippocampus in spatial and episodic memory(7,8), or may indicate a more general role of the hippocampus in relational/declarative memory(9,10).	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	O'Keefe, J (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	j.okeefe@ucl.ac.uk	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584	Medical Research Council [G0501672(76328), G0501672, G117/433] Funding Source: Medline; Wellcome Trust [071248] Funding Source: Medline; MRC [G117/433] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Eichenbaum H, 2004, CONDITIONING CONSCIO; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OKeefe J, 1991, BRAIN SPACE, P273, DOI DOI 10.1016/j.neuron.2015.06.011; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WIENER SI, 1989, J NEUROSCI, V9, P2737; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629	30	417	427	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					828	832		10.1038/nature02058	http://dx.doi.org/10.1038/nature02058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574410	Green Accepted			2022-12-01	WOS:000186118500043
J	Couzin, J				Couzin, J			Aging research - Is long life in the blood?	SCIENCE			English	News Item																			0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					373	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14563979				2022-12-01	WOS:000185963200006
J	Finney, SJ; Zekveld, C; Elia, A; Evans, TW				Finney, SJ; Zekveld, C; Elia, A; Evans, TW			Glucose control and mortality in critically ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	99th International Conference of the American-Thoracic-Society	MAY, 2003	SEATTLE, WASHINGTON	Amer Thorac Soc			ACUTE MYOCARDIAL-INFARCTION; INTENSIVE INSULIN THERAPY; ADMISSION PLASMA-GLUCOSE; INDEPENDENT RISK-FACTOR; DIABETIC-PATIENTS; HYPERGLYCEMIA; INFUSION; TRIAL; MODULATION; FAILURE	Context Hyperglycemia is common in critically ill patients, even in those without diabetes mellitus. Aggressive glycemic control may reduce mortality in this population. However, the relationship between mortality, the control of hyperglycemia, and the administration of exogenous insulin is unclear. Objective To determine whether blood glucose level or quantity of insulin administered is associated with reduced mortality in critically ill patients. Design, Setting, and Patients Single-center, prospective, observational study of 531 patients (median age, 64 years) newly admitted over the first 6 months of 2002 to an adult intensive care unit (ICU) in a UK national referral center for cardiorespiratory surgery and medicine. Main Outcome Measures The primary end point was intensive care unit (ICU) mortality. Secondary end points were hospital mortality, ICU and hospital length of stay, and predicted threshold glucose level associated with risk of death.. Results Of 531 patients admitted to the ICU, 523 underwent analysis of their glycemic control. Twenty-four-hour control of blood glucose levels was variable. Rates of ICU and hospital mortality were 5.2% and 5.7%, respectively; median lengths of stay were 1.8 (interquartile range, 0.9-3.7) days and 6 (interquartile range, 4.5-8.3) days, respectively. Multivariable logistic regression demonstrated that increased administration of insulin was positively and significantly associated with ICU mortality (odds ratio, 1.02 [95% confidence interval, 1.01-1.04] at a prevailing glucose level of 111-144 mg/dL [6.1-8.0 mmol/L] for a 1-IU/d increase), suggesting that mortality benefits are attributable to glycemic control rather than increased administration of insulin. Also, the regression models suggest that a mortality benefit accrues below a predicted threshold glucose level of 144 to 200 mg/dL (8.0-11.1 mmol/L), with a speculative upper limit of 145 mg/dL (8.0 mmol/L) for the target blood glucose level. Conclusions increased insulin administration is positively associated with death in the ICU regardless of the prevailing blood glucose level. Thus, control of glucose levels rather than of absolute levels of exogenous insulin appear to account for the mortality benefit associated with intensive insulin therapy demonstrated by others.	Royal Brompton Hosp, Adult Intens Care Unit, London SW3 6LY, England; Royal Brompton Hosp, Dept Occupat & Environm Med, London SW3 6LY, England; Royal Brompton Hosp, Dept Biomed Engn, London SW3 6LY, England	Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton Hospital	Evans, TW (corresponding author), Royal Brompton Hosp, Adult Intens Care Unit, Sydney St, London SW3 6LY, England.		Finney, Simon/A-2168-2012	Finney, Simon/0000-0001-8219-1952				Annane D, 2003, CRIT CARE MED, V31, P634, DOI 10.1097/01.CCM.0000045569.14948.F2; British Association for Parenteral and Enteral Nutrition, 1996, STAND GUID NUTR SUPP; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; *DEP HLTH, 2000, HOSP ACT STAT; Dhatariya K, 2003, JAMA-J AM MED ASSOC, V289, P1244, DOI 10.1001/jama.289.10.1244-a; Diaz R, 1998, CIRCULATION, V98, P2227, DOI 10.1161/01.CIR.98.21.2227; Evans TW, 2001, NEW ENGL J MED, V345, P1417, DOI 10.1056/NEJM200111083451910; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Malmberg K, 1999, CIRCULATION, V99, P2626, DOI 10.1161/01.CIR.99.20.2626; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; McManus LM, 2001, J LEUKOCYTE BIOL, V70, P395; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; Montori VM, 2002, JAMA-J AM MED ASSOC, V288, P2167, DOI 10.1001/jama.288.17.2167; Norhammar AM, 1999, DIABETES CARE, V22, P1827, DOI 10.2337/diacare.22.11.1827; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wass CT, 1996, MAYO CLIN PROC, V71, P801; Zindrou D, 2001, DIABETES CARE, V24, P1634, DOI 10.2337/diacare.24.9.1634	23	688	730	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2003	290	15					2041	2047		10.1001/jama.290.15.2041	http://dx.doi.org/10.1001/jama.290.15.2041			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CX	14559958	Bronze			2022-12-01	WOS:000185924200028
J	Deng, YB; Ren, XY; Yang, L; Lin, YH; Wu, XW				Deng, YB; Ren, XY; Yang, L; Lin, YH; Wu, XW			A JNK-dependent pathway is required for TNF alpha-induced apoptosis	CELL			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; INDUCED CELL-DEATH; CYTOCHROME-C; CASPASE ACTIVATION; MITOCHONDRIA; INDUCTION; INHIBITION; PROMOTES; PROTEIN	Tumor necrosis factor (TNFalpha) receptor signaling can simultaneously activate caspase 8, the transcription factor, NF-KB and the kinase, JNK. While activation of caspase 8 is required for TNFalpha-induced apoptosis, and induction of NF-KB inhibits cell death, the precise function of JNK activation in TNFa signaling is not clearly understood. Here, we report that TNFalpha-mediated caspase 8 cleavage and apoptosis require a sequential pathway involving JNK, Bid, and Smac/DIABLO. Activation of JNK induces caspase 8-independent cleavage of Bid at a distinct site to generate the Bid cleavage product jBid. Translocation of jBid to mitochondria leads to preferential release of Smac/DIABLO, but not cytochrome c. The released Smac/DIABLO then disrupts the TRAF2-cIAP1 complex. We propose that the JNK pathway described here is required to relieve the inhibition imposed by TRAF2-cIAP1 on caspase 8 activation and induction of apoptosis. Further, our findings define a mechanism for crosstalk between intrinsic and extrinsic cell death pathways.	Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Wu, XW (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.		ren, xianyan/J-3165-2018	Deng, Yibin/0000-0001-5711-3565				Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; LUO ZG, 1996, CELL, V94, P481; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Rennefahrt UEE, 2002, J BIOL CHEM, V277, P29510, DOI 10.1074/jbc.M203010200; Reuther JY, 1999, J BIOL CHEM, V274, P20664, DOI 10.1074/jbc.274.29.20664; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; VAN AD, 1996, SCIENCE, V274, P787; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XD, 2001, GENE DEV, V15, P2922; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	44	473	493	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 3	2003	115	1					61	70		10.1016/S0092-8674(03)00757-8	http://dx.doi.org/10.1016/S0092-8674(03)00757-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532003	Bronze			2022-12-01	WOS:000185815500009
J	Kim, D; Park, D; Choi, S; Lee, S; Sun, M; Kim, C; Shin, HS				Kim, D; Park, D; Choi, S; Lee, S; Sun, M; Kim, C; Shin, HS			Thalamic control of visceral nociception mediated by T-type Ca2+ channels	SCIENCE			English	Article							THALAMOCORTICAL RELAY; CALCIUM CHANNELS; DORSAL COLUMN; SPINAL-CORD; NEURONS; BURST; RESPONSES; PATHWAY; NUCLEUS; RATS	Sensations from viscera, like fullness, easily become painful if the stimulus persists. Mice lacking alpha1GT-typeCa(2+) channels show hyperalgesia to visceral pain. Thalamic infusion of a T-type blocker induced similar hyperalgesia in wild-type mice. In response to visceral pain, the ventroposterolateral thalamic neurons evoked a surge of single spikes, which then slowly decayed as T type-dependent burst spikes gradually increased. In alpha1G-deficient neurons, the single-spike response persisted without burst spikes. These results indicate that T-type Ca2+ channels underlie an antinociceptive mechanism operating in the thalamus and support the idea that burst. ring plays a critical role in sensory gating in the thalamus.	Korea Inst Sci & Technol, Natl Creat Res Initiat Ctr Calcium & Learning, Seoul 136791, South Korea	Korea Institute of Science & Technology (KIST)	Shin, HS (corresponding author), Korea Inst Sci & Technol, Natl Creat Res Initiat Ctr Calcium & Learning, Seoul 136791, South Korea.	shin@kist.re.kr	Kim, Daesoo/C-1625-2011	Kim, Daesoo/0000-0001-9915-1463				AlChaer ED, 1996, J NEUROPHYSIOL, V76, P2661, DOI 10.1152/jn.1996.76.4.2661; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; Clozel JP, 1997, J HYPERTENS, V15, pS17, DOI 10.1097/00004872-199715055-00004; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Dogrul A, 1998, GEN PHARMACOL-VASC S, V30, P613, DOI 10.1016/S0306-3623(97)00335-2; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Llinas R, 2001, ANN NY ACAD SCI, V929, P166; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Matthews EA, 2001, EUR J PHARMACOL, V415, P141, DOI 10.1016/S0014-2999(01)00812-3; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Montero VM, 1999, NEUROSCIENCE, V91, P805, DOI 10.1016/S0306-4522(98)00632-0; SEYBOLD VS, 1995, CAN J PHYSIOL PHARM, V73, P1007, DOI 10.1139/y95-141; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; Steriade M, 2001, NAT NEUROSCI, V4, P671, DOI 10.1038/89434; Steriade M., 1997, THALAMUS; Talley EM, 1999, J NEUROSCI, V19, P1895; Todorovic SM, 2002, BRAIN RES, V951, P336, DOI 10.1016/S0006-8993(02)03350-4; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; Willis WD, 1999, P NATL ACAD SCI USA, V96, P7675, DOI 10.1073/pnas.96.14.7675	29	189	199	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2003	302	5642					117	119		10.1126/science.1088886	http://dx.doi.org/10.1126/science.1088886			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526084				2022-12-01	WOS:000185678500049
J	Roman, MJ; Shanker, B; Davis, A; Lockshin, MD; Sammaritano, L; Simantov, R; Crow, MK; Schwartz, JE; Paget, SA; Devereux, RB; Salmon, JE				Roman, MJ; Shanker, B; Davis, A; Lockshin, MD; Sammaritano, L; Simantov, R; Crow, MK; Schwartz, JE; Paget, SA; Devereux, RB; Salmon, JE			Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; APPARENTLY HEALTHY-MEN; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FOLLOW-UP; CLASSIFICATION; EVENTS; PLASMA	BACKGROUND: Although systemic lupus erythematosus is associated with premature myocardial infarction, the prevalence of underlying atherosclerosis and its relation to traditional risk factors for cardiovascular disease and lupus-related factors have not been examined in a case-control study. METHODS: In 197 patients with lupus and 197 matched controls, we performed carotid ultrasonography, echocardiography, and an assessment for risk factors for cardiovascular disease. The patients were also evaluated with respect to their clinical and serologic features, inflammatory mediators, and disease treatment. RESULTS: The risk factors for cardiovascular disease were similar among patients and controls. Atherosclerosis (carotid plaque) was more prevalent among patients than the controls (37.1 percent vs. 15.2 percent, P<0.001). In multivariate analysis, only older age, the presence of systemic lupus erythematosus (odds ratio, 4.8; 95 percent confidence interval, 2.6 to 8.7), and a higher serum cholesterol level were independently related to the presence of plaque. As compared with patients without plaque, patients with plaque were older, had a longer duration of disease and more disease-related damage, and were less likely to have multiple autoantibodies or to have been treated with prednisone, cyclophosphamide, or hydroxychloroquine. In multivariate analyses including patients with lupus, independent predictors of plaque were a longer duration of disease, a higher damage-index score, a lower incidence of the use of cyclophosphamide, and the absence of anti-Smith antibodies. CONCLUSIONS: Atherosclerosis occurs prematurely in patients with systemic lupus erythematosus and is independent of traditional risk factors for cardiovascular disease. The clinical profile of patients with lupus and atherosclerosis suggests a role for disease-related factors in atherogenesis and underscores the need for trials of more focused and effective antiinflammatory therapy.	Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Div Rheumatol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY 10021 USA; Hosp Special Surg, New York, NY 10021 USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA	Cornell University; Cornell University; Cornell University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Roman, MJ (corresponding author), Cornell Univ, Weill Med Coll, Div Cardiol, 525 E 68th St, New York, NY 10021 USA.		Crow, Mary/R-8480-2019	Schwartz, Joseph/0000-0002-8944-3566	NCRR NIH HHS [M10RR0047] Funding Source: Medline; NHLBI NIH HHS [HL 47540, P01 HL047540] Funding Source: Medline; NIAMS NIH HHS [AR 45591] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045591] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Belcaro G, 1996, ARTERIOSCL THROM VAS, V16, P851, DOI 10.1161/01.ATV.16.7.851; DEVEREUX RB, 1995, HYPERTENSION PATHOPH, V2, P1969; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; JOHNSON H, 1989, MEDICINE, V68, P141; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; PETRI M, 1992, MEDICINE, V71, P291, DOI 10.1097/00005792-199209000-00004; PETRI M, 1994, AM J MED, V96, P254, DOI 10.1016/0002-9343(94)90151-1; PETRI M, 1992, AM J MED, V93, P513, DOI 10.1016/0002-9343(92)90578-Y; Petri M, 2002, ARTHRITIS RHEUM-US, V46, pS458; Petri M, 1996, LANCET, V348, P1120, DOI 10.1016/S0140-6736(96)03032-2; Petri M, 1998, ARTHRITIS RHEUM, V41, pS218; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Roman MJ, 1996, J AM COLL CARDIOL, V28, P1642; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Roman MJ, 2001, AM J CARDIOL, V87, P663, DOI 10.1016/S0002-9149(00)01453-3; Salmon JE, 2001, CURR OPIN RHEUMATOL, V13, P341, DOI 10.1097/00002281-200109000-00001; SALONEN JT, 1993, CIRCULATION, V87, P56; Schnall PL, 1998, PSYCHOSOM MED, V60, P697, DOI 10.1097/00006842-199811000-00007; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; SIMANTOV R, 1995, J CLIN INVEST, V96, P2211, DOI 10.1172/JCI118276; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; UELAND PM, 1993, CLIN CHEM, V39, P1764; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Vaarala O, 2000, J INTERN MED, V247, P381, DOI 10.1046/j.1365-2796.2000.00657.x; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F	33	1034	1103	0	18	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2399	2406		10.1056/NEJMoa035471	http://dx.doi.org/10.1056/NEJMoa035471			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681505				2022-12-01	WOS:000187326200005
J	Kolodgie, FD; Gold, HK; Burke, AP; Fowler, DR; Kruth, HS; Weber, DK; Farb, A; Guerrero, LJ; Hayase, M; Kutys, R; Narula, J; Finn, AV; Virmani, R				Kolodgie, FD; Gold, HK; Burke, AP; Fowler, DR; Kruth, HS; Weber, DK; Farb, A; Guerrero, LJ; Hayase, M; Kutys, R; Narula, J; Finn, AV; Virmani, R			Intraplaque hemorrhage and progression of coronary atheroma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RED-BLOOD-CELLS; LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROTIC LESIONS; PLAQUE MORPHOLOGY; CHOLESTEROL; ERYTHROCYTES; MEMBRANE; RECEPTOR; DISEASE; HYPERCHOLESTEROLEMIA	BACKGROUND: Intraplaque hemorrhage is common in advanced coronary atherosclerotic lesions. The relation between hemorrhage and the vulnerability of plaque to disruption may involve the accumulation of free cholesterol from erythrocyte membranes. METHODS: We stained multiple coronary lesions from 24 randomly selected patients who had died suddenly of coronary causes with an antibody against glycophorin A (a protein specific to erythrocytes that facilitates anion exchange) and Mallory's stain for iron (hemosiderin), markers of previous intraplaque hemorrhage. Coronary lesions were classified as lesions with pathologic intimal thickening, fibrous-cap atheromas with cores in an early or late stage of necrosis, or thin-cap fibrous atheromas (vulnerable plaques). The arterial response to plaque hemorrhage was further defined in a rabbit model of atherosclerosis. RESULTS: Only traces of glycophorin A and iron were found in lesions with pathologic intimal thickening or fibrous-cap atheromas with cores in an early stage of necrosis. In contrast, fibroatheromas with cores in a late stage of necrosis or thin caps had a marked increase in glycophorin A in regions of cholesterol clefts surrounded by iron deposits. Larger amounts of both glycophorin A and iron were associated with larger necrotic cores and greater macrophage infiltration. Rabbit lesions with induced intramural hemorrhage consistently showed cholesterol crystals with erythrocyte fragments, foam cells, and iron deposits. In contrast, control lesions from the same animals had a marked reduction in macrophages and lipid content. CONCLUSIONS: By contributing to the deposition of free cholesterol, macrophage infiltration, and enlargement of the necrotic core, the accumulation of erythrocyte membranes within an atherosclerotic plaque may represent a potent atherogenic stimulus. These factors may increase the risk of plaque destabilization.	Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA; Massachusetts Gen Hosp, Dept Internal Med, Cardiac Unit, Boston, MA 02114 USA; Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA; NHLBI, Sect Expt Atherosclerosis, NIH, Bethesda, MD 20892 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	United States Department of Defense; Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Drexel University	Virmani, R (corresponding author), Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Bldg 54,Rm 2005,6825 16th St, Washington, DC 20306 USA.				NHLBI NIH HHS [R01 HL61799-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061799, ZIAHL002832, Z01HL002832] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arbustini E, 2002, HEART, V88, P177, DOI 10.1136/heart.88.2.177; Auffray I, 2001, BLOOD, V97, P2872, DOI 10.1182/blood.V97.9.2872; Balkan J, 2002, BIOSCI BIOTECH BIOCH, V66, P2701, DOI 10.1271/bbb.66.2701; BARGER AC, 1984, NEW ENGL J MED, V310, P175, DOI 10.1056/NEJM198401193100307; Bloch K., 1991, NEW COMPREHENSIVE BI, V20, P363; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610; Burke AP, 1999, JAMA-J AM MED ASSOC, V281, P921, DOI 10.1001/jama.281.10.921; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; COFFEY MD, 1995, J CLIN INVEST, V96, P1866, DOI 10.1172/JCI118232; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Felton CV, 1997, ARTERIOSCL THROM VAS, V17, P1337, DOI 10.1161/01.ATV.17.7.1337; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Ishikawa K, 2001, CIRC RES, V88, P506, DOI 10.1161/01.RES.88.5.506; ITO N, 1990, HISTOCHEM J, V22, P113, DOI 10.1007/BF01885790; Kempaiah RK, 2002, MOL CELL BIOCHEM, V236, P155, DOI 10.1023/A:1016199000149; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Koter M, 2002, EUR J CLIN PHARMACOL, V58, P501, DOI 10.1007/s00228-002-0507-9; KRUTH HS, 1984, AM J PATHOL, V114, P201; LALONDE JMA, 1977, VIRCHOWS ARCH B, V25, P221; Leon ME, 2002, ARCH PATHOL LAB MED, V126, P217; Martinez M, 1996, THROMB RES, V83, P375, DOI 10.1016/0049-3848(96)00147-8; McCarthy MJ, 1999, J VASC SURG, V30, P261, DOI 10.1016/S0741-5214(99)70136-9; Mofidi R, 2001, BRIT J SURG, V88, P945, DOI 10.1046/j.0007-1323.2001.01823.x; NEOTE K, 1993, J BIOL CHEM, V268, P12247; PATTERSON JC, 1954, S ATH; SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265; SCHICK BP, 1985, BIOCHIM BIOPHYS ACTA, V833, P281, DOI 10.1016/0005-2760(85)90200-0; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Tabas I, 2000, BBA-MOL CELL BIOL L, V1529, P164, DOI 10.1016/S1388-1981(00)00146-3; Tulenko TN, 1998, J LIPID RES, V39, P947; Virmani R, 1998, AM HEART J, V136, P937, DOI 10.1016/S0002-8703(98)70144-9; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Virmani R., 1987, ADULT CONGENITAL HEA, P77; VIRMANI R, 1996, ATLAS CARDIOVASCULAR, P103; Wartman WB, 1938, AM HEART J, V15, P459, DOI 10.1016/S0002-8703(38)90300-X; WARTMAN WB, 1949, AM J PATHOL, V25, P383; WINTERNITZ MC, 1938, BIOL ARTERIOSCLEROSI, P94; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; YUAN XM, 1995, ARTERIOSCL THROM VAS, V15, P1345, DOI 10.1161/01.ATV.15.9.1345	40	1043	1109	4	48	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2316	2325		10.1056/NEJMoa035655	http://dx.doi.org/10.1056/NEJMoa035655			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668457				2022-12-01	WOS:000187125000007
J	Sharp, D				Sharp, D			The West Nile season	LANCET			English	Editorial Material							VIRUS		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2003, W NIL ACT 2003 HUM C; Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, P886; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Pletnev AG, 2003, VIROLOGY, V314, P190, DOI 10.1016/S0042-6822(03)00450-1	7	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1870	1870		10.1016/S0140-6736(03)14999-9	http://dx.doi.org/10.1016/S0140-6736(03)14999-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667740				2022-12-01	WOS:000187011600005
J	Ule, J; Jensen, KB; Ruggiu, M; Mele, A; Ule, A; Darnell, RB				Ule, J; Jensen, KB; Ruggiu, M; Mele, A; Ule, A; Darnell, RB			CLIP identifies Nova-regulated RNA networks in the brain	SCIENCE			English	Article							4 SPLICE VARIANTS; MESSENGER-RNAS; PROTEIN; BINDING; GEPHYRIN; RECEPTOR; DISEASE; CHANNELS; DOMAIN; MOUSE	Nova proteins are neuron-specific antigens targeted in paraneoplastic opsoclonus myoclonus ataxia (POMA), an autoimmune neurologic disease characterized by abnormal motor inhibition. Nova proteins regulate neuronal pre-messenger RNA splicing by directly binding to RNA. To identify Nova RNA targets, we developed a method to purify protein-RNA complexes from mouse brain with the use of ultraviolet cross-linking and immunoprecipitation (CLIP). Thirty-four transcripts were identified multiple times by Nova CLIP. Three-quarters of these encode proteins that function at the neuronal synapse, and one-third are involved in neuronal inhibition. Splicing targets confirmed in Nova(-/-) mice include c-Jun N-terminal kinase 2, neogenin, and gephyrin; the latter encodes a protein that clusters inhibitory gamma-aminobutyric acid and glycine receptors, two previously identified Nova splicing targets. Thus, CLIP reveals that Nova coordinately regulates a biologically coherent set of RNAs encoding multiple components of the inhibitory synapse, an observation that may relate to the cause of abnormal motor inhibition in POMA.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Univ Amsterdam, Ctr Res Expt Econ & Polit Decis Making, NL-1018 WB Amsterdam, Netherlands	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; University of Amsterdam	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.		Darnell, Robert B/B-9022-2008; Jensen, Kirk/B-4756-2008; Ule, Jernej/C-6315-2013; Jensen, Kirk/AAL-5883-2020	Darnell, Robert B/0000-0002-5134-8088; Jensen, Kirk/0000-0002-2084-1734; Ule, Jernej/0000-0002-2452-4277; Jensen, Kirk/0000-0002-2084-1734; Ruggiu, Matteo/0000-0002-6404-1210	NIMH NIH HHS [K01 MH64753] Funding Source: Medline; NINDS NIH HHS [NS40955, R01 NS34389] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH064753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R01NS040955] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Billups D, 2000, J NEUROSCI, V20, P8643; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Butler MH, 2000, NEURON, V26, P307, DOI 10.1016/S0896-6273(00)81165-4; Casanova E, 1996, NEUROREPORT, V7, P1320, DOI 10.1097/00001756-199605170-00021; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; GAO FB, 1994, P NATL ACAD SCI USA, V91, P11207, DOI 10.1073/pnas.91.23.11207; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; LERNER MR, 1981, CELL, V25, P298, DOI 10.1016/0092-8674(81)90047-7; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; RUGGIU M, UNPUB; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; ULE J, UNPUB; Villanueva A, 2001, EMBO J, V20, P5114, DOI 10.1093/emboj/20.18.5114; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25	33	788	815	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1212	1215		10.1126/science.1090095	http://dx.doi.org/10.1126/science.1090095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615540				2022-12-01	WOS:000186544300055
J	Ehlers, MD				Ehlers, MD			Eppendorf 2003 prize-winning essay - Ubiquitin and the deconstruction of synapses	SCIENCE			English	Editorial Material							POSTSYNAPTIC DENSITY; NMDA RECEPTOR; MODULATION; PROTEINS; FAMILY		Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu						Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Ehlers M.D., 2003, NAT NEUROSCI, V10, P10; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meyer T, 2000, TRENDS CELL BIOL, V10, P238, DOI 10.1016/S0962-8924(00)01764-5; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	22	16	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					800	801		10.1126/science.1092546	http://dx.doi.org/10.1126/science.1092546			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593160				2022-12-01	WOS:000186258000030
J	Martinowich, K; Hattori, D; Wu, H; Fouse, S; He, F; Hu, Y; Fan, GP; Sun, YE				Martinowich, K; Hattori, D; Wu, H; Fouse, S; He, F; Hu, Y; Fan, GP; Sun, YE			DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation	SCIENCE			English	Article							BINDING PROTEIN MECP2; TRANSCRIPTION FACTOR; HISTONE DEACETYLASE; CALCIUM REGULATION; RETT-SYNDROME; CNS NEURONS; EXPRESSION; LOCALIZATION; REGIONS	In conjunction with histone modi. cations, DNA methylation plays critical roles in gene silencing through chromatin remodeling. Changes in DNA methylation perturb neuronal function, and mutations in a methyl-CpG-binding protein, MeCP2, are associated with Rett syndrome. We report that increased synthesis of brain-derived neurotrophic factor (BDNF) in neurons after depolarization correlates with a decrease in CpG methylation within the regulatory region of the Bdnf gene. Moreover, increased Bdnf transcription involves dissociation of the MeCP2-histone deacetylase-mSin3A repression complex from its promoter. Our findings suggest that DNA methylation-related chromatin remodeling is important for activity-dependent gene regulation that may be critical for neural plasticity.	Univ Calif Los Angeles, ACCESS Program, Neurosci Interdept Program, Los Angeles, CA USA; Univ Calif Los Angeles, ACCESS Program, Dept Mol & Med Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, ACCESS Program, Dept Psychiat & Behav Sci, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fan, GP (corresponding author), Univ Calif Los Angeles, ACCESS Program, Neurosci Interdept Program, Los Angeles, CA USA.	gfan@mednet.ucla.edu; ysun@mednet.ucla.edu	Wu, Hao/G-4145-2013; Martinowich, Keri/F-9841-2012	Wu, Hao/0000-0002-1256-6891; Martinowich, Keri/0000-0002-5237-0789; Fan, Guoping/0000-0001-5235-6410; Wu, Hao/0000-0003-4395-6929	NINDS NIH HHS [NS44405] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044405] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen WG, 2003, J NEUROSCI, V23, P2572; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1007/s002580050019; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	28	1072	1115	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					890	893		10.1126/science.1090842	http://dx.doi.org/10.1126/science.1090842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593184				2022-12-01	WOS:000186258000056
J	Clement, AM; Nguyen, MD; Roberts, EA; Garcia, ML; Boillee, S; Rule, M; McMahon, AP; Doucette, W; Siwek, D; Ferrante, RJ; Brown, RH; Julien, JP; Goldstein, LSB; Cleveland, DW				Clement, AM; Nguyen, MD; Roberts, EA; Garcia, ML; Boillee, S; Rule, M; McMahon, AP; Doucette, W; Siwek, D; Ferrante, RJ; Brown, RH; Julien, JP; Goldstein, LSB; Cleveland, DW			Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; DISEASE ONSET; FAMILIAL ALS; EXPRESSION; DEATH; DEGENERATION; PROGRESSION; MUTATIONS	The most common form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting adult motor neurons, is caused by dominant mutations in the ubiquitously expressed Cu-Zn superoxide dismutase (SOD1). In chimeric mice that are mixtures of normal and SOD1 mutant-expressing cells, toxicity to motor neurons is shown to require damage from mutant SOD1 acting within nonneuronal cells. Normal motor neurons in SOD1 mutant chimeras develop aspects of ALS pathology. Most important, nonneuronal cells that do not express mutant SOD1 delay degeneration and significantly extend survival of mutant-expressing motor neurons.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; McGill Univ, Montreal Gen Hosp, Hlth Care Ctr, Res Inst,Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Massachusetts Gen Hosp E, Day Neuromuscular Res Lab, Charlestown, MA 02139 USA; Boston Univ, Sch Med, Bedford VA Med Ctr, Dept Neurol,Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA; Boston Univ, Sch Med, Bedford VA Med Ctr, Dept Pathol,Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA; Boston Univ, Sch Med, Bedford VA Med Ctr, Dept Psychiat,Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; McGill University; Harvard University; Boston University; Geriatric Research Education & Clinical Center; Boston University; Geriatric Research Education & Clinical Center; Boston University; Geriatric Research Education & Clinical Center	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; McMahon, Andrew P/ABE-7520-2020; Boillee, Severine/J-4027-2017; Doucette, Wilder/S-2019-2016	Doucette, Wilder/0000-0003-2249-0461; BOILLEE, Severine/0000-0001-5518-9005; Cleveland, Don/0000-0002-1934-3682	NIA NIH HHS [AG 12992, AG 13846] Funding Source: Medline; NICHD NIH HHS [HD 30249] Funding Source: Medline; NINDS NIH HHS [NS 37912, NS 27036, R37 NS027036, NS 31248] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS031248, P01NS031248, R01NS037912, R01NS027036, R37NS027036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012992, P30AG013846] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrus PK, 1998, J NEUROCHEM, V71, P2041; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bush AI, 2002, NAT NEUROSCI, V5, P919, DOI 10.1038/nn1002-919a; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadjantonakis AK, 2001, HISTOCHEM CELL BIOL, V115, P49, DOI 10.1007/s004180000233; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; JULIEN JP, 1990, J PHYSIOLOGY PARIS, V84, P50; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagy A, 1999, GENE TARGETING PRACT, P177; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	35	844	884	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2003	302	5642					113	117		10.1126/science.1086071	http://dx.doi.org/10.1126/science.1086071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526083				2022-12-01	WOS:000185678500048
J	Lonart, G; Schoch, S; Kaeser, PS; Larkin, CJ; Sudhof, TC; Linden, DJ				Lonart, G; Schoch, S; Kaeser, PS; Larkin, CJ; Sudhof, TC; Linden, DJ			Phosphorylation of RIM1 alpha by PKA triggers presynaptic long-term potentiation at cerebellar parallel fiber synapses	CELL			English	Article							DEPENDENT PROTEIN-KINASE; CA3 PYRAMIDAL NEURONS; RAB3 EFFECTOR; ACTIVE ZONE; 2 FORMS; LTP; RIM; EXPRESSION; MECHANISMS; PLASTICITY	Presynaptic activation of protein kinase A (PKA) induces LTP in cerebellar parallel fiber synapses. Presynaptic LTP is known to require the active zone protein RIM1alpha, but the underlying induction mechanism remains unclear. We now show that PKA directly phosphorylates RIM1alpha at two sites. Using paired recordings from cultured cerebellar granule and Purkinje neurons, we demonstrate that LTP is absent in neurons from RIM1alpha KO mice but is rescued by presynaptic expression of RIM1alpha. Mutant RIM1alpha lacking the N-terminal phosphorylation site is unable to rescue LTP in RIM1alpha knockout neurons but selectively suppresses LTP in wild-type neurons. Our findings suggest that PKA-mediated phosphorylation of the active zone protein RIM1alpha at a single N-terminal site induces presynaptic LTP.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Eastern Virginia Med Sch, Dept Pathol & Anat, Norfolk, VA 23501 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Eastern Virginia Medical School; Johns Hopkins University	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu; dlinden@jhmi.edu	Schoch, Susanne/F-7741-2012		NIMH NIH HHS [MH01505, MH51106, MH01590] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051106, R37MH051106, R01MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bear MF, 2001, SYNAPSES, P455; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Castro-Alamancos MA, 1999, J NEUROSCI, V19, P9090, DOI 10.1523/JNEUROSCI.19-20-09090.1999; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Daly C, 1997, J NEUROSCI, V17, P2365; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAMIYA H, 2002, J NEUROSCI, V22, P10524; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kapur A, 2001, NEUROSCIENCE, V107, P59, DOI 10.1016/S0306-4522(01)00293-7; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Linden DJ, 1998, J NEUROPHYSIOL, V79, P3151, DOI 10.1152/jn.1998.79.6.3151; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Linden DJ, 1999, J NEUROSCI, V19, P10221; Lonart G, 1998, J NEUROSCI, V18, P634; Lonart G, 2002, TRENDS NEUROSCI, V25, P329, DOI 10.1016/S0166-2236(02)02193-8; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; LopezGarcia JC, 1996, P NATL ACAD SCI USA, V93, P4712, DOI 10.1073/pnas.93.10.4712; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; REGEHR WG, 1991, NEURON, V7, P451, DOI 10.1016/0896-6273(91)90297-D; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Spencer JP, 2002, NEUROSCI LETT, V329, P217, DOI 10.1016/S0304-3940(02)00659-6; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang XL, 2001, J BIOL CHEM, V276, P32480, DOI 10.1074/jbc.M103337200; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WHITTAKER VP, 1993, J NEUROCYTOL, V22, P735, DOI 10.1007/BF01181319; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	64	173	183	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2003	115	1					49	60		10.1016/S0092-8674(03)00727-X	http://dx.doi.org/10.1016/S0092-8674(03)00727-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532002	Bronze			2022-12-01	WOS:000185815500008
J	Ellner, A				Ellner, A			Rethinking prescribing in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article									BMJ Knowledge, London WC1H 9JR, England		Ellner, A (corresponding author), BMJ Knowledge, London WC1H 9JR, England.	aellner@bmjgroup.com						*AM COLL PHYS, 2001, AMB CAR FORM PHARM B; [Anonymous], 2002, WORLD HLTH REP 2002; Blumenthal D, 2000, DESCRIPTION ANAL VA; Goff V V, 2001, Issue Brief Natl Health Policy Forum, P1; Holmer AF, 2002, NEW ENGL J MED, V346, P526, DOI 10.1056/NEJM200202143460714; Horn SD, 1996, LANCET, V348, P619, DOI 10.1016/S0140-6736(05)64839-8; Ioannides-Demos LL, 2002, PHARMACOECONOMICS, V20, P577, DOI 10.2165/00019053-200220090-00002; KITCHMAN M, 2002, SENIORS PRESCRIPTION; *NIH CAR MAN FDN, 2000, PRESCR DRUGS MASS ME; *PROD COMM, 2001, INT PHARM PRIC DIFF; *REF DRUG PROGR CO, 2002, REP MIN HLTH PLANN; Rennie D, 2000, JAMA-J AM MED ASSOC, V283, P2158, DOI 10.1001/jama.283.16.2158; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; RossDegnan D, 1996, LANCET, V347, P1264, DOI 10.1016/S0140-6736(96)90782-5; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schneeweiss S, 2002, CAN MED ASSOC J, V166, P737; Steinbrook R, 2002, NEW ENGL J MED, V346, P790, DOI 10.1056/NEJM200203143461102; STUART B, 2000, REPORT PRESIDENT PRE; WHO, WHO MOD LIST ESS MED	19	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2003	327	7428					1397	1400		10.1136/bmj.327.7428.1397	http://dx.doi.org/10.1136/bmj.327.7428.1397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670892	Green Published			2022-12-01	WOS:000187417900030
J	Ausmees, N; Kuhn, JR; Jacobs-Wagner, C				Ausmees, N; Kuhn, JR; Jacobs-Wagner, C			The bacterial cytoskeleton: An intermediate filament-like function	CELL			English	Article							PENICILLIN-BINDING-PROTEINS; ACTIN-LIKE FILAMENTS; CELL-SHAPE; CHROMOSOMAL INSERTION; LINEAR MOTOR; COILED COILS; DIVISION; PREDICTION; PHOSPHORYLATION; SEGREGATION	Various cell shapes are encountered in the prokaryotic world, but how they are achieved is poorly understood. Intermediate filaments (IFs) of the eukaryotic cytoskeleton play an important role in cell shape in higher organisms. No such filaments have been found in prokaryotes. Here, we describe a bacterial equivalent to IF proteins, named crescentin, whose cytoskeletal function is required for the vibrioid and helical shapes of Caulobacter crescentus. Without crescentin, the cells adopt a straight-rod morphology. Crescentin has characteristic features of IF proteins including the ability to assemble into filaments in vitro without energy or cofactor requirements. In vivo, crescentin forms a helical structure that colocalizes with the inner cell curvatures beneath the cytoplasmic membrane. We propose that IF-like filaments of crescentin assemble into a helical structure, which by applying its geometry to the cell, generates a vibrioid or helical cell shape depending on the length of the cell.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334	NIGMS NIH HHS [GM065835, GM26338] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835, R01GM026338] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brown JH, 1996, PROTEINS, V26, P134; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; CONCHELLO JA, 1996, 3 DIMENSIONAL MICROS, P199; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; DOMINGO A, 1992, P223; Dusenbery DB, 1998, J BACTERIOL, V180, P5978, DOI 10.1128/JB.180.22.5978-5983.1998; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Gindullis F, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-9; HENNING U, 1972, EUR J BIOCHEM, V26, P570, DOI 10.1111/j.1432-1033.1972.tb01800.x; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; HUIATT TW, 1980, J BIOL CHEM, V255, P6981; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mayordomo I, 2002, BIOCHEM J, V365, P51, DOI 10.1042/BJ20020053; Mewes HW, 1998, NUCLEIC ACIDS RES, V26, P33, DOI 10.1093/nar/26.1.33; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; SHOHAYEB M, 1987, J GEN MICROBIOL, V133, P1733; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; TOWNSEND R, 1980, J BACTERIOL, V142, P694, DOI 10.1128/JB.142.2.694-700.1980; Trachtenberg S, 2003, MOL MICROBIOL, V47, P671, DOI 10.1046/j.1365-2958.2003.t01-1-03200.x; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; van Hemert MJ, 2003, J BIOL CHEM, V278, P15049, DOI 10.1074/jbc.M212495200; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; Wortinger MA, 1998, MOL MICROBIOL, V29, P963, DOI 10.1046/j.1365-2958.1998.00959.x	52	272	279	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					705	713		10.1016/S0092-8674(03)00935-8	http://dx.doi.org/10.1016/S0092-8674(03)00935-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675535	Bronze			2022-12-01	WOS:000187366100010
J	Darwin, KH; Ehrt, S; Gutierrez-Ramos, JC; Weich, N; Nathan, CF				Darwin, KH; Ehrt, S; Gutierrez-Ramos, JC; Weich, N; Nathan, CF			The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide	SCIENCE			English	Article							20S PROTEASOME; SYNTHASE; DEGRADATION; INCREASES; PROTEINS; LUNG	The production of nitric oxide and other reactive nitrogen intermediates (RNI) by macrophages helps to control infection by Mycobacterium tuberculosis (Mtb). However, the protection is imperfect and infection persists. To identify genes that Mtb requires to resist RNI, we screened 10,100 Mtb transposon mutants for hypersusceptibility to acidified nitrite. We found 12 mutants with insertions in seven genes representing six pathways, including the repair of DNA (uvrB) and the synthesis of a flavin cofactor (fbiC). Five mutants had insertions in proteasome-associated genes. An Mtb mutant deficient in a presumptive proteasomal adenosine triphosphatase was attenuated in mice, and exposure to proteasomal protease inhibitors markedly sensitized wild-type Mtb to RNI. Thus, the mycobacterial proteasome serves as a defense against oxidative or nitrosative stress.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Cornell University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Cornell University; Cornell University	Nathan, CF (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.			Darwin, K Heran/0000-0002-5043-7548	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61241] Funding Source: Medline; NIAID NIH HHS [T32 AI07621, AI055549] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Facchetti F, 1999, AM J PATHOL, V154, P145, DOI 10.1016/S0002-9440(10)65261-3; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Nagy I, 1998, J BACTERIOL, V180, P5448, DOI 10.1128/JB.180.20.5448-5453.1998; Nathan C, 2002, AM J RESP CRIT CARE, V166, P130, DOI 10.1164/rccm.2205016; NATHAN C, 2003, TUBERCULOSIS, P215; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaible UE, 1998, J IMMUNOL, V160, P1290; SCHON T, 2002, THESIS LINKOPING U S; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589	22	407	423	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1963	1966		10.1126/science.1091176	http://dx.doi.org/10.1126/science.1091176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671303				2022-12-01	WOS:000187174000060
J	Davidson, BL				Davidson, BL			Hepatic diseases - Hitting the target with inhibitory RNAs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERFERENCE; MICE		Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.							McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828	2	12	13	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2357	2359		10.1056/NEJMcibr031609	http://dx.doi.org/10.1056/NEJMcibr031609			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668464				2022-12-01	WOS:000187125000014
J	Offit, PA; Peter, G				Offit, PA; Peter, G			The meningococcal vaccine - Public policy and individual choices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							C CONJUGATE VACCINE; POLYSACCHARIDE VACCINES; COLLEGE-STUDENTS; GROUP-A; DISEASE; CHILDREN; IMMUNOGENICITY; PREVENTION; INFANTS; ANTIBODIES		Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Rhode Isl Hosp, Div Pediat Infect Dis, Providence, RI USA; Brown Med Sch, Dept Pediat, Providence, RI USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.							Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; Centers for Disease Control and Prevention, 2000, MMWR Recomm Rep, V49, P1; ARTENSTEIN MS, 1970, NEW ENGL J MED, V282, P417, DOI 10.1056/NEJM197002192820803; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; Borrow R, 2001, J INFECT DIS, V184, P377, DOI 10.1086/322024; Campbell JD, 2002, J INFECT DIS, V186, P1848, DOI 10.1086/345763; *CDCP, 2002, ACT BACT COR SURV AB; Centers for Disease Control and Prevention (CDC), 1985, MMWR-MORBID MORTAL W, V34, P255; FINNE J, 1983, LANCET, V2, P355; GOLD R, 1979, J INFECT DIS, V140, P690, DOI 10.1093/infdis/140.5.690; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GRIFFISS JM, 1982, INFECT IMMUN, V37, P205, DOI 10.1128/IAI.37.1.205-208.1982; KAYHTY H, 1980, J INFECT DIS, V142, P861, DOI 10.1093/infdis/142.6.861; Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; Lebel MH, 2001, JAMA-J AM MED ASSOC, V285, P1578, DOI 10.1001/jama.285.12.1578; MacLennan JM, 2000, JAMA-J AM MED ASSOC, V283, P2795, DOI 10.1001/jama.283.21.2795; Meningococcal disease and college students, 2000, MMWR RECOMM REP, V49, P13; PICKERING LK, 2003, 2003 RED BOOK, P389; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; REINGOLD AL, 1985, LANCET, V2, P114; RIEDO FX, 1995, PEDIATR INFECT DIS J, V14, P643, DOI 10.1097/00006454-199508000-00001; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Scott RD, 2002, AM J PREV MED, V23, P98, DOI 10.1016/S0749-3797(02)00462-2; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514; ZANGWILL KM, 1994, J INFECT DIS, V169, P847, DOI 10.1093/infdis/169.4.847	25	25	27	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2353	2356		10.1056/NEJMsb035678	http://dx.doi.org/10.1056/NEJMsb035678			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668463				2022-12-01	WOS:000187125000013
J	Vellai, T; Takacs-Vellai, K; Zhang, Y; Kovacs, AL; Orosz, L; Muller, F				Vellai, T; Takacs-Vellai, K; Zhang, Y; Kovacs, AL; Orosz, L; Muller, F			Genetics - Influence of TOR kinase on lifespan in C-elegans	NATURE			English	Editorial Material							CAENORHABDITIS-ELEGANS		Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; Eotvos Lorand Univ, Dept Gen Zool, H-1117 Budapest, Hungary; Eotvos Lorand Univ, Dept Genet, H-1117 Budapest, Hungary; Agr Biotechnol Ctr, H-2100 Godollo, Hungary	University of Fribourg; Eotvos Lorand University; Eotvos Lorand University	Vellai, T (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	fritz.mueller@unifr.ch	Vellai, Tibor/AAG-2154-2020	Takacs-Vellai, Krisztina/0000-0002-4472-0363				Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KENYON C, 1997, C ELEGANS, V2, P701; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Riddle DL, 1997, C ELEGANS, P739; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Tissenbaum HA, 1998, GENETICS, V148, P703	11	771	814	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					620	620		10.1038/426620a	http://dx.doi.org/10.1038/426620a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668850	Green Published, Bronze			2022-12-01	WOS:000187132800027
J	Lieberman, DA; Prindiville, S; Weiss, DG; Willett, W				Lieberman, DA; Prindiville, S; Weiss, DG; Willett, W		VA Cooperative Study Grp 380	Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; PHYSICAL-ACTIVITY; LARGE-BOWEL; ASPIRIN USE; SCREENING SIGMOIDOSCOPY; SERUM-CHOLESTEROL; CIGARETTE-SMOKING; REDUCED RISK; VITAMIN-D; ADENOMA	Context Knowledge of risk factors for colorectal neoplasia could inform risk reduction strategies for asymptomatic individuals. Few studies have evaluated risk factors for advanced colorectal neoplasia in asymptomatic individuals, compared risk factors between persons with and without polyps, or included most purported risk factors in a multivariate analysis. Objective To determine risk factors associated with advanced colorectal neoplasia in a cohort of asymptomatic persons with complete colonoscopy. Design, Setting, and Participants Prospective, cross-sectional study of 3121 asymptomatic patients aged 50 to 75 years from 13 Veterans Affairs medical centers conducted between February 1994 and January 1997. All participants had complete colonoscopy to determine the prevalence of advanced neoplasia, defined as an adenoma that was 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasive cancer. Variables examined included history of first-degree relative with colorectal cancer, prior cholecystectomy, serum cholesterol level, physical activity, smoking, alcohol use, and dietary factors. Main Outcome Measures An age-adjusted analysis was performed for each variable to calculate the odds ratios (ORs) and 95% confidence intervals (CIS) associated with having advanced neoplasia compared with having no polyps. We developed a multivariate logistic regression model to identify the most informative risk factors. A secondary analysis examined risk factors for having hyperplastic polyps compared with having no polyps and compared with having advanced neoplasia. Results Three hundred twenty-nine participants had advanced neoplasia and 1441 had no polyps. In multivariate analyses, we found positive associations for history of a first-degree relative with colorectal cancer (OR, 1.66; 95% Cl, 1.16-2.35), current-smoking (OR, 1.85; 95% Cl, 1.33-2.58), and current moderate to heavy alcohol use (OR, 1.02; 95% Cl, 1.01 -1.03). Inverse associations were found for cereal fiber intake (OR, 0.95; 95% Cl, 0.91-0.99), vitamin D intake (OR, 0.94; 95% Cl, 0.90-0.99), and use of nonsteroidal anti-inflammatory drugs (NSAIDs) (OR, 0.66; 95% Cl, 0.48-0.91). In the univariate analysis, the inverse association was found with cereal fiber intake greater than 4.2 g/d, vitamin D intake greater than 645 IU/d, and daily use of NSAIDs. Marginal factors included physical activity, daily multivitamin use, and intake of calcium and fat derived from red meat. No association was found for body mass index, prior cholecystectomy, or serum cholesterol level. Three hundred ninety-one patients had hyperplastic polyps as the worst lesion found at colonoscopy. Risk variables were similar to those for patients with no polyps, except that past and current smoking were associated with an increased risk of hyperplastic polyps. Conclusions Our data endorse several important risk factors for advanced colonic neoplasia and provide a rationale for prudent risk reduction strategies. Further study is needed to determine if lifestyle changes can moderate the risk of colorectal cancer.	Dept Vet Affairs Med Ctr, Portland, OR USA; NCI, Bethesda, MD 20892 USA; Dept Vet Affairs Med Ctr, Perry Point, MD USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health	Lieberman, DA (corresponding author), Portland VA Med Ctr, Div Gastroenterol, P3-GI,POB 1034, Portland, OR 97207 USA.	lieberma@ohsu.edu			NCI NIH HHS [K07CA75159] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA075159] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Bardou M, 2002, GUT, V50, P38, DOI 10.1136/gut.50.1.38; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1993, GASTROENTEROLOGY, V105, P130, DOI 10.1016/0016-5085(93)90018-8; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KIKENDALL JW, 1989, GASTROENTEROLOGY, V97, P660, DOI 10.1016/0016-5085(89)90637-9; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lagergren J, 2001, GASTROENTEROLOGY, V121, P542, DOI 10.1053/gast.2001.27083; LEE IM, 1992, J NATL CANCER I, V84, P1326, DOI 10.1093/jnci/84.17.1326; LIEBERMAN DA, 1992, AM J GASTROENTEROL, V87, P1085; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANNES GA, 1986, NEW ENGL J MED, V315, P1634, DOI 10.1056/NEJM198612253152602; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; MCFARLANE MJ, 1993, AM J GASTROENTEROL, V88, P1994; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Niv Y, 2002, GUT, V50, P33, DOI 10.1136/gut.50.1.33; Pariente A, 1998, GASTROENTEROLOGY, V115, P7, DOI 10.1016/S0016-5085(98)70358-0; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTTER JD, 1996, PREVENTION EARLY DET, P23; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; SANDLER RS, 1993, GASTROENTEROLOGY, V104, P1445, DOI 10.1016/0016-5085(93)90354-F; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SHABAHANG M, 1994, CANCER RES, V54, P4057; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; TORNBERG SA, 1986, NEW ENGL J MED, V315, P1629, DOI 10.1056/NEJM198612253152601; Ulvik A, 2001, AM J MED GENET, V101, P246, DOI 10.1002/ajmg.1370; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	57	350	361	3	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2959	2967		10.1001/jama.290.22.2959	http://dx.doi.org/10.1001/jama.290.22.2959			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665657	Bronze			2022-12-01	WOS:000187112700027
J	Smith, GCS; Pell, JP; Dobbie, R				Smith, GCS; Pell, JP; Dobbie, R			Caesarean section and risk of unexplained stillbirth in subsequent pregnancy	LANCET			English	Article							PLACENTAL ABRUPTION; PERINATAL DEATH; ARTERY DOPPLER; DELIVERY; TERM; BIRTH; OUTCOMES; LABOR; MORTALITY; SCOTLAND	Background Caesarean section is associated with an increased risk of disorders of placentation in subsequent pregnancies, but effects on the rate of antepartum stillbirth are unknown. We aimed to establish whether previous caesarean delivery is associated with an increased risk of antepartum stillbirth. Methods We linked pregnancy discharge data from the Scottish Morbidity Record (1980-98) and the Scottish Stillbirth and Infant Death Enquiry (1985-98). We estimated the relative risk of antepartum stillbirth in second pregnancies using time-to-event analyses. Findings For 120 633 singleton second births, there were 68 antepartum stillbirths in 17 754 women previously delivered by caesarean section (2.39 per 10 000 women per week) and 244 in 102879 women previously delivered vaginally (1.44; p<0.001). Risk of unexplained stillbirth associated with previous caesarean delivery differed significantly with gestational age (p=0.04); the excess risk was apparent from 34 weeks (hazard ratio 2.23 [95% CI 1.48-3.36]). Risk was not attenuated by adjustment for maternal characteristics or outcome of the first pregnancy (2.74 [1.74-4.30]). The absolute risk of unexplained stillbirth at or after 39 weeks' gestation was 1.1 per 1000 women who had had a previous caesarean section and 0.5 per 1000 in those who had not. The difference was due mostly to an excess of unexplained stillbirths among women previously delivered by caesarean section. Interpretation Delivery by caesarean section in the first pregnancy could increase the risk of unexplained stillbirth in the second. In women with one previous caesarean delivery, the risk of unexplained antepartum stillbirth at or after 39 weeks' gestation is about double the risk of stillbirth or neonatal death from intrapartum uterine rupture.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Matern Hosp, Cambridge CB2 2SW, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; Castro LC, 2002, CURR OPIN OBSTET GYN, V14, P601, DOI 10.1097/00001703-200212000-00005; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; COLE SK, 1980, PERINATAL AUDIT SURV, P39; FELDMAN GB, 1992, OBSTET GYNECOL, V79, P547; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hemminki E, 1996, AM J OBSTET GYNECOL, V174, P1569, DOI 10.1016/S0002-9378(96)70608-7; Hosmer DW, 1999, APPL SURVIVAL ANAL R; *INF STAT DIV NHS, 2000, SCOTT PER INF MORT M; Jensen H, 1999, ACTA OBSTET GYN SCAN, V78, P799, DOI 10.1034/j.1600-0412.1999.780911.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kingdom JCP, 1997, ULTRASOUND OBST GYN, V9, P271, DOI 10.1046/j.1469-0705.1997.09040271.x; Lees C, 2001, OBSTET GYNECOL, V98, P369, DOI 10.1016/S0029-7844(01)01474-0; Lieberman E, 1997, CURR PROB OBST GYN F, V20, P98; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Lydon-Rochelle M, 2001, OBSTET GYNECOL, V97, P765, DOI 10.1016/S0029-7844(01)01121-8; MACARA LM, 1994, AM J OBSTET GYNECOL, V171, P71, DOI 10.1016/S0002-9378(94)70080-X; Maller RA, 1996, SURVIVAL ANAL LONG T; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Moore T. R., 1999, MATERNAL FETAL MED, P964; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Porreco RP, 1996, AM J OBSTET GYNECOL, V175, P369, DOI 10.1016/S0002-9378(96)70148-5; Rasmussen S, 1999, PAEDIATR PERINAT EP, V13, P9; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; SOPER DE, 1993, CURR OPIN OBSTET GYN, V5, P517; THORPEBEESTON JG, 1992, BRIT MED J, V305, P746, DOI 10.1136/bmj.305.6856.746; YUDKIN PL, 1987, LANCET, V1, P1192	35	252	260	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1779	1784		10.1016/S0140-6736(03)14896-9	http://dx.doi.org/10.1016/S0140-6736(03)14896-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654315	Green Accepted			2022-12-01	WOS:000186872900008
J	Lee, SJ; Sekimoto, T; Yamashita, E; Nagoshi, E; Nakagawa, A; Imamoto, N; Yoshimura, M; Sakai, H; Chong, KT; Tsukihara, T; Yoneda, Y				Lee, SJ; Sekimoto, T; Yamashita, E; Nagoshi, E; Nakagawa, A; Imamoto, N; Yoshimura, M; Sakai, H; Chong, KT; Tsukihara, T; Yoneda, Y			The structure of importin-beta bound to SREBP-2: Nuclear import of a transcription factor	SCIENCE			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEIN-2; 2.3 ANGSTROM RESOLUTION; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNAL; B/HLH/Z DOMAIN; IDENTIFICATION; RECOGNITION; ALPHA; MECHANISMS	The sterol regulatory element - binding protein 2 (SREBP-2), a nuclear transcription factor that is essential for cholesterol metabolism, enters the nucleus through a direct interaction of its helix-loop-helix leucine zipper domain with importin-beta. We show the crystal structure of importin-beta complexed with the active form of SREBP-2. Importin-beta uses characteristic long helices like a pair of chopsticks to interact with an SREBP-2 dimer. Importin-beta changes its conformation to reveal a pseudo-twofold symmetry on its surface structure so that it can accommodate a symmetric dimer molecule. Importin-beta may use a similar strategy to recognize other dimeric cargoes.	Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tsukihara, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Yamashita, Eiki/V-6758-2019; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009; Imamoto, Naoko/A-7458-2015	Yamashita, Eiki/0000-0002-4278-0039; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Imamoto, Naoko/0000-0002-2886-3022; Nagoshi, Emi/0000-0002-6365-4074; Yoshimura, Masato/0000-0002-7466-2192				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chan CK, 1998, GENE THER, V5, P1204, DOI 10.1038/sj.gt.3300708; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Fortelle E., 1997, METHOD ENZYMOL, P472; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lee SJ, 2000, J MOL BIOL, V302, P251, DOI 10.1006/jmbi.2000.4055; Luo X, 1996, MOL CELL BIOL, V16, P1367; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Saphire ACS, 1998, J BIOL CHEM, V273, P29764, DOI 10.1074/jbc.273.45.29764; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	33	164	173	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1571	1575		10.1126/science.1088372	http://dx.doi.org/10.1126/science.1088372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645851				2022-12-01	WOS:000186802200046
J	Sheng, GJ; dos Reis, M; Stern, CD				Sheng, GJ; dos Reis, M; Stern, CD			Churchill, a zinc finger transcriptional activator, regulates the transition between gastrulation and neurulation	CELL			English	Article							SMAD-INTERACTING PROTEIN-1; PRIMITIVE STREAK; NEURAL INDUCTION; CHICK-EMBRYO; MORPHOGENETIC MOVEMENT; MESODERM INDUCTION; XENOPUS-BRACHYURY; CELL MOVEMENTS; FGF; EXPRESSION	Gastrulation generates mesoderm and endoderm from embryonic epiblast; soon after, the neural plate is established within the epiblast-both events require FGF signaling. We describe a zinc finger transcriptional activator, Churchill (ChCh), which acts as a switch between different roles of FGF. FGF induces ChCh slowly; this activates Smad-interacting-protein-1 (Sip1), which blocks further induction of the mesoderm markers brachyury and Tbx6L by FGF. ChCh is first expressed as cells stop migrating through the primitive streak, and we show that it regulates cell ingression. We propose a simple mechanism by which FGF sensitizes cells to BMP signals. These results reveal that neural induction requires cessation of mesoderm formation at the midline in addition to the decision between epidermis and neural plate.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Stern, CD (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	c.stern@ucl.ac.uk	Stern, Claudio/AAZ-7381-2021; Sheng, Guojun/G-8746-2013; Reis, Mario dos/B-4938-2009; Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-4116-2014; Stern, Claudio D/C-6265-2008	Stern, Claudio/0000-0002-9907-889X; Reis, Mario dos/0000-0001-9514-3976; Stern, Claudio D/0000-0002-9907-889X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060156] Funding Source: NIH RePORTER; NIMH NIH HHS [5R01MH060156] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; CORNELL RA, 1994, DEVELOPMENT, V120, P453; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; Cox WG, 1995, DEVELOPMENT, V121, P4349; DIAS MS, 1990, ANAT RECORD, V228, P437, DOI 10.1002/ar.1092280410; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; GALLERA J, 1975, EXPERIENTIA, V31, P584, DOI 10.1007/BF01932472; GALLERA J, 1964, J EMBRYOL EXP MORPH, V12, P693; Gallera J., 1971, EXPERIENTIA, V26, P1953; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HATADA Y, 1994, DEVELOPMENT, V120, P2879; HEMMATIBRIVANLO.A, 1989, DEVELOPMENT, V106, P611; Holowacz T, 1999, DEV BIOL, V205, P296, DOI 10.1006/dbio.1998.9108; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Knezevic V, 1997, DEVELOPMENT, V124, P411; LABONNE C, 1994, DEVELOPMENT, V120, P463; Launay C, 1996, DEVELOPMENT, V122, P869; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; NICOLET G., 1965, ACTA EMBRYOL MORPHOL EXP, V8, P213; Nicolet G, 1970, J Embryol Exp Morphol, V23, P70; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Paterno G D, 1989, Prog Growth Factor Res, V1, P79, DOI 10.1016/0955-2235(89)90002-1; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; ROSENQUIST GC, 1971, DEV BIOL, V26, P323, DOI 10.1016/0012-1606(71)90131-X; ROSENQUIST GC, 1972, J EXP ZOOL, V180, P95, DOI 10.1002/jez.1401800108; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P71; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1997, DEVELOPMENT, V124, P1191; Streit A, 1998, DEVELOPMENT, V125, P507; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tada M, 2000, DEVELOPMENT, V127, P2227; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; WILSON V, 1995, DEVELOPMENT, V121, P877; Yamada K, 2001, AM J HUM GENET, V69, P1178, DOI 10.1086/324343; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3	65	152	155	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					603	613		10.1016/S0092-8674(03)00927-9	http://dx.doi.org/10.1016/S0092-8674(03)00927-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651851	Bronze			2022-12-01	WOS:000186885600010
J	Pauly, D; Alder, J; Bennett, E; Christensen, V; Tyedmers, P; Watson, R				Pauly, D; Alder, J; Bennett, E; Christensen, V; Tyedmers, P; Watson, R			The future for fisheries	SCIENCE			English	Article							MARINE; MANAGEMENT	Formal analyses of long-term global marine fisheries prospects have yet to be performed, because fisheries research focuses on local, species-specific management issues. Extrapolation of present trends implies expansion of bottom fisheries into deeper waters, serious impact on biodiversity, and declining global catches, the last possibly aggravated by fuel cost increases. Examination of four scenarios, covering various societal development choices, suggests that the negative trends now besetting fisheries can be turned around, and their supporting ecosystems rebuilt, at least partly.	Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS B3H 3J5, Canada	University of British Columbia; University of Wisconsin System; University of Wisconsin Madison; Dalhousie University	Pauly, D (corresponding author), Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada.	d.pauly@fisheries.ubc.ca	Tyedmers, Peter/N-1334-2019; Watson, Reg A/F-4850-2012; Bennett, Elena/A-9553-2008; Tyedmers, Peter H/I-7490-2012; Pauly, Daniel Marc/AAY-2316-2021; Christensen, Villy/C-3945-2009	Tyedmers, Peter/0000-0002-5150-0756; Watson, Reg A/0000-0001-7201-8865; Tyedmers, Peter H/0000-0002-5150-0756; Bennett, Elena/0000-0003-3944-2925; Christensen, Villy/0000-0003-0688-2633; Pauly, Daniel/0000-0003-3756-4793				Bennett EM, 2003, FRONT ECOL ENVIRON, V1, P322, DOI 10.1890/1540-9295(2003)001[0322:WGSNE]2.0.CO;2; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Christensen V, 1998, J FISH BIOL, V53, P128, DOI 10.1006/jfbi.1998.0809; CHRISTENSEN V, IN PRESS B MAR SCI; Cury P, 2001, FISH FISH, V2, P162, DOI 10.1046/j.1467-2960.2001.00044.x; HEINBERG R, 2003, PARTYS OVER OIL WAR; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Macinko Seth, 2002, WHO OWNS AM FISHERIE; Morgan LE, 2003, SHIFTING GEARS ADDRE; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Okey TA, 2003, MAR POLICY, V27, P193, DOI 10.1016/S0308-597X(03)00002-2; Parrish RH, 1998, GLOBAL VERSUS LOCAL CHANGES IN UPWELLING SYSTEMS, P525; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PAULY D, 2003, PERFECT OCEAN STATE; Pauly Daniel, 2000, P227; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Pew Oceans Commission, 2003, AM LIV OC CHART COUR; Pitcher TJ, 2001, ECOL APPL, V11, P601; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; POPE J, 1989, DANA-J FISH MAR RES, V8, P33; TYEDMERS P, 2003, IN PRESS ENCY ENERGY, V2; *UN ENV PROGR, 2002, GLOB ENV OUTL, V3; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050	26	332	346	1	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1359	1361		10.1126/science.1088667	http://dx.doi.org/10.1126/science.1088667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631031				2022-12-01	WOS:000186683500041
J	Ziemelis, K				Ziemelis, K			Hydrocarbon reservoirs	NATURE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					317	317		10.1038/426317a	http://dx.doi.org/10.1038/426317a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628059	Bronze			2022-12-01	WOS:000186660800051
J	Bradshaw, HD; Schemske, DW				Bradshaw, HD; Schemske, DW			Allele substitution at a flower colour locus produces a pollinator shift in monkeyflowers	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; REPRODUCTIVE ISOLATION; FLORAL TRAITS; MIMULUS; EVOLUTION; GENETICS; ADAPTATION	The role of major mutations in adaptive evolution has been debated for more than a century(1,2). The classical view is that adaptive mutations are nearly infinite in number with infinitesimally small phenotypic effect(3), but recent theory suggests otherwise(4). To provide empirical estimates of the magnitude of adaptive mutations in wild plants, we conducted field studies to determine the adaptive value of alternative alleles at a single locus, YELLOW UPPER5-7 (YUP). YUP controls the presence or absence of yellow carotenoid pigments in the petals of pink-flowered Mimulus lewisii, which is pollinated by bumblebees(5,8-10), and its red-flowered sister species(11) M. cardinalis, which is pollinated by hummingbirds(5,8-10). We bred near-isogenic lines (NILs) in which the YUP allele from each species was substituted into the other. M. cardinalis NILs with the M. lewisii YUP allele had dark pink flowers and received 74-fold more bee visits than the wild type, whereas M. lewisii NILs with the M. cardinalis yup allele had yellow-orange flowers and received 68-fold more hummingbird visits than the wild type. These results indicate that an adaptive shift in pollinator preference may be initiated by a single major mutation.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA	University of Washington; University of Washington Seattle; Michigan State University; Michigan State University	Bradshaw, HD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.							Beardsley PM, 2003, EVOLUTION, V57, P1397, DOI 10.1111/j.0014-3820.2003.tb00347.x; BRADSHAW HD, 1995, NATURE, V376, P762, DOI 10.1038/376762a0; Bradshaw HD, 1998, GENETICS, V149, P367; Fisher R., 2005, TEACHING CHILDREN TH; Gillham NW, 2001, GENETICS, V159, P1383; GRANT V, 1994, P NATL ACAD SCI USA, V91, P10407, DOI 10.1073/pnas.91.22.10407; HIESEY WM, 1971, CARNEGIE I WASH PUBL, V628; Hodges SA, 2002, AM NAT, V159, pS51, DOI 10.1086/338372; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; VICKERY RK, 1995, GREAT BASIN NAT, V55, P177	14	543	567	6	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					176	178		10.1038/nature02106	http://dx.doi.org/10.1038/nature02106			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614505				2022-12-01	WOS:000186517200042
J	Fuchizaki, U; Miyamori, H; Kitagawa, S; Kaneko, S; Kobayashi, K				Fuchizaki, U; Miyamori, H; Kitagawa, S; Kaneko, S; Kobayashi, K			Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease)	LANCET			English	Editorial Material							RECEPTOR-LIKE KINASE-1; GENE		Keiju Med Ctr, Dept Internal Med, Nanao, Ishikawa 9268605, Japan; Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 920, Japan	Kanazawa University	Fuchizaki, U (corresponding author), Keiju Med Ctr, Dept Internal Med, 94 Tomioka Cho, Nanao, Ishikawa 9268605, Japan.							Bliss Michael, 1999, W OSLER LIFE MED; Cushing H., 1925, LIFE W OSLER; GIBBS DD, 1986, J ROY SOC MED, V79, P742; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Haitjema T, 1996, ARCH INTERN MED, V156, P714, DOI 10.1001/archinte.156.7.714; Hall LA, 2001, MED HIST, V45, P523, DOI 10.1017/S002572730006840X; Hanes FA, 1909, B JOHNS HOPKINS HOSP, V20, P63; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Osler W, 1901, B JOHNS HOPKINS HOSP, V12, P333; Rendu Henri, 1844, JAMA-J AM MED ASSOC, V197, P583; RENDU HJ, 1896, GAZ HOPITAUX, P1322; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Weber FP, 1907, LANCET, V2, P160	15	63	66	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 1	2003	362	9394					1490	1494		10.1016/S0140-6736(03)14696-X	http://dx.doi.org/10.1016/S0140-6736(03)14696-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602446				2022-12-01	WOS:000186356600027
J	Hsieh, JJD; Cheng, EHY; Korsmeyer, SJ				Hsieh, JJD; Cheng, EHY; Korsmeyer, SJ			Taspase1: A threonine aspartase required for cleavage of MLL and proper HOX gene expression	CELL			English	Article							DROSOPHILA-TRITHORAX; CHROMOSOMAL TRANSLOCATIONS; PROTEOLYTIC CLEAVAGE; MAMMALIAN TRITHORAX; BITHORAX COMPLEX; HOMEOBOX GENES; PROTEIN; LEUKEMIA; MECHANISM; ACTIVATION	The Mixed-Lineage Leukemia gene (MLL/HRX/ALL1) encodes a large nuclear protein homologous to Drosophila trithorax that is required for the maintenance of HOX gene expression. MLL is cleaved at two conserved sites generating N320 and C180 fragments, which heterodimerize to stabilize the complex and confer its subnuclear destination. Here, we purify and clone the protease responsible for cleaving MLL. We entitle it Taspase1 as it initiates a class of endopeptidases that utilize an N-terminal threonine as the active site nucleophile to proteolyze polypeptide substrates following aspartate. Taspase1 proenzyme is intramolecularly proteolyzed generating an active 28 kDa alpha/22 kDa beta heterodimer. RNAi-mediated knockdown of Taspase1 results in the appearance of unprocessed MLL and the loss of proper HOX gene expression. Taspase1 coevolved with MLL/trithorax as Arthropoda and Chordata emerged from Metazoa suggesting that Taspase1 originated to regulate complex segmental body plans in higher organisms.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, 44 Binney St, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu			NCI NIH HHS [CA102594, CA68484] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA102594, P01CA068484] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; BREEN TR, 1993, DEVELOPMENT, V117, P119; Breen TR, 1999, GENETICS, V152, P319; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buske C, 2000, INT J HEMATOL, V71, P301; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Dash A, 2001, BEST PRACT RES CL HA, V14, P49, DOI 10.1053/beha.2000.0115; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; Downing J R, 1996, Cancer Treat Res, V84, P73; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; FIAR K, 2001, MOL CELL BIOL, V21, P3589; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; FURIE B, 1992, NEW ENGL J MED, V326, P800; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Liu Y, 1998, J BIOL CHEM, V273, P9688, DOI 10.1074/jbc.273.16.9688; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Ye YH, 2000, SEMIN CELL DEV BIOL, V11, P211, DOI 10.1006/scdb.2000.0167; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610	49	204	210	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					293	303		10.1016/S0092-8674(03)00816-X	http://dx.doi.org/10.1016/S0092-8674(03)00816-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636557	Bronze			2022-12-01	WOS:000186415000009
J	Vaux, DL; Silke, J				Vaux, DL; Silke, J			HtrA2/Omi, a sheep in wolf's clothing	CELL			English	Editorial Material							APOPTOSIS; PROTEASE; IDENTIFICATION; PROTEINS; BINDING		Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Vaux, DL (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3050, Australia.		Vaux, David L/C-7249-2013; Silke, John/B-7622-2008	Vaux, David L/0000-0003-2703-1651; Silke, John/0000-0002-7611-5774				Jin SK, 2003, GENE DEV, V17, P359, DOI 10.1101/gad.1047003; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Vaux DL, 2003, BIOCHEM BIOPH RES CO, V304, P499, DOI 10.1016/S0006-291X(03)00622-3; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903	8	36	40	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 31	2003	115	3					251	253		10.1016/S0092-8674(03)00851-1	http://dx.doi.org/10.1016/S0092-8674(03)00851-1			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636553	Bronze			2022-12-01	WOS:000186415000005
J	Dunlop, JA; Anderson, LI; Kerp, H; Hass, H				Dunlop, JA; Anderson, LI; Kerp, H; Hass, H			Preserved organs of Devonian harvestmen	NATURE			English	Article							ABERDEENSHIRE; SCOTLAND; OPILIONES; ARACHNIDA; SYSTEM; CHERTS; RHYNIE		Humboldt Univ, Museum Nat Kunde, Inst Systemat Zool, D-10115 Berlin, Germany; Natl Museums Scotland, Dept Geol & Zool, Edinburgh EH1 1JF, Midlothian, Scotland; Univ Munster, Forsch Stelle Palaobot, D-48143 Munster, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Munster	Dunlop, JA (corresponding author), Humboldt Univ, Museum Nat Kunde, Inst Systemat Zool, D-10115 Berlin, Germany.		Dunlop, Jason A./AAC-8042-2019; Kerp, Hans/AAJ-1102-2020	Dunlop, Jason/0000-0002-0179-6640				Anderson LI, 2003, PALAEONTOLOGY, V46, P467, DOI 10.1111/1475-4983.00308; CLARIDGE MF, 1961, NATURE, V191, P1190, DOI 10.1038/1911190b0; Edgecombe GD, 1998, NATURE, V394, P172, DOI 10.1038/28156; Giribet G, 2002, CLADISTICS, V18, P5, DOI 10.1006/clad.2001.0185; Hofer AM, 2000, ARTHROPOD STRUCT DEV, V29, P13, DOI 10.1016/S1467-8039(00)00009-8; Martens J., 1981, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V105, P13; MARTENS J, 1976, Entomologica Germanica, V3, P51; Rice CM, 2002, J GEOL SOC LONDON, V159, P203, DOI 10.1144/0016-764900-181; TREWIN NH, 1994, T ROY SOC EDIN-EARTH, V84, P433	9	50	50	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					916	916		10.1038/425916a	http://dx.doi.org/10.1038/425916a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586459				2022-12-01	WOS:000186230600031
J	Barnes, JW; Tischkau, SA; Barnes, JA; Mitchell, JW; Burgoon, PW; Hickok, JR; Gillette, MU				Barnes, JW; Tischkau, SA; Barnes, JA; Mitchell, JW; Burgoon, PW; Hickok, JR; Gillette, MU			Requirement of mammalian Timeless for circadian rhythmicity	SCIENCE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; DROSOPHILA TIMELESS; CLOCK; MPER1; EXPRESSION; ANTAGONISM; ORTHOLOG; GENETICS; LOOP; RNA	Despite a central circadian role in Drosophila for the transcriptional regulator Timeless (dTim), the relevance of mammalian Timeless (mTim) remains equivocal. Conditional knockdown of mTim protein expression in the rat suprachiasmatic nucleus (SCN) disrupted SCN neuronal activity rhythms, and altered levels of known core clock elements. Full-length mTim protein (mTIM-fl) exhibited a 24-hour oscillation, whereas a truncated isoform (mTIM-s) was constitutively expressed. mTIM-fl associated with the mammalian clock Period proteins (mPERs) in oscillating SCN cells. These data suggest that mTim is required for rhythmicity and is a functional homolog of dTim on the negative-feedback arm of the mammalian molecular clockwork.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Vet Biosci, Urbana, IL 61802 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022155, F32NS011134, F32NS010170, F32NS011158, R01NS035859] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL067007, HL67007] Funding Source: Medline; NIGMS NIH HHS [GM07143] Funding Source: Medline; NINDS NIH HHS [NS22155, NS11134, R01 NS035859, R01 NS022155, NS11158, NS10170, NS35859] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 2002, J APPL PHYSIOL, V92, P1348, DOI 10.1152/japplphysiol.00759.2001; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gerhold LM, 2002, J COMP NEUROL, V450, P135, DOI 10.1002/cne.10307; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Harney JP, 1996, ENDOCRINOLOGY, V137, P3696, DOI 10.1210/en.137.9.3696; Hastings M H, 1999, J Neurosci, V19, pRC11; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Li ZX, 2000, P NATL ACAD SCI USA, V97, P10038, DOI 10.1073/pnas.97.18.10038; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Sakamoto S, 2000, BIOCHEM BIOPH RES CO, V279, P131, DOI 10.1006/bbrc.2000.3927; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Tischkau S A, 1999, J Neurosci, V19, pRC15; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	24	153	162	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					439	442		10.1126/science.1086593	http://dx.doi.org/10.1126/science.1086593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14564007				2022-12-01	WOS:000185963200041
J	Emanuel, EJ				Emanuel, EJ			The lessons of SARS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIANS; AIDS	Given the low mortality and morbidity of the severe acute respiratory syndrome (SARS) compared with other public health scourges, is the attention devoted to it misdirected? The SARS experience has provided at least 4 enduring lessons. First, by providing a test of the capacity of each part of the public health system, from national to local and hospital responses, it has better prepared the world for the anticipated and much-feared next real pandemic. Second, SARS has reemphasized that from housing, sexual practices, and slaughtering techniques to health care capacity, the situation in other, especially developing, countries affects us. Global cooperation is necessary not only for justice but to ensure our own health. Third, despite trends toward commercialization, easier lives, and self-centered individualism, the response of health care professionals to SARS reaffirmed dedication to caring for the sick even at great personal risks as the core ethical principle of medicine. Finally, SARS also emphasized the importance of the duty of health care administrators and senior physicians to rapidly institute procedures to maximize the safety of frontline physicians and nurses. These lessons will be valuable far beyond the SARS episode.	NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Emanuel, EJ (corresponding author), NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bldg 10,1C118, Bethesda, MD 20892 USA.							Billings M., INFLUENZA PANDEMIC 1; *CAN ASS EM PHYS, GUID MAN SEV AC RESP; *CDCP, 2002, REP TUB US 2001 ATL; *COUNC ETH JUD AFF, 2002, AM MED ASS COD MED E; CROSBY AW, 1990, AM FORGOTTEN PANDEMI; DEFOE D, 1987, J PLAGUE YEAR; EMANUEL EJ, 1988, NEW ENGL J MED, V318, P1686, DOI 10.1056/NEJM198806233182511; FREEDMAN B, 1988, HASTINGS CENT REP, V18, pS20, DOI 10.2307/3562422; *HLTH CAN, 2003, CAN SARS NUMB AUG 12; KOLOTA F, 1999, FLU STORY GREAT INFL; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Park Katharine., 1985, DOCTORS MED EARLY RE; Reilley B, 2003, NEW ENGL J MED, V348, P1951, DOI 10.1056/NEJMp030080; *UNAIDS, 2002, AIDS EP UPD 2002; VIETS J, 1989, SURG URGES AIDS TEST, P1; *WHO, WHAT MAL; *WHO, 2002, TUB FACT SHEET 104; World Health Organization, 2003, SEV AC RESP SYNDR SA; ZUGER A, 1987, JAMA-J AM MED ASSOC, V258, P1924, DOI 10.1001/jama.258.14.1924	19	51	53	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2003	139	7					589	591		10.7326/0003-4819-139-7-200310070-00011	http://dx.doi.org/10.7326/0003-4819-139-7-200310070-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729AP	14530230				2022-12-01	WOS:000185748800007
J	Doran, T; Drever, F; Whitehead, M				Doran, T; Drever, F; Whitehead, M			Health of young and elderly informal carers: analysis of UK census data	BRITISH MEDICAL JOURNAL			English	Article									Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Doran, T (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.							Banks P, 2001, DISABIL SOC, V16, P797, DOI 10.1080/09687590120083967; *GEN REG OFF SCOTL, SCOTL CENS; MAHER J, 2002, CAREERS 2000; *NO IR STAT RES AG, 2001, NO IR CENS 2001 OUTP; *ONS, 2003, CENS 2001 S	5	43	43	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1388	1388		10.1136/bmj.327.7428.1388	http://dx.doi.org/10.1136/bmj.327.7428.1388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755PL	14670886	Bronze, Green Published			2022-12-01	WOS:000187417900025
J	Ganel, T; Goodale, MA				Ganel, T; Goodale, MA			Visual control of action but not perception requires analytical processing of object shape	NATURE			English	Article							SELECTIVE ATTENTION; RECOGNITION; INFORMATION; VIEWPOINT; PATHWAYS; FEATURES	The visual perception of object shape depends on ' holistic'(1 - 4) processing in which a given dimension cannot be perceptually isolated from the other dimensions of the object. The visual control of action ( such as grasping an object), however, which is mediated by cortical areas that are largely independent of those mediating conscious perception(5 - 8), must take into account only the most action- relevant dimension of an object without being misled by other non- relevant object features. Here we report the results of two experiments showing that vision for perception and vision for action deal with objects in a fundamentally different manner. We tested participants' ability to make perceptual judgements of the width of different rectangular objects or to grasp them across their width, while in both cases ignoring length(9,10). Participants could not ignore length when making perceptual judgements of width but they could completely ignore length when grasping the same objects. These results suggest that in situations in which the elementary dimensions of an object's shape are perceived in a holistic manner, the same dimensions are treated analytically when a visually guided action is directed at that same object.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Ganel, T (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada.	tganel@uwo.ca	Goodale, Melvyn A/M-5907-2013; Ganel, Tzvi/B-9344-2011	Goodale, Melvyn A/0000-0001-6748-0561; Ganel, Tzvi/0000-0003-0658-0598				Bar M, 2001, J COGNITIVE NEUROSCI, V13, P793, DOI 10.1162/08989290152541458; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; DYKES JR, 1978, PERCEPT PSYCHOPHYS, V23, P36, DOI 10.3758/BF03214292; Edelman S, 1997, PHILOS T R SOC B, V352, P1191, DOI 10.1098/rstb.1997.0102; FELFOLDY GL, 1974, PERCEPT PSYCHOPHYS, V15, P453, DOI 10.3758/BF03199285; Ganel T, 2002, J EXP PSYCHOL HUMAN, V28, P854, DOI 10.1037//0096-1523.28.4.854; GARNER WR, 1978, J EXP PSYCHOL GEN, V107, P287, DOI 10.1037/0096-3445.107.3.287; GARNER WR, 1974, PROCESSING INFORMATI; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Goodale MA, 1996, ADV MOTOR LEARNING C, P87; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUMPHREY GK, 1994, PERCEPTION, V23, P1457, DOI 10.1068/p231457; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Koffka K, 1935, PRINCIPLES GESTALT P; Kwok RM, 2003, NEUROPSYCHOLOGIA, V41, P932, DOI 10.1016/S0028-3932(02)00324-X; Law MB, 2002, PERCEPT PSYCHOPHYS, V64, P1017, DOI 10.3758/BF03194753; Macmillan NA, 1998, PERCEPT PSYCHOPHYS, V60, P250, DOI 10.3758/BF03206034; Maddox W. T., 1992, MULTIDIMENSIONAL MOD, P147; MARR D, 1980, PHILOS T ROY SOC B, V290, P199, DOI 10.1098/rstb.1980.0091; NATSOULAS T, 1983, AM J PSYCHOL, V96, P435, DOI 10.2307/1422567; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; POMERANTZ JR, 1989, J EXP PSYCHOL HUMAN, V15, P635, DOI 10.1037/0096-1523.15.4.635; Shalev L, 2000, J EXP PSYCHOL HUMAN, V26, P997, DOI 10.1037/0096-1523.26.3.997; Swinnen SP, 2002, J COGNITIVE NEUROSCI, V14, P463, DOI 10.1162/089892902317361976	29	151	156	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					664	667		10.1038/nature02156	http://dx.doi.org/10.1038/nature02156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752DY	14668865				2022-12-01	WOS:000187132800042
J	Tonkin, LA; Bass, BL				Tonkin, LA; Bass, BL			Mutations in RNAi rescue aberrant chemotaxis of ADAR mutants	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ADENOSINE DEAMINASES; MESSENGER-RNA; C-ELEGANS; RDE-1; GENE; INTERFERENCE; HAIRPINS; ACT		Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bass, BL (corresponding author), Univ Utah, Dept Biochem, 20 North 1900 East, Salt Lake City, UT 84132 USA.				NIGMS NIH HHS [R01 GM044073, GM44073] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044073] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Parrish S, 2001, RNA, V7, P1397; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	12	120	133	0	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1725	1725		10.1126/science.1091340	http://dx.doi.org/10.1126/science.1091340			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657490	Green Accepted			2022-12-01	WOS:000186970100037
J	Li, MO; Sarkisian, MR; Mehal, WZ; Rakic, P; Flavell, RA				Li, MO; Sarkisian, MR; Mehal, WZ; Rakic, P; Flavell, RA			Phosphatidylserine receptor is required for clearance of apoptotic cells	SCIENCE			English	Article							MEMBRANE PHOSPHATIDYLSERINE; LUNG DEVELOPMENT; DEATH; PHAGOCYTOSIS; MICE; RECOGNITION; ENGULFMENT; BRAIN; REDISTRIBUTION; MACROPHAGES	Cells undergoing apoptosis during development are removed by phagocytes, but the underlying mechanisms of this process are not fully understood. Phagocytes lacking the phosphatidylserine receptor (PSR) were defective in removing apoptotic cells. Consequently, in PSR-deficient mice, dead cells accumulated in the lung and brain, causing abnormal development and leading to neonatal lethality. A fraction of PSR knockout mice manifested a hyperplasic brain phenotype resembling that of mice deficient in the cell death - associated genes encoding Apaf-1, caspase-3, and caspase-9, which suggests that phagocytes may also be involved in promoting apoptosis. These data demonstrate a critical role for PSR in early stages of mammalian organogenesis and suggest that this receptor may be involved in respiratory distress syndromes and congenital brain malformations.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.			li, ming/0000-0002-1383-0535				Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cole FS, 2001, PEDIATR RES, V50, P157, DOI 10.1203/00006450-200108000-00001; De Paepe ME, 1999, J PEDIATR SURG, V34, P863, DOI 10.1016/S0022-3468(99)90389-5; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 2001, SEMIN IMMUNOL, V13, P365, DOI 10.1006/smim.2001.0333; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kresch MJ, 1998, PEDIATR RES, V43, P426, DOI 10.1203/00006450-199803000-00020; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Manfredi AA, 2002, APOPTOSIS, V7, P153, DOI 10.1023/A:1014366531885; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	28	305	318	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1560	1563		10.1126/science.1087621	http://dx.doi.org/10.1126/science.1087621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645847				2022-12-01	WOS:000186802200042
J	Weigel, LM; Clewell, DB; Gill, SR; Clark, NC; McDougal, LK; Flannagan, SE; Kolonay, JF; Shetty, J; Killgore, GE; Tenover, FC				Weigel, LM; Clewell, DB; Gill, SR; Clark, NC; McDougal, LK; Flannagan, SE; Kolonay, JF; Shetty, J; Killgore, GE; Tenover, FC			Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus	SCIENCE			English	Article							GLYCOPEPTIDE RESISTANCE; UNITED-STATES; CELL-WALL; ENTEROCOCCI; EVOLUTION; SEQUENCE	Vancomycin is usually reserved for treatment of serious infections, including those caused by multidrug-resistant Staphylococcus aureus. A clinical isolate of S. aureus with high-level resistance to vancomycin ( minimal inhibitory concentration = 1024 mug/ml) was isolated in June 2002. This isolate harbored a 57.9-kilobase multiresistance conjugative plasmid within which Tn1546 (vanA) was integrated. Additional elements on the plasmid encoded resistance to trimethoprim (dfrA), beta-lactams (blaZ), aminoglycosides (aacA-aphD), and disinfectants ( qacC). Genetic analyses suggest that the long-anticipated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by interspecies transfer of Tn1546 from a co-isolate of Enterococcus faecalis.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Inst Genom Res, Rockville, MD 20850 USA; J Craig Center Sci Fdn Joint Technol Ctr, Rockville, MD 20850 USA	Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; J. Craig Venter Institute	Weigel, LM (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.	lweigel@cdc.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095359] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-95359] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Berg T, 1998, J BACTERIOL, V180, P4350, DOI 10.1128/JB.180.17.4350-4359.1998; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; BYRNE ME, 1990, ANTIMICROB AGENTS CH, V34, P2106, DOI 10.1128/AAC.34.11.2106; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P902; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; CLARK NC, 1993, ANTIMICROB AGENTS CH, V37, P2311, DOI 10.1128/AAC.37.11.2311; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Firth N, 2000, GRAM-POSITIVE PATHOGENS, P326; FLANNAGAN SE, IN PRESS ANTIMICROB; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MORTON TM, 1993, J BACTERIOL, V175, P4436, DOI 10.1128/JB.175.14.4436-4447.1993; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Sieradzki K, 1999, J BACTERIOL, V181, P7566, DOI 10.1128/JB.181.24.7566-7570.1999; Sieradzki R, 1999, J BIOL CHEM, V274, P18942, DOI 10.1074/jbc.274.27.18942; Walsh C, 1999, SCIENCE, V284, P442, DOI 10.1126/science.284.5413.442	21	647	702	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1569	1571		10.1126/science.1090956	http://dx.doi.org/10.1126/science.1090956			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645850				2022-12-01	WOS:000186802200045
J	Li, WH; Moore, MJ; Vasilieva, N; Sui, JH; Wong, SK; Berne, MA; Somasundaran, M; Sullivan, JL; Luzuriaga, K; Greenough, TC; Choe, H; Farzan, M				Li, WH; Moore, MJ; Vasilieva, N; Sui, JH; Wong, SK; Berne, MA; Somasundaran, M; Sullivan, JL; Luzuriaga, K; Greenough, TC; Choe, H; Farzan, M			Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus	NATURE			English	Article							MESSENGER-RNA EXPRESSION; AMINOPEPTIDASE-N; LOCALIZATION; HOMOLOG; CLONING; DOMAIN; SITE	Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells(1,2). Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2)(3,4), isolated from SARS coronavirus (SARS-CoV)permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.	Harvard Univ, Sch Med, Childrens Hosp, Perlmutter Lab,Pulm Div,Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Dept Med Microbiol & Mol Genet, Brigham & Womens Hosp, Partners AIDS Res Ctr,Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Tufts Univ, Sch Med, Tufts Univ Core Facil, Boston, MA 02111 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tufts University; University of Massachusetts System; University of Massachusetts Worcester	Choe, H (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Perlmutter Lab,Pulm Div,Dept Pediat, Boston, MA 02115 USA.	hyeryun.choe@tch.harvard.edu; farzan@mbcrr.harvard.edu		Farzan, Michael/0000-0002-2990-5319; Li, Wenhui/0000-0003-1305-7404; SUI, JIANHUA/0000-0002-1272-9662				Bonavia A, 2003, J VIROL, V77, P2530, DOI 10.1128/JVI.77.4.2530-2538.2003; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Dales NA, 2002, J AM CHEM SOC, V124, P11852, DOI 10.1021/ja0277226; DELMAS B, 1994, J VIROL, V68, P5216, DOI 10.1128/JVI.68.8.5216-5224.1994; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DVEKSLER GS, 1993, J VIROL, V67, P1; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078; HOLMES KV, 1993, ADV EXP MED BIOL, V342, P261; Huang LL, 2003, J BIOL CHEM, V278, P15532, DOI 10.1074/jbc.M212934200; Jackwood MW, 2001, AVIAN DIS, V45, P366, DOI 10.2307/1592976; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1053/S0016-5085(03)01215-0, 10.1016/j.gastro.2003.08.001]; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sturman L S, 1984, Adv Exp Med Biol, V173, P25; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Tresnan DB, 1998, ADV EXP MED BIOL, V440, P69; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	30	3647	3946	15	331	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					450	454		10.1038/nature02145	http://dx.doi.org/10.1038/nature02145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647384	Bronze, Green Published			2022-12-01	WOS:000186800800040
J	Qurishi, N; Kreuzberg, C; Luchters, G; Effenberger, W; Kupfer, B; Sauerbruch, T; Rockstroh, JK; Spengler, U				Qurishi, N; Kreuzberg, C; Luchters, G; Effenberger, W; Kupfer, B; Sauerbruch, T; Rockstroh, JK; Spengler, U			Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR; INFECTED PATIENTS; DRUG-USERS; NATURAL-HISTORY; DISEASE; PROGRESSION; VIREMIA; IMPACT; HCV	Background Highly active antiretroviral therapy (HAART) has improved the prognosis of HIV infection. However, replication of hepatitis C virus (HCV) is not inhibited by HAART, and treatment-related hepatotoxicity is common. To clarify the effect of HAART in HIV/HCV-coinfected patients, we studied liver-related mortality and overall mortality in 285 patients who were regularly treated during the period 1990-2002 at our department. Methods Survival was analysed retrospectively by Kaplan-Meier and Cox's regression analyses after patients (81% haemophiliacs) had been stratified into three groups according to their antiretroviral therapy (HAART n=93, available after 1995; treatment exclusively with nucleoside analogues n=55, available after 1992; or no treatment, n=137). Findings Liver-related mortality rates were 0.45, 0.69, and 1.70 per 100 person-years in the HAART, antiretroviral-treatment, and untreated groups. Kaplan-Meier analysis of liver related mortality confirmed the significant survival benefit in patients with antiretroviral therapy (p=0.018), and regression analysis identified HAART (odds ratio 0.106 [95% CI 0.020-0.564]), antiretroviral treatment (0.283 [0.103-0.780]), CD4-positive T-cell count (0.746 [0.641-0.868] per 0.05X10(9) cells/L), serum cholinesterase (0.962 [0.938-0.986] per 100 U/L), and age (1.065 [1.027-1.105] per year) as independent predictors of liver-related survival. Severe drug-related hepatotoxicity was seen in five patients treated with nucleoside analogues alone and 13 treated with HAART. No patient died from drug-related hepatotoxicity. Interpretation In addition to improved overall survival, antiretroviral therapy significantly reduced long-term liver related mortality in our patients. This survival benefit seems to outweigh by far the associated risks of severe hepatotoxicity.	Univ Bonn, Med Klin & Poliklin 1, Dept Internal Med, D-53105 Bonn, Germany; Univ Bonn, Inst Expt Hematol & Transfus Med, D-53105 Bonn, Germany; Univ Bonn, Inst Microbiol & Immunol, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Spengler, U (corresponding author), Univ Bonn, Med Klin & Poliklin 1, Dept Internal Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	spengler@uni-bonn.de						Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Cacoub P, 2001, CLIN INFECT DIS, V32, P1207, DOI 10.1086/319747; Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9; *CDC, 1986, MMWR-MORBID MORTAL W, V35, P334; Daar ES, 2001, J INFECT DIS, V183, P589, DOI 10.1086/318539; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Delladetsima J, 2002, HAEMOPHILIA, V8, P668, DOI 10.1046/j.1365-2516.2002.00670.x; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Fialaire P, 1999, J INFECT DIS, V180, P574, DOI 10.1086/314910; Garcia-Samaniego J, 1998, J HEPATOL, V28, P526, DOI 10.1016/S0168-8278(98)80334-6; HAYASHI PH, 1991, J MED VIROL, V33, P177, DOI 10.1002/jmv.1890330307; Hernandez-Aguado I, 2001, EUR J EPIDEMIOL, V17, P539, DOI 10.1023/A:1014560431726; IMBERTI L, 1991, J VIROL METHODS, V34, P233, DOI 10.1016/0166-0934(91)90103-7; MARTIN P, 1989, GASTROENTEROLOGY, V97, P1559, DOI 10.1016/0016-5085(89)90405-8; Martin-Carbonero L, 2001, AIDS RES HUM RETROV, V17, P1467, DOI 10.1089/08892220152644160; Martinez-Sierra C, 2003, CLIN INFECT DIS, V36, P491, DOI 10.1086/367643; MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824; MILITO AD, 1999, J MED VIROL, V57, P140; Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perez-Olmeda M, 2000, AIDS, V14, P212, DOI 10.1097/00002030-200001280-00023; Pol S, 2002, J VIRAL HEPATITIS, V9, P1, DOI 10.1046/j.1365-2893.2002.00326.x; Puoti M, 2000, J ACQ IMMUN DEF SYND, V24, P211; Ragni MV, 1999, J INFECT DIS, V180, P2027, DOI 10.1086/315143; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Rizzieri DA, 1997, LANCET, V349, P775, DOI 10.1016/S0140-6736(05)60200-0; Rockstroh JK, 1996, AM J GASTROENTEROL, V91, P2563; Rockstroh JK, 1998, AIDS, V12, pS42; RUMI MG, 1990, ANN INTERN MED, V112, P379, DOI 10.7326/0003-4819-112-5-379; Rutschmann OT, 1998, J INFECT DIS, V177, P783, DOI 10.1086/517808; Saves M, 1999, AIDS, V13, pF115, DOI 10.1097/00002030-199912030-00002; SHERMAN KE, 1991, J INFECT DIS, V163, P414, DOI 10.1093/infdis/163.2.414; Soriano V, 1999, EUR J EPIDEMIOL, V15, P1, DOI 10.1023/A:1007506617734; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Sterling RK, 2003, JAIDS-J ACQ IMM DEF, V32, P30, DOI 10.1097/00126334-200301010-00005; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Takamatsu J, 2001, HAEMOPHILIA, V7, P575, DOI 10.1046/j.1365-2516.2001.00567.x; TELFER PT, 1994, BRIT J HAEMATOL, V88, P397, DOI 10.1111/j.1365-2141.1994.tb05038.x; Toyoda H, 1999, CLIN INFECT DIS, V29, P1332, DOI 10.1086/313480; VANGEMEN B, 1993, J VIROL METHODS, V43, P177, DOI 10.1016/0166-0934(93)90075-3; Vento S, 1998, AIDS, V12, P116; Woitas RP, 1997, J IMMUNOL, V159, P1012; Yokozaki S, 2000, BLOOD, V96, P4293; Zylberberg H, 1998, CLIN INFECT DIS, V26, P1104, DOI 10.1086/520281	48	398	407	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2003	362	9397					1708	1713		10.1016/S0140-6736(03)14844-1	http://dx.doi.org/10.1016/S0140-6736(03)14844-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643119				2022-12-01	WOS:000186767700009
J	Grunewald, K; Desai, P; Winkler, DC; Heymann, JB; Belnap, DM; Baumeister, W; Steven, AC				Grunewald, K; Desai, P; Winkler, DC; Heymann, JB; Belnap, DM; Baumeister, W; Steven, AC			Three-dimensional structure of herpes simplex virus from cryo-electron tomography	SCIENCE			English	Article							CELLS; DNA; MICROSCOPY	Herpes simplex virus, a DNA virus of high complexity, consists of a nucleocapsid surrounded by the tegument-a protein compartment-and the envelope. The latter components, essential for infectivity, are pleiomorphic. Visualized in cryo-electron tomograms of isolated virions, the tegument was seen to form an asymmetric cap: On one side, the capsid closely approached the envelope; on the other side, they were separated by similar to35 nanometers of tegument. The tegument substructure was particulate, with some short actin-like. laments. The envelope contained 600 to 750 glycoprotein spikes that varied in length, spacing, and in the angles at which they emerge from the membrane. Their distribution was nonrandom, suggesting functional clustering.	NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Johns Hopkins University; California Institute of Technology; Max Planck Society	Steven, AC (corresponding author), NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	Alasdair_Steven@nih.gov	Heymann, Bernard/F-6825-2011; Heymann, Bernard/H-8265-2019; Grünewald, Kay/AAW-3652-2020	Heymann, Bernard/0000-0002-8872-5326; Grünewald, Kay/0000-0002-4788-2691; Winkler, Dennis/0000-0003-1445-6554	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027002] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI033077, R01 AI033077-10, AI33077] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], FIELDS VIROLOGY FIEL; Baker T., 1997, STRUCTURAL BIOL VIRU, P38; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Frank J, 1992, ELECT TOMOGRAPHY; Granzow H, 2001, J VIROL, V75, P3675, DOI 10.1128/JVI.75.8.3675-3684.2001; Grunewald K, 2003, BIOPHYS CHEM, V100, P577, DOI 10.1016/S0301-4622(02)00307-1; Lee GE, 2003, J VIROL, V77, P2038, DOI 10.1128/JVI.77.3.2038-2045.2003; McIntosh JR, 2001, J CELL BIOL, V153, pF25, DOI 10.1083/jcb.153.6.F25; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Newcomb WW, 2000, J VIROL, V74, P1663, DOI 10.1128/JVI.74.4.1663-1673.2000; NEWCOMB WW, 1993, J MOL BIOL, V232, P499, DOI 10.1006/jmbi.1993.1406; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Roizman B., 1974, COMPREHENSIVE VIROLO, P229, DOI DOI 10.1007/978-1-4684-2703-5_4; ROIZMAN B, 2001, FIELDS VIROLOGY, V2, P2399; Skepper JN, 2001, J VIROL, V75, P5697, DOI 10.1128/JVI.75.12.5697-5702.2001; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; STANNARD LM, 1987, J GEN VIROL, V68, P715, DOI 10.1099/0022-1317-68-3-715; STEVEN AC, 1997, STRUCTURAL BIOL VIRU, P312; Trus BL, 1999, J VIROL, V73, P2181, DOI 10.1128/JVI.73.3.2181-2192.1999; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; Zhou ZH, 2000, SCIENCE, V288, P877, DOI 10.1126/science.288.5467.877	28	405	418	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1396	1398		10.1126/science.1090284	http://dx.doi.org/10.1126/science.1090284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631040				2022-12-01	WOS:000186683500052
J	Waisbren, SE; Albers, S; Amat, S; Ampola, M; Brewster, TG; Demmer, L; Eaton, RB; Greenstein, R; Korson, M; Larson, C; Marsden, D; Msall, M; Naylor, EW; Pueschel, S; Seashore, M; Shih, VE; Levy, HL				Waisbren, SE; Albers, S; Amat, S; Ampola, M; Brewster, TG; Demmer, L; Eaton, RB; Greenstein, R; Korson, M; Larson, C; Marsden, D; Msall, M; Naylor, EW; Pueschel, S; Seashore, M; Shih, VE; Levy, HL			Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TANDEM MASS-SPECTROMETRY; INBORN-ERRORS; DEFICIENCY; METABOLISM; INFANTS; PROGRAM; HEALTH; TESTS	Context Tandem mass spectrometry now allows newborn screening for more than 20 biochemical genetic disorders. Questions about the effectiveness and risks of expanded newborn screening for biochemical genetic disorders need to be answered prior to its widespread acceptance as a state-mandated program. Objectives To compare newborn identification by expanded screening with clinical identification of biochemical genetic disorders and to assess the impact on families of a false-positive screening result compared with a normal result in the expanded newborn screening program. Design Prospective study involving an inception cohort of newly diagnosed children. Setting Massachusetts, Maine, and a private laboratory in Pennsylvania with expanded newborn screening; other New England states with limited screening. Participants Families of 50 affected children identified through expanded newborn screening (82% of eligible cases); 33 affected children identified clinically (97% of eligible cases); 94 screened children with false-positive results (75% of eligible cases); and 81 screened children with normal results (63% of eligible cases). Main Outcome Measures Child's health and development and the Parental Stress Index. Results Within the first 6 months of life, 28% of children identified by newborn screening compared with 55% of clinically identified children required hospitalization (P=.02). One child identified by newborn screening compared with 8 (42%) identified clinically performed in the range of mental retardation (P<.001). Mothers in the screened group reported lower overall stress on the Parental Stress Index than mothers in the clinically identified group (z=3.38, P<.001). Children with false-positive results compared with children with normal results were twice as likely to experience hospitalization (21% [n=20] vs 10% [n=8], respectively; P=.06). Mothers of children in the false-positive group compared with mothers of children with normal screening results attained higher scores on the Parental Stress Index (z=4.25, P<.001) and the Parent-Child Dysfunction subscale (z=5.30, P<.001). Conclusions Expanded newborn screening may lead to improved health outcomes for affected children and lower stress for their parents. However, false-positive screening results may place families at risk for increased stress and parent-child dysfunction.	Childrens Hosp Boston, Boston, MA 02115 USA; Univ Munster, D-4400 Munster, Germany; Eastern Maine Med Ctr, Bangor, ME USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Maine Med Ctr, Portland, ME 04102 USA; Univ Massachusetts, Sch Med, New England Newborn Screening Program, Jamaica Plain, MA USA; Rhode Isl Hosp, Providence, RI USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA; Pediat Screening Inc, Bridgeville, PA USA; Yale Univ, Sch Med, New Haven, CT USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; University of Munster; Eastern Maine Medical Center; Tufts Medical Center; Maine Medical Center; University of Massachusetts System; Lifespan Health Rhode Island; Rhode Island Hospital; University of Connecticut; Yale University; Harvard University; Massachusetts General Hospital	Waisbren, SE (corresponding author), Childrens Hosp Boston, IC Smith 108,300 Longwood Ave, Boston, MA 02115 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002085] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG02085] Funding Source: Medline; PHS HHS [5H46 MC 00158] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abidin R.R, 1995, TEST MANUAL, V3; Albers S, 2001, J INHERIT METAB DIS, V24, P303, DOI 10.1023/A:1010391623104; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Atkinson K, 2001, PUBLIC HEALTH REP, V116, P122, DOI 10.1093/phr/116.2.122; Bayley N., 1993, BAYLEY SCALES INFANT; Bear M, 1998, PUBLIC HEALTH NURS, V15, P50, DOI 10.1111/j.1525-1446.1998.tb00321.x; Chace DH, 2001, CHEM REV, V101, P445, DOI 10.1021/cr990077+; Cunningham G, 2002, NEW ENGL J MED, V346, P1084, DOI 10.1056/NEJM200204043461411; Filiano JJ, 2002, PEDIATR NEUROL, V26, P201, DOI 10.1016/S0887-8994(01)00384-8; GUTHRIE R, 1968, Birth Defects Original Article Series, V4, P92; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Hermeren G, 1999, ACTA PAEDIATR, V88, P99, DOI 10.1080/080352599750029501; Hollingshead A. B., 1991, HDB RES DESIGN SOCIA, P351; Holtzman NA, 1999, CLIN CHEM, V45, P732; Insinga RP, 2002, J PEDIATR-US, V141, P524, DOI 10.1067/mpd.2002.128116; Leslie L K, 1996, Pediatr Rev, V17, P323, DOI 10.1542/pir.17-9-323; Levy HL, 1998, CLIN CHEM, V44, P2401; Levy HL, 2000, ANNU REV GENOM HUM G, V1, P139, DOI 10.1146/annurev.genom.1.1.139; MCNEIL TF, 1985, ACTA PSYCHIAT SCAND, V72, P491, DOI 10.1111/j.1600-0447.1985.tb02645.x; *NAT RES COUNC COM, 1975, GEN SCREEN PROGR PRI; *NEWB SCREEN TASK, 2000, PEDIATRICS, V106, P383; Paul D, 1999, PERSPECT BIOL MED, V42, P207; PIERCE GR, 1991, J PERS SOC PSYCHOL, V61, P1028, DOI 10.1037/0022-3514.61.6.1028; Pollitt RI, 1997, HEALTH TECHNOL ASSES, V1, pi; Pollitt RJ, 1999, ACTA PAEDIATR, V88, P40, DOI 10.1080/080352599750029358; Read CY, 2002, CLIN GENET, V61, P268, DOI 10.1034/j.1399-0004.2002.610405.x; Schoen EJ, 2002, PEDIATRICS, V110, P781, DOI 10.1542/peds.110.4.781; SORENSON JR, 1984, PEDIATRICS, V73, P183; Sparrow S. S., 2016, VINELAND ADAPTIVE BE; *STATACORP, 1999, STAT STAT SOFTW REL; THERRELL BL, US NATL SCREENING ST; Thomason MJ, 1998, J PUBLIC HEALTH MED, V20, P331, DOI 10.1093/oxfordjournals.pubmed.a024777; THORNDIKE RL, 1986, STANFORDBINET INTELL; TYMSTRA T, 1986, FAM PRACT, V3, P92, DOI 10.1093/fampra/3.2.92; Waisbren SE, 2002, J INHERIT METAB DIS, V25, P599, DOI 10.1023/A:1022003726224; Wang SS, 1999, GENET MED, V1, P332; Weglage J, 2001, PEDIATR RES, V49, P532, DOI 10.1203/00006450-200104000-00015; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	39	244	248	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2564	2572		10.1001/jama.290.19.2564	http://dx.doi.org/10.1001/jama.290.19.2564			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	744DQ	14625333	Bronze			2022-12-01	WOS:000186613000026
J	Jenkins, M				Jenkins, M			Prospects for biodiversity	SCIENCE			English	Article							WILD NATURE; ENDEMISM	Assuming no radical transformation in human behavior, we can expect important changes in biodiversity and ecosystem services by 2050. A considerable number of species extinctions will have taken place. Existing large blocks of tropical forest will be much reduced and fragmented, but temperate forests and some tropical forests will be stable or increasing in area, although the latter will be biotically impoverished. Marine ecosystems will be very different from today's, with few large marine predators, and freshwater biodiversity will be severely reduced almost everywhere. These changes will not, in themselves, threaten the survival of humans as a species.	UN, Environm Programme, World Conservat Monitoring Ctr, Cambridge CB3 ODL, England		Jenkins, M (corresponding author), UN, Environm Programme, World Conservat Monitoring Ctr, 219C Huntingdon Rd, Cambridge CB3 ODL, England.							Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; BALMFORD A, 1994, NATURE, V372, P623, DOI 10.1038/372623a0; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Birdlife International, 2000, THREAT BIRDS WORLD; Bruinsma J, 2003, WORLD AGR 2015 2030; Caldecott JO, 1996, BIODIVERS CONSERV, V5, P699, DOI 10.1007/BF00051782; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; *ESA P WP, 180 ESAPWP; *FAO UN, 2000, 140 FAO; Groombridge B, 2002, WORLD ATLAS BIODIVER; Intergovernmental Panel on Climate Change, 2001, 3 ASS REP; Jenkins M, 2003, CONSERV BIOL, V17, P20, DOI 10.1046/j.1523-1739.2003.01719.x; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; LEADERWILLIAMS N, 2002, 27 IUCN SPEC SURV CO; LOH J, 2002, LIVING PLANET REPORT; Martin P. S., 1984, QUATERNARY EXTINCTIO; PAULY D, IN PRESS SCIENCE; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Schule W., 1992, P45; Steadman DW, 2002, SCIENCE, V298, P2136, DOI 10.1126/science.1078915; *UNESCO BERGH BOOK, 2003, UN WORLD WAT DEV REP; *WORLD CONS MON CT, 1998, FRESHW BIOD PREL GLO	22	327	339	4	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1175	1177		10.1126/science.1088666	http://dx.doi.org/10.1126/science.1088666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615529				2022-12-01	WOS:000186544300043
J	Glatzel, M; Abela, E; Maissen, M; Aguzzi, A				Glatzel, M; Abela, E; Maissen, M; Aguzzi, A			Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INCLUSION-BODY MYOSITIS; TONSIL BIOPSY; VARIANT CJD; CLASSIFICATION; VCJD; BSE	BACKGROUND: In patients with sporadic Creutzfeldt-Jakob disease, pathologic disease-associated prion protein (PrP(sup Sc)) has been identified only in the central nervous system and olfactory-nerve tissue. Understanding the distribution of PrP(sup Sc) in Creutzfeldt-Jakob disease is important for classification and diagnosis and perhaps even for prevention. METHODS: We used a highly sensitive method of detection -- involving the concentration of PrP(sup Sc) by differential precipitation with sodium phosphotungstic acid, which increased the sensitivity of Western blot analysis by up to three orders of magnitude -- to search for PrP(sup Sc) in extraneural organs of 36 patients with sporadic Creutzfeldt-Jakob disease who died between 1996 and 2002. RESULTS: PrP(sup Sc) was present in the brain tissue of all patients. In addition, we found PrP(sup Sc) in 10 of 28 spleen specimens and in 8 of 32 skeletal-muscle samples. Three patients had PrP(sup Sc) in both spleen and muscle specimens. Patients with extraneural PrP(sup Sc) had a significantly longer duration of disease and were more likely to have uncommon molecular variants of sporadic Creutzfeldt-Jakob disease than were patients without extraneural PrP(sup Sc). CONCLUSIONS: Using sensitive techniques, we identified extraneural deposition of PrP(sup Sc) in spleen and muscle samples from approximately one third of patients who died with sporadic Creutzfeldt-Jakob disease. Extraneural PrP(sup Sc) appears to correlate with a long duration of disease.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Natl Reference Ctr Prion Dis, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Glatzel, Markus/V-8844-2019; Aguzzi, Adriano/A-3351-2008; Glatzel, Markus/G-3356-2011	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Aguzzi, Adriano/0000-0002-0344-6708; Abela, Eugenio/0000-0002-9356-1450				Aguzzi A, 2003, NATURE, V423, P127, DOI 10.1038/423127a; Aguzzi A, 2000, HAEMATOLOGICA, V85, P3; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; ASKANAS V, 1993, NEUROREPORT, V5, P25, DOI 10.1097/00001756-199310000-00006; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Collinge J, 1997, NATURE, V389, P526, DOI 10.1038/39116; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Glatzel M, 2002, LANCET, V360, P139, DOI 10.1016/S0140-6736(02)09384-4; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Nakamura Y, 2000, EPIDEMIOL INFECT, V125, P201, DOI 10.1017/S0950268899004240; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rossetti AO, 2003, J NEUROL, V250, P491, DOI 10.1007/s00415-003-1006-3; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096; Zanusso G, 2001, BRAIN PATHOL, V11, P182	31	266	274	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2003	349	19					1812	1820		10.1056/NEJMoa030351	http://dx.doi.org/10.1056/NEJMoa030351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739NR	14602879				2022-12-01	WOS:000186353800005
J	Marshall, CH; Pielke, RA; Steyaert, LT				Marshall, CH; Pielke, RA; Steyaert, LT			Wetlands: Crop freezes and land-use change in Florida	NATURE			English	Editorial Material									Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; US Geol Survey, EROS Data Ctr, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Colorado State University; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Marshall, CH (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.		Pielke, Roger A/A-5015-2009					Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Miller K.A., 1991, CLIM RES, V1, P133, DOI DOI 10.3354/CR001133; Walko RL, 2000, J APPL METEOROL, V39, P931, DOI 10.1175/1520-0450(2000)039<0931:CABHMF>2.0.CO;2; [No title captured]; [No title captured]; [No title captured]	6	36	37	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					29	30		10.1038/426029a	http://dx.doi.org/10.1038/426029a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603304				2022-12-01	WOS:000186370800028
J	Rak, A; Pylypenko, O; Durek, T; Watzke, A; Kushnir, S; Brunsveld, L; Waldmann, H; Goody, RS; Alexandrov, K				Rak, A; Pylypenko, O; Durek, T; Watzke, A; Kushnir, S; Brunsveld, L; Waldmann, H; Goody, RS; Alexandrov, K			Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPase	SCIENCE			English	Article							IN-VITRO; PROTEINS; DOMAIN; GERANYLGERANYLTRANSFERASE; GDI1	Rab/Ypt guanosine triphosphatases (GTPases) represent a family of key membrane traffic regulators in eukaryotic cells whose function is governed by the guanosine diphosphate (GDP) dissociation inhibitor (RabGDI). Using a combination of chemical synthesis and protein engineering, we generated and crystallized the monoprenylated Ypt1: RabGDI complex. The structure of the complex was solved to 1.5 angstrom resolution and provides a structural basis for the ability of RabGDI to inhibit the release of nucleotide by Rab proteins. Isoprenoid binding requires a conformational change that opens a cavity in the hydrophobic core of its domain II. Analysis of the structure provides a molecular basis for understanding a RabGDI mutant that causes mental retardation in humans.	Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; Univ Dortmund, Dept Organ Chem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Dortmund University of Technology	Alexandrov, K (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.		Goody, Roger S/J-8845-2014; Waldmann, Herbert/B-7406-2017; Alexandrov, Kirill/A-5830-2013; Durek, Thomas/I-8715-2014	Goody, Roger S/0000-0002-0772-0444; Waldmann, Herbert/0000-0002-9606-7247; Alexandrov, Kirill/0000-0002-0957-6511; Durek, Thomas/0000-0003-0686-227X; Brunsveld, Luc/0000-0001-5675-511X; Pylypenko, Olena/0000-0001-7073-5238				Alexandrov K, 2002, J AM CHEM SOC, V124, P5648, DOI 10.1021/ja017799e; Alory C, 2001, TRAFFIC, V2, P532, DOI 10.1034/j.1600-0854.2001.20803.x; An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Constantinescu AT, 2002, STRUCTURE, V10, P569, DOI 10.1016/S0969-2126(02)00737-2; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gilbert PM, 2001, J BIOL CHEM, V276, P8014, DOI 10.1074/jbc.M008845200; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; HORIUCHI H, 1995, METHOD ENZYMOL, V257, P9; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Luan P, 2000, TRAFFIC, V1, P270, DOI 10.1034/j.1600-0854.2000.010309.x; Ludolph B, 2002, J AM CHEM SOC, V124, P5954, DOI 10.1021/ja025768t; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; RAK A, UNPUB; Ricard CS, 2001, GENESIS, V31, P17, DOI 10.1002/gene.10000; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Shen F, 1996, J BIOL CHEM, V271, P3692; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	25	158	163	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					646	650		10.1126/science.1087761	http://dx.doi.org/10.1126/science.1087761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576435				2022-12-01	WOS:000186119900060
J	Hypponen, E; Smith, GD; Power, C				Hypponen, E; Smith, GD; Power, C			Effects of grandmothers' smoking in pregnancy on birth weight: intergenerational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY REVASCULARIZATION; FOLLOW-UP; ANGINA; WHITEHALL; ABNORMALITIES; TRANSMISSION; ASSOCIATION; VARIABILITY; MANAGEMENT; GUIDELINE	Objective To investigate the influences on birth weight of maternal smoking during pregnancy across generations. Design Intergenerational cohort study. Participants Members of the 1958 birth cohort and their offspring and mothers. Setting England, Scotland, and Wales. Main outcome measure Birth weight. Results Information on grandmothers' smoking during pregnancy was available for 9028 singleton offspring of 4302 female cohort members. Assuming heritable transmission through the intergenerational birth weight association, grandmothers' smoking was predicted to result in a 34 g reduction (95% confidence interval - 41 g to - 28 g) in the birth weight of grandchildren. Random effects models showed a negative association between grandmothers' smoking and birth weight of grandchildren (Beta regression coefficient - 24 g, - 50 g to 3 g), but this effect was eliminated after adjustment for maternal smoking (0 g, - 26 g to 26 g). No association was evident among if the offspring of non-smoking mothers G 105; 14 17 g to 46 g), and after adjustment for maternal birth weight and height and body mass index as adults, grandmothers' smoking was positively associated with the birth weight of grandchildren (45 g, 10 g to 80 g). Conclusion Deficits in mothers' birth weight attributable to their mother smoking was not evident in the grandchildren.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; University College London; University of Bristol	Hypponen, E (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	e.hypponen@ich.ucl.ac.uk	Hypponen, Elina/B-2596-2014; Davey Smith, George/A-7407-2013	Hypponen, Elina/0000-0003-3670-9399; Davey Smith, George/0000-0002-1407-8314				Butler N.R., 1963, PERINATAL MORTALITY; BUTLER NR, 1969, PERINATAL PROBLEMS; CLARKE KW, 1994, BRIT HEART J, V71, P38; *CTR LONG STUD I E, 1994, SN3148 CTR LONG STUD; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; *DEP HLTH, 2000, NAT SERV RAM COR HEA; Eccles M, 2001, FAM PRACT, V18, P217, DOI 10.1093/fampra/18.2.217; EMANUEL I, 1992, BRIT J OBSTET GYNAEC, V99, P67, DOI 10.1111/j.1471-0528.1992.tb14396.x; FERRI E, 1993, LIFE 33 5 FOLLOW UP; FERRI E, 1993, LIFE 33 5 FOLLOW NAT; FOGELMAN KR, 1988, BRIT MED J, V297, P1233, DOI 10.1136/bmj.297.6658.1233; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Hemingway H, 2000, J EPIDEMIOL COMMUN H, V54, P510, DOI 10.1136/jech.54.7.510; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hennessy E, 1998, PAEDIATR PERINAT EP, V12, P45, DOI 10.1046/j.1365-3016.1998.0120s1045.x; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Lampe FC, 1999, J CLIN EPIDEMIOL, V52, P73, DOI 10.1016/S0895-4356(98)00146-2; Lampe FC, 2001, AM J EPIDEMIOL, V153, P1173, DOI 10.1093/aje/153.12.1173; LAST JM, 1963, LANCET, V2, P28; LUMEY LH, 1994, INT J EPIDEMIOL, V23, P1006, DOI 10.1093/ije/23.5.1006; Macfarlane PW, 1996, J ELECTROCARDIOL, V29, P29, DOI 10.1016/S0022-0736(96)80016-1; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Martin RM, 2002, HEART, V88, P627, DOI 10.1136/heart.88.6.627; MCCORMICK A, 1995, MORBIDITY STAT GEN P; OUNSTED M, 1986, ANN HUM BIOL, V13, P143, DOI 10.1080/03014468600008281; Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Price KC, 1999, OBSTET GYNECOL, V94, P128, DOI 10.1016/S0029-7844(99)00269-0; Ramakrishnan U, 1999, J NUTR, V129, p544S, DOI 10.1093/jn/129.2.544S; Richards H, 2000, J EPIDEMIOL COMMUN H, V54, P714, DOI 10.1136/jech.54.9.714; ROSE G, 1968, BRIT J PREV SOC MED, V22, P12; Rose G.A., 1982, CARDIOVASCULAR SURVE; Sanderson M, 1998, AM J EPIDEMIOL, V147, P136; Stafford M, 1998, J EPIDEMIOL COMMUN H, V52, P353, DOI 10.1136/jech.52.6.353; Stein AD, 2000, HUM BIOL, V72, P641; SUSSER M, 1994, NUTR REV, V52, P84, DOI 10.1111/j.1753-4887.1994.tb01395.x; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Ware J.E., 1993, SCORING SF 36 SF 36, DOI DOI 10.6-10.7	40	27	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2003	327	7420					898	900A		10.1136/bmj.327.7420.898	http://dx.doi.org/10.1136/bmj.327.7420.898			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734RV	14563745	Bronze, Green Published			2022-12-01	WOS:000186072100017
J	Schiestl, FP; Peakall, R; Mant, JG; Ibarra, F; Schulz, C; Franke, S; Francke, W				Schiestl, FP; Peakall, R; Mant, JG; Ibarra, F; Schulz, C; Franke, S; Francke, W			The chemistry of sexual deception in an orchid-wasp pollination system	SCIENCE			English	Article							ORGANIC MASS SPECTROMETRY; ATTRACTION; VOLATILES	The "sexually deceptive" orchid Chiloglottis trapeziformis attracts males of its pollinator species, the thynnine wasp Neozeleboria cryptoides, by emitting a unique volatile compound, 2-ethyl-5-propylcyclohexan-1,3-dione, which is also produced by female wasps as a male-attracting sex pheromone.	Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany; Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	University of Hamburg; Australian National University	Francke, W (corresponding author), Univ Hamburg, Inst Organ Chem, Martin Luther King Pl 6, D-20146 Hamburg, Germany.		Peakall, Rod/C-9623-2009	Peakall, Rod/0000-0001-9407-8404; Schiestl, Florian/0000-0001-7637-6918				ATTYGALLE AB, 1988, ANGEW CHEM INT EDIT, V27, P460, DOI 10.1002/anie.198804601; ATTYGALLE AB, 1994, PURE APPL CHEM, V66, P2323, DOI 10.1351/pac199466102323; Ayasse M, 2003, P ROY SOC B-BIOL SCI, V270, P517, DOI 10.1098/rspb.2002.2271; Bower CC, 1996, AUST J BOT, V44, P15, DOI 10.1071/BT9960015; DAFNI A, 1990, EVOL BIOL, V24, P193; Kullenberg B., 1961, STUDIES OPHRYS POLLI; Mant JG, 2002, EVOLUTION, V56, P888; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; RAGUSO RA, COGNITIVE ECOLOGY PO, p8O; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schiestl FP, 2000, J COMP PHYSIOL A, V186, P567, DOI 10.1007/s003590000112; Schiestl FP, 2002, MOLEC METH PLAN ANAL, V21, P173; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; VANDEWAL.M, 1967, B SOC CHIM BELG, V76, P111; VANDEWALLE M, 1967, B SOC CHIM BELG, V76, P123; VOGEL S, 1983, ENCY PLANT PHYSL C, V12, P560; Wong BBM, 2002, P ROY SOC B-BIOL SCI, V269, P1529, DOI 10.1098/rspb.2002.2052	17	256	275	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					437	438		10.1126/science.1087835	http://dx.doi.org/10.1126/science.1087835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14564006				2022-12-01	WOS:000185963200040
J	Deleault, NR; Lucassen, RW; Supattapone, S				Deleault, NR; Lucassen, RW; Supattapone, S			RNA molecules stimulate prion protein conversion	NATURE			English	Article							NUCLEOCAPSID PROTEIN; AMPLIFICATION; HIV-1	Much evidence supports the hypothesis that the infectious agents of prion diseases are devoid of nucleic acid, and instead are composed of a specific infectious protein(1). This protein, PrPSc, seems to be generated by template-induced conformational change of a normally expressed glycoprotein, PrPC (ref. 2). Although numerous studies have established the conversion of PrPC to PrPSc as the central pathogenic event of prion disease, it is unknown whether cellular factors other than PrPC might be required to stimulate efficient PrPSc production. We investigated the biochemical amplification of protease-resistant PrPSc-like protein (PrPres) using a modified version(3) of the protein-misfolding cyclic amplification method(4). Here we report that stoichiometric transformation of PrPC to PrPres in vitro requires specific RNA molecules. Notably, whereas mammalian RNA preparations stimulate in vitro amplification of PrPres, RNA preparations from invertebrate species do not. Our findings suggest that host-encoded stimulatory RNA molecules may have a role in the pathogenesis of prion disease. They also provide a practical approach to improve the sensitivity of diagnostic techniques based on PrPres amplification.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Supattapone, S (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.							BANKS GR, 1974, EUR J BIOCHEM, V47, P499, DOI 10.1111/j.1432-1033.1974.tb03718.x; Caughey B, 1999, METHOD ENZYMOL, V309, P122; Chapon C, 1997, RNA, V3, P1337; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LOCKARD RE, 1981, NUCLEIC ACIDS RES, V9, P5125, DOI 10.1093/nar/9.19.5125; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Moscardini M, 2002, J MOL BIOL, V318, P149, DOI 10.1016/S0022-2836(02)00092-X; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1999, PRION BIOL DIS; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0	16	411	438	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					717	720		10.1038/nature01979	http://dx.doi.org/10.1038/nature01979			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562104				2022-12-01	WOS:000185924500042
J	Yang, H; Luo, GB; Karnchanaphanurach, P; Louie, TM; Rech, I; Cova, S; Xun, LY; Xie, XS				Yang, H; Luo, GB; Karnchanaphanurach, P; Louie, TM; Rech, I; Cova, S; Xun, LY; Xie, XS			Protein conformational dynamics probed by single-molecule electron transfer	SCIENCE			English	Article							NAD(P)H-FLAVIN OXIDOREDUCTASE; ANOMALOUS DIFFUSION; ESCHERICHIA-COLI; KINETICS; PHOTON; RELAXATION	Electron transfer is used as a probe for angstrom-scale structural changes in single protein molecules. In a flavin reductase, the fluorescence of flavin is quenched by a nearby tyrosine residue by means of photo-induced electron transfer. By probing the fluorescence lifetime of the single flavin on a photon-by-photon basis, we were able to observe the variation of flavin-tyrosine distance over time. We could then determine the potential of mean force between the flavin and the tyrosine, and a correlation analysis revealed conformational fluctuation at multiple time scales spanning from hundreds of microseconds to seconds. This phenomenon suggests the existence of multiple interconverting conformers related to the fluctuating catalytic reactivity.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Politecn Milan, Dept Elect & Informat, I-20133 Milan, Italy; CNR, Ctr Elettron Quantist & Strumentaz Elettron, I-20133 Milan, Italy	Harvard University; Washington State University; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR)	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Pakawatpanurut, Pasit/E-5419-2010; Yang, Haw/AHD-0857-2022	Pakawatpanurut, Pasit/0000-0002-7657-4161; Yang, Haw/0000-0003-0268-6352; Rech, Ivan/0000-0002-1430-1010	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061577] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM61577-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROSE WP, 1994, SCIENCE, V265, P364, DOI 10.1126/science.265.5170.364; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; COVA S, 1989, REV SCI INSTRUM, V60, P1104, DOI 10.1063/1.1140324; Cova S, 1996, APPL OPTICS, V35, P1956, DOI 10.1364/AO.35.001956; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Edman L, 1996, P NATL ACAD SCI USA, V93, P6710, DOI 10.1073/pnas.93.13.6710; Eggeling C, 1998, P NATL ACAD SCI USA, V95, P1556, DOI 10.1073/pnas.95.4.1556; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; GEHLEN JN, 1994, SCIENCE, V263, P499, DOI 10.1126/science.263.5146.499; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; JACKSON TA, 1994, CHEM PHYS, V180, P131, DOI 10.1016/0301-0104(93)E0414-Q; Jia YW, 1997, P NATL ACAD SCI USA, V94, P7932, DOI 10.1073/pnas.94.15.7932; Jortner J., 1999, ELECT TRANSFER ISOLA, V106; KLEINFELD D, 1984, BIOCHEMISTRY-US, V23, P5780, DOI 10.1021/bi00319a017; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; Louie TM, 2002, J BIOL CHEM, V277, P39450, DOI 10.1074/jbc.M206339200; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Lu HP, 1997, J PHYS CHEM B, V101, P2753, DOI 10.1021/jp9634518; MARCHI M, 1993, J AM CHEM SOC, V115, P4178, DOI 10.1021/ja00063a041; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mataga N, 2000, J PHYS CHEM B, V104, P10667, DOI 10.1021/jp002145y; MCCAMMON JA, 1979, BIOCHEMISTRY-US, V18, P927, DOI 10.1021/bi00573a001; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 1999, PHYS REV LETT, V82, P3563, DOI 10.1103/PhysRevLett.82.3563; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; SIDERS P, 1984, J CHEM PHYS, V81, P5613, DOI 10.1063/1.447665; Van Den Berg PAW, 2001, SPR S FLUOR, V1, P457; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Yang H, 2002, J CHEM PHYS, V117, P10965, DOI 10.1063/1.1521154; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	39	732	744	2	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					262	266		10.1126/science.1086911	http://dx.doi.org/10.1126/science.1086911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	14551431				2022-12-01	WOS:000185825900035
J	Ho, AS; Sung, JJY; Chan-Yeung, M				Ho, AS; Sung, JJY; Chan-Yeung, M			An outbreak of severe acute respiratory syndrome among hospital workers in a community hospital in Hong Kong	ANNALS OF INTERNAL MEDICINE			English	Article							CORONAVIRUS; SARS; IDENTIFICATION; TRANSMISSION	Background: During outbreaks, hospital workers are at high risk for nosocomial infection with severe acute respiratory syndrome (SARS)-associated coronavirus. Objective: To examine how hospital workers became infected and whether they transmit the virus to their families. Design: Retrospective descriptive study. Setting: 529-bed community hospital in Hong Kong. Patients: 40 hospital workers infected with SARS-associated coronavirus over a 6-week period (25 March through 5 May 2003). Measurements: Percentage of infected hospital workers according to job category. Results: The cumulative incidence was highest among health care assistants, followed by physicians and nurses (8%, 5%, and 4%, respectively). Most hospital workers were infected from direct contact with patients with SARS, who primarily were in general wards and had unsuspected infection. At the time of contact, all hospital workers had used masks but not necessarily other protective devices. Affected hospital workers did not infect their families. Conclusion: Before isolation of all patients with clinically confirmed or suspected SARS, routine use of several protective devices, and training of staff in infection control, many health care workers were infected with SARS from patients with unsuspected cases.	Chinese Univ Hong Kong, Alice Ho Miu Ling Nethersole Hosp, Sha Tin 100083, Peoples R China; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Alice Ho Miu Ling Nethersole Hospital; Chinese University of Hong Kong; University of Hong Kong	Chan-Yeung, M (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, 4-F Professorial Block, Hong Kong, Hong Kong, Peoples R China.	mmwchan@hkucc.hku.hk	Sung, Joseph J. Y./R-3203-2018	Sung, Joseph J. Y./0000-0003-3125-5199				*CDCP, 2003, CDC LAB SEQ GEN NEW; *DEP HLTH, AT PNEUM; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Dwosh HA, 2003, CAN MED ASSOC J, V168, P1415; *HOSP AUTH HONG KO, 2003, SEV AC RESP SYND CAS; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; *PPHB, SUMM SEV AC RESP SAR; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666	16	78	79	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2003	139	7					564	567		10.7326/0003-4819-139-7-200310070-00008	http://dx.doi.org/10.7326/0003-4819-139-7-200310070-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729AP	14530227				2022-12-01	WOS:000185748800004
J	Gravel, S; Jackson, SP				Gravel, S; Jackson, SP			Increased genome instability in aging yeast	CELL			English	Editorial Material								In the September 26 issue of Science, McMurray and Gottschling (2003) report that aged yeast cells display high rates of loss of heterozygosity. Furthermore, they show that this reflects an impaired ability to correctly detect and repair DNA double-strand breaks. These results provide insights into how aging can engender genomic instability in eukaryotic cells.	Univ Cambridge, Inst Canc & Dev Biol, Wellcome Trust Canc Res UK, Cambridge CB2 1QR, England	Cancer Research UK; University of Cambridge	Gravel, S (corresponding author), Univ Cambridge, Inst Canc & Dev Biol, Wellcome Trust Canc Res UK, Cambridge CB2 1QR, England.		Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937				Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; LOEB LA, 1991, CANCER RES, V51, P3075; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6	6	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2003	115	1					1	2		10.1016/S0092-8674(03)00766-9	http://dx.doi.org/10.1016/S0092-8674(03)00766-9			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14531992	Bronze			2022-12-01	WOS:000185815500001
J	Guo, FQ; Okamoto, M; Crawford, NM				Guo, FQ; Okamoto, M; Crawford, NM			Identification of a plant nitric oxide synthase gene involved in hormonal signaling	SCIENCE			English	Article							ABSCISIC-ACID; STOMATAL CLOSURE; GENERATION; PROTEIN; NO	Nitric oxide ( NO) serves as a signal in plants. An Arabidopsis mutant (Atnos1) was identified that had impaired NO production, organ growth, and abscisic acid-induced stomatal movements. Expression of AtNOS1 with a viral promoter in Atnos1 mutant plants resulted in overproduction of NO. Purified AtNOS1 protein used the substrates arginine and nicotinamide adenine dinucleotide phosphate and was activated by Ca2+ and calmodulin-like mammalian endothelial nitric oxide synthase and neuronal nitric oxide synthase, yet it is a distinct enzyme with no sequence similarities to any mammalian isoform. Thus, AtNOS1 encodes a distinct nitric oxide synthase that regulates growth and hormonal signaling in plants.	Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Crawford, NM (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	ncrawford@ucsd.edu	Okamoto, Mamoru/AAF-4265-2019; Bruening, Stefan/B-8505-2011	Okamoto, Mamoru/0000-0002-2989-607X; Guo, Fang-Qing/0000-0001-6889-394X	NIGMS NIH HHS [GM 40672] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM040672, R01GM040672] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Beck KF, 1999, J EXP BIOL, V202, P645; Butt YKC, 2003, PLANTA, V216, P762, DOI 10.1007/s00425-002-00926-y; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; CHEN YJ, 1995, J BACTERIOL, V177, P5122, DOI 10.1128/jb.177.17.5122-5128.1995; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Forstermann U, 1998, FASEB J, V12, P773; Garcia-Mata C, 2003, TRENDS PLANT SCI, V8, P20, DOI 10.1016/S1360-1385(02)00009-2; Garcia-Mata C, 2002, PLANT PHYSIOL, V128, P790, DOI 10.1104/pp.011020; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Huang S, 1997, J NEUROCHEM, V69, P2516; Ignarro L. J., 2000, NITRIC OXIDE BIOL PA; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Neill SJ, 2002, PLANT PHYSIOL, V128, P13, DOI 10.1104/pp.010707; Stohr C, 2002, J EXP BOT, V53, P2293, DOI 10.1093/jxb/erf110; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3	22	652	730	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2003	302	5642					100	103		10.1126/science.1086770	http://dx.doi.org/10.1126/science.1086770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526079				2022-12-01	WOS:000185678500044
J	Ono, T; Losada, A; Hirano, M; Myers, MP; Neuwald, AF; Hirano, T				Ono, T; Losada, A; Hirano, M; Myers, MP; Neuwald, AF; Hirano, T			Differential contributions of condensin I and condensin II to mitotic chromosome architecture in vertebrate cells	CELL			English	Article							CHROMATID SEGREGATION; SISTER CHROMATIDS; 13S CONDENSIN; SMC PROTEINS; COMPLEX; COHESIN; XENOPUS; DNA; IDENTIFICATION; ORGANIZATION	The canonical condensin complex (henceforth condensin I) plays an essential role in mitotic chromosome assembly and segregation from yeast to humans. We report here the identification of a second condensin complex (condensin II) from vertebrate cells. Condensins I and II share the same pair of structural maintenance of chromosomes (SMC) subunits but contain different sets of non-SMC subunits. siRNA-mediated depletion of condensin I- or condensin II-specific subunits in HeLa cells produces a distinct, highly characteristic defect in chromosome morphology. Simultaneous depletion of both complexes causes the severest defect. In Xenopus egg extracts, condensin I function is predominant, but lack of condensin II results in the formation of irregularly shaped chromosomes. Condensins I and II show different distributions along the axis of chromosomes assembled in vivo and in vitro. We propose that the two condensin complexes make distinct mechanistic contributions to mitotic chromosome architecture in vertebrate cells.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Hirano, T (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd,POB 100, Cold Spring Harbor, NY 11724 USA.	hirano@cshl.org	Ono, Takao/C-6065-2017; Losada, Ana/H-5917-2015; Hirano, Tatsuya/F-6008-2011	Ono, Takao/0000-0002-0498-8293; Losada, Ana/0000-0001-5251-3383; Hirano, Tatsuya/0000-0002-4219-6473	NCI NIH HHS [CA45508] Funding Source: Medline; NIGMS NIH HHS [GM53926] Funding Source: Medline; NLM NIH HHS [LM06747, R01 LM006747] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053926] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006747] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Bazett-Jones DP, 2002, MOL CELL, V9, P1183, DOI 10.1016/S1097-2765(02)00546-4; BELMONT AS, 1987, J CELL BIOL, V105, P77, DOI 10.1083/jcb.105.1.77; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; DELATOUR EB, 1988, CELL, V55, P937, DOI 10.1016/0092-8674(88)90239-5; Dietzel S, 2001, NAT CELL BIOL, V3, P767, DOI 10.1038/35087089; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Hirano M, 1998, EMBO J, V17, P7139, DOI 10.1093/emboj/17.23.7139; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; MacCallum DE, 2002, MOL BIOL CELL, V13, P25, DOI 10.1091/mbc.01-09-0441; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Marshall WF, 2001, CURR BIOL, V11, P569, DOI 10.1016/S0960-9822(01)00180-4; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; OHNUKI Y, 1968, CHROMOSOMA, V25, P402, DOI 10.1007/BF02327721; Poirier MG, 2002, MOL BIOL CELL, V13, P2170, DOI 10.1091/mbc.01-08-0401; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; RATTNER JB, 1985, CELL, V42, P291, DOI 10.1016/S0092-8674(85)80124-0; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Siddiqui NU, 2003, DEVELOPMENT, V130, P3283, DOI 10.1242/dev.00542; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; Stray JE, 2003, J BIOL CHEM, V278, P26238, DOI 10.1074/jbc.M302699200; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sumner AT., 2003, CHROMOSOMES ORG FUNC; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	52	381	408	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2003	115	1					109	121		10.1016/S0092-8674(03)00724-4	http://dx.doi.org/10.1016/S0092-8674(03)00724-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532007	Bronze			2022-12-01	WOS:000185815500013
J	Ringler, P; Schulz, GE				Ringler, P; Schulz, GE			Self-assembly of proteins into designed networks	SCIENCE			English	Article							CRYSTAL-STRUCTURE; RESOLUTION; DNA	A C-4-symmetric tetrameric aldolase was used to produce a quadratic network consisting of the enzyme as a rigid four-way connector and stiff streptavidin rods as spacers. Each aldolase subunit was furnished with a His 6 tag for oriented binding to a planar surface and two tethered biotins for binding streptavidin in an oriented manner. The networks were improved by starting with composite units and also by binding to nickel-nitrilotriacetic acid-lipid monolayers. The mesh was adjustable in 5-nanometer increments. The production of a net with switchable mesh was initiated with the use of a calcium ion-containing beta-helix spacer that denatured on calcium ion depletion.	Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Schulz, GE (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	schulz@bio.chemie.uni-freiburg.de						BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; Bischler N, 1998, BIOPHYS J, V74, P1522, DOI 10.1016/S0006-3495(98)77864-6; CHALCROFT JP, 1987, FEBS LETT, V211, P53, DOI 10.1016/0014-5793(87)81273-5; Dotan N, 1999, ANGEW CHEM INT EDIT, V38, P2363, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2363::AID-ANIE2363>3.3.CO;2-4; Drexler KE, 1999, TRENDS BIOTECHNOL, V17, P5, DOI 10.1016/S0167-7799(98)01278-5; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247; Kroemer M, 2002, ACTA CRYSTALLOGR D, V58, P824, DOI 10.1107/S0907444902004614; Michl J, 2002, P NATL ACAD SCI USA, V99, P4788, DOI 10.1073/pnas.052016299; MORALES P, 1995, MAT SCI ENG C-BIOMIM, V2, P173, DOI 10.1016/0928-4931(95)00056-9; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Reviakine I, 1998, J STRUCT BIOL, V121, P356, DOI 10.1006/jsbi.1998.4003; Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848; Ringler P, 2002, CHEMBIOCHEM, V3, P463, DOI 10.1002/1439-7633(20020503)3:5<463::AID-CBIC463>3.0.CO;2-P; Scheuring S, 1999, J MICROSC-OXFORD, V193, P28, DOI 10.1046/j.1365-2818.1999.00434.x; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Service RF, 2002, SCIENCE, V298, P2322, DOI 10.1126/science.298.5602.2322; Sleytr UB, 2002, PROG COLL POL SCI S, V121, P57; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; WIESMANN C, 1995, STRUCTURE, V3, P961, DOI 10.1016/S0969-2126(01)00230-1; Yeates TO, 2002, CURR OPIN STRUC BIOL, V12, P464, DOI 10.1016/S0959-440X(02)00350-0	24	238	255	0	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2003	302	5642					106	109		10.1126/science.1088074	http://dx.doi.org/10.1126/science.1088074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526081				2022-12-01	WOS:000185678500046
J	Boyd, PA; Tondi, F; Hicks, NR; Chamberlain, PF				Boyd, PA; Tondi, F; Hicks, NR; Chamberlain, PF			Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PRENATAL-DIAGNOSIS	Objective To study trends in termination of pregnancy for fetal anomaly over 10 years and to assess the contribution of autopsy to the final diagnosis and counselling after termination. Design Retrospective study with cases from a congenital anomaly register and a defined unselected population. Data sources Pregnancies resulting in termination for fetal anomaly identified from the Oxford congenital anomaly register. Details about the prenatal diagnosis and autopsy findings were retrieved from case notes. Results Of the 57 258 deliveries, 309 (0.5%) were terminated because of prenatally diagnosed abnormality. There Were 129/29 086 (0.4%) terminations for fetal anomaly carried out in 1991-5 and 180/28 172 (0.6%) in 1996-2000. The percentage of fetuses that underwent autopsy fell from 84% to 67%. Autopsy was performed in 132 cases identified by ultrasound scan, with no evidence for abnormal karyotype. In 95 (72%) the autopsy confirmed the suspected diagnosis and did not add important further information, two cases were not classified, and in 35 (27%) the autopsy added information that led to a refinement of the risk of recurrence (reduced in 17, increased in 18); in I I of these 18 cases it was increased to a one in four risk. Conclusions Though there has been an increase in the rate of terminations of pregnancy for fetal anomaly, there has been a decline in the autopsy rate. When a prenatal diagnosis was based on the results of a scan only, the addition of information from a autopsy by a specialist paediatric pathologist provided important information that changed the estimated risk of recurrence in 27% of cases and in 8% this was to a higher (one in four) risk.	Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; Univ Florence, Fac Med & Chirurg, Dept Ginecol Perinatol & Riprod Umana, Florence, Italy; Univ Oxford, Dept Publ Hlth & Primary Care, Inst Hlth Sci, Oxford OX3 7LF, England; Oxford Radcliffe NHS Trust, Prenatal Diag Unit, Oxford OX3 9DU, England	University of Oxford; University of Florence; University of Oxford	Boyd, PA (corresponding author), Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	Patricia.boyd@orh.nhs.uk						Bauchner H, 2001, BMJ-BRIT MED J, V322, P309, DOI 10.1136/bmj.322.7282.309; Boyd PA, 1998, LANCET, V352, P1577, DOI 10.1016/S0140-6736(98)03202-4; Bricker L, 2000, HEALTH TECHNOL ASSES, V4, P1; Brodlie M, 2002, BRIT MED J, V324, P761, DOI 10.1136/bmj.324.7340.761; Gaffney G, 1998, PRENATAL DIAG, V18, P357, DOI 10.1002/(SICI)1097-0223(199804)18:4<357::AID-PD276>3.0.CO;2-0; Hunter M, 2001, BRIT MED J, V322, P255, DOI 10.1136/bmj.322.7281.255; Khong TY, 2002, BRIT MED J, V324, P749, DOI 10.1136/bmj.324.7340.749; Laussel-Riera A, 2000, ANN PATHOL, V20, P549; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; *NAT PER EP UN, 2003, REP OXF CONG AN REG; Redfern Michael, 2001, ROYAL LIVERPOOL CHIL; *ROYAL COLL OBST G, 1997, ULTR SCANN FET ABN R; Wald NJ, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/HTA2010; 2002, BMJ, V325, P1121	14	115	116	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 17	2004	328	7432					137	140		10.1136/bmj.37939.570104.EE	http://dx.doi.org/10.1136/bmj.37939.570104.EE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765CQ	14662522	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000188249900017
J	Chen, CZ; Li, L; Lodish, HF; Bartel, DP				Chen, CZ; Li, L; Lodish, HF; Bartel, DP			MicroRNAs modulate hematopoietic lineage differentiation	SCIENCE			English	Article							EXPRESSION; RNAS; IDENTIFICATION; CONSERVATION; SEQUENCE; ENCODES; DEATH; FAT	MicroRNAs (miRNAs) are an abundant class of similar to22-nucleotide regulatory RNAs found in plants and animals. Some miRNAs of plants, Caenorhabditis elegans, and Drosophila play important gene-regulatory roles during development by pairing to target mRNAs to specify posttranscriptional repression of these messages. We identify three miRNAs that are specifically expressed in hematopoietic cells and show that their expression is dynamically regulated during early hematopoiesis and lineage commitment. One of these miRNAs, miR-181, was preferentially expressed in the B-lymphoid cells of mouse bone marrow, and its ectopic expression in hematopoietic stem/progenitor cells led to an increased fraction of B-lineage cells in both tissue-culture differentiation assays and adult mice. Our results indicate that microRNAs are components of the molecular circuitry that controls mouse hematopoiesis and suggest that other microRNAs have similar regulatory roles during other facets of vertebrate development.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu; dbartel@wi.mit.edu	Huang, H/E-9490-2010; Li, Ling/A-2008-2010	Chen, Chang-Zheng/0000-0002-1620-242X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081612-01, R01 HL081612] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Dostie J, 2003, RNA, V9, P631; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	27	2630	2943	3	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					83	86		10.1126/science.1091903	http://dx.doi.org/10.1126/science.1091903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14657504	Green Submitted			2022-12-01	WOS:000187710600038
J	Adams, WM; Brockington, D; Dyson, J; Vira, B				Adams, WM; Brockington, D; Dyson, J; Vira, B			Managing tragedies: Understanding conflict over common pool resources	SCIENCE			English	Article							NONEQUILIBRIUM	Conflicts over the management of common pool resources are not simply material. They also depend on the perceptions of the protagonists. Policy to improve management often assumes that problems are self-evident, but in fact careful and transparent consideration of the ways different stakeholders understand management problems is essential to effective dialogue.	Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England	University of Cambridge; University of Oxford	Adams, WM (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	wa12@cam.ac.uk	Brockington, Dan/AAK-9065-2021	Brockington, Dan/0000-0001-5692-0154; DYSON, JANE/0000-0003-4868-3229				Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Arnold J. E. M., 1997, FARMS TREES FARMERS; BEHNKE RH, 1993, RANGE ECOLOGY AT DISEQUILIBRIUM, P1; Bobbitt P., 1978, TRAGIC CHOICES; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Dryzek, 1997, POLITICS EARTH; Edwards VM, 1998, J THEOR POLIT, V10, P347, DOI 10.1177/0951692898010003008; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; Leach G., 1988, WOODFUEL CRISIS PEOP; Leach M., 1996, The lie of the land: challenging received wisdom on the African environment., P1; Oakerson R. J., 1992, Making the commons work: theory, practice, and policy., P41; Oakerson Ronald, 1986, P C COMM PROP RES MA, P13; OSTROM E, 1990, GOVT COMMONS EVOLUTI; ROE EM, 1991, WORLD DEV, V19, P287, DOI 10.1016/0305-750X(91)90177-J; SINCLAIR ARE, 1985, CAN J ZOOL, V63, P987, DOI 10.1139/z85-147; Sullivan S, 2002, J BIOGEOGR, V29, P1595, DOI 10.1046/j.1365-2699.2002.00799.x; Thomson J. T., 1992, Making the commons work: theory, practice, and policy., P129; Wilson James, 2002, DRAMA COMMONS, P327; Wollenberg E., 2001, International Journal of Agricultural Resources, Governance and Ecology, V1, P199, DOI 10.1504/IJARGE.2001.000012	19	204	213	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1915	1916		10.1126/science.1087771	http://dx.doi.org/10.1126/science.1087771			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671288	Green Submitted			2022-12-01	WOS:000187174000043
J	Guo, HW; Ecker, JR				Guo, HW; Ecker, JR			Plant responses to ethylene gas are mediated by SCF (EBF1/EBF2)-dependent proteolysis of EIN3 transcription factor	CELL			English	Article							RECEPTOR GENE FAMILY; F-BOX SUBUNIT; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; PROTEIN-DEGRADATION; UBIQUITIN-LIGASE; PATHWAY; COMPLEX; MUTANT; KINASE	Plants use ethylene gas as a signal to regulate myriad developmental processes and stress responses. The Arabidopsis EIN3 protein is a key transcription factor mediating ethylene-regulated gene expression and morphological responses. Here, we report that EIN3 protein levels rapidly increase in response to ethylene and this response requires several ethylene-signaling pathway components including the ethylene receptors (ETR1 and EIN4), CTR1, EIN2, EIN5, and EIN6. In the absence of ethylene, EIN3 is quickly degraded through a ubiquitin/proteasome pathway mediated by two F box proteins, EBF1 and EBF2. Plants containing mutations in either gene show enhanced ethylene response by stabilizing EIN3, whereas efb1 efb2 double mutants show constitutive ethylene phenotypes. Plants over-expressing either F box gene display ethylene insensitivity and destabilization of EIN3 protein. These results reveal that a ubiquitin/proteasome pathway negatively regulates ethylene responses by targeting EIN3 for degradation, and pinpoint EIN3 regulation as the key step in the response to ethylene.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895	NIGMS NIH HHS [1F32GM66639] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066639] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeles F.B., 2012, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bechtold N, 1998, METH MOL B, V82, P259; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Larsen PB, 2001, PLANT PHYSIOL, V125, P1061, DOI 10.1104/pp.125.2.1061; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LIN C, 1995, P NATL ACAD SCI USA, V92, P8423, DOI 10.1073/pnas.92.18.8423; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; ROMAN G, 1995, GENETICS, V139, P1393; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	43	614	681	13	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					667	677		10.1016/S0092-8674(03)00969-3	http://dx.doi.org/10.1016/S0092-8674(03)00969-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675532	Bronze			2022-12-01	WOS:000187366100007
J	Opferman, JT; Letai, A; Beard, C; Sorcinelli, MD; Ong, CC; Korsmeyer, SJ				Opferman, JT; Letai, A; Beard, C; Sorcinelli, MD; Ong, CC; Korsmeyer, SJ			Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1	NATURE			English	Article							HEMATOPOIETIC-CELLS; DEFICIENT MICE; BCL-2 FAMILY; APOPTOSIS; DEATH; SURVIVAL; HOMEOSTASIS; LACKING; MEMBER; IL-7	Regulated apoptosis is essential for both the development and the subsequent maintenance of the immune system(1,2). Interleukins, including IL- 2, IL- 4, IL- 7 and IL- 15, heavily influence lymphocyte survival during the vulnerable stages of VDJ rearrangement and later in ensuring cellular homeostasis, but the genes specifically responsible for the development and maintenance of lymphocytes have not been identified(3 - 8). The antiapoptotic protein MCL- 1 is an attractive candidate, as it is highly regulated(9), appears to enhance short- term survival(10) and functions at an apical step in genotoxic deaths(11). However, Mcl- 1 deficiency results in peri- implantation lethality(12). Here we show that mice conditional for Mcl- 1 display a profound reduction in B and T lymphocytes when MCL- 1 is removed. Deletion of Mcl- 1 during early lymphocyte differentiation increased apoptosis and arrested the development at pro- B- cell and double- negative T- cell stages. Induced deletion of Mcl- 1 in peripheral B- and T- cell populations resulted in their rapid loss. Moreover, IL- 7 both induced and required MCL- 1 to mediate lymphocyte survival. Thus, MCL- 1, which selectively inhibits the proapoptotic protein BIM, is essential both early in lymphoid development and later on in the maintenance of mature lymphocytes.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee PD., 2001, J LIGHT MET, V1, P15; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rinkenberger JL, 2000, GENE DEV, V14, P23; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	30	644	676	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					671	676		10.1038/nature02067	http://dx.doi.org/10.1038/nature02067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668867				2022-12-01	WOS:000187132800044
J	Curtis, JP; Wang, YF; Portnay, EL; Masoudi, FA; Havranek, EP; Krumholz, HM				Curtis, JP; Wang, YF; Portnay, EL; Masoudi, FA; Havranek, EP; Krumholz, HM			Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article									Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Dis, New Haven, CT 06520 USA; Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA	Yale University; Denver Health Medical Center	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Dis, Room I-456 SHM,333 Cedar St,POB 208088, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020; Masoudi, Frederick/Q-7467-2019		NATIONAL INSTITUTE ON AGING [K08AG001011] Funding Source: NIH RePORTER; NIA NIH HHS [K08-AG01011] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		FitzGerald GA, 2003, LANCET, V361, P542, DOI 10.1016/S0140-6736(03)12560-3; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; MacDonald TM, 2003, LANCET, V361, P573, DOI 10.1016/S0140-6736(03)12509-3; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; 2003, US TODAY        0213, pD1	5	62	63	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1322	1323		10.1136/bmj.327.7427.1322	http://dx.doi.org/10.1136/bmj.327.7427.1322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656840	Green Published, Bronze			2022-12-01	WOS:000187131100018
J	von Kries, R; Ihme, N; Oberle, D; Lorani, A; Stark, R; Altenhofen, L; Niethard, FU				von Kries, R; Ihme, N; Oberle, D; Lorani, A; Stark, R; Altenhofen, L; Niethard, FU			Effect of ultrasound screening on the rate of first operative procedures for developmental hip dysplasia in Germany	LANCET			English	Article							CONGENITAL DISLOCATION; NEWBORN-INFANTS; DIAGNOSIS; INSTABILITY; ULTRASONOGRAPHY; CHILDREN; TRIAL; UK	Background Ultrasound screening for developmental hip dysplasia and early conservative treatment might prevent later hip operations. A national hip ultrasound-screening programme, undertaken during the first 6 weeks of life, was introduced across Germany in 1996 and was continued for 5 years. We assessed the rate of first operation on the hip during this programme. Methods A national active surveillance programme of initial operations for developmental hip dysplasia was started in 1997 and continued for 5 years. Screening participation was assessed by a random digit dialling telephone survey. Cases were children aged between 10 weeks and 5 years at first operation, who had had no underlying disease leading to developmental hip dysplasia. Completeness of case ascertainment was validated with a capture-recapture study in a representative subsample. Calculated incidences were compared with previously established rates. Findings About 90% of all children were screened. 147 cases in the first year, and between 81 and 105 for subsequent years were reported. Treatment included closed reductions 353 (66%), open reductions 61 (11%), and osteotomies 121 (23%). Developmental hip dysplasia was diagnosed by ultrasound before 6 weeks of age in 272 (55%) of cases, 64 (13%) were screened at the recommended time but had normal findings, 70 (14%) had delayed screening, and 89 (18%) were not screened. Capture-recapture estimates suggested that 52% of cases were reported. The corrected incidence for first operation was 0.26 per 1000 livebirths (95% CI 0.22-0.32). Interpretation Ultrasound screening seems to prevent many, but not all, operations for developmental hip dysplasia. Rates of timely screening (ie, before 6 weeks of age) and training of doctors in ultrasound screening need to be improved.	Univ Munich, Inst Social Paediat & Adolescent Med, Dept Paediat Epidemiol, D-81377 Munich, Germany; Univ Aachen, Dept Orthopaed, Aachen, Germany; Cent Res Inst Ambulatory Hlth Care Germany, Cologne, Germany	University of Munich; RWTH Aachen University	von Kries, R (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Dept Paediat Epidemiol, Heiglhofstr 63, D-81377 Munich, Germany.	AG.EPI@LRZ.uni-muenchen.de	Stark, Renée/B-6733-2013	Stark, Renée/0000-0002-6612-292X				Altenhofen L, 1996, DEUT ARZTEBLATT, V93; Andersson JE, 2002, ACTA PAEDIATR, V91, P926, DOI 10.1080/080352502760148658; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; Chan A, 1999, LANCET, V354, P1514, DOI 10.1016/S0140-6736(98)12469-8; Duppe H, 2002, J BONE JOINT SURG BR, V84B, P878, DOI 10.1302/0301-620X.84B6.12326; Eastwood DM, 2003, LANCET, V361, P595, DOI 10.1016/S0140-6736(03)12519-6; Elbourne D, 2002, LANCET, V360, P2009, DOI 10.1016/S0140-6736(02)12024-1; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; GRAF R, 1983, J PEDIATR ORTHOPED, V3, P354, DOI 10.1097/01241398-198307000-00015; Holen KJ, 2002, J BONE JOINT SURG BR, V84B, P886, DOI 10.1302/0301-620X.84B6.12093; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; KATTHAGEN BD, 1988, Z ORTHOP GRENZGEB, V126, P475, DOI 10.1055/s-2008-1044470; Laubereau B, 2001, MONATSSCHR KINDERH, V149, P367, DOI 10.1007/s001120050777; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; Maxwell SL, 2002, BMJ-BRIT MED J, V324, P1031, DOI 10.1136/bmj.324.7344.1031; NIETHARD FU, 2000, DTSCH ARZTEBLATT, V97, P1593; Ortolani M., 1937, PEDIATRIA NAPOLI, V45, P129; Pauwels F, 1976, BIOMECHANICS NORMAL; ROSENDAHL K, 1992, ACTA PAEDIATR, V81, P177, DOI 10.1111/j.1651-2227.1992.tb12198.x; ROSENDAHL K, 1994, PEDIATRICS, V94, P47; von Kries R, 2001, MONATSSCHR KINDERH, V149, P1191, DOI 10.1007/s001120170044; VON ROSEN S, 1956, Acta Orthop Scand, V26, P136; WEIDTMAN V, 1984, HUFTGELENKSVERANDERU; *ZENTR, 1991, HINW DURCHF FRUH KIN	24	101	103	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1883	1887		10.1016/S0140-6736(03)14957-4	http://dx.doi.org/10.1016/S0140-6736(03)14957-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667743				2022-12-01	WOS:000187011600008
J	He, YH; Michaels, SD; Amasino, RM				He, YH; Michaels, SD; Amasino, RM			Regulation of flowering time by histone acetylation in Arabidopsis	SCIENCE			English	Article							POLYAMINE OXIDASE; LOCUS-C; GENE; THALIANA; ENCODES; PROTEIN; VERNALIZATION; REPRESSION; EXPRESSION; COMPLEXES	The Arabidopsis autonomous floral-promotion pathway promotes flowering independently of the photoperiod and vernalization pathways by repressing FLOWERING LOCUS C (FLC), a MADS-box transcription factor that blocks the transition from vegetative to reproductive development. Here, we report that FLOWERING LOCUS D (FLD), one of six genes in the autonomous pathway, encodes a plant homolog of a protein found in histone deacetylase complexes in mammals. Lesions in FLD result in hyperacetylation of histones in FLC chromatin, up-regulation of FLC expression, and extremely delayed flowering. Thus, the autonomous pathway regulates flowering in part by histone deacetylation. However, not all autonomous-pathway mutants exhibit FLC hyperacetylation, indicating that multiple means exist by which this pathway represses FLC expression.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Amasino, RM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.		HE, Yuehui/H-9795-2012; HE, Yuehui/Y-8792-2018; Michaels, Scott/D-5458-2009	HE, Yuehui/0000-0003-3304-4555; HE, Yuehui/0000-0003-3304-4555; Michaels, Scott/0000-0001-5248-3487				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aravind L, 2002, GENOME BIOL, V3; Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9; Chua YL, 2003, PLANT CELL, V15, P1468, DOI 10.1105/tpc.011825; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Murray-Stewart T, 2002, BIOCHEM J, V368, P673, DOI 10.1042/BJ20021587; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sanda SL, 1996, PLANT PHYSIOL, V111, P641, DOI 10.1104/pp.111.2.641; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998	24	370	416	10	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1751	1754		10.1126/science.1091109	http://dx.doi.org/10.1126/science.1091109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14593187				2022-12-01	WOS:000186970100044
J	Hall, C; Tharakan, P; Hallock, J; Cleveland, C; Jefferson, M				Hall, C; Tharakan, P; Hallock, J; Cleveland, C; Jefferson, M			Hydrocarbons and the evolution of human culture	NATURE			English	Editorial Material							LOWER 48 STATES; OIL PRODUCTION; ENERGY	Most of the progress in human culture has required the exploitation of energy resources. About 100 years ago, the major source of energy shifted from recent solar to fossil hydrocarbons, including liquid and gaseous petroleum. Technology has generally led to a greater use of hydrocarbon fuels for most human activities, making civilization vulnerable to decreases in supply. At this time our knowledge is not sufficient for us to choose between the different estimates of, for example, resources of conventional oil.	SUNY Coll Environm Sci & Forestry, Dept Environm, Syracuse, NY 13210 USA; SUNY Coll Environm Sci & Forestry, Dept Forest Biol, Syracuse, NY 13210 USA; SUNY Coll Environm Sci & Forestry, Grad Program Environm Sci, Syracuse, NY 13210 USA; Univ Montana, Flathead Lake Biol Stn, Polson, MT 59860 USA; Syracuse Univ, Maxwell Sch Citizenship & Publ Affairs, Syracuse, NY USA; Boston Univ, Ctr Energy & Environm Studies, Boston, MA 02215 USA; Boston Univ, Dept Geog, Boston, MA 02215 USA; Global Energy & Environm Consultants, Old Stables, Felmersham MK43 7HJ, Beds, England	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University of Montana System; University of Montana; Syracuse University; Boston University; Boston University	Hall, C (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm, Syracuse, NY 13210 USA.	chall@esf.edu; cutler@bu.edu; jeffers@dircon.co.uk						Campbell CJ, 1998, SCI AM, V278, P77; CLEVELAND CJ, 1984, SCIENCE, V225, P890, DOI 10.1126/science.225.4665.890; Cooper C., 1998, WALL STREET J   1012; *EN INF ADM, 2003, DOEEIA0484 US DEP EN; HAKES J, LONG TERM WORLD OIL; Hall C, 2001, BIOSCIENCE, V51, P663, DOI 10.1641/0006-3568(2001)051[0663:TNTRTN]2.0.CO;2; HALLOCK J, IN PRESS ENERGY; Hubbert M., 1962, ENERGY RESOURCES REP; *INT WORK GROUP, 2000, LBNL44029; KAUFMANN RK, 1991, RESOUR ENERG, V13, P111, DOI 10.1016/0165-0572(91)90022-U; Kaufmann RK, 2001, ENERG J, V22, P27; KAUFMANN RK, IN PRESS ENERGY J; Lynch M.C., 2002, Q REV EC FINANCE, V42, P373, DOI DOI 10.1016/S1062-9769(02)00126-6; Munasinghe M., 2002, INT J SUSTAIN DEV, V5, P125, DOI [DOI 10.1504/IJSD.2002.002563, 10.1504/IJSD.2002.002563]; Sadorsky P, 1999, ENERG ECON, V21, P449, DOI 10.1016/S0140-9883(99)00020-1; Smulders S, 2003, RESOUR ENERGY ECON, V25, P59, DOI 10.1016/S0928-7655(02)00017-9; Tainter J., 1988, COLLAPSE COMPLEX SYS; Tharakan P.J, 2001, ENVIRON SCI POLICY, V4, P319, DOI [10.1016/S1462-9011(01)00036-3, DOI 10.1016/S1462-9011(01)00036-3]; Tissot B. P., 1978, PETROLEUM FORMATION; United States Geological Survey (USGS), 2003, WORLD PETR ASS 2000; *USGS, 2000, US DEP LONG TERM WOR	21	155	161	0	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					318	322		10.1038/nature02130	http://dx.doi.org/10.1038/nature02130			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628060				2022-12-01	WOS:000186660800052
J	Ira, G; Malkova, A; Liberi, G; Foiani, M; Haber, JE				Ira, G; Malkova, A; Liberi, G; Foiani, M; Haber, JE			Srs2 and Sgs1-Top3 suppress crossovers during double-strand break repair in yeast	CELL			English	Article							SYNDROME GENE-PRODUCT; SACCHAROMYCES-CEREVISIAE; MITOTIC RECOMBINATION; TOPOISOMERASE-III; CROSSING-OVER; HOMOLOGOUS RECOMBINATION; DNA HELICASE; FUNCTIONAL OVERLAP; HOLLIDAY JUNCTIONS; SGS1	Very few gene conversions in mitotic cells are associated with crossovers, suggesting that these events are regulated. This may be important for the maintenance of genetic stability. We have analyzed the relationship between homologous recombination and crossing-over in haploid budding yeast and identified factors involved in the regulation of crossover outcomes. Gene conversions unaccompanied by a crossover appear 30 min before conversions accompanied by exchange, indicating that there are two different repair mechanisms in mitotic cells. Crossovers are rare (5%), but deleting the BLM/WRN homolog, SGS1, or the SRS2 helicase increases crossovers 2- to 3-fold. Overexpressing SRS2 nearly eliminates crossovers, whereas overexpression of RAD51 in srs2Delta cells almost completely eliminates the noncrossover recombination pathway. We suggest Sgs1 and its associated topoisomerase Top3 remove double Holliday junction intermediates from a crossover-producing repair pathway, thereby reducing crossovers. Srs2 promotes the noncrossover synthesis-dependent strand-annealing (SDSA) pathway, apparently by regulating Rad51 binding during strand exchange.	Brandeis Univ, Rosentiel Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Ist FIRC Oncol Mol, I-20141 Milan, Italy; Univ Milan, Dipartimento Genet & Biol Microrganismi, I-20133 Milan, Italy	Brandeis University; Brandeis University; IFOM - FIRC Institute of Molecular Oncology; University of Milan	Haber, JE (corresponding author), Brandeis Univ, Rosentiel Ctr, Waltham, MA 02454 USA.	haber@brandeis.edu	LIBERI, GIORDANO/AAY-7273-2020; Foiani, Marco/M-8234-2014; Ira, Grzegorz/B-7912-2010	LIBERI, GIORDANO/0000-0003-3160-2242; Foiani, Marco/0000-0003-4795-834X; Haber, James/0000-0002-1878-0610	NIGMS NIH HHS [R01 GM080600, R37 GM020056, R01 GM020056, R01 GM061766, GM20056, GM61766] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080600, R01GM020056, R01GM061766, R37GM020056] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; AGUILERA A, 1988, GENETICS, V119, P779; Ajima J, 2002, MUTAT RES-FUND MOL M, V504, P157, DOI 10.1016/S0027-5107(02)00089-1; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Church G M, 1985, Prog Clin Biol Res, V177, P17; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; ESPOSITO MS, 1978, P NATL ACAD SCI USA, V75, P4436, DOI 10.1073/pnas.75.9.4436; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Frei C, 2000, GENE DEV, V14, P81; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; HASTINGS PJ, 1988, BIOESSAYS, V9, P61, DOI 10.1002/bies.950090206; Hickson ID, 2001, BIOCHEM SOC T, V29, P201, DOI 10.1042/0300-5127:0290201; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kang LE, 2000, MOL CELL BIOL, V20, P9162, DOI 10.1128/MCB.20.24.9162-9172.2000; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Khazanehdari KA, 2000, CHROMOSOMA, V109, P94, DOI 10.1007/s004120050416; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malkova A, 2000, P NATL ACAD SCI USA, V97, P14500, DOI 10.1073/pnas.97.26.14500; Mankouri HW, 2002, NUCLEIC ACIDS RES, V30, P1103, DOI 10.1093/nar/30.5.1103; MCGILL C, 1989, CELL, V57, P459, DOI 10.1016/0092-8674(89)90921-5; MILNE GT, 1995, GENETICS, V139, P1189; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Prado F, 2003, TRENDS GENET, V19, P428, DOI 10.1016/S0168-9525(03)00173-2; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; RONG L, 1991, GENETICS, V127, P75; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; Shen JC, 2001, MECH AGEING DEV, V122, P921, DOI 10.1016/S0047-6374(01)00248-2; Shor E, 2002, GENETICS, V162, P647; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; THALER DS, 1988, ANNU REV GENET, V22, P169, DOI 10.1146/annurev.ge.22.120188.001125; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Virgin JB, 2001, GENETICS, V157, P63; Watt PM, 1996, GENETICS, V144, P935; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636	67	454	461	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					401	411		10.1016/S0092-8674(03)00886-9	http://dx.doi.org/10.1016/S0092-8674(03)00886-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622595	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000186627100007
J	Morillon, A; Karabetsou, N; O'Sullivan, J; Kent, N; Proudfoot, N; Mellor, J				Morillon, A; Karabetsou, N; O'Sullivan, J; Kent, N; Proudfoot, N; Mellor, J			Isw1 chromatin remodeling ATPase coordinates transcription elongation and termination by RNA polymerase II	CELL			English	Article							PRE-MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROCESSING FACTORS; GENE-EXPRESSION; CAPPING ENZYME; HISTONE H3; YEAST; COMPLEX; RECRUITMENT	We demonstrate that distinct forms of the yeast chromatin-remodeling enzyme lsw1p sequentially regulate each stage of the transcription cycle. The lsw1a complex (lswlp/loc3p) represses gene expression at initiation through specific positioning of a promoter proximal dinucleosome, whereas the lsw1b complex (lswlp/loc2p/loc4p) acts within coding regions to control the amount of RNA polymerase (RNAPII) released into productive elongation and to coordinate elongation with termination and pre-mRNA processing. These effects of lsw1b are controlled via phosphorylation of the heptad repeat carboxy-terminal domain (CTD) of RNAPII and methylation of the chromatin template. The transcription elongation factor Spt4p antagonizes lsw1p and overcomes the lsw1p dependent pausing of RNAPII at the onset of the elongation cycle. Overall these studies establish the central role played by lsw1p in the coordination of transcription.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Mellor, J (corresponding author), Univ Oxford, Dept Biochem, S Pk Rd, Oxford OX1 3QU, England.	jane.mellor@bioch.ox.ac.uk	Morillon, Antonin/M-4751-2017; O'Sullivan, Justin/HDO-1639-2022; Pillay, Nischalan/F-9536-2012; Kent, Nicholas/A-4503-2010	Morillon, Antonin/0000-0002-0575-5264; O'Sullivan, Justin/0000-0003-2927-450X; Kent, Nicholas/0000-0002-4114-1307; Proudfoot, Nicholas/0000-0001-8646-3222				Adams A, 1997, METHODS YEAST GENETI; Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hartzog GA, 2003, CURR OPIN GENET DEV, V13, P119, DOI 10.1016/S0959-437X(03)00024-8; Hartzog GA, 2002, BBA-GENE STRUCT EXPR, V1577, P276, DOI 10.1016/S0167-4781(02)00458-X; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Moreau JL, 2003, MOL CELL, V11, P1609, DOI 10.1016/S1097-2765(03)00184-9; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teng YM, 1997, J MOL BIOL, V267, P324, DOI 10.1006/jmbi.1996.0908; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503	57	140	145	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					425	435		10.1016/S0092-8674(03)00880-8	http://dx.doi.org/10.1016/S0092-8674(03)00880-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622597	Bronze			2022-12-01	WOS:000186627100009
J	Lu, D; Searles, MA; Klug, A				Lu, D; Searles, MA; Klug, A			Crystal structure of a zinc-finger - RNA complex reveals two modes of molecular recognition	NATURE			English	Article							TRANSCRIPTION FACTOR IIIA; 5S RNA; DNA RECOGNITION; BINDING; PROTEIN; OOCYTES; TFIIIA	Zinc-finger proteins of the classical Cys(2)His(2) type are the most frequently used class of transcription factor and account for about 3% of genes in the human genome(1,2). The zinc-finger motif was discovered(3) during biochemical studies on the transcription factor TFIIIA, which regulates the 5S ribosomal RNA genes of Xenopus laevis(4,5). Zinc-fingers mostly interact with DNA, but TFIIIA binds not only specifically to the promoter DNA, but also to 5S RNA itself(6-9). Increasing evidence indicates that zinc-fingers are more widely used to recognize RNA(10-13). There have been numerous structural studies on DNA binding(14), but none on RNA binding by zinc-finger proteins. Here we report the crystal structure of a three-finger complex with 61 bases of RNA, derived(15) from the central regions of the complete nine-finger TFIIIA - 5S RNA complex. The structure reveals two modes of zinc-finger binding, both of which differ from that in common use for DNA: first, the zinc-fingers interact with the backbone of a double helix; and second, the zinc-fingers specifically recognize individual bases positioned for access in otherwise intricately folded 'loop' regions of the RNA.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Klug, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	akl@mrc-lmb.cam.ac.uk						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BOGENHAGEN DF, 1992, NUCLEIC ACIDS RES, V20, P2639, DOI 10.1093/nar/20.11.2639; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; CLEMENS KR, 1993, SCIENCE, V260, P530, DOI 10.1126/science.8475383; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; Finerty PJ, 1997, J MOL BIOL, V271, P195, DOI 10.1006/jmbi.1997.1177; Friesen WJ, 1997, J BIOL CHEM, V272, P10994; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Ladomery M, 2003, J CELL SCI, V116, P1539, DOI 10.1242/jcs.00324; MCBRYANT SJ, 1995, J MOL BIOL, V248, P44, DOI 10.1006/jmbi.1995.0201; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Nagai K, 2001, BIOCHEM SOC T, V29, P15; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PICARD B, 1979, P NATL ACAD SCI USA, V76, P241, DOI 10.1073/pnas.76.1.241; SAKONJU S, 1982, CELL, V31, P395, DOI 10.1016/0092-8674(82)90133-7; Searles MA, 2000, J MOL BIOL, V301, P47, DOI 10.1006/jmbi.2000.3946; Setzer DR, 1996, RNA, V2, P1254; SHELDRICK GM, 1995, ACTA CRYSTALLOGR B, V51, P423, DOI 10.1107/S0108768195003661; THEUNISSEN O, 1992, CELL, V71, P679, DOI 10.1016/0092-8674(92)90601-8; Theunissen O, 1998, EUR J BIOCHEM, V258, P758, DOI 10.1046/j.1432-1327.1998.2580758.x; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	30	148	153	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					96	100		10.1038/nature02088	http://dx.doi.org/10.1038/nature02088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603324				2022-12-01	WOS:000186370800049
J	Rappuoli, R; Covacci, A				Rappuoli, R; Covacci, A			Reverse vaccinology and genomics	SCIENCE			English	Article							SEQUENCE	The genomic revolution has had a dramatic effect on our ability to find new vaccine targets and develop effective vaccines.	IRIS, Chiron Vaccines, I-53100 Siena, Italy	Novartis	Rappuoli, R (corresponding author), IRIS, Chiron Vaccines, I-53100 Siena, Italy.							FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Foster I, 1999, GRID: BLUEPRINT FOR A NEW COMPUTING INFRASTRUCTURE, P15; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; RAPPUOLI R, UNPUB; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; IN PRESS BIOTECHNOLO	9	75	86	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					602	602		10.1126/science.1092329	http://dx.doi.org/10.1126/science.1092329			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576423				2022-12-01	WOS:000186119900046
J	Ota, S; Ueoka, H; Tanimoto, M				Ota, S; Ueoka, H; Tanimoto, M			Clinical picture - Retroperitoneal paraganglioma	LANCET			English	Editorial Material									Okayama Univ, Sch Med & Dent, Dept Internal Med 2, Okayama 7008558, Japan	Okayama University	Ota, S (corresponding author), Okayama Univ, Sch Med & Dent, Dept Internal Med 2, Okayama 7008558, Japan.								0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1266	1266		10.1016/S0140-6736(03)14569-2	http://dx.doi.org/10.1016/S0140-6736(03)14569-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575970				2022-12-01	WOS:000186036900009
J	Schwartz, E; Parise, M; Kozarsky, P; Cetron, M				Schwartz, E; Parise, M; Kozarsky, P; Cetron, M			Delayed onset of malaria - Implications for chemoprophylaxis in travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PLACEBO-CONTROLLED TRIAL; UNITED-STATES TROOPS; DOUBLE-BLIND; ATOVAQUONE-PROGUANIL; VIVAX MALARIA; NONIMMUNE TRAVELERS; PYRIMETHAMINE-SULFADOXINE; CHLOROQUINE-PROGUANIL; AMERICAN TRAVELERS	BACKGROUND: Most antimalarial agents used by travelers act on the parasite's blood stage and therefore do not prevent late-onset illness, particularly that due to species that cause relapsing malaria. We examined the magnitude of this problem among Israeli and American travelers. METHODS: We examined malaria surveillance data from Israel and the United States to determine the traveler's destination, the infecting species, the type of chemoprophylaxis used, and the incubation period. RESULTS: In Israel, from 1994 through 1999, there were 300 cases of malaria among returning travelers in which one species of plasmodium could be identified. In 134 of these cases (44.7 percent), the illness developed more than two months after the traveler's return; nearly all of these cases were due to infection with Plasmodium vivax or P. ovale. In 108 of the 134 cases (80.6 percent), the patient had used an antimalarial regimen according to national guidelines. In the United States, from 1992 through 1998, there were 2822 cases of malaria among travelers in which the cause could be evaluated. Late illness developed in 987 (35.0 percent) of these travelers. The infection was due to P. vivax in 811 travelers, P. ovale in 66, P. falciparum in 59, and P. malariae in 51; 614 (62.2 percent) of those with late-onset illness had appropriately taken an effective antimalarial agent. CONCLUSIONS: In more than one third of malaria-infected travelers, the illness developed more than two months after their return. Most of these late-onset illnesses are not prevented by the commonly used and effective blood schizonticides. Agents that act on the liver phase of malaria parasites are needed for more effective prevention of malaria in travelers.	Chaim Sheba Med Ctr, Ctr Geog Med, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Dept Med, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; CDCP, Malaria Epidemiol Branch, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA USA; CDCP, Surveillance & Epidemiol Branch, Div Global Migrat & Quarantine, Natl Ctr Infect Dis, Atlanta, GA USA; US PHS, US Dept HHS, Atlanta, GA USA; Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Public Health Service; Emory University	Schwartz, E (corresponding author), Chaim Sheba Med Ctr, Ctr Geog Med, IL-52621 Tel Hashomer, Israel.							ALVING AS, 1952, JAMA-J AM MED ASSOC, V149, P1558, DOI 10.1001/jama.1952.72930340017010; Anabwani G, 1999, PEDIATR INFECT DIS J, V18, P456, DOI 10.1097/00006454-199905000-00011; Baird JK, 2001, CLIN INFECT DIS, V33, P1990, DOI 10.1086/324085; Baudon D, 1999, T ROY SOC TROP MED H, V93, P302, DOI 10.1016/S0035-9203(99)90030-5; Berman JD, 2001, T ROY SOC TROP MED H, V95, P429, DOI 10.1016/S0035-9203(01)90206-8; Brueckner RP, 1998, AM J TROP MED HYG, V58, P645, DOI 10.4269/ajtmh.1998.58.645; Bustos DG, 1999, J INFECT DIS, V179, P1587, DOI 10.1086/314770; *CDCP, 2001, HLTH INF INT TRAV 20; Croft A, 1997, BRIT MED J, V315, P1412, DOI 10.1136/bmj.315.7120.1412; Croft AMJ, 1996, LANCET, V347, P326, DOI 10.1016/S0140-6736(96)90500-0; deAlencar FEC, 1997, J INFECT DIS, V175, P1544, DOI 10.1086/516497; FRYAUFF DJ, 1995, LANCET, V346, P1190, DOI 10.1016/S0140-6736(95)92898-7; HATTON CSR, 1986, LANCET, V1, P411; HENNEQUIN C, 1994, ARCH INTERN MED, V154, P2360, DOI 10.1001/archinte.154.20.2360; Hogh B, 2000, LANCET, V356, P1888, DOI 10.1016/S0140-6736(00)03260-8; Lacy MD, 2002, CLIN INFECT DIS, V35, pE92, DOI 10.1086/343750; Lell B, 2000, LANCET, V355, P2041, DOI 10.1016/S0140-6736(00)02352-7; Lell B, 1998, LANCET, V351, P709, DOI 10.1016/S0140-6736(97)09222-2; Ling J, 2002, CLIN INFECT DIS, V35, P825, DOI 10.1086/342578; LOBEL HO, 1990, B WORLD HEALTH ORGAN, V68, P209; Looareesuwan S, 1999, T ROY SOC TROP MED H, V93, P637, DOI 10.1016/S0035-9203(99)90079-2; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; Looareesuwan S, 1999, AM J TROP MED HYG, V60, P526, DOI 10.4269/ajtmh.1999.60.526; MILLER KD, 1986, AM J TROP MED HYG, V35, P451, DOI 10.4269/ajtmh.1986.35.451; Mulenga M, 1999, CLIN THER, V21, P841, DOI 10.1016/S0149-2918(99)80006-X; NEFTEL KA, 1986, BRIT MED J, V292, P721, DOI 10.1136/bmj.292.6522.721; Ohrt C, 1997, ANN INTERN MED, V126, P963, DOI 10.7326/0003-4819-126-12-199706150-00006; Overbosch D, 2001, CLIN INFECT DIS, V33, P1015, DOI 10.1086/322694; PHILLIPSHOWARD PA, 1986, BRIT MED J, V293, P932, DOI 10.1136/bmj.293.6552.932; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; Sabchareon A, 1998, T ROY SOC TROP MED H, V92, P201, DOI 10.1016/S0035-9203(98)90749-0; SANCHEZ JL, 1993, LANCET, V341, P1021, DOI 10.1016/0140-6736(93)91107-W; Schwartz E, 1998, CLIN INFECT DIS, V26, P1089, DOI 10.1086/520279; Schwartz E, 1999, CLIN INFECT DIS, V29, P1502, DOI 10.1086/313527; Shanks GD, 1999, J TRAVEL MED, V6, pS21; Shanks GD, 1998, CLIN INFECT DIS, V27, P494, DOI 10.1086/514710; Shapiro TA, 1999, AM J TROP MED HYG, V60, P831, DOI 10.4269/ajtmh.1999.60.831; Soto J, 1998, ANN INTERN MED, V129, P241, DOI 10.7326/0003-4819-129-3-199808010-00013; STEFFEN R, 1990, B WORLD HEALTH ORGAN, V68, P313; Sukwa TY, 1999, AM J TROP MED HYG, V60, P521, DOI 10.4269/ajtmh.1999.60.521; Taylor WRJ, 1999, CLIN INFECT DIS, V28, P74, DOI 10.1086/515071; Wallace MR, 1996, AM J MED, V100, P49, DOI 10.1016/S0002-9343(96)90011-X; *WHO, 2000, INT TRAV HLTH VACC R	43	116	120	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2003	349	16					1510	1516		10.1056/NEJMoa021592	http://dx.doi.org/10.1056/NEJMoa021592			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731ZM	14561793				2022-12-01	WOS:000185916400005
J	Taylor, GK; Nudds, RL; Thomas, ALR				Taylor, GK; Nudds, RL; Thomas, ALR			Flying and swimming animals cruise at a Strouhal number tuned for high power efficiency	NATURE			English	Article							LOCUSTA-MIGRATORIA L; OSCILLATING FOILS; INTERMITTENT FLIGHT; WINGBEAT FREQUENCY; NEUROMUSCULAR CONTROL; FLAPPING FLIGHT; NATURAL FLIGHT; WIDE-RANGE; KINEMATICS; PROPULSION	Dimensionless numbers are important in biomechanics because their constancy can imply dynamic similarity between systems, despite possible differences in medium or scale(1). A dimensionless parameter that describes the tail or wing kinematics of swimming and flying animals is the Strouhal number(1), St = fA/U, which divides stroke frequency (f) and amplitude (A) by forward speed (U)(2-8). St is known to govern a well-defined series of vortex growth and shedding regimes for airfoils undergoing pitching and heaving motions(6,8). Propulsive efficiency is high over a narrow range of St and usually peaks within the interval 0.2 < St < 0.4 (refs 3-8). Because natural selection is likely to tune animals for high propulsive efficiency, we expect it to constrain the range of St that animals use. This seems to be true for dolphins(2-5), sharks(3-5) and bony fish(3-5), which swim at 0.2 < St < 0.4. Here we show that birds, bats and insects also converge on the same narrow range of St, but only when cruising. Tuning cruise kinematics to optimize St therefore seems to be a general principle of oscillatory lift-based propulsion.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Taylor, GK (corresponding author), Univ Oxford, Dept Zool, Tinbergen Bldg,S Parks Rd, Oxford OX1 3PS, England.		tay, wee beng/B-1095-2010; Taylor, Graham/A-5041-2010; Usoh, Chigozie/H-5517-2011					Alexander RM., 2003, PRINCIPLES ANIMAL LO; Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; BAKER PS, 1981, J COMP PHYSIOL, V141, P233, DOI 10.1007/BF01342669; BAKER PS, 1979, J COMP PHYSIOL, V131, P79, DOI 10.1007/BF00613086; Bandyopadhyay PR, 2000, J FLUID ENG-T ASME, V122, P219, DOI 10.1115/1.483274; Bullen RD, 2002, J EXP BIOL, V205, P2615; DUDLEY R, 1990, J COMP PHYSIOL A, V167, P145; GOPALKRISHNAN R, 1994, J FLUID MECH, V274, P1, DOI 10.1017/S0022112094002016; Huang RF, 2001, J FLUID MECH, V441, P265, DOI 10.1017/S002211200100489X; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; PENNYCUICK CJ, 1989, J EXP BIOL, V142, P1; Pennycuick CJ, 2001, J EXP BIOL, V204, P3283; PENNYCUICK CJ, 1990, J EXP BIOL, V150, P171; Pennycuick CJ, 1996, J EXP BIOL, V199, P1613; RAYNER JMV, 1987, CURRENT ORNITHOLOGY, V5, P1; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9; ROHR JJ, 1998, 1769 SPAC NAV WARF S; SCHOLEY KD, 1983, THESIS U BRISTOL; Tobalske BW, 1996, AUK, V113, P151, DOI 10.2307/4088943; Tobalske BW, 1999, J EXP BIOL, V202, P1725; Tobalske BW, 1996, J EXP BIOL, V199, P263; TOBALSKE BW, 1995, J EXP BIOL, V198, P1259; TOBALSKE BW, 1994, J EXP BIOL, V187, P1; TRIANTAFYLLOU GS, 1993, J FLUID STRUCT, V7, P205, DOI 10.1006/jfls.1993.1012; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; TRIANTAFYLLOU MS, 1991, PHYS FLUIDS A-FLUID, V3, P2835, DOI 10.1063/1.858173; VIDELER JJ, 1988, J EXP BIOL, V134, P185; Wang ZJ, 2000, J FLUID MECH, V410, P323, DOI 10.1017/S0022112099008071; WITHERS PC, 1977, J EXP BIOL, V70, P13; Wolfgang MJ, 1999, J EXP BIOL, V202, P2303	30	565	578	10	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					707	711		10.1038/nature02000	http://dx.doi.org/10.1038/nature02000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562101				2022-12-01	WOS:000185924500039
J	Heath, I				Heath, I			A wolf in sheep's clothing: a critical look at the ethics of drug taking	BRITISH MEDICAL JOURNAL			English	Article							CONCORDANCE; WOMEN	In 1997 a report of a working party of the Royal Pharmaceutical Society of Great Britain acknowledged that prescribing is "a technically difficult, and morally complex, problem" and that compliance is an ethically dubious aspiration.(1) The report proposed the use of a new term-concordance-which was intended to describe the creation, during the process of prescribing, of an agreement that respected the beliefs and wishes of the patient.(2) The intention of the working party was to foster a distinct change in culture in the relation between prescribing and drug taking and between patient and prescriber. The intention was honourable, but the initiative seems to be foundering.	Caversham Grp Practice, London NW5 2UP, England		Heath, I (corresponding author), Caversham Grp Practice, Kentish Town, London NW5 2UP, England.							Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bashir A, 2001, INT J PHARM PRACT S, V9, pR78; Butler CC, 2001, J ANTIMICROB CHEMOTH, V48, P435, DOI 10.1093/jac/48.3.435; Carter S, 2003, QUESTION CHOICE COMP; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; DONALDSON MR, 1992, ALL ER, V4, P649; Dowell J, 2002, BRIT J GEN PRACT, V52, P24; Hodgkin P, 1996, BRIT MED J, V313, P1568, DOI 10.1136/bmj.313.7072.1568; Marinker M, 2003, BRIT MED J, V326, P348, DOI 10.1136/bmj.326.7385.348; METCALFE D, 1986, J ROY COLL GEN PRACT, V36, P349; POLLOCK AM, 2003, BRIT MED J, V377, P571; Rochon PA, 1997, BMJ-BRIT MED J, V315, P1096, DOI 10.1136/bmj.315.7115.1096; Royal Pharmaceutical Society of Great Britain, 1997, COMPL CONC ACH SHAR; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; Tuckett D, 1985, M EXPERTS APPROACH S; ZBIGNIEW H, 1983, REPORT BESIEGED CITY	16	23	23	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2003	327	7419					856	858		10.1136/bmj.327.7419.856	http://dx.doi.org/10.1136/bmj.327.7419.856			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732BP	14551104	Green Published			2022-12-01	WOS:000185921200026
J	Eisenberger, NI; Lieberman, MD; Williams, KD				Eisenberger, NI; Lieberman, MD; Williams, KD			Does rejection hurt? An fMRI study of social exclusion	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN ACTIVITY; PAIN; CONNECTIONS; ACTIVATION; RESPONSES; MONKEYS; NETWORK	A neuroimaging study examined the neural correlates of social exclusion and tested the hypothesis that the brain bases of social pain are similar to those of physical pain. Participants were scanned while playing a virtual ball-tossing game in which they were ultimately excluded. Paralleling results from physical pain studies, the anterior cingulate cortex (ACC) was more active during exclusion than during inclusion and correlated positively with self-reported distress. Right ventral prefrontal cortex (RVPFC) was active during exclusion and correlated negatively with self-reported distress. ACC changes mediated the RVPFC-distress correlation, suggesting that RVPFC regulates the distress of social exclusion by disrupting ACC activity.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	University of California System; University of California Los Angeles; Macquarie University	Eisenberger, NI (corresponding author), Univ Calif Los Angeles, Dept Psychol, Franz Hall, Los Angeles, CA 90095 USA.	neisenbe@ucla.edu	Williams, Kipling D/B-2620-2012; Tudusciuc, Oana/C-1339-2011; Lieberman, Matthew/ABD-8197-2020; Li, Chong/F-4265-2015	Lieberman, Matthew/0000-0002-4447-7359; 	NIMH NIH HHS [R21MH66709-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066709] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brown JL, 2003, PSYCHOSOM MED, V65, P276, DOI 10.1097/01.PSY.0000030388.62434.46; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; FOLTZ EL, 1962, J NEUROSURG, V19, P89, DOI 10.3171/jns.1962.19.2.0089; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; Leary M.R., 2001, BEHAV BADLY AVERSIVE, P151, DOI [DOI 10.1037/10365-006, 10.1037/10365-006]; LIEBERMAN ML, UNPUB; Lorberbaum JP, 1999, DEPRESS ANXIETY, V10, P99, DOI 10.1002/(SICI)1520-6394(1999)10:3<99::AID-DA2>3.0.CO;2-#; MACLEAN PD, 1988, BRAIN RES, V450, P111, DOI 10.1016/0006-8993(88)91550-8; MURPHY MR, 1981, SCIENCE, V213, P459, DOI 10.1126/science.7244642; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; PANKSEPP J, 1998, AFFECTIVE NEUROSCIEC; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; ZADRO L, IN PRESS RESPONDING; Zhang YQ, 1997, PAIN, V72, P127, DOI 10.1016/S0304-3959(97)00025-0	23	2168	2224	12	481	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					290	292		10.1126/science.1089134	http://dx.doi.org/10.1126/science.1089134			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	730HT	14551436				2022-12-01	WOS:000185825900043
J	Macfarlane, GJ; Biggs, AM; Maconochie, N; Hotopf, M; Doyle, P; Lunt, M				Macfarlane, GJ; Biggs, AM; Maconochie, N; Hotopf, M; Doyle, P; Lunt, M			Incidence of cancer among UK Gulf War veterans: cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEALTH; MORTALITY	Objectives To determine whether incidence rates of cancer are higher in UK service personnel who were deployed in the Gulf war than in those not deployed and whether any increased risk of cancer is related to self reported exposures to potentially hazardous material during the period of deployment. Design A cohort study with follow up from 1 April 1991 (the end of the Gulf war) to 31 July 2002. Participants 51721 Gulf war veterans and 50 755 service personnel matched for age, sex, rank, service, and level of fitness who were not deployed in the Gulf (the Era cohort). Main outcome measures Incident cancers, identified on the NHS central register. Results There were 270 incident cancers among the Gulf cohort and 269 among the Era cohort (incidence rate ratio 0.99, 95% confidence interval 0.83 to 1.17). There was no excess in site specific cancers among the Gulf cohort. Adjustment for lifestyle factors (smoking and alcohol consumption) did not alter these results. In the Gulf cohort, risk of cancer was not related to multiple vaccinations or exposure to pesticides or depleted uranium during deployment. Conclusion There is no current excess risk of cancer overall nor of site specific cancers in Gulf war veterans. Specific exposures during deployment have not resulted in a subsequent increased risk of cancer. The long latent period for cancer, however, necessitates the continued follow up of these cohorts.	Univ Manchester, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Guys Kings & St Thomass Sch Med, Dept Psychol Med, Gulf War Illnesses Res Unit, London SE5 8AZ, England; Univ Manchester, Sch Epidemiol & Hlth Sci, Epidemiol Unit, Arthrit Res Campaign, Manchester M13 9PL, Lancs, England	University of Manchester; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England.		Lunt, Mark/A-7132-2014; Hotopf, Matthew/E-4971-2010; Lunt, Mark/N-3413-2019; Macfarlane, Gary J/I-9521-2014	Lunt, Mark/0000-0002-2391-5575; Lunt, Mark/0000-0002-2391-5575; Macfarlane, Gary J/0000-0003-2322-3314; Hotopf, Matthew/0000-0002-3980-4466				Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Everitt B, 2002, PSYCHOL MED, V32, P1371, DOI 10.1017/S0033291702006311; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Knoke JD, 1998, EPIDEMIOLOGY, V9, P648, DOI 10.1097/00001648-199811000-00015; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; Maconochie N, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-4; *ROYAL SOC, 2002, HLTH EFF DEPL UR M 1; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7	8	30	30	1	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1373	1375		10.1136/bmj.327.7428.1373	http://dx.doi.org/10.1136/bmj.327.7428.1373			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670879	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000187417900016
J	Utzinger, J; Bergquist, R; Xiao, SH; Singer, BH; Tanner, M				Utzinger, J; Bergquist, R; Xiao, SH; Singer, BH; Tanner, M			Sustainable schistosomiasis control - the way forward	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; HELMINTH INFECTIONS; SANITATION; EFFICACY		Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; WHO, UNDP, World Bank, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Shanghai, Peoples R China; Swiss Trop Inst, CH-4002 Basel, Switzerland	Princeton University; The World Bank; World Health Organization; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Basel; Swiss Tropical & Public Health Institute	Utzinger, J (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.							Asaolu SO, 2003, ACTA TROP, V86, P283, DOI 10.1016/S0001-706X(03)00060-3; Bergquist NR, 2002, TRENDS PARASITOL, V18, P309, DOI 10.1016/S1471-4922(02)02301-2; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; El Khoby T, 1998, PARASITOL TODAY, V14, P92, DOI 10.1016/S0169-4758(97)01206-4; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Katz N, 1998, MEM I OSWALDO CRUZ, V93, P33, DOI 10.1590/S0074-02761998000700005; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; N'Goran EK, 2003, ANN TROP MED PARASIT, V97, P37, DOI 10.1179/000349803125002553; Savioli L, 1999, MONITORING HELMINTH; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Watts J, 2003, LANCET, V361, P1022, DOI 10.1016/S0140-6736(03)12849-8; WEHAB Working Group, 2002, FRAM ACT WAT SAN; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2002, WHO TECH REP SER; *WHO, 2002, GLOB PLAN STOP TUB; 2002, WORLD BANK LOAN PROG	20	152	156	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1932	1934		10.1016/S0140-6736(03)14968-9	http://dx.doi.org/10.1016/S0140-6736(03)14968-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667754				2022-12-01	WOS:000187011600028
J	Kuhlman, B; Dantas, G; Ireton, GC; Varani, G; Stoddard, BL; Baker, D				Kuhlman, B; Dantas, G; Ireton, GC; Varani, G; Stoddard, BL; Baker, D			Design of a novel globular protein fold with atomic-level accuracy	SCIENCE			English	Article							AMINO-ACID-SEQUENCE; DE-NOVO DESIGN; ELECTRON-DENSITY; SPECIFICITY; PREDICTION; SELECTION; DATABASE; VARIANT; SURFACE; DOMAIN	A major challenge of computational protein design is the creation of novel proteins with arbitrarily chosen three-dimensional structures. Here, we used a general computational strategy that iterates between sequence design and structure prediction to design a 93-residue alpha/beta protein called Top7 with a novel sequence and topology. Top7 was found experimentally to be folded and extremely stable, and the x-ray crystal structure of Top7 is similar (root mean square deviation equals 1.2 angstroms) to the design model. The ability to design a new protein fold makes possible the exploration of the large regions of the protein universe not yet observed in nature.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.		Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Dantas, Gautam/0000-0003-0455-8370; Kuhlman, Brian/0000-0003-4907-9699				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bonneau R, 2001, PROTEINS, P119; Bowers PM, 2000, J BIOMOL NMR, V18, P311, DOI 10.1023/A:1026744431105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Jaramillo A, 2002, P NATL ACAD SCI USA, V99, P13554, DOI 10.1073/pnas.212068599; Jin WZ, 2003, STRUCTURE, V11, P581, DOI 10.1016/S0969-2126(03)00075-3; Johnson EC, 1999, STRUCTURE, V7, P967, DOI 10.1016/S0969-2126(99)80123-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keating AE, 2001, P NATL ACAD SCI USA, V98, P14825, DOI 10.1073/pnas.261563398; KISSINGER CR, EPMR PROGRAM CRYSTAL; Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Larson SM, 2002, PROTEIN SCI, V11, P2804, DOI 10.1110/ps.0203902; LAZARIDIS T, 1999, PROTEINS, V35, P132; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mirny L, 2001, J MOL BIOL, V308, P123, DOI 10.1006/jmbi.2001.4602; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MURZIN AV, COMMUNICATION; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Raha K, 2000, PROTEIN SCI, V9, P1106, DOI 10.1110/ps.9.6.1106; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; ROHL C, IN PRESS METHODS ENZ; Su A, 1997, PROTEIN SCI, V6, P1701, DOI 10.1002/pro.5560060810	36	1146	1192	9	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1364	1368		10.1126/science.1089427	http://dx.doi.org/10.1126/science.1089427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631033				2022-12-01	WOS:000186683500043
J	Dufour, SC; Felbeck, H				Dufour, SC; Felbeck, H			Sulphide mining by the superextensile foot of symbiotic thyasirid bivalves	NATURE			English	Article							MOLLUSKS; ADAPTATIONS; TRANSPORT; HABITAT	In a symbiotic association between an invertebrate host and chemoautotrophic bacteria, each partner has different metabolic requirements, and the host typically supplies the bacteria with necessary reduced chemicals ( sulphide or methane). Some combination of anatomical, physiological and behavioural adaptations in the host often facilitates uptake and transport of reduced chemicals to the symbionts(1-4). We have studied five species of bivalve molluscs of the family Thyasiridae ( that is, thyasirids) three of which harbour chemoautotrophic bacteria. Here we show that the symbiotic bivalves extend their feet to form elongated and ramifying burrows in the sediment, most probably to gain access to reduced sulphur. Closely related bivalves ( including some thyasirid species) without bacterial symbionts show no comparable foot extension behaviour. The length and number of burrows formed by chemosymbiotic thyasirids are related to the concentration of hydrogen sulphide in the sediment. The burrows are formed by the foot of each bivalve, which can extend up to 30 times the length of the shell, and may be the most extreme case of animal structure elongation documented to date.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Dufour, SC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.							ALLEN JA, 1958, PHILOS T R SOC B, V241, P421, DOI 10.1098/rstb.1958.0010; ALLEN JA, 1953, NATURE, V171, P1117, DOI 10.1038/1711117b0; ARP AJ, 1984, PHYSIOL ZOOL, V57, P648, DOI 10.1086/physzool.57.6.30155991; CHILDRESS JJ, 1993, J EXP BIOL, V179, P131; CHILDRESS JJ, 1986, SCI AM, V256, P114; DANDO PR, 1986, J MAR BIOL ASSOC UK, V66, P915, DOI 10.1017/S0025315400048529; DANDO PR, 1986, PROC R SOC SER B-BIO, V227, P227, DOI 10.1098/rspb.1986.0021; GIERE O, 1991, MAR ECOL PROG SER, V68, P287; GILBOAGARBER N, 1971, ANAL BIOCHEM, V43, P129, DOI 10.1016/0003-2697(71)90116-3; Julian D, 1999, J EXP BIOL, V202, P2245; LEPENNEC M, 1995, COMP BIOCHEM PHYS A, V111, P183, DOI 10.1016/0300-9629(94)00211-B; McALESTER A. LEE, 1966, MALACOLOGIA, V3, P433; PAYNE CM, 1991, PHILOS T ROY SOC B, V334, P481, DOI 10.1098/rstb.1991.0128; REID RGB, 1986, VELIGER, V29, P3; Seilacher A., 1990, Historical Biology, V3, P289; SOUTHWARD EC, 1986, J MAR BIOL ASSOC UK, V66, P889, DOI 10.1017/S0025315400048517; Stanley SM, 1970, GEOL SOC AM MEM, V125, P1; TRUEMAN ER, 1986, J MOLLUS STUD, V52, P265, DOI 10.1093/mollus/52.3.265; Zuschin Martin, 2001, Historical Biology, V15, P123	19	59	64	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					65	67		10.1038/nature02095	http://dx.doi.org/10.1038/nature02095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603317				2022-12-01	WOS:000186370800041
J	Karl, DM; Laws, EA; Morris, P; Williams, PJL; Emerson, S				Karl, DM; Laws, EA; Morris, P; Williams, PJL; Emerson, S			Global carbon cycle - Metabolic balance of the open sea	NATURE			English	Editorial Material							PRODUCTIVITY; RESPIRATION; FLUX		Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Univ Coll N Wales, Sch Ocean Sci, Menai Bridge LL59 5PP, Gwynedd, Wales; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Hawaii System; Bangor University; University of Washington; University of Washington Seattle	Karl, DM (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	dkarl@hawaii.edu	Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721				delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duarte CM, 1999, SCIENCE, V284, P1735, DOI DOI 10.1126/SCIENCE.284.5421.1735B; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EMERSON S, 1995, J GEOPHYS RES-OCEANS, V100, P15873, DOI 10.1029/95JC01333; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gregg MC, 2003, NATURE, V422, P513, DOI 10.1038/nature01507; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Najjar RG, 2000, GLOBAL BIOGEOCHEM CY, V14, P573, DOI 10.1029/1999GB900086; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; Williams P. J. le B, 2002, PHYTOPLANKTON PRODUC, P222, DOI [10.1002/9780470995204.ch9, DOI 10.1002/9780470995204.CH9]; Young RW, 1991, GLOBAL BIOGEOCHEM CY, V5, P119, DOI 10.1029/91GB00927	12	143	146	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					32	32		10.1038/426032a	http://dx.doi.org/10.1038/426032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603308	Bronze			2022-12-01	WOS:000186370800032
J	Messerli, FH				Messerli, FH			ALLHAT, or the soft science of the secondary end point	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIURETIC THERAPY; METAANALYSIS; HYPERTENSION; OUTCOMES; RISK	The recent Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) showed that the primary end point, coronary heart disease, was identical in the chlorthalidone, lisinopril, and amlodipine groups. Yet the major conclusion of this trial was that thiazide diuretics are superior in preventing 1 or more major forms of cardiovascular disease and should be preferred for first-line antihypertensive therapy. This conclusion was based solely on an analysis of secondary end points and cost As evidenced by the dictum to "use thiazides for most patients with uncomplicated hypertension" in the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, this interpretation of, ALLHAT broadly adumbrated these guidelines. Although diuretics will rightfully remain a cornerstone in anti hypertensive therapy, we should remember (as we were told by the ALLHAT investigators) that secondary end points are "soft data" that should not form a basis for main conclusions or lead to a labeling of a drug class as preferred.	Ochsner Clin Fdn, New Orleans, LA 70121 USA	Ochsner Health System	Messerli, FH (corresponding author), Ochsner Clin Fdn, 1514 Jefferson Highway, New Orleans, LA 70121 USA.	fmesserli@aol.com	Messerli, Franz/AAR-4783-2021					*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; ALTMAN LK, 2000, NY TIMES        0829, pA17; [Anonymous], 1990, Circulation, V82, P1616; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLUCCI WS, 1986, NEW ENGL J MED, V314, P290, DOI 10.1056/NEJM198601303140506; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lindholm LH, 2003, J HYPERTENS, V21, P1563, DOI 10.1097/00004872-200308000-00022; McAlister FA, 2003, ANN INTERN MED, V138, P938, DOI 10.7326/0003-4819-138-11-200306030-00016; MESSERLI FH, 1995, ANN INTERN MED, V123, P888, DOI 10.7326/0003-4819-123-11-199512010-00015; Messerli FH, 2003, JAMA-J AM MED ASSOC, V289, P2067, DOI 10.1001/jama.289.16.2067; Messerli FH, 1998, JAMA-J AM MED ASSOC, V279, P1903, DOI 10.1001/jama.279.23.1903; Messerli FH, 1999, EUR HEART J, V20, P1441, DOI 10.1053/euhj.1999.1534; MESSERLI FH, 2003, JAMA-J AM MED ASSOC, V289, P2069; MESSERLI FH, IN PRESS AM J HYPERT; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; Schrier RW, 2000, HYPERTENSION, V35, P1031, DOI 10.1161/01.HYP.35.5.1031; Tenenbaum A, 2001, AM J MED, V110, P143, DOI 10.1016/S0002-9343(00)00674-4; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Yusuf S, 2000, NEW ENGL J MED, V342, P145	21	34	35	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2003	139	9					777	780		10.7326/0003-4819-139-9-200311040-00012	http://dx.doi.org/10.7326/0003-4819-139-9-200311040-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738XJ	14597462				2022-12-01	WOS:000186312900007
J	Liu, HB; Gao, JM; Lynch, SR; Saito, YD; Maynard, L; Kool, ET				Liu, HB; Gao, JM; Lynch, SR; Saito, YD; Maynard, L; Kool, ET			A four-base paired genetic helix with expanded size	SCIENCE			English	Article							NUCLEIC-ACIDS; BASE-PAIR; LIN-BENZOADENOSINE; HYDROPHOBIC BASE; DNA; OLIGONUCLEOTIDES; RECOGNITION; ISOGUANINE; ALPHABET; THYMINE	We describe a new molecular class of genetic-pairing system that has a native DNA backbone but has all four base pairs replaced by new, larger pairs. The base pairs include size-expanded analogs of thymine and of adenine, both extended by the width of a benzene ring (2.4 Angstrom). The expanded-diameter double helices are more thermodynamically stable than the Watson-Crick helix, likely because of enhanced base stacking. Structural data confirm a right-handed, double-stranded, and base-paired helical form. Because of the larger base size, all the pairs of this helical system are fluorescent, which suggests practical applications in detection of natural DNA and RNA. Our findings establish that there is no apparent structural or thermodynamic prohibition against genetic systems having sizes different from the natural one.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Kool, ET (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.			Gao, Jianmin/0000-0001-9341-1287; Kool, Eric/0000-0002-7310-2935	NIGMS NIH HHS [GM63587, GM52956] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052956, R01GM063587] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benner SA, 1998, PURE APPL CHEM, V70, P263, DOI 10.1351/pac199870020263; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Groebke K, 1998, HELV CHIM ACTA, V81, P375, DOI 10.1002/hlca.19980810302; HOFFER M, 1960, CHEM BER-RECL, V93, P2777, DOI 10.1002/cber.19600931204; Hoffmann MFH, 2000, HELV CHIM ACTA, V83, P2580, DOI 10.1002/1522-2675(20000906)83:9<2580::AID-HLCA2580>3.0.CO;2-6; KAUFFMAN RF, 1978, BIOCHEMISTRY-US, V17, P3686, DOI 10.1021/bi00611a002; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; LEONARD NJ, 1976, J AM CHEM SOC, V98, P3987, DOI 10.1021/ja00429a040; LESSOR RA, 1984, BIOCHEMISTRY-US, V23, P3868, DOI 10.1021/bi00312a012; Liu H., UNPUB; Matray TJ, 1998, J AM CHEM SOC, V120, P6191, DOI 10.1021/ja9803310; MATSUKURA M, 1987, P NATL ACAD SCI USA, V84, P7706, DOI 10.1073/pnas.84.21.7706; McMinn DL, 1999, J AM CHEM SOC, V121, P11585, DOI 10.1021/ja9925150; Michel J, 1996, NUCLEIC ACIDS RES, V24, P1127, DOI 10.1093/nar/24.6.1127; Mitsui T, 2003, J AM CHEM SOC, V125, P5298, DOI 10.1021/ja028806h; MURAKAMI A, 1985, BIOCHEMISTRY-US, V24, P4041, DOI 10.1021/bi00336a036; PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0; PRAKASH G, 1992, J AM CHEM SOC, V114, P3523, DOI 10.1021/ja00035a056; RAPPAPORT HP, 1988, NUCLEIC ACIDS RES, V16, P7253, DOI 10.1093/nar/16.15.7253; Seela F, 1998, NUCLEOS NUCLEOT, V17, P2045, DOI 10.1080/07328319808004745; SEELA F, 1997, BIOORG MED CHEM LETT, V17, P2173; Tanaka K, 2003, SCIENCE, V299, P1212, DOI 10.1126/science.1080587	23	205	215	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					868	871		10.1126/science.1088334	http://dx.doi.org/10.1126/science.1088334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593180				2022-12-01	WOS:000186258000050
J	Prinz, M; Heikenwalder, M; Junt, T; Schwarz, P; Glatzel, M; Heppner, FL; Fu, YX; Lipp, M; Aguzzi, A				Prinz, M; Heikenwalder, M; Junt, T; Schwarz, P; Glatzel, M; Heppner, FL; Fu, YX; Lipp, M; Aguzzi, A			Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion	NATURE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SYMPATHETIC INNERVATION; GERMINAL-CENTERS; MICE; SCRAPIE; REPLICATION; SUSCEPTIBILITY; EXPRESSION; INFECTION; RECEPTOR	Peripheral infection is the natural route of transmission in most prion diseases(1). Peripheral prion infection is followed by rapid prion replication in lymphoid organs, neuroinvasion(2) and progressive neurological disease. Both immune cells and nerves are involved in pathogenesis(3,4), but the mechanisms of prion transfer from the immune to the nervous system are unknown. Here we show that ablation of the chemokine receptor CXCR5 juxtaposes follicular dendritic cells (FDCs) to major splenic nerves, and accelerates the transfer of intraperitoneally administered prions into the spinal cord. Neuroinvasion velocity correlated exclusively with the relative locations of FDCs and nerves: transfer of CXCR5(-/-) bone marrow to wild-type mice induced perineural FDCs and enhanced neuroinvasion, whereas reciprocal transfer to CXCR5(-/-) mice abolished them and restored normal efficiency of neuroinvasion. Suppression of lymphotoxin signalling depleted FDCs, abolished splenic infectivity, and suppressed acceleration of pathogenesis in CXCR5(-/-) mice. This suggests that prion neuroimmune transition occurs between FDCs and sympathetic nerves, and relative positioning of FDCs and nerves controls the efficiency of peripheral prion infection.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, D-13092 Berlin, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Chicago; University of Chicago; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Glatzel, Markus/V-8844-2019; Lipp, Martin/G-2235-2010; Glatzel, Markus/G-3356-2011; Junt, Tobias/AAE-4389-2021; Heikenwalder, Mathias/AAA-2269-2020; Heppner, Frank/ABH-8393-2020; Aguzzi, Adriano/A-3351-2008	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Heppner, Frank/0000-0001-9816-8917; Lipp, Martin/0000-0002-0087-2672; Aguzzi, Adriano/0000-0002-0344-6708; fu, yang-xin/0000-0001-8441-6617				Aguzzi A, 1997, LANCET, V349, P742, DOI 10.1016/S0140-6736(97)22011-8; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Beekes M, 1996, J GEN VIROL, V77, P1925, DOI 10.1099/0022-1317-77-8-1925; CARLSON SL, 1995, J NEUROSCI, V15, P5892; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; FELTEN D L, 1988, Brain Behavior and Immunity, V2, P293, DOI 10.1016/0889-1591(88)90031-1; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; HEINEN E, 1995, CURR TOP MICROBIOL, V201, P15; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Karrer U, 2000, J IMMUNOL, V164, P768, DOI 10.4049/jimmunol.164.2.768; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Oldstone MBA, 2002, J VIROL, V76, P4357, DOI 10.1128/JVI.76.9.4357-4363.2002; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Prusiner S B, 1981, Adv Exp Med Biol, V134, P385; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; Wu Q, 2001, J EXP MED, V193, P1327, DOI 10.1084/jem.193.11.1327	29	170	175	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					957	962		10.1038/nature02072	http://dx.doi.org/10.1038/nature02072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14562059				2022-12-01	WOS:000186230600041
J	MacMicking, JD; Taylor, GA; McKinney, JD				MacMicking, JD; Taylor, GA; McKinney, JD			Immune control of tuberculosis by IFN-gamma-inducible LRG-47	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; ENDOPLASMIC-RETICULUM; NITRIC-OXIDE; MACROPHAGES; RESISTANCE; RESPONSES; ROLES	Interferon-gamma (IFN-gamma) provides an essential component of immunity to tuberculosis by activating infected host macrophages to directly inhibit the replication of Mycobacterium tuberculosis (Mtb). IFN-gamma-inducible nitric oxide synthase 2 (NOS2) is considered a principal effector mechanism, although other pathways may also exist. Here, we identify one member of a newly emerging 47-kilodalton (p47) guanosine triphosphatase family, LRG-47, that acts independently of NOS2 to protect against disease. Mice lacking LRG-47 failed to control Mtb replication, unlike those missing the related p47 guanosine triphosphatases IRG-47 or IGTP. Defective bacterial killing in IFN-gamma-activated LRG-47(-/-) macrophages was associated with impaired maturation of Mtb-containing phagosomes, vesicles that otherwise recruited LRG-47 in wild-type cells. Thus, LRG-47 may serve as a critical vacuolar trafficking component used to dispose of intracellular pathogens like Mtb.	Rockefeller Univ, Lab Infect Biol, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA; Duke Univ, Med Ctr, Dept Immunol, Div Geriatr, Durham, NC 27705 USA; Duke Univ, Med Ctr, Ctr Aging & Human Dev, Durham, NC 27705 USA; Durham Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27705 USA	Rockefeller University; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center	MacMicking, JD (corresponding author), Rockefeller Univ, Lab Infect Biol, 1230 York Ave, New York, NY 10021 USA.	macmicj@mail.rockefeller.edu			PHS HHS [R01 A1051702] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boehm U, 1998, J IMMUNOL, V161, P6715; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Hayashi T, 2001, INFECT IMMUN, V69, P6156, DOI 10.1128/IAI.69.10.6156-6164.2001; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 2003, HANDB EXP PHARM, V158, P409; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; OLAKAMNI O, 2003, J BIOL CHEM, V277, P49727; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428	31	516	544	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					654	659		10.1126/science.1088063	http://dx.doi.org/10.1126/science.1088063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576437				2022-12-01	WOS:000186119900062
J	Sivars, U; Aivazian, D; Pfeffer, SR				Sivars, U; Aivazian, D; Pfeffer, SR			Yip3 catalyses the dissociation of endosomal Rab-GDI complexes	NATURE			English	Article							GOLGI MEMBRANE-PROTEIN; PRENYLATED RAB; NUCLEOTIDE EXCHANGE; BINDING PROTEIN; GTPASES; INHIBITOR; IDENTIFICATION; TRANSPORT; INTERACTS; RECEPTOR	Human cells contain more than 60 small G proteins of the Rab family, which are localized to the surfaces of distinct membrane compartments and regulate transport vesicle formation, motility, docking and fusion(1-3). Prenylated Rabs also occur in the cytosol bound to GDI(4,5) (guanine nucleotide dissociation inhibitor), which binds to Rabs in their inactive state. Prenyl Rab-GDI complexes contain all of the information necessary to direct Rab delivery onto distinct membrane compartments(6-8). The late endosomal, prenyl Rab9 binds GDI with very high affinity(9), which led us to propose that there might be a 'GDI-displacement factor' to catalyse dissociation of Rab-GDI complexes and to enable transfer of Rabs from GDI onto membranes(6,10). Indeed, we have previously shown that endosomal membranes contain a proteinaceous factor that can act in this manner(10). Here we show that the integral membrane protein, Yip3, acts catalytically to dissociate complexes of endosomal Rabs bound to GDI, and to deliver them onto membranes. We propose that the conserved Yip proteins serve as GDI-displacement factors for the targeting of Rab GTPases in eukaryotic cells.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.							Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; BARROWMAN J, 2002, J BIOL CHEM, V278, P1978; Bucci C, 1999, BIOCHEM BIOPH RES CO, V258, P657, DOI 10.1006/bbrc.1999.0651; Calero M, 2002, BIOCHEM BIOPH RES CO, V290, P676, DOI 10.1006/bbrc.2001.6242; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; SHAPIRO AD, 1995, J BIOL CHEM, V270, P11085, DOI 10.1074/jbc.270.19.11085; SOLDATI T, 1995, J BIOL CHEM, V270, P25541, DOI 10.1074/jbc.270.43.25541; SOLDATI T, 1995, METHOD ENZYMOL, V257, P253; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	26	195	207	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					856	859		10.1038/nature02057	http://dx.doi.org/10.1038/nature02057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574414				2022-12-01	WOS:000186118500049
J	Zhang, JW; Niu, C; Ye, L; Huang, HY; He, X; Tong, WG; Ross, J; Haug, J; Johnson, T; Feng, JQ; Harris, S; Wiedemann, LM; Mishina, Y; Li, LH				Zhang, JW; Niu, C; Ye, L; Huang, HY; He, X; Tong, WG; Ross, J; Haug, J; Johnson, T; Feng, JQ; Harris, S; Wiedemann, LM; Mishina, Y; Li, LH			Identification of the haematopoietic stem cell niche and control of the niche size	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-2; DROSOPHILA-OVARY; IN-VIVO; DIFFERENTIATION; OSTEOBLAST; CADHERIN; LINEAGES; PROLIFERATION; MESODERM; MARROW	Haematopoietic stem cells (HSCs) are a subset of bone marrow cells that are capable of self-renewal and of forming all types of blood cells (multi-potential)(1). However, the HSC 'niche'-the in vivo regulatory microenvironment where HSCs reside-and the mechanisms involved in controlling the number of adult HSCs remain largely unknown. The bone morphogenetic protein (BMP) signal has an essential role in inducing haematopoietic tissue during embryogenesis(2,3). We investigated the roles of the BMP signalling pathway in regulating adult HSC development in vivo by analysing mutant mice with conditional inactivation of BMP receptor type IA (BMPRIA). Here we show that an increase in the number of spindle-shaped N-cadherin(+)CD45(-) osteoblastic (SNO) cells correlates with an increase in the number of HSCs. The long-term HSCs are found attached to SNO cells. Two adherens junction molecules, N-cadherin and beta-catenin, are asymmetrically localized between the SNO cells and the long-term HSCs. We conclude that SNO cells lining the bone surface function as a key component of the niche to support HSCs, and that BMP signalling through BMPRIA controls the number of HSCs by regulating niche size.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA; NIEHS, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Missouri System; University of Missouri Kansas City; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.		Wiedemann, Leanne/E-3316-2010	Wiedemann, Leanne/0000-0002-0964-4676; Li, Linheng/0000-0001-9963-430X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071004] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Askenasy N, 2002, STEM CELLS, V20, P501, DOI 10.1634/stemcells.20-6-501; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Charbord P, 2001, THERAPIE, V56, P383; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Davidson AJ, 2000, CURR TOP DEV BIOL, V50, P45, DOI 10.1016/S0070-2153(00)50003-9; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; El-Badri NS, 1998, EXP HEMATOL, V26, P110; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.3.CO;2-R; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Puch S, 2001, J CELL SCI, V114, P1567; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Simmons PJ, 2001, HEMATOPOIESIS DEV AP, P718; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; SZILVASSY SJ, 2002, HAEMATOPOIETIC STEM, P167; Taichman RUSSELL S., 2000, Hematology, V4, P421; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Visnjic D, 2001, J BONE MINER RES, V16, P2222, DOI 10.1359/jbmr.2001.16.12.2222; WEISSMAN IL, 1994, CELL, V76, P207, DOI 10.1016/0092-8674(94)90329-8; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328	31	2191	2338	4	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					836	841		10.1038/nature02041	http://dx.doi.org/10.1038/nature02041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574412	Bronze			2022-12-01	WOS:000186118500045
J	Kadan-Lottick, NS; Ness, KK; Bhatia, S; Gurney, JG				Kadan-Lottick, NS; Ness, KK; Bhatia, S; Gurney, JG			Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LYMPHOID LEUKEMIA; ACUTE LYMPHOCYTIC-LEUKEMIA; RACIAL-DIFFERENCES; CHILDREN; CANCER; WHITE; BLACK; CURE	Context The role of race/ethnicity in survival of children with acute lymphoblastic leukemia (ALL) is unclear, with some studies reporting poorer survival among minority children and others reporting equivalent survival across race/ethnicity in the modern, risk-stratified treatment era. Objective To investigate the relation between race/ethnicity and survival in a large, population-based analysis of incident ALL cases in the United States. Design, Population, and Setting This study included 4952 individuals diagnosed with ALL between 1973 and 1999 at age 19 years or younger. ALL cases were identified from 9 population-based registries of the National Cancer Institute's Surveillance, Epidemiology, and End Results program. Main Outcome Measures Survival probabilities were compared among white, black, Hispanic, Asian/Pacific Islander, and American Indian/Alaskan Native children. Kaplan-Meier curves and proportional hazard ratios from Cox regression analysis were calculated, accounting for treatment era (1973-1982, 1983-1989, and 1990-1999), age at diagnosis (<1, 1-9, and 10-19 years), and sex. Results Although overall 5-year survival probabilities improved with each successive treatment era, differences according to race/ethnicity persisted. For 1990-1999, 5-year survival was 84% for white children, 81 % for Asian/Pacific Islander children, 75% for black children, and 72% for both American Indian/Alaskan Native children and Hispanic children. The largest difference by race/ethnicity was observed among children diagnosed between ages 1 and 9 years. Compared with white children, after adjusting for treatment era, age at diagnosis, and sex, children of black, Hispanic, and American Indian/Alaskan Native descent had hazard ratios of 1.50 (95% Cl, 1.0-2.2; P=.03), 1.83 (95% Cl, 1.4-2.4; P<.001), and 1.90 (95% Cl, 0.8-4.6; P=.16). Conclusions Black, Hispanic, and American Indian/Alaskan Native children with ALL have worse survival than white and Asian/Pacific Islander children, even in the contemporary treatment era. Future work must delineate the social and biological factors, including any differences in pharmacokinetics associated with chemotherapeutic agents, that account for disparities in outcome.	Univ Minnesota, Div Pediat Epidemiol & Clin Res, Minneapolis, MN 55455 USA; Yale Univ, Div Pediat Hematol Oncol, New Haven, CT USA; City Hope Natl Med Ctr, Div Pediat, Duarte, CA 91010 USA	University of Minnesota System; University of Minnesota Twin Cities; Yale University; City of Hope	Gurney, JG (corresponding author), Univ Minnesota, Div Pediat Epidemiol & Clin Res, Mayo Mail Code 715,420 Delaware St SE, Minneapolis, MN 55455 USA.		Ness, Kirsten K/N-2550-2018	Ness, Kirsten K/0000-0002-2084-1507; Kadan-Lottick, Nina/0000-0002-6857-396X				ALLISON PD, 1999, LOGISTIC REGRESSION, P30; ALLISON PD, 1999, LOGISTIC REGRESSION, P113; Bach PB, 2002, JAMA-J AM MED ASSOC, V287, P2106, DOI 10.1001/jama.287.16.2106; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Brenner MK, 1999, SEMIN HEMATOL, V36, P73; COLLETT D, 1991, MODELING BINARY DATA, P16; *DCCPS NAT CANC I, 2002, SURV EP END RES PROG; FALLETTA JM, 1984, PATHOGENESIS LEUKEMI, P191; FOUCAR K, 1991, CANCER-AM CANCER SOC, V67, P2125, DOI 10.1002/1097-0142(19910415)67:8<2125::AID-CNCR2820670820>3.0.CO;2-A; Hord MH, 1996, CANCER-AM CANCER SOC, V77, P563; MARUBINI E, 1985, ANAL SURVIVAL DATA C, P41; McKinney PA, 1999, BRIT J CANCER, V80, P1844, DOI 10.1038/sj.bjc.6690609; MCLEOD HL, 1994, CLIN PHARMACOL THER, V55, P15, DOI 10.1038/clpt.1994.4; *NCI, SEER STAT VERS 4 2; *NCI, CANC CONTR POP SCI S; NOVAKOVIC B, 1994, MED PEDIATR ONCOL, V23, P480, DOI 10.1002/mpo.2950230606; Percy C., 1990, INT CLASSIFICATION D; PINKEL D, 1993, LEUKEMIA, V7, pS146; Pollock BH, 2000, J CLIN ONCOL, V18, P813, DOI 10.1200/JCO.2000.18.4.813; Powell JE, 2000, BRIT J CANCER, V82, P1568; PRATT JA, 1988, J CLIN EPIDEMIOL, V41, P367, DOI 10.1016/0895-4356(88)90144-8; PUI CH, 1995, JAMA-J AM MED ASSOC, V273, P633, DOI 10.1001/jama.273.8.633; REAMAN GH, 1984, PATHOGENESIS LEUKEMI, P163; Ries LAG, 2002, SEER CANC STAT REV 1; Rivera-Luna R, 2000, J CLIN ONCOL, V18, P2349; *SAS I, SAS VERS 8 2; SATHER H, 1984, PATHOGENESIS LEUKEMI, P179; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; SMITH MA, 1999, NIH PUB; Walker A H, 1998, Hum Mutat, V12, P289; WALTERS TR, 1972, CANCER, V29, P210, DOI 10.1002/1097-0142(197201)29:1<210::AID-CNCR2820290131>3.0.CO;2-U; YOUNG J L JR, 1986, Cancer, V58, P598, DOI 10.1002/1097-0142(19860715)58:2+<598::AID-CNCR2820581332>3.0.CO;2-C	32	163	164	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2003	290	15					2008	2014		10.1001/jama.290.15.2008	http://dx.doi.org/10.1001/jama.290.15.2008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732CX	14559954	Bronze			2022-12-01	WOS:000185924200024
J	Apesteguia, S; Novas, FE				Apesteguia, S; Novas, FE			Large Cretaceous sphenodontian from Patagonia provides insight into lepidosaur evolution in Gondwana	NATURE			English	Article							JURASSIC KOTA FORMATION; CENTRAL MEXICO; DIAPSIDA; REPTILIA; RHYNCHOCEPHALIA	Sphenodontian reptiles successfully radiated during Triassic and Jurassic times, but were driven almost to extinction during the Cretaceous period(1). The sparse Early Cretaceous record of sphenodontians has been interpreted as reflecting the decline of the group in favour of lizards, their suspected ecological successors(2). However, recent discoveries in Late Cretaceous beds in Patagonia partially modify this interpretation. Numerous skeletons of a new sphenodontian, Priosphenodon avelasi gen. et sp. nov., were collected from a single locality in the Cenomanian-Turonian Candeleros Formation, where it is more abundant than any other tetrapod group recorded in the quarry (for example, Crocodyliformes, Serpentes, Dinosauria and Mammalia)(3,4). Adult specimens of Priosphenodon reached one metre in length, larger than any previously known terrestrial sphenodontian. Here we propose, using available evidence, that sphenodontians were not a minor component of the Cretaceous terrestrial ecosystems of South America, and that their ecological replacement by squamates was delayed until the early Tertiary. The new discovery helps to bridge the considerable gap in the fossil record (around 120 million years) that separates the Early Cretaceous sphenodontians(5-7) from their living relatives (Sphenodon).	Museo Argentino Ciencias Nat Bernardino Rivadavia, RA-1405 Buenos Aires, DF, Argentina	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Apesteguia, S (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Av Angel Gallardo 470, RA-1405 Buenos Aires, DF, Argentina.		Apesteguía, Sebastian/F-4034-2018	Apesteguía, Sebastian/0000-0002-0414-0524				ALBINO A, 1 C OA REIG VERT BAS; APESTEGUIA S, IN PRESS C ARG PAL B; APESTEGUIA S, IN PRESS 1 C OA REIG; APESTEGUIA S, 2002, AMEGHINIANA, V39, pR5; Baez A. M., 1977, ACTA GEOLOGICA LILLO, V14, P149; Barbera C., 1992, Memorie della Societa Geologica Italiana, V41, P567; Broschinski Annette, 1996, Annales de Paleontologie, V82, P147; Carroll RL., 1988, VERTEBRATE PALEONTOL; Estes R., 1985, GREAT AM BIOTIC INTE, P139; Evans SE, 2002, J VERTEBR PALEONTOL, V22, P299, DOI 10.1671/0272-4634(2002)022[0299:FLFTJK]2.0.CO;2; Evans SE, 1997, J VERTEBR PALEONTOL, V17, P45, DOI 10.1080/02724634.1997.10010952; Evans SE, 2001, ZOOL J LINN SOC-LOND, V133, P309, DOI 10.1006/zjls.2000.0266; Evans Susan E., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V6, P349; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; FRASER NC, 1989, ZOOL J LINN SOC-LOND, V96, P413, DOI 10.1111/j.1096-3642.1989.tb02521.x; GALLINA P.A., 2002, AMEGHINIANA, V39, p10R; Haeckel E., 1866, GENERELLE MORPHOLOGI; HUGO C, 1999, I GEOL REC NAT SEGEM, V309, P1; Novas F. E., 1999, AMEGHINIANA, V36, p16R; POL D, IN PRESS C ARG PALEO; RASMUSSEN TE, 1981, J PALEONTOL, V55, P1109; Reynoso VH, 1997, J VERTEBR PALEONTOL, V17, P52, DOI 10.1080/02724634.1997.10010953; Reynoso VH, 2000, J PALEONTOL, V74, P133, DOI 10.1666/0022-3360(2000)074<0133:AUASRD>2.0.CO;2; Rich T.H.V., 1983, Transactions of the Geological Society of South Africa, V86, P281; Smith Krister T., 2001, Journal of Vertebrate Paleontology, V21, p102A; THROCKMORTON GS, 1981, J PALEONTOL, V55, P586; WILLISTON S. W., 1925, OSTEOLOGY REPTILES; Wu X.-C., 1991, THESIS MCGILL U; Zils Wolfgang, 1995, Documenta Naturae, V97, P1	29	84	87	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2003	425	6958					609	612		10.1038/nature01995	http://dx.doi.org/10.1038/nature01995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534584				2022-12-01	WOS:000185801000034
J	Ito, S; Stuphorn, V; Brown, JW; Schall, JD				Ito, S; Stuphorn, V; Brown, JW; Schall, JD			Performance monitoring by the anterior cingulate cortex during saccade countermanding	SCIENCE			English	Article							SUPPLEMENTARY EYE FIELD; REWARD; MOVEMENT; MACAQUE; DOPAMINE; MONKEY	Consensus is emerging that the medial frontal lobe of the brain is involved in monitoring performance, but precisely what is monitored remains unclear. A saccade-countermanding task affords an experimental dissociation of neural signals of error, reinforcement, and conflict. Single-unit activity was monitored in the anterior cingulate cortex of monkeys performing this task. Neurons that signaled errors were found, half of which responded to the omission of earned reinforcement. A further diversity of neurons signaled earned or unexpected reinforcement. No neurons signaled the form of conflict engendered by interruption of saccade preparation produced in this task. These results are consistent with the hypothesis that the anterior cingulate cortex monitors the consequences of actions.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA; Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Vanderbilt University; Washington University (WUSTL)	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Wilson Hall, Nashville, TN 37203 USA.	jeffrey.d.schall@vanderbilt.edu	Brown, Joshua/G-2867-2011		NEI NIH HHS [P30-EY008126] Funding Source: Medline; NIMH NIH HHS [R01-MH55806] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055806] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown J, 1999, J NEUROSCI, V19, P10502; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luppino G, 2003, EUR J NEUROSCI, V17, P559, DOI 10.1046/j.1460-9568.2003.02476.x; McPeek RM, 2003, J NEUROPHYSIOL, V89, P2577, DOI 10.1152/jn.00657.2002; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Pare M, 2003, J NEUROSCI, V23, P6480; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; SCHALL JD, 1993, VISUAL NEUROSCI, V10, P385, DOI 10.1017/S0952523800003771; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576	23	427	433	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2003	302	5642					120	122		10.1126/science.1087847	http://dx.doi.org/10.1126/science.1087847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526085				2022-12-01	WOS:000185678500050
J	Geijsen, N; Horoschak, M; Kim, K; Gribnau, J; Eggan, K; Daley, GQ				Geijsen, N; Horoschak, M; Kim, K; Gribnau, J; Eggan, K; Daley, GQ			Derivation of embryonic germ cells and male gametes from embryonic stem cells	NATURE			English	Article							MALE-STERILITY GENE; RET FINGER PROTEIN; IN-VITRO; YOLK-SAC; MOUSE; EXPRESSION; DAZ; DIFFERENTIATION; SPERMATOGENESIS; PROLIFERATION	Egg and sperm cells ( gametes) of the mouse are derived from a founder population of primordial germ cells that are set aside early in embryogenesis. Primordial germ cells arise from the proximal epiblast, a region of the early mouse embryo that also contributes to the first blood lineages of the embryonic yolk sac(1). Embryonic stem cells differentiate in vitro into cystic structures called embryoid bodies consisting of tissue lineages typical of the early mouse embryo(2,3). Because embryoid bodies sustain blood development, we reasoned that they might also support primordial germ cell formation. Here we isolate primordial germ cells from embryoid bodies, and derive continuously growing lines of embryonic germ cells. Embryonic germ cells show erasure of the methylation markers ( imprints) of the Igf2r and H19 genes, a property characteristic of the germlineage. We show that embryoid bodies support maturation of the primordial germ cells into haploid male gametes, which when injected into oocytes restore the somatic diploid chromosome complement and develop into blastocysts. Our ability to derive germ cells from embryonic stem cells provides an accessible in vitro model system for studies of germline epigenetic modification and mammalian gametogenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University	Daley, GQ (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	george.daley@childrens.harvard.edu	Eggan, Kevin/P-7119-2018					BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Cao TY, 1996, DEV GENET, V19, P309, DOI 10.1002/(SICI)1520-6408(1996)19:4<309::AID-DVG4>3.3.CO;2-1; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; FENDERSON BA, 1984, DEV BIOL, V103, P117, DOI 10.1016/0012-1606(84)90013-7; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1994, CIBA F SYMP, V182, P84; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V251, P515, DOI 10.1006/bbrc.1998.9502; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Tezel G, 2002, PATHOL INT, V52, P623, DOI 10.1046/j.1440-1827.2002.01401.x; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; WASSARMAN PM, 1992, BIOL REPROD, V46, P186, DOI 10.1095/biolreprod46.2.186; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.0.CO;2-F	31	615	703	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					148	154		10.1038/nature02247	http://dx.doi.org/10.1038/nature02247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14668819				2022-12-01	WOS:000187863900034
J	Asbury, CL; Fehr, AN; Block, SM				Asbury, CL; Fehr, AN; Block, SM			Kinesin moves by an asymmetric hand-over-hand mechanism	SCIENCE			English	Article							OPTICAL FORCE CLAMP; COILED-COIL; 8-NM STEP; MICROTUBULES; MOLECULES; MOVEMENT; ATP; HYDROLYZES; REGION	Kinesin is a double-headed motor protein that moves along microtubules in 8-nanometer steps. Two broad classes of model have been invoked to explain kinesin movement: hand-over-hand and inchworm. In hand-over-hand models, the heads exchange leading and trailing roles with every step, whereas no such exchange is postulated for inchworm models, where one head always leads. By measuring the stepwise motion of individual enzymes, we find that some kinesin molecules exhibit a marked alternation in the dwell times between sequential steps, causing these motors to "limp" along the microtubule. Limping implies that kinesin molecules strictly alternate between two different conformations as they step, indicative of an asymmetric, hand-over-hand mechanism.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.				NIGMS NIH HHS [R01 GM051453] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051453] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; MANLY BFJ, 2001, RANDOMIZATION BOOTST, P34; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SVOBODA K, 1995, BIOPHYS J, V68, pS69; Tripet B, 1997, J BIOL CHEM, V272, P8946; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	28	418	434	7	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2130	2134		10.1126/science.1092985	http://dx.doi.org/10.1126/science.1092985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14657506	Green Accepted, Green Submitted			2022-12-01	WOS:000187385200047
J	Hagen, T; Taylor, CT; Lam, F; Moncada, S				Hagen, T; Taylor, CT; Lam, F; Moncada, S			Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1 alpha	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; COMPLEX-III; HEART-MITOCHONDRIA; ALPHA-SUBUNIT; HIF; TRANSCRIPTION; EXPRESSION; FACTOR-1-ALPHA; STABILIZATION; ACTIVATION	Cells exposed to low oxygen concentrations respond by initiating defense mechanisms, including the stabilization of hypoxia-inducible factor (HIF) 1alpha, a transcription factor that upregulates genes such as those involved in glycolysis and angiogenesis. Nitric oxide and other inhibitors of mitochondrial respiration prevent the stabilization of HIF1alpha during hypoxia. In studies of cultured cells, we show that this effect is a result of an increase in prolyl hydroxylase dependent degradation of HIF1alpha. With the use of Renilla luciferase to detect intracellular oxygen concentrations, we also demonstrate that, upon inhibition of mitochondrial respiration in hypoxia, oxygen is redistributed toward non-respiratory oxygen-dependent targets such as prolyl hydroxylases so that they do not register hypoxia. Thus, the signaling consequences of hypoxia may be profoundly modified by nitric oxide.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomed & Biochem Res, Dublin 4, Ireland	University of London; University College London; University College Dublin	Moncada, S (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	s.moncada@ucl.ac.uk		Taylor, Cormac/0000-0002-0946-1247				Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FANDREY J, 1994, BIOCHEM J, V303, P507, DOI 10.1042/bj3030507; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/BST0300252; HAGEN T, UNPUB; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yang ZZ, 2003, AM J PHYSIOL-RENAL, V284, pF1207, DOI 10.1152/ajprenal.00017.2002	24	597	620	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1975	1978		10.1126/science.1088805	http://dx.doi.org/10.1126/science.1088805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671307				2022-12-01	WOS:000187174000064
J	Silver, RA; Lubke, J; Sakmann, B; Feldmeyer, D				Silver, RA; Lubke, J; Sakmann, B; Feldmeyer, D			High-probability uniquantal transmission at excitatory synapses in barrel cortex	SCIENCE			English	Article							PYRAMIDAL CELLS; SYNAPTIC CONNECTIONS; NEURONS; RELEASE; SINGLE; INFORMATION; LAYER-4; HIPPOCAMPUS; POTENTIALS; PLASTICITY	The number of vesicles released at excitatory synapses and the number of release sites per synaptic connection are key determinants of information processing in the cortex, yet they remain uncertain. Here we show that the number of functional release sites and the number of anatomically identified synaptic contacts are equal at connections between spiny stellate and pyramidal cells in rat barrel cortex. Moreover, our results indicate that the amount of transmitter released per synaptic contact is independent of release probability and the intrinsic release probability is high. These properties suggest that connections between layer 4 and layer 2/3 are tuned for reliable transmission of spatially distributed, timing-based signals.	UCL, Dept Physiol, London WC1E 6BT, England; Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	University of London; University College London; Helmholtz Association; Research Center Julich; Max Planck Society	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk	Feldmeyer, Dirk/H-5940-2013; Lubke, Joachim/H-8762-2013	Feldmeyer, Dirk/0000-0002-1716-8972; Lubke, Joachim/0000-0002-4086-3199; Silver, Robin/0000-0002-5480-6638				Bekkers JM, 1999, J PHYSIOL-LONDON, V516, P227, DOI 10.1111/j.1469-7793.1999.227aa.x; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; CastroAlamancos MA, 1997, P NATL ACAD SCI USA, V94, P4161, DOI 10.1073/pnas.94.8.4161; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Diamond JS, 1997, J NEUROSCI, V17, P4672; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SILVER RA, 1998, CENTRAL SYNAPSES QUA, P130; VEREJONE.D, 1966, AUST J STAT, V8, P53, DOI 10.1111/j.1467-842X.1966.tb00164.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	26	164	166	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1981	1984		10.1126/science.1087160	http://dx.doi.org/10.1126/science.1087160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671309				2022-12-01	WOS:000187174000066
J	Giot, L; Bader, JS; Brouwer, C; Chaudhuri, A; Kuang, B; Li, Y; Hao, YL; Ooi, CE; Godwin, B; Vitols, E; Vijayadamodar, G; Pochart, P; Machineni, H; Welsh, M; Kong, Y; Zerhusen, B; Malcolm, R; Varrone, Z; Collis, A; Minto, M; Burgess, S; McDaniel, L; Stimpson, E; Spriggs, F; Williams, J; Neurath, K; Ioime, N; Agee, M; Voss, E; Furtak, K; Renzulli, R; Aanensen, N; Carrolla, S; Bickelhaupt, E; Lazovatsky, Y; DaSilva, A; Zhong, J; Stanyon, CA; Finley, RL; White, KP; Braverman, M; Jarvie, T; Gold, S; Leach, M; Knight, J; Shimkets, RA; McKenna, MP; Chant, J; Rothberg, JM				Giot, L; Bader, JS; Brouwer, C; Chaudhuri, A; Kuang, B; Li, Y; Hao, YL; Ooi, CE; Godwin, B; Vitols, E; Vijayadamodar, G; Pochart, P; Machineni, H; Welsh, M; Kong, Y; Zerhusen, B; Malcolm, R; Varrone, Z; Collis, A; Minto, M; Burgess, S; McDaniel, L; Stimpson, E; Spriggs, F; Williams, J; Neurath, K; Ioime, N; Agee, M; Voss, E; Furtak, K; Renzulli, R; Aanensen, N; Carrolla, S; Bickelhaupt, E; Lazovatsky, Y; DaSilva, A; Zhong, J; Stanyon, CA; Finley, RL; White, KP; Braverman, M; Jarvie, T; Gold, S; Leach, M; Knight, J; Shimkets, RA; McKenna, MP; Chant, J; Rothberg, JM			A protein interaction map of Drosophila melanogaster	SCIENCE			English	Article							BINDING-PROTEIN; SYSTEMATIC ANALYSIS; UBIQUITIN-LIGASE; ADAPTER PROTEIN; IDENTIFICATION; REPRESSION; REAPER; DOMAIN; GRIM; RNA	Drosophila melanogaster is a proven model system for many aspects of human biology. Here we present a two-hybrid-based protein-interaction map of the fly proteome. A total of 10,623 predicted transcripts were isolated and screened against standard and normalized complementary DNA libraries to produce a draft map of 7048 proteins and 20,405 interactions. A computational method of rating two-hybrid interaction confidence was developed to re. ne this draft map to a higher confidence map of 4679 proteins and 4780 interactions. Statistical modeling of the network showed two levels of organization: a short-range organization, presumably corresponding to multiprotein complexes, and a more global organization, presumably corresponding to intercomplex connections. The network recapitulated known pathways, extended pathways, and uncovered previously unknown pathway components. This map serves as a starting point for a systems biology modeling of multicellular organisms, including humans.	GuraGen Corp, New Haven, CT 06511 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Wayne State University; Yale University	Chant, J (corresponding author), GuraGen Corp, 555 Long Wharf Dr, New Haven, CT 06511 USA.	jchant@curagen.com	Stanyon, Clem/AAM-5040-2020; guntain, sodsri/C-5090-2009; Bader, Joel/A-1818-2009; Kong, Yong/B-5105-2014	Bader, Joel/0000-0002-6020-4625; Kong, Yong/0000-0002-2881-5274; Finley, Russ/0000-0003-1144-6887; Stanyon, Clement/0000-0001-5030-6823	NHGRI NIH HHS [HG01536] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001536, R29HG001536] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BADER JS, IN PRESS NATURE BIOT; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; Courey AJ, 2001, GENE DEV, V15, P2786; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Du C, 1998, MOL CELL, V2, P741, DOI 10.1016/S1097-2765(00)80289-0; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Feller SM, 2002, MECH DEVELOP, V116, P129, DOI 10.1016/S0925-4773(02)00147-8; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Graham P, 2003, BIOESSAYS, V25, P1, DOI 10.1002/bies.10207; Graveley BR, 2002, CELL, V109, P409, DOI 10.1016/S0092-8674(02)00750-X; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Heinrichs V, 1997, P NATL ACAD SCI USA, V94, P115, DOI 10.1073/pnas.94.1.115; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jimenez G, 1999, MOL CELL BIOL, V19, P2080; Jimenez G, 2000, GENE DEV, V14, P224; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Khush RS, 2002, CURR BIOL, V12, P1728, DOI 10.1016/S0960-9822(02)01214-9; KIM YJ, 1992, GENE DEV, V6, P2569, DOI 10.1101/gad.6.12b.2569; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lai ZC, 1996, P NATL ACAD SCI USA, V93, P5025, DOI 10.1073/pnas.93.10.5025; Li SH, 2002, MOL CELL BIOL, V22, P6854, DOI 10.1128/MCB.22.19.6854-6865.2002; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Pazman C, 2000, DEVELOPMENT, V127, P1715; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Raj L, 2000, CURR BIOL, V10, P1265, DOI 10.1016/S0960-9822(00)00745-4; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	57	1762	1834	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1727	1736		10.1126/science.1090289	http://dx.doi.org/10.1126/science.1090289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14605208				2022-12-01	WOS:000186970100038
J	Wu, XC; Li, Z; Zhou, BC; Dong, ZM				Wu, XC; Li, Z; Zhou, BC; Dong, ZM			A polydactylous amniote from the Triassic period	NATURE			English	Editorial Material							TETRAPOD LIMB; EVOLUTION		Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; Shanghai Sci & Technol Museum, Shanghai 200127, Peoples R China; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wu, XC (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.							Clack J. A., 2012, GAINING GROUND ORIGI; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; DANFORTH CH, 1947, AM J ANAT, V80, P143, DOI 10.1002/aja.1000800202; EDWARDS JL, 1989, AM ZOOL, V29, P235; GOULD SJ, 1991, NAT HIST, V1, P22; LEBEDEV OA, 1984, DOKL AKAD NAUK SSSR+, V278, P1470; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SHUBIN NH, 1986, EVOL BIOL, V20, P319	11	21	25	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					516	516		10.1038/426516a	http://dx.doi.org/10.1038/426516a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654831	Bronze			2022-12-01	WOS:000186944300028
J	Ryan, EA				Ryan, EA			Hormones and insulin resistance during pregnancy	LANCET			English	Editorial Material							SKELETAL-MUSCLE; OBESE WOMEN; PHOSPHORYLATION; EXPRESSION; ALPHA		Univ Alberta, Heritage Med Res Ctr, Dept Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada	University of Alberta	Ryan, EA (corresponding author), Univ Alberta, Heritage Med Res Ctr, Dept Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada.	Edmond.Ryan@UAlberta.ca						Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Melczer Z, 2003, ACTA OBSTET GYN SCAN, V82, P432; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Shao JH, 2000, DIABETES, V49, P603, DOI 10.2337/diabetes.49.4.603; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sugden MC, 2003, ENDOCRINOLOGY, V144, P146, DOI 10.1210/en.2002-220811; Yura S, 2003, J CLIN ENDOCR METAB, V88, P1394, DOI 10.1210/jc.2002-011926	10	70	72	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1777	1778		10.1016/S0140-6736(03)14942-2	http://dx.doi.org/10.1016/S0140-6736(03)14942-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654313				2022-12-01	WOS:000186872900006
J	Dandonneau, Y; Vega, A; Loisel, H; du Penhoat, Y; Menkes, C				Dandonneau, Y; Vega, A; Loisel, H; du Penhoat, Y; Menkes, C			Oceanic Rossby waves acting as a "hay rake" for ecosystem floating by-products	SCIENCE			English	Article							SEA-SURFACE; PACIFIC; FLUXES; LIGHT; PHYTOPLANKTON; VARIABILITY; ATTENUATION; ABSORPTION; NUTRIENTS; WATERS	Recent satellite observations of Rossby waves and chlorophyll anomalies propagating in subtropical gyres have suggested that wave-induced upwelling could stimulate photosynthesis. Instead, we show that chlorophyll maxima are located in abnormally warm water, in Rossby wave - induced convergences. This excludes inputs of nutrients from deeper water. We argue that the sea color anomalies are not caused by chlorophyll but by floating particles evolved from the ecosystem and accumulated by Rossby waves, acting as "marine hay rakes," in convergence zones. Such processes may be determinant for the distribution of living organisms in oligotrophic areas.	IRD, IPSL, Lab Oceanog Dynam & Climatol, F-75252 Paris 05, France; IRD, Lab Etud Geophys & Oceanog Spatiale, Toulouse, France; Univ Littoral Cote dOpale, MREN, UMR 8013, Wimereux, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Universite du Littoral-Cote-d'Opale	Dandonneau, Y (corresponding author), IRD, IPSL, Lab Oceanog Dynam & Climatol, F-75252 Paris 05, France.	yd@lodyc.jussieu.fr	menkes, christophe/X-6073-2019; menkes, christophe/H-9085-2016	menkes, christophe/0000-0002-1457-9696; menkes, christophe/0000-0002-1457-9696				Aufdenkampe AK, 2001, GLOBAL BIOGEOCHEM CY, V15, P101, DOI 10.1029/2000GB001268; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; CARDER KL, 1989, LIMNOL OCEANOGR, V34, P68, DOI 10.4319/lo.1989.34.1.0068; Christian JR, 1997, J GEOPHYS RES-OCEANS, V102, P15667, DOI 10.1029/97JC00369; Cipollini P, 2001, GEOPHYS RES LETT, V28, P323, DOI 10.1029/1999GL011231; Claustre H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014056; Claustre H, 1999, J GEOPHYS RES-OCEANS, V104, P3401, DOI 10.1029/98JC01334; CULLEN JJ, 1995, J GEOPHYS RES-OCEANS, V100, P13255, DOI 10.1029/95JC00454; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Gill A. E., 2016, ATMOSPHERE OCEAN DYN; HAURY LR, 1994, DEEP-SEA RES PT I, V41, P1191, DOI 10.1016/0967-0637(94)90040-X; Legendre L, 1998, J GEOPHYS RES-OCEANS, V103, P2897, DOI 10.1029/97JC02706; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; Mobley C. D., 1998, HYDROLIGHT 4 0 USERS; Neuer S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015393; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Petzold T. J., 1972, 7278 SCRIPPS I OC; Romano JC, 1996, DEEP-SEA RES PT I, V43, P411, DOI 10.1016/0967-0637(96)00024-6; Siegel DA, 1996, DEEP-SEA RES PT II, V43, P321, DOI 10.1016/0967-0645(96)00088-4; Siegel DA, 2001, NATURE, V409, P576, DOI 10.1038/35054659; SMITH KL, 1989, NATURE, V337, P724, DOI 10.1038/337724a0; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; Vega A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015886; Villareal TA, 1996, J PLANKTON RES, V18, P1103, DOI 10.1093/plankt/18.7.1103; Wallace BB, 1999, LIMNOL OCEANOGR, V44, P273, DOI 10.4319/lo.1999.44.2.0273; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0; Zhang XD, 1998, APPL OPTICS, V37, P6525, DOI 10.1364/AO.37.006525	29	58	58	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1548	1551		10.1126/science.1090729	http://dx.doi.org/10.1126/science.1090729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645844	Green Submitted			2022-12-01	WOS:000186802200038
J	Thompson, M; Haeusler, RA; Good, PD; Engelke, DR				Thompson, M; Haeusler, RA; Good, PD; Engelke, DR			Nucleolar clustering of dispersed tRNA genes	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; RIBONUCLEASE-P; YEAST; LOCALIZATION; 5S; HYBRIDIZATION; TRANSCRIPTION; COMPLEXES; SUBUNIT; REGION	Early transfer RNA (tRNA) processing events in Saccharomyces cerevisiae are co-ordinated in the nucleolus, the site normally associated with ribosome biosynthesis. To test whether spatial organization of the tRNA pathway begins with nucleolar clustering of the genes, we have probed the subnuclear location of five different tRNA gene families. The results show that tRNA genes, though dispersed in the linear genome, colocalize with 5S ribosomal DNA and U14 small nucleolar RNA at the nucleolus. Nucleolar localization requires tRNA gene transcription-complex formation, because inactivation of the promoter at a single locus removes its nucleolar association. This organization of tRNA genes must profoundly affect the spatial packaging of the genome and raises the question of whether gene types might be coordinated in three dimensions to regulate transcription.	Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Engelke, DR (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.			Haeusler, Rebecca/0000-0002-6973-9845	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063142, T32GM007544] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007544, R01 GM063142, GM63142] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; BOEKE JD, 1991, MOL CELLULAR BIOL YE, P193; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; HIGHETT MI, 1993, J CELL SCI, V105, P1151; HUIBREGTSE JM, 1989, MOL CELL BIOL, V9, P3244, DOI 10.1128/MCB.9.8.3244; HULL M, 1994, MOL CELL BIOL, V14, P3244; Jacobson MR, 1997, J CELL SCI, V110, P829; Jarrous N, 1999, J CELL BIOL, V146, P559, DOI 10.1083/jcb.146.3.559; KAPLAN FS, 1993, GENOMICS, V15, P123, DOI 10.1006/geno.1993.1020; Kendall A, 2000, P NATL ACAD SCI USA, V97, P13108, DOI 10.1073/pnas.240454997; KINSEY PT, 1991, NUCLEIC ACIDS RES, V19, P1317, DOI 10.1093/nar/19.6.1317; Lee B, 1996, P NATL ACAD SCI USA, V93, P11471, DOI 10.1073/pnas.93.21.11471; LEE Y, 1995, NUCLEIC ACIDS RES, V23, P634, DOI 10.1093/nar/23.4.634; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; METZENBERG RL, 1985, P NATL ACAD SCI USA, V82, P2067, DOI 10.1073/pnas.82.7.2067; Montijn MB, 1999, CHROMOSOME RES, V7, P387, DOI 10.1023/A:1009272115295; NARAYANSWAMI S, 1990, CYTOMETRY, V11, P144, DOI 10.1002/cyto.990110117; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241	26	246	267	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1399	1401		10.1126/science.1089814	http://dx.doi.org/10.1126/science.1089814			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631041	Green Accepted, Green Published			2022-12-01	WOS:000186683500053
J	McLaughlin, T; Abbasi, F; Cheal, K; Chu, J; Lamendola, C; Reaven, G				McLaughlin, T; Abbasi, F; Cheal, K; Chu, J; Lamendola, C; Reaven, G			Use of metabolic markers to identify overweight individuals who are insulin resistant	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; MEDIATED GLUCOSE DISPOSAL; HIGH-DENSITY-LIPOPROTEIN; DEPENDENT DIABETES-MELLITUS; WEIGHT-LOSS; HDL-CHOLESTEROL; OBESITY; RISK; HYPERINSULINEMIA; PREDICTOR	Background: Insulin resistance is more common in overweight individuals and is associated with increased risk for type 2 diabetes mellitus and cardiovascular disease. Given the current epidemic of obesity and the fact that lifestyle interventions, such as weight loss and exercise, decrease insulin resistance, a relatively simple means to identify overweight individuals who are insulin resistant would be clinically useful. Objective: To evaluate the ability of metabolic markers associated with insulin resistance and increased risk for cardiovascular disease to identify the subset of overweight individuals who are insulin resistant. Design: Cross-sectional study. Setting: General clinical research center. Patients: 258 nondiabetic, normotensive overweight volunteers. Measurements: Body mass index; fasting glucose, insulin, lipid and lipoprotein concentrations; and insulin-mediated glucose disposal as quantified by the steady-state plasma glucose concentration during the insulin suppression test. Overweight was defined as body mass index of 25 kg/m(2) or greater, and insulin resistance was defined as being in the top tertile of steady-state plasma glucose concentrations. Receiver-operating characteristic curve analysis was used to identify the best markers of insulin resistance; optimal cut-points were identified and analyzed for predictive power. Results: Plasma triglyceride concentration, ratio,of triglyceride to high-density lipoprotein cholesterol concentrations, and insulin concentration were the most useful metabolic markers in identifying insulin-resistant individuals. The optimal cut-points were 1.47 mmol/L (130 mg/dL) for triglycericle, 1.8 in SI units (3.0 in traditional units) for the triglyceride-high-density lipoprotein cholesterol ratio, and 109 pmol/L for insulin. Respective sensitivity and specifity for these cut-points were 67%, 64%, and 57% and 71%, 68%, and 85%. Their ability to identify insulin-resistant individuals was similar to the ability of the criteria proposed by the Adult Treatment Panel III to diagnose the metabolic syndrome (sensitivity, 52%, and specificity, 85%). Conclusions: Three relatively simple metabolic markers can help identify overweight individuals who are sufficiently insulin resistant to be at increased risk for various adverse outcomes. In the absence of a standardized insulin assay, we suggest that the most practical approach to identify overweight individuals who are insulin resistant is to use the cut-points for either triglycericle concentration or the triglyceride-high-density lipoprotein cholesterol concentration ratio.	Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University	Reaven, G (corresponding author), Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Div Cardiovasc Med, 300 Pasteur Dr, Stanford, CA 94305 USA.				NCRR NIH HHS [RR16071-01, RR000070-40] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016071] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; GREENFIELD MS, 1981, DIABETES, V30, P387, DOI 10.2337/diabetes.30.5.387; HALES CN, 1963, BIOCHEM J, V88, P137, DOI 10.1042/bj0880137; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Jeppesen J, 1998, J INTERN MED, V243, P293; Jeppesen J, 2001, ARCH INTERN MED, V161, P361, DOI 10.1001/archinte.161.3.361; Jones CNO, 2000, AM J PHYSIOL-ENDOC M, V278, pE501, DOI 10.1152/ajpendo.2000.278.3.E501; KADISH AH, 1968, CLIN CHEM, V14, P116; Khan LK, 2001, ANN INTERN MED, V134, P282, DOI 10.7326/0003-4819-134-4-200102200-00011; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; LAWS A, 1992, J INTERN MED, V231, P25, DOI 10.1111/j.1365-2796.1992.tb00494.x; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; McLaughlin T, 2002, CIRCULATION, V106, P2908, DOI 10.1161/01.CIR.0000041046.32962.86; McLaughlin T, 2001, METABOLISM, V50, P795, DOI 10.1053/meta.2001.24210; McLaughlin T, 1999, J CLIN ENDOCR METAB, V84, P578, DOI 10.1210/jc.84.2.578; MILLER GJ, 1975, LANCET, V1, P16; OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560; PEI D, 1994, DIABETOLOGIA, V37, P843, DOI 10.1007/BF00404344; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Reaven G, 2001, AM J CARDIOL, V87, P827, DOI 10.1016/S0002-9149(00)01521-6; REAVEN GM, 1993, DIABETES, V42, P1324, DOI 10.2337/diabetes.42.9.1324; REAVEN GM, 2001, HDB PHYSL 7, V2, P1169; SHEN SW, 1970, J CLIN INVEST, V49, P2151, DOI 10.1172/JCI106433; Tuan CY, 2003, AM J CARDIOL, V92, P606, DOI 10.1016/S0002-9149(03)00735-5; WAHLEFELD A., 1974, METHOD ENZYMAT AN, P1831; WHO Expert Comm, 1998, WHO TECH REP SER, V881, P1; WOODWARD M., 1999, EPIDEMIOLOGY STUDY D; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773; ZAVARONI I, 1994, J INTERN MED, V235, P51, DOI 10.1111/j.1365-2796.1994.tb01031.x; Zavaroni I, 1999, METABOLISM, V48, P989, DOI 10.1016/S0026-0495(99)90195-6	43	684	710	3	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2003	139	10					802	809		10.7326/0003-4819-139-10-200311180-00007	http://dx.doi.org/10.7326/0003-4819-139-10-200311180-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744ZV	14623617				2022-12-01	WOS:000186663500002
J	Stevens, AM; Hermes, HM; Rutledge, JC; Buyon, JP; Nelson, JL				Stevens, AM; Hermes, HM; Rutledge, JC; Buyon, JP; Nelson, JL			Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block	LANCET			English	Article							UMBILICAL-CORD BLOOD; IN-SITU HYBRIDIZATION; BONE-MARROW; AUTOIMMUNE-DISEASE; CELLS; ANTIBODIES; CHIMERISM; ERYTHEMATOSUS; IDENTIFICATION; AUTOANTIBODIES	Background During pregnancy, maternal cells pass into the fetus, where they can persist for many years after birth. We investigated the presence of maternal cells in neonatal lupus syndrome (NLS), an autoimmune disease that develops in utero. The most serious complication of NLS is inflammation of the atrioventricular node leading to congenital heart block (CHB). Methods In a blinded case-control study, maternal (female) cells were detected and quantified in male NLS and control heart-tissue samples. We used fluorescence in-situ hybridisation to label X and Y chromosomes. Studies in transplantation suggest that donor cells can differentiate into somatic tissue cells. Therefore, we asked whether maternal cells transferred in utero have cellular plasticity. To simultaneously identify and characterise maternal cells, we developed a technique by which multiple phenotypic markers could be detected concurrently with fluorescence in-situ hybridisation in the same cells of a tissue section. Findings Maternal cells were found in 15 of 15 sections of NLS heart tissue, ranging from 0.025% to 2.2% of total cells. By contrast, maternal cells were found in two of eight control sections (0-0.1%). Very few maternal cells expressed the haemopoietic cell marker CD45. Most expressed sarcomeric alpha actin, a specific marker for cardiac myocytes. Interpretation Our findings suggest that differentiated tissue-specific maternal microchimerism can occur in neonates. Thus, semiallogeneic maternal cells could be the target of an immune response. Alternatively, maternal cells could contribute to a secondary process of tissue repair.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Hosp Joint Dis & Med Ctr, New York, NY USA; Univ Washington, Dept Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of Washington; University of Washington Seattle	Stevens, AM (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,D2-100,POB 19024, Seattle, WA 98109 USA.	astevens@fhcrc.org		Buyon, Jill/0000-0002-3852-7129	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041721] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNAIZVILLENA A, 1989, ARTHRITIS RHEUM-US, V32, P1421, DOI 10.1002/anr.1780321111; Artlett CM, 2000, LANCET, V356, P2155, DOI 10.1016/S0140-6736(00)03499-1; BENIISCHKE K, 1990, PATHOLOGY HUMAN PLAC, P684; Boutjdir M, 1997, CIRC RES, V80, P354, DOI 10.1161/01.RES.80.3.354; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brucato A, 2001, ARTHRITIS RHEUM-US, V44, P1832, DOI 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C; BUYON JP, 1995, LUPUS, V4, P116, DOI 10.1177/096120339500400207; CANNAT A, 1973, BIOMEDICINE, V19, P108; DESAI RG, 1963, BLOOD, V21, P665, DOI 10.1182/blood.V21.6.665.665; HALL JM, 1995, BLOOD, V86, P2829; HORSFALL AC, 1991, J AUTOIMMUN, V4, P165, DOI 10.1016/0896-8411(91)90015-5; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; Kita H, 2002, J EXP MED, V195, P113, DOI 10.1084/jem.20010956; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Lee TH, 1999, BLOOD, V93, P3127; Lo YMD, 2000, CLIN CHEM, V46, P1301; Lo YMD, 1996, BLOOD, V88, P4390; Lo YMD, 1998, BRIT J HAEMATOL, V100, P605; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Miranda-Carus ME, 1998, J IMMUNOL, V161, P5886; Miyagawa S, 1997, ARTHRITIS RHEUM, V40, P982, DOI 10.1002/art.1780400532; Nelson JL, 2002, TRENDS MOL MED, V8, P109, DOI 10.1016/S1471-4914(01)02269-9; OREILLY RJ, 1973, TRANSPLANTATION, V15, P505; Petit T, 1997, BRIT J HAEMATOL, V98, P767, DOI 10.1046/j.1365-2141.1997.2603076.x; Petit T, 1995, EXP HEMATOL, V23, P1601; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reed AM, 2000, LANCET, V356, P2156, DOI 10.1016/S0140-6736(00)03500-5; REICHLIN M, 1994, ARTHRITIS RHEUM, V37, P1698, DOI 10.1002/art.1780371120; Rinkevich B, 2001, HUM IMMUNOL, V62, P651, DOI 10.1016/S0198-8859(01)00249-X; Saleeb S, 1999, ARTHRITIS RHEUM, V42, P2335, DOI 10.1002/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3; Setiady YY, 2003, J IMMUNOL, V170, P4656, DOI 10.4049/jimmunol.170.9.4656; SOCIE G, 1994, BLOOD, V83, P340; Stevens Anne, 2002, NEOREVIEWS, V3, pe11, DOI DOI 10.1542/NEO.3-1-E11; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Tran HB, 2002, ARTHRITIS RHEUM-US, V46, P1572, DOI 10.1002/art.10316; Tseng CE, 1997, RHEUM DIS CLIN N AM, V23, P31, DOI 10.1016/S0889-857X(05)70313-6; VANDERVEEN FM, 1982, ADV EXP MED BIOL, V149, P669; WATSON RM, 1984, MEDICINE, V63, P362, DOI 10.1097/00005792-198411000-00003; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	42	103	113	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2003	362	9396					1617	1623		10.1016/S0140-6736(03)14795-2	http://dx.doi.org/10.1016/S0140-6736(03)14795-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744MZ	14630442				2022-12-01	WOS:000186637400010
J	Yu, XH; Yu, YK; Liu, BD; Luo, K; Kong, W; Mao, PY; Yu, XF				Yu, XH; Yu, YK; Liu, BD; Luo, K; Kong, W; Mao, PY; Yu, XF			Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL VIF PROTEIN; SOR GENE-PRODUCT; HTLV-III/LAV; TYPE-1 VIF; DNA; SCF; IDENTIFICATION; HYPERMUTATION; LYMPHOCYTES	Human immunodeficiency virus-1 (HIV-1) Vif is essential for viral evasion of host antiviral factor CEM15/APOBEC3G. We report that Vif interacts with cellular proteins Cul5, elongins B and C, and Rbx1 to form an Skp1-cullin-F-box (SCF)-like complex. The ability of Vif to suppress antiviral activity of APOBEC3G was specifically dependent on Cul5-SCF function, allowing Vif to interact with APOBEC3G and induce its ubiquitination and degradation. A Vif mutant that interacted with APOBEC3G but not with Cul5-SCF was functionally inactive. The Cul5-SCF was also required for Vif function in distantly related simian immunodeficiency virus mac. These results indicate that the conserved Cul5-SCF pathway used by Vif is a potential target for antiviral development.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Jilin Univ, Changchun, Peoples R China; Zhejiang Univ, Hangzhou 310027, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jilin University; Zhejiang University	Yu, XF (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014702] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10-RR14702] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dettenhofer M, 2000, J VIROL, V74, P8938, DOI 10.1128/JVI.74.19.8938-8945.2000; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KAN NC, 1986, SCIENCE, V231, P1553, DOI 10.1126/science.3006245; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; LEE TH, 1986, SCIENCE, V231, P1546, DOI 10.1126/science.3006243; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; SODROSKI J, 1986, SCIENCE, V231, P1549, DOI 10.1126/science.3006244; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	27	958	1003	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1056	1060		10.1126/science.1089591	http://dx.doi.org/10.1126/science.1089591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14564014				2022-12-01	WOS:000186396300052
J	Cao, K; Nakajima, R; Meyer, HH; Zheng, YX				Cao, K; Nakajima, R; Meyer, HH; Zheng, YX			The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis	CELL			English	Article							MICROTUBULE DYNAMIC INSTABILITY; XENOPUS EGG EXTRACTS; CELL-CYCLE; MITOTIC-SPINDLE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; PROTEIN DISLOCATION; IMPORTIN-ALPHA; RAN	Spindle disassembly at the end of mitosis is a complex and poorly understood process. Here, we report that the AAA-ATPase Cdc48/p97 and its adapters Ufd1-Np14, which have a well-established role in membrane functions, also regulate spindle disassembly by modulating microtubule dynamics and bundling at the end of mitosis. In the absence of p97-Ufd1-Np14 function, microtubules in Xenopus egg extracts remain as monopolar spindles attached to condensed chromosomes after Cdc2 kinase activity has returned to the interphase level. Consequently, interphase microtubule arrays and nuclei are not established. Genetic analyses of Cdc48, the yeast homolog of p97, reveal that Cdc48 is also required for disassembly of mitotic spindles after execution of the mitotic exit pathway. Furthermore, Cdc48/p97-Ufd1-Np14 directly binds to spindle assembly factors and regulates their interaction with microtubules at the end of mitosis. Therefore, Cdc48/p97-Ufd1-Np14 is an essential chaperone that regulates transformation of the microtubule structure as cells reenter interphase.	Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21210 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	zheng@ciwemb.edu	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796				Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; FELIX MA, 1989, EMBO J, V8, P3059, DOI 10.1002/j.1460-2075.1989.tb08457.x; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoyt MA, 2000, CELL, V102, P267, DOI 10.1016/S0092-8674(00)00031-3; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Jensen S, 2002, CURR BIOL, V12, pR221, DOI 10.1016/S0960-9822(02)00756-X; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; MOIR D, 1982, GENETICS, V100, P547; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; PELLMAN D, 1995, J CELL BIOL, V130, P1373, DOI 10.1083/jcb.130.6.1373; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201	58	166	174	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					355	367		10.1016/S0092-8674(03)00815-8	http://dx.doi.org/10.1016/S0092-8674(03)00815-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636562	Bronze			2022-12-01	WOS:000186415000014
J	Zhong, NS; Zheng, BJ; Li, YM; Poon, LLM; Xie, ZH; Chan, KH; Li, PH; Tan, SY; Chang, Q; Xie, JP; Liu, XQ; Xu, J; Li, DX; Yuen, KY; Peiris, JSM; Guan, Y				Zhong, NS; Zheng, BJ; Li, YM; Poon, LLM; Xie, ZH; Chan, KH; Li, PH; Tan, SY; Chang, Q; Xie, JP; Liu, XQ; Xu, J; Li, DX; Yuen, KY; Peiris, JSM; Guan, Y			Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003	LANCET			English	Article							HONG-KONG; CORONAVIRUS	Background An epidemic of severe acute respiratory syndrome (SARS) has been associated with an outbreak of atypical pneumonia originating in Guangdong Province, People's Republic of China. We aimed to identify the causative agent in the Guangdong outbreak and describe the emergence and spread of the disease within the province. Methods We analysed epidemiological information and collected serum and nasopharyngeal aspirates from patients with SARS in Guangdong in mid-February, 2003. We did virus isolation, serological tests, and molecular assays to identify the causative agent. Findings SARS had been circulating in other cities of Guangdong Province for about 2 months before causing a major outbreak in Guangzhou, the province's capital. A novel coronavirus, SARS coronavirus (CoV), was isolated from specimens from three patients with SARS. Viral antigens were also directly detected in nasopharyngeal aspirates from these patients. 48 of 55 (87%) patients had antibodies to SARS CoV in their convalescent sera. Genetic analysis showed that the SARS CoV isolates from Guangzhou shared the same origin with those in other countries, and had a phylogenetic pathway that matched the spread of SARS to the other parts of the world. Interpretation SARS CoV is the infectious agent responsible for the epidemic outbreak of SARS in Guangdong. The virus isolated from patients in Guangdong is the prototype of the SARS CoV in other regions and countries.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Guangzhou Med Coll, Guangzhou Inst Resp Dis, Guangzhou, Guangdong Prov, Peoples R China; Guangzhou Chest Hosp, Guangzhou, Guangdong Prov, Peoples R China; Guangzhou Childrens Hosp, Guangzhou, Guangdong Prov, Peoples R China	University of Hong Kong; Guangzhou Medical University	Guan, Y (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Yuen, Kwok Yung/C-4465-2009; Chan, Kwok Hung/ABD-5399-2021; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; li, yimin/0000-0003-0810-5256; Yuen, Kwok-yung/0000-0002-2083-1552; Guan, Yi/0000-0001-6057-9243; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	PHS HHS [A195357] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; DEJONG JC, 1997, NATURE, V389, P544; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; *GUANGD PUBL HLTH, 2003, 2 GUANGD PUBL HLTH O; HOLLAND JJ, 1991, J VIROL, V65, P1960; Knipe D, 2001, FIELDS VIROLOGY, P1187; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; [彭国文 Peng Guowen], 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P350; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; SHORTRIDGE KF, 1982, LANCET, V2, P812; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; WHO, CUM NUMB REP PROB CA; *WHO, CAS DEF SURV SEV AC; 2003, MMWR MORB MORT WKL R, V52, P241	20	863	925	7	168	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 25	2003	362	9393					1353	1358		10.1016/S0140-6736(03)14630-2	http://dx.doi.org/10.1016/S0140-6736(03)14630-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585636	Green Published, Bronze			2022-12-01	WOS:000186143300008
J	Strachan, MWJ				Strachan, MWJ			Insulin and cognitive function	LANCET			English	Editorial Material							ALZHEIMERS-DISEASE; HYPERINSULINEMIA; POPULATION; MEMORY		Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Strachan, MWJ (corresponding author), Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland.							Craft S, 1996, NEUROBIOL AGING, V17, P123, DOI 10.1016/0197-4580(95)02002-0; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Galasko D, 2003, NEUROLOGY, V60, P1886, DOI 10.1212/WNL.60.12.1886; KALMIJN S, 1995, DIABETOLOGIA, V38, P1096, DOI 10.1007/BF00402181; KUUSISTO J, 1993, HYPERTENSION, V22, P771, DOI 10.1161/01.HYP.22.5.771; Kuusisto J, 1997, BRIT MED J, V315, P1045, DOI 10.1136/bmj.315.7115.1045; Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25	10	44	44	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1253	1253		10.1016/S0140-6736(03)14615-6	http://dx.doi.org/10.1016/S0140-6736(03)14615-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575966				2022-12-01	WOS:000186036900005
J	Abe, E; Marians, RC; Yu, WQ; Wu, XB; Ando, T; Li, YN; Iqbal, J; Eldeiry, L; Rajendren, G; Blair, HC; Davies, TF; Zaidi, M				Abe, E; Marians, RC; Yu, WQ; Wu, XB; Ando, T; Li, YN; Iqbal, J; Eldeiry, L; Rajendren, G; Blair, HC; Davies, TF; Zaidi, M			TSH is a negative regulator of skeletal remodeling	CELL			English	Article							STIMULATING HORMONE-RECEPTOR; THYROID-HORMONE; THYROTROPIN RECEPTOR; OSTEOCLAST DIFFERENTIATION; PHOSPHATASE-ACTIVITY; BONE-MARROW; RANK LIGAND; KAPPA-B; EXPRESSION; CELLS	The established function of thyroid stimulating hormone (TSH) is to promote thyroid follicle development and hormone secretion. The osteoporosis associated with hyperthyroidism is traditionally viewed as a secondary consequence of altered thyroid function. We provide evidence for direct effects of TSH on both components of skeletal remodeling, osteoblastic bone formation, and osteoclastic bone resorption, mediated via the TSH receptor (TSHR) found on osteoblast and osteoclast precursors. Even a 50% reduction in TSHR expression produces profound osteoporosis (bone loss) together with focal osteosclerosis (localized bone formation). TSH inhibits osteoclast formation and survival by attenuating JNK/c-jun and NFkappaB signaling triggered in response to RANK-L and TNFalpha. TSH also inhibits osteoblast differentiation and type 1 collagen expression in a Runx-2- and osterix-independent manner by downregulating Wnt (LRP-5) and VEGF (Flk) signaling. These studies define a role for TSH as a single molecular switch in the independent control of both bone formation and resorption.	CUNY Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA; Vet Affairs Med Ctr, Bronx, NY 10463 USA; Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; Vet Affairs Med Ctr, Pittsburgh, PA 15213 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Zaidi, M (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA.	mone.zaidi@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045011, R01DK052464, T32DK007646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014917, R01AG023176] Funding Source: NIH RePORTER; NIA NIH HHS [AG-14917-8, AG23176-01] Funding Source: Medline; NIDDK NIH HHS [DK52464, DK45011, DK07646] Funding Source: Medline; PHS HHS [A124671] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Bagriacik EU, 2000, J IMMUNOL, V164, P6158, DOI 10.4049/jimmunol.164.12.6158; Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165; BORDIER P, 1967, P ROY SOC MED, V60, P1132, DOI 10.1177/003591576706011P130; BRITTO JM, 1994, ENDOCRINOLOGY, V134, P169, DOI 10.1210/en.134.1.169; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; ENDO T, 1995, J BIOL CHEM, V270, P10833, DOI 10.1074/jbc.270.18.10833; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Greenspan SL, 1999, ANN INTERN MED, V130, P750, DOI 10.7326/0003-4819-130-9-199905040-00016; Hofbauer LC, 2002, J CELL BIOCHEM, V86, P642, DOI 10.1002/jcb.10242; Inoue M, 1998, THYROID, V8, P1059, DOI 10.1089/thy.1998.8.1059; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kohn L D, 1995, Vitam Horm, V50, P287, DOI 10.1016/S0083-6729(08)60658-5; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Prummel MF, 2000, J CLIN ENDOCR METAB, V85, P4347, DOI 10.1210/jc.85.11.4347; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; SATO K, 1987, ENDOCRINOLOGY, V120, P1873, DOI 10.1210/endo-120-5-1873; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Sun L, 2003, FASEB J, V17, P369, DOI 10.1096/fj.02-0205com; Takahashi N, 2003, METH MOLEC MED, V80, P129; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Valyasevi RW, 1999, J CLIN ENDOCR METAB, V84, P2557, DOI 10.1210/jc.84.7.2557; Vincent BL, 2001, J BONE MINER RES, V16, pS268; Wang HC, 2003, BLOOD, V101, P119, DOI 10.1182/blood-2002-02-0544; WANG J, 1995, CELL IMMUNOL, V161, P299, DOI 10.1006/cimm.1995.1040; WEBBER DM, 1988, HISTOCHEM J, V20, P269, DOI 10.1007/BF01745605; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Zaidi M, 2003, J BONE MINER RES, V18, P599, DOI 10.1359/jbmr.2003.18.4.599; Zelzer E, 2002, DEVELOPMENT, V129, P1893	42	459	504	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2003	115	2					151	162		10.1016/S0092-8674(03)00771-2	http://dx.doi.org/10.1016/S0092-8674(03)00771-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567913	Bronze			2022-12-01	WOS:000186039200007
J	Kinoshita, T; Miura, A; Choi, YH; Kinoshita, Y; Cao, XF; Jacobsen, SE; Fischer, RL; Kakutani, T				Kinoshita, T; Miura, A; Choi, YH; Kinoshita, Y; Cao, XF; Jacobsen, SE; Fischer, RL; Kakutani, T			One-way control of FWA imprinting in Arabidopsis endosperm by DNA methylation	SCIENCE			English	Article							CYTOSINE METHYLTRANSFERASE; EPIGENETIC ALLELES; POLYCOMB GENE; THALIANA; GLYCOSYLASE; MAINTENANCE; MUTATIONS; MUTANTS; MEA; DRM	The Arabidopsis FWA gene was initially identified from late-flowering epigenetic mutants that show ectopic FWA expression associated with heritable hypomethylation of repeats around transcription starting sites. Here, we show that wild-type FWA displays imprinted (maternal origin-specific) expression in endosperm. The FWA imprint depends on the maintenance DNA methyltransferase MET1, as is the case in mammals. Unlike mammals, however, the FWA imprint is not established by allele-specific de novo methylation. It is established by maternal gametophyte-specific gene activation, which depends on a DNA glycosylase gene, DEMETER. Because endosperm does not contribute to the next generation, the activated FWA gene need not be silenced again. Double fertilization enables plants to use such "one-way" control of imprinting and DNA methylation in endosperm.	Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kinoshita, T (corresponding author), Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	tekinosh@lab.nig.ac.jp; tkakutan@lab.nig.ac.jp			NIGMS NIH HHS [GM60398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; BIRCHLER JA, 1993, ANNU REV GENET, V27, P181, DOI 10.1146/annurev.ge.27.120193.001145; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7	24	426	463	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					521	523		10.1126/science.1089835	http://dx.doi.org/10.1126/science.1089835			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14631047				2022-12-01	WOS:000188316400037
J	Serizawa, S; Miyamichi, K; Nakatani, H; Suzuki, M; Saito, M; Yoshihara, Y; Sakano, H				Serizawa, S; Miyamichi, K; Nakatani, H; Suzuki, M; Saito, M; Yoshihara, Y; Sakano, H			Negative feedback regulation ensures the one receptor-one olfactory neuron rule in mouse	SCIENCE			English	Article							IMMUNOGLOBULIN HEAVY; ODORANT RECEPTORS; GENE-EXPRESSION; LIGHT-CHAIN; ORGANIZATION; PROJECTION	In the mouse olfactory system, each olfactory sensory neuron (OSN) expresses only one odorant receptor (OR) gene in a monoallelic and mutually exclusive manner. Such expression forms the genetic basis for OR-instructed axonal projection of OSNs to the olfactory bulb of the brain during development. Here, we identify an upstream cis-acting DNA region that activates the OR gene cluster in mouse and allows the expression of only one OR gene within the cluster. Deletion of the coding region of the expressed OR gene or a naturally occurring frame-shift mutation allows a second OR gene to be expressed. We propose that stochastic activation of only one OR gene within the cluster and negative feedback regulation by that OR gene product are necessary to ensure the one receptor - one neuron rule.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Corp, CREST Programs, Kawaguchi, Saitama 3320012, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan; RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University; RIKEN	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Miyamichi, Kazunari/AAO-3705-2021; Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166				BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; SERIZAWA S, UNPUB; SMITH AFA, REPEATMASKER; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	28	385	393	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2088	2094		10.1126/science.1089122	http://dx.doi.org/10.1126/science.1089122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14593185				2022-12-01	WOS:000187385200034
J	Getahun, H; Lambein, F; Vanhoorne, M; Van der Stuyft, P				Getahun, H; Lambein, F; Vanhoorne, M; Van der Stuyft, P			Food-aid cereals to reduce neurolathyrism related to grass-pea preparations during famine	LANCET			English	Article							EPIDEMIC	Neurolathyrism is a spastic paraparesis that can be caused by excessive consumption of the drought-resistant grass pea (Lathyrus sativus). Devastating neurolathyrism epidemics have occurred during major famine crises in various parts of the world. We investigated in a case-control study the effects of food aid on risk of paralysis. Risk increased with consumption of boiled grass pea (adjusted odds ratio 2.78, 95% CI 1.09-7.13 with cereals; 5.22, 2.01-13.55 without cereal) and raw unripe green grass pea (1.96, 1-1.6-3.31; p=0.011), but not with the fermented pancake, unleavened bread, and gravy preparations. In a correlational study there was an inverse relation between the number of new cases and the amount of food-aid cereals distributed per person. During famine, cereals and nutritional information should reach people before they have grass pea as the only food.	S Gonder Hlth Dept, Debre Tabor, Amhara Regional, Ethiopia; Univ Ghent, Fac Med & Hlth Sci, Physiol Chem Lab, B-9000 Ghent, Belgium; Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; Univ Ghent, Inst Plant Biotechnol Dev Countries, B-9000 Ghent, Belgium; Inst Trop Med, Epidemiol Unit, B-2000 Antwerp, Belgium	Ghent University; Ghent University; Ghent University; Institute of Tropical Medicine (ITM)	Lambein, F (corresponding author), Josef Kluyskensstr 27, B-9000 Ghent, Belgium.	fernand.lambein@UGent.be	Getahun, Haileyesus/ABC-5181-2020					Getahun H, 2002, TROP MED INT HEALTH, V7, P118, DOI 10.1046/j.1365-3156.2002.00836.x; Getahun H, 1999, LANCET, V354, P306, DOI 10.1016/S0140-6736(99)02532-5; KUO YH, 1995, J SCI FOOD AGR, V69, P81, DOI 10.1002/jsfa.2740690113; Moszynski P, 2002, LANCET, V360, P1952, DOI 10.1016/S0140-6736(02)11949-0; *US AG INT DEV CHE, FAM EARL WARN SYST N	5	48	52	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1808	1810		10.1016/S0140-6736(03)14902-1	http://dx.doi.org/10.1016/S0140-6736(03)14902-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654321				2022-12-01	WOS:000186872900014
J	Keren, K; Berman, RS; Buchstab, E; Sivan, U; Braun, E				Keren, K; Berman, RS; Buchstab, E; Sivan, U; Braun, E			DNA-templated carbon nanotube field-effect transistor	SCIENCE			English	Article							ROOM-TEMPERATURE; SEPARATION; MOLECULES; RECOGNITION; CIRCUITS; LOGIC; WIRE	The combination of their electronic properties and dimensions makes carbon nanotubes ideal building blocks for molecular electronics. However, the advancement of carbon nanotube-based electronics requires assembly strategies that allow their precise localization and interconnection. Using a scheme based on recognition between molecular building blocks, we report the realization of a self-assembled carbon nanotube field-effect transistor operating at room temperature. A DNA scaffold molecule provides the address for precise localization of a semiconducting single-wall carbon nanotube as well as the template for the extended metallic wires contacting it.	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Solid State, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Braun, E (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	erez@physics.technion.ac.il		Keren, Kinneret/0000-0002-2962-6977				Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bockrath M, 2002, NANO LETT, V2, P187, DOI 10.1021/nl0100724; Bradley K, 2003, NANO LETT, V3, P639, DOI 10.1021/nl025941j; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x; Eichen Y, 1998, ACTA POLYM, V49, P663, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<663::AID-APOL663>3.0.CO;2-4; Gomez-Navarro C, 2002, P NATL ACAD SCI USA, V99, P8484, DOI 10.1073/pnas.122610899; Heath JR, 2003, PHYS TODAY, V56, P43, DOI 10.1063/1.1583533; Javey A, 2002, NANO LETT, V2, P929, DOI [10.1021/nl025647r, 10.1021/n1025647r]; Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Niemeyer CM, 2000, CURR OPIN CHEM BIOL, V4, P609, DOI 10.1016/S1367-5931(00)00140-X; Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	27	671	701	3	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1380	1382		10.1126/science.1091022	http://dx.doi.org/10.1126/science.1091022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631035				2022-12-01	WOS:000186683500047
J	Kelman, CW; Kortt, MA; Becker, NG; Li, Z; Mathews, JD; Guest, CS; Holman, CD				Kelman, CW; Kortt, MA; Becker, NG; Li, Z; Mathews, JD; Guest, CS; Holman, CD			Deep vein thrombosis and air travel: record linkage study	BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOSIS; PULMONARY-EMBOLISM; RISK; EVENTS	Objective To investigate the time relations between long haul air travel and venous thromboembolisin. Design Record linkage study using the case crossover approach. Setting Western Australia. Participants 5408 patients admitted to hospital with venous thromboembolism and matched with data for arrivals of international flights during 1981-99. Results ne risk of venous thromboembolism is increased for only two weeks after a long haul flight; 46 Australian citizens and 200 non-Australian citizens had an episode of venous thromboembolism during this so called hazard period. The relative risk during this period for Australian citizens was 4.17 (95% confidence interval, 2.94 to 5.40), with 76% of cases (n=35) attributable to the preceding flight. A "healthy traveller" effect was observed, particularly for Australian citizens. Conclusions The annual risk of venous thromboembolism is increased by 12% if one long haul flight is taken yearly. The average risk of death from flight related venous thromboembolisin is small compared with that from motor vehicle crashes and injuries at work. The individual risk of death from flight related venous thromboembolism for people with certain pre-existing medical conditions is, however, likely to be greater than the average risk of 1 per 2 million for passengers arriving from a flight. Airlines and health authorities should continue to advise passengers on how to minimise risk.	Commonwealth Dept Hlth & Ageing, Canberra, ACT 2601, Australia; Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	Australian National University; University of Western Australia	Kelman, CW (corresponding author), Commonwealth Dept Hlth & Ageing, GPO Box 9848, Canberra, ACT 2601, Australia.		Holman, Cashel DJ/B-6173-2009	Kelman, Chris/0000-0001-5126-8179; Kortt, Michael/0000-0002-3556-3001				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Ansell JE, 2001, NEW ENGL J MED, V345, P828, DOI 10.1056/NEJM200109133451110; *AUSTR BUR STAT, 1999, 1998 CAUS DEATH; *DEP TRANSP REG DE, 1999, ROAD FAT AUSTR 1998; Eekhoff EMW, 2000, THROMB HAEMOSTASIS, V83, P408, DOI 10.1055/s-0037-1613828; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Gallus AS, 2001, MED J AUSTRALIA, V174, P264, DOI 10.5694/j.1326-5377.2001.tb143263.x; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; *INT CIV AV ORG, 2000, 1999 AN REP COUNC IN; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Kesteven PJL, 2001, AVIAT SPACE ENVIR MD, V72, P125; Kraaijenhagen RA, 2000, LANCET, V356, P1492, DOI 10.1016/S0140-6736(00)02878-6; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LORD RSA, 2000, HAWAII MED J, V59, P155; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; MARSHALL RJ, 1993, STAT MED, V12, P2333, DOI 10.1002/sim.4780122409; *NAT TRANSP SAF BO, 2001, ACC FAT RAT 1982 200; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Scurr JH, 2001, LANCET, V357, P1485, DOI 10.1016/S0140-6736(00)04645-6	22	79	80	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 8	2003	327	7423					1072	1075		10.1136/bmj.327.7423.1072	http://dx.doi.org/10.1136/bmj.327.7423.1072			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742QW	14604926	Bronze, Green Published			2022-12-01	WOS:000186530400015
J	Gong, SC; Zheng, C; Doughty, ML; Losos, K; Didkovsky, N; Schambra, UB; Nowak, NJ; Joyner, A; Leblanc, G; Hatten, ME; Heintz, N				Gong, SC; Zheng, C; Doughty, ML; Losos, K; Didkovsky, N; Schambra, UB; Nowak, NJ; Joyner, A; Leblanc, G; Hatten, ME; Heintz, N			A gene expression atlas of the central nervous system based on bacterial artificial chromosomes	NATURE			English	Article							ESCHERICHIA-COLI; TRANSGENIC MICE; GOOSECOID-LIKE; NEURONS; RECEPTORS; CELL; SEMAPHORINS; STRIATUM; NEUROSCIENCE; MIGRATION	The mammalian central nervous system (CNS) contains a remarkable array of neural cells, each with a complex pattern of connections that together generate perceptions and higher brain functions. Here we describe a large-scale screen to create an atlas of CNS gene expression at the cellular level, and to provide a library of verified bacterial artificial chromosome (BAC) vectors and transgenic mouse lines that offer experimental access to CNS regions, cell classes and pathways. We illustrate the use of this atlas to derive novel insights into gene function in neural cells, and into principal steps of CNS development. The atlas, library of BAC vectors and BAC transgenic mice generated in this screen provide a rich resource that allows a broad array of investigations not previously available to the neuroscience community.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, GENSAT Project, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Dev Neurobiol Lab, New York, NY 10021 USA; E Tennessee State Univ, Dept Anat & Cell Biol, Johnson City, TN 37614 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Dev Genet Program, New York, NY 10016 USA; Howard Hughes Med Inst, New York, NY 10016 USA; Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; East Tennessee State University; Roswell Park Cancer Institute; New York University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave,Box 260, New York, NY 10021 USA.	gensat@rockefeller.edu						Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BAIRD DH, 1992, J NEUROSCI, V12, P619; Bernard V, 1999, J NEUROSCI, V19, P10237; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chen H, 1998, NAT NEUROSCI, V1, P436, DOI 10.1038/2154; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; EDWARDS MA, 1986, J COMP NEUROL, V248, P395, DOI 10.1002/cne.902480308; EDWARDS MA, 1986, J COMP NEUROL, V248, P410, DOI 10.1002/cne.902480309; Emanuel B S, 2001, Adv Pediatr, V48, P39; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gottlieb S, 1998, HUM MOL GENET, V7, P1497, DOI 10.1093/hmg/7.9.1497; Gottlieb S, 1997, AM J HUM GENET, V60, P1194; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Meyer G, 1998, J COMP NEUROL, V397, P493; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; PAXINOS G, 2001, MOUSE BRAIN STEREOTA, V132; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; ROSS CA, 1989, P NATL ACAD SCI USA, V86, P2923, DOI 10.1073/pnas.86.8.2923; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; SACHS GM, 1984, J COMP NEUROL, V230, P155, DOI 10.1002/cne.902300202; Schambra UB, 1992, ATLAS PRENATAL MOUSE; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Valjakka A, 1998, BRAIN RES BULL, V47, P171, DOI 10.1016/S0361-9230(98)00006-9; Valverde F, 1998, GOLGI ATLAS OF THE POSTNATAL MOUSE BRAIN, P1; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang X, 2002, J NEUROSCI, V22, P9185; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	46	1537	1561	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2003	425	6961					917	925		10.1038/nature02033	http://dx.doi.org/10.1038/nature02033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586460				2022-12-01	WOS:000186230600032
J	Manke, IA; Lowery, DM; Nguyen, A; Yaffe, MB				Manke, IA; Lowery, DM; Nguyen, A; Yaffe, MB			BRCT repeats as phosphopeptide-binding modules involved in protein targeting	SCIENCE			English	Article							PEPTIDE LIBRARIES; DOMAIN; ATM; CHECKPOINT; 53BP1; CAFFEINE; PTIP	We used a proteomic approach to identify phosphopeptide-binding modules mediating signal transduction events in the DNA damage response pathway. Using a library of partially degenerate phosphopeptides, we identified tandem BRCT (BRCA1 carboxyl-terminal) domains in PTIP (Pax transactivation domain-interacting protein) and in BRCA1 as phosphoserine- or phosphothreonine-specific binding modules that recognize substrates phosphorylated by the kinases ATM (ataxia telangiectasia-mutated) and ATR (ataxia telangiectasia- and RAD3-related) in response to gamma-irradiation. PTIP tandem BRCT domains are responsible for phosphorylation-dependent protein localization into 53BP1- and phospho-H2AX (gamma-H2AX)-containing nuclear foci, a marker of DNA damage. These findings provide a molecular basis for BRCT domain function in the DNA damage response and may help to explain why the BRCA1 BRCT domain mutation Met(1775) --> Arg, which fails to bind phosphopeptides, predisposes women to breast and ovarian cancer.	MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), MIT, Dept Biol, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60594] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; MANKE IA, UNPUB; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Williams RS, 2003, J BIOL CHEM, V278, P2630, DOI 10.1074/jbc.M210019200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	22	528	538	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					636	639		10.1126/science.1088877	http://dx.doi.org/10.1126/science.1088877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576432				2022-12-01	WOS:000186119900057
J	Rokas, A; Williams, BL; King, N; Carroll, SB				Rokas, A; Williams, BL; King, N; Carroll, SB			Genome-scale approaches to resolving incongruence in molecular phylogenies	NATURE			English	Article							COMBINING DATA; SEQUENCE DATA; GENES; DNA; COMPLEX; DUPLICATION; EVOLUTION; POSITION; TREES	One of the most pervasive challenges in molecular phylogenetics is the incongruence between phylogenies obtained using different data sets, such as individual genes. To systematically investigate the degree of incongruence, and potential methods for resolving it, we screened the genome sequences of eight yeast species and selected 106 widely distributed orthologous genes for phylogenetic analyses, singly and by concatenation. Our results suggest that data sets consisting of single or a small number of concatenated genes have a significant probability of supporting conflicting topologies. By contrast, analyses of the entire data set of concatenated genes yielded a single, fully resolved species tree with maximum support. Comparable results were obtained with a concatenation of a minimum of 20 genes; substantially more genes than commonly used but a small fraction of any genome. These results have important implications for resolving branches of the tree of life.	Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, RM Bock Labs, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, RM Bock Labs, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1996, MOL SYSTEMATICS; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Kopp A, 2002, SYST BIOL, V51, P786, DOI 10.1080/10635150290102410; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Loytynoja A, 2001, P NATL ACAD SCI USA, V98, P10202, DOI 10.1073/pnas.181187698; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.1093/sysbio/46.3.523; Martin AP, 2002, SYST BIOL, V51, P570, DOI 10.1080/10635150290069995; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.2307/2413529; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Naylor GJP, 1998, SYST BIOL, V47, P61, DOI 10.1080/106351598261030; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PHILIPPE H, 1994, DEVELOPMENT, P15; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rieseberg LH, 1996, ACTA BOT NEERL, V45, P243; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; Swofford DL, 2002, PAUP VERSION 4 0 B10, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; YANG ZH, 1994, MOL BIOL EVOL, V11, P316	50	1115	1138	0	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 23	2003	425	6960					798	804		10.1038/nature02053	http://dx.doi.org/10.1038/nature02053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574403				2022-12-01	WOS:000186118500036
J	Campbell, DB; Black, GJ; Carter, LM; Ostro, SJ				Campbell, DB; Black, GJ; Carter, LM; Ostro, SJ			Radar evidence for liquid surfaces on Titan	SCIENCE			English	Article							DIELECTRIC-PROPERTIES; ICY SATELLITES; ATMOSPHERE; TELESCOPE	Arecibo radar observations of Titan at 13-centimeter wavelength indicate that most of the echo power is in a diffusely scattered component but that a small specular component is present for about 75% of the subearth locations observed. These specular echoes have properties consistent with those expected for areas of liquid hydrocarbons. Knowledge of the areal extent and depth of any deposits of liquid hydrocarbons could strongly constrain the history of Titan's atmosphere and surface.	Cornell Univ, Natl Astron & Ionosphere Ctr, Ithaca, NY 14853 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; CALTECH, Jet Prop Lab 300 233, Pasadena, CA 91109 USA	Cornell University; Cornell University; University of Virginia; California Institute of Technology	Campbell, DB (corresponding author), Cornell Univ, Natl Astron & Ionosphere Ctr, Space Sci Bldg, Ithaca, NY 14853 USA.	campbell@astro.cornell.edu	Carter, Lynn/D-2937-2012	Carter, Lynn/0000-0002-6245-4142; Black, Gregory/0000-0001-7237-8270				CAMPBELL DB, 1978, ICARUS, V34, P254, DOI 10.1016/0019-1035(78)90166-5; COUSTENIS A, 1995, ICARUS, V118, P87, DOI 10.1006/icar.1995.1179; EVANS JV, 1968, RADAR ASTRONOMY, pCH4; Ghafoor NAL, 2000, J GEOPHYS RES-PLANET, V105, P12077, DOI 10.1029/1999JE001066; Gibbard SG, 1999, ICARUS, V139, P189, DOI 10.1006/icar.1999.6095; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; HAGFORS T, 1964, J GEOPHYS RES, V69, P3779, DOI 10.1029/JZ069i018p03779; Lorenz RD, 1998, ICARUS, V136, P344, DOI 10.1006/icar.1998.6017; Lorenz RD, 2001, GEOPHYS RES LETT, V28, P215, DOI 10.1029/2000GL012199; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; Meier R, 2000, ICARUS, V145, P462, DOI 10.1006/icar.2000.6360; MUHLEMAN DO, 1990, SCIENCE, V248, P975, DOI 10.1126/science.248.4958.975; OSTRO SJ, 1992, J GEOPHYS RES-PLANET, V97, P18227, DOI 10.1029/92JE01992; Rodriguez S, 2003, ICARUS, V164, P213, DOI 10.1016/S0019-1035(03)00125-8; SAGAN C, 1982, NATURE, V300, P731, DOI 10.1038/300731a0; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; THOMPSON WR, 1990, ICARUS, V86, P336, DOI 10.1016/0019-1035(90)90224-W	18	86	86	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2003	302	5644					431	434		10.1126/science.1088969	http://dx.doi.org/10.1126/science.1088969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14526087				2022-12-01	WOS:000185963200038
J	Wilkinson, MJ; Elliott, LJ; Allainguillaume, J; Shaw, MW; Norris, C; Welters, R; Alexander, M; Sweet, J; Mason, DC				Wilkinson, MJ; Elliott, LJ; Allainguillaume, J; Shaw, MW; Norris, C; Welters, R; Alexander, M; Sweet, J; Mason, DC			Hybridization between Brassica napus and B-rapa on a national scale in the United Kingdom	SCIENCE			English	Article							OILSEED RAPE; HERBICIDE RESISTANCE; WILD RELATIVES; MOVEMENT; POLLINATION; TRANSGENE; IMPACT; CROPS	Measures blocking hybridization would prevent or reduce biotic or environmental change caused by gene flow from genetically modified (GM) crops to wild relatives. The efficacy of any such measure depends on hybrid numbers within the legislative region over the life-span of the GM cultivar. We present a national assessment of hybridization between rapeseed (Brassica napus) and B. rapa from a combination of sources, including population surveys, remote sensing, pollen dispersal profiles, herbarium data, local Floras, and other floristic databases. Across the United Kingdom, we estimate that 32,000 hybrids form annually in waterside B. rapa populations, whereas the less abundant weedy populations contain 17,000 hybrids. These findings set targets for strategies to eliminate hybridization and represent the first step toward quantitative risk assessment on a national scale.	Univ Reading, Sch Plant Sci, Reading RG6 6AS, Berks, England; Univ Reading, Nat Environm Res Council, Environm Syst Sci Ctr, Reading RG6 6AL, Berks, England; Ctr Ecol & Hydrol, Winfrith, Dorset, England	University of Reading; University of Reading; UK Centre for Ecology & Hydrology (UKCEH)	Wilkinson, MJ (corresponding author), Univ Reading, Sch Plant Sci, Reading RG6 6AS, Berks, England.	m.j.wilkinson@rdg.ac.uk	Shaw, Michael/A-1926-2011	Shaw, Michael/0000-0002-6993-048X; Wilkinson, Michael/0000-0002-9881-6993	Biotechnology and Biological Sciences Research Council [GM114202] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; Davenport IJ, 2000, INT J REMOTE SENS, V21, P3567, DOI 10.1080/014311600750037598; JAMES C, 2002, ISAAA BRIEFS, V27; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; Metz PLJ, 1997, THEOR APPL GENET, V95, P442, DOI 10.1007/s001220050581; RAYBOULD AF, 1993, J APPL ECOL, V30, P199, DOI 10.2307/2404623; Rieger MA, 2002, SCIENCE, V296, P2386, DOI 10.1126/science.1071682; Rosellini D, 2001, EUPHYTICA, V118, P313, DOI 10.1023/A:1017568201732; SCHEFFLER JA, 1994, TRANSGENIC RES, V3, P263, DOI 10.1007/BF01973586; Stace C. A., 1975, HYBRIDIZATION FLORA; TIMMONS AM, 1995, EUPHYTICA, V85, P417, DOI 10.1007/BF00023975; Trewavas AJ, 2001, EMBO REP, V2, P455, DOI 10.1093/embo-reports/kve123; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wilkinson MJ, 2003, TRENDS PLANT SCI, V8, P208, DOI 10.1016/S1360-1385(03)00057-8; Wilkinson MJ, 2000, MOL ECOL, V9, P983, DOI 10.1046/j.1365-294x.2000.00986.x; Zuo JR, 2000, CURR OPIN BIOTECH, V11, P146, DOI 10.1016/S0958-1669(00)00073-2	17	130	145	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2003	302	5644					457	459		10.1126/science.1088200	http://dx.doi.org/10.1126/science.1088200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14551318				2022-12-01	WOS:000185963200046
J	Madsen, EB; Madsen, LH; Radutoiu, S; Olbryt, M; Rakwalska, M; Szczyglowski, K; Sato, S; Kaneko, T; Tabata, S; Sandal, N; Stougaard, J				Madsen, EB; Madsen, LH; Radutoiu, S; Olbryt, M; Rakwalska, M; Szczyglowski, K; Sato, S; Kaneko, T; Tabata, S; Sandal, N; Stougaard, J			A receptor kinase gene of the LysM type is involved in legume perception of rhizobial signals	NATURE			English	Article							LIPO-OLIGOSACCHARIDE SIGNALS; PISUM-SATIVUM-L; LOTUS-JAPONICUS; NODULE ORGANOGENESIS; NODULATION FACTORS; SYMBIOTIC MUTANTS; HOST-SPECIFICITY; MELILOTI; PEA; BACTERIAL	Plants belonging to the legume family develop nitrogen-fixing root nodules in symbiosis with bacteria commonly known as rhizobia. The legume host encodes all of the functions necessary to build the specialized symbiotic organ, the nodule, but the process is elicited by the bacteria(1-3). Molecular communication initiates the interaction, and signals, usually flavones, secreted by the legume root induce the bacteria to produce a lipochitin-oligosaccharide signal molecule (Nod-factor), which in turn triggers the plant organogenic process(4-7). An important determinant of bacterial host specificity is the structure of the Nodfactor, suggesting that a plant receptor is involved in signal perception and signal transduction initiating the plant developmental response(8,9). Here we describe the cloning of a putative Nod-factor receptor kinase gene (NFR5) from Lotus japonicus. NFR5 is essential for Nod-factor perception and encodes an unusual transmembrane serine/ threonine receptor-like kinase required for the earliest detectable plant responses to bacteria and Nod-factor. The extracellular domain of the putative receptor has three modules with similarity to LysM domains known from peptidoglycan-binding proteins and chitinases. Together with an atypical kinase domain structure this characterizes an unusual receptor-like kinase.	Univ Aarhus, Dept Mol Biol, Gene Express Lab, DK-8000 Aarhus C, Denmark; Agr & Agri Food Canada, SCPFRC, London, ON NV5 4T3, Canada; Kazusa DNA Res Inst, Chiba 2920812, Japan	Aarhus University; Agriculture & Agri Food Canada; Kazusa DNA Research Institute	Stougaard, J (corresponding author), Univ Aarhus, Dept Mol Biol, Gene Express Lab, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.	stougaard@mb.au.dk	poinssot, benoit/B-2569-2009; Sato, Shusei/A-3616-2015	poinssot, benoit/0000-0001-5890-4318; Sato, Shusei/0000-0002-0293-5366; Olbryt, Magdalena/0000-0001-9961-6427; Stougaard, Jens/0000-0002-9312-2685				Amon P, 1998, PLANT CELL, V10, P781; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bras CP, 2000, MOL PLANT MICROBE IN, V13, P475, DOI 10.1094/MPMI.2000.13.4.475; BUTLER AR, 1991, EUR J BIOCHEM, V199, P483, DOI 10.1111/j.1432-1033.1991.tb16147.x; DUC G, 1989, PLANT SCI, V60, P207, DOI 10.1016/0168-9452(89)90168-4; ENGVILD KC, 1987, THEOR APPL GENET, V74, P711, DOI 10.1007/BF00247546; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KNEEN BE, 1994, J HERED, V85, P129, DOI 10.1093/oxfordjournals.jhered.a111410; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; LOPEZLARA IM, 1995, MOL MICROBIOL, V15, P627, DOI 10.1111/j.1365-2958.1995.tb02372.x; Nakamura Y, 2002, DNA RES, V9, P63, DOI 10.1093/dnares/9.2.63; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Sandal N, 2002, GENETICS, V161, P1673; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Schneider A, 2002, THEOR APPL GENET, V104, P1312, DOI 10.1007/s00122-002-0896-2; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Stougaard J, 1995, Methods Mol Biol, V49, P49; Stougaard J, 2001, CURR OPIN PLANT BIOL, V4, P328, DOI 10.1016/S1369-5266(00)00181-3; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; TRUCHET G, 1989, MOL GEN GENET, V219, P65, DOI 10.1007/BF00261158; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0; Wegel E, 1998, MOL PLANT MICROBE IN, V11, P933, DOI 10.1094/MPMI.1998.11.9.933; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	31	646	706	7	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2003	425	6958					637	640		10.1038/nature02045	http://dx.doi.org/10.1038/nature02045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534591				2022-12-01	WOS:000185801000042
J	Radutoiu, S; Madsen, LH; Madsen, EB; Felle, HH; Umehara, Y; Gronlund, M; Sato, S; Nakamura, Y; Tabata, S; Sandal, N; Stougaard, J				Radutoiu, S; Madsen, LH; Madsen, EB; Felle, HH; Umehara, Y; Gronlund, M; Sato, S; Nakamura, Y; Tabata, S; Sandal, N; Stougaard, J			Plant recognition of symbiotic bacteria requires two LysM receptor-like kinases	NATURE			English	Article							LIPO-OLIGOSACCHARIDE SIGNALS; LEGUME LOTUS-JAPONICUS; ALFALFA ROOT HAIRS; RHIZOBIUM-MELILOTI; NOD FACTORS; HOST-SPECIFICITY; MUTANTS; GENE; EXPRESSION; DOMAIN	Although most higher plants establish a symbiosis with arbuscular mycorrhizal fungi, symbiotic nitrogen fixation with rhizobia is a salient feature of legumes. Despite this host range difference, mycorrhizal and rhizobial invasion shares a common plant-specified genetic programme controlling the early host interaction. One feature distinguishing legumes is their ability to perceive rhizobial-specific signal molecules. We describe here two LysM-type serine/threonine receptor kinase genes, NFR1 and NFR5, enabling the model legume Lotus japonicus to recognize its bacterial microsymbiont Mesorhizobium loti. The extracellular domains of the two transmembrane kinases resemble LysM domains of peptidoglycan- and chitin-binding proteins, suggesting that they may be involved directly in perception of the rhizobial lipochitin-oligosaccharide signal. We show that NFR1 and NFR5 are required for the earliest physiological and cellular responses to this lipochitin-oligosaccharide signal, and demonstrate their role in the mechanism establishing susceptibility of the legume root for bacterial infection.	Univ Aarhus, Dept Mol Biol, Gene Express Lab, DK-8000 Aarhus C, Denmark; Univ Giessen, Inst Bot 1, D-35390 Giessen, Germany; Kazusa DNA Res Inst, Chiba 2920812, Japan	Aarhus University; Justus Liebig University Giessen; Kazusa DNA Research Institute	Stougaard, J (corresponding author), Univ Aarhus, Dept Mol Biol, Gene Express Lab, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.	stougaard@mb.au.dk	poinssot, benoit/B-2569-2009; Nakamura, Yasukazu/T-9038-2019; Sato, Shusei/A-3616-2015	poinssot, benoit/0000-0001-5890-4318; Sato, Shusei/0000-0002-0293-5366; Stougaard, Jens/0000-0002-9312-2685; Nakamura, Yasukazu/0000-0002-6782-5715				Amon P, 1998, PLANT CELL, V10, P781; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Bras CP, 2000, MOL PLANT MICROBE IN, V13, P475, DOI 10.1094/MPMI.2000.13.4.475; BUTLER AR, 1991, EUR J BIOCHEM, V199, P483, DOI 10.1111/j.1432-1033.1991.tb16147.x; Colebatch G, 2002, MOL PLANT MICROBE IN, V15, P411, DOI 10.1094/MPMI.2002.15.5.411; DUC G, 1989, PLANT SCI, V60, P215, DOI 10.1016/0168-9452(89)90169-6; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Felle HH, 2000, PLANT PHYSIOL, V124, P1373, DOI 10.1104/pp.124.3.1373; FELLE HH, 1995, PLANT J, V7, P939, DOI 10.1046/j.1365-313X.1995.07060939.x; Felle HH, 1998, PLANT J, V13, P455, DOI 10.1046/j.1365-313X.1998.00041.x; Gadkar V, 2001, PLANT PHYSIOL, V127, P1493, DOI 10.1104/pp.010783; Gerard CJ, 2000, MOL DIAGN, V5, P39, DOI 10.1016/S1084-8592(00)00009-6; GOVERS F, 1991, MOL GEN GENET, V228, P160, DOI 10.1007/BF00282461; Gressent F, 1999, P NATL ACAD SCI USA, V96, P4704, DOI 10.1073/pnas.96.8.4704; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JORIS B, 1992, FEMS MICROBIOL LETT, V91, P257; Kaneko T, 2003, DNA RES, V10, P27, DOI 10.1093/dnares/10.1.27; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Kosuta S, 2003, PLANT PHYSIOL, V131, P952, DOI 10.1104/pp.011882; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LOPEZLARA IM, 1995, MOL MICROBIOL, V15, P627, DOI 10.1111/j.1365-2958.1995.tb02372.x; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Parniske M, 2000, CURR OPIN PLANT BIOL, V3, P320, DOI 10.1016/S1369-5266(00)00088-1; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Sandal N, 2002, GENETICS, V161, P1673; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; SCHLAMAN HRM, 1991, J BACTERIOL, V173, P4277, DOI 10.1128/JB.173.14.4277-4287.1991; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Stougaard J, 1995, Methods Mol Biol, V49, P49; Stougaard J, 2001, CURR OPIN PLANT BIOL, V4, P328, DOI 10.1016/S1369-5266(00)00181-3; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; Szczyglowski K, 2003, PLANT PHYSIOL, V131, P935, DOI 10.1104/pp.017186; Timmers ACJ, 1998, DEVELOPMENT, V125, P339; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097; Webb KJ, 2000, MOL PLANT MICROBE IN, V13, P606, DOI 10.1094/MPMI.2000.13.6.606; Wegel E, 1998, MOL PLANT MICROBE IN, V11, P933, DOI 10.1094/MPMI.1998.11.9.933	47	782	849	11	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2003	425	6958					585	592		10.1038/nature02039	http://dx.doi.org/10.1038/nature02039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534578				2022-12-01	WOS:000185801000028
J	Aungst, JL; Heyward, PM; Puche, AC; Karnup, SV; Hayar, A; Szabo, G; Shipley, MT				Aungst, JL; Heyward, PM; Puche, AC; Karnup, SV; Hayar, A; Szabo, G; Shipley, MT			Centre-surround inhibition among olfactory bulb glomeruli	NATURE			English	Article							MITRAL CELLS; PRESYNAPTIC INHIBITION; 2-DEOXYGLUCOSE UPTAKE; FUNCTIONAL MRI; RAT; LAYER; REPRESENTATIONS; DISCRIMINATION; LOCALIZATION; ORGANIZATION	Centre - surround inhibition - the suppression of activity of neighbouring cells by a central group of neurons - is a fundamental mechanism that increases contrast in patterned sensory processing. The initial stage of neural processing in olfaction occurs in olfactory bulb glomeruli, but evidence for functional interactions between glomeruli is fragmentary. Here we show that the so- called ' short axon' cells, contrary to their name, send interglomerular axons over long distances to form excitatory synapses with inhibitory periglomerular neurons up to 20 - 30 glomeruli away. Interglomerular excitation of these periglomerular cells potently inhibits mitral cells and forms an on- centre, off- surround circuit. This interglomerular centre - surround inhibitory network, along with the well- established mitral - granule - mitral inhibitory circuit, forms a serial, two- stage inhibitory circuit that could enhance spatiotemporal responses to odours.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Program Neurosci, Baltimore, MD 21201 USA; Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary	University System of Maryland; University of Maryland Baltimore; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Shipley, MT (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Program Neurosci, Room 222,685 W Baltimore St, Baltimore, MD 21201 USA.		Szabo, Gabor/A-5087-2008	Szabo, Gabor/0000-0001-5438-5151				Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; ASTIC L, 1982, BRAIN RES, V245, P17, DOI 10.1016/0006-8993(82)90335-3; BENSON TE, 1985, BRAIN RES, V339, P67, DOI 10.1016/0006-8993(85)90622-5; Cajal S.R.y., 1909, HISTOLOGIE SYSTEME N; Carlson GC, 2000, J NEUROSCI, V20, P2011; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; CORNWALL J, 1988, J NEUROSCI METH, V24, P1, DOI 10.1016/0165-0270(88)90028-3; GOLGI C, 1875, FINA STRUTTURA BULBI; GREER CA, 1981, BRAIN RES, V217, P279, DOI 10.1016/0006-8993(81)90004-4; GROSSBERG S, 1976, BIOL CYBERN, V23, P121, DOI 10.1007/BF00344744; GROSSBERG S, 1970, J THEOR BIOL, V27, P291, DOI 10.1016/0022-5193(70)90143-8; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; HALASZ N, 1993, J COMP NEUROL, V337, P307, DOI 10.1002/cne.903370211; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JASTREBOFF PJ, 1984, P NATL ACAD SCI-BIOL, V81, P5250, DOI 10.1073/pnas.81.16.5250; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; KAWANO T, 1982, J NEUROCHEM, V39, P342, DOI 10.1111/j.1471-4159.1982.tb03953.x; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; MARTINEZ DP, 1984, BRAIN RES, V308, P223, DOI 10.1016/0006-8993(84)91061-8; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MUGNAINI E, 1984, NEUROSCI LETT, V47, P221, DOI 10.1016/0304-3940(84)90517-2; ONODA N, 1992, NEUROSCI LETT, V137, P157, DOI 10.1016/0304-3940(92)90393-L; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1972, J CELL SCI, V10, P637; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rubin BD, 2001, NAT NEUROSCI, V4, P355, DOI 10.1038/85997; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, V3rd Edn, P133; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 1998, J NEUROPHYSIOL, V80, P1011, DOI 10.1152/jn.1998.80.2.1011; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	47	311	315	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					623	629		10.1038/nature02185	http://dx.doi.org/10.1038/nature02185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668854				2022-12-01	WOS:000187132800031
J	Zarrinpar, A; Park, SH; Lim, WA				Zarrinpar, A; Park, SH; Lim, WA			Optimization of specificity in a cellular protein interaction network by negative selection	NATURE			English	Article							SH3 DOMAIN; PEPTIDE RECOGNITION; CAENORHABDITIS-ELEGANS; PEX13P; SRC; LOCALIZATION; PREDICTION; STABILITY; PATHWAYS; MODULES	Most proteins that participate in cellular signalling networks contain modular protein- interaction domains. Multiple versions of such domains are present within a given organism(1): the yeast proteome, for example, contains 27 different Src homology 3 ( SH3) domains(2). This raises the potential problem of crossreaction. It is generally thought that isolated domain - ligand pairs lack sufficient information to encode biologically unique interactions, and that specificity is instead encoded by the context in which the interaction pairs are presented(3,4). Here we show that an isolated peptide ligand from the yeast protein Pbs2 recognizes its biological partner, the SH3 domain from Sho1, with near- absolute specificity - no other SH3 domain present in the yeast genome cross- reacts with the Pbs2 peptide, in vivo or in vitro. Such high specificity, however, is not observed in a set of non- yeast SH3 domains, and Pbs2 motif variants that cross- react with other SH3 domains confer a fitness defect, indicating that the Pbs2 motif might have been optimized to minimize interaction with competing domains specifically found in yeast. System- wide negative selection is a subtle but powerful evolutionary mechanism to optimize specificity within an interaction network composed of overlapping recognition elements.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu						Barnett P, 2000, EMBO J, V19, P6382, DOI 10.1093/emboj/19.23.6382; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kwok Pui-Yan, 2003, Methods Mol Biol, V212, P71; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; LIM WA, 1994, PROTEIN SCI, V3, P1261, DOI 10.1002/pro.5560030812; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mayer BJ, 2001, J CELL SCI, V114, P1253; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZARRINPAR A, SCIENCE, DOI DOI 10.1126/STKE.2003.179.RE8	29	199	206	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					676	680		10.1038/nature02178	http://dx.doi.org/10.1038/nature02178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668868				2022-12-01	WOS:000187132800045
J	Thomas, RK; Diehl, V				Thomas, RK; Diehl, V			Unhappy neighbourhood: spatial genome organisation and lymphomagenesis in B cells	LANCET			English	Editorial Material							SOMATIC HYPERMUTATION; GENE; LOCI; MUTATION		Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50924 Cologne, Germany	University of Cologne; University of Cologne	Thomas, RK (corresponding author), Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany.							JAEGER U, 1993, BLOOD, V81, P1833; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848	10	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1868	1870		10.1016/S0140-6736(03)14998-7	http://dx.doi.org/10.1016/S0140-6736(03)14998-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667739				2022-12-01	WOS:000187011600004
J	de Joussineau, C; Soule, J; Martin, M; Anguille, C; Montcourrier, P; Alexandre, D				de Joussineau, C; Soule, J; Martin, M; Anguille, C; Montcourrier, P; Alexandre, D			Delta-promoted filopodia mediate long-range lateral inhibition in Drosophila	NATURE			English	Article							CELL EXTENSION ACTIVITY; NOTCH; EXPRESSION; PROTEIN; EZRIN; MORPHOGENESIS; GENES; DETERMINANTS; EMERGENCE; ENHANCER	Drosophila thoracic mechanosensory bristles originate from cells that are singled out from 'proneural' groups of competent epithelial cells. Neural competence is restricted to individual sensory organ precursors (SOPs) by Delta/Notch-mediated 'lateral inhibition', whereas other cells in the proneural field adopt an epidermal fate. The precursors of the large macrochaetes differentiate separately from individual proneural clusters that comprise about 20 - 30 cells or as heterochronic pairs from groups of more than 100 cells(1), whereas the precursors of the small regularly spaced microchaetes emerge from even larger proneural fields(2). This indicates that lateral inhibition might act over several cell diameters; it was difficult to reconcile with the fact that the inhibitory ligand Delta is membrane-bound until the observation that SOPs frequently extend thin processes(3,4) offered an attractive hypothesis. Here we show that the extension of these planar filopodia - a common attribute of wing imaginal disc cells - is promoted by Delta and that their experimental suppression reduces Notch signalling in distant cells and increases bristle density in large proneural groups, showing that these membrane specializations mediate long- range lateral inhibition.	Univ Montpellier 2, UMR 5539, Lab Dynam Mol Interact Membranaires, F-34095 Montpellier 5, France	Universite de Montpellier	Alexandre, D (corresponding author), Univ Montpellier 2, UMR 5539, Lab Dynam Mol Interact Membranaires, CC 107,Pl Eugene Bataillon, F-34095 Montpellier 5, France.			MARTIN, Marianne/0000-0001-8932-3129				ANDREOLI C, 1994, J CELL SCI, V107, P2509; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; BENDER LB, 1993, GENETICS, V133, P967; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; HAENLIN M, 1994, MECH DEVELOP, V47, P99, DOI 10.1016/0925-4773(94)90099-X; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; HUANG F, 1991, DEVELOPMENT, V111, P1087; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; KOOH PJ, 1993, DEVELOPMENT, V117, P493; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LOCKE M, 1981, NATURE, V293, P733, DOI 10.1038/293733a0; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Renaud O, 2001, DEV BIOL, V240, P361, DOI 10.1006/dbio.2001.0482; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Seugnet L, 1997, DEVELOPMENT, V124, P2015; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Wigglesworth VB, 1940, J EXP BIOL, V17, P180; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	30	142	143	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					555	559		10.1038/nature02157	http://dx.doi.org/10.1038/nature02157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654840				2022-12-01	WOS:000186944300038
J	Col, NF; Pauker, SG				Col, NF; Pauker, SG			The discrepancy between observational studies and randomized trials of menopausal hormone therapy: Did expectations shape experience?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNRECOGNIZED MYOCARDIAL-INFARCTION; ESTROGEN REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; PLUS PROGESTIN; PRIMARY PREVENTION; SEX-DIFFERENCES; CASE-FATALITY; PREVALENCE	Differences between observational and randomized studies of the effects of menopausal hormone therapy (HT) on coronary heart disease (CHD) have been attributed to the fact that women who choose to use HT tend to be healthier than those who do not. Although this bias should affect all clinical outcomes with modifiable risk factors, estimates for stroke and pulmonary embolism were unaffected. The authors sought possible explanations for this isolated discrepancy in CHD findings. Unlike the randomized Women's Health Initiative (WHI) trial, the observational Nurses' Health Study (NHS) did not try to detect silent myocardial infarctions. Many women present with atypical ischemic symptoms. Hormone therapy users who believe that HT reduces CHD risks might not interpret ischemic symptoms as related to CHD, might not seek medical attention, and might present differently to their physicians, all of which could lead to more unrecognized myocardial infarctions among HT users in the NHS. In addition, persons completing death certificates and NHS physicians interpreting death certificates were not blinded to the use of HT. If persons assigning cause of death knew the patient had used HT and believed that HT prevented CHD, they might have been more likely to assign a condition other than CHD as the cause of death. If HT users were 20% less likely to have their infarctions recognized and their deaths attributed to CHID, a true increase in CHD due to HT use would appear to be a reduction in CHD. Combining these reporting biases with socioeconomic differences between users and nonusers could explain discrepancies. Beliefs held by patients, clinicians, and investigators might have affected the ascertainment of CHD outcomes in observational studies.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Womens Hlth, Boston, MA 02120 USA; Tufts Univ New England Med Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts Medical Center	Col, NF (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Womens Hlth, 1620 Tremont St, Boston, MA 02120 USA.	ncol@partners.org	Col, Nananda/AAE-3445-2019	Col, Nananda/0000-0001-7106-662X	AHRQ HHS [R01 HS01332901] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BUTLER C, 1986, BRIT J CLIN PSYCHOL, V25, P173, DOI 10.1111/j.2044-8260.1986.tb00693.x; CAMPBELL S, 1977, CLIN OBSTET GYNAECOL, V4, P31; Campisi R, 2002, CIRCULATION, V105, P425, DOI 10.1161/hc0402.102860; CAULEY JA, 1990, AM J OBSTET GYNECOL, V163, P1438, DOI 10.1016/0002-9378(90)90602-4; Flaten MA, 1999, PSYCHOSOM MED, V61, P250, DOI 10.1097/00006842-199903000-00018; Girdler SS, 1999, J WOMEN HEALTH GEN-B, V8, P637, DOI 10.1089/jwh.1.1999.8.637; Goldberg RJ, 1998, AM HEART J, V136, P189, DOI 10.1053/hj.1998.v136.88874; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRIMM RH, 1987, CIRCULATION, V75, P6; Grodstein F, 1996, AM J EPIDEMIOL, V143, P979; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Jonsdottir LS, 1998, EUR HEART J, V19, P1011, DOI 10.1053/euhj.1998.0980; KANNEL WB, 1979, AM J CARDIOL, V44, P53, DOI 10.1016/0002-9149(79)90250-9; KANNEL WB, 1990, ADV CARDIOL, V37, P202; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kessler KM, 2001, ANN INTERN MED, V135, P1092, DOI 10.7326/0003-4819-135-12-200112180-00023; LINDBERG HA, 1960, ARCH INTERN MED, V106, P628, DOI 10.1001/archinte.1960.03820050040008; LUPARELLO TJ, 1970, PSYCHOSOM MED, V32, P509, DOI 10.1097/00006842-197009000-00009; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; NADELMANN J, 1990, AM J CARDIOL, V66, P533, DOI 10.1016/0002-9149(90)90477-I; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V266, P559; Peterson ED, 1998, AM HEART J, V136, P186, DOI 10.1053/hj.1998.v136.89736; Petitti DB, 1998, JAMA-J AM MED ASSOC, V280, P650, DOI 10.1001/jama.280.7.650; POSTHUMA WFM, 1994, BRIT MED J, V308, P1268; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Qizilbash N, 1995, LANCET, V346, P1647; ROSENBERG L, 1993, AM J EPIDEMIOL, V137, P54, DOI 10.1093/oxfordjournals.aje.a116602; ROSENMAN RH, 1967, AM J CARDIOL, V19, P776, DOI 10.1016/0002-9149(67)90498-5; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sacco RL, 1999, NEUROLOGY, V53, pS15; SARTWELL PE, 1969, AM J EPIDEMIOL, V90, P365, DOI 10.1093/oxfordjournals.aje.a121082; SCHLESSELMAN JJ, 1992, J CLIN EPIDEMIOL, V45, P449, DOI 10.1016/0895-4356(92)90094-4; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sheifer SE, 2001, ANN INTERN MED, V135, P801, DOI 10.7326/0003-4819-135-9-200111060-00010; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; Simon J A, 2001, Climacteric, V4, P19, DOI 10.1080/713605032; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; STERNBACH RA, 1964, PSYCHOPHYSIOLOGY, V1, P67; STURGEON SR, 1995, EPIDEMIOLOGY, V6, P227, DOI 10.1097/00001648-199505000-00006; Tunstall-Pedoe H, 1998, HEART, V80, P112, DOI 10.1136/hrt.80.2.112; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; TUNSTALLPEDOE H, 1978, BRIT HEART J, V40, P510; Wagner KR, 1996, J RHEUMATOL, V23, P2079; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WENGER NK, 1990, ANN INTERN MED, V112, P557, DOI 10.7326/0003-4819-112-8-557; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; YANO K, 1989, ARCH INTERN MED, V149, P1528, DOI 10.1001/archinte.149.7.1528; 1973, JAMA, V226, P652; 1973, CIRCULATION S, V47, pI1; 1980, N ENGL J MED, V303, P1083	64	36	36	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2003	139	11					923	929		10.7326/0003-4819-139-11-200312020-00011	http://dx.doi.org/10.7326/0003-4819-139-11-200312020-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WW	14644895				2022-12-01	WOS:000186884800006
J	El-Serag, H; Davila, JA; Petersen, NJ; McGlynn, KA				El-Serag, H; Davila, JA; Petersen, NJ; McGlynn, KA			The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATITIS-C-VIRUS; PRIMARY LIVER-CANCER; DIABETES-MELLITUS; RISING INCIDENCE; RISK-FACTORS; PREVALENCE; INFECTION; JAPAN	Background: The incidence of hepatocellular carcinoma was reported to be increasing in the United States. However, alternate explanations were diagnostic or reclassification bias and changes in the demographic features of the general population. Objective: To examine the temporal trends in the incidence of hepatocellular carcinoma. Design: Retrospective cohort study. Setting: Information collected by population-based registries of the Surveillance, Epidemiology, and End Results (SEER) program. Patients: Persons given a diagnosis of hepatocellular carcinoma between 1975 and 1998. Measurements: Linear Poisson multivariate regression model, controlling for differences in age, sex, race or ethnicity, and geographic region among patients with hepatocellular carcinoma and in the underlying population. Results: The overall age-adjusted incidence rates of hepatocellular carcinoma increased from 1.4 per 100 000 in 1975 to 1977 to 3.0 per 100 000 in 1996 to 1998. There was a 25% increase during the last 3 years of the study compared with the preceding 3 years (1993 to 1995). The increase affected most age groups above 40 years, with the greatest increase in the 45- to 49-year-old age group. White men had the greatest increase (31%) in the last time period (1996 to 1998) compared with 1993 to 1995. The Poisson regression model confirmed an almost 2-fold increase in the incidence rate ratio for hepatocellular carcinoma between 1975 to 1978 and 1996 to 1998. Conclusions: The incidence of hepatocellular carcinoma continues to increase rapidly in the United States, with rates increasing the fastest in white men 45 to 54 years of age. These findings are consistent with a true increase and could be explained by consequences of hepatitis C virus acquired during the 1960s and 1970s.	Houston Vet Affairs Med Ctr, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	El-Serag, H (corresponding author), Houston Vet Affairs Med Ctr, 2002 Holcombe Blvd 152, Houston, TX 77030 USA.	hasheme@bcm.tmc.edu			NATIONAL CANCER INSTITUTE [Z01CP010158, ZIACP010158] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adami HO, 1996, J NATL CANCER I, V88, P1472, DOI 10.1093/jnci/88.20.1472; Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; COLOMBO M, 1989, LANCET, V2, P1006; Davila JA, 2003, J CLIN EPIDEMIOL, V56, P487, DOI 10.1016/S0895-4356(02)00605-4; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Kaczynski J, 1999, NEW ENGL J MED, V341, P451; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; MCQUILLAN GM, 1989, AM J MED, V87, pS5; *NAT CANC I, 2001, SURV EP END RES SEER; OKUDA K, 1987, CANCER RES, V47, P4967; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Warren JL, 2002, MED CARE S, V40; World Health Organization, 1976, INT CLASS DIS ONC	19	764	790	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2003	139	10					817	823		10.7326/0003-4819-139-10-200311180-00009	http://dx.doi.org/10.7326/0003-4819-139-10-200311180-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744ZV	14623619				2022-12-01	WOS:000186663500005
J	Gupta, R; Sheikh, A; Strachan, D; Anderson, HR				Gupta, R; Sheikh, A; Strachan, D; Anderson, HR			Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions' data	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England	St Georges University London	Gupta, R (corresponding author), St George Hosp, Sch Med, Dept Community Hlth Sci, Cranmer Terrace, London SW17 0RE, England.		Anderson, Hugh R/A-7417-2016; Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				*DEP HLTH, PRESCR COST AN; *DEP HLTH, 1991, HOSP EP STAT, V1; Sheikh A, 2000, BRIT MED J, V320, P1441, DOI 10.1136/bmj.320.7247.1441; *UCB I ALL, 1997, EUR ALL WHIT PAP ALL; *WHO, 1977, INT CLASS DIS MAN IN	5	99	100	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 15	2003	327	7424					1142	1143		10.1136/bmj.327.7424.1142	http://dx.doi.org/10.1136/bmj.327.7424.1142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744HL	14615340	Green Published, Bronze			2022-12-01	WOS:000186622100021
J	Robinson, BWS; Creaney, J; Lake, R; Nowak, A; Musk, AW; de Klerk, N; Winzell, P; Hellstrom, KE; Hellstrom, I				Robinson, BWS; Creaney, J; Lake, R; Nowak, A; Musk, AW; de Klerk, N; Winzell, P; Hellstrom, KE; Hellstrom, I			Mesothelin-family proteins and diagnosis of mesothelioma	LANCET			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; MOLECULAR-CLONING; OVARIAN-CARCINOMA; GENE-THERAPY; CELL-LINE; CANCER; EXPRESSION; ANTIBODY; SERUM; CDNA	Background Mesothelioma is a highly aggressive tumour for which there are no reliable serum tumour. markers. Identification of such a marker would be useful in diagnosis of mesothelioma and for monitoring responses to treatment and screening at-risk individuals. Methods We assayed serum concentrations of soluble mesothelin-related proteins (SMR) using a double determinant (sandwich) ELISA in a blinded study of serum samples from 44 patients with histologically proven mesothelioma; 68 matched healthy controls, 40 of whom had been exposed to asbestos; and 160 patients with other inflammatory or malignant lung and pleural diseases. Findings 37 (84%) of 44 patients with mesothelioma had raised concentrations of SMR at a serum dilution of 1/80, compared with three (2%) of 160 patients with other cancers or other inflammatory lung or pleural diseases, and with none of 28 controls who had not been exposed to asbestos. SMR concentrations correlated with tumour size and increased during tumour progression. Seven of the 40 asbestos-exposed individuals had increased serum concentrations of SMR; three of those seven developed mesothelioma and one developed lung carcinoma within 1-5 years. None of the 33 asbestos-exposed participants whose serum samples had normal concentrations of SMR and who were followed up over 8 years developed mesothelioma. Interpretation Determination of SMR in serum could be a useful marker for diagnosis of mesothelioma and to monitor disease progression. It might also prove helpful for screening asbestos-exposed individuals for early evidence of mesothelioma.	Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Med, Perth, WA 6009, Australia; Western Australian Inst Med Res, Perth, WA, Australia; Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia; Telethon Inst Child Hlth Res, Subiaco, WA, Australia; UWA Ctr Child Hlth Res, Subiaco, WA, Australia; Pacific NW Res Inst, Seattle, WA USA	University of Western Australia; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia	Robinson, BWS (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Med, 4th Floor,G Block, Perth, WA 6009, Australia.	bwsrobin@cyllene.uwa.edu.au	Robinson, Bruce/N-1900-2014; de Klerk, Nicholas H/D-8388-2016; Nowak, Anna K/B-2487-2013	de Klerk, Nicholas H/0000-0001-9223-0767; Nowak, Anna K/0000-0002-9317-9526	NATIONAL CANCER INSTITUTE [R01CA079490, K22CA098008, R01CA085780] Funding Source: NIH RePORTER; NCI NIH HHS [CA 85780, CA 79490, CA 98008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTMAN K, 1988, J CLIN ONCOL, V6, P147, DOI 10.1200/JCO.1988.6.1.147; Argani P, 2001, CLIN CANCER RES, V7, P3862; BATES SE, 1991, ANN INTERN MED, V115, P623, DOI 10.7326/0003-4819-115-8-623; Boutin C, 1998, EUR RESPIR J, V12, P972, DOI 10.1183/09031936.98.12040972; Byrne MJ, 1999, J CLIN ONCOL, V17, P25, DOI 10.1200/JCO.1999.17.1.25; Caminschi I, 1999, AM J RESP CELL MOL, V21, P347, DOI 10.1165/ajrcmb.21.3.3575; Carretta A, 2000, EUR J CARDIO-THORAC, V17, P377, DOI 10.1016/S1010-7940(00)00377-8; CHANG K, 1992, CANCER RES, V52, P181; CHANG K, 1994, INT J CANCER, V57, P90, DOI 10.1002/ijc.2910570117; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; CONAGHAN P, 1996, IMMUNOPATHOLOGY LUNG, P147; Henderson DW, 1998, AM J CLIN PATHOL, V110, P397, DOI 10.1093/ajcp/110.3.397; HILLERDAL G, 1991, CANCER, V67, P2410, DOI 10.1002/1097-0142(19910501)67:9<2410::AID-CNCR2820670933>3.0.CO;2-D; Ho L, 2001, Cancer Treat Res, V105, P327; Johnson P J, 2001, Clin Liver Dis, V5, P145, DOI 10.1016/S1089-3261(05)70158-6; Kagan E., 1996, IMMUNOPATHOLOGY LUNG, P421; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; McIntosh MW, 2002, CANCER EPIDEM BIOMAR, V11, P159; McLaren BR, 2000, CANCER CHEMOTH PHARM, V45, P502, DOI 10.1007/s002800051026; Musk AW, 1998, INT J CANCER, V75, P355, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;355::AID-IJC5&gt;3.0.CO;2-1; Nowak AK, 2002, SEMIN ONCOL, V29, P82, DOI 10.1053/sonc.2002.30234; Olt G, 1990, Obstet Gynecol Surv, V45, P570, DOI 10.1097/00006254-199009000-00002; Poteat HT, 2000, AM J CLIN PATHOL, V113, P421, DOI 10.1309/E11X-491Y-GUJH-EGGF; Robinson B., 1996, IMMUNOPATHOLOGY LUNG, P165; ROBINSON BWS, 1993, LUNG CANCER, V9, P413; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; Rusch VW, 1999, ANN THORAC SURG, V68, P1799, DOI 10.1016/S0003-4975(99)01038-3; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Scott B., 2000, TXB LUNG CANC, P273; Spurzem J., 1996, IMMUNOPATHOLOGY LUNG, P119; Urwin Debra, 2000, Molecular Cell Biology Research Communications, V3, P26, DOI 10.1006/mcbr.2000.0181; Vauthey JN, 1996, DIGEST DIS, V14, P5, DOI 10.1159/000171535; YAMAGUCHI N, 1994, J BIOL CHEM, V269, P805; Zellos LS, 2002, SEMIN ONCOL, V29, P41, DOI 10.1053/sonc.2002.30230	35	427	444	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2003	362	9396					1612	1616		10.1016/S0140-6736(03)14794-0	http://dx.doi.org/10.1016/S0140-6736(03)14794-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744MZ	14630441				2022-12-01	WOS:000186637400009
J	Schumacher, MA; Lau, AOT; Johnson, PJ				Schumacher, MA; Lau, AOT; Johnson, PJ			Structural basis of core promoter recognition in a primitive eukaryote	CELL			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; PROTEIN-CODING GENES; LARGEST-SUBUNIT; DNA-BINDING; CRYSTAL-STRUCTURE; ETS-DOMAIN; INITIATOR ELEMENT; CAPPING ENZYME; TRANSCRIPTION	Transcription start site selection in eukaryotes is mediated through combinations of the TATA, initiator (lnr), and downstream promoter elements (DPE). In Trichomonas vaginalis, a parabasalian flagellate thought to represent an ancient eukaryote lineage, the lnr appears to be solely responsible for start site selection and is recognized by the initiator binding protein 39 kDa (IBP39). IBP39 contains an N-terminal lnr binding domain (IBD) connected via a flexible linker to a C-terminal domain (C domain). Here we present crystal structures of the apoIBD and IBD-lnr complexes and the C domain. The 11313 structures reveal a winged-helix motif with prokaryotic and eukaryotic features and a scaffold similar to that of ETS-family proteins. The C domain structure and biochemical studies indicate that it interacts with the T. vaginalis RNAP 11 large subunit C-terminal domain. These data suggest that binding of IBP39 to the lnr directly recruits RNAP 11 and in this way initiates transcription.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Sch Med, Los Angeles, CA 90095 USA	Oregon Health & Science University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schumacher, MA (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.			Lau, Audrey/0000-0001-8212-0142	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI050359, R01AI030537] Funding Source: NIH RePORTER; NIAID NIH HHS [F32AI50359, AI30537] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARKHIPOVA IR, 1995, GENETICS, V139, P1359; BARRONCASELLA E, 1992, J MOL EVOL, V35, P405, DOI 10.1007/BF00171818; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHAPMAN AB, 1994, J BIOL CHEM, V269, P4754; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; EVERS R, 1989, NUCLEIC ACIDS RES, V17, P3403, DOI 10.1093/nar/17.9.3403; EVERS R, 1989, CELL, V56, P585, DOI 10.1016/0092-8674(89)90581-3; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Keeling PJ, 2000, NATURE, V405, P635, DOI 10.1038/35015167; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KOWESTRA D, 1991, NATURE, V349, P178; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Liston DR, 2001, MOL CELL BIOL, V21, P7872, DOI 10.1128/MCB.21.22.7872-7882.2001; Litingtung Y, 1999, MOL GEN GENET, V261, P100, DOI 10.1007/s004380050946; Lo K, 1996, GENE, V182, P13, DOI 10.1016/S0378-1119(96)00438-6; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Myers JK, 2001, BIOCHEMISTRY-US, V40, P8479, DOI 10.1021/bi0027884; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; QUON DVK, 1994, P NATL ACAD SCI USA, V91, P4579, DOI 10.1073/pnas.91.10.4579; Quon DVK, 1996, J MOL EVOL, V43, P253, DOI 10.1007/PL00006084; RAVISHANKER G, 1989, J BIOMOL STRUCT DYN, V6, P669, DOI 10.1080/07391102.1989.10507729; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/S0968-0004(96)10050-5; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 1998, COLD SPRING HARB SYM, V63, P21, DOI 10.1101/sqb.1998.63.21; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; WEMER MH, 1997, J BIOMOL NMR, V10, P317; WEST ML, 1995, GENETICS, V140, P1223; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514	56	50	51	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					413	424		10.1016/S0092-8674(03)00887-0	http://dx.doi.org/10.1016/S0092-8674(03)00887-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622596	Bronze			2022-12-01	WOS:000186627100008
J	Huangfu, DW; Liu, AM; Rakeman, AS; Murcia, NS; Niswander, L; Anderson, KV				Huangfu, DW; Liu, AM; Rakeman, AS; Murcia, NS; Niswander, L; Anderson, KV			Hedgehog signalling in the mouse requires intraflagellar transport proteins	NATURE			English	Article							KINESIN-II; GENE; DISEASE; GLI3; MORPHOGENESIS; EXPRESSION; DELETION; PATHWAY; LACKING; MUTANTS	Intraflagellar transport (IFT) proteins were first identified as essential factors for the growth and maintenance of flagella in the single-celled alga Chlamydomonas reinhardtii(1). In a screen for embryonic patterning mutations induced by ethylnitrosourea, here we identify two mouse mutants, wimple (wim) and flexo (fxo), that lack ventral neural cell types and show other phenotypes characteristic of defects in Sonic hedgehog signalling. Both mutations disrupt IFT proteins: the wim mutation is an allele of the previously uncharacterized mouse homologue of IFT172; and fxo is a new hypomorphic allele of polaris, the mouse homologue of IFT88. Genetic analysis shows that Wim, Polaris and the IFT motor protein Kif3a are required for Hedgehog signalling at a step downstream of Patched1 ( the Hedgehog receptor) and upstream of direct targets of Hedgehog signalling. Our data show that IFT machinery has an essential and vertebrate-specific role in Hedgehog signal transduction.	Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Mol Cell & Dev Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Neurosci Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Howard Hughes Med Inst, New York, NY 10021 USA; Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	k-anderson@ski.mskcc.org	Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594; Anderson, Kathryn/0000-0003-1657-2161; Huangfu, Danwei/0000-0002-1145-6199				Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; HAN Y, 1932, CURR BIOL, V13, P1679; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Motoyama J, 2003, DEV BIOL, V259, P150, DOI 10.1016/S0012-1606(03)00159-3; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schimenti JC, 2000, GENOME RES, V10, P1043, DOI 10.1101/gr.10.7.1043; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Sloboda RD, 2002, CELL MOTIL CYTOSKEL, V52, P1, DOI 10.1002/cm.10035; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Vetter DE, 2002, NAT GENET, V31, P363, DOI 10.1038/ng914; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Ying LT, 2000, DEV DYNAM, V219, P143, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1050>3.3.CO;2-H; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	30	997	1021	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					83	87		10.1038/nature02061	http://dx.doi.org/10.1038/nature02061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603322				2022-12-01	WOS:000186370800046
J	Kodama, A; Karakesisoglou, L; Wong, E; Vaezi, A; Fuchs, E				Kodama, A; Karakesisoglou, L; Wong, E; Vaezi, A; Fuchs, E			ACF7: An essential integrator of microtubule dynamics	CELL			English	Article							ADENOMATOUS POLYPOSIS-COLI; CELL POLARITY; MITOTIC SPINDLE; FISSION YEAST; MIGRATING CELLS; RHO-GTPASES; PLUS-END; F-ACTIN; CYTOSKELETON; PROTEINS	ACF7 is a member of the spectraplakin family of cytoskeletal crosslinking proteins possessing actin and microtubule binding domains. Here, we show that ACF7 is an essential integrator of MT-actin dynamics. In endodermal cells, ACF7 binds along microtubules but concentrates at their distal ends and at cell borders when polarized. In ACF7's absence, microtubules still bind EB1 and CLIP170, but they no longer grow along polarized actin bundles, nor do they pause and tether to actin-rich cortical sites. The consequences are less stable, long microtubules with skewed cytoplasmic trajectories and altered dynamic instability. In response to wounding, ACF7 null cultures activate polarizing signals, but fail to maintain them and coordinate migration. Rescue of these defects requires ACF7's actin and microtubule binding domains. Thus, spectraplakins are important for controlling microtubule dynamics and reinforcing links between microtubules and polarized F-actin, so that cellular polarization and coordinated cell movements can be sustained.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.		Fuchs, Elaine/G-1565-2016	Karakesisoglou, Iakowos (Akis)/0000-0002-8549-0728	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR027883-28] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abe K, 1996, EXP CELL RES, V229, P27, DOI 10.1006/excr.1996.0340; Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Andra K, 1998, GENE DEV, V12, P3442, DOI 10.1101/gad.12.21.3442; Barth AIM, 2002, J CELL SCI, V115, P1583; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; GOTLIEB AI, 1981, J CELL BIOL, V91, P589, DOI 10.1083/jcb.91.2.589; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 2002, J CELL SCI, V115, P2283; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kofron M, 2002, J CELL BIOL, V158, P695, DOI 10.1083/jcb.200202123; Komarova YA, 2002, J CELL SCI, V115, P3527; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lee S, 2002, DEVELOPMENT, V129, P1195; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; LIU JJ, 2003, IN PRESS J CELL BIOL; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Murray P, 2001, DIFFERENTIATION, V68, P227, DOI 10.1046/j.1432-0436.2001.680410.x; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Sun DM, 2001, J CELL SCI, V114, P161; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; TIMAUER JS, 2002, MOL BIOL CELL, V13, P3614; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.E02-04-0236; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wittmann T, 2001, J CELL SCI, V114, P3795; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	62	254	263	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 31	2003	115	3					343	354		10.1016/S0092-8674(03)00813-4	http://dx.doi.org/10.1016/S0092-8674(03)00813-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636561	Bronze			2022-12-01	WOS:000186415000013
J	Wang, L				Wang, L			Expanding the genetic code	SCIENCE			English	Editorial Material							UNNATURAL AMINO-ACID; ESCHERICHIA-COLI; TRANSFER-RNA; GENERATION; PROTEINS		Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, L (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.		Wang, Lei/E-7912-2011	Wang, Lei/0000-0002-5859-2526				BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Liu HT, 2003, J AM CHEM SOC, V125, P1702, DOI 10.1021/ja029433n; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang L, 2003, J ORG CHEM, V68, P174, DOI 10.1021/jo026570u; Wang L, 2002, J AM CHEM SOC, V124, P1836, DOI 10.1021/ja012307j; Wang L, 2002, THESIS U CALIFORNIA	15	7	8	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					584	585		10.1126/science.302.5645.584	http://dx.doi.org/10.1126/science.302.5645.584			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576413				2022-12-01	WOS:000186119900037
J	Foerster, K; Delhey, K; Johnsen, A; Lifjeld, JT; Kempenaers, B				Foerster, K; Delhey, K; Johnsen, A; Lifjeld, JT; Kempenaers, B			Females increase offspring heterozygosity and fitness through extra-pair matings	NATURE			English	Article							TIT PARUS-CAERULEUS; BLUE TIT; MATE CHOICE; GENETIC SIMILARITY; PATERNITY; MICROSATELLITES; POPULATIONS; POLYANDRY; PARENTAGE; BENEFITS	Females in a variety of species commonly mate with multiple males, and there is evidence that they benefit by producing offspring of higher genetic quality(1-3); however, the nature of these genetic benefits is debated(1-4). Enhanced offspring survival or quality can result from intrinsic effects of paternal genes- 'good genes'-or from interactions between the maternal and paternal genomes-'compatible genes'(1-5). Evidence for the latter process is accumulating(2,6): matings between relatives lead to decreased reproductive success, and the individual level of inbreeding-measured as average heterozygosity-is a strong fitness predictor(7-13). Females should thus benefit from mating with genetically dissimilar males(2,14). In many birds, social monogamy restricts mate choice, but females may circumvent this by pursuing extra-pair copulations(15,16). Here we show that female blue tits, Parus caeruleus, increase the heterozygosity of their progeny through extra-pair matings. Females thereby produce offspring of higher reproductive value, because less inbred individuals have increased survival chances, a more elaborate male secondary sexual trait (crown colour) and higher reproductive success. The cost of inbreeding may therefore be an important factor driving the evolution of female extra-pair mating.	Max Planck Res Ctr Ornithol, D-82305 Starnberg, Germany; Univ Oslo, Zool Museum, N-0318 Oslo, Norway	Max Planck Society; University of Oslo	Kempenaers, B (corresponding author), Max Planck Res Ctr Ornithol, POB 1564, D-82305 Starnberg, Germany.		Lifjeld, Jan T/B-1978-2008; Delhey, Kaspar/AAZ-5362-2020; Delhey, Kaspar/F-6515-2010; Foerster, Katharina/AAX-3894-2020	Lifjeld, Jan T/0000-0002-9172-9985; Delhey, Kaspar/0000-0001-5190-5406; Johnsen, Arild/0000-0003-4864-6284; Kempenaers, Bart/0000-0002-7505-5458				Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; Aparicio JM, 2001, ANIM BEHAV, V62, P1001, DOI 10.1006/anbe.2001.1840; Bensch S, 1997, MOL ECOL, V6, P91, DOI 10.1046/j.1365-294X.1997.00150.x; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Dawson DA, 2000, MOL ECOL, V9, P1941, DOI 10.1046/j.1365-294x.2000.01094-14.x; Fridolfsson AK, 1997, HEREDITAS, V126, P127, DOI 10.1111/j.1601-5223.1997.00127.x; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hoglund J, 2002, P ROY SOC B-BIOL SCI, V269, P711, DOI 10.1098/rspb.2001.1937; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; JAMIESON A, 1994, ANIM GENET, V25, P37, DOI 10.1111/j.1365-2052.1994.tb00401.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kempenaers B, 1996, P ROY SOC B-BIOL SCI, V263, P179, DOI 10.1098/rspb.1996.0029; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Pemberton J.M., 1999, MICROSATELLITES EVOL, P151; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; TURELLI M, 1983, GENETICS, V104, P191; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	30	396	402	6	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					714	717		10.1038/nature01969	http://dx.doi.org/10.1038/nature01969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562103				2022-12-01	WOS:000185924500041
J	Grynszpan, D				Grynszpan, D			Lessons from the French heatwave	LANCET			English	Editorial Material							MORTALITY; WAVE		The Lancet, London NW1 7BY, England		Grynszpan, D (corresponding author), The Lancet, London NW1 7BY, England.							*COMM AFF CULT FAM, 2003, COMPT REND, V58; Hemon D., 2003, SURMORTALITE LIEE CA; *I VEILL SAN, 2003, IMP SAN VAG CHAL FRA; Klinenberg Eric, 2002, HEAT WAVE SOCIAL AUT; Lalande F., 2003, MISSION EXPERTISE EV; Naughton MP, 2002, AM J PREV MED, V22, P221, DOI 10.1016/S0749-3797(02)00421-X; Weisskopf MG, 2002, AM J PUBLIC HEALTH, V92, P830, DOI 10.2105/AJPH.92.5.830	7	33	33	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 11	2003	362	9391					1169	1170		10.1016/S0140-6736(03)14555-2	http://dx.doi.org/10.1016/S0140-6736(03)14555-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CW	14568735				2022-12-01	WOS:000185924100005
J	Kennedy, JG				Kennedy, JG			"Doc, tell me what I need to know" - a doctor's perspective	BRITISH MEDICAL JOURNAL			English	Article									Cedar Brook Practice, Middlesex UB4 8DD, England		Kennedy, JG (corresponding author), Cedar Brook Practice, 11 Kingshill Close, Middlesex UB4 8DD, England.							*DEP HLTH, 2001, EXP PAT NEW APPR CHR, P12; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; National Audit Office, 1993, REP PRESCR GEN MED P; Say RE, 2003, BMJ-BRIT MED J, V327, P542, DOI 10.1136/bmj.327.7414.542	5	8	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2003	327	7419					862	863		10.1136/bmj.327.7419.862	http://dx.doi.org/10.1136/bmj.327.7419.862			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732BP	14551108	Green Published			2022-12-01	WOS:000185921200030
J	Ye, KQ; Malinina, L; Patel, DJ				Ye, KQ; Malinina, L; Patel, DJ			Recognition of small interfering RNA by a viral suppressor of RNA silencing	NATURE			English	Article							DOUBLE-STRANDED-RNA; GENE; SYSTEM; PCR	RNA silencing (also known as RNA interference) is a conserved biological response to double-stranded RNA that regulates gene expression, and has evolved in plants as a defence against viruses(1-3). The response is mediated by small interfering RNAs (siRNAs), which guide the sequence-specific degradation of cognate messenger RNAs. As a counter-defence, many viruses encode proteins that specifically inhibit the silencing machinery(3,4). The p19 protein from the tombusvirus is such a viral suppressor of RNA silencing(5) and has been shown to bind specifically to siRNA(6). Here, we report the 1.85-Angstrom crystal structure of p19 bound to a 21-nucleotide siRNA, where the 19-basepair RNA duplex is cradled within the concave face of a continuous eight-stranded beta-sheet, formed across the p19 homodimer interface. Direct and water-mediated intermolecular contacts are restricted to the backbone phosphates and sugar 20-OH groups, consistent with sequence-independent p19-siRNA recognition. Two alpha-helical 'reading heads' project from opposite ends of the p19 homodimer and position pairs of tryptophans for stacking over the terminal base pairs, thereby measuring and bracketing both ends of the siRNA duplex. Our structure provides an illustration of siRNA sequestering by a viral protein.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org	Malinina, Lucy/B-8161-2013		NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIAID NIH HHS [R01 AI068776] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casimiro DR, 1997, STRUCTURE, V5, P1407, DOI 10.1016/S0969-2126(97)00291-8; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8	24	319	335	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					874	878		10.1038/nature02213	http://dx.doi.org/10.1038/nature02213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14661029	Green Accepted			2022-12-01	WOS:000187342000067
J	Methe, BA; Nelson, KE; Eisen, JA; Paulsen, IT; Nelson, W; Heidelberg, JF; Wu, D; Wu, M; Ward, N; Beanan, MJ; Dodson, RJ; Madupu, R; Brinkac, LM; Daugherty, SC; DeBoy, RT; Durkin, AS; Gwinn, M; Kolonay, JF; Sullivan, SA; Haft, DH; Selengut, J; Davidsen, TM; Zafar, N; White, O; Tran, B; Romero, C; Forberger, HA; Weidman, J; Khouri, H; Feldblyum, TV; Utterback, TR; Van Aken, SE; Lovley, DR; Fraser, CM				Methe, BA; Nelson, KE; Eisen, JA; Paulsen, IT; Nelson, W; Heidelberg, JF; Wu, D; Wu, M; Ward, N; Beanan, MJ; Dodson, RJ; Madupu, R; Brinkac, LM; Daugherty, SC; DeBoy, RT; Durkin, AS; Gwinn, M; Kolonay, JF; Sullivan, SA; Haft, DH; Selengut, J; Davidsen, TM; Zafar, N; White, O; Tran, B; Romero, C; Forberger, HA; Weidman, J; Khouri, H; Feldblyum, TV; Utterback, TR; Van Aken, SE; Lovley, DR; Fraser, CM			Genome of Geobacter sulfurreducens: Metal reduction in subsurface environments	SCIENCE			English	Article							URANIUM-CONTAMINATED AQUIFER; MYXOCOCCUS-XANTHUS; OXYGEN; EXPRESSION; SEDIMENTS; SEQUENCE; PROTEIN	The complete genome sequence of Geobacter sulfurreducens, a delta-proteobacterium, reveals unsuspected capabilities, including evidence of aerobic metabolism, one-carbon and complex carbon metabolism, motility, and chemotactic behavior. These characteristics, coupled with the possession of many two-component sensors and many c-type cytochromes, reveal an ability to create alternative, redundant, electron transport networks and offer insights into the process of metal ion reduction in subsurface environments. As well as playing roles in the global cycling of metals and carbon, this organism clearly has the potential for use in bioremediation of radioactive metals and in the generation of electricity.	Inst Genom Res, Rockville, MD 20850 USA; Univ Massachusetts, Dept Microbiol, Amherst, MA 01002 USA	J. Craig Venter Institute; University of Massachusetts System; University of Massachusetts Amherst	Methe, BA (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Paulsen, Ian T/K-3832-2012; Eisen, Jonathan A./H-2706-2019; Nelson, William C/E-9263-2016	Paulsen, Ian T/0000-0001-9015-9418; Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224; Fraser, Claire/0000-0003-1462-2428; Wu, Martin/0000-0003-3093-4077				Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; BLAUT M, 1994, ANTON LEEUW INT J G, V66, P187, DOI 10.1007/BF00871639; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; HEISE R, 1993, FEMS MICROBIOL LETT, V112, P261, DOI 10.1111/j.1574-6968.1993.tb06460.x; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Jolley KA, 2000, MICROBIOL-UK, V146, P1061, DOI 10.1099/00221287-146-5-1061; Kirby JR, 2003, P NATL ACAD SCI USA, V100, P2008, DOI 10.1073/pnas.0330944100; LEHMANN M, 1995, J BIOL CHEM, V270, P14420, DOI 10.1074/jbc.270.24.14420; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Lovley D.R., 1997, IRON RELATED TRANSIT, P187; LOVLEY DR, 2003, PROKARYOTES RELEASE; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Tsujibo H, 2000, APPL ENVIRON MICROB, V66, P3778, DOI 10.1128/AEM.66.9.3778-3783.2000; WHITE DC, 2000, PHYSL BIOCH PROKARYO, V2	20	548	1011	21	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1967	1969		10.1126/science.1088727	http://dx.doi.org/10.1126/science.1088727			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671304				2022-12-01	WOS:000187174000061
J	Tanser, FC; Sharp, B; le Sueur, D				Tanser, FC; Sharp, B; le Sueur, D			Potential effect of climate change on malaria transmission in Africa	LANCET			English	Article							DISEASE; MODEL	Background Climate change is likely to affect transmission of vector-borne diseases such as malaria. We quantitatively estimated current malaria exposure and assessed the potential effect of projected climate scenarios on malaria transmission. Methods We produced a spatiotemporally validated (against 3791 parasite surveys) model of Plasmodium falciparum malaria transmission in Africa. Using different climate scenarios from the Hadley Centre global climate model (HAD CM3) climate experiments, we projected the potential effect of climate change on transmission patterns. Findings Our model showed sensitivity and specificity of 63% and 96%, respectively (within 1 month temporal accuracy), when compared with the parasite surveys. We estimate that on average there are 3.1 billion person-months of exposure (445 million people exposed) in Africa per year. The projected scenarios would estimate a 5-7% potential increase (mainly altitudinal) in malaria distribution with surprisingly little increase in the latitudinal extents of the disease by 2100. Of the overall potential increase (although transmission will decrease in some countries) of 16-28% in person-months of exposure (assuming a constant population), a large proportion will be seen in areas of existing transmission. Interpretation The effect of projected climate change indicates that a prolonged transmission season is as important as geographical expansion in correct assessment of the effect of changes in transmission patterns. Our model constitutes a valid baseline against which climate scenarios can be assessed and interventions planned.	MRC, Malaria Res Lead Programme, ZA-4067 Overport, South Africa; Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa	University of Kwazulu Natal	Tanser, FC (corresponding author), MRC, Malaria Res Lead Programme, ZA-4067 Overport, South Africa.	tanserf@mrc.ac.za	Tanser, Frank/ABE-8326-2021	Tanser, Frank/0000-0001-9797-0000				Akhtar R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P451; [Anonymous], 2000, SPECIAL REPORT EMISS; Barnett TP, 1999, J CLIMATE, V12, P511, DOI 10.1175/1520-0442(1999)012<0511:CONSAT>2.0.CO;2; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DEICHMANN U, 1996, AFRICA POPULATION DA; Fisher R. W., 1996, FUTURE RES Q, V31, P43; Hammond A., 1996, WHICH WORLD; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hutchinson M. F., 1995, AFRICA TOPOGRAPHIC C; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; MARA, 1998, ATL MAL RISK AFR 1 T; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Molineaux L, 1988, MALARIA PRINCIPLES P, P919; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; ONORI E, 1980, B WORLD HEALTH ORGAN, V58, P91; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Reiter P, 2000, EMERG INFECT DIS, V6, P1; Reiter P, 1998, LANCET, V351, P839, DOI 10.1016/S0140-6736(05)78979-0; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; SLOOFF R., 1961, Tropical and Geographical Medicine, V13, P67; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; STUCKENBERG BR, 1969, ZOOL AFR, P145; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; World Health Organization, 1999, WORLD HLTH REP 1999; World Health Organization, 1993, GLOB STRAT MAL CONTR	30	262	271	3	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1792	1798		10.1016/S0140-6736(03)14898-2	http://dx.doi.org/10.1016/S0140-6736(03)14898-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654317				2022-12-01	WOS:000186872900010
J	Huang, TT; Wuerzbrger-Davis, SM; Wu, ZH; Miyamoto, S				Huang, TT; Wuerzbrger-Davis, SM; Wu, ZH; Miyamoto, S			Sequential modification of NEMO/IKK gamma by SUMO-1 and ubiquitin mediates NF-kappa B activation by genotoxic stress	CELL			English	Article							NUCLEAR EXPORT SIGNAL; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; ECTODERMAL DYSPLASIA; IONIZING-RADIATION; GENE-EXPRESSION; IKK ACTIVATION; FAMILY-MEMBERS; KINASE COMPLEX; PORE COMPLEX	The transcription factor NF-kappaB is critical for setting the cellular sensitivities to apoptotic stimuli, including DNA damaging anticancer agents. Central to NF-kappaB signaling pathways is NEMO/IKKgamma, the regulatory subunit of the cytoplasmic IkappaB kinase (IKK) complex. While NF-kappaB activation by genotoxic stress provides an attractive paradigm for nuclear-to-cytoplasmic signaling pathways, the mechanism by which nuclear DNA damage modulates NEMO to activate cytoplasmic IKK remains unknown. Here, we show that genotoxic stress causes nuclear localization of IKK-unbound NEMO via site-specific SUMO-1 attachment. Surprisingly, this sumoylation step is ATM-independent, but nuclear localization allows subsequent ATM-dependent ubiquitylation of NEMO to ultimately activate IKK in the cytoplasm. Thus, genotoxic stress induces two independent signaling pathways, SUMO-1 modification and ATM activation, which work in concert to sequentially cause nuclear targeting and ubiquitylation of free NEMO to permit the NF-kappaB survival pathway. These SUMO and ubiquitin modification pathways may serve as anticancer drug targets.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA; Univ Wisconsin, Program Canc Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miyamoto, S (corresponding author), Univ Wisconsin, Dept Pharmacol, 301 SMI,1300 Univ Ave, Madison, WI 53706 USA.	smiyamot@wisc.edu			NATIONAL CANCER INSTITUTE [R01CA081065, R01CA077474] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA077474, R01-CA081065] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Smahi A, 2000, NATURE, V405, P466; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	453	475	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					565	576		10.1016/S0092-8674(03)00895-X	http://dx.doi.org/10.1016/S0092-8674(03)00895-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651848	Bronze			2022-12-01	WOS:000186885600007
J	Fliers, E; Sauerwein, HP; Romijn, JA; Reiss, P; van der Valk, M; Kalsbeek, A; Kreier, F; Buijs, RM				Fliers, E; Sauerwein, HP; Romijn, JA; Reiss, P; van der Valk, M; Kalsbeek, A; Kreier, F; Buijs, RM			HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy	LANCET			English	Article							VIRUS-INFECTED PATIENTS; PROTEASE INHIBITORS; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; INSULIN-RESISTANCE; LIPODYSTROPHY; GLUTAMATE; INNERVATION; NUCLEUS; TISSUE	Abnormal body-fat distribution in HIV-1-associated adipose redistribution syndrome (HARS) remains unexplained at present. White adipose tissue is controlled by humoral factors and by neural regulation. Sympathetic innervation stimulates lipolysis, whereas parasympathetic innervation has an anabolic influence on white adipose tissue. Results of neuroanatomical studies showed a clear somatotopy with respect to autonomic control of white adipose tissue by both the sympathetic and parasympathetic branch, with separate sets of autonomic neurons innervating either the subcutaneous or the visceral fat compartment. Thus, the CNS is likely to be a key player in regulation of body-fat distribution. We propose that HARS is mediated by effects of antiretroviral treatment on the CNS and could indicate a change in autonomic balance resulting in redistribution of adipose tissue.	Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Infect Dis Trop Med & AIDS, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Int Antiviral Therapy Evaluat Ctr, NL-1100 DE Amsterdam, Netherlands; Netherlands Inst Brain Res, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Endocrinol & Metab, NL-2300 RC Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Fliers, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, F5-168,POB 22700, NL-1100 DE Amsterdam, Netherlands.		van der valk, marc/AAQ-9026-2020; Kalsbeek, Andries/H-3076-2019; Kreier, Felix/C-3371-2008; Buijs, Rudolf/AAD-5707-2020	van der valk, marc/0000-0002-8290-6425; Kalsbeek, Andries/0000-0001-9606-8453; Fliers, Eric/0000-0001-8048-9050				Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bastard JP, 2002, LANCET, V359, P1026, DOI 10.1016/S0140-6736(02)08094-7; Buijs RM, 2001, J COMP NEUROL, V431, P405, DOI 10.1002/1096-9861(20010319)431:4<405::AID-CNE1079>3.0.CO;2-D; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Chen DL, 2002, J CLIN ENDOCR METAB, V87, P4845, DOI 10.1210/jc.2002-020794; Christeff N, 2002, EUR J CLIN INVEST, V32, P775, DOI 10.1046/j.1365-2362.2002.01068.x; Dawson R, 1997, AM J PHYSIOL-ENDOC M, V273, pE202, DOI 10.1152/ajpendo.1997.273.1.E202; Flier JS, 2000, J CLIN INVEST, V105, P859, DOI 10.1172/JCI9725; GRIPSHOVER B, 2003, P 10 C RETR OPP INF; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Ledru E, 2000, BLOOD, V95, P3191, DOI 10.1182/blood.V95.10.3191.010k10_3191_3198; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Morris MJ, 1998, REGUL PEPTIDES, V75-6, P441, DOI 10.1016/S0167-0115(98)00100-1; van der Valk M, 2002, J CLIN ENDOCR METAB, V87, P5066, DOI 10.1210/jc.2002-020892; van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005; Vesce S, 1997, FEBS LETT, V411, P107, DOI 10.1016/S0014-5793(97)00674-1; Wulff EA, 2000, DRUGS, V59, P1251, DOI 10.2165/00003495-200059060-00005; Wynn HE, 2002, CNS DRUGS, V16, P595, DOI 10.2165/00023210-200216090-00002; Yanovski JA, 1999, J CLIN ENDOCR METAB, V84, P1925, DOI 10.1210/jc.84.6.1925	21	43	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1758	1760		10.1016/S0140-6736(03)14858-1	http://dx.doi.org/10.1016/S0140-6736(03)14858-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643128				2022-12-01	WOS:000186767700027
J	Mah, TF; Pitts, B; Pellock, B; Walker, GC; Stewart, PS; O'Toole, GA				Mah, TF; Pitts, B; Pellock, B; Walker, GC; Stewart, PS; O'Toole, GA			A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance	NATURE			English	Article							MOLECULAR-WEIGHT; SUCCINOGLYCAN; PENETRATION; LIMITATION; EXPRESSION	Biofilms are surface-attached microbial communities with characteristic architecture and phenotypic and biochemical properties distinct from their free-swimming, planktonic counterparts(1). One of the best-known of these biofilm-specific properties is the development of antibiotic resistance that can be up to 1,000-fold greater than planktonic cells(2). We report a genetic determinant of this high-level resistance in the Gram-negative opportunistic pathogen, Pseudomonas aeruginosa. We have identified a mutant of P. aeruginosa that, while still capable of forming biofilms with the characteristic P. aeruginosa architecture, does not develop high-level biofilm-specific resistance to three different classes of antibiotics. The locus identified in our screen, ndvB, is required for the synthesis of periplasmic glucans. Our discovery that these periplasmic glucans interact physically with tobramycin suggests that these glucose polymers may prevent antibiotics from reaching their sites of action by sequestering these antimicrobial agents in the periplasm. Our results indicate that biofilms themselves are not simply a diffusion barrier to these antibiotics, but rather that bacteria within these microbial communities employ distinct mechanisms to resist the action of antimicrobial agents.	Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA; Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; MIT, Dept Biol, Cambridge, MA 02412 USA	Dartmouth College; Montana State University System; Montana State University Bozeman; Massachusetts Institute of Technology (MIT)	O'Toole, GA (corresponding author), Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	georgeo@Dartmouth.edu		/0000-0001-7243-8261; Stewart, Philip/0000-0001-7773-8570				Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Bhagwat AA, 1996, J BACTERIOL, V178, P4635, DOI 10.1128/jb.178.15.4635-4642.1996; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; Chen RJ, 2002, CAN J MICROBIOL, V48, P1008, DOI 10.1139/W02-099; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Gonzalez JE, 1998, P NATL ACAD SCI USA, V95, P13477, DOI 10.1073/pnas.95.23.13477; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoyle B D, 1991, Prog Drug Res, V37, P91; LOEWUS FA, 1952, ANAL CHEM, V24, P219, DOI 10.1021/ac60061a050; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0; SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; SZEJTLI J, 1990, CARBOHYD POLYM, V12, P375, DOI 10.1016/0144-8617(90)90088-A; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627	24	797	862	3	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					306	310		10.1038/nature02122	http://dx.doi.org/10.1038/nature02122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628055				2022-12-01	WOS:000186660800048
J	Mofenson, LM; Harris, DR; Moye, J; Bethel, J; Korelitz, J; Read, JS; Nugent, R; Meyer, W				Mofenson, LM; Harris, DR; Moye, J; Bethel, J; Korelitz, J; Read, JS; Nugent, R; Meyer, W		NICHD IVIG Clinical Trial Study Gr	Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings	LANCET			English	Article								Cheaper, simpler alternatives to CD4 lymphocyte count and HIV-1 RNA detection for assessing the prognosis of HIV-1 infection are needed for resource-poor settings. However, little is known about the predictive value of alternative assays, in particular in children. We assessed the prognostic value of total lymphocyte count, immune complex-dissociated p24 antigen, white blood cell count, packed-cell volume (haematocrit), and serum albumin for mortality in 376 HIV-1-infected, mainly African-American or Hispanic children enrolled during March, 1988 to January, 1991. In a Cox proportional hazards model, including all assay-alternatives to CD4 and RNA, total lymphocyte count (p<0.0001) and serum albumin (p=0.0107) independently predicted mortality. Further assessment of these markers is warranted in resource-poor settings.	NICHHD, Pediat Adolescent & Maternal AIDS Branch, NIH, Rockville, MD 20852 USA; WESTAT Corp, Rockville, MD 20850 USA; Quest Diagnost, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Westat	Mofenson, LM (corresponding author), NICHHD, Pediat Adolescent & Maternal AIDS Branch, NIH, 6100 Execut Blvd, Rockville, MD 20852 USA.	LM65D@nih.gov	Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808; moye, john/0000-0001-9976-8586	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033162] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1998, MMWR Recomm Rep, V47, P1; MOFENSON LM, 1991, NEW ENGL J MED, V325, P73, DOI 10.1056/NEJM199107113250201; Mofenson LM, 1997, J INFECT DIS, V175, P1029, DOI 10.1086/516441; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; Taha TE, 2000, AIDS, V14, P453, DOI 10.1097/00002030-200003100-00021	5	34	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2003	362	9396					1625	1627		10.1016/S0140-6736(03)14825-8	http://dx.doi.org/10.1016/S0140-6736(03)14825-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744MZ	14630444				2022-12-01	WOS:000186637400012
J	Pagliarini, RA; Xu, T				Pagliarini, RA; Xu, T			A genetic screen in Drosophila for metastatic behavior	SCIENCE			English	Article							E-CADHERIN; ECTOPIC EXPRESSION; CELL REARRANGEMENT; GROWTH; CANCER; DEATH; SUPPRESSORS; BAZOOKA; ENCODES; MOSAICS	A genetic screen was designed in Drosophila to interrogate its genome for mutations sufficient to cause noninvasive tumors of the eye disc to invade neighboring or distant tissues. We found that cooperation between oncogenic Ras(V12) expression and inactivation of any one of a number of genes affecting cell polarity leads to metastatic behavior, including basement membrane degradation, loss of E-cadherin expression, migration, invasion, and secondary tumor formation. Inactivation of these cell polarity genes cannot drive metastatic behavior alone or in combination with other tumor-initiating alterations. These findings suggest that the oncogenic background of tissues makes a distinct contribution toward metastatic development.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Boyer Ctr Mol Med, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	tian.xu@yale.edu			NCI NIH HHS [CA69408] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Du W, 1996, EMBO J, V15, P3684, DOI 10.1002/j.1460-2075.1996.tb00738.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Geneva JL, 2000, DEV BIOL, V221, P181, DOI 10.1006/dbio.2000.9671; Guilford P, 1999, MOL MED TODAY, V5, P172, DOI 10.1016/S1357-4310(99)01461-6; HAY BA, 1994, DEVELOPMENT, V120, P2121; Ito K, 1997, DEVELOPMENT, V124, P761; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Karim FD, 1998, DEVELOPMENT, V125, P1; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Newsome TP, 2000, DEVELOPMENT, V127, P851; Pagliarini Raymond A, 2003, Methods Mol Biol, V223, P349; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Potter CJ, 2000, TRENDS GENET, V16, P33, DOI 10.1016/S0168-9525(99)01878-8; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Therrien M, 1998, CELL, V95, P343, DOI 10.1016/S0092-8674(00)81766-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	34	431	440	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2003	302	5648					1227	1231		10.1126/science.1088474	http://dx.doi.org/10.1126/science.1088474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14551319				2022-12-01	WOS:000186544300059
J	Tovar, J; Leon-Avila, G; Sanchez, LB; Sutak, R; Tachezy, J; van der Giezen, M; Hernandez, M; Muller, M; Lucocq, JM				Tovar, J; Leon-Avila, G; Sanchez, LB; Sutak, R; Tachezy, J; van der Giezen, M; Hernandez, M; Muller, M; Lucocq, JM			Mitochondrial remnant organelles of Giardia function in iron-sulphur protein maturation	NATURE			English	Article							PARASITE ENTAMOEBA-HISTOLYTICA; TRICHOMONAS-VAGINALIS; LAMBLIA; HYDROGENOSOMES; INTESTINALIS; EUKARYOTES; GENE; GENOME; PHYLOGENY; EVOLUTION	Giardia intestinalis (syn. lamblia) is one of the most widespread intestinal protozoan pathogens worldwide, causing hundreds of thousands of cases of diarrhoea each year(1). Giardia is a member of the diplomonads, often described as an ancient protist group whose primitive nature is suggested by the lack of typical eukaryotic organelles (for example, mitochondria, peroxisomes), the presence of a poorly developed endomembrane system and by their early branching in a number of gene phylogenies(1,2). The discovery of nuclear genes of putative mitochondrial ancestry in Giardia(3-7) and the recent identification of mitochondrial remnant organelles in amitochondrial protists such as Entamoeba histolytica(8,9) and Trachipleistophora hominis(10) suggest that the eukaryotic amitochondrial state is not a primitive condition but is rather the result of reductive evolution. Using an in vitro protein reconstitution assay and specific antibodies against IscS and IscU-two mitochondrial marker proteins involved in iron sulphur cluster biosynthesis-here we demonstrate that Giardia contains mitochondrial remnant organelles (mitosomes) bounded by double membranes that function in iron-sulphur protein maturation. Our results indicate that Giardia is not primitively amitochondrial and that it has retained a functional organelle derived from the original mitochondrial endosymbiont.	Univ London, Royal Holloway, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Rockefeller Univ, New York, NY 10021 USA; Charles Univ, Fac Sci, Dept Parasitol, CR-12844 Prague, Czech Republic; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	University of London; Royal Holloway University London; Rockefeller University; Charles University Prague; University of Dundee	Tovar, J (corresponding author), Univ London, Royal Holloway, Sch Biol Sci, Egham TW20 0EX, Surrey, England.		van der Giezen, Mark/J-9550-2019; sutak, robert/R-4369-2017; Tachezy, Jan/R-4945-2017	van der Giezen, Mark/0000-0002-1033-1335; sutak, robert/0000-0001-5588-1683; Tachezy, Jan/0000-0001-6976-8446; lucocq, john/0000-0002-5191-0093				Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Arisue N, 2002, PARASITOL INT, V51, P9, DOI 10.1016/S1383-5769(01)00093-9; Cochran W.G., 1963, SAMPLING TECHNIQUES; Doolittle WE, 1998, TRENDS GENET, V14, P307; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190; Hashimoto T, 1998, P NATL ACAD SCI USA, V95, P6860, DOI 10.1073/pnas.95.12.6860; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lloyd D, 2002, MICROBIOL-SGM, V148, P1349, DOI 10.1099/00221287-148-5-1349; Lloyd D, 2002, TRENDS MICROBIOL, V10, P122, DOI 10.1016/S0966-842X(02)02306-5; Lloyd D, 2002, MICROBIOL-SGM, V148, P727, DOI 10.1099/00221287-148-3-727; Mai ZM, 1999, MOL CELL BIOL, V19, P2198; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morrison HG, 2001, MOL BIOL EVOL, V18, P530, DOI 10.1093/oxfordjournals.molbev.a003832; Muller M., 2003, MOL MED PARASITOLOGY, P125, DOI DOI 10.1016/B978-012473346-6/50008-9; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; RIORDAN CE, 2003, CURR GENET      0820; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Sogin ML, 1998, INT J PARASITOL, V28, P11, DOI 10.1016/S0020-7519(97)00181-1; SOLTYS BJ, 1994, J PARASITOL, V80, P580, DOI 10.2307/3283195; Strong WB, 2000, MOL BIOCHEM PARASIT, V107, P1, DOI 10.1016/S0166-6851(99)00225-X; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Tokumoto U, 2002, J BIOCHEM, V131, P713, DOI 10.1093/oxfordjournals.jbchem.a003156; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Vidakovic MS, 1996, J BIOL CHEM, V271, P14734, DOI 10.1074/jbc.271.25.14734; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949	31	369	389	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					172	176		10.1038/nature01945	http://dx.doi.org/10.1038/nature01945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614504				2022-12-01	WOS:000186517200041
J	Mantyselka, PT; Turunen, JHO; Ahonen, RS; Kumpusalo, EA				Mantyselka, PT; Turunen, JHO; Ahonen, RS; Kumpusalo, EA			Chronic pain and poor self-rated health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BACK-PAIN; GENERAL-POPULATION; MUSCULOSKELETAL PAIN; DEPRESSIVE SYMPTOMS; PRIMARY-CARE; PREVALENCE; COMMUNITY; COMPLAINTS; IMPACT; ADULTS	Context Chronic pain is common in Western societies. Self-rated health is an important indicator of morbidity and mortality, but little is known about the relation between chronic pain and self-rated health in the general population. Objective To analyze the association between chronic pain and self-rated health. Design, Setting, and Population A questionnaire survey carried out during the spring of 2002 of an age- and sex-stratified population sample of 6500 individuals in Finland aged 15 to 74 years, with a response rate of 71% (N=4542) after exclusion of those with unobtainable data (n=38). Chronic pain was defined as pain with a duration of at least 3 months and was graded by frequency: (1) at most once a week; (2) several times a week; and (3) daily or continuously. On the basis of a 5-item questionnaire on self-rated health; individuals were classified as having good, moderate, or poor health. Multinominal logistic regression analysis was used to assess the determinants of health. Analysis included sex, age, education, working status, chronic diseases, and mood. Main Outcome Measures Perceived chronic pain graded by,frequency and self-rated health status. Results The prevalence of any chronic pain was 35.1%; that of daily chronic pain, 14.3%. The prevalence of moderate self-rated health was 26.6% and of poor health, 7.6%. For moderate self-rated health among individuals having chronic pain at most once a week compared with individuals having no chronic pain, the adjusted odds were 1.36 (95% confidence interval [CI], 1.05-1.76); several times a week, 2.41 (95% CI, 1.94-3.00); and daily, 3.69 (95% CI, 2.97-4.59). Odds for poor self-rated health were as follows: having chronic pain at most once a week, 1.16 (95% CI, 0.65-2.07); several times a week, 2.62 (95% CI, 1.76-3.90); and daily, 11.82 (95% CI, 8.67-16.10). Conclusion Chronic pain is independently related to low self-rated health in the general population.	Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Unit Gen Practice, Kuopio, Finland; Univ Kuopio, Dept Social Pharm, FIN-70211 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Mantyselka, PT (corresponding author), Univ Kuopio, Dept Publ Hlth & Gen Practice, POB 1627, FIN-70211 Kuopio, Finland.	pekka.mantyselka@uku.fi		Turunen, Juha/0000-0002-9913-1240				Andersson HI, 1999, SCAND J PRIM HEALTH, V17, P87, DOI 10.1080/028134399750002700; ARINEN S, 1998, HLTH USE HLTH SERVIC; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Buskila D, 2000, J RHEUMATOL, V27, P1521; Cott CA, 1999, J EPIDEMIOL COMMUN H, V53, P731, DOI 10.1136/jech.53.11.731; CROFT P, 1993, J RHEUMATOL, V20, P710; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Elliott AM, 2002, PAIN, V99, P299, DOI 10.1016/S0304-3959(02)00138-0; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Frolund F, 1986, Scand J Prim Health Care, V4, P97; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; MAGNI G, 1990, PAIN, V43, P299, DOI 10.1016/0304-3959(90)90027-B; Mantyselka P, 2001, PAIN, V89, P175, DOI 10.1016/S0304-3959(00)00361-4; Mantyselka PT, 2002, EUR J PAIN, V6, P141, DOI 10.1053/eujp.2001.0311; Molarius A, 2002, J CLIN EPIDEMIOL, V55, P364, DOI 10.1016/S0895-4356(01)00491-7; *NAT AG MED SOC IN, 2002, FINN STAT MED 2001; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Reyes-Gibby CC, 2002, PAIN, V95, P75, DOI 10.1016/S0304-3959(01)00375-X; SALOKANGAS RKR, 1995, ACTA PSYCHIAT SCAND, V92, P10, DOI 10.1111/j.1600-0447.1995.tb09536.x; Salokangas RKR, 2002, J AFFECT DISORDERS, V68, P215, DOI 10.1016/S0165-0327(00)00315-3; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; WEBSTER BS, 1994, SPINE, V19, P1111, DOI 10.1097/00007632-199405001-00001; *WHO, REG OFF EUR COUNTR I	29	219	227	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2003	290	18					2435	2442		10.1001/jama.290.18.2435	http://dx.doi.org/10.1001/jama.290.18.2435			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742LH	14612480	Bronze			2022-12-01	WOS:000186518300030
J	Stewart, WF; Ricci, JA; Chee, E; Morganstein, D; Lipton, R				Stewart, WF; Ricci, JA; Chee, E; Morganstein, D; Lipton, R			Lost productive time and cost due to common pain conditions in the US workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; UNITED-STATES; MUSCULOSKELETAL DISORDERS; BACK-PAIN; WORK LOSS; AMERICAN MIGRAINE; HEALTH LITERACY; ECONOMIC COST; DOUBLE-BLIND; IMPACT	Context Common pain conditions appear to have an adverse effect on work, but no comprehensive estimates exist on the amount of productive time lost in the US workforce due to pain. Objective To measure lost productive time (absence and:reduced performance due to common pain conditions) during a 2-week period. Design,and Setting Cross-sectional study using survey data from the American Productivity Audit (a telephone survey that uses the Work and Health Interview) of working adults between August 1, 2001, and July 30, 2002. Participants Random sample of 28902 working adults in the United States. Main Outcome Measures Lost productive time due to common pain conditions (arthritis, back, headache, and other musculoskeletal) expressed in hours per worker per week and calculated in US dollars. Results Thirteen percent of the total workforce experienced a loss in productive time during a 2-week period due to a common pain condition. Headache was the most common (5.4%) pain condition resulting in lost productive time. It was followed by back pain (3.2%), arthritis pain (2.0%), and other mosculoskeletal pain. (2.0%) Workers who experienced lost productive time from a pain condition lost a mean (SE) of 4.6 (0.09) h/wk. Workers who had a headache had a mean (SE) loss in productive time of 3.5 (0.1) h/wk. Workers who reported arthritis or back pain had mean (SE) lost productive times of 5.2 (0.25) h/wk. Other common pain conditions resulted in a mean (SE) loss in productive time of 5.5 (0.22) h/wk. Lost productive time from common pain conditions among active workers costs an estimated $61.2 billion per year. The majority (76.6%) of the lost productive time was explained by reduced performance while at work and not work absence. Conclusions Pain is an inordinately common and disabling condition in the US work-force. Most of the pain-related lost productive time occurs while employees are at work-force. Most of the pain-related lost productive time occurs while employees are at work and is in the form of reduced. performance.	Geisinger Hlth Syst, Ctr Hlth Res & Rural Advocacy, Danville, PA 17822 USA; AdvancePCS Ctr Work & Hlth, Hunt VAlley, MD USA; WESTAT Corp, Stat Grp, Rockville, MD 20850 USA; Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA	Geisinger Health System; Westat; Yeshiva University; Albert Einstein College of Medicine	Stewart, WF (corresponding author), Geisinger Hlth Syst, Ctr Hlth Res & Rural Advocacy, 100 N Acad Ave, Danville, PA 17822 USA.		Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783				Berger ML, 2001, J OCCUP ENVIRON MED, V43, P18, DOI 10.1097/00043764-200101000-00005; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; *BUR LAB STAT BUR, CURR POP SURV; Cady RC, 1998, ARCH INTERN MED, V158, P1013, DOI 10.1001/archinte.158.9.1013; Clark RG, 2002, INT STAT REV, V70, P289, DOI 10.2307/1403911; Cockburn I M, 1999, Bus Health, V17, P49; Cole DC, 2001, OCCUP ENVIRON MED, V58, P728, DOI 10.1136/oem.58.11.728; Coyte PC, 1998, ARTHRIT CARE RES, V11, P315, DOI 10.1002/art.1790110503; Crystal-Peters J, 2000, AM J MANAG CARE, V6, P373; Cull RE, 1992, BRIT J EC, V2, P103; Dartigues JF, 1998, CEPHALALGIA, V18, P26, DOI 10.1177/0333102498018S2107; Dasbach EJ, 2000, CEPHALALGIA, V20, P830, DOI 10.1046/j.1468-2982.2000.00126.x; Fautrel B, 2002, CURR OPIN RHEUMATOL, V14, P121, DOI 10.1097/00002281-200203000-00008; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Gerth WC, 2001, PHARMACOECONOMICS, V19, P197, DOI 10.2165/00019053-200119020-00006; Greenberg P E, 1995, Bus Health, V13, P27; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; GROVES RM, 1988, TELEPHONE SURVEY MET, P208; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Henke CJ, 2000, AM J GASTROENTEROL, V95, P788; HILDEBRANDT VH, 1995, ERGONOMICS, V38, P1283, DOI 10.1080/00140139508925188; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; KARASEK R, 1986, JOB CONTENT INSTRUME; Kessler RC, 2001, ANN ALLERG ASTHMA IM, V87, P289, DOI 10.1016/S1081-1206(10)62242-9; LEE P, 1994, QUAL LIFE RES, V3, pS85, DOI 10.1007/BF00433381; Lerner D, 2002, J CLIN EPIDEMIOL, V55, P197, DOI 10.1016/S0895-4356(01)00424-3; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; McCunney RJ, 2001, J OCCUP ENVIRON MED, V43, P30, DOI 10.1097/00043764-200101000-00007; Merkesdal S, 2001, ARTHRITIS RHEUM-US, V44, P528, DOI 10.1002/1529-0131(200103)44:3<528::AID-ANR100>3.0.CO;2-U; Michel P, 1997, HEADACHE, V37, P71, DOI 10.1046/j.1526-4610.1997.3702071.x; Osterhaus J T, 1992, Pharmacoeconomics, V2, P67, DOI 10.2165/00019053-199202010-00008; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; RASMUSSEN BK, 1992, J EPIDEMIOL COMMUN H, V46, P443, DOI 10.1136/jech.46.4.443; RICCI JA, 2001, VALUE HEALTH, V4, P460, DOI DOI 10.1016/S1098-3015(11)71634-5; Rizzo JA, 1998, MED CARE, V36, P1471, DOI 10.1097/00005650-199810000-00006; Schulman EA, 2000, MAYO CLIN PROC, V75, P782, DOI 10.4065/75.8.782; Schwartz BS, 1997, J OCCUP ENVIRON MED, V39, P320, DOI 10.1097/00043764-199704000-00009; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Stang P, 2001, PHARMACOECONOMICS, V19, P231, DOI 10.2165/00019053-200119030-00002; STANG PE, 1993, HEADACHE, V33, P29, DOI 10.1111/j.1526-4610.1993.hed3301029.x; Stewart W, 2002, CNS DRUGS, V16, P5, DOI 10.2165/00023210-200216001-00002; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Stewart WF, 1996, CEPHALALGIA, V16, P231, DOI 10.1046/j.1468-2982.1996.1604231.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; STEWART WF, IN PRESS J OCCUP ENV; STEWART WF, IN PRESS U OCCUP ENV; *US OFF PERS MAN, 1999, FED CIV WORKF STAT O; Von Korff M, 1998, NEUROLOGY, V50, P1741, DOI 10.1212/WNL.50.6.1741; YELIN E, 1992, ARTHRITIS RHEUM, V35, P489, DOI 10.1002/art.1992.35.5.489; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002; Yelin EH, 1995, ARTHRIT CARE RES, V8, P311, DOI 10.1002/art.1790080417	52	1025	1044	1	56	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2003	290	18					2443	2454		10.1001/jama.290.18.2443	http://dx.doi.org/10.1001/jama.290.18.2443			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742LH	14612481	Bronze			2022-12-01	WOS:000186518300031
J	Artsimovitch, I; Chu, C; Lynch, AS; Landick, R				Artsimovitch, I; Chu, C; Lynch, AS; Landick, R			A new class of bacterial RNA polymerase inhibitor affects nucleotide addition	SCIENCE			English	Article							3.3 ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSCRIPTION; DNA; ELONGATION; COMPLEX; INITIATION; MECHANISM; MUTATIONS	RNA polymerase (RNAP) is the central enzyme of gene expression. Despite availability of crystal structures, details of its nucleotide addition cycle remain obscure. We describe bacterial RNAP inhibitors (the CBR703 series) whose properties illuminate this mechanism. These compounds inhibit known catalytic activities of RNAP (nucleotide addition, pyrophosphorolysis, and Gre-stimulated transcript cleavage) but not translocation of RNA or DNA when translocation is uncoupled from catalysis. CBR703-resistance substitutions occur on an outside surface of RNAP opposite its internal active site. We propose that CBR703 compounds inhibit nucleotide addition allosterically by hindering movements of active site structures that are linked to the CBR703 binding site through a bridge helix.	Cumbre Inc, Dallas, TX 75235 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lynch, AS (corresponding author), Cumbre Inc, 1502 Viceroy Dr, Dallas, TX 75235 USA.	simon.lynch@cumbre.net; landick@bact.wisc.edu	Artsimovitch, Irina/L-3467-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R29GM038660, R01GM038660] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38660] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIVAZASHVILI VA, 1982, MOL BIOL, V15, P711; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; ARTSIMOVITCH I, UNPUB; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; FENG GH, 1994, J BIOL CHEM, V269, P22282; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; PALANGAT M, UNPUB; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; Santangelo TJ, 2003, GENE DEV, V17, P1281, DOI 10.1101/gad.1082103; SEVERINOV K, 1995, J BIOL CHEM, V270, P23926, DOI 10.1074/jbc.270.41.23926; SMAGOWICZ WJ, 1978, NUCLEIC ACIDS RES, V5, P1919, DOI 10.1093/nar/5.6.1919; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	27	80	83	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					650	654		10.1126/science.1087526	http://dx.doi.org/10.1126/science.1087526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	735MV	14576436				2022-12-01	WOS:000186119900061
J	Kisinza, WN; McCall, PJ; Mitani, H; Talbert, A; Fukunaga, M				Kisinza, WN; McCall, PJ; Mitani, H; Talbert, A; Fukunaga, M			A newly identified tick-borne Borrelia species and relapsing fever in Tanzania	LANCET			English	Article								Tick-borne relapsing fever caused by the spirochaete Borrelia duttonii is a common cause of serious illness in central Tanzania. Screening of Ornithodoros sp ticks from infested houses for the presence of B duttonii had detected a previously unidentified species of Borrelia. We investigated whether this species infected the human population in a central Tanzanian village, by use of blood slide examination and PCR. PCR was twice as sensitive in detection of infections, showing Borrelia sp in six (11%) of 54 children with fever, and in 13 (4%) of 307 otherwise healthy children. Genotyping Borrelia from 17 infections identified Borrelia duttonii and an unnamed species. Our findings show that the newly discovered species is a causal agent of tick-borne relapsing fever.	Univ Liverpool, Liverpool Sch Trop Med, Vector Res Grp, Liverpool L3 5QA, Merseyside, England; Natl Inst Med Res, Dar Es Salaam, Tanzania; Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Mol Microbiol Lab, Hiroshima, Japan; Mvumi Hosp, Dodoma, Tanzania	Liverpool School of Tropical Medicine; University of Liverpool; National Institute of Medical Research; Fukuyama University	McCall, PJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Res Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.			McCall, Philip J/0000-0002-0007-3985				BARCLAY AJG, 1990, T ROY SOC TROP MED H, V84, P852, DOI 10.1016/0035-9203(90)90106-O; Dennis DT, 1998, ZOONOSES, P17; Fukunaga M, 2001, VECTOR-BORNE ZOONOT, V1, P331, DOI 10.1089/15303660160025949; Talbert A, 1998, T ROY SOC TROP MED H, V92, P251, DOI 10.1016/S0035-9203(98)90998-1; TRAPE JF, 1991, LANCET, V337, P473, DOI 10.1016/0140-6736(91)93404-W	5	38	40	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1283	1284		10.1016/S0140-6736(03)14609-0	http://dx.doi.org/10.1016/S0140-6736(03)14609-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575974				2022-12-01	WOS:000186036900013
J	Dickinson, D; Raynor, DKT				Dickinson, D; Raynor, DKT			Ask the patients - they may want to know more than you think	BRITISH MEDICAL JOURNAL			English	Article							INFORMATION; MEDICINES		Consumation, Consumer Informat Design, London SW17 7QW, England; Univ Leeds, Pharm Practice & Med Management, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Dickinson, D (corresponding author), Consumation, Consumer Informat Design, 53 Hosack Rd, London SW17 7QW, England.		Sturchio, Jeffrey/GWZ-3472-2022					Berry DC, 1997, PSYCHOL HEALTH, V12, P467, DOI 10.1080/08870449708406723; Berry DC, 2002, LANCET, V359, P853, DOI 10.1016/S0140-6736(02)07923-0; Blenkinsopp A, 1998, BRIT MED J, V317, P413; Coulter A, 1999, BRIT MED J, V318, P318, DOI 10.1136/bmj.318.7179.318; Dickinson D, 2001, PATIENT EDUC COUNS, V43, P147, DOI 10.1016/S0738-3991(00)00156-7; RAYNOR DK, IN PRESS PATIENT ED	6	69	72	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2003	327	7419					861	861		10.1136/bmj.327.7419.861-a	http://dx.doi.org/10.1136/bmj.327.7419.861-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732BP	14551106	Green Accepted, Green Published			2022-12-01	WOS:000185921200028
J	Okamoto, I; Otte, AP; Allis, CD; Reinberg, D; Heard, E				Okamoto, I; Otte, AP; Allis, CD; Reinberg, D; Heard, E			Epigenetic dynamics of imprinted X inactivation during early mouse development	SCIENCE			English	Article							CHROMOSOME INACTIVATION; XIST EXPRESSION; LINKED GENES; FEMALE MOUSE; HISTONE H3; PREIMPLANTATION EMBRYOS; CELL-DIFFERENTIATION; STEM-CELLS; IMPLANTATION; METHYLATION	The initiation of X-chromosome inactivation is thought to be tightly correlated with early differentiation events during mouse development. Here, we show that although initially active, the paternal X chromosome undergoes imprinted inactivation from the cleavage stages, well before cellular differentiation. A reversal of the inactive state, with a loss of epigenetic marks such as histone modi. cations and polycomb proteins, subsequently occurs in cells of the inner cell mass (ICM), which give rise to the embryo-proper in which random X inactivation is known to occur. This reveals the remarkable plasticity of the X-inactivation process during preimplantation development and underlines the importance of the ICM in global reprogramming of epigenetic marks in the early embryo.	Inst Curie, CNRS, UMR218, F-75005 Paris, France; Univ Amsterdam, BioCtr Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands; Rockefeller Univ, New York, NY 10021 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem,Div Nucleic Acids Enzymol, Piscataway, NJ 08854 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; University of Amsterdam; Rockefeller University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Heard, E (corresponding author), Inst Curie, CNRS, UMR218, 26 Rue Ulm, F-75005 Paris, France.	edith.heard@curie.fr	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Reinberg, Danny/0000-0003-4288-2016				Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; CHAUMEIL J, UNPUB; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; LATHAM KE, 1995, DEV GENET, V17, P212, DOI 10.1002/dvg.1020170306; LEBON JM, 1995, GENET RES, V65, P223, DOI 10.1017/S0016672300033292; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matsui J, 2001, HUM MOL GENET, V10, P1393, DOI 10.1093/hmg/10.13.1393; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Monk M, 2002, CYTOGENET GENOME RES, V99, P200, DOI 10.1159/000071594; MOORE T, 1995, DEV GENET, V17, P206, DOI 10.1002/dvg.1020170305; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; PAPAIOANNOU VE, 1981, GENET RES, V37, P183, DOI 10.1017/S0016672300020152; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; ROSSANT J, 1975, J EMBRYOL EXP MORPH, V33, P991; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; SUGAWARA O, 1985, CYTOGENET CELL GENET, V39, P210, DOI 10.1159/000132137; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	40	602	630	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					644	649		10.1126/science.1092727	http://dx.doi.org/10.1126/science.1092727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14671313				2022-12-01	WOS:000188530800032
J	Asanuma, Y; Oeser, A; Shintani, AK; Turner, E; Olsen, N; Fazio, S; Linton, MF; Raggi, P; Stein, CM				Asanuma, Y; Oeser, A; Shintani, AK; Turner, E; Olsen, N; Fazio, S; Linton, MF; Raggi, P; Stein, CM			Premature coronary-artery atherosclerosis in systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; RISK-FACTORS; MYOCARDIAL-INFARCTION; ACCELERATED ATHEROSCLEROSIS; DISEASE; CALCIUM; WOMEN; PREVALENCE; PREDICTION; PLAQUE	BACKGROUND: Premature coronary artery disease is a major cause of illness and death in patients with systemic lupus erythematosus, but little is known about the prevalence, extent, and causes of coronary-artery atherosclerosis. METHODS: We used electron-beam computed tomography to screen for the presence of coronary-artery calcification in 65 patients with systemic lupus erythematosus (mean [+/-SD] age, 40.3+/-11.6 years) and 69 control subjects (mean age, 42.7+/-12.6 years) with no history of coronary artery disease. When calcification was detected, the extent was measured by means of the Agatston score. The frequency of risk factors for coronary artery disease was compared in patients and controls, and the relation between the patients' clinical characteristics and the presence or absence of coronary-artery calcification was examined. RESULTS: The two groups were similar with respect to age, race, and sex. Coronary-artery calcification was more frequent in patients with lupus (20 of 65 patients) than in control subjects (6 of 69 subjects) (P=0.002). The mean calcification score was 68.9+/-244.2 in the patients and 8.8+/-41.8 (P<0.001) in controls. Levels of total, high-density lipoprotein, and low-density lipoprotein cholesterol were not elevated in patients with lupus, but levels of triglycerides (P=0.02) and homocysteine (P<0.001) were. Among patients with lupus, measures of disease activity were similar in those with and those without coronary-artery calcification, but those with calcification were more likely to be older (P<0.001) and male (P=0.008). CONCLUSIONS: In patients with systemic lupus erythematosus, the prevalence of coronary-artery atherosclerosis is elevated and the age at onset is reduced. Early detection of atherosclerosis may provide an opportunity for therapeutic intervention.	Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Gen Internal Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; Tulane Univ, Sch Med, Cardiol Sect, New Orleans, LA 70112 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tulane University	Asanuma, Y (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA.				NHLBI NIH HHS [HL04012] Funding Source: Medline; NIDDK NIH HHS [DK26657] Funding Source: Medline; NIGMS NIH HHS [GM5M01-RR00095] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026657] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bruce IN, 2000, J RHEUMATOL, V27, P2372; Budoff MJ, 2002, CIRCULATION, V105, P1791, DOI 10.1161/01.CIR.0000014483.43921.8C; BULKLEY BH, 1975, AM J MED, V58, P243, DOI 10.1016/0002-9343(75)90575-6; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Jara LJ, 2003, CLIN REV ALLERG IMMU, V25, P79, DOI 10.1385/CRIAI:25:1:79; Keelan PC, 2001, CIRCULATION, V104, P412, DOI 10.1161/hc2901.093112; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pearson TA, 2002, CIRCULATION, V105, P886, DOI 10.1161/hc0702.103727; PETRI M, 1992, AM J MED, V93, P513, DOI 10.1016/0002-9343(92)90578-Y; Petri M, 1996, LANCET, V348, P1120, DOI 10.1016/S0140-6736(96)03032-2; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Raggi P, 2000, CIRCULATION, V101, P850, DOI 10.1161/01.CIR.101.8.850; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUBIN LA, 1985, Q J MED, V55, P87; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; RUMBERGER JA, 1995, CIRCULATION, V91, P1363, DOI 10.1161/01.CIR.91.5.1363; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schmermund A, 2002, AM J CARDIOL, V90, P168, DOI 10.1016/S0002-9149(02)02445-1; Schmermund A, 1999, J AM COLL CARDIOL, V34, P777, DOI 10.1016/S0735-1097(99)00265-X; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; von der Thusen JH, 2003, PHARMACOL REV, V55, P133, DOI 10.1124/pr.55.1.5; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U	34	627	647	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2407	2415		10.1056/NEJMoa035611	http://dx.doi.org/10.1056/NEJMoa035611			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681506				2022-12-01	WOS:000187326200006
J	Hornekaer, L; Baurichter, A; Petrunin, VV; Field, D; Luntz, AC				Hornekaer, L; Baurichter, A; Petrunin, VV; Field, D; Luntz, AC			Importance of surface morphology in interstellar H-2 formation	SCIENCE			English	Article							MOLECULAR-HYDROGEN FORMATION; VIBRATIONAL-RELAXATION	Detailed laboratory experiments on the formation of HD from atom recombination on amorphous solid water films show that this process is extremely efficient in a temperature range of 8 to 20 kelvin, temperatures relevant for H-2 formation on dust grain surfaces in the interstellar medium (ISM). The fate of the 4.5 electron volt recombination energy is highly dependent on film morphology. These results suggest that grain morphology, rather than the detailed chemical nature of the grain surface, is most important in determining the energy content of the H 2 as it is released from the grain into the ISM.	Univ So Denmark, Dept Phys, Esbjerg, Denmark; Univ Aarhus, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	University of Southern Denmark; Aarhus University	Hornekaer, L (corresponding author), Univ So Denmark, Dept Phys, Esbjerg, Denmark.	hornekaer@fysik.sdu.dk	Hornekær, Liv/B-3043-2019	Hornekær, Liv/0000-0003-0828-3642				ANDERSSON S, 1989, PHYS REV B, V40, P8146, DOI 10.1103/PhysRevB.40.8146; BONN M, 1995, CHEM PHYS LETT, V233, P309, DOI 10.1016/0009-2614(94)01411-N; CHANG HC, 1990, J ELECTRON SPECTROSC, V54, P39, DOI 10.1016/0368-2048(90)80199-K; Collings MP, 2003, ASTROPHYS J, V583, P1058, DOI 10.1086/345389; Diekhoner L, 2001, J CHEM PHYS, V115, P3356, DOI 10.1063/1.1386810; DULEY WW, 1993, MON NOT R ASTRON SOC, V260, P37, DOI 10.1093/mnras/260.1.37; FLOWER DR, 1990, MON NOT R ASTRON SOC, V247, P500; Gibb EL, 2000, ASTROPHYS J, V536, P347, DOI 10.1086/308940; Greenberg JM, 2002, SURF SCI, V500, P793, DOI 10.1016/S0039-6028(01)01555-2; Gry C, 2002, ASTRON ASTROPHYS, V391, P675, DOI 10.1051/0004-6361:20020691; HOLLENBACH D, 1971, ASTROPHYS J, V163, P155, DOI 10.1086/150754; HORNEKAER L, UNPUB; JURA M, 1975, ASTROPHYS J, V197, P575, DOI 10.1086/153545; Katz N, 1999, ASTROPHYS J, V522, P305, DOI 10.1086/307642; Manico G, 2001, ASTROPHYS J, V548, pL253, DOI 10.1086/319116; Schnaiter M, 1999, ASTROPHYS J, V519, P687, DOI 10.1086/307396; Stevenson KP, 1999, SCIENCE, V283, P1505, DOI 10.1126/science.283.5407.1505; Takahashi J, 1999, ASTROPHYS J, V520, P724, DOI 10.1086/307461	18	143	143	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1943	1946		10.1126/science.1090820	http://dx.doi.org/10.1126/science.1090820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671297				2022-12-01	WOS:000187174000054
J	Kanadia, RN; Johnstone, KA; Mankodi, A; Lungu, C; Thornton, CA; Esson, D; Timmers, AM; Hauswirth, WW; Swanson, MS				Kanadia, RN; Johnstone, KA; Mankodi, A; Lungu, C; Thornton, CA; Esson, D; Timmers, AM; Hauswirth, WW; Swanson, MS			A muscleblind knockout model for myotonic dystrophy	SCIENCE			English	Article							PRE-MESSENGER-RNA; TRINUCLEOTIDE REPEAT; SKELETAL-MUSCLE; NUCLEAR FOCI; IN-VIVO; TRANSCRIPTS; EXPANSION; PROTEIN; DROSOPHILA; MBNL	The neuromuscular disease myotonic dystrophy (DM) is caused by microsatellite repeat expansions at two different genomic loci. Mutant DM transcripts are retained in the nucleus together with the muscleblind (Mbnl) proteins, and these abnormal RNAs somehow interfere with pre-mRNA splicing regulation. Here, we show that disruption of the mouse Mbnl1 gene leads to muscle, eye, and RNA splicing abnormalities that are characteristic of DM disease. Our results support the hypothesis that manifestations of DM can result from sequestration of specific RNA binding proteins by a repetitive element expansion in a mutant RNA.	Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Rochester	Swanson, MS (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA.	mswanson@ufl.edu		Swanson, Maurice/0000-0001-6245-5367; Mankodi, Ami/0000-0002-5131-7767	NIAMS NIH HHS [AR46799, AR46806, R01 AR046799, AR48143] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046806, K24AR048143, R01AR046799] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Harper P.S., 1989, MYOTONIC DYSTROPHY; HO T, UNPUB; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; MANKODI A, IN PRESS ANN NEUROL; MANKODI A, UNPUB; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Wang J, 1997, GENE, V193, P105, DOI 10.1016/S0378-1119(97)00100-5; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	25	547	572	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1978	1980		10.1126/science.1088583	http://dx.doi.org/10.1126/science.1088583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671308				2022-12-01	WOS:000187174000065
J	Girou, E; Brun-Buisson, C; Taille, S; Lemaire, F; Brochard, L				Girou, E; Brun-Buisson, C; Taille, S; Lemaire, F; Brochard, L			Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-FAILURE; POSITIVE-PRESSURE VENTILATION; RANDOMIZED CONTROLLED-TRIAL; CONVENTIONAL MECHANICAL VENTILATION; OBSTRUCTIVE LUNG-DISEASE; FACE MASK; MULTICENTER; SURVIVAL; SUPPORT; THERAPY	Context Randomized controlled trials have shown that the use of noninvasive ventilation (NIV) reduces the need for endotracheal intubation and invasive mechanical ventilation and reduces complication rates and mortality in selected groups of patients. But whether these benefits translate to a clinical setting is unclear. Objective To evaluate longitudinally the routine implementation of NIV and its effect on patients admitted to the intensive care unit (ICU) with acute exacerbation of chronic obstructive pulmonary disease (COPD) or severe cardiogenic pulmonary edema (CPE). Design Retrospective, observational cohort study using prospectively collected data from January 1, 1994, through December 31, 2001. Setting A 26-bed medical intensive care unit (ICU) of a French university referral hospital. Participants A cohort of 479 consecutive patients ventilated for acute exacerbation of COPD or CPE. Main Outcome Measures The ICU mortality and incidence rates of ICU-acquired infections. Results A significant increase in NIV use and a concomitant decrease in mortality and ICU-acquired infection rates were observed over the study years. With adjustment for relevant covariates and propensity scores, NIV was identified as an independent factor linked with a reduced risk of death in the cohort (odds ratio [OR], 0.37; 95% confidence interval [CI], 0.18-0.78), whereas a high severity score on admission (OR, 1.05; 95% Cl, 1.01-1.10) and the occurrence of a nosocomial infection (OR, 3.08; 95% Cl, 1.62-5.84) were independently associated with death. Rates of ICU-acquired pneumonia decreased from 20% in 1994 to 8% in 2001 (P=.04). Conclusion Implementing routine use of NIV in critically ill patients with acute exacerbation of COPD or severe CPE was associated with improved survival and reduction of nosocomial infections.	Hop Henri Mondor, Assistance Publ Hop Paris, Unite Hyg & Prevent Infect, F-94010 Creteil, France; Hop Henri Mondor, Assistance Publ Hop Paris, Serv Reanimat Med, F-94010 Creteil, France; Hop Henri Mondor, Assistance Publ Hop Paris, INSERM, U492, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Brun-Buisson, C (corresponding author), Hop Henri Mondor, Unite Hyg & Prevent Infect, F-94010 Creteil, France.	emmanuelle.girou@hmn.ap-hop-paris.fr						Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Auriant I, 2001, AM J RESP CRIT CARE, V164, P1231, DOI 10.1164/ajrccm.164.7.2101089; Azoulay E, 2001, CRIT CARE MED, V29, P519, DOI 10.1097/00003246-200103000-00009; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; Brochard L, 2002, JAMA-J AM MED ASSOC, V288, P932, DOI 10.1001/jama.288.8.932; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Calverley PMA, 2001, EUR RESPIR J, V18, p60S, DOI 10.1183/09031936.01.00229801; Carlucci A, 2001, AM J RESP CRIT CARE, V163, P874, DOI 10.1164/ajrccm.163.4.2006027; Carlucci A, 2003, INTENS CARE MED, V29, P419, DOI 10.1007/s00134-002-1574-1; Celikel T, 1998, CHEST, V114, P1636, DOI 10.1378/chest.114.6.1636; CHEVROLET JC, 1991, CHEST, V100, P775, DOI 10.1378/chest.100.3.775; Confalonieri M, 1999, AM J RESP CRIT CARE, V160, P1585, DOI 10.1164/ajrccm.160.5.9903015; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Ely JW, 1997, INFECT CONT HOSP EP, V18, P267; Evans T W, 2001, Intensive Care Med, V27, P166, DOI 10.1007/s001340000721; Fagon J Y, 1996, Semin Respir Infect, V11, P109; Fein A, 2000, Curr Opin Pulm Med, V6, P122; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Gregoretti C, 2002, INTENS CARE MED, V28, P278, DOI 10.1007/s00134-002-1208-7; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Hill NS, 2002, INTENS CARE MED, V28, P227, DOI 10.1007/s00134-002-1228-3; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Martin TJ, 2000, AM J RESP CRIT CARE, V161, P807, DOI 10.1164/ajrccm.161.3.9808143; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540, DOI 10.1164/ajrccm.163.2.9906116; Nava S, 1997, CHEST, V111, P1631, DOI 10.1378/chest.111.6.1631; Nava S, 1998, ANN INTERN MED, V128, P721, DOI 10.7326/0003-4819-128-9-199805010-00004; Nourdine K, 1999, INTENS CARE MED, V25, P567, DOI 10.1007/s001340050904; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Radford MJ, 2001, JAMA-J AM MED ASSOC, V286, P1228, DOI 10.1001/jama.286.10.1228; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339	46	165	179	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2985	2991		10.1001/jama.290.22.2985	http://dx.doi.org/10.1001/jama.290.22.2985			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665660	Bronze			2022-12-01	WOS:000187112700030
J	Sokol, RJ; Delaney-Black, V; Nordstrom, B				Sokol, RJ; Delaney-Black, V; Nordstrom, B			Fetal alcohol spectrum disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRENATAL ALCOHOL; IN-UTERO; EXPOSURE; AGE; ATTENTION; CHILDREN; IDENTIFICATION; RECOGNITION; PREVALENCE; CHILDHOOD		Wayne State Univ, CS Mott Ctr Human Growth & Dev, Childrens Res Ctr, Detroit, MI 48201 USA; Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA; E Tennessee State Univ, Dept Family Med, Johnson City, TN USA	Wayne State University; Wayne State University; East Tennessee State University	Sokol, RJ (corresponding author), Wayne State Univ, CS Mott Ctr Human Growth & Dev, Childrens Res Ctr, 275 E Hancock, Detroit, MI 48201 USA.	rsokol@moose.med.wayne.edu						Abel EL, 1998, ALCOHOL CLIN EXP RES, V22, P979, DOI 10.1111/j.1530-0277.1998.tb03692.x; [Anonymous], 1981, FDA Drug Bull, V11, P9; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P261; Chang G, 1998, OBSTET GYNECOL, V91, P892, DOI 10.1016/S0029-7844(98)00088-X; Chang G, 2000, J SUBST ABUSE TREAT, V18, P365, DOI 10.1016/S0740-5472(99)00105-1; Coles CD, 2000, J STUD ALCOHOL, V61, P607, DOI 10.15288/jsa.2000.61.607; COLES CD, 1991, NEUROTOXICOL TERATOL, V13, P357, DOI 10.1016/0892-0362(91)90084-A; Connor PD, 2000, DEV NEUROPSYCHOL, V18, P331, DOI 10.1207/S1532694204Connor; Connor PD, 1999, ALCOHOL CLIN EXP RES, V23, P1395; Cook JD, 2003, CLIN BIOCHEM, V36, P9, DOI 10.1016/S0009-9120(02)00424-1; Ebrahim SH, 1998, OBSTET GYNECOL, V92, P187, DOI 10.1016/S0029-7844(98)00205-1; ERNHART CB, 1988, ALCOHOL CLIN EXP RES, V12, P506, DOI 10.1111/j.1530-0277.1988.tb00233.x; FRIED PA, 1992, NEUROTOXICOL TERATOL, V14, P299, DOI 10.1016/0892-0362(92)90036-A; Handmaker NS, 1999, J STUD ALCOHOL, V60, P285, DOI 10.15288/jsa.1999.60.285; Handmaker NS, 2001, ALCOHOL RES HEALTH, V25, P219; HANKIN JR, 1995, SEMIN PERINATOL, V19, P286, DOI 10.1016/S0146-0005(05)80043-6; HANKIN JR, 1993, ALCOHOL CLIN EXP RES, V17, P284, DOI 10.1111/j.1530-0277.1993.tb00764.x; Jacobson JL, 1996, ALCOHOL CLIN EXP RES, V20, P359, DOI 10.1111/j.1530-0277.1996.tb01653.x; JACOBSON SW, 1994, ALCOHOL CLIN EXP RES, V18, P1125, DOI 10.1111/j.1530-0277.1994.tb00092.x; JONES KL, 1973, LANCET, V2, P999; Kaskutas L. A., 1998, J HLTH ED, V28, P11; Klein J, 2002, NEW ENGL J MED, V347, P2086, DOI 10.1056/NEJM200212193472523; Korkman M, 2003, CHILD NEUROPSYCHOL, V9, P117, DOI 10.1076/chin.9.2.117.14503; LANDESMANDWYER S, 1981, NEUROBEH TOXICOL TER, V3, P187; Langbehn DR, 2001, COMPR PSYCHIAT, V42, P272, DOI 10.1053/comp.2001.24579; LARSSON G, 1983, ACTA OBSTET GYN SCAN, V62, P171, DOI 10.3109/00016348309155786; LITTLE BB, 1990, AM J DIS CHILD, V144, P1142, DOI 10.1001/archpedi.1990.02150340088030; Mattson SN, 1999, ALCOHOL CLIN EXP RES, V23, P1808, DOI 10.1097/00000374-199911000-00014; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; Miller WR., 2012, MOTIVATIONAL INTERVI; Nevin Alexandra C, 2002, BMC Fam Pract, V3, P2, DOI 10.1186/1471-2296-3-2; O'Connor MJ, 2002, AM J DRUG ALCOHOL AB, V28, P745, DOI 10.1081/ADA-120015880; OLSON HC, 1992, DEV PSYCHOPATHOL, V4, P341, DOI 10.1017/S0954579400000821; Roebuck TM, 1999, ALCOHOL CLIN EXP RES, V23, P1070, DOI 10.1111/j.1530-0277.1999.tb04227.x; ROSETT HL, 1983, JAMA-J AM MED ASSOC, V249, P2029; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.3.CO;2-T; SOKOL RJ, 1989, AM J OBSTET GYNECOL, V160, P863, DOI 10.1016/0002-9378(89)90302-5; Sood B, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e34; Stoler JM, 1999, J PEDIATR-US, V135, P430, DOI 10.1016/S0022-3476(99)70164-2; Stratton K., 1996, FETAL ALCOHOL SYNDRO; STREISSGUTH AP, 1989, NEUROTOXICOL TERATOL, V11, P493, DOI 10.1016/0892-0362(89)90026-3; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; STREISSGUTH AP, 1986, NEUROTOXICOL TERATOL, V8, P717; STREISSGUTH AP, 1984, CIBA F SYMP, V105, P176; STREISSGUTH AP, 1994, ALCOHOL CLIN EXP RES, V18, P202, DOI 10.1111/j.1530-0277.1994.tb00904.x; Yates WR, 1998, ALCOHOL CLIN EXP RES, V22, P914, DOI 10.1111/j.1530-0277.1998.tb03889.x; 1997, MMWR MORB MORTAL WKL, V46, P346; 2002, MMWR MORB MORTAL WKL, V51, P433	48	468	476	0	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2996	2999		10.1001/jama.290.22.2996	http://dx.doi.org/10.1001/jama.290.22.2996			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751WH	14665662				2022-12-01	WOS:000187112700032
J	Walker, A; Sirel, JM; Marsden, AK; Cobbe, SM; Pell, JP				Walker, A; Sirel, JM; Marsden, AK; Cobbe, SM; Pell, JP			Cost effectiveness and cost utility model of public place defibrillators in improving survival after prehospital cardiopulmonary arrest	BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; HOSPITAL CARDIAC-ARREST; ACCESS DEFIBRILLATION; PERINATAL-MORTALITY; TASK-FORCE; RISK; PROFESSIONALS; RESUSCITATION; STATEMENT; COHORT	Objective To determine the cost effectiveness and cost utility of locating defibrillators in all major airports, railway stations, and bus stations throughout Scotland. Design Economic modelling exercise with data from Heartstart (Scotland). Parameters used in economic model included direct costs derived for increased accident and emergency attendances, increased hospital bed days, purchase and maintenance of defibrillators, and training in their use; life years gained calculated from increased discharges from hospital and mean survival after discharge; utility (quality of life) obtained from published data. Sensitivity analyses tested the robustness of model. Future gains discounted at 1.5% a year and future costs at 6%. Setting Whole of Scotland. Subjects Records,of all prehospital cardiac arrests due to presumed heart disease that occurred in a major airport, railway, or bus station between May 1991 and March 1998 and were not witnessed by ambulance or medical staff. Main outcome measures Observed survival to hospital admission and observed survival to discharge. Predicted survival calculated by applying observed survival in patients attended by ambulance staff within three minutes to those who waited longer. Results The total discounted direct costs were pound18 325 a year. The cost per life year gained was pound29 625 ($49 625, (sic)43 151) and the cost per quality adjusted life year (QALY) gained was pound41 146 ($68 924, (sic)59 932). More widespread provision of public place defibrillators would increase these figures. Conclusions The cost per QALY calculated for public place defibrillators represents poorer value for money than some alternative strategies for improving survival after prehospital cardiopulmonary arrest, such as the use of other trained first responders. The figure exceeds the commonly discussed cut off levels for funding in the United Kingdom and United States of pound30 000 and $50 000 per QALY, respectively.	Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh EH10 5UU, Midlothian, Scotland; Univ Glasgow, Dept Med Cardiol, Glasgow G32 2ER, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Pell, JP (corresponding author), Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland.			Pell, Jill/0000-0002-8898-7035				Banister J., 1987, CHINAS CHANGING POPU; Chu JH, 2001, POPUL DEV REV, V27, P259; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Gratton M, 1999, Prehosp Emerg Care, V3, P303, DOI 10.1080/10903129908958958; GROENEVELD P, 2001, JAMA-J AM MED ASSOC, V28, P1482; Hummel S, 1997, PHARMACOECONOMICS, V12, P182, DOI 10.2165/00019053-199712020-00008; *I POP STUD, 2000, ZHONG GUO REN KOU NI; *INF STAT DIV, 2001, SCOTT HLTH SERV COST; Kane R, 1999, BRIT MED J, V319, P992, DOI 10.1136/bmj.319.7215.992; Kulmala T, 2000, PAEDIATR PERINAT EP, V14, P219, DOI 10.1046/j.1365-3016.2000.00270.x; Kuntz KM, 1996, CIRCULATION, V94, P957, DOI 10.1161/01.CIR.94.5.957; Lee KH, 1996, CRIT CARE MED, V24, P2046, DOI 10.1097/00003246-199612000-00019; LI XT, 1995, ZHONG GUO FU YOU BAO, V10, P246; Liu Y, 2001, WORLD J MICROB BIOT, V17, P111, DOI 10.1023/A:1016625209839; MU L, 1995, ZHONG GUO CHU JI WEI, V9, P34; *NAT I CLIN EXC, 2000, GUID IMPL CARD DEF A; NETTEN A, 2002, UNIT COSTS HLTH SOCI; Nichol G, 1998, CIRCULATION, V97, P1309, DOI 10.1161/01.CIR.97.13.1309; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; Pell JP, 2002, BRIT MED J, V325, P515, DOI 10.1136/bmj.325.7363.515; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; Shah D, 2000, INT J GYNECOL OBSTET, V71, P209, DOI 10.1016/S0020-7292(00)00215-0; Shah NM, 2000, SOC SCI MED, V51, P539, DOI 10.1016/S0277-9536(99)00485-2; WEI YZ, 1992, GUI YANG YI XUE YUAN, V17, P42; WEISFELDT ML, 1995, CIRCULATION, V92, P2763, DOI 10.1161/01.CIR.92.9.2763; Woollard M, 2001, J PUBLIC HEALTH MED, V23, P98, DOI 10.1093/pubmed/23.2.98; XU BZ, 1995, PERINATAL MORTALITY; Yao J S, 1991, Zhonghua Fu Chan Ke Za Zhi, V26, P224; ZHANG J, 1991, INT J EPIDEMIOL, V20, P958, DOI 10.1093/ije/20.4.958; ZHU XL, 1996, XIN JIANG YI XUE YUA, V19, P83	34	27	28	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1316	1319		10.1136/bmj.327.7427.1316	http://dx.doi.org/10.1136/bmj.327.7427.1316			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752DE	14656838	Green Published, Bronze			2022-12-01	WOS:000187131100016
J	Nolan, MF; Malleret, G; Lee, KH; Gibbs, E; Dudman, JT; Santoro, B; Yin, DQ; Thompson, RF; Siegelbaum, SA; Kandel, ER; Morozov, A				Nolan, MF; Malleret, G; Lee, KH; Gibbs, E; Dudman, JT; Santoro, B; Yin, DQ; Thompson, RF; Siegelbaum, SA; Kandel, ER; Morozov, A			The hyperpolarization-activated HCN1 channel is important for motor learning and neuronal integration by cerebellar Purkinje cells	CELL			English	Article							LONG-TERM DEPRESSION; MUTANT MICE; NUCLEAR NEURONS; BASKET CELLS; COORDINATION; INHIBITION; RESPONSES; PACEMAKER; CURRENTS; CORTEX	In contrast to our increasingly detailed understanding of how synaptic plasticity provides a cellular substrate for learning and memory, it is less clear how a neuron's voltage-gated ion channels interact with plastic changes in synaptic strength to influence behavior. We find, using generalized and regional knockout mice, that deletion of the HCN1 channel causes profound motor learning and memory deficits in swimming and rotarod tasks. In cerebellar Purkinje cells, which are a key component of the cerebellar circuit for learning of correctly timed movements, HCN1 mediates an inward current that stabilizes the integrative properties of Purkinje cells and ensures that their input-output function is independent of the previous history of their activity. We suggest that this nonsynaptic integrative function of HCN1 is required for accurate decoding of input patterns and thereby enables synaptic plasticity to appropriately influence the performance of motor activity.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Physiol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Psychiat, New York, NY 10032 USA; Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; NIMH, Unit Behav Genet, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Nolan, MF (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Nolan, Matthew/A-1356-2009	Nolan, Matthew/0000-0003-1062-6501; Santoro, Bina/0000-0002-4277-1992; Dudman, Joshua/0000-0002-4436-1057	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045923, R37MH045923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER; NIMH NIH HHS [MH045923] Funding Source: Medline; NINDS NIH HHS [NS36658] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1138, DOI 10.1152/jn.1964.27.6.1138; [Anonymous], [No title captured]; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CREPEL F, 1986, J PHYSIOL-LONDON, V372, P1; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; Fairbanks CA, 1997, J PHARMACOL EXP THER, V282, P1408; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HESSLOW G, 1994, NEUROREPORT, V5, P649, DOI 10.1097/00001756-199401000-00030; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; LI SJ, 1993, BRAIN RES, V617, P87, DOI 10.1016/0006-8993(93)90617-V; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nam SC, 1997, J NEUROBIOL, V33, P18, DOI 10.1002/(SICI)1097-4695(199707)33:1<18::AID-NEU3>3.0.CO;2-G; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 1999, J NEUROSCI, V19, P1663; Raymond JL, 1998, J NEUROSCI, V18, P9112; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Thach WT, 1998, NEUROBIOL LEARN MEM, V70, P177, DOI 10.1006/nlme.1998.3846; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023	45	245	251	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					551	564		10.1016/S0092-8674(03)00884-5	http://dx.doi.org/10.1016/S0092-8674(03)00884-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651847	Bronze			2022-12-01	WOS:000186885600006
J	Wu, YW; Escobar, GJ; Grether, JK; Croen, LA; Greene, JD; Newman, TB				Wu, YW; Escobar, GJ; Grether, JK; Croen, LA; Greene, JD; Newman, TB			Chorioamnionitis and cerebral palsy in term and near-term infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUSTRALIAN CASE-CONTROL; V-LEIDEN MUTATION; NEONATAL ENCEPHALOPATHY; NEWBORN ENCEPHALOPATHY; MATERNAL FEVER; BRAIN-DAMAGE; RISK-FACTORS; APGAR SCORE; CHILDREN; ANTECEDENTS	Context Half of all cases of cerebral palsy (CP) occur in term infants, for whom risk factors have not been clearly defined. Recent studies suggest a possible role of chorioamnionitis. Objective To determine whether clinical chorioamnionitis increases the risk of CP in term and near-term infants. Design, Setting, and Patients Case-control study nested within a cohort of 231582 singleton infants born at 36 or more weeks' gestation between January 1, 1991, and December 31,1998, in the Kaiser Permanente Medical Care Program, a managed care organization providing care for more than 3 million residents of northern California. Case patients were identified from electronic records and confirmed by chart review by a child neurologist, and comprised all children with moderate to severe spastic or. dyskinetic CP not due to postnatal brain injury or developmental abnormalities (n=109). Controls (n=218) were randomly selected from the study population. Main Outcome Measure Association between clinical chorioamnionitis and increased risk of CP in term and near-term infants. Results Most CP cases had hemiparesis (40%) or quadriparesis (38%); 87% had been diagnosed by a neurologist and 83% had undergone neuroimaging. Chorioamnionitis, considered present if a treating physician made a diagnosis of chorioamnionitis or endometritis clinically, was noted in 14% of cases and 4% of controls (odds ratio [OR], 3.8; 95% confidence interval [CI], 1.5-10.1; P=.001). Independent risk factors identified in multiple logistic regression included chorioamnionitis (OR, 4.1; 95% CI, 1.6-10.1), intrauterine growth restriction (OR, 4.0;95% CI, 1.3-12.0), maternal black ethnicity (OR, 3.6; 95% CI, 1.4-9.3), maternal age older than 25 years (OR, 2.6; 95% CI, 1.3-5.2), and nulliparity (OR, 1.8; 95% CI, 1.0-3.0). The population-attributable fraction of chorioamnionitis for CP is 11%. Conclusion Our data suggest that chorioamnionitis is an independent risk factor for CP among term and near-term infants.	Univ Calif San Francisco, Dept Neurol, Div Child Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Kaiser Permanente Div Res, Oakland, CA USA; Calif Dept Hlth Serv, Sacramento, CA 95814 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; California Department of Health Care Services	Wu, YW (corresponding author), Univ Calif San Francisco, Dept Neurol, Div Child Neurol, Box 0136,500 Parnassus Ave,MUE 411, San Francisco, CA 94143 USA.			Croen, Lisa/0000-0001-7849-9428	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001692] Funding Source: NIH RePORTER; NINDS NIH HHS [5 K12 NSO1692] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 2003, NEON ENC CER PALS; Badawi N, 1998, DEV MED CHILD NEUROL, V40, P520; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; BLAIR E, 1993, DEV MED CHILD NEUROL, V35, P449; Bloomenthal D, 2002, AM J PERINAT, V19, P37, DOI 10.1055/s-2002-20172; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Dammann O, 1998, Semin Pediatr Neurol, V5, P190, DOI 10.1016/S1071-9091(98)80034-X; Dite GS, 1998, AUST NZ J OBSTET GYN, V38, P377, DOI 10.1111/j.1479-828X.1998.tb03091.x; EASTMAN NJ, 1955, AM J OBSTET GYNECOL, V69, P950, DOI 10.1016/0002-9378(55)90094-6; Eun BL, 2000, PEDIATR RES, V47, P73, DOI 10.1203/00006450-200001000-00014; Foster-Barber A, 2002, MENT RETARD DEV D R, V8, P20, DOI 10.1002/mrdd.10009; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Grether J K, 1992, Paediatr Perinat Epidemiol, V6, P339, DOI 10.1111/j.1365-3016.1992.tb00774.x; Grether JK, 2003, ARCH PEDIAT ADOL MED, V157, P26, DOI 10.1001/archpedi.157.1.26; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Gugino, 1998, Prim Care Update Ob Gyns, V5, P148, DOI 10.1016/S1068-607X(98)00026-2; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Hagstrom JN, 1998, J PEDIATR-US, V133, P777, DOI 10.1016/S0022-3476(98)70150-7; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Humphreys P, 2000, CAN J NEUROL SCI, V27, P210; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Lieberman E, 2000, PEDIATRICS, V105, P8, DOI 10.1542/peds.105.1.8; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Lynch JK, 2001, J CHILD NEUROL, V16, P735, DOI 10.1177/088307380101601006; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; MENKES JH, 1994, AM J NEURORADIOL, V15, P451; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; MURPHY CC, 1993, J PEDIATR-US, V123, pS13, DOI 10.1016/S0022-3476(05)80892-3; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; NELSON KB, 1982, PEDIATRICS, V69, P529; NELSON KB, 1985, AM J DIS CHILD, V139, P1031, DOI 10.1001/archpedi.1985.02140120077032; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; Nelson KB, 2002, MENT RETARD DEV D R, V8, P146, DOI 10.1002/mrdd.10037; Pasternak JF, 1998, PEDIATR NEUROL, V18, P391, DOI 10.1016/S0887-8994(98)00002-2; Perlman JN, 1999, CLIN PEDIATR, V38, P287, DOI 10.1177/000992289903800506; *PMIC, 1999, INT CLASS DIS 9 REV; Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205; Russel P., 1979, AM J DIAG GYN OBSTET, V1, P127; Shalak LF, 2002, MENT RETARD DEV D R, V8, P14, DOI 10.1002/mrdd.10006; Smulian JC, 1999, OBSTET GYNECOL, V94, P1000, DOI 10.1016/S0029-7844(99)00416-0; *STAT CA DEP HLTH, 1976, INTR GROWTH NEON RIS; Suzuki J, 2002, BRAIN DEV-JPN, V24, P39, DOI 10.1016/S0387-7604(01)00395-3; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Topp M, 2001, PAEDIATR PERINAT EP, V15, P271, DOI 10.1046/j.1365-3016.2001.00354.x; Uvebrant P, 1988, Acta Paediatr Scand Suppl, V345, P1; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; [No title captured]; 2000, STATA 7 REFERENCE MA	57	369	378	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2677	2684		10.1001/jama.290.20.2677	http://dx.doi.org/10.1001/jama.290.20.2677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645309				2022-12-01	WOS:000186788100019
J	Basu, AR; Petaev, MI; Poreda, RJ; Jacobsen, SB; Becker, L				Basu, AR; Petaev, MI; Poreda, RJ; Jacobsen, SB; Becker, L			Chondritic meteorite fragments associated with the Permian-Triassic boundary in Antarctica	SCIENCE			English	Article							GIGANTIC RELEASE; SIBERIAN TRAPS; BOLIDE IMPACT; CATASTROPHE; FULLERENES; EXTINCTION; SULFUR	Multiple chondritic meteorite fragments have been found in two sedimentary rock samples from an end-Permian bed at Graphite Peak in Antarctica. The Ni/Fe, Co/Ni, and P/Fe ratios in metal grains; the Fe/Mg and Mn/Fe ratios in olivine and pyroxene; and the chemistry of Fe-, Ni-, P-, and S-bearing oxide in the meteorite fragments are typical of CM-type chondritic meteorites. In one sample, the meteoritic fragments are accompanied by more abundant discrete metal grains, which are also found in an end-Permian bed at Meishan, southern China. We discuss the implications of this finding for a suggested global impact event at the Permian-Triassic boundary.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Calif Santa Barbara, Dept Geol, Inst Crustal Studies, Santa Barbara, CA 93106 USA	University of Rochester; Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Santa Barbara	Basu, AR (corresponding author), Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA.	abasu@earth.rochester.edu	Jacobsen, Stein/B-1759-2013; Jacobsen, Stein/ABA-1063-2021	Jacobsen, Stein/0000-0003-2164-0720				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; BASU AR, 1995, SCIENCE, V269, P822, DOI 10.1126/science.269.5225.822; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; BECKERLING W, 1995, PLANET SPACE SCI, V43, P435, DOI 10.1016/0032-0633(94)00175-Q; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; BREARLEY AJ, 1998, REV MINERAL, V36, P3; Brownlee DE, 1997, METEORIT PLANET SCI, V32, P157, DOI 10.1111/j.1945-5100.1997.tb01257.x; CAMPBELL IH, 1992, SCIENCE, V258, P1760, DOI 10.1126/science.258.5089.1760; ERWIN DH, 1993, GREATEST PALEOZOIC C; Farley KA, 2001, SCIENCE, V293, P2343; HALLAM A, 1997, MASS EXTINCTIONS THE; Jessberger EK, 2001, ASTR AST LI, P253; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Kaiho K, 2001, GEOLOGY, V29, P815, DOI 10.1130/0091-7613(2001)029<0815:EPCBAB>2.0.CO;2; Koeberl C, 2002, GEOLOGY, V30, P855, DOI 10.1130/0091-7613(2002)030<0855:EPCBBI>2.0.CO;2; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; KURAT G, 1994, GEOCHIM COSMOCHIM AC, V58, P3879, DOI 10.1016/0016-7037(94)90369-7; Kyte FT, 1998, NATURE, V396, P237, DOI 10.1038/24322; KYTE FT, 2002, LUNAR PLANETARY SCI, V31; Miono S, 1999, NUCL INSTRUM METH B, V150, P516, DOI 10.1016/S0168-583X(98)00917-3; Poreda RJ, 2003, ASTROBIOLOGY, V3, P75, DOI 10.1089/153110703321632435; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; RENNE PR, 1991, SCIENCE, V253, P176, DOI 10.1126/science.253.5016.176; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; Retallack GJ, 1998, GEOLOGY, V26, P979, DOI 10.1130/0091-7613(1998)026<0979:SFEOIA>2.3.CO;2; Rietmeijer F. J. M., 1998, REV MINERAL, V36, P1; Schmitz B, 2003, SCIENCE, V300, P961, DOI 10.1126/science.1082182; Schmitz B, 2001, EARTH PLANET SC LETT, V194, P1, DOI 10.1016/S0012-821X(01)00559-3; Sheldon ND, 2002, GEOLOGY, V30, P919, DOI 10.1130/0091-7613(2002)030<0919:LOLIET>2.0.CO;2; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; SUN Y, 1984, 27 INT GEOL C	33	106	122	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1388	1392		10.1126/science.1090852	http://dx.doi.org/10.1126/science.1090852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631038				2022-12-01	WOS:000186683500050
J	Garcia-Ruiz, JM; Hyde, ST; Carnerup, AM; Christy, AG; Van Kranendonk, MJ; Welham, NJ				Garcia-Ruiz, JM; Hyde, ST; Carnerup, AM; Christy, AG; Van Kranendonk, MJ; Welham, NJ			Self-assembled silica-carbonate structures and detection of ancient microfossils	SCIENCE			English	Article							EARTHS EARLIEST FOSSILS; ARRHENIUS EQUATION; WESTERN-AUSTRALIA; LIFE	We have synthesized inorganic micron-sized filaments, whose microstucture consists of silica-coated nanometer-sized carbonate crystals, arranged with strong orientational order. They exhibit noncrystallographic, curved, helical morphologies, reminiscent of biological forms. The. laments are similar to supposed cyanobacterial microfossils from the Precambrian Warrawoona chert formation in Western Australia, reputed to be the oldest terrestrial microfossils. Simple organic hydrocarbons, whose sources may also be abiotic and indeed inorganic, readily condense onto these. laments and subsequently polymerize under gentle heating to yield kerogenous products. Our results demonstrate that abiotic and morphologically complex microstructures that are identical to currently accepted biogenic materials can be synthesized inorganically.	Univ Granada, Fac Ciencias, Inst Andaluz Ciencias Tierra, CSIC, Granada 18002, Spain; Australian Natl Univ, Res Sch Phys Sci, Dept Appl Math, Canberra, ACT 0200, Australia; Geol Survey Western Australia, Perth, WA 6004, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Australian National University; Geological Survey of Western Australia	Garcia-Ruiz, JM (corresponding author), Univ Granada, Fac Ciencias, Inst Andaluz Ciencias Tierra, CSIC, Campus Fuentenueva, Granada 18002, Spain.		Christy, Andrew/C-3205-2013; Van Kranendonk, Martin J/J-8755-2012; García-Ruiz, Juan Manuel/U-1085-2019; Garcia-Ruiz, Juan Manuel/C-4389-2015; Hyde, Stephen T/N-2928-2019; Hyde, Stephen/F-9248-2010	Christy, Andrew/0000-0002-2203-1444; Van Kranendonk, Martin J/0000-0002-0611-2703; García-Ruiz, Juan Manuel/0000-0002-4743-8718; Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; Hyde, Stephen T/0000-0003-2003-9992; Hyde, Stephen/0000-0003-2003-9992; Welham, Nicholas/0000-0002-4716-9837				AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; BAIRD T, 1992, MATER RES BULL, V27, P1031, DOI 10.1016/0025-5408(92)90241-Q; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Cartwright JHE, 2002, J COLLOID INTERF SCI, V256, P351, DOI 10.1006/jcis.2002.8620; CLOUD P, 1979, PRECAMBRIAN RES, V9, P81, DOI 10.1016/0301-9268(79)90052-4; DEGENNES PG, 1993, PHYSICS LIQUID CRYST; GARCIA-RUIZ J.M., 2002, ASTROBIOLOGY, V2, P335; Garcia-Ruiz J. M., 2000, CARBONATE SEDIMENTAT, V67, P75; Garcia-Ruiz JM, 1998, GEOLOGY, V26, P843; GarciaRuiz JM, 1997, AN QUIM, V93, P1; Garrels RM, 1965, SOLUTIONS MINERALS E; Hofmann BA, 2000, PLANET SPACE SCI, V48, P1077, DOI 10.1016/S0032-0633(00)00081-7; HUNT JM, 1991, AAPG BULL, V75, P795; Ko TH, 2000, POLYM COMPOSITE, V21, P745, DOI 10.1002/pc.10229; Lowenstam H.A., 1989, BIOMINERALISATION; McCollom TM, 2003, GEOCHIM COSMOCHIM AC, V67, P311, DOI 10.1016/S0016-7037(02)00945-6; Pasteris JD, 2002, NATURE, V420, P476, DOI 10.1038/420476b; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; SCHOPF JW, 1983, EARTHS EARLIEST BIOS, pCH9; SVENSSON IL, 1986, J CHEM SOC FARAD T 1, V82, P3635, DOI 10.1039/f19868203635; THORPE RI, 1992, ARCHAEAN TERRAINS PR, V22, P395; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; VANKRANENDONK MJ, UNPUB; WOOD DA, 1988, AAPG BULL, V72, P115; Yang H, 1997, NATURE, V386, P692, DOI 10.1038/386692a0	28	335	345	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1194	1197		10.1126/science.1090163	http://dx.doi.org/10.1126/science.1090163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615534	Green Submitted			2022-12-01	WOS:000186544300049
J	Kurisu, G; Zhang, HM; Smith, JL; Cramer, WA				Kurisu, G; Zhang, HM; Smith, JL; Cramer, WA			Structure of the cytochrome b(6)f complex of oxygenic photosynthesis: Tuning the cavity	SCIENCE			English	Article							IRON-SULFUR PROTEIN; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; BC(1) COMPLEX; MEMBRANE-PROTEINS; PHOTOSYSTEM-II; BOVINE HEART; BC COMPLEXES; B/F COMPLEX	The cytochrome b(6)f complex provides the electronic connection between the photosystem I and photosystem II reaction centers of oxygenic photosynthesis and generates a transmembrane electrochemical proton gradient for adenosine triphosphate synthesis. A 3.0 angstrom crystal structure of the dimeric b(6)f complex from the thermophilic cyanobacterium Mastigocladus laminosus reveals a large quinone exchange cavity, stabilized by lipid, in which plastoquinone, a quinone-analog inhibitor, and a novel heme are bound. The core of the b(6)f complex is similar to the analogous respiratory cytochrome bc(1) complex, but the domain arrangement outside the core and the complement of prosthetic groups are strikingly different. The motion of the Rieske iron-sulfur protein extrinsic domain, essential for electron transfer, must also be different in the b(6)f complex.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Osaka University	Cramer, WA (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	wac@bilbo.bio.purdue.edu	KURISU, GENJI/ABA-5960-2020; KURISU, GENJI/AAD-7109-2022	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807	NIGMS NIH HHS [GM-38323] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM038323, R01GM038323] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Carrell CJ, 1999, BIOCHEMISTRY-US, V38, P9590, DOI 10.1021/bi9903190; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; CRAMER WA, 1991, ENERGY TRANSDUCTION, pCH6; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; HAUSKA G, 1996, OXYGENIC PHOTOSYNTHE; HUANG D, 1994, BIOCHEMISTRY-US, V33, P4401, DOI 10.1021/bi00180a038; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JOLIOT P, 1994, P NATL ACAD SCI USA, V91, P1034, DOI 10.1073/pnas.91.3.1034; JOLIOT P, 1988, BIOCHIM BIOPHYS ACTA, V933, P319, DOI 10.1016/0005-2728(88)90039-4; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kallas T, 1994, MOL BIOL CYANOBACTER, V1, P259, DOI DOI 10.1007/978-94-011-0227-8_9; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; KRAMER DM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P72, DOI 10.1016/0005-2728(93)90006-2; LAVERGNE J, 1983, BIOCHIM BIOPHYS ACTA, V725, P25, DOI 10.1016/0005-2728(83)90220-7; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Pierre Y, 1997, J BIOL CHEM, V272, P21901, DOI 10.1074/jbc.272.35.21901; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; RIEDEL A, 1991, J BIOL CHEM, V266, P17838; Roberts AG, 2001, BIOCHEMISTRY-US, V40, P13407, DOI 10.1021/bi015774m; Sainz G, 2000, BIOCHEMISTRY-US, V39, P9164, DOI 10.1021/bi0004596; Schunemann V, 1999, BIOCHEMISTRY-US, V38, P8981, DOI 10.1021/bi990080n; STROEBEL D, COMMUNICATION; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TURRO NJ, 1965, MOL PHOTOCHEM, P92; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; WIDGER WR, 1984, P NATL ACAD SCI-BIOL, V81, P674, DOI 10.1073/pnas.81.3.674; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yan JS, 2003, J BIOL CHEM, V278, P20925, DOI 10.1074/jbc.M212616200; Zhang HM, 1999, J BIOL CHEM, V274, P1581, DOI 10.1074/jbc.274.3.1581; Zhang HM, 2003, P NATL ACAD SCI USA, V100, P5160, DOI 10.1073/pnas.0931431100; ZHANG HY, UNPUB; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; ZHAO J, 1993, MOL MICROBIOL, V9, P183, DOI 10.1111/j.1365-2958.1993.tb01680.x; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	42	578	621	7	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1009	1014		10.1126/science.1090165	http://dx.doi.org/10.1126/science.1090165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14526088				2022-12-01	WOS:000186396300037
J	Pizzari, T; Cornwallis, CK; Lovlie, H; Jakobsson, S; Birkhead, TR				Pizzari, T; Cornwallis, CK; Lovlie, H; Jakobsson, S; Birkhead, TR			Sophisticated sperm allocation in male fowl	NATURE			English	Article							GALLUS-GALLUS; COMPETITION; STRATEGIES; EJACULATE; BEHAVIOR; CHOICE; EXPENDITURE	When a female is sexually promiscuous, the ejaculates of different males compete for the fertilization of her eggs(1); the more sperm a male inseminates into a female, the more likely he is to fertilize her eggs(2). Because sperm production is limited and costly, theory predicts that males will strategically allocate sperm (1) according to female promiscuity(1,3-5), (2) saving some for copulations with new females(3,6,7), and (3) to females producing more and/or better offspring(3,8). Whether males allocate sperm in all of these ways is not known, particularly in birds where the collection of natural ejaculates only recently became possible. Here we demonstrate male sperm allocation of unprecedented sophistication in the fowl Gallus gallus. Males show status-dependent sperm investment in females according to the level of female promiscuity; they progressively reduce sperm investment in a particular female but, on encountering a new female, instantaneously increase their sperm investment; and they preferentially allocate sperm to females with large sexual ornaments signalling superior maternal investment. Our results indicate that female promiscuity leads to the evolution of sophisticated male sexual behaviour.	Swedish Univ Agr Sci, Dept Anim Environm & Hlth, SE-53223 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Swedish University of Agricultural Sciences; University of Sheffield	Pizzari, T (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.	t.pizzari@leeds.ac.uk	Cornwallis, Charlie/A-6276-2012					Bakst M.R., 1997, TECHNIQUES SEMEN EVA; BIRKHEAD TR, 1988, NATURE, V334, P60, DOI 10.1038/334060a0; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; DER G, 2001, HDB STAT ANAL USING; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Evans JP, 2003, BEHAV ECOL, V14, P268, DOI 10.1093/beheco/14.2.268; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; Hunter FM, 2000, P ROY SOC B-BIOL SCI, V267, P1541, DOI 10.1098/rspb.2000.1176; ISHIKAWA H, 1930, P WORLD POULT J C, P90; MARTIN PA, 1974, J REPROD FERTIL, V39, P251, DOI 10.1530/jrf.0.0390251; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Parker J. E., 1942, MISS AGR EXP STATION, V347, P3; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; PITNICK S, 1994, AM NAT, V143, P785, DOI 10.1086/285633; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Pizzari T, 2002, TRENDS ECOL EVOL, V17, P456, DOI 10.1016/S0169-5347(02)02591-0; Pizzari T, 2001, ANIM BEHAV, V61, P601, DOI 10.1006/anbe.2000.1620; Pizzari T, 2001, P ROY SOC B-BIOL SCI, V268, P181, DOI 10.1098/rspb.2000.1348; PIZZARI T, IN PRESS BEHAV ECOL; Reinhold K, 2002, J EVOLUTION BIOL, V15, P201, DOI 10.1046/j.1420-9101.2002.00390.x; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Westneat DF, 1998, BEHAV ECOL SOCIOBIOL, V43, P161, DOI 10.1007/s002650050477; WILSON JR, 1963, J COMP PHYSIOL PSYCH, V56, P636, DOI 10.1037/h0042469; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	25	246	249	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					70	74		10.1038/nature02004	http://dx.doi.org/10.1038/nature02004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603319	Green Accepted			2022-12-01	WOS:000186370800043
J	Li, SX; Chen, W; Srinivasan, SR; Bond, MG; Tang, R; Urbina, EM; Berenson, GS				Li, SX; Chen, W; Srinivasan, SR; Bond, MG; Tang, R; Urbina, EM; Berenson, GS			Childhood cardiovascular risk factors and carotid vascular changes in adulthood - The Bogalusa Heart Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTIMA-MEDIA THICKNESS; ARTERIAL-WALL THICKNESS; BLACK-WHITE DIFFERENCES; B-MODE ULTRASOUND; YOUNG-ADULTS; INSULIN-RESISTANCE; ATHEROSCLEROTIC LESIONS; ADIPOSE-TISSUE; SERUM-LIPOPROTEINS; CHOLESTEROL LEVELS	Context Carotid artery intima-media thickness (IMT) is associated with cardiovascular risk factors and is recognized as an important predictive measure of clinical coronary atherosclerosis events in middle-aged and elderly populations. However, information on the association of carotid IMT in young adults with different risk factors measured in childhood, adulthood, or as a cumulative burden of each of the risk factors measured serially from childhood to adulthood is limited. Objective To examine the association between carotid IMT in young adults and traditional cardiovascular risk factors measured since childhood. Design, Setting, and Participants A cohort study of 486 adults aged 25 to 37 years from a semirural black and white community in Bogalusa, La (71% white, 39% men), who had at least 3 measurements of traditional risk factors since childhood, conducted between September 1973 and December 1996. Main Outcome Measure Association of carotid IMT with risk factors, including systolic blood pressure, lipoprotein levels, and body mass index. Results Male vs female (0.757 mm Vs 0.719 mm) and black vs white (0.760 mm vs 0.723 mm) participants had increased carotid IMT (P<.001 for both). In multivariable analyses, significant predictors for being in top vs lower 3 quartiles of carotid IMT in young adults were childhood measures of low-density lipoprotein cholesterol (LDL-C) level (odds ratio [OR], 1.42, corresponding to 1-SD change specific for age, race, and sex; 95% confidence interval [CI], 1.14-1.78) and body mass index (BMI; OR, 1.25; 95% CI, 1.01-1.54); adulthood measures of LDL-C level (OR, 1.46; 95% CI, 1.16-1.82), high-density lipoprotein cholesterol (HDL-C) level (OR; 0.67; 95% CI, 0.51-0.88), and systolic blood pressure (OR, 1.36; 95% CI, 1.08-1.72); and long-term cumulative burden of LDL-C (OR, 1.58; 95% CI, 1.24-2.01) and HDL-C (OR, 0.75; 95% CI, 0.58-0.97) levels measured serially from childhood to adulthood. An increasing trend in carotid IMT across quartiles of LDL-C level measured in childhood was observed, with a mean value of 0.761 mm (95% CI, 0.743-0.780 mm) for those at the top quartile vs 0.724 mm (95% CI, 0.715-0.734 mm) for those in the lower 3 quartiles (P<.001). Conclusions Childhood measures of LDL-C level and BMI predict carotid IMT in young adults: The prevention implications of these findings remains to be explored.	Tulane Univ, Hlth Sci Ctr, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70112 USA; Tulane Univ, Hlth Sci Ctr, Dept Epidemiol, New Orleans, LA 70112 USA; Wake Forest Univ, Bowman Gray Sch Med, Div Vasc Ultrasound Res, Winston Salem, NC USA	Tulane University; Tulane University; Wake Forest University; Wake Forest Baptist Medical Center	Berenson, GS (corresponding author), Tulane Univ, Hlth Sci Ctr, Tulane Ctr Cardiovasc Hlth, 1440 Canal St,Suite 1829, New Orleans, LA 70112 USA.		Li, Shengxu/D-8915-2012		NHLBI NIH HHS [HL-38844] Funding Source: Medline; NIA NIH HHS [AG-16592] Funding Source: Medline; NICHD NIH HHS [HD-043820] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043820] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038844, U01HL038844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKERBLOM HK, 1991, ANN MED, V23, P35, DOI 10.3109/07853899109147928; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Bao WH, 1996, ARCH INTERN MED, V156, P1315, DOI 10.1001/archinte.156.12.1315; Berenson G.S., 1986, CAUSATION CARDIOVASC; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BUCULO G, 1973, CLIN CHEM, V19, P476; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chambless LE, 2002, AM J EPIDEMIOL, V155, P38, DOI 10.1093/aje/155.1.38; Chobanian AV, 1996, ARCH INTERN MED, V156, P1952, DOI 10.1001/archinte.156.17.1952; Crouse JR, 2002, CIRCULATION, V106, P2061, DOI 10.1161/01.CIR.0000033833.54884.34; DAgostino RB, 1996, STROKE, V27, P1744, DOI 10.1161/01.STR.27.10.1744; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; DONAHUE RP, 1989, ARTERIOSCLEROSIS, V9, P656, DOI 10.1161/01.ATV.9.5.656; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Greenlund KJ, 1998, ANN EPIDEMIOL, V8, P22, DOI 10.1016/S1047-2797(97)00127-0; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hulthe J, 1997, STROKE, V28, P1189, DOI 10.1161/01.STR.28.6.1189; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; LAUER RM, 1988, PEDIATRICS, V82, P309; LAUER RM, 1980, CHILDHOOD PREVENTION; Lipid Research Clinics Program, 1974, DHEW PUBL; Mannami T, 2000, ARCH INTERN MED, V160, P2297, DOI 10.1001/archinte.160.15.2297; MANOLIO TA, 1995, J CLIN EPIDEMIOL, V48, P1141, DOI 10.1016/0895-4356(94)00240-Q; McGill HC, 1998, ARTERIOSCL THROM VAS, V18, P1108, DOI 10.1161/01.ATV.18.7.1108; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; MORRISON JA, 1979, METABOLISM, V28, P241, DOI 10.1016/0026-0495(79)90070-2; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; PORKKA KVK, 1994, AM J EPIDEMIOL, V140, P1096, DOI 10.1093/oxfordjournals.aje.a117210; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Riley WA, 1991, J NEUROIMAGING, V1, P168, DOI DOI 10.1111/JON199114168; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; *SAS I INC, 1997, SAS STAT SOFTW CHANG; SRINIVASAN SR, 1975, BIOCHIM BIOPHYS ACTA, V388, P58, DOI 10.1016/0005-2760(75)90062-4; SRINIVASAN SR, 1991, PREV MED, V20, P671, DOI 10.1016/0091-7435(91)90063-A; Srinivasan SR., 1983, CRC HDB ELECTROPHORE, P185; STARY HC, 1989, ARTERIOSCLEROSIS, V9, pI19; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; STOUT RW, 1987, LANCET, V1, P1077; Tang R, 2000, J HYPERTENS, V18, P197, DOI 10.1097/00004872-200018020-00010; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; 1995, AM J MED SCI S1, V310, pS1	49	713	746	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2003	290	17					2271	2276		10.1001/jama.290.17.2271	http://dx.doi.org/10.1001/jama.290.17.2271			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PZ	14600185	Bronze			2022-12-01	WOS:000186356800021
J	Blutt, SE; Kirkwood, CD; Parreno, V; Warfield, KL; Ciarlet, M; Estes, MK; Bok, K; Bishop, RF; Conner, ME				Blutt, SE; Kirkwood, CD; Parreno, V; Warfield, KL; Ciarlet, M; Estes, MK; Bok, K; Bishop, RF; Conner, ME			Rotavirus antigenaemia and viraemia: a common event?	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; CEREBROSPINAL-FLUID; REVERSE TRANSCRIPTION; LYMPHOID-TISSUES; GASTROENTERITIS; INFECTION; IMMUNODEFICIENCY; ENCEPHALOPATHY; CHILD; VP7	Background Rotavirus infection is thought to be confined to the intestine. Reports of rotavirus RNA in the cerebral spinal fluid and serum of children infected with rotavirus suggest the possibility that rotavirus escapes the intestine into the circulatory system. We assessed whether rotavirus antigen, RNA, or both, were present in serum samples from immunocompetent rotavirus-infected children and animals. Methods We obtained sera from immunocompetent mice, rats, rabbits, and calves 1-10 days after inoculation with rotavirus or matched vehicle. We obtained sera retrospectively from immunocompetent children diagnosed with rotavirus diarrhoea (n=33), healthy children (n=6) and adults (n=12), children convalescing from rotavirus (n=6), and children with non-rotavirus diarrhoea (n=11). Samples were analysed for the presence of rotavirus antigen or RNA by EIA or RT-PCR, respectively. Findings Rotavirus antigen was present in sera from rotavirus-infected animals, but not in sera from control animals. Infectious rotavirus or rotavirus RNA was detected in sera of mice and calves, respectively. Antigen was present in 22 of 33 serum samples from children with confirmed rotavirus infection but in none of 35 samples from controls. Detection of serum antigen was inversely related to the number of days between symptom onset and sample collection, and directly related to stool antigen concentration. Rotavirus RNA was detected by RT-PCR in three of six rotavirus-positive sera. Interpretation Rotavirus can escape the gastrointestinal tract in children, resulting in antigenaemia and possible viraemia. This finding is important for the understanding of the pathogenesis, immunology, and clinical manifestations of rotavirus infection.	Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Murdoch Childrens Res Inst,Enter Virus Res Grp, Melbourne, Vic, Australia; INTA, CICVyA, Inst Virol, Buenos Aires, DF, Argentina; INEI ANLIS, Dept Virol, Lab Gastroenteritis Virales, Buenos Aires, DF, Argentina; Vet Affairs Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Instituto Nacional de Tecnologia Agropecuaria (INTA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Conner, ME (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.		Conner, Margaret E./I-7230-2019	parreno, viviana/0000-0003-0385-5592	NIAID NIH HHS [R01 AI24998, F32-AI10604] Funding Source: Medline; NIDDK NIH HHS [DK56338] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024998, F32AI010604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown KA, 1998, MICROB PATHOGENESIS, V24, P327, DOI 10.1006/mpat.1997.0198; Conner Margaret E., 1997, P713; COULSON BS, 1987, J CLIN MICROBIOL, V25, P509, DOI 10.1128/JCM.25.3.509-515.1987; DHARAKUL T, 1988, CLIN EXP IMMUNOL, V74, P14; ESTES MK, 1997, FIELDS VIROLOGY, P1625; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Goldwater PN, 2001, J PAEDIATR CHILD H, V37, P206, DOI 10.1046/j.1440-1754.2001.00596.x; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1338, DOI 10.1128/JCM.32.5.1338-1340.1994; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Iturriza-Gomara M, 2002, J CLIN MICROBIOL, V40, P4797, DOI 10.1128/JCM.40.12.4797-4799.2002; KRAFT LM, 1958, YALE J BIOL MED, V31, P122; Limbos MAP, 1996, CLIN INFECT DIS, V22, P834, DOI 10.1093/clinids/22.5.834; Lynch M, 2001, CLIN INFECT DIS, V33, P932, DOI 10.1086/322650; MCCORMACK JG, 1982, J INFECTION, V4, P167, DOI 10.1016/S0163-4453(82)93777-X; Morrison C, 2001, HUM PATHOL, V32, P216, DOI 10.1053/hupa.2001.21565; Mossel EC, 2002, J VIROL, V76, P6502, DOI 10.1128/JVI.76.13.6502-6509.2002; Nigrovic LE, 2002, CLIN INFECT DIS, V34, P130, DOI 10.1086/323560; NISHIMURA S, 1993, BRAIN DEV-JPN, V15, P457, DOI 10.1016/0387-7604(93)90088-P; ONeal CM, 1997, J VIROL, V71, P8707, DOI 10.1128/JVI.71.11.8707-8717.1997; Pang XL, 1996, PEDIATR INFECT DIS J, V15, P543, DOI 10.1097/00006454-199606000-00015; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Takahashi S, 1999, EUR J PEDIATR, V158, P133, DOI 10.1007/s004310051033; USHIJIMA H, 1994, J CLIN MICROBIOL, V32, P2893, DOI 10.1128/JCM.32.12.2893-2897.1994; YOSHIDA A, 1995, PEDIATR INFECT DIS J, V14, P914	24	163	178	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 1	2003	362	9394					1445	1449		10.1016/S0140-6736(03)14687-9	http://dx.doi.org/10.1016/S0140-6736(03)14687-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602437				2022-12-01	WOS:000186356600009
J	Mallucci, G; Dickinson, A; Linehan, J; Klohn, PC; Brandner, S; Collinge, J				Mallucci, G; Dickinson, A; Linehan, J; Klohn, PC; Brandner, S; Collinge, J			Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; KNOCKOUT MICE; PROTEIN PRP; SCRAPIE; EXPRESSION; RESISTANT; STRAINS	The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of non-neuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.	MRC, Prion Unit, London WC1, England; Inst Neurol, Dept Neurodgenerat Dis, London WC1, England		Collinge, J (corresponding author), MRC, Prion Unit, Queen Sq, London WC1, England.		Kloehn, Peter/AAS-3719-2021; Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Mallucci, Giovanna/0000-0001-8504-1191	Medical Research Council [MC_U123160654, MC_U132692719] Funding Source: Medline; MRC [MC_U123160654] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Baker CA, 1999, J VIROL, V73, P5089, DOI 10.1128/JVI.73.6.5089-5097.1999; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Goelz MF, 1998, LAB ANIM SCI, V48, P34; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; JULIEN JP, 1988, GENE, V68, P307, DOI 10.1016/0378-1119(88)90033-9; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MEDORI R, 1992, PRION DIS HUMANS ANI, pCH18; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580	22	529	551	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					871	874		10.1126/science.1090187	http://dx.doi.org/10.1126/science.1090187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593181				2022-12-01	WOS:000186258000051
J	Coupland, RM				Coupland, RM			Incapacitating chemical weapons: a year after the Moscow theatre siege	LANCET			English	Editorial Material							FENTANYL; TOXICOLOGY		Int Comm Red Cross, Legal Div, CH-1202 Geneva, Switzerland		Coupland, RM (corresponding author), Int Comm Red Cross, Legal Div, CH-1202 Geneva, Switzerland.	rcoupland@icrc.org						Bartfield JM, 2003, ACAD EMERG MED, V10, P215, DOI 10.1111/j.1553-2712.2003.tb01993.x; Coupland RM, 1997, BRIT MED J, V315, P72, DOI 10.1136/bmj.315.7100.72; Enserink M, 2002, SCIENCE, V298, P1150, DOI 10.1126/science.298.5596.1150; *ICRC, 2003, 1 SPEC SESS C STAT P; Lakoski J. M., 2000, ADVANTAGES LIMITATIO; Mather LE, 1998, BRIT J CLIN PHARMACO, V46, P37, DOI 10.1046/j.1365-2125.1998.00035.x; *NAT RES COUNC COM, 2003, ASS NONL WEAP SCI TE; Schiermeier Q, 2002, NATURE, V420, P7, DOI 10.1038/420007a; Wax PM, 2003, ANN EMERG MED, V41, P700, DOI 10.1067/mem.2003.148; Wheelis M, 2003, ISSUES SCI TECHNOL, V19, P74; *WORLD MED ASS, 1996, WORLD MED ASS 48 GEN; WORSLEY MH, 1990, ANAESTHESIA, V45, P449, DOI 10.1111/j.1365-2044.1990.tb14331.x; 2002, BBC NEWS        1029	13	11	13	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2003	362	9393					1346	1346		10.1016/S0140-6736(03)14684-3	http://dx.doi.org/10.1016/S0140-6736(03)14684-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585634				2022-12-01	WOS:000186143300006
J	Yla-Herttuala, S				Yla-Herttuala, S			Percutaneous transcoronary venous access for cellular cardiomyoplasty	LANCET			English	Editorial Material							GENE-TRANSFER; TRANSPLANTATION; REGENERATION; CELLS		Univ Kuopio, Kuopio Univ Hosp, Gene Therapy Unit, AI Virtanen Inst, FIN-70211 Kuopio, Finland; Univ Kuopio, Kuopio Univ Hosp, Gene Therapy Unit, Dept Med, FIN-70211 Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Yla-Herttuala, S (corresponding author), Univ Kuopio, Kuopio Univ Hosp, Gene Therapy Unit, AI Virtanen Inst, FIN-70211 Kuopio, Finland.			Yla-Herttuala, Seppo/0000-0001-7593-2708				Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Boekstegers P, 2000, GENE THER, V7, P232, DOI 10.1038/sj.gt.3301079; Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694	7	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1252	1252		10.1016/S0140-6736(03)14614-4	http://dx.doi.org/10.1016/S0140-6736(03)14614-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575965				2022-12-01	WOS:000186036900004
J	Zhang, OH; Yoshimatsu, Y; Hildebrand, J; Frisch, SM; Goodman, RH				Zhang, OH; Yoshimatsu, Y; Hildebrand, J; Frisch, SM; Goodman, RH			Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP	CELL			English	Article							TERMINAL-BINDING-PROTEIN; DROSOPHILA EMBRYO; ACTIVATION; REPRESSOR; RECEPTOR; KINASE; CREB; PHOSPHORYLATION; ACETYLATION; ASSOCIATION	Genetic knockout of the transcriptional corepressor CtBP in mouse embryo fibroblasts upregulates several genes involved in apoptosis. We predicted, therefore, that a propensity toward apoptosis might be regulated through changes in cellular CtBP. To identify pathways involved in this regulation, we screened a mouse embryo cDNA library with an E1A-CtBP complex and identified the homeodomain interacting protein kinase 2 (HIPK2), which had previously been linked to UV-directed apoptosis through its ability to phosphorylate p53. Expression of HIPK2 or exposure to UV irradiation reduced CtBP levels via a proteosome-mediated pathway. The UV effect was prevented by coexpression of kinase-inactive HIPK2 or reduction in HIPK2 levels via siRNA. Mutation of the residue phosphorylated by HIPK2 prevented UV- and HIPK2-directed CtBP clearance. Finally, reduction in CtBP levels, either by genetic knockout or siRNA, promoted apoptosis in p53-deficient cells. These findings provide a pathway for UV-induced apoptosis in cells lacking p53.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Burnham Inst, La Jolla, CA 92037 USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sanford Burnham Prebys Medical Discovery Institute	Zhang, OH (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhangq@ohsu.edu	Yoshimatsu, Yasuhiro/AAY-2259-2020	Yoshimatsu, Yasuhiro/0000-0002-3571-1596	NATIONAL CANCER INSTITUTE [K01CA096561, R01CA115468] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA096561, R01 CA115468, R01 CA115468-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes CJ, 2003, NAT STRUCT BIOL, V10, P622, DOI 10.1038/nsb957; BODE AM, 2003, SCI STKE; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; La Rosee-Borggreve A, 1999, MECH DEVELOP, V89, P133, DOI 10.1016/S0925-4773(99)00219-1; Lai ZC, 1999, GENETICS, V152, P299; Landon, 1977, Methods Enzymol, V47, P145; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shih HM, 1996, P NATL ACAD SCI USA, V93, P13896, DOI 10.1073/pnas.93.24.13896; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Zhang HL, 1999, P NATL ACAD SCI USA, V96, P535, DOI 10.1073/pnas.96.2.535; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598	31	186	194	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2003	115	2					177	186		10.1016/S0092-8674(03)00802-X	http://dx.doi.org/10.1016/S0092-8674(03)00802-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567915	Bronze			2022-12-01	WOS:000186039200009
J	Marsicano, G; Goodenough, S; Monory, K; Hermann, H; Eder, M; Cannich, A; Azad, SC; Cascio, MG; Gutierrez, SO; van der Stelt, M; Lopez-Rodriguez, ML; Casanova, E; Schutz, G; Zieglgansberger, W; Di Marzo, V; Behl, C; Lutz, B				Marsicano, G; Goodenough, S; Monory, K; Hermann, H; Eder, M; Cannich, A; Azad, SC; Cascio, MG; Gutierrez, SO; van der Stelt, M; Lopez-Rodriguez, ML; Casanova, E; Schutz, G; Zieglgansberger, W; Di Marzo, V; Behl, C; Lutz, B			CB1 cannabinoid receptors and on-demand defense against excitotoxicity	SCIENCE			English	Article							N-ACYLETHANOLAMINE PHOSPHOLIPIDS; ACUTE NEURONAL INJURY; ANANDAMIDE; BRAIN; RAT; ENDOCANNABINOIDS; GLUTAMATE; MICE; NEUROPROTECTION; NEUROTOXICITY	Abnormally high spiking activity can damage neurons. Signaling systems to protect neurons from the consequences of abnormal discharge activity have been postulated. We generated conditional mutant mice that lack expression of the cannabinoid receptor type 1 in principal forebrain neurons but not in adjacent inhibitory interneurons. In mutant mice, the excitotoxin kainic acid (KA) induced excessive seizures in vivo. The threshold to KA-induced neuronal excitation in vitro was severely reduced in hippocampal pyramidal neurons of mutants. KA administration rapidly raised hippocampal levels of anandamide and induced protective mechanisms in wild-type principal hippocampal neurons. These protective mechanisms could not be triggered in mutant mice. The endogenous cannabinoid system thus provides on-demand protection against acute excitotoxicity in central nervous system neurons.	Max Planck Inst Psychiat, Clin Neuropharmacol Grp, D-80804 Munich, Germany; Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany; Univ Munich, Klinikum Grosshadern, Clin Anaesthesiol, D-81377 Munich, Germany; CNR, Inst Biomol Chem, Endocannabinoid Res Grp, I-80078 Naples, Italy; Univ Complutense, Dept Organ Chem, E-28040 Madrid, Spain; German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany	Max Planck Society; Johannes Gutenberg University of Mainz; University of Munich; Consiglio Nazionale delle Ricerche (CNR); Complutense University of Madrid; Helmholtz Association; German Cancer Research Center (DKFZ)	Lutz, B (corresponding author), Max Planck Inst Psychiat, Clin Neuropharmacol Grp, Kraepelinstr 2-10, D-80804 Munich, Germany.	lutz@mpipsykl.mpg.de	Lutz, Beat/AFK-6229-2022; Di Marzo, Vincenzo/AAD-7742-2019; Ortega-Gutierrez, Silvia/I-1935-2017; Casanova, Emilio/Y-6553-2019; Lutz, Beat/AAG-4538-2022; Lopez-Rodriguez, Maria L/S-6342-2016; Ortega-Gutierrez, Silvia/ABC-7653-2021; Marsicano, Giovanni/I-9603-2016	Di Marzo, Vincenzo/0000-0002-1490-3070; Ortega-Gutierrez, Silvia/0000-0002-0257-6754; Casanova, Emilio/0000-0001-7992-5361; Lopez-Rodriguez, Maria L/0000-0001-8607-1085; Marsicano, Giovanni/0000-0003-3804-1951; Behl, Christian/0000-0001-8453-2378; Eder, Matthias/0000-0002-2579-2628				Baker D, 2001, FASEB J, V15, P300, DOI 10.1096/fj.00-0399fje; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Cadas H, 1996, J NEUROSCI, V16, P3934; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chan GCK, 1998, J NEUROSCI, V18, P5322, DOI 10.1523/JNEUROSCI.18-14-05322.1998; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clement AB, 2003, J NEUROSCI, V23, P3916; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Croxford JL, 2003, CNS DRUGS, V17, P179, DOI 10.2165/00023210-200317030-00004; de Lago E, 2002, EUR J PHARMACOL, V449, P99, DOI 10.1016/S0014-2999(02)01996-9; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Ferrer I, 2002, ACTA NEUROPATHOL, V103, P391, DOI 10.1007/s00401-001-0481-9; Gratacos E, 2001, J NEUROCHEM, V78, P1287, DOI 10.1046/j.1471-4159.2001.00538.x; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Hansen HH, 2002, J NEUROCHEM, V82, P154, DOI 10.1046/j.1471-4159.2002.00961.x; Hansen HH, 2001, J NEUROCHEM, V76, P39, DOI 10.1046/j.1471-4159.2001.00006.x; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Katona I, 1999, J NEUROSCI, V19, P4544; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MARSICANO G, UNPUB; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; MECHOULAM R, 2002, SCI STKE, pRE1; Moesgaard B, 2003, LIPIDS, V38, P387, DOI 10.1007/s11745-003-1073-1; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Selley DE, 2001, J NEUROCHEM, V77, P1048, DOI 10.1046/j.1471-4159.2001.00308.x; Tandon P, 1999, NEUROSCIENCE, V91, P293, DOI 10.1016/S0306-4522(98)00609-5; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Veldhuis WB, 2003, J NEUROSCI, V23, P4127; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	40	918	956	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2003	302	5642					84	88		10.1126/science.1088208	http://dx.doi.org/10.1126/science.1088208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526074				2022-12-01	WOS:000185678500039
J	Antia, R; Regoes, RR; Koella, JC; Bergstrom, CT				Antia, R; Regoes, RR; Koella, JC; Bergstrom, CT			The role of evolution in the emergence of infectious diseases	NATURE			English	Article							TRANSMISSION DYNAMICS; NIPAH VIRUS; MONKEYPOX; HEALTH; SARS; OUTBREAK	It is unclear when, where and how novel pathogens such as human immunodeficiency virus ( HIV), monkeypox and severe acute respiratory syndrome ( SARS) will cross the barriers that separate their natural reservoirs from human populations and ignite the epidemic spread of novel infectious diseases. New pathogens are believed to emerge from animal reservoirs when ecological changes increase the pathogen's opportunities to enter the human population(1) and to generate subsequent human- to-human transmission(2). Effective human- to- human transmission requires that the pathogen's basic reproductive number, R-0, should exceed one, where R-0 is the average number of secondary infections arising from one infected individual in a completely susceptible population(3). However, an increase in R-0, even when insufficient to generate an epidemic, nonetheless increases the number of subsequently infected individuals. Here we show that, as a consequence of this, the probability of pathogen evolution to R-0 > 1 and subsequent disease emergence can increase markedly.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Univ Paris 06, Lab Parasitol Evolut, F-75252 Paris, France; Univ Washington, Dept Biol, Seattle, WA 98195 USA	Emory University; UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle	Antia, R (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	rantia@emory.edu	Regoes, Roland R/A-6538-2008; Bergstrom, Carl T./H-2299-2011	Regoes, Roland R/0000-0001-8319-5293; Bergstrom, Carl T./0000-0002-2070-385X				ANDERSON R M, 1991; Athreya K.B., 2004, BRANCHING PROCESSES, P1; Breman JG, 1998, NEW ENGL J MED, V339, P556, DOI 10.1056/NEJM199808203390811; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Cyranoski D, 2003, NATURE, V423, P467, DOI 10.1038/423467a; DEMETRIUS L, 1985, B MATH BIOL, V47, P239; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Elton C. S, 1958, ECOLOGY INVASIONS AN; Enserink M, 2000, SCIENCE, V289, P518, DOI 10.1126/science.289.5479.518; Enserink M, 1999, SCIENCE, V284, P407, DOI 10.1126/science.284.5413.407; Enserink M, 2003, SCIENCE, V300, P1351; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Holmes EC, 2001, BIOL REV, V76, P239, DOI 10.1017/S1464793101005668; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; KORNBERG H, 1987, QUANTITATIVE BIOL EC; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; MAY RM, 1990, PARASITOLOGY, V100, pS89, DOI 10.1017/S0031182000073042; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Stivers DN, 1996, MATH BIOSCI, V137, P25, DOI 10.1016/S0025-5564(96)00066-1; WALLACE B, 1989, AM NAT, V133, P578, DOI 10.1086/284937; Wilke CO, 2003, GENETICS, V163, P467; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	29	347	351	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					658	661		10.1038/nature02104	http://dx.doi.org/10.1038/nature02104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668863	Green Published, Green Submitted			2022-12-01	WOS:000187132800040
J	Sakaguchi, N; Takahashi, T; Hata, H; Nomura, T; Tagami, T; Yamazaki, S; Sakihama, T; Matsurtani, T; Negishi, I; Nakatsuru, S; Sakaguchi, S				Sakaguchi, N; Takahashi, T; Hata, H; Nomura, T; Tagami, T; Yamazaki, S; Sakihama, T; Matsurtani, T; Negishi, I; Nakatsuru, S; Sakaguchi, S			Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TCR-ZETA-CHAIN; RHEUMATOID-ARTHRITIS; TYROSINE KINASE; TRANSGENIC MICE; RECEPTOR; DISEASE; THYMOCYTES; ANTIGEN	Rheumatoid arthritis (RA), which afflicts about 1% of the world population, is a chronic systemic inflammatory disease of unknown aetiology that primarily affects the synovial membranes of multiple joints(1-3). Although CD4+ T cells seem to be the prime mediators of RA, it remains unclear how arthritogenic CD4(+) T cells are generated and activated(1-3). Given that highly self-reactive T-cell clones are deleted during normal T-cell development in the thymus, abnormality in T-cell selection has been suspected as one cause of autoimmune disease(4,5). Here we show that a spontaneous point mutation of the gene encoding an SH2 domain of ZAP-70, a key signal transduction molecule in T cells(6), causes chronic autoimmune arthritis in mice that resembles human RA in many aspects. Altered signal transduction from T-cell antigen receptor through the aberrant ZAP-70 changes the thresholds of T cells to thymic selection, leading to the positive selection of otherwise negatively selected autoimmune T cells. Thymic production of arthritogenic T cells due to a genetically determined selection shift of the T-cell repertoire towards high self-reactivity might also be crucial to the development of disease in a subset of patients with RA.	Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; RIKEN, Immunopathol Lab, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; Shionogi Inst Med Sci, Dept Immunol, Osaka 5660022, Japan; Gunma Univ Hosp, Dept Dermatol, Maebashi, Gumma 3718511, Japan	Kyoto University; RIKEN; Shionogi & Company Limited; Gunma University	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.		Tagami, Takashi/HGA-3038-2022; Sakaguchi, Shimon/C-9535-2009	Tagami, Takashi/0000-0001-6953-1932; 				Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Dayer JM, 1999, ARTHRITIS RES, V1, P17, DOI 10.1186/ar5; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein G.S, 1997, TXB RHEUMATOLOGY, P851; Harris ED, 1997, RHEUMATOID ARTHRITIS; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Itoh M, 1999, J IMMUNOL, V162, P5317; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nambiar MP, 2001, ARTHRITIS RHEUM, V44, P1336, DOI 10.1002/1529-0131(200106)44:6<1336::AID-ART226>3.0.CO;2-8; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Noraz N, 2000, J BIOL CHEM, V275, P15832, DOI 10.1074/jbc.M908568199; PALS ST, 1985, J IMMUNOL, V134, P1475; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; SAKAGUCHI S, 1990, J EXP MED, V172, P537, DOI 10.1084/jem.172.2.537; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Takeuchi T, 1998, INT IMMUNOL, V10, P911, DOI 10.1093/intimm/10.7.911; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	30	608	643	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					454	460		10.1038/nature02119	http://dx.doi.org/10.1038/nature02119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647385				2022-12-01	WOS:000186800800041
J	Tekkis, PP; Poloniecki, JD; Thompson, MR; Stamatakis, JD				Tekkis, PP; Poloniecki, JD; Thompson, MR; Stamatakis, JD		Assoc Coloproctology Great Britain	Operative mortality in colorectal cancer: prospective national study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL CARE; RISK; PERFORMANCE; RATES; SURGEONS; QUALITY; POSSUM	Objective To develop a mathematical model that will predict the probability of death after surgery for colorectal cancer. Design Descriptive study using routinely collected clinical data. Data source The database of the Association of Coloproctology of Great Britain and Ireland (ACPGBI), encompassing 8077 patients with a new diagnosis of colorectal cancer in 73 hospitals during a 12 month period. Statistical analysis A three level hierarchical logistic regression model was used to identify independent predictors of operative mortality. The model was developed on 60% of the patient population and its validity tested on the remaining 40%. Results Overall postoperative mortality was 7.5% (95% confidence interval 6.9% to 8.1%). Independent predictors of death were age, American Society of Anesthesiology (ASA) grade, Dukes's stage, urgency of the operation, and cancer excision. When tested the predictive model showed good discrimination (area under the receiver operating characteristic curve = (0.775) and calibration (comparison of observed with expected mortality across different procedures; Hosmer-Lemeshow statistic = 6.34, 8 df, P = 0.610). Conclusions Clinicians can predict postoperative death by using a simple numerical table derived from the statistical model of the ACPGBI. The model can be used in everyday practice for preoperative counselling of patients and their carers as a part of multidisciplinary care. It may also be used to compare the outcomes between multidisciplinary teams for colorectal cancer.	Prince Wales Hosp, Dept Surg, Bridgend CF31 1RQ, Wales; St Marks Hosp, Dept Surg, Harrow HA1 3UJ, Middx, England; Univ London St Georges Hosp, Dept Publ Hlth Sci, London SW17 0WT, England; Queen Alexandra Hosp, Dept Surg, Portsmouth, Hants, England	Imperial College London; St Georges University London; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Stamatakis, JD (corresponding author), Prince Wales Hosp, Dept Surg, Bridgend CF31 1RQ, Wales.	jeff.stamatakis@bromor-tr.wales.nhs.uk						Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; Callum KG.AppendixA, 2000, NOW 2000 REPORT NATL, P125; Copeland G P, 1992, J R Coll Surg Edinb, V37, P145; COPELAND GP, 1991, BRIT J SURG, V78, P356; Daley J, 2001, ANNU REV MED, V52, P275, DOI 10.1146/annurev.med.52.1.275; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Department of Health, HOSP EP STAT; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P149, DOI 10.2307/2983475; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Holm T, 1997, BRIT J SURG, V84, P657, DOI 10.1002/bjs.1800840520; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 1997, J AM COLL SURGEONS, V185, P315, DOI 10.1016/S1072-7515(01)00938-3; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; Sagar PM, 1996, DIS COLON RECTUM, V39, P654, DOI 10.1007/BF02056945; Spiegelhalter DJ, 2002, J R STAT SOC A STAT, V165, P191, DOI 10.1111/1467-985X.02021; Tekkis PP, 2000, DIS COLON RECTUM, V43, P1528, DOI 10.1007/BF02236732; Treasure T, 2002, THORAX, V57, P3, DOI 10.1136/thorax.57.1.3; TURNBULL RB, 1967, ANN SURG, V166, P420	20	195	202	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2003	327	7425					1196	1199		10.1136/bmj.327.7425.1196	http://dx.doi.org/10.1136/bmj.327.7425.1196			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747BB	14630754	Bronze, Green Published			2022-12-01	WOS:000186784300017
J	Wada, S; Oishi, M; Yamada, TK				Wada, S; Oishi, M; Yamada, TK			A newly discovered species of living baleen whale	NATURE			English	Article							MITOCHONDRIAL-DNA; FIN WHALE; SEQUENCES; REGION	In the late 1970s eight Balaenoptera specimens of unknown identity were caught in the lower latitudinal Indo-Pacific waters by Japanese research whaling vessels(1). The combination of the allozyme patterns and physical maturity of the eight specimens separated them from all acknowledged Balaenoptera species(2). In September 1998 we collected a medium-sized baleen whale carcass on a coastal island in the Sea of Japan. This specimen and the previously collected eight specimens resembled Balaenoptera physalus (fin whale) in external appearance but were much smaller. Comparison of external morphology, osteology and mitochondrial DNA data grouped the nine specimens as a single species but separated them from all known baleen whale species. Therefore, here we describe a new species of Balaenoptera, which is characterized by its unique cranial morphology, its small number of baleen plates, and by its distant molecular relationships with all of its congeners. Our analyses also separated Balaenoptera brydei (Bryde's whale)(3,4) and Balaenoptera edeni (Eden's whale)(5) into two distinct species, raising the number of known living Balaenoptera species to eight.	Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; Iwate Prefectural Museum, Morioka, Iwate 0200102, Japan; Museum Nat Sci, Shinjuku Ku, Tokyo 1690073, Japan	Fisheries Research Agency - Japan	Wada, S (corresponding author), Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.		Yamada, Tadasu K./C-3362-2008					ANDERSON J, 1978, ANATOMICAL ZOOLOGICA, V1, P551; Andrews R. C., 1918, Records of the Indian Museum, V15; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; ARNASON U, 1993, J MOL EVOL, V37, P312; ARNASON U, 1993, MOL BIOL EVOL, V10, P960; ARNASON U, 1991, J MOL EVOL, V33, P556, DOI 10.1007/BF02102808; Arnold P., 1987, SCI REP WHALES RES I, V38, P1; BEST PB, 1985, SCI REP WHALES RES, V36, P1; BEST PB, 1977, REPORTS INT WHALING, V1, P10; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Junge G. C. A., 1950, Zool Verh Leiden 1950, VNo. 9, P1; Kato H., 2002, ENCY MARINE MAMMALS, P171; LeDuc Richard G., 2002, P100; LONNBERG EINAR, 1931, ARK ZOOL, V23B, P1; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P183; Ohsumi S., 1980, REPORT INT WHALING C, V30, P319; OLSEN O, 1913, P ZOOL SOC LOND, P1073; Omura H., 1981, SCI REP WHALES RES, V33, P1; OMURA H, 1966, WHALES DOLPHINS PORP, P70; Pilleri G., 1974, INVEST CETACEA, VV, P95; RICE DW, 1998, MAR MAMMAL SCI, V4, P67; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soot-Eyen T., 1961, Norsk Hvalfangsttidende Sandefjord, V50, P323; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRUE FW, 1904, SMITHSONIAN CONTRIBU, V33, P1; WADA S, 1991, REPORTS INT WHALING, V13, P125	27	134	167	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					278	281		10.1038/nature02103	http://dx.doi.org/10.1038/nature02103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628049				2022-12-01	WOS:000186660800041
J	Feldmann, J; Callebaut, I; Raposo, G; Certain, S; Bacq, D; Dumont, C; Lambert, N; Ouachee-Chardin, M; Chedeville, G; Tamary, H; Minard-Colin, V; Vilmer, E; Blanche, S; Le Deist, F; Fischer, A; Saint Basile, GD				Feldmann, J; Callebaut, I; Raposo, G; Certain, S; Bacq, D; Dumont, C; Lambert, N; Ouachee-Chardin, M; Chedeville, G; Tamary, H; Minard-Colin, V; Vilmer, E; Blanche, S; Le Deist, F; Fischer, A; Saint Basile, GD			Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)	CELL			English	Article							CHEDIAK-HIGASHI-SYNDROME; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; LYMPHOCYTES-T; DOMAIN; EXOCYTOSIS; UNC-13; CELLS; PROTEINS; SYNTAXIN	Secretion of cytolytic granules content at the immunological synapse is a highly regulated process essential for lymphocyte cytotoxicity. This process requires the rapid transfer of perforin containing lytic granules to the target cell interface, followed by their docking and fusion with the plasma membrane. Defective cytotoxicity characterizes a genetically heterogeneous condition named familial hemophagocytic lymphohistiocytosis (FHL), which can be associated with perforin deficiency. The locus of a perforin (+) FHL subtype (FHL3), observed in 10 patients, was mapped to 17q25. This region contains hMunc13-4, a member of the Munc13 family of proteins involved in vesicle priming function. HMunc13-4 mutations were shown to cause FHL3. HMunc13-4 deficiency results in defective cytolytic granule exocytosis, despite polarization of the secretory granules and docking with the plasma membrane. Expressed tagged hMunc13-4 localizes with cytotoxic granules at the immunological synapse. HMunc13-4 is therefore essential for the priming step of cytolytic granules secretion preceding vesicle membrane fusion.	Hop Necker Enfants Malad, INSERM U429, F-75743 Paris, France; Univ Paris 06, CNRS UMR7590, LMCP, F-75005 Paris, France; Univ Paris 07, CNRS UMR7590, LMCP, F-75005 Paris, France; Inst Curie, CNRS UMR 144, Paris, France; Ctr Natl Genotypage, F-91057 Evry, France; Hop Necker Enfants Malad, Unite Immunol Hematol, F-75015 Paris, France; Schneiders Children Med Ctr, Pediat Hematol Unit, IL-49202 Petah Tiqwa, Israel; Hop Robert Debre, Unite Immunohematol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Saint Basile, GD (corresponding author), Hop Necker Enfants Malad, INSERM U429, F-75743 Paris, France.		de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269; Raposo, graca/0000-0001-9590-1298; DOGNIAUX, Stephanie/0000-0003-3309-1204				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BAETZ K, 1995, J IMMUNOL, V154, P6122; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; de Saint Basile G, 2001, CURR OPIN IMMUNOL, V13, P549, DOI 10.1016/S0952-7915(00)00257-0; Dufourcq-Lagelouse R, 1999, AM J HUM GENET, V64, P172, DOI 10.1086/302194; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; FORTIER AH, 1989, CELL IMMUNOL, V124, P64, DOI 10.1016/0008-8749(89)90112-3; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ohadi M, 1999, AM J HUM GENET, V64, P165, DOI 10.1086/302187; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sassa T, 1999, J NEUROSCI, V19, P4772; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V251, P158, DOI 10.1006/bbrc.1998.9408; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	655	688	1	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					461	473		10.1016/S0092-8674(03)00855-9	http://dx.doi.org/10.1016/S0092-8674(03)00855-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622600	Bronze			2022-12-01	WOS:000186627100012
J	Gstaiger, M; Luke, B; Hess, D; Oakeley, EJ; Wirbelauer, C; Blondel, M; Vigneron, M; Peter, M; Krek, W				Gstaiger, M; Luke, B; Hess, D; Oakeley, EJ; Wirbelauer, C; Blondel, M; Vigneron, M; Peter, M; Krek, W			Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOSOLIC CHAPERONIN; UNFOLDED PROTEINS; AMINO-ACID; YEAST; EXPRESSION; STARVATION; CELLS; TOR; P45(SKP2)	Prefoldins (PFDs) are members of a recently identified, small-molecular weight protein family able to assemble into molecular chaperone complexes. Here we describe an unusually large member of this family, termed URI, that forms complexes with other small-molecular weight PFDs and with RPB5, a shared subunit of all three RNA polymerases. Functional analysis of the yeast and human orthologs of URI revealed that both are targets of nutrient signaling and participate in gene expression controlled by the TOR kinase. Thus, URI is a component of a signaling pathway that coordinates nutrient availability with gene expression.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland; Univ Strasbourg 1, Ecole Super Biotechnol Strasbourg, CNRS, UMR 7100, F-67412 Illkirch Graffenstaden, France	Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Krek, W (corresponding author), ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland.		Blondel, Marc/AAJ-9049-2020	Blondel, Marc/0000-0003-4897-2995; Peter, Matthias/0000-0002-2160-6824; Luke, Brian/0000-0002-1648-5511				Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kanemaki M, 1997, BIOCHEM BIOPH RES CO, V235, P64, DOI 10.1006/bbrc.1997.6729; KRON SJ, 1995, CURR OPIN CELL BIOL, V7, P845, DOI 10.1016/0955-0674(95)80069-7; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; LUKE BT, UNPUB; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; MURAKAMI Y, 1995, NAT GENET, V10, P261, DOI 10.1038/ng0795-261; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; WIRBELAUER C, UNPUB; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; WOYCHIK NA, 1990, GENE DEV, V4, P313, DOI 10.1101/gad.4.3.313	25	135	142	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1208	1212		10.1126/science.1088401	http://dx.doi.org/10.1126/science.1088401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615539				2022-12-01	WOS:000186544300054
J	Koechlin, E; Ody, C; Kouneiher, F				Koechlin, E; Ody, C; Kouneiher, F			The architecture of cognitive control in the human prefrontal cortex	SCIENCE			English	Article							WORKING-MEMORY; MAINTENANCE; MECHANISMS; BEHAVIOR; MOTOR; FMRI	The prefrontal cortex (PFC) subserves cognitive control: the ability to coordinate thoughts or actions in relation with internal goals. Its functional architecture, however, remains poorly understood. Using brain imaging in humans, we showed that the lateral PFC is organized as a cascade of executive processes from premotor to anterior PFC regions that control behavior according to stimuli, the present perceptual context, and the temporal episode in which stimuli occur, respectively. The results support an unified modular model of cognitive control that describes the overall functional organization of the human lateral PFC and has basic methodological and theoretical implications.	Univ Paris 06, INSERM, F-75005 Paris, France; Hop La Pitie Salpetriere, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Koechlin, E (corresponding author), Univ Paris 06, INSERM, 9 Quai St Bernard, F-75005 Paris, France.	koechlin@ccr.jussieu.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311				Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; BERLYNE DE, 1957, PSYCHOL REV, V64, P329, DOI 10.1037/h0041135; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI, V2; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston K. J., 1993, Human Brain Mapping, V1, P69, DOI 10.1002/hbm.460010108; Furey ML, 1997, P NATL ACAD SCI USA, V94, P6512, DOI 10.1073/pnas.94.12.6512; Fuster J, 1989, PREFRONTAL CORTEX; Goldman-Rakic P. S., 1987, HDB PHYSL, V5, P373, DOI DOI 10.1002/CPHY.CP010509; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nagahama Y, 2001, CEREB CORTEX, V11, P85, DOI 10.1093/cercor/11.1.85; Norwich KH, 1997, PERCEPT PSYCHOPHYS, V59, P929, DOI 10.3758/BF03205509; Pandya DN, 1996, RES PER NEUROSCI, P13; Passingham R. E., 1993, OXFORD PSYCHOL SERIE; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Shallice T, 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	30	1176	1182	2	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1181	1185		10.1126/science.1088545	http://dx.doi.org/10.1126/science.1088545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615530				2022-12-01	WOS:000186544300045
J	Nystul, TG; Goldmark, JP; Padilla, PA; Roth, MB				Nystul, TG; Goldmark, JP; Padilla, PA; Roth, MB			Suspended animation in C-elegans requires the spindle checkpoint	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; OXYGEN DEPRIVATION; MECHANISMS; HYPOXIA; PROTEIN; ARREST; ANOXIA; VISUALIZATION; DIAPAUSE; ENCODES	In response to environmental signals such as anoxia, many organisms enter a state of suspended animation, an extreme form of quiescence in which microscopically visible movement ceases. We have identified a gene, san-1, that is required for suspended animation in Caenorhabditis elegans embryos. We show that san-1 functions as a spindle checkpoint component in C. elegans. During anoxia-induced suspended animation, embryos lacking functional SAN-1 or a second spindle checkpoint component, MDF-2, failed to arrest the cell cycle, exhibited chromosome missegregation, and showed reduced viability. These data provide a model for how a dynamic biological process is arrested in suspended animation.	Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA; Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Texas System; University of North Texas Denton	Roth, MB (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.		Nystul, Todd/AAA-7344-2022	Nystul, Todd/0000-0002-6250-2394	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM048435] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48435, T32 GM07270] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Clegg JS, 1997, J EXP BIOL, V200, P467; Douglas RM, 2003, J APPL PHYSIOL, V94, P2068, DOI 10.1152/japplphysiol.01029.2002; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; NYSTUL TG, UNPUB; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Safar P, 2000, CRIT CARE MED, V28, pN214, DOI 10.1097/00003246-200011001-00012; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Storey KB, 2002, COMP BIOCHEM PHYS A, V133, P733, DOI 10.1016/S1095-6433(02)00206-4; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1	23	72	78	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1038	1041		10.1126/science.1089705	http://dx.doi.org/10.1126/science.1089705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605367				2022-12-01	WOS:000186396300046
J	Alvarez-Dolado, M; Pardal, R; Garcia-Vardugo, JM; Fike, JR; Lee, HO; Pfeffer, K; Lois, C; Morrison, SJ; Alvarez-Buylla, A				Alvarez-Dolado, M; Pardal, R; Garcia-Vardugo, JM; Fike, JR; Lee, HO; Pfeffer, K; Lois, C; Morrison, SJ; Alvarez-Buylla, A			Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes	NATURE			English	Article							STEM-CELLS; MONOCLONAL-ANTIBODIES; IN-VIVO; MICE; DNA; DIFFERENTIATION; PLASTICITY; MICROGLIA; ANTIGENS; BRAIN	Recent studies have suggested that bone marrow cells possess a broad differentiation potential, being able to form new liver cells, cardiomyocytes and neurons(1,2). Several groups have attributed this apparent plasticity to 'transdifferentiation'(3-5). Others, however, have suggested that cell fusion could explain these results(6-9). Using a simple method based on Cre/lox recombination to detect cell fusion events, we demonstrate that bone-marrow-derived cells (BMDCs) fuse spontaneously with neural progenitors in vitro. Furthermore, bone marrow transplantation demonstrates that BMDCs fuse in vivo with hepatocytes in liver, Purkinje neurons in the brain and cardiac muscle in the heart, resulting in the formation of multinucleated cells. No evidence of transdifferentiation without fusion was observed in these tissues. These observations provide the first in vivo evidence for cell fusion of BMDCs with neurons and cardiomyocytes, raising the possibility that cell fusion may contribute to the development or maintenance of these key cell types.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Valencia, Inst Cavanilles, E-46100 Valencia, Spain; Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Valencia; Heinrich Heine University Dusseldorf; Massachusetts Institute of Technology (MIT)	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.		IBIS, FISIOPATOLOGIA/O-9510-2015; Pardal, Ricardo/C-4370-2015; Alvarez-Dolado, Manuel/C-2706-2017; Morrison, Sean/ABD-5326-2021; García-Verdugo, José Manuel/L-8421-2017	Pardal, Ricardo/0000-0003-1085-0714; Alvarez-Dolado, Manuel/0000-0002-0655-8289; García-Verdugo, José Manuel/0000-0001-9872-6499; Morrison, Sean/0000-0003-1587-8329; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Pfeffer, Klaus/0000-0002-5652-6330				Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; ARIAS IM, 2001, LIVER BIOL PATHOBIOL; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LAPHAM LW, 1968, SCIENCE, V159, P310, DOI 10.1126/science.159.3812.310; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; MARES V, 1973, BRAIN RES, V53, P273, DOI 10.1016/0006-8993(73)90214-X; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; PALAY LP, 1974, CEREBELLAR CORTEX, P15; PIPER HM, 1989, ISOLATED ADULT CARDI; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Spector D. L., 1998, CELLS LAB MANUAL; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; VANEWIJK W, 1981, J IMMUNOL, V127, P2594; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weiss S, 1996, J NEUROSCI, V16, P7599; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	30	1249	1350	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					968	973		10.1038/nature02069	http://dx.doi.org/10.1038/nature02069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14555960	Green Published			2022-12-01	WOS:000186230600043
J	Arantes-Oliveira, N; Berman, JR; Kenyon, C				Arantes-Oliveira, N; Berman, JR; Kenyon, C			Healthy animals with extreme longevity	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; SIGNALS; GENES		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Mission Bay Genentech Hall,600 16th St,Room S312D, San Francisco, CA 94143 USA.			Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [R0I AG20932] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG020932] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gems D, 1998, GENETICS, V150, P129; HEKIMI S, COMMUNICATION; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1995, GENETICS, V139, P1567; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447	7	128	140	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					611	611		10.1126/science.1089169	http://dx.doi.org/10.1126/science.1089169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576426				2022-12-01	WOS:000186119900049
J	Flum, DR; Cheadle, A; Prela, C; Dellinger, EP; Chan, L				Flum, DR; Cheadle, A; Prela, C; Dellinger, EP; Chan, L			Bile duct injury during cholecystectomy and survival in medicare beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BENIGN BILIARY STRICTURES; QUALITY-OF-LIFE; LAPAROSCOPIC CHOLECYSTECTOMY; INTRAOPERATIVE CHOLANGIOGRAPHY; TRACT INJURY; MANAGEMENT; SURGERY; COMPLICATIONS; HEPATICOJEJUNOSTOMY; ANASTOMOSIS	Context Common bile duct (CBD) injury during cholecystectomy is a significant source of patient morbidity, but its impact on survival is unclear. Objective To demonstrate the relation between CBD injury and survival and to identify the factors associated with improved survival among Medicare beneficiaries. Design, Setting, and Patients Retrospective study using Medicare National Claims History Part B data(January 1, 1992, through December 31, 1999) linked to death records and to the American Medical Association's (AMA's) Physician Masterfile. Records with a procedure code for cholecystectomy were reviewed and those with an additional procedure code for repair of the CBD within 365 days were defined as having a CBD injury. Main Outcome Measure Survival after cholecystectomy, controlling for patient (sex, age, comorbidity index, disease severity) and surgeon (procedure year, case order, surgeon specialty) characteristics. Results Of the 1570361 patients identified as having had a cholecystectomy (62.9% women), 7911 patients (0.5%) had CBD injuries. The entire population had a mean (SD) age of 71.4 (10.2) years. Thirty-three percent of all patients died within the 9.2-year follow-up period (median survival, 5.6 years; interquartile range, 3.2-7.4 years), with 55.2% of patients without and 19.5% with a CBD injury remained alive. The adjusted hazard ratio (HR) for death during the follow-up period was significantly higher (2.79; 95% confidence interval [Cl]; 2.71-2.88) for patients with a CBD injury than those without CBD injury. The hazard significantly increased with advancing age and comorbidities and decreased with the experience of the repairing surgeon. The adjusted hazard of death during the follow-up period was 11% greater (HR, 1.11; 95% Cl, 1.02-1.20) if the repairing surgeon was the same as the injuring surgeon. Conclusions The association between CBD injury during cholecystectomy and survival among Medicare beneficiaries is stronger than suggested by previous reports. Referring patients with CBD injuries to surgeons or institutions with greater experience in CBD repair may represent a system-level opportunity to improve outcome.	Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Ctr Med & Med Serv, Div Clin Stand & Qual, Seattle, WA USA; Univ Washington, Robert Wood Johnson Clin Scholars Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Flum, DR (corresponding author), Univ Washington, Dept Surg, BB 431,1959 NE Pacific St,Box 356410, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022					Al-Ghnaniem R, 2002, BRIT J SURG, V89, P1118, DOI 10.1046/j.1365-2168.2002.02182.x; Bauer T W, 1998, J Gastrointest Surg, V2, P61, DOI 10.1016/S1091-255X(98)80104-2; Boerma D, 2001, ANN SURG, V234, P750, DOI 10.1097/00000658-200112000-00006; Buanes T, 1998, SURG ENDOSC-ULTRAS, V12, P852, DOI 10.1007/s004649900728; Carroll BJ, 1998, SURG ENDOSC-ULTRAS, V12, P310, DOI 10.1007/s004649900660; Chaudhary A, 2002, DIGEST SURG, V19, P22, DOI 10.1159/000052001; Csendes A, 2001, WORLD J SURG, V25, P1346, DOI 10.1007/s00268-001-0121-5; CSENDES A, 1992, HEPATO-GASTROENTEROL, V39, P333; DAVIDS PHP, 1993, ANN SURG, V217, P237, DOI 10.1097/00000658-199303000-00004; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DEZIEL DJ, 1993, AM J SURG, V165, P9, DOI 10.1016/S0002-9610(05)80397-6; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Gigot JF, 1997, SURG ENDOSC-ULTRAS, V11, P1171, DOI 10.1007/s004649900563; Gouma DJ, 2002, BRIT J SURG, V89, P385, DOI 10.1046/j.0007-1323.2002.02051.x; INNES JT, 1988, AM SURGEON, V54, P27; Johnson SR, 2000, SURGERY, V128, P668, DOI 10.1067/msy.2000.108422; Kern KA, 1997, ARCH SURG-CHICAGO, V132, P392; KERN KA, 1994, AM J SURG, V168, P217, DOI 10.1016/S0002-9610(05)80189-8; Krahenbuhl L, 2001, WORLD J SURG, V25, P1325; Lillemoe KD, 2000, ANN SURG, V232, P430, DOI 10.1097/00000658-200009000-00015; Ludwig K, 2002, SURG ENDOSC, V16, P1098, DOI 10.1007/s00464-001-9183-6; MACAULAY FX, 1967, SCIENCE, V157, P1261, DOI 10.1126/science.157.3794.1261-b; MacFadyen BV, 1998, SURG ENDOSC-ULTRAS, V12, P315, DOI 10.1007/s004649900661; Mathisen O, 2002, SCAND J GASTROENTERO, V37, P476, DOI 10.1080/003655202317316123; Mirza DF, 1997, BRIT J SURG, V84, P786, DOI 10.1002/bjs.1800840614; Nealon WH, 1996, ANN SURG, V223, P639, DOI 10.1097/00000658-199606000-00002; PELLEGRINI CA, 1984, AM J SURG, V147, P175, DOI 10.1016/0002-9610(84)90054-0; PITT HA, 1989, ANN SURG, V210, P417, DOI 10.1097/00000658-198910000-00001; Russell JC, 1996, ARCH SURG-CHICAGO, V131, P382; Slater K, 2002, ANZ J SURG, V72, P83, DOI 10.1046/j.1445-2197.2002.02315.x; STEWART L, 1995, ARCH SURG-CHICAGO, V130, P1123; Targarona EM, 1998, SURG ENDOSC-ULTRAS, V12, P322, DOI 10.1007/s004649900662; Tocchi A, 2000, ARCH SURG-CHICAGO, V135, P153, DOI 10.1001/archsurg.135.2.153; Topal B, 1999, SURG ENDOSC, V13, P53, DOI 10.1007/s004649900897; Tsatis KG, 2003, SURG ENDOSC, V17, P31, DOI 10.1007/s00464-001-9230-3; Walsh R M, 1998, J Gastrointest Surg, V2, P458, DOI 10.1016/S1091-255X(98)80037-1; WOODS MS, 1994, AM J SURG, V167, P27, DOI 10.1016/0002-9610(94)90050-7; Z'graggen K, 1998, SURG ENDOSC-ULTRAS, V12, P1303, DOI 10.1007/s004649900846	38	316	351	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2003	290	16					2168	2173		10.1001/jama.290.16.2168	http://dx.doi.org/10.1001/jama.290.16.2168			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CB	14570952	Bronze			2022-12-01	WOS:000186036700026
J	Dickinson, D; Raynor, DKT; Kennedy, JG; Bonaccorso, S; Sturchio, JL				Dickinson, D; Raynor, DKT; Kennedy, JG; Bonaccorso, S; Sturchio, JL			What information do patients need about medicines?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Consumation, Consumer Informat Design, London SW17 7QW, England; Univ Leeds, Pharm Practice & Med Management Grp, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Dickinson, D (corresponding author), Consumation, Consumer Informat Design, 53 Hosack Rd, London SW17 7QW, England.		Sturchio, Jeffrey/GWZ-3472-2022						0	69	72	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2003	327	7419					861	861		10.1136/bmj.327.7419.861-a	http://dx.doi.org/10.1136/bmj.327.7419.861-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732BP	14551106	Green Accepted, Green Published			2022-12-01	WOS:000185921200029
J	Gent, JF; Triche, EW; Holford, TR; Belanger, K; Bracken, MB; Beckett, WS; Leaderer, BP				Gent, JF; Triche, EW; Holford, TR; Belanger, K; Bracken, MB; Beckett, WS; Leaderer, BP			Association of low-level ozone and fine particles with respiratory symptoms in children with asthma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AFRICAN-AMERICAN CHILDREN; AIR-POLLUTION; MEDICATION USE; AMBIENT OZONE; 1ST YEAR; PARTICULATE; EXPOSURE; SUMMER; HEALTH; LIFE	Context Exposure to ozone and particulate matter of 2.5 mum or less (PM2.5) in air at levels above current US Environmental Protection Agency (EPA) standards is a risk factor for respiratory symptoms in children with asthma. Objective To examine simultaneous effects of ozone and PM2.5 at levels below EPA standards on daily respiratory symptoms and rescue medication use among children with asthma. Design, Setting, and Participants Daily respiratory symptoms and medication use were examined prospectively for 271 children younger than 12 years with physician-diagnosed, active asthma residing in southern New England. Exposure to ambient concentrations of ozone and PM2.5 from April 1 through September 30, 2001, was assessed using ozone (peak 1-hour and 8-hour) and 24-hour PM2.5. Logistic regression analyses using generalized estimating equations were performed separately for maintenance medication users (n=130) and nonusers (n=141). Associations between pollutants (adjusted for temperature, controlling for same- and previous-day levels) and respiratory symptoms and use of rescue medication were evaluated. Main Outcome Measures Respiratory symptoms and rescue medication use recorded on calendars by subjects' mothers. Results Mean (SD) levels were 59 (19) ppb (1-hour average) and 51 (16) ppb (8-hour average) for ozone and 13 (8) mug/m(3) for PM2.5. In copollutant models, ozone level but not PM2.5 was significantly associated with respiratory symptoms and rescue medication use among children using maintenance medication; a 50-ppb increase in 1-hour ozone was associated with increased likelihood of wheeze (by 35%) and chest tightness (by 47%). The highest levels of ozone (1-hour or 8-hour averages) were associated with increased shortness of breath and rescue medication use. No significant, exposure-dependent associations were observed for any outcome by any pollutant among children who did not use maintenance medication. Conclusion Asthmatic children using maintenance medication are particularly vulnerable to ozone, controlling for exposure to fine particles, at levels below EPA standards.	Yale Univ, Ctr Perinatal Pediat & Environm Epidemiol, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA	Yale University; University of Rochester	Gent, JF (corresponding author), Yale Univ, Ctr Perinatal Pediat & Environm Epidemiol, Sch Med, Dept Epidemiol & Publ Hlth, 1 Church St,6th Floor, New Haven, CT 06510 USA.	janneane.gent@yale.edu	Triche, Elizabeth/I-4986-2014		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011013, P30ES001247, R01ES007456] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES11013, ES01247, ES05410, ES07456] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allison P.D., 1999, LOGISTIC REGRESSION; Belanger K, 2003, AM J EPIDEMIOL, V158, P195, DOI 10.1093/aje/kwg148; *COMM MASS DEP ENV, 2000, AIR QUAL REP; Delfino RJ, 1998, ENVIRON HEALTH PERSP, V106, P751, DOI 10.2307/3434265; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Gent JF, 2002, ENVIRON HEALTH PERSP, V110, pA781, DOI 10.1289/ehp.021100781; Gielen MH, 1997, AM J RESP CRIT CARE, V155, P2105, DOI 10.1164/ajrccm.155.6.9196122; Gold DR, 1999, EPIDEMIOLOGY, V10, P8, DOI 10.1097/00001648-199901000-00004; Hanania NA, 1998, CHEST, V114, P752, DOI 10.1378/chest.114.3.752; Kehrl HR, 1999, J ALLERGY CLIN IMMUN, V104, P1198, DOI 10.1016/S0091-6749(99)70013-8; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Mortimer KM, 2000, AM J RESP CRIT CARE, V162, P1838, DOI 10.1164/ajrccm.162.5.9908113; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; OSTRO BD, 1995, INHAL TOXICOL, V7, P711, DOI 10.3109/08958379509014475; Peters A, 1997, ENVIRON HEALTH PERSP, V105, P430, DOI 10.1289/ehp.97105430; Romieu I, 1997, ARCH ENVIRON HEALTH, V52, P368, DOI 10.1080/00039899709602213; Romieu I, 1996, AM J RESP CRIT CARE, V154, P300, DOI 10.1164/ajrccm.154.2.8756798; *SAS I INC, 2001, SAS VERS 8; SILVERMAN F, 1979, ENVIRON HEALTH PERSP, V29, P131, DOI 10.2307/3429055; SPEKTOR DM, 1988, AM REV RESPIR DIS, V137, P313, DOI 10.1164/ajrccm/137.2.313; *STAT CONN DEP ENV, 1999, ANN AIR QUAL SUMM; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; Ulmer C, 1997, PEDIATR PULM, V23, P344, DOI 10.1002/(SICI)1099-0496(199705)23:5<344::AID-PPUL6>3.3.CO;2-4; *US EPA, 1996, EPA600AP93004AC US E	24	323	333	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2003	290	14					1859	1867		10.1001/jama.290.14.1859	http://dx.doi.org/10.1001/jama.290.14.1859			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729CB	14532314				2022-12-01	WOS:000185752600026
J	Grzybowski, M; Clements, EA; Parsons, L; Welch, R; Tintinalli, AT; Ross, MA; Zalenski, RJ				Grzybowski, M; Clements, EA; Parsons, L; Welch, R; Tintinalli, AT; Ross, MA; Zalenski, RJ			Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy - A propensity analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; PRIMARY ANGIOPLASTY; NATIONAL REGISTRY; RANDOMIZED TRIALS; ACUTE MI; SCORES; ANGIOGRAPHY; VOLUME	Context There are no definitive recommendations for the management of acute myocardial infarction (AMI) in patients with ST-segment elevation who have contraindications to thrombolytic therapy. It is not clear whether, and the extent to which, immediate mechanical reperfusion (IMR) reduces in-hospital mortality in this population. Objective To determine whether IMR (defined as percutaneous coronary intervention or coronary artery bypass graft surgery) is associated with a mortality benefit in patients with acute ST-segment elevation AMI who are eligible for IMR but have contraindications to thrombolytic therapy. Design, Setting, and Patients From June 1994 to January 2003, the National Registry of Myocardial Infarction 2, 3, and 4 enrolled 1799704 patients with AMI. A total of 19917 patients with acute ST-segment elevation were eligible for IMR but had thrombolytic contraindications after excluding patients who were transferred in from or out to other facilities, patients who received intracoronary thrombolytics, and those who received no medications within 24 hours of arrival. Main Outcome Measure In-hospital mortality. Results Of the 19917 patients, 4705 patients (23.6%) received IMR and 5173 patients (25.9%) died. In-hospital mortality rates in the IMR and non-IMR treated groups in the unadjusted analysis were 11.1%, representing 521 of 4705 patients, and 30.6%, representing 4652 of 15212 patients, respectively, for a risk reduction of 63.7% (odds ratio [OR], 0.28; 95% confidence interval [CI], 0.26-0.31). In a further analysis using a propensity matching score to reduce the effects of bias, 3905 patients who received IMR remained at lower risk for in-hospital mortality than 3905 matched patients (10.9% vs 20.1%, respectively, for a risk reduction of 45.8%; OR, 0.48; 95% Cl, 0.43-0.55). Following a second logistic model applied to the matched groups to adjust for residual differences, a significant treatment effect persisted (OR, 0.64; 95% Cl, 0.56-0.75). Conclusions In this population, IMR was associated with a reduced risk of in-hospital mortality after appropriate adjustments. Of those we studied who were eligible for IMR, 15212 patients (76.4%) did not receive it. These results suggest that using IMR in patients with acute ST-segment elevation AMI and contrainclications to thrombolytics should be strongly considered.	Wayne State Univ, Sch Med, Dept Emergency Med, Ctr Healthcare Effectiveness, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Med, Div Cardiol, Detroit, MI 48201 USA; Spectrum Hlth Hosp, Dept Pharm, Grand Rapids, MI USA; Ovat Res Grp, Chicago, IL USA; William Beaumont Hosp, Dept Emergency Med, Royal Oak, MI 48072 USA; John D Dingell Vet Affairs Hosp, Dept Med, Sect Urgent Care, Detroit, MI USA	Wayne State University; Wayne State University; Beaumont Health	Grzybowski, M (corresponding author), Wayne State Univ, Sch Med, Dept Emergency Med, Ctr Healthcare Effectiveness, UHC 6-G,4201 St Antoine, Detroit, MI 48201 USA.							Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Barron HV, 2000, AM J CARDIOL, V85, P294, DOI 10.1016/S0002-9149(99)00735-3; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; CRAGG DR, 1991, ANN INTERN MED, V115, P173, DOI 10.7326/0003-4819-115-3-173; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; HIMBERT D, 1993, AM J CARDIOL, V71, P377, DOI 10.1016/0002-9149(93)90435-F; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; McCullough PA, 1998, J AM COLL CARDIOL, V32, P596, DOI 10.1016/S0735-1097(98)00284-8; Moon JCC, 2002, INT J CARDIOL, V85, P199, DOI 10.1016/S0167-5273(02)00183-3; MOSES LE, 1995, MED CARE, V33, pAS8; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Parsons LS, REDUCING BIAS PROPEN; Peterson ED, 2003, J AM COLL CARDIOL, V42, P45, DOI 10.1016/S0735-1097(03)00514-X; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Stone GW, 1996, CATHETER CARDIO DIAG, V39, P333, DOI 10.1002/(SICI)1097-0304(199612)39:4<333::AID-CCD1>3.0.CO;2-E; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Zahn R, 1999, CATHETER CARDIO INTE, V46, P127, DOI 10.1002/(SICI)1522-726X(199902)46:2<127::AID-CCD2>3.3.CO;2-7	26	79	82	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2003	290	14					1891	1898		10.1001/jama.290.14.1891	http://dx.doi.org/10.1001/jama.290.14.1891			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729CB	14532318	Bronze			2022-12-01	WOS:000185752600030
J	He, WZ; Cowin, P; Stokes, DL				He, WZ; Cowin, P; Stokes, DL			Untangling desmosomal knots with electron tomography	SCIENCE			English	Article							CELL-CELL ADHESION; PEMPHIGUS-VULGARIS ANTIGEN; E-CADHERIN; MOLECULE UVOMORULIN; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; BINDING; IDENTIFICATION; SUPERFAMILY; ACTIN	Cell adhesion by adherens junctions and desmosomes relies on interactions between cadherin molecules. However, the molecular interfaces that de. ne molecular specificity and that mediate adhesion remain controversial. We used electron tomography of plastic sections from neonatal mouse skin to visualize the organization of desmosomes in situ. The resulting three-dimensional maps reveal individual cadherin molecules forming discrete groups and interacting through their tips. Fitting of an x-ray crystal structure for C-cadherin to these maps is consistent with a flexible intermolecular interface mediated by an exchange of amino-terminal tryptophans. This flexibility suggests a novel mechanism for generating both cis and trans interactions and for propagating these adhesive interactions along the junction.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; New York Struct Biol Ctr, New York, NY 10027 USA	New York University; New York University	Stokes, DL (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	stokes@saturn.med.nyu.edu		Cowin, Pamela/0000-0002-1827-1154	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047429] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM47429] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Angst BD, 2001, J CELL SCI, V114, P629; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Birchmeier C, 1996, ACTA ANAT, V156, P217; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; COLLINS JE, 1991, J CELL BIOL, V113, P381, DOI 10.1083/jcb.113.2.381; DEROSIER DJ, 1980, NATURE, V287, P291, DOI 10.1038/287291a0; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; GEIGER B, 1990, CELL DIFFER DEV, V32, P343, DOI 10.1016/0922-3371(90)90049-3; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hatsell S, 2001, NAT CELL BIOL, V3, pE270, DOI 10.1038/ncb1201-e270; Huber O, 1999, J CELL SCI, V112, P4415; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LELOUP R, 1979, BIOL CELLULAIRE, V34, P137; McDonald K, 1999, METH MOL B, V117, P77; McEwen BF, 2001, J HISTOCHEM CYTOCHEM, V49, P553, DOI 10.1177/002215540104900502; MECHANIC S, 1991, P NATL ACAD SCI USA, V88, P4476, DOI 10.1073/pnas.88.10.4476; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1990, MECH DEVELOP, V33, P49, DOI 10.1016/0925-4773(90)90134-8; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; ROH JY, 1995, J CELL BIOL, V128, P939, DOI 10.1083/jcb.128.5.939; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Sivasankar S, 2001, BIOPHYS J, V80, P1758, DOI 10.1016/S0006-3495(01)76146-2; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; WAGNER G, 1995, SCIENCE, V267, P342, DOI 10.1126/science.7824932; WINKELMANN DA, 1991, J CELL BIOL, V114, P701, DOI 10.1083/jcb.114.4.701; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	46	192	195	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2003	302	5642					109	113		10.1126/science.1086957	http://dx.doi.org/10.1126/science.1086957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526082				2022-12-01	WOS:000185678500047
J	Tadokoro, S; Shattil, SJ; Eto, K; Tai, V; Liddington, RC; de Pereda, JM; Ginsberg, MH; Calderwood, DA				Tadokoro, S; Shattil, SJ; Eto, K; Tai, V; Liddington, RC; de Pereda, JM; Ginsberg, MH; Calderwood, DA			Talin binding to integrin beta tails: A final common step in integrin activation	SCIENCE			English	Article							AFFINITY MODULATION; CYTOPLASMIC DOMAIN; ALPHA(IIB)BETA(3); LIGAND; CELLS; IIIA; IIB	Control of integrin affinity for ligands (integrin activation) is essential for normal cell adhesion, migration, and assembly of an extracellular matrix. Integrin activation is usually mediated through the integrin beta subunit cytoplasmic tail and can be regulated by many different biochemical signaling pathways. We report that specific binding of the cytoskeletal protein talin to integrin beta subunit cytoplasmic tails leads to the conformational rearrangements of integrin extracellular domains that increase their affinity. Thus, regulated binding of talin to integrin beta tails is a final common element of cellular signaling cascades that control integrin activation.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Burnham Inst, Program Cell Adhes, La Jolla, CA 92037 USA	Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Ginsberg, MH (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ginsberg@scripps.edu	de Pereda, Jose M/AAE-5226-2022; de Pereda, Jose M/F-1733-2010; Calderwood, David A/AAC-6954-2019	de Pereda, Jose M/0000-0002-8912-6739; de Pereda, Jose M/0000-0002-8912-6739; Calderwood, David A/0000-0002-0791-4142				Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kashiwagi H, 1997, J CELL BIOL, V137, P1433, DOI 10.1083/jcb.137.6.1433; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; TAPLEY P, 1989, ONCOGENE, V4, P325; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	23	943	967	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2003	302	5642					103	106		10.1126/science.1086652	http://dx.doi.org/10.1126/science.1086652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526080				2022-12-01	WOS:000185678500045
J	Benton, R; St Johnston, D				Benton, R; St Johnston, D			Drosophila PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 to establish complementary cortical domains in polarized cells	CELL			English	Article							EPITHELIAL TIGHT JUNCTION; PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; AXIS FORMATION; OOCYTE DIFFERENTIATION; LOCALIZATION; MAINTENANCE; NEUROBLASTS; TUMOR; STARDUST	PAR-1 kinases are required for polarity in diverse cell types, such as epithelial cells, where they localize laterally. PAR-1 activity is believed to be transduced by binding of 14-3-3 proteins to its phosphorylated substrates, but the relevant targets are unknown. We show that PAR-1 phosphorylates Bazooka/PAR-3 on two conserved serines to generate 14-3-3 binding sites. This inhibits formation of the Bazooka/PAR-6/ aPKC complex by blocking Bazooka oligomerization and binding to aPKC. In epithelia, this complex localizes apically and defines the apical membrane, whereas Bazooka lacking PAR-1 phosphorylation/14-3-3 binding sites forms ectopic lateral complexes. Lateral exclusion by PAR-1/14-3-3 cooperates with apical anchoring by Crumbs/Stardust to restrict Bazooka localization, and loss of both pathways disrupts epithelial polarity. PAR-1 also excludes Bazooka from the posterior of the oocyte, and disruption of this regulation causes anterior-posterior polarity defects. Thus, antagonism of Bazooka by PAR-1/14-3-3 may represent a general mechanism for establishing complementary cortical domains in polarized cells.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England.		St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301				Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Doerflinger H, 2003, DEVELOPMENT, V130, P3965, DOI 10.1242/dev.00616; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hirose T, 2002, J CELL SCI, V115, P2485; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; HURD TW, 2003, IN PRESS CURR BIOL; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Huynh JR, 2001, CURR BIOL, V11, P901, DOI 10.1016/S0960-9822(01)00244-5; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; James P, 1996, GENETICS, V144, P1425; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Mizuno K, 2003, J BIOL CHEM, V278, P31240, DOI 10.1074/jbc.M303593200; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pielage J, 2003, DEV CELL, V5, P841, DOI 10.1016/S1534-5807(03)00358-7; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Vaccari T, 2002, CURR BIOL, V12, P1524, DOI 10.1016/S0960-9822(02)01079-5; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; XU T, 1993, DEVELOPMENT, V117, P1223; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	53	318	319	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					691	704		10.1016/S0092-8674(03)00938-3	http://dx.doi.org/10.1016/S0092-8674(03)00938-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675534	Bronze			2022-12-01	WOS:000187366100009
J	Gross, JD; Moerke, NJ; von der Haar, T; Lugovskoy, AA; Sachs, AB; McCarthy, JEG; Wagner, G				Gross, JD; Moerke, NJ; von der Haar, T; Lugovskoy, AA; Sachs, AB; McCarthy, JEG; Wagner, G			Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E	CELL			English	Article							DEPENDENT TRANSLATION INITIATION; FACTOR 4G EIF4G; PROTEIN-SYNTHESIS; BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; FACTOR EIF-4E; 4E BINDING; FACTOR 4F; YEAST; PHOSPHORYLATION	The eukaryotic initiation factor 4G (eIF4G) is the core of a multicomponent switch controlling gene expression at the level of translation initiation. It interacts with the small ribosomal subunit interacting protein eIF3, and the eIF4E/cap-mRNA complex in order to load the ribosome onto mRNA during cap-dependent translation. We describe the solution structure of the complex between yeast eIF4E/cap and eIF4G (393490). Binding triggers a coupled folding transition of eIF4G (393-490) and the eIF4E N terminus resulting in a molecular bracelet whereby eIF4G (393-490) forms a right-handed helical ring that wraps around the N terminus of eIF4E. Cofolding allosterically enhances association of eIF4E with the cap and is required for maintenance of optimal growth and polysome distributions in vivo. Our data explain how mRNA, eIF4E, and eIF4G exists as a stable mRNP that may facilitate multiple rounds of ribosomal loading during translation initiation, a key determinant in the overall rate of protein synthesis.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA 02115 USA; Univ Manchester, Inst Sci & Technol, Posttranscript Control Grp, Dept Biomol Sci, Manchester M60 1QD, Lancs, England; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Manchester; University of California System; University of California Berkeley	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu		von der Haar, Tobias/0000-0002-6031-9254	NCI NIH HHS [CA68262] Funding Source: Medline; NCRR NIH HHS [RR00995] Funding Source: Medline; NIGMS NIH HHS [GM47467, P01 GM047467] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; ALTMANN M, 1987, MOL CELL BIOL, V7, P998, DOI 10.1128/MCB.7.3.998; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BENNE R, 1976, P NATL ACAD SCI USA, V73, P3005, DOI 10.1073/pnas.73.9.3005; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRUNGER AT, 1996, X PLOR VERSION 3 851; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fletcher CM, 1998, BIOCHEMISTRY-US, V37, P9, DOI 10.1021/bi972494r; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; Hershey J. W. B., 2000, TRANSLATIONAL CONTRO; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Jacobson A, 1996, TRANSLATIONAL CONTRO; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE KAW, 1982, P NATL ACAD SCI-BIOL, V79, P3447, DOI 10.1073/pnas.79.11.3447; Luo YJ, 2001, J BIOL CHEM, V276, P43083, DOI 10.1074/jbc.M104970200; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Ohlmann T, 1997, EMBO J, V16, P844, DOI 10.1093/emboj/16.4.844; OLIVEIRA CC, 1993, MOL MICROBIOL, V9, P521, DOI 10.1111/j.1365-2958.1993.tb01713.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; RAUGHT B, 2000, TRANSLATIONAL CONTRO; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; SHA M, 1995, J BIOL CHEM, V270, P29904; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Vasilescu S, 1996, J BIOL CHEM, V271, P7030, DOI 10.1074/jbc.271.12.7030; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7	56	268	271	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					739	750		10.1016/S0092-8674(03)00975-9	http://dx.doi.org/10.1016/S0092-8674(03)00975-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675538	Bronze			2022-12-01	WOS:000187366100013
J	McGuire, SE; Le, PT; Osborn, AJ; Matsumoto, K; Davis, RL				McGuire, SE; Le, PT; Osborn, AJ; Matsumoto, K; Davis, RL			Spatiotemporal rescue of memory dysfunction in Drosophila	SCIENCE			English	Article							MUSHROOM BODIES; ADENYLATE-CYCLASE; EXPRESSION; ACQUISITION; RUTABAGA; GENE	We have developed a method for temporal and regional gene expression targeting (TARGET) in Drosophila and show the simultaneous spatial and temporal rescue of a memory defect. The transient expression of the rutabaga-encoded adenylyl cyclase in the mushroom bodies of the adult brain was necessary and sufficient to rescue the rutabaga memory deficit, which rules out a developmental brain defect in the etiology of this deficit and demonstrates an acute role for rutabaga in memory formation in these neurons. The TARGET system offers general utility in simultaneously addressing issues of when and where gene products are required.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Nagoya University	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63929] Funding Source: Medline; NINDS NIH HHS [NS19904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; Armstrong JD, 1998, LEARN MEMORY, V5, P102; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1988, J COMP PHYSIOL A, V162, P101, DOI 10.1007/BF01342707; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Hitier R, 1998, NEUROREPORT, V9, P2717, DOI 10.1097/00001756-199808240-00006; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; YANG MY, 1995, NEURON, V15, P45; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	19	911	925	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1765	1768		10.1126/science.1089035	http://dx.doi.org/10.1126/science.1089035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657498				2022-12-01	WOS:000186970100048
J	Zuber, MT				Zuber, MT			Planetary science - Learning to think like Martians	SCIENCE			English	Editorial Material							CARBON-DIOXIDE; BEHAVIOR; MARS/; TES		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.							BOYNTON WV, 2003, 3 INT C MARS POL SCI; FELDMAN WC, 2003, 3 INT C MARS POL SCI; Haberle R.M, 2003, 3 INT C MARS POL SCI; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; KIEFFER HH, 2003, 3 INT C MARS POL SCI; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; LITVAK ML, 2003, 3 INT C MARS POL SCI; LONGHI J, 2003, 3 INT C MARS POL SCI; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; SMITH DE, 2003, 3 INT C MARS POL SCI; Titus TN, 2001, J GEOPHYS RES-PLANET, V106, P23181, DOI 10.1029/2000JE001284; ZUBER MT, 2003, 3 INT C MAR POL SCI; 2003, 3 INT C MARS POL SCI	14	7	7	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1694	1695		10.1126/science.1090517	http://dx.doi.org/10.1126/science.1090517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657483				2022-12-01	WOS:000186970100030
J	Lorenz, K; Lohse, MJ; Quitterer, U				Lorenz, K; Lohse, MJ; Quitterer, U			Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2	NATURE			English	Article							ADRENERGIC-RECEPTOR KINASE; BETA-GAMMA-SUBUNITS; PHOSPHORYLATION; DESENSITIZATION; HETERODIMERS; SUPPRESSION; ACTIVATION; TERMINUS; BINDING	Feedback inhibition is a fundamental principle in signal transduction allowing rapid adaptation to different stimuli. In mammalian cells, the major feedback inhibitor for G-protein-coupled receptors (GPCR) is G-protein-coupled receptor kinase 2 (GRK-2), which phosphorylates activated receptors, uncouples them from G proteins and initiates their internalization(1,2). The functions of GRK-2 are indispensable and need to be tightly controlled(3). Dysregulation promotes disorders such as hypertension(4) or heart failure(5). In our search for a control mechanism for this vital kinase, here we show that the Raf kinase inhibitor protein(6-8) (RKIP) is a physiological inhibitor of GRK-2. After stimulation of GPCR, RKIP dissociates from its known target, Raf-1 (refs 6 - 8), to associate with GRK-2 and block its activity. This switch is triggered by protein kinase C (PKC)- dependent phosphorylation of the RKIP on serine 153. The data delineate a new principle in signal transduction: by activating PKC, the incoming receptor signal is enhanced both by removing an inhibitor from Raf-1 and by blocking receptor internalization. A physiological role for this mechanism is shown in cardiomyocytes in which the downregulation of RKIP restrains beta-adrenergic signalling and contractile activity.	Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany	University of Wurzburg	Quitterer, U (corresponding author), Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.	toph029@rzbox.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Lorenz, Kristina/0000-0002-5747-2207				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Dunigan CD, 2000, METH MOL B, V136, P329; Eichmann T, 2003, J BIOL CHEM, V278, P8052, DOI 10.1074/jbc.M204795200; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Ritter O, 2002, FASEB J, V16, P283, DOI 10.1096/fj.02-0321fje; Slupsky JR, 1999, CURR BIOL, V9, P971, DOI 10.1016/S0960-9822(99)80426-6; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wu JC, 2003, J CELL BIOCHEM, V88, P823, DOI 10.1002/jcb.10390; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	27	282	324	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					574	579		10.1038/nature02158	http://dx.doi.org/10.1038/nature02158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654844				2022-12-01	WOS:000186944300043
J	Poskanzer, KE; Marek, KW; Sweeney, ST; Davis, GW				Poskanzer, KE; Marek, KW; Sweeney, ST; Davis, GW			Synaptotagmin I is necessary for compensatory synaptic vesicle endocytosis in vivo	NATURE			English	Article							NEUROTRANSMITTER RELEASE; C2B DOMAIN; DROSOPHILA; MUTANTS; SYNAPSES; REGULATOR; BINDING; SENSOR	Neurotransmission requires a balance of synaptic vesicle exocytosis and endocytosis(1). Synaptotagmin I (Syt I) is widely regarded as the primary calcium sensor for synaptic vesicle exocytosis(2-6). Previous biochemical data suggest that Syt I may also function during synaptic vesicle endocytosis(7-16); however, ultrastructural analyses at synapses with impaired Syt I function have provided an indirect and conflicting view of the role of Syt I during synaptic vesicle endocytosis(3,8-10,14). Until now it has not been possible experimentally to separate the exocytic and endocytic functions of Syt I in vivo. Here, we test directly the role of Syt I during endocytosis in vivo. We use quantitative live imaging of a pH-sensitive green fluorescent protein fused to a synaptic vesicle protein (synapto-pHluorin) to measure the kinetics of endocytosis in sytI-null Drosophila. We then combine live imaging of the synapto-pHluorins with photoinactivation of Syt I, through fluorescein-assisted light inactivation, after normal Syt I-mediated vesicle exocytosis. By inactivating Syt I only during endocytosis, we demonstrate that Syt I is necessary for the endocytosis of synaptic vesicles that have undergone exocytosis using a functional Syt I protein.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, 513 Parnassus Ave, San Francisco, CA 94143 USA.			Sweeney, Sean/0000-0003-2673-9578				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reist NE, 1998, J NEUROSCI, V18, P7662; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	30	201	209	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					559	563		10.1038/nature02184	http://dx.doi.org/10.1038/nature02184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14634669				2022-12-01	WOS:000186944300039
J	MacDonald, MP; Spalding, GC; Dholakia, K				MacDonald, MP; Spalding, GC; Dholakia, K			Microfluidic sorting in an optical lattice	NATURE			English	Article							SEPARATION; DNA; MACROMOLECULES; ARRAY; TRAP	The response of a microscopic dielectric object to an applied light field can profoundly affect its kinetic motion(1). A classic example of this is an optical trap, which can hold a particle in a tightly focused light beam(2). Optical fields can also be used to arrange, guide or deflect particles in appropriate light-field geometries(3,4). Here we demonstrate an optical sorter for microscopic particles that exploits the interaction of particles-biological or otherwise-with an extended, interlinked, dynamically reconfigurable, three-dimensional optical lattice. The strength of this interaction with the lattice sites depends on the optical polarizability of the particles, giving tunable selection criteria. We demonstrate both sorting by size (of protein microcapsule drug delivery agents) and sorting by refractive index (of other colloidal particle streams). The sorting efficiency of this method approaches 100%, with values of 96% or more observed even for concentrated solutions with throughputs exceeding those reported for fluorescence-activated cell sorting(5). This powerful, non-invasive technique is suited to sorting and fractionation within integrated ('lab-on-a-chip') microfluidic systems, and can be applied in colloidal, molecular and biological research.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Illinois Wesleyan Univ, Dept Phys, Bloomington, IL 61702 USA	University of St Andrews; Illinois Wesleyan University	MacDonald, MP (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.		Spalding, Gabriel C/C-8246-2009; Dholakia, Kishan/C-9873-2009; MacDonald, Michael P/F-5880-2011	Spalding, Gabriel C/0000-0003-1126-3968; MacDonald, Michael P/0000-0003-4415-5437; Dholakia, Kishan/0000-0001-6534-9009				ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Athanasopoulou A, 1996, INSTRUM SCI TECHNOL, V24, P79, DOI 10.1080/10739149608000470; BURNS MM, 1990, SCIENCE, V249, P749, DOI 10.1126/science.249.4970.749; Chou CF, 2002, BIOPHYS J, V83, P2170, DOI 10.1016/S0006-3495(02)73977-5; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dholakia K, 2002, PHYS WORLD, V15, P31, DOI 10.1088/2058-7058/15/10/37; Duke TAJ, 1998, PHYS REV LETT, V80, P1552, DOI 10.1103/PhysRevLett.80.1552; Ertas D, 1998, PHYS REV LETT, V80, P1548, DOI 10.1103/PhysRevLett.80.1548; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Galbraith DW, 1999, METHOD CELL BIOL, V58, P315; Greiner M, 2002, NATURE, V415, P39, DOI 10.1038/415039a; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; IMASAKA T, 1995, ANAL CHEM, V67, P1763, DOI 10.1021/ac00107a003; Korda PT, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.128301; Korda PT, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024504; MacDonald MP, 2002, SCIENCE, V296, P1101, DOI 10.1126/science.1069571; MACDONALD MP, UNPUB PHYS REV LETT; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; Nykypanchuk D, 2002, SCIENCE, V297, P987, DOI 10.1126/science.1073277; Tatarkova SA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.038101	20	1069	1110	9	392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					421	424		10.1038/nature02144	http://dx.doi.org/10.1038/nature02144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647376				2022-12-01	WOS:000186800800032
J	Miyamoto, T; Hasuike, S; Yogev, L; Maduro, MR; Ishikawa, M; Westphal, H; Lamb, DJ				Miyamoto, T; Hasuike, S; Yogev, L; Maduro, MR; Ishikawa, M; Westphal, H; Lamb, DJ			Azoospermia in patients heterozygous for a mutation in SYCP3	LANCET			English	Article							SYNAPTONEMAL COMPLEX; PROTEIN; GENE; SCP3	Background Many cases of male infertility are diagnosed as idiopathic, reflecting poor understanding of the molecular defects underlying the abnormality. As more gene mutations causing male infertility in mice become known, there are improving prospects that knowledge about the genetic aetiology of human male infertility can be expanded. Sycp3 encodes a component of the synaptonemal complex. A null mutation of Sycp3 in mice causes azoospermia with meiotic arrest. We tested the hypothesis that mutation of the human testis-specific SYCP3 is associated with human nonobstructive azoospermia. Methods Human SYCP3 was isolated on the basis of homology between mouse Sycp3 cDNA and human genome sequences at the aminoacid level. Tissue-specific expression of SYCP3 was analysed by PCR of human cDNA. Samples of DNA from 19 azoospermic patients with maturation arrest and 75 normal fertile control men were screened for mutations in the SYCP3 gene by sequence analysis of the gene. The functional significance of the mutations found was analysed by a protein interaction study of the wild-type and truncated SYCP3 proteins. Findings We identified in two patients a 1 bp deletion (643delA) that results in a premature stop codon and truncation of the C-terminal, coiled-coil-forming region of the SYCP3 protein. The mutant protein showed greatly reduced interaction with the wild-type protein in vitro and interfered with SYCP3 fibre formation in cultured cells. Interpretation We suggest that SYCP3 has an essential meiotic function in human spermatogenesis that is compromised by the mutant protein via dominant negative interference.	Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; Asahikawa Med Coll, Dept Obstet & Gynecol, Asahikawa, Hokkaido 078, Japan; Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Inst Study Fertil, Tel Aviv, Israel; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Asahikawa Medical College; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Baylor College of Medicine	Lamb, DJ (corresponding author), Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.	dlamb@www.urol.bcm.tmc.edu		Maduro, Maria Rosa/0000-0001-8988-6722	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD036289] Funding Source: NIH RePORTER; NICHD NIH HHS [P01HD36289] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Botelho RJ, 2001, BBA-GENE STRUCT EXPR, V1518, P294, DOI 10.1016/S0167-4781(01)00171-3; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; Martinez-Garay I, 2002, GENOMICS, V80, P259, DOI 10.1006/geno.2002.6834; Matzuk MM, 2002, NAT MED, V8, P41, DOI 10.1038/nm-fertilityS41; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Offenberg HH, 1998, NUCLEIC ACIDS RES, V26, P2572, DOI 10.1093/nar/26.11.2572; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	16	196	224	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2003	362	9397					1714	1719		10.1016/S0140-6736(03)14845-3	http://dx.doi.org/10.1016/S0140-6736(03)14845-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643120				2022-12-01	WOS:000186767700010
J	Svenningsson, P; Tzavara, ET; Carruthers, R; Rachleff, I; Wattler, S; Nehls, M; McKinzie, DL; Fienberg, AA; Nomikos, GG; Greengard, P				Svenningsson, P; Tzavara, ET; Carruthers, R; Rachleff, I; Wattler, S; Nehls, M; McKinzie, DL; Fienberg, AA; Nomikos, GG; Greengard, P			Diverse psychotomimetics act through a common signaling pathway	SCIENCE			English	Article							CAMP-REGULATED PHOSPHOPROTEIN; SCHIZOPHRENIA; PHOSPHORYLATION; DARPP-32; MODELS; DRUG	Three distinct classes of drugs: dopaminergic agonists (such as D-amphetamine), serotonergic agonists (such as LSD), and glutamatergic antagonists (such as PCP) all induce psychotomimetic states in experimental animals that closely resemble schizophrenia symptoms in humans. Here we implicate a common signaling pathway in mediating these effects. In this pathway, dopamine- and an adenosine 3', 5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kilodaltons (DARPP-32) is phosphorylated or dephosphorylated at three sites, in a pattern predicted to cause a synergistic inhibition of protein phosphatase-1 and concomitant regulation of its downstream effector proteins glycogen synthesis kinase-3 (GSK-3), cAMP response element-binding protein (CREB), and c-Fos. In mice with a genetic deletion of DARPP-32 or with point mutations in phosphorylation sites of DARPP-32, the effects of D-amphetamine, LSD, and PCP on two behavioral parameters-sensorimotor gating and repetitive movements-were strongly attenuated.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Eli Lilly & Co, Lilly Corp Ctr, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Lexicon Genet Inc, The Woodlands, TX 77381 USA; Intracellular Therapies Inc, New York, NY 10032 USA	Rockefeller University; Eli Lilly; Lexicon Pharmaceuticals	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.		Svenningsson, Per JL/K-5210-2014		NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; BERMAN KF, 1988, ARCH GEN PSYCHIAT, V45, P616; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; DESDOUITS F, 1995, P NATL ACAD SCI USA, V92, P2682, DOI 10.1073/pnas.92.7.2682; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; LIPSKA BK, 1994, NEUROPSYCHOPHARMACOL, V10, P199, DOI 10.1038/npp.1994.22; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SHAW E, 1956, SCIENCE, V124, P121, DOI 10.1126/science.124.3212.121; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; SNYDER SH, 1973, AM J PSYCHIAT, V130, P61, DOI 10.1176/ajp.130.1.61; SVENNINGSSON P, UNPUB; Vollenweider FX, 1998, PHARMACOPSYCHIATRY, V31, P92, DOI 10.1055/s-2007-979353	20	255	262	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1412	1415		10.1126/science.1089681	http://dx.doi.org/10.1126/science.1089681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631045				2022-12-01	WOS:000186683500057
J	Li, X; Oghi, KA; Zhang, J; Krones, A; Bush, KT; Glass, CK; Nigam, SK; Aggarwal, AK; Maas, R; Rose, DW; Rosenfeld, MG				Li, X; Oghi, KA; Zhang, J; Krones, A; Bush, KT; Glass, CK; Nigam, SK; Aggarwal, AK; Maas, R; Rose, DW; Rosenfeld, MG			Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis	NATURE			English	Article							EYES-ABSENT GENE; MUSCLE PRECURSOR CELLS; KIDNEY DEVELOPMENT; DROSOPHILA DACHSHUND; NUCLEAR RECEPTORS; SKELETAL-MUSCLE; MULTIPLE STEPS; MYOGENIN GENE; MICE LACKING; EXPRESSION	The precise mechanistic relationship between gene activation and repression events is a central question in mammalian organogenesis, as exemplified by the evolutionarily conserved sine oculis ( Six), eyes absent (Eya) and dachshund ( Dach) network of genetically interacting proteins. Here, we report that Six1 is required for the development of murine kidney, muscle and inner ear, and that it exhibits synergistic genetic interactions with Eya factors. We demonstrate that the Eya family has a protein phosphatase function, and that its enzymatic activity is required for regulating genes encoding growth control and signalling molecules, modulating precursor cell proliferation. The phosphatase function of Eya switches the function of Six1-Dach from repression to activation, causing transcriptional activation through recruitment of co-activators. The gene-specific recruitment of a co-activator with intrinsic phosphatase activity provides a molecular mechanism for activation of specific gene targets, including those regulating precursor cell proliferation and survival in mammalian organogenesis.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Li, X (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.		Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592				Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Brohmann H, 2000, DEVELOPMENT, V127, P437; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Daston G, 1996, DEVELOPMENT, V122, P1017; Davies JA, 1998, CURR TOP DEV BIOL, V39, P245, DOI 10.1016/S0070-2153(08)60458-5; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Davis RJ, 1999, DEV GENES EVOL, V209, P526, DOI 10.1007/s004270050285; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Glass CK, 2000, GENE DEV, V14, P121; Gross MK, 2000, DEVELOPMENT, V127, P413; Hammond KL, 1998, MECH DEVELOP, V74, P121, DOI 10.1016/S0925-4773(98)00071-9; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hausmann S, 2002, J BIOL CHEM, V277, P21213, DOI 10.1074/jbc.M202056200; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Li X, 2002, SCIENCE, V297, P1180; MARDON G, 1994, DEVELOPMENT, V120, P3473; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Oliver G, 1995, DEVELOPMENT, V121, P4045; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Pohl M, 2000, ANNU REV PHYSIOL, V62, P595, DOI 10.1146/annurev.physiol.62.1.595; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shen WP, 1997, DEVELOPMENT, V124, P45; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Torres M, 1995, DEVELOPMENT, V121, P4057; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 1997, DEVELOPMENT, V124, P219; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	50	475	499	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					247	254		10.1038/nature02083	http://dx.doi.org/10.1038/nature02083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628042				2022-12-01	WOS:000186660800034
J	McLeod, H; Ham, C; Kipping, R				McLeod, H; Ham, C; Kipping, R			Booking patients for hospital admissions: evaluation of a pilot programme for day cases	BRITISH MEDICAL JOURNAL			English	Article								Problem NHS patients requiring elective surgery usually have to wait before being treated and are usually told when a date becomes available. Design 18 month pilot programme to enable day case patients to book date of hospital admission at time of decision to operate. Background and setting 24 pilot sites in England with relatively short waiting times and some experience of booking appointments. Key measures for improvement Proportion of patients with booked or "to come in" date during and after pilot programme, proportion not attending for admission, and proportion waiting greater than or equal to6 months. Comparison of pilot sites with non-pilot sites. Strategies for change National Patients' Access Team established to help pilot sites enable patients to book admission dates. Provision of pound9.9m to pilot sites to employ project managers, purchase equipment, buy extra time from clinical and other staff, and invest in information and communications technology. Effects of change Proportion of patients with booked or "to come in" date increased from 51.1% to 72.7% between end of March 1999 and end of March 2000, and then fell to 66.2% by end of March 2001. Over the same periods, the proportion of patients waiting 6 months fell from 10.9% to 10.5% and then increased to 11.9%. The proportion of patients failing to attend fell from 5.7% to 3.1% between the first quarter of 1999 and the first quarter of 2000, and then increased to 4.0% in the first quarter of 2001. Pilot sites varied widely in performance during and after the pilot phase. Pilot sites had higher proportions of patients with booked or "to come in" date than non-pilot sites at end of each period. Lessons learnt Increasing the proportion of patients who book their date of hospital admission is possible, but there are difficulties in sustaining this. Several factors facilitated or hindered the implementation of booking, and the roll out of the programme across the NHS is seeking to incorporate these factors.	Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of Birmingham	McLeod, H (corresponding author), Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England.			Kipping, Ruth/0000-0002-5446-8077; McLeod, Hugh/0000-0002-2266-7303				[Anonymous], IMPR EXP REF NEXT 3; Armitage P., 1987, STAT METHODS MED RES; BEECHAM L, 1991, BRIT MED J, V302, P929; COX AG, 1977, LANCET, V1, P301; Department of Health, 2002, IMPR EXP REF NEXT 3; DONNER A, 1987, STAT MED, V6, P43, DOI 10.1002/sim.4780060106; Donner A, 2000, DESIGN ANAL CLUSTER; Fraser G, 1993, WAITING LISTS WAITIN; HAM C, 2002, CAPACITY CULTURE LEA; *S W REG HLTH AUTH, 1991, PROV HIGH QUAL SERV; *SECR STAT HLTH, 2000, NHS PLAN PLAN INV PL; YATES JM, 1998, BOOKING SYSTEMS SCOR	12	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 15	2003	327	7424					1147	+		10.1136/bmj.327.7424.1147	http://dx.doi.org/10.1136/bmj.327.7424.1147			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744HL	14615342	Green Published			2022-12-01	WOS:000186622100023
J	Campbell, BA; Campbell, DB; Chandler, JF; Hine, AA; Nolan, MC; Perillat, PJ				Campbell, BA; Campbell, DB; Chandler, JF; Hine, AA; Nolan, MC; Perillat, PJ			Radar imaging of the lunar poles - Long-wavelength measurements reveal a paucity of ice in the Moon's polar craters.	NATURE			English	Editorial Material									Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20013 USA; Cornell Univ, Ithaca, NY 14853 USA; Arecibo Observ, Arecibo, PR 00612 USA; Smithsonian Astrophys Observ, Cambridge, MA 02138 USA	Smithsonian Institution; Cornell University; National Aeronautics & Space Administration (NASA); Harvard University; Smithsonian Institution	Campbell, BA (corresponding author), Smithsonian Inst, Ctr Earth & Planetary Studies, Box 37012, Washington, DC 20013 USA.	campbellb@nasm.si.edu	Nolan, Michael C/H-4980-2012	Nolan, Michael C/0000-0001-8316-0680				Black GJ, 2001, ICARUS, V151, P167, DOI 10.1006/icar.2001.6616; BLACK GJ, 2002, LUNAR PLANET SCI C, V33; Bussey DB, 1999, GEOPHYS RES LETT, V26, P1187, DOI 10.1029/1999GL900213; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; HARMON JK, 1994, NATURE, V369, P213, DOI 10.1038/369213a0; Margot JL, 1999, SCIENCE, V284, P1658, DOI 10.1126/science.284.5420.1658; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495; Nozette S, 2001, J GEOPHYS RES-PLANET, V106, P23253, DOI 10.1029/2000JE001417; Stacy NJS, 1997, SCIENCE, V276, P1527, DOI 10.1126/science.276.5318.1527	9	38	40	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					137	138		10.1038/426137a	http://dx.doi.org/10.1038/426137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614491				2022-12-01	WOS:000186517200028
J	Choi, KW; Chau, TN; Tsang, O; Tso, E; Chiu, MC; Tong, WL; Lee, PO; Ng, TK; Ng, WF; Lee, KC; Lam, W; Yu, WC; Lai, JY; Lai, ST				Choi, KW; Chau, TN; Tsang, O; Tso, E; Chiu, MC; Tong, WL; Lee, PO; Ng, TK; Ng, WF; Lee, KC; Lam, W; Yu, WC; Lai, JY; Lai, ST		Princess Margaret Hosp Study Grp	Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong	ANNALS OF INTERNAL MEDICINE			English	Article							CORONAVIRUS; OUTBREAK; SARS; IDENTIFICATION	Background: severe acute respiratory syndrome (SARS) has become a global public health emergency. Objective: To evaluate the characteristics and outcomes of patients with SARS in Hong Kong and to identify predictors of mortality. Design: Retrospective cohort study. Setting: Quarantine hospital for patients with SARS in Hong Kong. Patients: 267 consecutive patients hospitalized from 26 February to 31 March 2003 for probable or confirmed SARS. Measurements: Clinical, laboratory, and radiographic measures; 3-month mortality rate. Results: According to our case definition, there were 227 cases of confirmed SARS and 40 cases of probable SARS. Common presenting symptoms were fever (99% of patients), chills (74%), malaise (63%), and myalgia (50%). Laboratory findings included lymphopenia (73%), thrombocytopenia (50%), hyponatremia (60%), and elevated levels of lactate dehydrogenase (47%) and C-reactive protein (75%). During hospitalization, incidence of diarrhea (53%), anemia (53%), and acute renal failure (6%) increased. Sixty-nine patients (26%) required intensive care because of respiratory failure. The 3-month mortality rate was 12% (95% Cl, 8% to 16%). Factors contributing to mortality were respiratory failure, acute renal failure, and nosocomial sepsis. On multivariate Cox regression, age older than 60 years (relative risk, 5.10 [Cl, 2.30 to 11.31]; P < 0.001) and lactate dehydrogenase level greater than 3.8 mu kat/L at presentation (relative risk, 2.20 [Cl, 1.03 to 4.71]; P = 0.04) were independent predictors of mortality. Conclusion: Because of the longer follow-up period in our cohort, the mortality rate in these patients is higher than rates reported in previous studies. Advanced age and high lactate dehydrogenase level at presentation predict mortality.	Princess Margaret Hosp, Dept Med & Geriatr, Kowloon, Hong Kong, Peoples R China		Lai, ST (corresponding author), Princess Margaret Hosp, Dept Med & Geriatr, Kowloon, Hong Kong, Peoples R China.	stpmh@netvigator.com						[Anonymous], 2003, UPD INT US CAS DEF S; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Cameron CE, 2001, CURR OPIN INFECT DIS, V14, P757, DOI 10.1097/00001432-200112000-00015; Chan-Yeung M, 2003, BRIT MED J, V326, P850, DOI 10.1136/bmj.326.7394.850; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; *DEP HLTH, 2003, AT PNEUM; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; World Health Organization, 2003, CAS DEF SURV SEV AC; ZUCKERFRANKLIN D, 1994, SEMIN HEMATOL, V31, P329	21	251	267	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2003	139	9					715	723		10.7326/0003-4819-139-9-200311040-00005	http://dx.doi.org/10.7326/0003-4819-139-9-200311040-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738XJ	14597455				2022-12-01	WOS:000186312900001
J	Ball, C; Kirkby, M; Williams, S				Ball, C; Kirkby, M; Williams, S			Effect of the critical care outreach team on patient survival to discharge from hospital and readmission to critical care: non-randomised population based study	BRITISH MEDICAL JOURNAL			English	Article							MEDICAL EMERGENCY TEAM; INTENSIVE-CARE; MORTALITY; ADMISSIONS; ARRESTS; DEATHS; UNITS	Objectives To determine the effect of the critical care outreach team on patient survival to discharge from hospital after discharge from critical care and readmission to critical care. Design Non-randomised population based study. Setting Tertiary referral teaching hospital with 1200 beds. Participants Patients discharged from the critical care unit after their first or only admission for two study periods, 26 February 2000 to 25 February 2001 and 26 February 2001 to 25 February 2002. Main outcome measures Survival to discharge from hospital after discharge from critical care and readmission to critical care. Results The introduction of a critical care outreach team increased survival to discharge from hospital after discharge from critical care by 6.8% (risk ratio 1.08). Readmission to critical care decreased by 6.4% (0.48). Conclusions The activity of the critical care outreach team seems to improve patient survival to discharge from hospital and may reduce the number of readmissions to critical care.	Royal Free Hampstead NHS Trust, Crit Care Unit, London NW3 2QG, England	University of London; University College London	Ball, C (corresponding author), Royal Free Hampstead NHS Trust, Crit Care Unit, London NW3 2QG, England.							Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Cuthbertson BH, 2003, BRIT J ANAESTH, V90, P4, DOI 10.1093/bja/aeg004; DALY K, 2001, BRIT MED J, V322, P1; *DEP HLTH, 2001, COMPR CRIT CAR; Garrard C, 1998, BMJ-BRIT MED J, V316, P1841; Goldhill DR, 1999, ANAESTHESIA, V54, P853; Goldhill DR, 1996, INTENS CARE MED, V22, P415, DOI 10.1007/BF01712157; Goldhill DR, 2002, CURR ANAESTH CRIT CA, V13, P356, DOI DOI 10.1054/cacc.2003.0433; Hillman K, 2003, BRIT J ANAESTH, V90, P808, DOI 10.1093/bja/aeg573; *ICNARC, 1997, INT CAR NAT AUD RES; *INT CAR NAT AUD R, 1997, INT CAR NAT AUD RES; Leary T, 2003, ANAESTHESIA, V58, P328, DOI 10.1046/j.1365-2044.2003.03077.x; McGloin H, 1999, J ROY COLL PHYS LOND, V33, P255; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Patel PA, 1999, INTENS CARE MED, V25, P977, DOI 10.1007/s001340050992; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; *SCOTT EX HLTH DEP, 2000, BETT CRIT CAR REP SH; Trivedi M, 2001, ANAESTHESIA, V56, P841, DOI 10.1046/j.1365-2044.2001.02174.x	20	174	177	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2003	327	7422					1014	1016A		10.1136/bmj.327.7422.1014	http://dx.doi.org/10.1136/bmj.327.7422.1014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738NE	14593033	Bronze, Green Published			2022-12-01	WOS:000186294100017
J	Burke, MD; Berger, EM; Schreiber, SL				Burke, MD; Berger, EM; Schreiber, SL			Generating diverse skeletons of small molecules combinatorially	SCIENCE			English	Article							FURAN COMPOUNDS; LIBRARY	Lack of efficient access to collections of synthetic compounds that have skeletal diversity is a key bottleneck in the small-molecule discovery process. We report a synthesis strategy that involves transforming substrates with different appendages that pre-encode skeletal information, named sigma elements, into products that have different skeletons with the use of common reaction conditions. With this approach, split-pool synthesis can be used to pre-encode skeletal diversity combinatorially and thereby generate such small molecules very efficiently. A split-pool synthesis of more than 1000 compounds produced overlapping, combinatorial matrices of molecular skeletons and appended building blocks in both enantiomeric and diastereomeric forms.	Harvard Univ, Inst Chem & Cell Biol, Howard Hughes Med Inst, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Schreiber, SL (corresponding author), Harvard Univ, Inst Chem & Cell Biol, Howard Hughes Med Inst, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	sls@slsiris.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080436] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080436] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHMATOWICZ O, 1971, TETRAHEDRON, V27, P1973, DOI 10.1016/S0040-4020(01)98229-8; Bach T, 1999, EUR J ORG CHEM, V1999, P2045; Blackwell HE, 2001, CHEM BIOL, V8, P1167, DOI 10.1016/S1074-5521(01)00085-0; Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879; BUNIN BA, 1992, J AM CHEM SOC, V114, P10997, DOI 10.1021/ja00053a067; BURGESS K, 1994, J MED CHEM, V37, P2985, DOI 10.1021/jm00045a001; CLAUSONKAAS N, 1953, ACTA CHEM SCAND, V7, P845, DOI 10.3891/acta.chem.scand.07-0845; DEWITT SH, 1993, P NATL ACAD SCI USA, V90, P6909, DOI 10.1073/pnas.90.15.6909; Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302; Dolle RE, 2002, J COMB CHEM, V4, P369, DOI 10.1021/cc020039v; EVANS DA, 1981, J AM CHEM SOC, V103, P2127, DOI 10.1021/ja00398a058; Furka A, 1988, HIGHLIGHTS MODERN BI, P47; Harris JM, 2000, TETRAHEDRON LETT, V41, P183, DOI 10.1016/S0040-4039(99)02050-X; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Kobayashi Y, 1998, J ORG CHEM, V63, P7505, DOI 10.1021/jo980942a; Kwon O, 2002, J AM CHEM SOC, V124, P13402, DOI 10.1021/ja028086e; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lee DS, 2000, ORG LETT, V2, P709, DOI 10.1021/ol005574n; NESTLER HP, 1994, J ORG CHEM, V59, P4723, DOI 10.1021/jo00096a008; NEWTH FH, 1951, ADV CARBOHYD CHEM, V6, P83; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Tan DS, 1998, J AM CHEM SOC, V120, P8565, DOI 10.1021/ja981746o; Taniguchi T, 1998, TETRAHEDRON-ASYMMETR, V9, P1451, DOI 10.1016/S0957-4166(98)00117-7; Weber L, 2000, CURR OPIN CHEM BIOL, V4, P295, DOI 10.1016/S1367-5931(00)00092-2; [No title captured]	26	336	342	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					613	618		10.1126/science.1089946	http://dx.doi.org/10.1126/science.1089946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576427				2022-12-01	WOS:000186119900050
J	Wilson, JF				Wilson, JF			Should doctors prescribe alcohol to adults?	ANNALS OF INTERNAL MEDICINE			English	News Item							CONSUMPTION; DRINKING; MORTALITY						Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; Ellison RC, 2002, ANN NY ACAD SCI, V957, P1, DOI 10.1111/j.1749-6632.2002.tb02900.x; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Goldberg IJ, 2003, NEW ENGL J MED, V348, P163, DOI 10.1056/NEJMe020163; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Nicolas JM, 2002, ANN INTERN MED, V136, P192, DOI 10.7326/0003-4819-136-3-200202050-00007; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401	7	5	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2003	139	8					711	714		10.7326/0003-4819-139-8-200310210-00036	http://dx.doi.org/10.7326/0003-4819-139-8-200310210-00036			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734DW	14568873				2022-12-01	WOS:000186040800022
J	Gu, Y; Filippi, MD; Cancelas, JA; Siefring, JE; Williams, EP; Jasti, AC; Harris, CE; Lee, AW; Prabhakar, R; Atkinson, SJ; Kwiatkowski, DJ; Williams, DA				Gu, Y; Filippi, MD; Cancelas, JA; Siefring, JE; Williams, EP; Jasti, AC; Harris, CE; Lee, AW; Prabhakar, R; Atkinson, SJ; Kwiatkowski, DJ; Williams, DA			Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases	SCIENCE			English	Article							RHO-GTPASES; MAST-CELLS; STEM-CELLS; T-CELLS; BINDING; GENE; EXPRESSION; ACTIVATION; DELETION; ADHESION	The Rho guanosine triphosphatases (GTPases) Rac1 and Rac2 are critical signaling regulators in mammalian cells. The deletion of both Rac1 and Rac2 murine alleles leads to a massive egress of hematopoietic stem/progenitor cells (HSC/Ps) into the blood from the marrow, whereas Rac1(-/-) but not Rac2(-/-) HSC/Ps fail to engraft in the bone marrow of irradiated recipient mice. In contrast, Rac2, but not Rac1, regulates superoxide production and directed migration in neutrophils, and in each cell type, the two GTPases play distinct roles in actin organization, cell survival, and proliferation. Thus, Rac1 and Rac2 regulate unique aspects of hematopoietic development and function.	Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Hoxworth Blood Ctr, Cincinnati, OH 45267 USA; Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Brigham & Women's Hospital	Williams, DA (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA.		Cancelas, Jose/AAR-9324-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK62757] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Gu Y, 2002, MOL CELL BIOL, V22, P7645, DOI 10.1128/MCB.22.21.7645-7657.2002; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MOLL J, 1991, ONCOGENE, V6, P863; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Palacios R, 1996, P NATL ACAD SCI USA, V93, P5247, DOI 10.1073/pnas.93.11.5247; Papayannopoulou T, 1997, ACTA HAEMATOL-BASEL, V97, P97; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; SHIRSAT NV, 1990, ONCOGENE, V5, P769; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; VAN AL, 1997, GENE DEV, V11, P2295; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898	25	396	417	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					445	449		10.1126/science.1088485	http://dx.doi.org/10.1126/science.1088485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14564009				2022-12-01	WOS:000185963200043
J	Bonaccorso, S; Sturchio, JL				Bonaccorso, S; Sturchio, JL			Perspectives from the pharmaceutical industry	BRITISH MEDICAL JOURNAL			English	Article									Merck & Co Inc, Mkt & Med Serv, Whitehouse Stn, NJ 08889 USA; Merck & Co Inc, External Affairs Europe Middle E & Africa, Whitehouse Stn, NJ 08889 USA	Merck & Company; Merck & Company	Bonaccorso, S (corresponding author), Merck & Co Inc, Mkt & Med Serv, 1 Merck Dr, Whitehouse Stn, NJ 08889 USA.							Bonaccorso SN, 2002, BRIT MED J, V324, P910, DOI 10.1136/bmj.324.7342.910; Calfee JE, 2002, J LAW ECON, V45, P673, DOI 10.1086/374704; Coulter A, 2003, EUROPEAN PATIENT FUT; *EUR FED PHARM IND, 2001, GUID INT WEB SIT AV; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; Organization WH, 2003, ADHERENCE LONG TERM	6	14	14	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2003	327	7419					863	864		10.1136/bmj.327.7419.863	http://dx.doi.org/10.1136/bmj.327.7419.863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732BP	14551109	Green Published			2022-12-01	WOS:000185921200031
J	Narayan, KMV; Boyle, JP; Thompson, TJ; Sorensen, SW; Williamson, DF				Narayan, KMV; Boyle, JP; Thompson, TJ; Sorensen, SW; Williamson, DF			Lifetime risk for diabetes mellitus in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; BREAST-CANCER; US; PREVALENCE; POPULATION; MORTALITY; PERSPECTIVE; IMPACT; ADULTS; BURDEN	Context Although diabetes mellitus is one of the most prevalent and costly chronic diseases in the United States, no estimates have been published of individuals' average lifetime risk of developing diabetes. Objective Toe stimate age-, sex-, and race/ethnicity-specific lifetime risk. of diabetes in the cohort born in 2000 in the United States. Design, Setting, and Participants Data from the National Health Interview Survey (1984-2000) were used to estimate age-, sex-, and race/ethnicity-specific prevalence and incidence in 2000. US Census Bureau data. and data from a previous study of diabetes as a cause of death were used to estimate age-, sex-, and race/ethnicity- specific mortality rates for diabetic and nondiabetic populations. Main Outcome Measures, Residual (remaining) lifetime risk of diabetes (from birth to 80, years in 1-year intervals), duration with diabetes, and life-years and quality-adjusted life-years lost from diabetes. Results the estimated lifetime risk of developing diabetes for individuals born in 2000 is 32.8% for males and 38.5% for females. Females have higher residual lifetime risks at all ages. The highest. estimated lifetime risk for diabetes is among Hispanics (males, 45.4% and females, 515%) Individuals diagnosed as having diabetes have large reductions in life expectancy. For example, we estimate that if an individual is diagnosed at age 40 years, men will lose 11.6 life-years and 18.6 quality-adjusted life-years and women will lose 14.3 life-years and 22.0 quality-adjusted life-years. Conclusions, For individuals born in the United States in 2000, the lifetime probability of being diagnosed with diabetes mellitus is substantial. Primary prevention of diabetes and its complications are important public health priorities.	Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Narayan, KMV (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, 4770 Buford Hwy NE,MSK-10, Atlanta, GA 30341 USA.							Botman S, 2000, VITAL HLTH STAT, V2; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; *BUR CENS, 2000, COMP ASS RES POP AG; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; Davidson MB, 2002, DIABETES CARE, V25, P1, DOI 10.2337/diacare.25.1.1; *DEP HLTH HUM SERV, 1998, SUMM HLTH STAT US CH; Engelgau MM, 2000, DIABETES CARE, V23, P1563, DOI 10.2337/diacare.23.10.1563; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; GEISS LS, 1995, DIABETES AM, P233; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; HARRIS MI, 1995, NIH PUBLICATION, P1; HOEL PG, 1972, INTRO STOCHASTIC PRO; Honeycutt Amanda A, 2003, Health Care Manag Sci, V6, P155, DOI 10.1023/A:1024467522972; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Jagger C, 2003, J PUBLIC HEALTH MED, V25, P42, DOI 10.1093/pubmed/fdg009; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Leibson CL, 1997, AM J EPIDEMIOL, V146, P12, DOI 10.1093/oxfordjournals.aje.a009187; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NARAYAN KM, 2002, EPIDEMIOLOGY DIABETE; Narayan KMV, 2000, DIABETES CARE, V23, P1794, DOI 10.2337/diacare.23.12.1794; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; *NAT CTR HLTH STAT, 2002, HLTH US; *NAT CTR HLTH STAT, 2000 NAT HLTH INT SU; *NAT CTR HLTH STAT, 1993, CD ROM SERIES, V10; O'Connor PJ, 1998, AM J MANAG CARE, V4, P335; Phillips KA, 1999, NEW ENGL J MED, V340, P141, DOI 10.1056/NEJM199901143400211; Ray NF, 1998, DIABETES CARE, V21, P296; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869; Saydah SH, 2002, AM J EPIDEMIOL, V156, P714, DOI 10.1093/aje/kwf111; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Tierney EF, 2001, AM J PUBLIC HEALTH, V91, P84, DOI 10.2105/AJPH.91.1.84; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003	44	1021	1045	0	43	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2003	290	14					1884	1890		10.1001/jama.290.14.1884	http://dx.doi.org/10.1001/jama.290.14.1884			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729CB	14532317	Bronze			2022-12-01	WOS:000185752600029
J	van den Berg, B; Clemons, WM; Collinson, I; Modis, Y; Hartmann, E; Harrison, SC; Rapoport, TA				van den Berg, B; Clemons, WM; Collinson, I; Modis, Y; Hartmann, E; Harrison, SC; Rapoport, TA			X-ray structure of a protein-conducting channel	NATURE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; ESCHERICHIA-COLI; ER MEMBRANE; CROSS-LINKING; PREPROTEIN TRANSLOCATION; SEC PROTEINS; COMPLEX; TRANSPORT; ANGSTROM	A conserved heterotrimeric membrane protein complex, the Sec61 or SecY complex, forms a protein-conducting channel, allowing polypeptides to be transferred across or integrated into membranes. We report the crystal structure of the complex from Methanococcus jannaschii at a resolution of 3.2 Angstrom. The structure suggests that one copy of the heterotrimer serves as a functional translocation channel. The alpha-subunit has two linked halves, transmembrane segments 1-5 and 6-10, clamped together by the gamma-subunit. A cytoplasmic funnel leading into the channel is plugged by a short helix. Plug displacement can open the channel into an 'hourglass' with a ring of hydrophobic residues at its constriction. This ring may form a seal around the translocating polypeptide, hindering the permeation of other molecules. The structure also suggests mechanisms for signal-sequence recognition and for the lateral exit of transmembrane segments of nascent membrane proteins into lipid, and indicates binding sites for partners that provide the driving force for translocation.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Max Planck Inst Biophys, D-60439 Frankfurt, Germany; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Med Univ Lubeck, Inst Biol, D-23538 Lubeck, Germany	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Lubeck	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Hartmann, Enno/C-5687-2013; Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; Collinson, Ian/0000-0002-3931-0503; Modis, Yorgo/0000-0002-6084-0429; van den Berg, Bert/0000-0003-1966-8804				Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; FLOWER AM, 1995, EMBO J, V14, P884, DOI 10.1002/j.1460-2075.1995.tb07070.x; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heritage D, 2001, J BIOL CHEM, V276, P22655, DOI 10.1074/jbc.M102409200; Irihimovitch V, 2003, J BIOL CHEM, V278, P12881, DOI 10.1074/jbc.M210762200; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KURZCHALIA TV, 1988, EUR J BIOCHEM, V172, P663, DOI 10.1111/j.1432-1033.1988.tb13940.x; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; MURPHY CK, 1994, P NATL ACAD SCI USA, V91, P2557, DOI 10.1073/pnas.91.7.2557; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; PLATH K, IN PRESS MOL BIOL CE; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Satoh Y, 2003, BIOCHEMISTRY-US, V42, P7442, DOI 10.1021/bi034333v; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; TANI K, 1990, J BIOL CHEM, V265, P17341; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393	50	953	975	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					36	44		10.1038/nature02218	http://dx.doi.org/10.1038/nature02218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14661030				2022-12-01	WOS:000187710000026
J	Huynh, KD; Lee, JT				Huynh, KD; Lee, JT			Inheritance of a pre-inactivated paternal X chromosome in early mouse embryos	NATURE			English	Article							XIST RNA ACCUMULATION; GENE-EXPRESSION; STAGE	In mammals, dosage compensation ensures equal X-chromosome expression between males (XY) and females (XX) by transcriptionally silencing one X chromosome in XX embryos(1). In the prevailing view, the XX zygote inherits two active X chromosomes, one each from the mother and father, and X inactivation does not occur until after implantation(2-6). Here, we report evidence to the contrary in mice. We find that one X chromosome is already silent at zygotic gene activation (2-cell stage). This X chromosome is paternal in origin and exhibits a gradient of silencing. Genes close to the X-inactivation centre show the greatest degree of inactivation, whereas more distal genes show variable inactivation and can partially escape silencing. After implantation, imprinted silencing in extraembryonic tissues becomes globalized and more complete on a gene-by-gene basis. These results argue that the XX embryo is in fact dosage compensated at conception along much of the X chromosome. We propose that imprinted X inactivation results from inheritance of a pre-inactivated X chromosome from the paternal germ line.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@frodo.mgh.harvard.edu						ADLER DA, 1977, NATURE, V267, P838, DOI 10.1038/267838a0; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; Chadwick BP, 2003, DEV CELL, V4, P445, DOI 10.1016/S1534-5807(03)00097-2; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hartshorn C, 2003, MOL REPROD DEV, V64, P41, DOI 10.1002/mrd.10223; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Huynh KD, 2001, CURR OPIN CELL BIOL, V13, P690, DOI 10.1016/S0955-0674(00)00272-6; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; KRIETSCH WKG, 1982, DIFFERENTIATION, V23, P141, DOI 10.1111/j.1432-0436.1982.tb01276.x; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1999, RESULTS PROBLEMS CEL, P73; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matsui J, 2001, HUM MOL GENET, V10, P1393, DOI 10.1093/hmg/10.13.1393; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MUKHERJEE AB, 1976, P NATL ACAD SCI USA, V73, P1608, DOI 10.1073/pnas.73.5.1608; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	30	293	301	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					857	862		10.1038/nature02222	http://dx.doi.org/10.1038/nature02222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14661031				2022-12-01	WOS:000187342000063
J	Carnethon, MR; Gidding, SS; Nehgme, R; Sidney, S; Jacobs, DR; Liu, K				Carnethon, MR; Gidding, SS; Nehgme, R; Sidney, S; Jacobs, DR; Liu, K			Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; FOLLOW-UP; EXERCISE; HYPERTENSION; MEN; WEIGHT; OVERWEIGHT; PREVENTION; GLUCOSE	Context Low cardiorespiratory fitness is an established risk factor for cardiovascular and total mortality; however, mechanisms responsible for these associations are uncertain. Objective To test whether low fitness, estimated by short duration on a maximal treadmill test, predicted the development of cardiovascular disease risk factors and whether improving fitness (increase in treadmill test duration between examinations) was associated with risk reduction. Design, Setting, and Participants Population-based longitudinal cohort study of men and women 18 to 30 years of age in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Participants who completed the treadmill examination according to the Balke protocol at baseline were followed up from 1985-1986 to 2000-2001. A subset of participants (n=2478) repeated the exercise test in 1992-1993. Main Outcome Measures Incident type 2 diabetes, hypertension, the metabolic syndrome (defined according to National Cholesterol Education Program Adult-Treatment Panel 111), and hypercholesterolemia (low-density lipoprotein cholesterol greater than or equal to160 mg/dL [4.14 mmol/L]). Results During the 15-year study period, the rates of incident diabetes, hypertension, the metabolic syndrome, and hypercholesterolemia were 2.8, 13.0, 10.2, and 11.7 per 1000 person-years, respectively. After adjustment for age, race, sex, smoking, and family history of diabetes, hypertension, or premature myocardial infarction, participants with low fitness (<20th percentile) were 3- to 6-fold more likely to develop diabetes, hypertension, and the metabolic syndrome than participants with high fitness ( >= 60th percentile), all P<.001. Adjusting for baseline body mass index diminished the strength of these associations to 2-fold (all P<.001). In contrast, the association between low fitness and hypercholesterolemia was modest (hazard ratio [HR], 1.4; 95% confidence interval [CI], 1.1-1.7; P=.02) and attenuated to marginal significance after body mass index adjustment (P=13). Improved fitness over 7 years was associated with a reduced risk of developing diabetes (HR, 0.4; 95% Cl, 0.2-1.0; P=.04) and the metabolic syndrome (HR, 0.5; 95% Cl, 0.3-0.7; P<.001), but the strength and significance of these associations was reduced after accounting for changes in weight. Conclusions Poor fitness in young adults is associated with the development of cardiovascular disease risk factors. These associations involve obesity and may be modified by improving fitness.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Thomas Jefferson Univ, Nemours Cardiac Ctr, Wilmington, DE USA; Thomas Jefferson Univ, Dept Pediat, Wilmington, DE USA; Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA	Northwestern University; Feinberg School of Medicine; Jefferson University; Jefferson University; Kaiser Permanente; University of Minnesota System; University of Minnesota Twin Cities	Carnethon, MR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	carnethon@northwestern.edu		Jacobs, David/0000-0002-7232-0543; Gidding, Samuel/0000-0002-8557-7225	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC048047, N01HC048048, N01HC095095, N01HC048049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL073249] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARIAS E, 2003, DEATHS PRELIMINARY D; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Centers for Disease Control and Prevention, 1996, PHYS ACT HLTH REP SU; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Fagard RH, 1999, MED SCI SPORT EXER, V31, pS624, DOI 10.1097/00005768-199911001-00022; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Juhaeri, 2002, INT J OBESITY, V26, P58, DOI 10.1038/sj.ijo.0801846; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI [10.1056/NEJMoa020194, DOI 10.1056/NEJMOA020194, DOI 10.1056/NEJMoa020194]; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lee CD, 2002, MED SCI SPORT EXER, V34, P592; Lee CD, 2002, MED SCI SPORT EXER, V34, P735; Melanson EL, 2001, EUR J APPL PHYSIOL, V85, P442, DOI 10.1007/s004210100479; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Petrella RJ, 2003, AM J PREV MED, V24, P316, DOI 10.1016/S0749-3797(03)00022-9; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; Rothman KJ., 2012, EPIDEMIOLOGY INTRO, V2nd; Sidney S, 1998, MED SCI SPORT EXER, V30, P427, DOI 10.1097/00005768-199803000-00014; SIDNEY S, 1992, MED SCI SPORT EXER, V24, P177; STAMLER R, 1978, JAMA-J AM MED ASSOC, V240, P1607, DOI 10.1001/jama.240.15.1607; STEFANICK ML, 1984, PHYSICAL ACTIVITY FI, P417; Sternfeld B, 1999, ANN EPIDEMIOL, V9, P25, DOI 10.1016/S1047-2797(98)00030-1; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547	38	423	434	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3092	3100		10.1001/jama.290.23.3092	http://dx.doi.org/10.1001/jama.290.23.3092			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679272	Bronze			2022-12-01	WOS:000187277300028
J	Chatterjee, S; Callaway, EM				Chatterjee, S; Callaway, EM			Parallel colour-opponent pathways to primary visual cortex	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; S-CONE; GANGLION-CELLS; OLD-WORLD; MORPHOLOGY; RETINA; ORGANIZATION; MECHANISMS; LAMINAE; AXONS	The trichromatic primate retina parses the colour content of a visual scene into ' red/ green' and ` blue/ yellow' representations(1 - 2). Cortical circuits must combine the information encoded in these colour- opponent signals to reconstruct the full range of perceived colours(3). Red/ green and blue/ yellow inputs are relayed by the lateral geniculate nucleus ( LGN) of thalamus to primary visual cortex ( V1), so understanding how cortical circuits transform these signals requires understanding how LGN inputs to V1 are organized. Here we report direct recordings from LGN afferent axons in muscimol- inactivated V1. We found that blue/ yellow afferents terminated exclusively in superficial cortical layers 3B and 4A, whereas red/ green afferents were encountered only in deeper cortex, in lower layer 4C. We also describe a distinct cortical target for ' blue- OFF' cells, whose afferents terminated in layer 4A and seemed patchy in organization. The more common ` blue- ON' afferents were found in 4A as well as lower layer 2/ 3. Chromatic information is thus conveyed to V1 by parallel, anatomically segregated colour- opponent systems, to be combined at a later stage of the colour circuit.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Chatterjee, S (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sochatte@ucsd.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267				Ahmad KM, 2003, VISUAL NEUROSCI, V20, P189, DOI 10.1017/S0952523803202091; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CONLEY M, 1989, VISUAL NEUROSCI, V2, P287, DOI 10.1017/S0952523800001206; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; Klug K, 2003, J NEUROSCI, V23, P9881; LENNIE P, 1988, CRIT REV NEUROBIOL, V3, P333; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; Martin PR, 1997, EUR J NEUROSCI, V9, P1536, DOI 10.1111/j.1460-9568.1997.tb01509.x; MICHAEL CR, 1988, P NATL ACAD SCI USA, V85, P4914, DOI 10.1073/pnas.85.13.4914; Reid RC, 2002, J NEUROSCI, V22, P6158; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; VALBERG A, 1986, VISION RES, V26, P1061, DOI 10.1016/0042-6989(86)90040-4; Wandell B. A., 1995, FDN VISION, P413; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	30	146	152	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					668	671		10.1038/nature02167	http://dx.doi.org/10.1038/nature02167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668866				2022-12-01	WOS:000187132800043
J	White, MF				White, MF			Insulin signaling in health and disease	SCIENCE			English	Article							STIMULATES TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-2; RESISTANCE; GROWTH; CELLS; PROTEIN; OBESITY	The signaling pathways used by insulin have been identified [M. White, Insulin Signaling Pathway, Sci. STKE (Connections Map, as seen November 2003), http://stke.sciencemag. org/cgi/cm/cmp_12069]. Now our challenge is to understand how the failure of these signals is associated with obesity and the progressive failure of pancreatic beta cells that leads to diabetes. Whether better management of chronic inflammation can improve insulin action is an important area of investigation. Drugs that stimulate IRS2 (insulin receptor substrate protein 2) synthesis or signaling might be a good starting point. This knowledge will lead to rational strategies that prevent or cure diabetes.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	White, MF (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, 1 Joslin Pl, Boston, MA 02215 USA.							Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Bliss M., 1982, DISCOVERY INSULIN; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KREBS DL, 2003, SCI STKE, pE6; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 2003, SCI STKE; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	21	489	528	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1710	1711		10.1126/science.1092952	http://dx.doi.org/10.1126/science.1092952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657487	Green Submitted			2022-12-01	WOS:000186970100034
J	Go, AS; Hylek, EM; Chang, YC; Phillips, KA; Henault, LE; Capra, AM; Jensvold, NG; Selby, JV; Singer, DE				Go, AS; Hylek, EM; Chang, YC; Phillips, KA; Henault, LE; Capra, AM; Jensvold, NG; Selby, JV; Singer, DE			Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ORAL ANTICOAGULATION; ANTITHROMBOTIC THERAPY; PREDICTING STROKE; RHYTHM CONTROL; INTENSITY; WARFARIN; VALIDATION; MORTALITY; EFFICACY	Context Warfarin has been shown to be highly efficacious for preventing thromboembolism in atrial fibrillation in randomized trials, but its effectiveness and safety in clinical practice is less clear. Objective To evaluate the effect of warfarin on risk of thromboembolism, hemorrhage, and death in atrial fibrillation within a usual care setting. Design Cohort study assembled between July 1, 1996, and December 31,1997, and followed up through August 31, 1999. Setting Large integrated health care system in Northern California. Patients Of 13559 adults with nonvalvular atrial fibrillation, 11526 were studied, 43% of whom were women, mean age 71 years, with no known contraindications to anticoagulation at baseline. Main Outcomes Ischemic stroke, peripheral embolism, hemorrhage, and death according to warfarin use and comorbidity status, as determined by automated databases, review of medical records, and state mortality files. Results Among 11526 patients, 397 incident thromboembolic events (372 ischemic strokes, 25 peripheral embolism) occurred during 25341 person-years of follow-up, and warfarin therapy was associated with a 51% (95% confidence interval [CI], 39%-60%) lower risk of thromboembolism compared with no warfarin therapy (either no antithrombotic therapy or aspirin) after adjusting for potential confounders and likelihood of receiving warfarin. Warfarin was effective in reducing thromboembolic risk in the presence or absence of risk factors for stroke. A nested case-control analysis estimated a 64% reduction in odds of thromboembolism with warfarin compared with no antithrombotic therapy. Warfarin was also associated with a reduced risk of all-cause mortality. (adjusted hazard ratio, 0.69; 95% CI, 0.61-0.77). Intracranial hemorrhage was uncommon, but the rate was moderately higher among those taking vs those not taking warfarin (0.46 vs 0.23 per 100 person-years, respectively; P=.003, adjusted hazard ratio, 1.97; 95% CI, 1.24-3.13). However, warfarin therapy was not associated with an increased adjusted risk of nonintracranial major hemorrhage. The effects of warfarin were similar when patients with contraindications at baseline were analyzed separately or combined with those without contraindications (total cohort of 13559). Conclusions Warfarin is very effective for preventing ischemic stroke inpatients with atrial fibrillation in clinical practice while the absolute increase in the risk of intracranial hemorrhage is small. Results of randomized trials of anticoagulation translate well into clinical care for patients with atrial fibrillation.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Dept Med, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Floor, Oakland, CA 94612 USA.	Alan.S.Go@kp.org	Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER; NIA NIH HHS [AG15478] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; [Anonymous], 1997, ARCH INTERN MED, V157, P1237; Ansell JE, 1997, ANN PHARMACOTHER, V31, P604, DOI 10.1177/106002809703100516; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Aronow WS, 1999, J AM GERIATR SOC, V47, P366, DOI 10.1111/j.1532-5415.1999.tb03004.x; Blackshear JL, 1996, LANCET, V348, P633; Caro JJ, 2000, CAN MED ASSOC J, V162, P973; Caro JJ, 1999, CAN MED ASSOC J, V161, P493; CARO JJ, 1999, CMAJ, V161, P533; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Diggle P., 2002, ANAL LONGITUDINAL DA; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Evans A, 2001, ARCH INTERN MED, V161, P1443, DOI 10.1001/archinte.161.11.1443; Evans A, 2001, STROKE, V32, P2828, DOI 10.1161/hs1201.099520; Evans A, 2000, STROKE, V31, P2106, DOI 10.1161/01.STR.31.9.2106; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; EZEKOWITZ MD, 1993, NEW ENGL J MED, V328, P148; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Fleiss J.L., 1981, STAT METHODS RATES P; Frost L, 2002, J INTERN MED, V252, P64, DOI 10.1046/j.1365-2796.2002.01009.x; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Go AS, 2000, CIRCULATION, V102, P11, DOI 10.1161/01.CIR.102.1.11; Goldenberg GM, 1999, CLIN DRUG INVEST, V17, P483, DOI 10.2165/00044011-199917060-00009; GOTTLIEB LK, 1994, ARCH INTERN MED, V154, P1945, DOI 10.1001/archinte.154.17.1945; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Hart RG, 2000, CEREBROVASC DIS, V10, P39, DOI 10.1159/000016023; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kalra L, 2000, BMJ-BRIT MED J, V320, P1236, DOI 10.1136/bmj.320.7244.1236; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Kleinbaum D.G., 1988, APPL REGRESSION ANAL; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schlesselman J.J., 1982, CASE CONTROL STUDIES; SELBY JV, 1994, EPIDEMIOL REV, V16, P90, DOI 10.1093/oxfordjournals.epirev.a036148; Stokes ME, 2000, CATEGORICAL DATA ANA; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	49	571	593	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2685	2692		10.1001/jama.290.20.2685	http://dx.doi.org/10.1001/jama.290.20.2685			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645310	Bronze			2022-12-01	WOS:000186788100020
J	Hughes-Davies, L; Huntsman, D; Ruas, M; Fuks, F; Bye, J; Chin, SF; Milner, J; Brown, LA; Hsu, F; Gilks, B; Nielsen, T; Schulzer, M; Chia, S; Ragaz, J; Cahn, A; Linger, L; Ozdag, H; Cattaneo, E; Jordanova, ES; Schuuring, E; Yu, DS; Venkitaraman, A; Ponder, B; Doherty, A; Aparicio, S; Bentley, D; Theillet, C; Ponting, CP; Caldas, C; Kouzarides, T				Hughes-Davies, L; Huntsman, D; Ruas, M; Fuks, F; Bye, J; Chin, SF; Milner, J; Brown, LA; Hsu, F; Gilks, B; Nielsen, T; Schulzer, M; Chia, S; Ragaz, J; Cahn, A; Linger, L; Ozdag, H; Cattaneo, E; Jordanova, ES; Schuuring, E; Yu, DS; Venkitaraman, A; Ponder, B; Doherty, A; Aparicio, S; Bentley, D; Theillet, C; Ponting, CP; Caldas, C; Kouzarides, T			EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer	CELL			English	Article							HISTONE H3; LYSINE 9; DOMAIN; METHYLATION; PROTEINS; CHROMO; GENE; METHYLTRANSFERASE; SUSCEPTIBILITY; EXPRESSION	The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, which binds BRCA2 within a region (exon 3) deleted in cancer. EMSY is capable of silencing the activation potential of BRCA2 exon 3, associates with chromatin regulators HP1beta and BS69, and localizes to sites of repair following DNA damage. EMSY maps to chromosome 11q13.5, a region known to be involved in breast and ovarian cancer. We show that the EMSY gene is amplified almost exclusively in sporadic breast cancer (13%) and higher-grade ovarian cancer (17%). In addition, EMSY amplification is associated with worse survival, particularly in node-negative breast cancer, suggesting that it may be of prognostic value. The remarkable clinical overlap between sporadic EMSY amplification and familial BRCA2 deletion implicates a BRCA2 pathway in sporadic breast and ovarian cancer.	Canc Res UK, Wellcome Trust Inst, Cambridge CB2 1QR, England; Canc Res UK, Dept Pathol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Oncol, MRC, Res Ctr, Cambridge CB2 2XZ, England; Vancouver Gen Hosp, Dept Pathol, Genet Pathol Evaluat Ctr, Vancouver, BC V6H 3Z6, Canada; Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V6H 3Z6, Canada; Univ British Columbia, Vancouver, BC V6H 3Z6, Canada; Wellcome Trust Sanger Inst Hinxton, Cambridge CB10 1SA, England; Univ British Columbia, Dept Stat & Med, Vancouver, BC V6T 2B5, Canada; British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada; Leiden Univ, Ctr Med, Dept Pathol, NL-2300 RC Leiden, Netherlands; Univ Groningen Hosp, Dept Pathol, NL-9700 RB Groningen, Netherlands; MRC, Canc Cell Unit, Res Ctr, Cambridge CB2 2XZ, England; Cambridge Inst Med Res, Cambridge CB2 2XZ, England; Ctr Val Aurelle, INSERM, EMI 229, Montpellier, France; Univ Oxford, MRC, Funct Genet Unit, Oxford OX1 3QX, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Wellcome Trust Sanger Institute; University of British Columbia; British Columbia Cancer Agency; Leiden University; Leiden University - Excl LUMC; University of Groningen; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); University of Oxford	Hughes-Davies, L (corresponding author), Canc Res UK, Wellcome Trust Inst, Tennsi Court Rd, Cambridge CB2 1QR, England.	lh205@cus.cam.ac.uk; cc234@cam.ac.uk; tkl06@mole.bio.cam.ac.uk	Caldas, Carlos/U-7250-2019; Huntsman, David/ABE-6082-2020; Theillet, Charles/O-7634-2018; Ponting, Chris/AAV-2621-2021; Özdag, Hilal/C-9929-2009; Caldas, Carlos/A-7543-2008	Caldas, Carlos/0000-0003-3547-1489; Özdag, Hilal/0000-0001-7940-2499; Kouzarides, Tony/0000-0002-8918-4162; Jordanova, Ekaterina S./0000-0002-8121-1322; chin, suet-feung/0000-0001-5697-1082; Aparicio, Samuel/0000-0002-0487-9599; Jordanova, Ekaterina/0000-0003-3890-7102; Doherty, Aidan/0000-0002-6370-1109; Ruas, Margarida/0000-0002-4872-7618; CATTANEO, ELENA/0000-0002-0755-4917; Brown, Lindsay/0000-0002-2790-5112; Theillet, Charles/0000-0001-5555-2759; Ponting, Chris/0000-0003-0202-7816				Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bekri S, 1997, CYTOGENET CELL GENET, V79, P125, DOI 10.1159/000134699; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bornemann D, 1998, GENETICS, V150, P675; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Collins N, 1997, BRIT J CANCER, V76, P1150, DOI 10.1038/bjc.1997.526; Courjal F, 1997, CANCER RES, V57, P4360; COX DR, 1972, J R STAT SOC B, V34, P187; Dobrovic A, 1997, CANCER RES, V57, P3347; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Gayther SA, 1998, J MAMMARY GLAND BIOL, V3, P365, DOI 10.1023/A:1018779830743; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nordling M, 1998, CANCER RES, V58, P1372; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shin S, 2003, P NATL ACAD SCI USA, V100, P7201, DOI 10.1073/pnas.1132020100; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049	37	341	366	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					523	535		10.1016/S0092-8674(03)00930-9	http://dx.doi.org/10.1016/S0092-8674(03)00930-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651845	Bronze			2022-12-01	WOS:000186885600004
J	McLeod, P; Reed, N; Dienes, Z				McLeod, P; Reed, N; Dienes, Z			Psychophysics - How fielders arrive in time to catch the ball	NATURE			English	Editorial Material									Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Sussex, Dept Expt Psychol, Brighton BN1 9QG, E Sussex, England	University of Oxford; University of Sussex	McLeod, P (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.			Reed, Nick/0000-0002-7794-6123; Dienes, Zoltan/0000-0001-7454-3161				Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; McLeod P, 2001, J EXP PSYCHOL HUMAN, V27, P1347, DOI 10.1037/0096-1523.27.6.1347; MCLEOD P, UNPUB J EXP PSYCHOL; TRESILIAN JR, 1995, Q J EXP PSYCHOL-A, V48, P688, DOI 10.1080/14640749508401411	5	39	41	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					244	245		10.1038/426244a	http://dx.doi.org/10.1038/426244a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628038				2022-12-01	WOS:000186660800030
J	Seymour, RS; White, CR; Gibernan, M				Seymour, RS; White, CR; Gibernan, M			Environmental biology: Heat reward for insect pollinators	NATURE			English	Editorial Material							PHILODENDRON; INFLORESCENCES; RESPIRATION		Univ Adelaide, Adelaide, SA 5005, Australia; Univ Toulouse 3, Lab Evolut & Divers Biol, F-31062 Toulouse, France	University of Adelaide; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Seymour, RS (corresponding author), Univ Adelaide, Adelaide, SA 5005, Australia.	roger.seymour@adelaide.edu.au	Seymour, Roger/C-3469-2009; White, Craig R/F-9062-2010; Gibernau, Marc/A-7388-2010	Seymour, Roger/0000-0002-3395-0059; White, Craig R/0000-0002-0200-2187; 				Barabe D, 2002, BOT J LINN SOC, V139, P79, DOI 10.1046/j.1095-8339.2002.00040.x; BARTHOLOMEW GA, 1977, SCIENCE, V195, P882, DOI 10.1126/science.841312; Bernhardt P, 2000, PLANT SYST EVOL, V222, P293, DOI 10.1007/BF00984108; Endress P.K., 1994, DIVERSITY EVOLUTIONA; Gibernau M, 2000, CAN J BOT, V78, P685, DOI 10.1139/cjb-78-5-685; GOTTSBERGER G, 1991, BIOTROPICA, V23, P23, DOI 10.2307/2388684; GOTTSBERGER G, 1988, TAXON, V37, P630, DOI 10.2307/1221105; Heinrich B., 1993, HOT BLOODED INSECTS; Schatz GE, 1990, REPROD ECOLOGY TROPI, P69; Seymour RS, 1999, J EXP BOT, V50, P845, DOI 10.1093/jexbot/50.335.845; Seymour RS, 1997, ENDEAVOUR, V21, P125, DOI 10.1016/S0160-9327(97)80222-0; Seymour RS, 1999, P ROY SOC B-BIOL SCI, V266, P1975, DOI 10.1098/rspb.1999.0875; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575	13	155	163	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					243	244		10.1038/426243a	http://dx.doi.org/10.1038/426243a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628037				2022-12-01	WOS:000186660800029
J	Stankiewicz, BA				Stankiewicz, BA			Integration of geoscience and engineering in the oil industry - just a dream?	NATURE			English	Editorial Material								The past two decades of the twentieth century have been very 'rocky' for the oil industry, as shown by the overall negative perception of the oil companies by the general public. Fluctuating oil prices, many rounds of staff redundancies, environmental disasters and budget cuts supported the overall image of the oil industry as being 'the technology impaired and environmentally insensible giant'. But advances and positive changes have been quietly happening in most of the oil companies. In the twenty-first century, we will witness the metamorphosis of the oil and gas companies into energy businesses - the era of cleaner and safer oil and gas production, and alternative energy resources such as wind, solar and hydrogen is already underway.	Shell Int Explorat & Prod BV, NL-2280 AB Rijswijk, Netherlands	Royal Dutch Shell	Stankiewicz, BA (corresponding author), Shell Int Explorat & Prod BV, Volmerlaan 8, NL-2280 AB Rijswijk, Netherlands.	astankiewicz@wanadoo.nl						Hammami A, 2000, ENERG FUEL, V14, P14, DOI 10.1021/ef990104z; Hammami A, 1999, SPE J, V4, P9, DOI 10.2118/54021-PA; Jamaluddin AKM, 2002, J CAN PETROL TECHNOL, V41, P25; Karan K, 2003, PETROL SCI TECHNOL, V21, P629, DOI 10.1081/LFT-120018543; KOOL H, 2002, PETROMI, V28, P26; MACLEOD G, 2004, INTEGRATION ORGANIC; MEHTA A, 2000, ANN NY ACAD SCI, V912, P361; Ratulowski J, 2003, SPE RESERV EVAL ENG, V6, P168, DOI 10.2118/84777-PA; STANKIEWICZ BA, 2001, 20 INT M ORG GEOCH, V1, P121; Yergin Daniel, 1991, PRIZE EPIC QUEST OIL; [No title captured]	11	5	5	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					360	363		10.1038/nature02136	http://dx.doi.org/10.1038/nature02136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628066				2022-12-01	WOS:000186660800058
J	Guskiewicz, KM; McCrea, M; Marshall, SW; Cantu, RC; Randolph, C; Barr, W; Onate, JA; Kelly, JP				Guskiewicz, KM; McCrea, M; Marshall, SW; Cantu, RC; Randolph, C; Barr, W; Onate, JA; Kelly, JP			Cumulative effects associated with recurrent concussion in collegiate football players - The NCAA Concussion Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPERIMENTAL HEAD-INJURY; LONGITUDINAL DATA-ANALYSIS; POISSON REGRESSION-MODELS; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN INJURY; NEUROPSYCHOLOGICAL DEFICITS; CEREBRAL CONCUSSION; SAFE RETURN; PERFORMANCE; METABOLISM	Context Approximately 300000 sport-related concussions occur annually in the United States, and the likelihood of serious sequelae may increase with repeated head injury. Objective To estimate the incidence of concussion and time to recovery after concussion in collegiate football players. Design, Setting, and Participants Prospective cohort study of 2905 football players from 25 US colleges were tested at preseason baseline in 1999, 2000, and 2001 on a variety of measures and followed up prospectively to ascertain concussion occurrence. Players injured with a concussion were monitored until their concussion symptoms resolved and were followed up for repeat concussions until completion of their collegiate football career or until the end of the 2001 football season. Main Outcome Measures Incidence of concussion and repeat concusion; type and duration of symptoms and course of recovery among players who were injured with a concussion during the seasons. Results During follow-up of 4251 player-seasons, 184 players (6.3%) had a concussion, and 12 (6.5%) of these players had a repeat concussion within the same season. There was an association between reported number of previous concussions and likelihood of incident concussion. Players reporting a history of 3 or more previous concussions were 3.0 (95% confidence interval, 1.6-5.6) times more likely to have an incident concussion than players with no concussion history. Headache was the most commonly reported symptom at the time of injury (85.2%), and mean overall symptom duration was 82 hours. Slowed recovery was associated with a history of multiple previous concussions (30.0% of those with greater than or equal to3 previous concussions had symptoms lasting >1 week compared with 14.6% of those with 1 previous concussion). Of the 12 incident within-season repeat concussions, 11 (91.7%) occurred within 10 days of the first injury, and 9 (75.0%) occurred within 7 days of the first injury. Conclusions Our study suggests that players with a history of previous concussions are more likely to have future concussive injuries than those with no history; 1 in 15 players With a concussion may have additional concussions in the same playing season; and previous concussions may be associated with slower recovery of neurological function.	Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthopaed, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Northwestern Univ, Feinberg Sch Med, Chicago Neurol Inst, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Dept Neurol, Maywood, IL 60153 USA; NYU, Sch Med, Dept Neurol, New York, NY USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Dept Rehabil Sci, Athlet Training Program, Boston, MA 02215 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Medical College of Wisconsin; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; New York University; Boston University	Guskiewicz, KM (corresponding author), Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, CB 8700,211 Fetzer, Chapel Hill, NC 27599 USA.		Onate, James/E-3790-2011	Guskiewicz, Kevin/0000-0002-8682-2130; Barr, William/0000-0001-7711-7758; Marshall, Stephen/0000-0002-2664-9233				ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; Barth J.T., 1989, MILD HEAD INJURY, P257; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bruce D A, 1982, Clin Sports Med, V1, P495; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu, 1991, Adolesc Med, V2, P141; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 2001, J ATHL TRAINING, V36, P244; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; *COL MED SOC SPORT, 1994, P MILD BRAIN INJ SPO, P106; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; Dick R, 2002, 2001 2002 NCAA INJUR; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2001, J ATHL TRAINING, V36, P280; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza C. C., 2000, NEUROLOGIC ATHLETIC, P80; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenland S, 1998, MODERN EPIDEMIOLOGY; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; JORDAN B, 1994, P MILD BRAIN INJ SPO, P43; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; MCCREA M, IN PRESS CLIN J SPOR; MCCULLOCH CE, 2001, GEN LINEAR MIXED MOD, P223; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; *NAT COLL ATHL ASS, 2002, 1981 1982 2001 2002; Nelson S, 1966, HEAD INJURY, P444; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; Ommaya A, 1994, P MILD BRAIN INJ SPO, P72; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; PRINCE DA, 1973, BRAIN RES, V50, P489, DOI 10.1016/0006-8993(73)90758-0; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	54	1118	1132	4	249	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2549	2555		10.1001/jama.290.19.2549	http://dx.doi.org/10.1001/jama.290.19.2549			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744DQ	14625331	Bronze			2022-12-01	WOS:000186613000024
J	Jaenicke-Despres, V; Buckler, ES; Smith, BD; Gilbert, MTP; Cooper, A; Doebley, J; Paabo, S				Jaenicke-Despres, V; Buckler, ES; Smith, BD; Gilbert, MTP; Cooper, A; Doebley, J; Paabo, S			Early allelic selection in maize as revealed by ancient DNA	SCIENCE			English	Article							BRANCH CHAIN-LENGTH; PROLAMIN BOX; DOMESTICATION; STARCH; EVOLUTION; DETERMINANT; DOMINANCE; DIVERSITY; GENES	Maize was domesticated from teosinte, a wild grass, by similar to6300 years ago in Mexico. After initial domestication, early farmers continued to select for advantageous morphological and biochemical traits in this important crop. However, the timing and sequence of character selection are, thus far, known only for morphological features discernible in corn cobs. We have analyzed three genes involved in the control of plant architecture, storage protein synthesis, and starch production from archaeological maize samples from Mexico and the southwestern United States. The results reveal that the alleles typical of contemporary maize were present in Mexican maize by 4400 years ago. However, as recently as 2000 years ago, allelic selection at one of the genes may not yet have been complete.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; ARS, USDA, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA; Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	Max Planck Society; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford; University of Wisconsin System; University of Wisconsin Madison	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.		Gilbert, Marcus TP/A-8936-2013; Buckler, Edward/L-7651-2019; Cooper, Alan/E-8171-2012; Buckler, Edward/GPS-4932-2022	Gilbert, Marcus TP/0000-0002-5805-7195; Buckler, Edward/0000-0002-3100-371X; Cooper, Alan/0000-0002-7738-7851; 				Benz BF, 2001, P NATL ACAD SCI USA, V98, P2104, DOI 10.1073/pnas.98.4.2104; Benz BF, 2000, CURR ANTHROPOL, V41, P459; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; DOEBLEY J, 1992, TRENDS GENET, V8, P302, DOI 10.1016/0168-9525(92)90261-2; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Handt O, 1996, AM J HUM GENET, V59, P368; Huckell BB, 1996, J WORLD PREHIST, V10, P305, DOI 10.1007/BF02286419; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; JANE JL, 1992, CEREAL CHEM, V69, P60; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Rahman A, 1998, PLANT PHYSIOL, V117, P425, DOI 10.1104/pp.117.2.425; Smith BD, 1997, LAT AM ANTIQ, V8, P342, DOI 10.2307/972107; SMITH BD, 1989, SCIENCE, V246, P1566, DOI 10.1126/science.246.4937.1566; Smith BD, 1998, EMERGENCE AGR; UEDA T, 1994, MOL CELL BIOL, V14, P4350, DOI 10.1128/MCB.14.7.4350; VicenteCarbajosa J, 1997, P NATL ACAD SCI USA, V94, P7685, DOI 10.1073/pnas.94.14.7685; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang ZD, 1998, GENE, V223, P321, DOI 10.1016/S0378-1119(98)00244-3; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999	24	181	191	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1206	1208		10.1126/science.1089056	http://dx.doi.org/10.1126/science.1089056			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615538				2022-12-01	WOS:000186544300053
J	Libina, N; Berman, JR; Kenyon, C				Libina, N; Berman, JR; Kenyon, C			Tissue-specific activities of C-elegans DAF-16 in the regulation of lifespan	CELL			English	Article							CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR; STRESS RESISTANCE; INTERACTING GENES; OXIDATIVE STRESS; DAUER FORMATION; FAMILY-MEMBER; LONGEVITY; NEMATODE; IDENTIFICATION	In C. elegans, the transcription factor DAF-16 promotes longevity in response to reduced insulin/IGF-1 signaling or germline ablation. In this study, we have asked how different tissues interact to specify the life-span of the animal. We find that several tissues act as signaling centers. In particular, DAF-16 activity in the intestine, which is also the animal's adipose tissue, completely restores the longevity of daf-16(-) germline-deficient animals, and increases the lifespans of daf-16(-) insulin/IGF-1-pathway mutants substantially. Our findings indicate that DAF-16 may control two types of downstream signals: DAF-16 activity in signaling cells upregulates DAF-16 in specific responding tissues, possibly via regulation of insulin-like peptides, and also evokes DAF-16-independent responses. We suggest that this network of tissue interactions and feedback regulation allows the tissues to equilibrate and fine-tune their expression of downstream genes, which, in turn, coordinates their rates of aging within the animal.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Miss Bay Genentech Hall,600 16th St,Room S312D, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [AG11816] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG011816, R01AG011816] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; APFELD J, 1999, THESIS U CALIFORNIA; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; den Boer BGW, 1998, DEVELOPMENT, V125, P3213; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; HEDGECOCK EM, 1995, GENETICS, V141, P989; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HERMAN RK, 1984, GENETICS, V108, P165; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LABOUESSE M, 1994, DEVELOPMENT, V120, P2359; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; LAWLESS JF, 1982, MODELS METHODS LIFET; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; MADURO M, 1995, GENETICS, V141, P977; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murakami S, 2001, CURR BIOL, V11, P1517, DOI 10.1016/S0960-9822(01)00453-5; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ookuma S, 2003, CURR BIOL, V13, P427, DOI 10.1016/S0960-9822(03)00108-8; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; RIDDLE DL, 1997, ELEGANS, V2, P739; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VOWELS JJ, 1992, GENETICS, V130, P105; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	58	561	589	4	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					489	502		10.1016/S0092-8674(03)00889-4	http://dx.doi.org/10.1016/S0092-8674(03)00889-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622602	Bronze			2022-12-01	WOS:000186627100014
J	Guthrie, RD				Guthrie, RD			Rapid body size decline in Alaskan Pleistocene horses before extinction	NATURE			English	Article							POLLEN RECORDS; BERINGIA; TRANSITION; EUROPE; STEPPE; END	About 70% of North American large mammal species were lost at the end of the Pleistocene epoch(1). The causes of this extinction the role of humans versus that of climate-have been the focus of much controversy(1-6). Horses have figured centrally in that debate, because equid species dominated North American late Pleistocene faunas in terms of abundance, geographical distribution, and species variety, yet none survived into the Holocene epoch. The timing of these equid regional extinctions and accompanying evolutionary changes are poorly known. In an attempt to document better the decline and demise of two Alaskan Pleistocene equids, I selected a large number of fossils from the latest Pleistocene for radiocarbon dating. Here I show that horses underwent a rapid decline in body size before extinction, and I propose that the size decline and subsequent regional extinction at 12,500 radiocarbon years before present are best attributed to a coincident climatic/vegetational shift. The present data do not support human overkill(1) and several other proposed extinction causes(2,3), and also show that large mammal species responded somewhat individualistically to climate changes(4-6) at the end of the Pleistocene.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Guthrie, RD (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.							Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; AMTHEUS P, 2003, 3 INT MAMM C 3 5 YUK; ANDERSON PM, 1988, QUATERNARY RES, V29, P263, DOI 10.1016/0033-5894(88)90035-X; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; EISENMANN V, 1982, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V4, P75; FORSTEN A, 1991, MAMMALIA, V55, P407, DOI 10.1515/mamm.1991.55.3.407; FORSTREN A, 1982, J MAMMAL, V67, P422; Goetcheus VG, 2001, QUATERNARY SCI REV, V20, P135, DOI 10.1016/S0277-3791(00)00127-X; Graham RW, 1984, QUATERNARY EXTINCTIO; Guthrie R.D., 1984, P259; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie R. Dale, 2001, BAR International Series, V944, P32; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; GUTHRIE RD, 1965, EVOLUTION, V19, P214, DOI 10.1111/j.1558-5646.1965.tb01708.x; GUTHRIE RD, 1984, MAMMOTH HOT SPRINGS, V1, P42; GUTHRIE RD, 1964, CONTRIBUTIONS VERTEB, P482; Harington C.R., 2003, ANNOTATED BIBLIO QUA; Holmes CE, 2001, ARCTIC ANTHROPOL, V38, P154; Kachigan S.K., 1991, MULTIVARIATE STAT AN; Lamb H.F., 1988, VEGETATION HIST, P519, DOI DOI 10.1007/978-94-009-3081-0_14; LOWE JJ, 1994, J QUATERNARY SCI, V9, P185, DOI 10.1002/jqs.3390090215; LOZHKIN AV, 1993, QUATERNARY RES, V39, P314, DOI 10.1006/qres.1993.1038; MacPhee Ross D.E., 1997, P169; Martin P. S., 1984, QUATERNARY EXTINCTIO, P345; MCDONALD J, 1984, QUATERNARY EXTINCTIO, P409; Sher AV, 1997, NATO ASI SER SER I, V47, P319; Stuart AJ, 2002, QUATERNARY SCI REV, V21, P1559, DOI 10.1016/S0277-3791(02)00026-4; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wilson MC, 1996, QUATERN INT, V32, P97, DOI 10.1016/1040-6182(95)00056-9; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824	31	156	169	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					169	171		10.1038/nature02098	http://dx.doi.org/10.1038/nature02098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614503				2022-12-01	WOS:000186517200040
J	Yamada, K; Lim, J; Dale, JM; Chen, HM; Shinn, P; Palm, CJ; Southwick, AM; Wu, HC; Kim, C; Nguyen, M; Pham, P; Cheuk, R; Karlin-Newmann, G; Liu, SX; Lam, B; Sakano, H; Wu, T; Yu, GX; Miranda, M; Quach, HL; Tripp, M; Chang, CH; Lee, JM; Toriumi, M; Chan, MMH; Tang, CC; Onodera, CS; Deng, JM; Akiyama, K; Ansari, Y; Arakawa, T; Banh, J; Banno, F; Bowser, L; Brooks, S; Carninci, P; Chao, QM; Choy, N; Enju, A; Goldsmith, AD; Gurjal, M; Hansen, NF; Hayashizaki, Y; Johnson-Hopson, C; Hsuan, VW; Iida, K; Karnes, M; Khan, S; Koesema, E; Ishida, J; Jiang, PX; Jones, T; Kawai, J; Kamiya, A; Meyers, C; Nakajima, M; Narusaka, M; Seki, M; Sakurai, T; Satou, M; Tamse, R; Vaysberg, M; Wallender, EK; Wong, C; Yamamura, Y; Yuan, SL; Shinozaki, K; Davis, RW; Theologis, A; Ecker, JR				Yamada, K; Lim, J; Dale, JM; Chen, HM; Shinn, P; Palm, CJ; Southwick, AM; Wu, HC; Kim, C; Nguyen, M; Pham, P; Cheuk, R; Karlin-Newmann, G; Liu, SX; Lam, B; Sakano, H; Wu, T; Yu, GX; Miranda, M; Quach, HL; Tripp, M; Chang, CH; Lee, JM; Toriumi, M; Chan, MMH; Tang, CC; Onodera, CS; Deng, JM; Akiyama, K; Ansari, Y; Arakawa, T; Banh, J; Banno, F; Bowser, L; Brooks, S; Carninci, P; Chao, QM; Choy, N; Enju, A; Goldsmith, AD; Gurjal, M; Hansen, NF; Hayashizaki, Y; Johnson-Hopson, C; Hsuan, VW; Iida, K; Karnes, M; Khan, S; Koesema, E; Ishida, J; Jiang, PX; Jones, T; Kawai, J; Kamiya, A; Meyers, C; Nakajima, M; Narusaka, M; Seki, M; Sakurai, T; Satou, M; Tamse, R; Vaysberg, M; Wallender, EK; Wong, C; Yamamura, Y; Yuan, SL; Shinozaki, K; Davis, RW; Theologis, A; Ecker, JR			Empirical analysis of transcriptional activity in the Arabidopsis genome	SCIENCE			English	Article							FULL-LENGTH; FUNCTIONAL ANNOTATION; SEQUENCE; GENES; PREDICTION; CLONING; CDNAS; DNA; L.	Functional analysis of a genome requires accurate gene structure information and a complete gene inventory. A dual experimental strategy was used to verify and correct the initial genome sequence annotation of the reference plant Arabidopsis. Sequencing full-length cDNAs and hybridizations using RNA populations from various tissues to a set of high-density oligonucleotide arrays spanning the entire genome allowed the accurate annotation of thousands of gene structures. We identified 5817 novel transcription units, including a substantial amount of antisense gene transcription, and 40 genes within the genetically defined centromeres. This approach resulted in completion of similar to30% of the Arabidopsis ORFeome as a resource for global functional experimentation of the plant proteome.	Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Penn, Dept Biol, Arabidopsis Thaliana Genome Ctr, Philadelphia, PA 19104 USA; Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; RIKEN, Yokohama Inst, Genom Sci Ctr,Plant Mutat Explorat Team, Plant Funct Genom Res Grp, Tsukuba, Ibaraki 3050074, Japan; RIKEN, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; RIKEN GSC, Yokohama Inst, Lab Genome Explorat Res Grp, Kanagawa 2300045, Japan; RIKEN, Tsukuba Inst, Plant Mol Biol Lab, Tsukuba, Ibaraki 3050074, Japan; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Salk Institute; University of Pennsylvania; Stanford University; RIKEN; RIKEN; RIKEN; RIKEN; Stanford University	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	theo@nature.berkeley.edu; ecker@salk.edu	Hayashizaki, Yoshihide/N-6590-2015; Kawai, Jun/A-6451-2016; Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/G-4202-2013; Carninci, Piero/K-1568-2014; Ecker, Joseph R/B-9144-2008; Sakurai, Tetsuya/B-2690-2010	Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Carninci, Piero/0000-0001-7202-7243; Ecker, Joseph R/0000-0001-5799-5895; Sakurai, Tetsuya/0000-0003-2046-8973; Sakano, Hitomi/0000-0002-7471-8352; Yuan, Shiaulou/0000-0002-5061-6132; Koesema, Eric/0000-0002-7743-0127; Chen, Huaming/0000-0001-5289-7882; IIDA, Kei/0000-0001-7130-8705				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Brizuela L, 2002, ARCH MED RES, V33, P318, DOI 10.1016/S0188-4409(02)00372-7; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Haas BJ, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0029; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kirst M, 2003, P NATL ACAD SCI USA, V100, P7383, DOI 10.1073/pnas.1132171100; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; *MAMM GEN COLL PRO, 2003, P NATL ACAD SCI USA, V99, P16899; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MEYEROWITZ EM, 1994, ARABIDOPSIS; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; *NAT AC SCI REP, 2002, NAT PLANT GEN IN OBJ; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Osato N, 2002, GENOME RES, V12, P1127, DOI 10.1101/gr.75202; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Steinmetz LM, 2000, BIOTECHNOL GENET ENG, V17, P109, DOI 10.1080/02648725.2000.10647990; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Xiao YL, 2002, PLANT PHYSIOL, V130, P2118, DOI 10.1104/pp.010207; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang MQ, 2002, NAT REV GENET, V3, P698, DOI 10.1038/nrg890	40	705	9092	4	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					842	846		10.1126/science.1088305	http://dx.doi.org/10.1126/science.1088305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593172				2022-12-01	WOS:000186258000042
J	Hocker, M; Hohenberger, P				Hocker, M; Hohenberger, P			Helicobacter pylori virulence factors - one part of a big picture	LANCET			English	Review							CLINICAL-RELEVANCE; BABA2; ADHESIN; VACA; CAGA; ATTACHMENT; INFECTION; GENES; RISK	Context At least half the world's population is infected with Helicobacter pylori, although only 10-20% of carriers develop gastric diseases, ranging from ulcer to MALT-lymphoma and adenocarcinoma (MALT is mucosa-associated lymphoid tissue). The clinical outcome of H pylori infection is determined by a complex interaction of environmental influences and host and microbial virulence factors'. H pylori genotypes carrying the babA2 gene, encoding a bacterial adhesin mediating interaction With gastric epithelial cells, have enhanced pathogenicity. Moreover, coexistence of babA2 with other, bacterial virulence factors further worsens clinical outcomes. Starting point To further elucidate the clinical relevance of babA2-genopositive H pylori strains, Carlo-Frederico Zambon and colleagues analysed the association of babA2 genotypes with gastritis, gastroduodenal ulcer disease, or intestinal metaplasia in 167 infected Italian individuals. The coexistence of babA2 with other potentially disease-related H pylori genes, such as cag4, vacA, or oipA, correlated with clinical outcome. 36% of H pylori strains were babA2 genopositive, and abundance of babA2 was associated with the genomic presence of the other potential virulence-factor genes. H pylon strains carrying babA2, cagA, and the vacA genotype s1m1 were associated with the highest risk of developing intestinal metaplasia, whereas this condition was rarely (<10%) associated with strains with a cagA-, babA2-, vacA s2m2 genotype. Whilst the risk-of developing more serious gastric lesions increased as the number of virulence factor genes accumulated in a given H pylori strain, there was no indication of any one specific bacterial gene-pattern being associated with a particular clinical disease. Where next? Identifying the factors responsible for the enhanced pathogenicity of H pylori leading to development of life-threatening diseases in a subset of infected individuals is a mandatory task for the future. Identification of virulence-associated H pylori genes and investigation of their clinical relevance in large prospective studies will help to define such, strains with increased pathogenicity. The value of H pylori genotypes as predictors of disease outcome is limited, because the pathogenic impact of bacterial virulence factors, is greatly influenced by coexisting environmental and host factors.	Charite Univ Med Berlin, Robert Rossle Klin, Div Surg & Surg Oncol, D-13125 Berlin, Germany; Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hohenberger, P (corresponding author), Charite Univ Med Berlin, Robert Rossle Klin, Div Surg & Surg Oncol, Campus Berlin Buch, D-13125 Berlin, Germany.	hohenberger@rrk.charite-buch.de						Bjorkholm B, 2003, J INTERN MED, V253, P102, DOI 10.1046/j.1365-2796.2003.01119.x; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Guruge JL, 1998, P NATL ACAD SCI USA, V95, P3925, DOI 10.1073/pnas.95.7.3925; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Israel DA, 2001, ALIMENT PHARM THER, V15, P1271, DOI 10.1046/j.1365-2036.2001.01052.x; Maeda S, 1998, GUT, V42, P338, DOI 10.1136/gut.42.3.338; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Megraud F, 2001, DIGEST DIS, V19, P99, DOI 10.1159/000050662; Mizushima T, 2001, J CLIN MICROBIOL, V39, P2463, DOI 10.1128/JCM.39.7.2463-2465.2001; Nogueira C, 2001, AM J PATHOL, V158, P647, DOI 10.1016/S0002-9440(10)64006-0; Parsonnent J., 1998, GUT               S1, V43, P3247; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Podzorski RP, 2003, DIAGN MICR INFEC DIS, V46, P83, DOI 10.1016/S0732-8893(03)00034-8; Prinz C, 2001, CANCER RES, V61, P1903; Rad R, 2003, J INFECT DIS, V188, P272, DOI 10.1086/376458; Sheu BS, 2003, GUT, V52, P927, DOI 10.1136/gut.52.7.927; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Zambon CF, 2003, J CLIN PATHOL, V56, P287, DOI 10.1136/jcp.56.4.287	24	92	101	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2003	362	9391					1231	1233		10.1016/S0140-6736(03)14547-3	http://dx.doi.org/10.1016/S0140-6736(03)14547-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CW	14568748				2022-12-01	WOS:000185924100027
J	Beheregaray, LB; Ciofi, C; Geist, D; Gibbs, JP; Caccone, A; Powell, JR				Beheregaray, LB; Ciofi, C; Geist, D; Gibbs, JP; Caccone, A; Powell, JR			Genes record a prehistoric volcano eruption in the Galapagos	SCIENCE			English	Article							POPULATIONS; TORTOISES; HISTORY		Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Univ Idaho, Dept Geol Sci, Moscow, ID 83844 USA; SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06520 USA	Yale University; Idaho; University of Idaho; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Yale University	Beheregaray, LB (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	luciano.beheregaray@bio.mq.edu.au	Caccone, Adalgisa/AAE-4238-2021; Beheregaray, Luciano/AAY-6384-2021; Ciofi, Claudio/AAH-9461-2019; Beheregaray, Luciano B/A-8621-2008	Caccone, Adalgisa/0000-0002-8949-9260; Beheregaray, Luciano/0000-0003-0944-3003; Beheregaray, Luciano B/0000-0003-0944-3003; CIOFI, CLAUDIO/0000-0001-8537-8659				BEHEREGARAY LB, UNPUB; Caccone A, 2002, EVOLUTION, V56, P2052; CARSON HL, 1990, P NATL ACAD SCI USA, V87, P7055, DOI 10.1073/pnas.87.18.7055; Ciofi C, 2002, MOL ECOL, V11, P2265, DOI 10.1046/j.1365-294X.2002.01617.x; GEIST D, 1994, B VOLCANOL, V56, P243, DOI 10.1007/BF00302078; MACFARLAND C G, 1974, Biological Conservation, V6, P118, DOI 10.1016/0006-3207(74)90024-X; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1	7	60	72	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2003	302	5642					75	75		10.1126/science.1087486	http://dx.doi.org/10.1126/science.1087486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526072				2022-12-01	WOS:000185678500036
J	Hendrikson, CA; Howell, EE; Bush, DE; Miles, JS; Meininger, GR; Friedlander, T; Bushnell, AC; Chandra-Strobos, N				Hendrikson, CA; Howell, EE; Bush, DE; Miles, JS; Meininger, GR; Friedlander, T; Bushnell, AC; Chandra-Strobos, N			Chest pain relief by nitroglycerin does not predict active coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES COMMITTEE; RANDOMIZED-TRIAL; AMERICAN-COLLEGE; MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT; ACC/AHA GUIDELINES; UNSTABLE ANGINA; DIAGNOSIS; MANAGEMENT	Background: The belief that chest pain relief with nitroglycerin Indicates the presence of active coronary artery disease is common. However, this hypothesis has not been tested. Objective: To define the diagnostic and prognostic value of chest pain relief with nitroglycerin. Design: Prospective observational cohort study. Setting: urban community teaching hospital. Patients: 459 consecutive patients with chest pain admitted through the emergency department who received nitroglycerin from emergency services personnel or an emergency department nurse. Follow-up was obtained by telephone contact at 4 months. Measurements: Chest pain relief was defined as a decrease of at least 50% in patients' self-reported pain within 5 minutes of the Initial dose of sublingual or spray nitroglycerin. Active coronary artery disease was defined as any elevated serum enzyme levels, coronary angiography demonstrating a 70% or greater stenosis, or a positive exercise test result. Results: Nitroglycerin relieved chest pain in 39% of patients (181 of 459). In patients with active coronary artery disease as the likely cause of their chest pain, 35% (49 of 141) had chest pain relief with nitroglycerin. In contrast, in patients without active coronary artery disease, 41% (113 of 275) had chest pain relief (P > 0.2). Four-month clinical outcomes were similar in patients with or without chest pain relief with nitroglycerin (P > 0.2). Conclusions: These data suggest that, in a general population admitted for chest pain, relief of pain after nitroglycerin treatment does not predict active coronary artery disease and should not be used to guide diagnosis.	Johns Hopkins Bayview Med Ctr, Div Cardiol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Chandra-Strobos, N (corresponding author), Johns Hopkins Bayview Med Ctr, Div Cardiol, 4940 Eastern Ave, Baltimore, MD 21224 USA.	nchandra@jhmi.edu	Friedlander, Tracy/AFK-5288-2022; Friedlander, Tracy/AAG-3839-2022		NHLBI NIH HHS [T32-HLO7227-26] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007227] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AG HLTH CAR POL R, 1992, CLIN PRACT GUID AC P; *AM HEART ASS, 2001, HEART STROK STAT UPD; *AM HEART ASS, 2002, WHAT IS ANG; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; CALIFF RM, 2003, ACUTE CORONARY SYNDR; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Decker WW, 2003, ANN EMERG MED, V41, P342, DOI 10.1067/mem.2003.78; DIAMOND GA, 1980, J CLIN INVEST, V65, P1210, DOI 10.1172/JCI109776; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P474; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Engelberg S, 2000, Prehosp Emerg Care, V4, P290, DOI 10.1080/10903120090940967; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; GOLDMAN L, 1982, NEW ENGL J MED, V307, P588, DOI 10.1056/NEJM198209023071004; Goodacre S, 2002, ACAD EMERG MED, V9, P203; Goodman SG, 2000, J AM COLL CARDIOL, V36, P693, DOI 10.1016/S0735-1097(00)00808-1; Goyal RK, 1996, ANN INTERN MED, V124, P1008, DOI 10.7326/0003-4819-124-11-199606010-00010; KAUL S, 1994, ANN INTERN MED, V121, P976, DOI 10.7326/0003-4819-121-12-199412150-00013; LEE TH, 2001, HARRISONS PRINCIPLES, P60; Mathew V, 2001, J AM COLL CARDIOL, V37, P2053, DOI 10.1016/S0735-1097(01)01291-8; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Shry EA, 2002, AM J CARDIOL, V90, P1264, DOI 10.1016/S0002-9149(02)02850-3; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simoons ML, 2001, LANCET, V357, P1915; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; Storrow AB, 2000, ANN EMERG MED, V35, P449, DOI 10.1067/mem.2000.105601; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; WEINER DA, 1979, NEW ENGL J MED, V301, P230, DOI 10.1056/NEJM197908023010502; Zarich SW, 2002, CLIN CHIM ACTA, V326, P185, DOI 10.1016/S0009-8981(02)00303-0	31	66	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					979	986		10.7326/0003-4819-139-12-200312160-00007	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678917				2022-12-01	WOS:000187443200003
J	Ito, A; Nakao, M; Wandra, T				Ito, A; Nakao, M; Wandra, T			Human taeniasis and cysticercosis in Asia	LANCET			English	Review							IRIAN-JAYA; PHYLOGENETIC HYPOTHESIS; SOLIUM; INDONESIA; PAPUA; TAENIASIS/CYSTICERCOSIS; JAYAWIJAYA; TAPEWORMS; DIAGNOSIS; GENOTYPES	Context Human taeniasis caused by the pork, Taenia solium, or beef, T saginata, tapeworm arises after eating pork or beef contaminated with metacestodes, the larval stage of these parasites. Taeniasis with T solium can lead to neurocysticercosis and threaten others by accidental ingestion of eggs released from asymptomatic taeniasis patients. The 2003 World Health Assembly declared that T solium is of worldwide public-health importance, and that it is an eradicable parasitic disease worldwide. Adult taeniid tapeworms expelled from people in almost all Asian countries appeared to be T saginata (the so-called Asian Taenia), even though they ate pork. The organism is now named T asiatica, and has been found in Taiwan, Korea, China, Vietnam, and Indonesia. But it has been difficult to differentiate T saginata from beef and Asian Taenia from pork. Starting point Marshall Lightowlers and colleagues (Int J Parasitol 2003; 33: 1207-17) recently demonstrated that recombinant oncosphere vaccines against several taeniid cestodes, including T ovis, T saginata, T solium, and Echinococcus granulosus, are highly effective. Protection was almost 100%, in the laboratory and in the field. These researchers found several common features, including a predicted secretory signal sequence, and one or two copies of a fibronectin type III domain, each encoded by separate exons within the associated gene. Where next? Molecular and immunological techniques, including vaccine research and development of animal models for differentiation of taeniid species in humans, have greatly advanced over the past decade. The clinical importance of infections by these taeniids, including T asiatica, in humans, and the potential for cysticercosis attributable to T asiatica in humans, needs further study.	Asahikawa Med Coll, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan; Minist Hlth, Directorate Gen Communicable Dis Control & Enviro, Jakarta, Indonesia	Asahikawa Medical College; Ministry of Health - Indonesia	Ito, A (corresponding author), Asahikawa Med Coll, Dept Parasitol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	akiraito@asahikawa-med.ac.jp	Ito, A./E-9377-2014; WANDRA, TONI/AAD-5736-2021	Ito, A./0000-0002-5070-9187; Wandra, Toni/0000-0002-4606-5411				[Anonymous], [No title captured]; de Queiroz A, 1998, J PARASITOL, V84, P379, DOI 10.2307/3284501; Eom Keeseon S., 1993, Korean Journal of Parasitology, V31, P1, DOI 10.3347/kjp.1993.31.1.1; Eom KS, 2002, J PARASITOL, V88, P758, DOI 10.1645/0022-3395(2002)088[0758:IOTAIC]2.0.CO;2; FAN PC, 1988, PARASITOL TODAY, V4, P86, DOI 10.1016/0169-4758(88)90204-9; Gonzalez AE, 2003, ACTA TROP, V87, P103, DOI 10.1016/S0001-706X(03)00025-1; GUJDUSEK DC, 1978, PNG MED J, V21, P329; Hoberg EP, 2002, MICROBES INFECT, V4, P859, DOI 10.1016/S1286-4579(02)01606-4; Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Hoberg EP, 2000, J PARASITOL, V86, P89, DOI 10.1645/0022-3395(2000)086[0089:APHFSO]2.0.CO;2; Ito A, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P85; Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X; Ito A, 2003, TRENDS PARASITOL, V19, P377, DOI 10.1016/S1471-4922(03)00200-9; Ito A, 2003, ACTA TROP, V86, P3, DOI 10.1016/S0001-706X(02)00269-3; Ito A, 2002, J HELMINTHOL, V76, P311, DOI 10.1079/JOH2002128; ITO A, 1992, PARASITOL TODAY, V8, P182, DOI 10.1016/0169-4758(92)90259-5; Lightowlers MW, 2003, INT J PARASITOL, V33, P1207, DOI 10.1016/S0020-7519(03)00174-7; Margono SS, 2003, J HELMINTHOL, V77, P39, DOI 10.1079/JOH2002146; Nakao M, 2002, MITOCHONDRION, V1, P497, DOI 10.1016/S1567-7249(02)00040-5; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; Nakao M, 2000, MOL BIOCHEM PARASIT, V111, P415, DOI 10.1016/S0166-6851(00)00334-0; Nakao M, 2003, INFECT GENET EVOL, V3, P159, DOI 10.1016/S1567-1348(03)00070-4; Pawlowski Zbigniew S., 2002, P1, DOI 10.1079/9780851996288.0001; RAJSHEKHAR V, 2000, SOLITARY CYSTICERCUS; Schantz PM, 1998, EMERG INFECT DIS, V2, P213, DOI [10.1128/9781555816957.ch12, DOI 10.1128/9781555816957.CH12]; Simanjuntak GM, 1997, PARASITOL TODAY, V13, P321, DOI 10.1016/S0169-4758(97)01104-6; Singh Gagandeep, 2002, P111, DOI 10.1079/9780851996288.0111; Subahar R, 2001, T ROY SOC TROP MED H, V95, P388, DOI 10.1016/S0035-9203(01)90190-7; Sutisna IP, 1999, TROP MED INT HEALTH, V4, P288, DOI 10.1046/j.1365-3156.1999.00394.x; Wandra T, 2000, T ROY SOC TROP MED H, V94, P46, DOI 10.1016/S0035-9203(00)90433-4; Wandra T, 2003, EMERG INFECT DIS, V9, P884; Willingham A Lee 3rd, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 1, P35; Yamasaki H, 2002, J CLIN MICROBIOL, V40, P3818, DOI 10.1128/JCM.40.10.3818-3821.2002; YAMASAKI H, IN PRESS J CLIN MICR	34	117	121	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1918	1920		10.1016/S0140-6736(03)14965-3	http://dx.doi.org/10.1016/S0140-6736(03)14965-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667751	Green Submitted			2022-12-01	WOS:000187011600025
J	Willingham, S; Outeiro, TF; DeVit, MJ; Lindquist, SL; Muchowski, PJ				Willingham, S; Outeiro, TF; DeVit, MJ; Lindquist, SL; Muchowski, PJ			Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; PARKINSONS-DISEASE; DROSOPHILA MODEL; SCA1 MICE; NEURODEGENERATION; MUTATION; SUPPRESSION; EXPRESSION; PROTEINS; HSP70	Genome-wide screens were performed in yeast to identify genes that enhance the toxicity of a mutant huntingtin fragment or of alpha-synuclein. Of 4850 haploid mutants containing deletions of nonessential genes, 52 were identified that were sensitive to a mutant huntingtin fragment, 86 that were sensitive to alpha-synuclein, and only one mutant that was sensitive to both. Genes that enhanced toxicity of the mutant huntingtin fragment clustered in the functionally related cellular processes of response to stress, protein folding, and ubiquitin-dependent protein catabolism, whereas genes that modified alpha-synuclein toxicity clustered in the processes of lipid metabolism and vesicle-mediated transport. Genes with human orthologs were overrepresented in our screens, suggesting that we may have discovered conserved and nonoverlapping sets of cell-autonomous genes and pathways that are relevant to Huntington's disease and Parkinson's disease.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Muchowski, PJ (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.		Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago/M-8106-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; 				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO;2-E; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Scherzer CR, 2003, HUM MOL GENET, V12, P2457, DOI 10.1093/hmg/ddg265; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	30	324	341	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1769	1772		10.1126/science.1090389	http://dx.doi.org/10.1126/science.1090389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657499				2022-12-01	WOS:000186970100049
J	Topol, EJ; Lauer, MS				Topol, EJ; Lauer, MS			The rudimentary phase of personalised medicine: coronary risk scores	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE; PREDICTION		Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177; Topol, Eric/0000-0002-1478-4729				Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; *NAT CHOL ED PROGR, RISK ASS TOOL EST 10; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	7	26	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1776	1777		10.1016/S0140-6736(03)14941-0	http://dx.doi.org/10.1016/S0140-6736(03)14941-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654312				2022-12-01	WOS:000186872900005
J	Zheng, M; Jagota, A; Strano, MS; Santos, AP; Barone, P; Chou, SG; Diner, BA; Dresselhaus, MS; McLean, RS; Onoa, GB; Samsonidze, GG; Semke, ED; Usrey, M; Walls, DJ				Zheng, M; Jagota, A; Strano, MS; Santos, AP; Barone, P; Chou, SG; Diner, BA; Dresselhaus, MS; McLean, RS; Onoa, GB; Samsonidze, GG; Semke, ED; Usrey, M; Walls, DJ			Structure-based carbon nanotube sorting by sequence-dependent DNA assembly	SCIENCE			English	Article							SEPARATION	Wrapping of carbon nanotubes (CNTs) by single-stranded DNA (ssDNA) was found to be sequence-dependent. A systematic search of the ssDNA library selected a sequence d(GT) n, n = 10 to 45 that self-assembles into a helical structure around individual nanotubes in such a way that the electrostatics of the DNA-CNT hybrid depends on tube diameter and electronic properties, enabling nanotube separation by anion exchange chromatography. Optical absorption and Raman spectroscopy show that early fractions are enriched in the smaller diameter and metallic tubes, whereas late fractions are enriched in the larger diameter and semiconducting tubes.	DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA; Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; MIT, Dept Phys Elect Engn & Comp Sci, Cambridge, MA 02139 USA; CDTN, CNEN, Ctr Desenvolvimento Tecnol Nucl, BR-30123970 Belo Horizonte, MG, Brazil	DuPont; University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT); Centro de Desenvolvimento da Tecnologia Nuclear (CDTN); Comissao Nacional de Energia Nuclear (CNEN)	Zheng, M (corresponding author), DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA.		Samsonidze, Georgy/G-3613-2016; Santos, Adelina/V-3087-2019	Samsonidze, Georgy/0000-0002-3759-1794; 				Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; BENEDICT LX, 1995, PHYS REV B, V52, P8541, DOI 10.1103/PhysRevB.52.8541; Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l; Chattopadhyay D, 2002, J AM CHEM SOC, V124, P728, DOI 10.1021/ja0172159; Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640; Doorn SK, 2002, J AM CHEM SOC, V124, P3169, DOI 10.1021/ja012364c; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Jackson JD., 1999, CLASSICAL ELECTRODYN, V3rd edn; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Manning GS, 2002, BIOPHYS CHEM, V101, P461, DOI 10.1016/S0301-4622(02)00162-X; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MARSH TC, 1995, NUCLEIC ACIDS RES, V23, P696, DOI 10.1093/nar/23.4.696; Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Saito R., 1998, PHYS PROPERTIES CARB; Sauvajol JL, 2002, CARBON, V40, P1697, DOI 10.1016/S0008-6223(02)00010-6; Strano MS, 2003, NANO LETT, V3, P1091, DOI 10.1021/nl034196n; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	21	1427	1496	6	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1545	1548		10.1126/science.1091911	http://dx.doi.org/10.1126/science.1091911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645843				2022-12-01	WOS:000186802200037
J	Kim, SJ; Kim, YS; Yuan, JP; Petralia, RS; Worley, PF; Linden, DJ				Kim, SJ; Kim, YS; Yuan, JP; Petralia, RS; Worley, PF; Linden, DJ			Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1	NATURE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC ACTIVATION; CEREBELLAR; CONDUCTANCE; RELEASE; DEFICIT; HOMER	Group I metabotropic glutamate receptors (consisting of mGluR1 and mGluR5) are G-protein-coupled neurotransmitter receptors(1) that are found in the perisynaptic region of the postsynaptic membrane(2). These receptors are not activated by single synaptic volleys but rather require bursts of activity(3-5). They are implicated in many forms of neural plasticity including hippocampal long-term potentiation and depression(6-8), cerebellar long-term depression(8-11), associative learning(7,11), and cocaine addiction(12). When activated, group I mGluRs engage two G-protein-dependent signalling mechanisms: stimulation of phospholipase C and activation of an unidentified, mixed-cation excitatory postsynaptic conductance (EPSC), displaying slow activation, in the plasma membrane(4,5,13-15). Here we report that the mGluR1-evoked slow EPSC is mediated by the TRPC1 cation channel. TRPC1 is expressed in perisynaptic regions of the cerebellar parallel fibre-Purkinje cell synapse and is physically associated with mGluR1. Manipulations that interfere with TRPC1 block the mGluR1-evoked slow EPSC in Purkinje cells; however, fast transmission mediated by AMPA-type glutamate receptors remains unaffected. Furthermore, co-expression of mGluR1 and TRPC1 in a heterologous system reconstituted a mGluR1-evoked conductance that closely resembles the slow EPSC in Purkinje cells.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon 20071, South Korea; NIDCD, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	pworley@jhmi.edu; dlinden@jhmi.edu	Kim, Sang Jeong/J-2740-2012	Kim, Sang Jeong/0000-0001-8931-3713				AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Bortolotto ZA, 1999, CURR OPIN NEUROBIOL, V9, P299, DOI 10.1016/S0959-4388(99)80044-0; Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gee CE, 2003, J PHYSIOL-LONDON, V546, P655, DOI 10.1113/jphysiol.2002.032961; HARTMANN J, 2002, SOC NEUR ABSTR; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Knopfel T, 2000, EUR J NEUROSCI, V12, P2199, DOI 10.1046/j.1460-9568.2000.00122.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Narasimhan K, 1998, J NEUROPHYSIOL, V80, P2963, DOI 10.1152/jn.1998.80.6.2963; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tabata T, 2002, MOL CELL NEUROSCI, V20, P56, DOI 10.1006/mcne.2002.1118; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 2001, J NEUROPHYSIOL, V86, P1389, DOI 10.1152/jn.2001.86.3.1389; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	30	283	291	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					285	291		10.1038/nature02162	http://dx.doi.org/10.1038/nature02162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14614461	Bronze			2022-12-01	WOS:000186660800043
J	Pebay-Peyroula, E; Dahout-Gonzalez, C; Kahn, R; Trezeguet, V; Lauquin, GJM; Brandolin, R				Pebay-Peyroula, E; Dahout-Gonzalez, C; Kahn, R; Trezeguet, V; Lauquin, GJM; Brandolin, R			Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside	NATURE			English	Article							ADENINE-NUCLEOTIDE CARRIER; BEEF-HEART MITOCHONDRIA; ELECTRON-DENSITY MAPS; ADP ATP CARRIER; OXIDATIVE-PHOSPHORYLATION; LIVER MITOCHONDRIA; TRITON X-100; PROTEIN; YEAST; ATRACTYLOSIDE	ATP, the principal energy currency of the cell, fuels most biosynthetic reactions in the cytoplasm by its hydrolysis into ADP and inorganic phosphate. Because resynthesis of ATP occurs in the mitochondrial matrix, ATP is exported into the cytoplasm while ADP is imported into the matrix. The exchange is accomplished by a single protein, the ADP/ATP carrier. Here we have solved the bovine carrier structure at a resolution of 2.2 Angstrom by X-ray crystallography in complex with an inhibitor, carboxyatractyloside. Six alpha-helices form a compact transmembrane domain, which, at the surface towards the space between inner and outer mitochondrial membranes, reveals a deep depression. At its bottom, a hexapeptide carrying the signature of nucleotide carriers ( RRRMMM) is located. Our structure, together with earlier biochemical results, suggests that transport substrates bind to the bottom of the cavity and that translocation results from a transient transition from a 'pit' to a 'channel' conformation.	Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, F-38027 Grenoble 1, France; Univ Grenoble 1, CNRS,CEA,UMR 5092, Dept Reponse & Dynam Cellulaires, Lab Biochim & Biophys Syst Integres, F-38054 Grenoble, France; CNRS, Inst Biochim & Genet Cellulaires, Lab Physiol Mol & Cellulaire, UMR 5095, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Pebay-Peyroula, E (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.			Trezeguet, Veronique/0000-0003-2487-7571				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; BECK JC, 1968, P NATL ACAD SCI USA, V60, P186, DOI 10.1073/pnas.60.1.186; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; BLOCK MR, 1984, BIOCHIM BIOPHYS ACTA, V767, P369, DOI 10.1016/0005-2728(84)90207-X; BLOCK MR, 1982, BIOCHEM BIOPH RES CO, V109, P471, DOI 10.1016/0006-291X(82)91745-4; BOGNER W, 1986, EUR J BIOCHEM, V161, P611, DOI 10.1111/j.1432-1033.1986.tb10485.x; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1985, BIOCHEMISTRY-US, V24, P1991, DOI 10.1021/bi00329a029; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNI A, 1964, NATURE, V201, P1219, DOI 10.1038/2011219a0; CANDY HA, 1977, PHYTOCHEMISTRY, V16, P1308, DOI 10.1016/S0031-9422(00)94388-7; CRAIG JC, 1976, PHYTOCHEMISTRY, V15, P1178, DOI 10.1016/0031-9422(76)85126-6; Denessiouk KA, 2000, PROTEINS, V38, P310, DOI 10.1002/(SICI)1097-0134(20000215)38:3<310::AID-PROT7>3.0.CO;2-T; Dianoux AC, 2000, BIOCHEMISTRY-US, V39, P11477, DOI 10.1021/bi000618l; DUEE ED, 1965, BIOCHIM BIOPHYS ACTA, V107, P184, DOI 10.1016/0304-4165(65)90419-8; DUYCKAERTS C, 1980, EUR J BIOCHEM, V106, P1; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fiore C, 2001, CLIN CHIM ACTA, V311, P125, DOI 10.1016/S0009-8981(01)00581-2; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; HACKENBERG H, 1980, BIOCHEMISTRY-US, V19, P548, DOI 10.1021/bi00544a024; Harrenga A, 1999, J BIOL CHEM, V274, P33296, DOI 10.1074/jbc.274.47.33296; HEDDI A, 1993, J BIOL CHEM, V268, P12156; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOVAC L, 1967, SCIENCE, V158, P1564, DOI 10.1126/science.158.3808.1564; Kunji ERS, 2003, J BIOL CHEM, V278, P36985, DOI 10.1074/jbc.C300304200; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; Moodie SL, 1996, J MOL BIOL, V263, P486, DOI 10.1006/jmbi.1996.0591; Muller V, 1997, BIOCHEMISTRY-US, V36, P16008, DOI 10.1021/bi971867l; Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panneels V, 2003, BIOCHEM BIOPH RES CO, V300, P65, DOI 10.1016/S0006-291X(02)02795-X; PFAFF E, 1965, BIOCHIM BIOPHYS ACTA, V104, P312, DOI 10.1016/0304-4165(65)90258-8; TORRONI A, 1990, J BIOL CHEM, V265, P20589; Trezeguet V, 2000, BBA-BIOENERGETICS, V1457, P81, DOI 10.1016/S0005-2728(99)00115-2; VIGNAIS PV, 1976, BIOCHIM BIOPHYS ACTA, V456, P1, DOI 10.1016/0304-4173(76)90007-0; Walker J.E., 1992, CURR OPIN STRUC BIOL, V2, P519, DOI DOI 10.1016/0959-440X(92)90081-H; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Zeman I, 2003, J BIOENERG BIOMEMBR, V35, P243, DOI 10.1023/A:1024611731860	50	748	764	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					39	44		10.1038/nature02056	http://dx.doi.org/10.1038/nature02056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603310				2022-12-01	WOS:000186370800034
J	Shearman, AM; Cupples, LA; Demissie, S; Peter, I; Schmid, CH; Karas, RH; Mendelsohn, ME; Housman, DE; Levy, D				Shearman, AM; Cupples, LA; Demissie, S; Peter, I; Schmid, CH; Karas, RH; Mendelsohn, ME; Housman, DE; Levy, D			Association between estrogen receptor alpha gene variation and cardiovascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; BONE-MINERAL DENSITY; HORMONE REPLACEMENT THERAPY; VITAMIN-D-RECEPTOR; POSTMENOPAUSAL WOMEN; PLUS PROGESTIN; BREAST-CANCER; HEART-DISEASE; MYOCARDIAL-INFARCTION; DISRUPTIVE MUTATION	Context Estrogen and related hormone therapies activate estrogen receptors, which in turn regulate genes for several cardiovascular disease (CVD) risk factors. Relatively little is known, however, about the impact of genetic variation in estrogen receptor a (ESR1) on CVD risk. Objective To investigate whether the ESR1 c.454-397T>C polymorphism is associated with CVD risk. Design, Setting, and Participants Prospective study of 1739 unrelated men and women from the population-based offspring cohort of the Framingham Heart Study, who were followed up from 1971 to 1998. Main Outcome Measures Total atherosclerotic CVD events, defined as recognized or unrecognized myocardial infarction (MI), angina pectoris, coronary insufficiency, intermittent claudication, coronary heart disease death, or atherothrombotic stroke (n=178); major atherosclerotic CVD, defined as recognized acute MI, coronary insufficiency, coronary heart disease death, or atherothrombotic stroke (n=83); and recognized acute MI (n=59). Results Twenty percent of participants (n=352) were homozygous for the ESR1 c.454-397C allele. After adjustment for covariates (age, sex, body mass index, hypertension, diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, and cigarette smoking), the CC genotype was significantly associated with major atherosclerotic CVD, with an odds ratio of 2.0 (95% confidence interval [CI], 1.3-3.2; P=.004) compared with individuals with the CT or TT genotypes. Participants with the CC genotype had 3.0-fold greater odds of MI (95% Cl, 1.7-5,2; P<.001) compared with those with the CT or TT genotype. The results remained significant when analyses were restricted to men; too few women had events to study them separately. Conclusions Individuals with the common ESR1 c.454-397CC genotype have a substantial increase in risk of MI. Whether ESR1 c.454-397T>C is causally related to MI risk or in linkage disequilibrium with 1 or more causal variants remains to be determined. These findings support the importance of estrogen receptors in CVD susceptibility, especially in men. Estrogen receptor variation also has potential to explain recent conflicting data regarding the effects of hormone therapy on CVD susceptibility in women.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Tufts Univ New England Med Ctr, Dept Med, Div Clin Care Res, Biostat Res Ctr, Boston, MA USA; Tufts Univ New England Med Ctr, Dept Med, Mol Cardiol Res Inst, Boston, MA USA; Tufts Univ New England Med Ctr, Specialized Ctr Res Ischem Heart Dis, Boston, MA USA; NHLBI, Framingham Heart Study, Framingham, MA USA	Massachusetts Institute of Technology (MIT); Boston University; Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Shearman, AM (corresponding author), MIT, Ctr Canc Res, E17-536, Cambridge, MA 02139 USA.	shearman@mit.edu	Schmid, Christopher H./J-2398-2014; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Schmid, Christopher H./0000-0002-0855-5313; Levy, Daniel/0000-0003-1843-8724; Cupples, L. Adrienne/0000-0003-0273-7965; Demissie, Serkalem/0000-0002-8009-0987	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038, N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL063494, R01HL065230] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, N01-HC-25195, R01-HL65230, P50-HL63494, P50 HL63494] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1999, NAT GENET, V22, P1; Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; Braunstein JB, 2002, CHEST, V121, P906, DOI 10.1378/chest.121.3.906; Brouchet L, 2001, CIRCULATION, V103, P423; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; CASTAGNOLI A, 1987, NUCLEIC ACIDS RES, V15, P866, DOI 10.1093/nar/15.2.866; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Deng HW, 1999, OSTEOPOROSIS INT, V9, P499, DOI 10.1007/s001980050268; Evangelopoulos D, 2003, CLIN CHIM ACTA, V331, P37, DOI 10.1016/S0009-8981(03)00080-9; Ferrara A, 2003, CIRCULATION, V107, P43, DOI 10.1161/01.CIR.0000042701.17528.95; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Holmberg-Marttila D, 2000, CALCIFIED TISSUE INT, V66, P184, DOI 10.1007/PL00005836; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jeng MH, 1998, ENDOCRINOLOGY, V139, P4164, DOI 10.1210/en.139.10.4164; Kang HJ, 2002, CANCER LETT, V178, P175, DOI 10.1016/S0304-3835(01)00861-8; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kim JG, 2001, MENOPAUSE, V8, P222, DOI 10.1097/00042192-200105000-00013; Kunnas TA, 2000, BRIT MED J, V321, P273, DOI 10.1136/bmj.321.7256.273; Langdahl BL, 2000, J BONE MINER RES, V15, P2222, DOI 10.1359/jbmr.2000.15.11.2222; Lau EMC, 2001, BONE, V29, P96, DOI 10.1016/S8756-3282(01)00481-1; Lehtimaki T, 2002, J MOL MED-JMM, V80, P176, DOI 10.1007/s00109-001-0311-5; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lu H, 2002, ARTERIOSCL THROM VAS, V22, P817, DOI 10.1161/01.ATV.0000014424.18209.21; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Matsubara Y, 1997, ARTERIOSCL THROM VAS, V17, P3006, DOI 10.1161/01.ATV.17.11.3006; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mizunuma H, 1997, BONE, V21, P379, DOI 10.1016/S8756-3282(97)00178-6; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Pendaries C, 2002, P NATL ACAD SCI USA, V99, P2205, DOI 10.1073/pnas.042688499; Petrovic D, 2003, CARDIOLOGY, V99, P163, DOI 10.1159/000070673; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sudhir K, 1997, CIRCULATION, V96, P3774; Sudhir K, 1997, LANCET, V349, P1146, DOI 10.1016/S0140-6736(05)63022-X; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Willing M, 1998, J BONE MINER RES, V13, P695, DOI 10.1359/jbmr.1998.13.4.695; YAICH L, 1992, CANCER RES, V52, P77; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	43	230	234	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2003	290	17					2263	2270		10.1001/jama.290.17.2263	http://dx.doi.org/10.1001/jama.290.17.2263			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PZ	14600184	Bronze			2022-12-01	WOS:000186356800020
J	Molofsky, AV; Pardal, R; Iwashita, T; Park, IK; Clarke, MF; Morrison, SJ				Molofsky, AV; Pardal, R; Iwashita, T; Park, IK; Clarke, MF; Morrison, SJ			Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation	NATURE			English	Article							ADULT MAMMALIAN FOREBRAIN; TRANSGENIC MICE; TRANSFORMATION; TUMORIGENESIS; P16(INK4A); SENESCENCE; REPRESSION; EXPRESSION; P19(ARF); MEMBERS	Stem cells persist throughout life by self-renewing in numerous tissues including the central(1) and peripheral(2) nervous systems. This raises the issue of whether there is a conserved mechanism to effect self-renewing divisions. Deficiency in the polycomb family transcriptional repressor Bmi-1 leads to progressive postnatal growth retardation and neurological defects(3). Here we show that Bmi-1 is required for the self-renewal of stem cells in the peripheral and central nervous systems but not for their survival or differentiation. The reduced self-renewal of Bmi-1-deficient neural stem cells leads to their postnatal depletion. In the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16(Ink4a) is upregulated in neural stem cells, reducing the rate of proliferation. p16(Ink4a) deficiency partially reverses the self-renewal defect in Bmi-1(-/-) neural stem cells. This conserved requirement for Bmi-1 to promote self-renewal and to repress p16(Ink4a) expression suggests that a common mechanism regulates the self-renewal and postnatal persistence of diverse types of stem cell. Restricted neural progenitors from the gut and forebrain proliferate normally in the absence of Bmi-1. Thus, Bmi-1 dependence distinguishes stem cell self-renewal from restricted progenitor proliferation in these tissues.	Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.		Morrison, Sean/ABD-5326-2021; Nam, Jae Do/F-2201-2013; Pardal, Ricardo/C-4370-2015; IBIS, FISIOPATOLOGIA/O-9510-2015; Molofsky, Anna Victoria/P-2506-2018	Pardal, Ricardo/0000-0003-1085-0714; Molofsky, Anna Victoria/0000-0002-4709-2411; Morrison, Sean/0000-0003-1587-8329	NINDS NIH HHS [R01 NS040750, R01 NS040750-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; BUNKER CA, 1994, MOL CELL BIOL, V14, P1721, DOI 10.1128/MCB.14.3.1721; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; HAUPT Y, 1993, ONCOGENE, V8, P3161; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; STRITT TN, 1995, CELL, V80, P661; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	27	1045	1133	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					962	967		10.1038/nature02060	http://dx.doi.org/10.1038/nature02060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14574365	Green Published, Green Accepted			2022-12-01	WOS:000186230600042
J	Blankenberg, S; Rupprecht, HJ; Bickel, C; Torzewski, M; Hafner, G; Tiret, L; Smieja, M; Cambien, F; Meyer, J; Lackner, KJ				Blankenberg, S; Rupprecht, HJ; Bickel, C; Torzewski, M; Hafner, G; Tiret, L; Smieja, M; Cambien, F; Meyer, J; Lackner, KJ		AtheroGene Investigators	Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERYTHROCYTE GLUTATHIONE-PEROXIDASE; ISCHEMIC-HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; ANTIOXIDANT ENZYMES; SERUM SELENIUM; ATHEROSCLEROSIS; CELLS; 5-LIPOXYGENASE; EXPRESSION	BACKGROUND: Cellular antioxidant enzymes such as glutathione peroxidase 1 and superoxide dismutase have a central role in the control of reactive oxygen species. In vitro data and studies in animal models suggest that these enzymes may protect against atherosclerosis, but little is known about their relevance to human disease. METHODS: We conducted a prospective study among 636 patients with suspected coronary artery disease, with a median follow-up period of 4.7 years (maximum, 5.4) to assess the risk of cardiovascular events associated with base-line erythrocyte glutathione peroxidase 1 and superoxide dismutase activity. RESULTS: Glutathione peroxidase 1 activity was among the strongest univariate predictors of the risk of cardiovascular events, whereas superoxide dismutase activity had no association with risk. The risk of cardiovascular events was inversely associated with increasing quartiles of glutathione peroxidase 1 activity (P for trend <0.001); patients in the highest quartile of glutathione peroxidase 1 activity had a hazard ratio of 0.29 (95 percent confidence interval, 0.15 to 0.58; P<0.001), as compared with those in the lowest quartile. Glutathione peroxidase 1 activity was affected by sex and smoking status but retained its predictive power in these subgroups. After adjustment for these and other cardiovascular risk factors, the inverse association between glutathione peroxidase 1 activity and cardiovascular events remained nearly unchanged. CONCLUSIONS: In patients with coronary artery disease, a low level of activity of red-cell glutathione peroxidase 1 is independently associated with an increased risk of cardiovascular events. Glutathione peroxidase 1 activity may have prognostic value in addition to that of traditional risk factors. Furthermore, increasing glutathione peroxidase 1 activity might lower the risk of cardiovascular events.	Johannes Gutenberg Univ Mainz, Dept Med 2, D-55131 Mainz, Germany; Johannes Gutenberg Univ Mainz, Dept Clin Chem & Lab Med, D-55131 Mainz, Germany; Univ Paris 06, INSERM, U525, Paris, France; Bundeswehrzent Krankenhaus, Innere Abt, Koblenz, Germany; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; McMaster University	Blankenberg, S (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med 2, Langenbeckstr 1, D-55131 Mainz, Germany.	stefan.blankenberg@uni-mainz.de; lackner@zentrallabor.klinik.uni-mainz.de		Blankenberg, Stefan/0000-0001-6488-2362				Alissa EM, 2003, MED SCI MONITOR, V9, pRA9; Andersen HR, 1997, CLIN CHEM, V43, P562; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Dayal S, 2002, ARTERIOSCL THROM VAS, V22, P1996, DOI 10.1161/01.ATV.0000041629.92741.DC; Flohe L, 1988, Basic Life Sci, V49, P663; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001; Forsberg L, 2001, ARCH BIOCHEM BIOPHYS, V389, P84, DOI 10.1006/abbi.2001.2295; Forsberg L, 2000, BLOOD CELL MOL DIS, V26, P423, DOI 10.1006/bcmd.2000.0325; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guo ZM, 2001, ARTERIOSCL THROM VAS, V21, P1131, DOI 10.1161/hq0701.092092; Hussein O, 1997, TRANSPLANTATION, V63, P679, DOI 10.1097/00007890-199703150-00012; Kardinaal AFM, 1997, AM J EPIDEMIOL, V145, P373, DOI 10.1093/oxfordjournals.aje.a009115; Lapenna D, 1998, CIRCULATION, V97, P1930, DOI 10.1161/01.CIR.97.19.1930; Liu DJ, 2000, CHINESE MED J-PEKING, V113, P771; Massafra C, 2002, CLIN ENDOCRINOL, V57, P663, DOI 10.1046/j.1365-2265.2002.01657.x; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Mulholland CW, 1999, QJM-INT J MED, V92, P579, DOI 10.1093/qjmed/92.10.579; OSTER O, 1982, CLIN CHIM ACTA, V124, P277, DOI 10.1016/0009-8981(82)90422-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; RAES M, 1987, FREE RADICAL BIO MED, V3, P3, DOI 10.1016/0891-5849(87)90032-3; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rupprecht HJ, 2001, CIRCULATION, V104, P25, DOI 10.1161/hc2601.091703; SALONEN JT, 1988, ATHEROSCLEROSIS, V70, P155, DOI 10.1016/0021-9150(88)90109-8; SALVINI S, 1995, AM J CARDIOL, V76, P1218, DOI 10.1016/S0002-9149(99)80344-0; SHINGU M, 1985, INFLAMMATION, V9, P309, DOI 10.1007/BF00916279; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; Straif D, 2000, BIOCHEM J, V349, P455, DOI 10.1042/0264-6021:3490455; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; SUADICANI P, 1992, ATHEROSCLEROSIS, V96, P33, DOI 10.1016/0021-9150(92)90035-F; URSINI F, 1995, METHOD ENZYMOL, V252, P38	37	452	474	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2003	349	17					1605	1613		10.1056/NEJMoa030535	http://dx.doi.org/10.1056/NEJMoa030535			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZT	14573732				2022-12-01	WOS:000186088400005
J	Ubersax, JA; Woodbury, EL; Quang, PN; Paraz, M; Blethrow, JD; Shah, K; Shokat, KM; Morgan, DO				Ubersax, JA; Woodbury, EL; Quang, PN; Paraz, M; Blethrow, JD; Shah, K; Shokat, KM; Morgan, DO			Targets of the cyclin-dependent kinase Cdk1	NATURE			English	Article							UNNATURAL NUCLEOTIDE SPECIFICITY; ANAPHASE-PROMOTING COMPLEX; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; PHOSPHORYLATION; CDC28; UBIQUITINATION; IDENTIFICATION; LOCALIZATION; REPLICATION	The events of cell reproduction are governed by oscillations in the activities of cyclin-dependent kinases (Cdks)(1). Cdks control the cell cycle by catalysing the transfer of phosphate from ATP to specific protein substrates. Despite their importance in cell-cycle control, few Cdk substrates have been identified(2). Here, we screened a budding yeast proteomic library for proteins that are directly phosphorylated by Cdk1 in whole-cell extracts. We identified about 200 Cdk1 substrates, several of which are phosphorylated in vivo in a Cdk1-dependent manner. The identities of these substrates reveal that Cdk1 employs a global regulatory strategy involving phosphorylation of other regulatory molecules as well as phosphorylation of the molecular machines that drive cell-cycle events. Detailed analysis of these substrates is likely to yield important insights into cell-cycle regulation.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Novartis Fdn, Genom Inst, San Diego, CA 92121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Novartis	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416				Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kraybill BC, 2002, J AM CHEM SOC, V124, P12118, DOI 10.1021/ja0264798; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Witucki LA, 2002, CHEM BIOL, V9, P25, DOI 10.1016/S1074-5521(02)00091-1; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	30	716	772	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					859	864		10.1038/nature02062	http://dx.doi.org/10.1038/nature02062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574415				2022-12-01	WOS:000186118500050
J	Li, L; Parsons, TJ; Power, C				Li, L; Parsons, TJ; Power, C			Breast feeding and obesity in childhood: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OVERWEIGHT; DURATION; PROTECT		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Li, L (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	L.Li@ich.ucl.ac.uk						BARROS FC, 1990, PAEDIATR PERINAT EP, V4, P267; Beral V, 2003, LANCET, V361, P177, DOI 10.1016/S0140-6736(03)12209-X; BLOCK G, 1989, J NUTR EDUC, V21, P199; Butte NE, 2001, PEDIATR CLIN N AM, V48, P189, DOI 10.1016/S0031-3955(05)70293-5; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Dewey Kathryn G, 2003, J Hum Lact, V19, P9; Dietz WH, 2001, JAMA-J AM MED ASSOC, V285, P2506, DOI 10.1001/jama.285.19.2506; Elliott KG, 1997, OBES RES, V5, P538, DOI 10.1002/j.1550-8528.1997.tb00574.x; FERRI E, 1993, LIFE 33 5 FOLLOW UP; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; Hediger ML, 2001, JAMA-J AM MED ASSOC, V285, P2453, DOI 10.1001/jama.285.19.2453; HUTTLY SRA, 1990, AM J EPIDEMIOL, V132, P572, DOI 10.1093/oxfordjournals.aje.a115693; KRAMER MS, 1981, J PEDIATR-US, V98, P883, DOI 10.1016/S0022-3476(81)80579-3; Parsons TJ, 2003, ARCH DIS CHILD, V88, P793, DOI 10.1136/adc.88.9.793; Tulldahl J, 1999, OBES RES, V7, P431, DOI 10.1002/j.1550-8528.1999.tb00430.x; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; VICTORA CG, 2003, IN PRESS CAD SAUDE P; von Kries R, 2000, ADV EXP MED BIOL, V478, P29; WELLS JCK, 2003, INT J BODY COMPOSITI, V1, P1; *WHO DIV DIARRH AC, 1991, IND ASS BREAST FEED; *WHO EXP COMM NUTR, 1995, WHO TECHN REP SER, V854	22	72	79	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2003	327	7420					904	905		10.1136/bmj.327.7420.904	http://dx.doi.org/10.1136/bmj.327.7420.904			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734RV	14563747	Green Published, Bronze			2022-12-01	WOS:000186072100019
J	Townsend, A; Hunt, K; Wyke, S				Townsend, A; Hunt, K; Wyke, S			Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; PRIMARY-CARE; MEDICATIONS; DECISIONS; MEDICINES	Objective To examine attitudes towards drug use among middle aged respondents with high levels of chronic morbidity. Design Qualitative study with detailed interviews. Setting West of Scotland. Participants 23 men and women aged about 50 years with four or more chronic illnesses. Main outcome measure Participants' feelings about long term use of drugs to manage chronic multiple morbidity. Results Drugs occupied a central place in the way people managed their comorbidities. Respondents expressed an aversion to taking drugs, despite acknowledging that they depended on drugs to live as "normal" a life as possible. Respondents expressed ambivalence to their drugs in various ways. Firstly, they adopted both regular and more flexible regimens and might adhere to a regular regimen in treating one condition (such as hypertension) while adopting a flexible regimen in relation to others, in response to their experience of symptoms or varying demands of their daily life. Secondly, they expressed reluctance to take drugs, but an inability to be free of them. Thirdly, drugs both facilitated performance of social roles and served as evidence of an inability to perform such roles. Conclusions Insight into the considerable tension experienced by people managing complex drug regimens to manage multiple chronic illness may help medical carets to support self care practices among patients and to optimise concordance in their use of prescribed drugs.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; NHS Educ Scotland, Scottish Sch Primary Care, Edinburgh EH8 9DR, Midlothian, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; NHS Education for Scotland	Hunt, K (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.			Hunt, Kate/0000-0002-5873-3632				Benson J, 2002, BRIT MED J, V325, P873, DOI 10.1136/bmj.325.7369.873; Britten N, 2000, BMJ-BRIT MED J, V320, P484, DOI 10.1136/bmj.320.7233.484; BRITTEN N, 1994, BRIT J GEN PRACT, V44, P465; BRITTEN N, 1995, FAM PRACT, V12, P104, DOI 10.1093/fampra/12.1.104; Britten N, 1996, MODERN MED LAY PERSP, P48; Britten Nicky, 2002, Health Expect, V5, P256, DOI 10.1046/j.1369-6513.2002.00187.x; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; Department of Health, 2001, EXP PAT NEW APPR CHR; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; FORD G, 1994, SOC SCI MED, V39, P1037, DOI 10.1016/0277-9536(94)90375-1; Geest S.V.D., 1989, MED ANTHROPOL Q, V3, P345, DOI DOI 10.1525/MAQ.1989.3.4.02A00030; Haynes RB, 1996, LANCET, V348, P383; HUNT K, 2000, J EPIDEMIOL COMMUNIT, V54, P786; Macintyre S, 1999, SOC SCI MED, V48, P89, DOI 10.1016/S0277-9536(98)00292-5; Macintyre S, 1989, READINGS NEW PUBLIC, P56; Marinker M, 2003, BRIT MED J, V326, P348, DOI 10.1136/bmj.326.7385.348; Morgan M., 1996, MODERN MED LAY PERSP, P95; *OFF NAT STAT, 2000, LIV BRIT RES 1998 GE; Rogers A, 1998, SOC SCI MED, V47, P1313, DOI 10.1016/S0277-9536(98)00209-3; Royal Pharmaceutical Society of Great Britain, 1997, COMPL CONC ACH SHAR; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Strauss A., 1990, BASICS QUALITATIVE R; Wyke Sally, 2003, Eur J Gen Pract, V9, P48	23	118	120	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2003	327	7419					837	840		10.1136/bmj.327.7419.837	http://dx.doi.org/10.1136/bmj.327.7419.837			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732BP	14551097	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000185921200017
J	Gardai, SJ; Xiao, YQ; Dickinson, M; Nick, JA; Voelker, DR; Greene, KE; Henson, PM				Gardai, SJ; Xiao, YQ; Dickinson, M; Nick, JA; Voelker, DR; Greene, KE; Henson, PM			By binding SIRP alpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation	CELL			English	Article							SURFACTANT-PROTEIN-A; CARBOHYDRATE-RECOGNITION DOMAINS; CELL-SURFACE; ALVEOLAR MACROPHAGES; PSEUDOMONAS-AERUGINOSA; APOPTOTIC CELLS; DEFICIENT MICE; RAT LUNG; C1Q; RECEPTOR	Surfactant proteins A and D (SP-A and SP-D) are lung collectins composed of two regions, a globular head domain that binds PAMPs and a collagenous tail domain that initiates phagocytosis. We provide evidence that SP-A and SP-D act in a dual manner, to enhance or suppress inflammatory mediator production depending on binding orientation. SP-A and SP-D bind SIRPalpha through their globular heads to initiate a signaling pathway that blocks proinflammatory mediator production. In contrast, their collagenous tails stimulate proinflammatory mediator production through binding to calreticulin/CD91. Together a model is implied in which SP-A and SP-D help maintain a non/anti-inflammatory lung environment by stimulating SIRPalpha on resident cells through their globular heads. However, interaction of these heads with PAMPs on foreign organisms or damaged cells and presentation of the collagenous tails in an aggregated state to calreticulin/CD91, stimulates phagocytosis and proinflammatory responses.	Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Henson, PM (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, 1400 Jackson St, Denver, CO 80206 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048211, R01GM061031] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48211, GM61031] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen MJ, 2001, INFECT IMMUN, V69, P2037, DOI 10.1128/IAI.69.4.2037-2044.2001; Arias-Diaz J, 2000, SHOCK, V14, P300, DOI 10.1097/00024382-200014030-00010; Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BLAU S, 1994, AM J PHYSIOL, V266, pL148; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bridges JP, 2000, J BIOL CHEM, V275, P38848, DOI 10.1074/jbc.M005322200; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chiba H, 2001, INFECT IMMUN, V69, P1587, DOI 10.1128/IAI.69.3.1587-1592.2001; Coppolino MG, 1998, INT J BIOCHEM CELL B, V30, P553, DOI 10.1016/S1357-2725(97)00153-2; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; GREENE KE, 1996, AM J RESP CRIT CARE, V153, pA662; GREENE KE, 2000, AM THOR SOC 2000 INT; GREENE KE, 1998, AM J RESP CRIT CARE, V157, pA562; Harrod KS, 1999, AM J PHYSIOL-LUNG C, V277, pL580, DOI 10.1152/ajplung.1999.277.3.L580; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KREMLEV SG, 1994, AM J PHYSIOL-LUNG C, V267, pL712, DOI 10.1152/ajplung.1994.267.6.L712; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; LeVine AM, 1999, AM J RESP CELL MOL, V20, P279, DOI 10.1165/ajrcmb.20.2.3303; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; OGASAWARA Y, 1994, J BIOL CHEM, V269, P29785; OGASAWARA Y, 1995, J BIOL CHEM, V270, P19052, DOI 10.1074/jbc.270.32.19052; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Poornima S, 2002, LUNG, V180, P33, DOI 10.1007/s004080000079; REID KBM, 1976, BIOCHEM J, V155, P5, DOI 10.1042/bj1550005; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Rosseau S, 1999, J IMMUNOL, V163, P4495; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 1998, J BIOL CHEM, V273, P4783, DOI 10.1074/jbc.273.8.4783; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; Sim RB, 1998, IMMUNOBIOLOGY, V199, P208, DOI 10.1016/S0171-2985(98)80028-4; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Tenner AJ, 1998, IMMUNOBIOLOGY, V199, P250, DOI 10.1016/S0171-2985(98)80031-4; van den Berg RH, 1998, J IMMUNOL, V161, P6924; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203; White MK, 2002, EXP CELL RES, V280, P270, DOI 10.1006/excr.2002.5646; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200	50	529	565	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 3	2003	115	1					13	23		10.1016/S0092-8674(03)00758-X	http://dx.doi.org/10.1016/S0092-8674(03)00758-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14531999	Bronze			2022-12-01	WOS:000185815500005
J	Ebralidze, A; Wang, Y; Petkova, V; Ebralidse, K; Junghans, RP				Ebralidze, A; Wang, Y; Petkova, V; Ebralidse, K; Junghans, RP			RNA leaching of transcription factors disrupts transcription in myotonic dystrophy	SCIENCE			English	Article							CUG-BINDING PROTEIN; CHLORIDE CHANNEL; MESSENGER-RNA; TRINUCLEOTIDE REPEAT; MUSCLE; GENE; EXPANSION; EXPRESSION; CLONING; DISEASE	Myotonic dystrophy type 1 (DM1) is caused by a CUG(n) expansion (n approximate to 50 to 5000) in the 3' untranslated region of the mRNA of the DM protein kinase gene. We show that mutant RNA binds and sequesters transcription factors (TFs), with up to 90% depletion of selected TFs from active chromatin. Diverse genes are consequently reduced in expression, including the ion transporter CIC-1, which has been implicated in myotonia. When TF specificity protein 1 (Sp1) was overexpressed in DM1-affected cells, low levels of messenger RNA for CIC-1 were restored to normal. Transcription factor leaching from chromatin by mutant RNA provides a potentially unifying pathomechanistic explanation for this disease.	Harvard Univ, Sch Med, Harvard Inst Human Genet, Biotherapeut Dev Lab, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Junghans, RP (corresponding author), Harvard Univ, Sch Med, Harvard Inst Human Genet, Biotherapeut Dev Lab, 4 Blackfan Circle, Boston, MA 02215 USA.							Bergmann E, 2001, TRENDS GENET, V17, P279, DOI 10.1016/S0168-9525(01)02280-6; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; EBRALIDZE A, UNPUB; Finsterer J, 2002, EUR J NEUROL, V9, P441, DOI 10.1046/j.1468-1331.2002.00453.x; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Junghans RP, 2001, NEUROGENETICS, V3, P59, DOI 10.1007/s100480000103; Kimura T, 2000, NEUROSCI LETT, V295, P93, DOI 10.1016/S0304-3940(00)01598-6; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Ohshima K, 1996, J BIOL CHEM, V271, P16773, DOI 10.1074/jbc.271.28.16773; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036	27	115	118	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					383	387		10.1126/science.1088679	http://dx.doi.org/10.1126/science.1088679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14657503				2022-12-01	WOS:000188111800047
J	Lawlor, DA; Smith, GD; Ebrahim, S				Lawlor, DA; Smith, GD; Ebrahim, S			Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				*ER U ROTT, EUROQOL INSTRUMENT V; FRAYN K, 1995, J CLIN NUTR S, V62, pS250; Golomb BA, 2002, J CLIN EPIDEMIOL, V55, P767, DOI 10.1016/S0895-4356(02)00407-9; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lipsett D, 1973, LIFE SCI, V9, P215	5	86	90	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1383	1384		10.1136/bmj.327.7428.1383	http://dx.doi.org/10.1136/bmj.327.7428.1383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670883	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000187417900022
J	Andersen, JS; Wilkinson, CJ; Mayor, T; Mortensen, P; Nigg, EA; Mann, M				Andersen, JS; Wilkinson, CJ; Mayor, T; Mortensen, P; Nigg, EA; Mann, M			Proteomic characterization of the human centrosome by protein correlation profiling	NATURE			English	Article							COMPONENT; CYCLE; GENE; IDENTIFICATION; DUPLICATION; ALMS1	The centrosome is the major microtubule-organizing centre of animal cells and through its influence on the cytoskeleton is involved in cell shape, polarity and motility. It also has a crucial function in cell division because it determines the poles of the mitotic spindle that segregates duplicated chromosomes between dividing cells(1-5). Despite the importance of this organelle to cell biology and more than 100 years of study, many aspects of its function remain enigmatic and its structure and composition are still largely unknown. We performed a mass-spectrometry-based proteomic analysis of human centrosomes in the interphase of the cell cycle by quantitatively profiling hundreds of proteins across several centrifugation fractions. True centrosomal proteins were revealed by both correlation with already known centrosomal proteins and in vivo localization. We identified and validated 23 novel components and identified 41 likely candidates as well as the vast majority of the known centrosomal proteins in a large background of nonspecific proteins. Protein correlation profiling permits the analysis of any multiprotein complex that can be enriched by fractionation but not purified to homogeneity.	Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	University of Southern Denmark; Max Planck Society	Nigg, EA (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, Campusvej 55, DK-5230 Odense M, Denmark.	nigg@biochem.mpg.de; mann@bmb.sdu.dk	Mann, Matthias/A-3454-2013; Andersen, Jens S/L-2100-2015	Mann, Matthias/0000-0003-1292-4799; Andersen, Jens S/0000-0002-6091-140X; Wilkinson, Christopher/0000-0002-7448-0938; nigg, erich/0000-0003-4835-5719				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Brown CR, 1996, J BIOL CHEM, V271, P824, DOI 10.1074/jbc.271.2.824; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Kenedy AA, 2003, GENE, V303, P35, DOI 10.1016/S0378-1119(02)01141-1; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; KLOTZ C, 1990, J CELL BIOL, V110, P405, DOI 10.1083/jcb.110.2.405; Lamond AI, 1997, TRENDS CELL BIOL, V7, P139, DOI 10.1016/S0962-8924(97)01031-3; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Romio L, 2003, J AM SOC NEPHROL, V14, P680, DOI 10.1097/01.ASN.0000054497.48394.D2; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153	30	1006	1064	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					570	574		10.1038/nature02166	http://dx.doi.org/10.1038/nature02166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654843				2022-12-01	WOS:000186944300042
J	Saleska, SR; Miller, SD; Matross, DM; Goulden, ML; Wofsy, SC; da Rocha, HR; de Camargo, PB; Crill, P; Daube, BC; de Freitas, HC; Hutyra, L; Keller, M; Kirchhoff, V; Menton, M; Munger, JW; Pyle, EH; Rice, AH; Silva, H				Saleska, SR; Miller, SD; Matross, DM; Goulden, ML; Wofsy, SC; da Rocha, HR; de Camargo, PB; Crill, P; Daube, BC; de Freitas, HC; Hutyra, L; Keller, M; Kirchhoff, V; Menton, M; Munger, JW; Pyle, EH; Rice, AH; Silva, H			Carbon in amazon forests: Unexpected seasonal fluxes and disturbance-induced losses	SCIENCE			English	Article							TROPICAL FORESTS; RAIN-FOREST; EL-NINO; DIOXIDE UPTAKE; CLIMATE; DYNAMICS; STORAGE; TREE; CO2; VARIABILITY	The net ecosystem exchange of carbon dioxide was measured by eddy covariance methods for 3 years in two old-growth forest sites near Santarem, Brazil. Carbon was lost in the wet season and gained in the dry season, which was opposite to the seasonal cycles of both tree growth and model predictions. The 3-year average carbon loss was 1.3 (confidence interval: 0.0 to 2.0) megagrams of carbon per hectare per year. Biometric observations confirmed the net loss but imply that it is a transient effect of recent disturbance superimposed on long-term balance. Given that episodic disturbances are characteristic of old-growth forests, it is likely that carbon sequestration is lower than has been inferred from recent eddy covariance studies at undisturbed sites.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Univ Sao Paulo, Dept Atmospher Sci, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Ctr Energia Nucl Agr, BR-13416000 Piracicaba, Brazil; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; US Forest Serv, USDA, Int Inst Trop Forestry, San Juan, PR 00926 USA; INPE, BR-12227010 Sao Paulo, Brazil	Harvard University; University of California System; University of California Irvine; Universidade de Sao Paulo; Universidade de Sao Paulo; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service; Instituto Nacional de Pesquisas Espaciais (INPE)	Saleska, SR (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	saleska@fas.harvard.edu	Silva, Hudson/D-1564-2013; Crill, Patrick/ABC-1357-2021; Mitchard, Edward T A/C-6346-2009; Keller, Michael/A-8976-2012; Freitas, Helber Custódio/D-3293-2012; Goulden, Michael L/B-9934-2008; Munger, J William/H-4502-2013; Saleska, Scott R/K-1733-2016; de Camargo, Plínio B./D-6635-2012	Mitchard, Edward T A/0000-0002-5690-4055; Keller, Michael/0000-0002-0253-3359; Munger, J William/0000-0002-1042-8452; Saleska, Scott R/0000-0002-4974-3628; de Camargo, Plínio B./0000-0002-0696-3778; Menton, Mary/0000-0002-9892-2657; Crill, Patrick/0000-0003-1110-3059; Goulden, Michael/0000-0002-9379-3948				Andreae MO, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000524; Araujo AC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000676; Botta A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013607; Carswell FE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000284; Clark DA, 2002, ECOL APPL, V12, P3, DOI 10.1890/1051-0761(2002)012[0003:ATFAIC]2.0.CO;2; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DENNING AS, 1995, NATURE, V376, P240, DOI 10.1038/376240a0; GOULDEN ML, IN PRESS ECOL APPL; Grace J, 1996, GLOBAL CHANGE BIOL, V2, P209, DOI 10.1111/j.1365-2486.1996.tb00073.x; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Grace J, 2002, NATURE, V416, P594, DOI 10.1038/416594b; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keller M, 1996, SCIENCE, V273, P201, DOI 10.1126/science.273.5272.201; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; KRUIJT B, IN PRESS ECOL APPL; Lee XH, 1998, AGR FOREST METEOROL, V91, P39, DOI 10.1016/S0168-1923(98)00071-9; MAHLI Y, 1998, J GEOPHYS RES, V103, P31593, DOI DOI 10.1029/98JD02647; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; MARTENS C, IN PRESS GLOB CHANGE; McPhaden MJ, 1999, NATURE, V398, P559, DOI 10.1038/19193; MILLER SD, IN PRESS ECOL APPL; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2002, ECOL APPL, V12, P576, DOI 10.1890/1051-0761(2002)012[0576:CIGOTF]2.0.CO;2; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Potter C, 2001, J GEOPHYS RES-ATMOS, V106, P10423, DOI 10.1029/2000JD900563; Prentice IC, 1998, NATURE, V396, P619, DOI 10.1038/25224; RICE AH, IN PRESS ECOL APPL; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; ROCHA HR, IN PRESS ECOL APPL; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; Sakai RK, 2001, J APPL METEOROL, V40, P2178, DOI 10.1175/1520-0450(2001)040<2178:IOLFCT>2.0.CO;2; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; SCOTT RL, IN PRESS AGR FOR MET; Sheil D, 2003, TRENDS ECOL EVOL, V18, P18, DOI 10.1016/S0169-5347(02)00005-8; Telles EDC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001953; Tian H, 2000, GLOBAL ECOL BIOGEOGR, V9, P315, DOI 10.1046/j.1365-2699.2000.00198.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x	45	518	543	2	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1554	1557		10.1126/science.1091165	http://dx.doi.org/10.1126/science.1091165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645845	Green Submitted			2022-12-01	WOS:000186802200040
J	Benkova, E; Michniewicz, M; Sauer, M; Teichmann, T; Seifertova, D; Jurgens, G; Friml, J				Benkova, E; Michniewicz, M; Sauer, M; Teichmann, T; Seifertova, D; Jurgens, G; Friml, J			Local, efflux-dependent auxin gradients as a common module for plant organ formation	CELL			English	Article							LATERAL ROOT INITIATION; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; OVULE DEVELOPMENT; POLAR TRANSPORT; GENE; GRAVITROPISM; LOCALIZATION; ORGANIZATION; EXPRESSION	Plants, compared to animals, exhibit an amazing adaptability and plasticity in their development. This is largely dependent on the ability of plants to form new organs, such as lateral roots, leaves, and flowers during postembryonic development. Organ primordia develop from founder cell populations into organs by coordinated cell division and differentiation. Here, we show that organ formation in Arabidopsis involves dynamic gradients of the signaling molecule auxin with maxima at the primordia tips. These gradients are mediated by cellular efflux requiring asymmetrically localized PIN proteins, which represent a functionally redundant network for auxin distribution in both aerial and underground organs. PIN1 polar localization undergoes a dynamic rearrangement, which correlates with establishment of auxin gradients and primordiurn development. Our results suggest that PIN-dependent, local auxin gradients represent a common module for formation of all plant organs, regardless of their mature morphology or developmental origin.	Univ Tubingen, Zentrum Molekularbiol Pflanzen, D-72076 Tubingen, Germany; Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; ASCR, Inst Biophys, Brno, Czech Republic	Eberhard Karls University of Tubingen; Max Planck Society; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Benkova, E (corresponding author), Univ Tubingen, Zentrum Molekularbiol Pflanzen, Morgenstelle 1, D-72076 Tubingen, Germany.		Benkova, Eva/E-2910-2012; Sauer, Michael/F-6519-2014; Friml, Jiri/D-9511-2012; Sauer, Michael/G-3424-2011	Sauer, Michael/0000-0002-4014-9825; Friml, Jiri/0000-0002-8302-7596; 				Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; BLAKELY LM, 1979, PLANT SCI LETT, V14, P79, DOI 10.1016/0304-4211(79)90158-5; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Caruso John L., 1995, P433; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Esau K., 1977, ANATOMY SEED PLANTS; FERREIRA PCG, 1994, PLANT CELL, V6, P1763, DOI 10.1105/tpc.6.12.1763; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; FRIML J., 2003, PLANT BIOLOGY, V6, P7; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; GELDNER N, 2003, IN PRESS DEVELOPMENT; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; Lomax Terri L., 1995, P509; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Maves L, 1999, CURR TOP DEV BIOL, V43, P115; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; MAYER U, 1993, DEVELOPMENT, V117, P149; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Oka M, 1999, PLANT CELL PHYSIOL, V40, P231, DOI 10.1093/oxfordjournals.pcp.a029532; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Steeves TA, 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203	39	1834	1929	30	515	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					591	602		10.1016/S0092-8674(03)00924-3	http://dx.doi.org/10.1016/S0092-8674(03)00924-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651850	Bronze			2022-12-01	WOS:000186885600009
J	Krause, AE; Frank, KA; Mason, DM; Ulanowicz, RE; Taylor, WW				Krause, AE; Frank, KA; Mason, DM; Ulanowicz, RE; Taylor, WW			Compartments revealed in food-web structure	NATURE			English	Article							STABILITY; DIVERSITY; ECOLOGY	Compartments(1) in food webs are subgroups of taxa in which many strong interactions occur within the subgroups and few weak interactions occur between the subgroups(2). Theoretically, compartments increase the stability in networks(1-5), such as food webs. Compartments have been difficult to detect in empirical food webs because of incompatible approaches(6-9) or insufficient methodological rigour(8,10,11). Here we show that a method for detecting compartments from the social networking science(12-14) identified significant compartments in three of five complex, empirical food webs. Detection of compartments was influenced by food web resolution, such as interactions with weights. Because the method identifies compartmental boundaries in which interactions are concentrated, it is compatible with the definition of compartments. The method is rigorous because it maximizes an explicit function, identifies the number of non-overlapping compartments, assigns membership to compartments, and tests the statistical significance of the results(12-14). A graphical presentation(14) reveals systemic relationships and taxa-specific positions as structured by compartments. From this graphic, we explore two scenarios of disturbance to develop a hypothesis for testing how compartmentalized interactions increase stability in food webs(15-17).	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Michigan State Univ, Dept Educ Psychol Counseling & Special Educ, E Lansing, MI 48824 USA; NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI 48105 USA; Univ Maryland, Chesapeake Biol Lab, Solomons, MD 20688 USA	Michigan State University; Michigan State University; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland Center for Environmental Science	Krause, AE (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	krausean@msu.edu	Krause, Ann/GRT-0163-2022; Mason, Doran/ABF-1415-2020; Ulanowicz, Robert E/G-1021-2013	frank, kenneth/0000-0002-6116-5509; Mason, Doran/0000-0002-6017-4243				Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; Blau PM., 1977, INEQUALITY HETEROGEN; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Frank KA, 1996, SOC NETWORKS, V18, P93, DOI 10.1016/0378-8733(95)00257-X; FRANK KA, 1995, SOC NETWORKS, V17, P27, DOI 10.1016/0378-8733(94)00247-8; Frank KA, 1998, AM J SOCIOL, V104, P642, DOI 10.1086/210083; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; Grimm Volker, 1996, Senckenbergiana Maritima, V27, P215; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; Johnson JC, 2001, J SOC STRUCTURE; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; May R.M., 1973, STABILITY COMPLEXITY; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McMahon SM, 2001, SCIENCE, V293, P1604, DOI 10.1126/science.1062026; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; RAFFAELLI D, 1992, J ANIM ECOL, V61, P551, DOI 10.2307/5610; Raffaelli D, 2002, SCIENCE, V296, P1035, DOI 10.1126/science.1072080; Simmel, 1950, SOCIOLOGY GEORG SIMM; Simmel G., 1955, CONFLICT WEB GROUP A; SIMON HA, 1965, GEN SYST, V10, P63; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; YODIZ P, 1982, AM NAT, V120, P551	30	507	519	2	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					282	285		10.1038/nature02115	http://dx.doi.org/10.1038/nature02115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628050	Green Published			2022-12-01	WOS:000186660800042
J	McCrea, M; Guskiewicz, KM; Marshall, SW; Barr, W; Randolph, C; Cantu, RC; Onate, JA; Yang, JZ; Kelly, JP				McCrea, M; Guskiewicz, KM; Marshall, SW; Barr, W; Randolph, C; Cantu, RC; Onate, JA; Yang, JZ; Kelly, JP			Acute effects and recovery time following concussion in collegiate football players - The NCAA Concussion Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; LONGITUDINAL DATA-ANALYSIS; STANDARDIZED ASSESSMENT; POSTURAL STABILITY; AUSTRALIAN RULES; SPORTS; DEFICITS; SEVERITY	Context Lack of empirical data on recovery time following sport-related concussion hampers clinical decision making about return to play after injury. Objective To prospectively measure immediate effects and natural recovery course relating to symptoms, cognitive functioning, and postural stability following sport-related concussion. Design, Setting, and Participants Prospective cohort study of 1631 football players from 15 US colleges. All players underwent preseason baseline testing on concussion assessment measures in 1999, 2000, and 2001. Ninety-four players with concussion (based on American Academy of Neurology criteria) and 56 noninjured controls underwent assessment of symptoms, cognitive functioning, and postural stability immediately, 3 hours, and 1, 2, 3, 5, 7, and 90 days after injury. Main Outcome Measures Scores on the Graded Symptom Checklist (GSC), Standardized Assessment of Concussion (SAC), Balance Error Scoring System (BESS), and a neuropsychological test battery. Results No player with concussion was excluded from participation; 79 players with concussion (84%) completed the protocol through day 90. Players with concussion exhibited more severe symptoms (mean GSC score 20.93 [95% confidence interval (CI), 15.65-26.21] points higher than that of controls), cognitive impairment (mean SAC score 2.94 [95% CI, 1.50-4.38] points lower than that of controls), and balance problems (mean BESS score 5.81 [95% CI, -0.67 to 12.30] points higher than that of controls) immediately after concussion. On average, symptoms gradually resolved by day 7 (GSC mean difference, 0.33; 95% CI, -1.41 to 2.06), cognitive functioning improved to baseline levels within 5 to 7 days (day 7 SAC mean difference, -0.03; 95% CI, -1.33 to 1.26), and balance deficits dissipated within 3 to 5 days after injury (day 5 BESS mean difference, -0.31; 95% CI, -3.02 to 2.40). Mild impairments in cognitive processing and verbal memory evident on neuropsychological testing 2 days after concussion resolved by day 7. There were no significant differences in symptoms or functional impairments in the concussion and control groups 90 days after concussion. Conclusions Collegiate football players may require several days for recovery of symptoms, cognitive dysfunction, and postural instability after concussion. Further research is required to determine factors that predict variability in recovery time after concussion. Standardized measurement of postconcussive symptoms, cognitive functioning, and postural stability may enhance clinical management of athletes recovering from concussion.	Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI 53188 USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; NYU, Sch Med, Dept Neurol, New York, NY USA; Northwestern Univ, Feonberg Sch Med, Chicago Neurol Inst, Chicago, IL 60611 USA; Northwestern Univ, Feonberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Dept Neurol, Maywood, IL 60153 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Athlet Training Program, Dept Rehabil Sci, Boston, MA 02215 USA	Medical College of Wisconsin; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; New York University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Boston University	McCrea, M (corresponding author), Waukesha Mem Hosp, Ctr Neurosci, 721 Amer Ave,Suite 501, Waukesha, WI 53188 USA.	michael.mccrea@phci.org	Onate, James/E-3790-2011; Yang, Jingzhen/N-4786-2014	Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233; Barr, William/0000-0001-7711-7758				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Benton A., 1983, MULTILINGUAL APHASIA, DOI DOI 10.1037/T10132-000; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Colorado Medical Society, 1991, REP SPORTS MED COMM; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; DICK R, 2003, NATL COLL ATHLETIC A; DIGGLE PJ, 1994, ANAL LONGITUDINAL DA, pCH11; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golden J.C., 1978, STROOP COLOR WORD TE; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead WC, 1985, HALSTEADREITAN NEURO; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; MCCREA M, 2003, J INT NEUROPSYCH SOC, V9, P206; MCCREA M, IN PRESS CLIN J SPOR; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Smith A., 1991, SYMBOL DIGIT MODALIT; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Vastag B, 2002, JAMA-J AM MED ASSOC, V287, P437, DOI 10.1001/jama.287.4.437; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	58	1033	1038	2	207	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2556	2563		10.1001/jama.290.19.2556	http://dx.doi.org/10.1001/jama.290.19.2556			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	744DQ	14625332				2022-12-01	WOS:000186613000025
J	Sandidge, JS				Sandidge, JS			Arachnology - Scavenging by brown recluse spiders	NATURE			English	Editorial Material							ARANEAE		Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Kansas	Sandidge, JS (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.							ATKINS JA, 1958, AM J TROP MED HYG, V7, P165, DOI 10.4269/ajtmh.1958.7.165; Gertsch W. J., 1983, B AM MUS NAT HIST, V175, P264; HITE JM, 1966, U ARKANSAS AGR EXP S, V711, P1; JACKSON RR, 1982, J ZOOL, V196, P255; KNOST SJ, 1975, AM MIDL NAT, V93, P239, DOI 10.2307/2424125; POLLARD SD, 1993, NAT HIST, V102, P58; SMITH RB, 1984, SCIENCE, V226, P1330, DOI 10.1126/science.226.4680.1330; VERTER R, 2002, J MED ENTOMOL, V39, P948	8	35	40	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					30	30		10.1038/426030a	http://dx.doi.org/10.1038/426030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603305				2022-12-01	WOS:000186370800029
J	Gibb, DM; Duong, T; Tookey, PA; Sharland, M; Tudor-Williams, G; Novelli, V; Butler, K; Riordan, A; Farrelly, L; Masters, J; Peckham, CS; Dunn, DT				Gibb, DM; Duong, T; Tookey, PA; Sharland, M; Tudor-Williams, G; Novelli, V; Butler, K; Riordan, A; Farrelly, L; Masters, J; Peckham, CS; Dunn, DT		NSHPC; CHIPS	Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIRETROVIRAL THERAPY; HIV-INFECTION	Objective To describe changes in demographic factors, disease progression, hospital admissions, and use of antiretroviral therapy in children with HIV. Design Active surveillance through the national study of HIV in pregnancy and childhood (NSHPC and additional data from a subset of children in the collaborative HIV paediatric study (CHIPS). Setting United Kingdom and Ireland. Participants 944 children with perinatally acquired HIV-1 under clinical care. Main outcome measures Changes over time in progression to AIDS and death, hospital admission rates, and use of antiretroviral therapy. Results 944 children with perinatally acquired HIV were reported in the United Kingdom and Ireland by October 2002; 628 (67%) were black African, 205 (22%) were aged ! 10 years at last follow up, 193 (20%) are know to have died. The proportion of children presenting who were born abroad increased from 20% in 1994-5 to 60% during 2000-2. Mortality was stable before 1997 at 9.3 per 100 child years at risk but fell to 2.0 in 2001-2 (trend P < 0.001). Progression to AIDS)S also declined (P < 0.00 1). From 1997 onwards the proportion of children on three or four drug antiretroviral therapy increased. Hospital admission rates declined by 80%, but with more children in follow up the absolute number of admissions fell by only 26%. Conclusion In children with HIV infection, mortality, AIDS, and hospital admission rates have declined substantially since the introduction of three or four drug antiretroviral therapy in 1997. As infected children in the United Kingdom and Ireland are living longer, there is an increasing need to address their medical, social, and psychological needs as they enter adolescence and adult life.	MRC, Clin Trials Unit, London NW1 2DA, England; Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ London St Georges Hosp, Paediat Infect Dis Unit, London SW17 0QT, England; St Marys Hosp, Dept Paediat, London W2 1NY, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Our Ladys Hosp Sick Children, Dublin 12, Ireland; Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England	Medical Research Council Clinical Trials Unit; University of London; University College London; St Georges University London; Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Our Ladys Children Hospital Crumlin; Heart of England NHS Foundation Trust; University of Birmingham	Gibb, DM (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	D.Gibb@ctu.mrc.ac.uk	peckham, catherine s/I-6300-2013; Tookey, Pat A/G-2732-2010	Tookey, Pat A/0000-0001-6258-0387; sharland, mike/0000-0001-8626-8291; Dunn, David/0000-0003-1836-4446; Gibb, Diana/0000-0002-9738-5490				Aboulker JP, 2001, ARCH DIS CHILD, V84, P230, DOI 10.1136/adc.84.3.230; ADES AE, 1993, BRIT MED J, V306, P1296, DOI 10.1136/bmj.306.6888.1296; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; [Anonymous], GUIDELINES USE ANTIR; *BRIT HIV ASS, GUID TREATM HIV INF; CLAYTON C, 1993, STAT MODELS EPIDEMIO; Cliffe S, 2001, BRIT MED J, V323, P376, DOI 10.1136/bmj.323.7309.376; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Kinghorn G, 2001, BMJ-BRIT MED J, V323, P243, DOI 10.1136/bmj.323.7307.243; Litalien C, 2003, PEDIATR INFECT DIS J, V22, P48, DOI 10.1097/00006454-200301000-00014; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Sharland M, 2002, HIV Med, V3, P215, DOI 10.1046/j.1468-1293.2002.00120.x; Tarwater PM, 2001, AM J EPIDEMIOL, V154, P675, DOI 10.1093/aje/154.7.675; *UNL AN SURV STEER, 2002, PREV HIV HEP INF UK; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; *WORK GROUP ANT TH, 2001, GUID US ANT AG PED H; *WORK GROUP ANT TH, MED MAN HIV INF CHIL; World Health Organization, 2002, SCAL ANT THER RES LT	22	164	171	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2003	327	7422					1019	1023		10.1136/bmj.327.7422.1019	http://dx.doi.org/10.1136/bmj.327.7422.1019			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738NE	14593035	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-01	WOS:000186294100020
J	Singleton, AB; Farrer, M; Johnson, J; Singleton, A; Hague, S; Kachergus, J; Hulihan, M; Peuralinna, T; Dutra, A; Nussbaum, R; Lincoln, S; Crawley, A; Hanson, M; Maraganore, D; Adler, C; Cookson, MR; Muenter, M; Baptista, M; Miller, D; Blancato, J; Hardy, J; Gwinn-Hardy, K				Singleton, AB; Farrer, M; Johnson, J; Singleton, A; Hague, S; Kachergus, J; Hulihan, M; Peuralinna, T; Dutra, A; Nussbaum, R; Lincoln, S; Crawley, A; Hanson, M; Maraganore, D; Adler, C; Cookson, MR; Muenter, M; Baptista, M; Miller, D; Blancato, J; Hardy, J; Gwinn-Hardy, K			alpha-synuclein locus triplication causes Parkinson's disease	SCIENCE			English	Article									NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Mayo Clin, Genet Neurodgenerat Lab, Jacksonville, FL 32224 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Georgetown University	Singleton, AB (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.		Sander-Effron, Samuel/AAX-2231-2020; Cookson, Mark/AAW-2516-2021; Gwinn, Katrina A/C-2508-2009; Resource Center, NINDS Human Genetics/AGF-2474-2022; Johnson, Janel/A-7136-2010; Singleton, Andrew B/C-3010-2009; Hardy, John/C-2451-2009	Cookson, Mark/0000-0002-1058-3831; Hardy, John/0000-0002-3122-0423; Gwinn, Katrina/0000-0002-8277-651X; Farrer, Matthew/0000-0003-1159-5321	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002974, ZIANS002974, Z01NS003006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000953, Z01AG000953, ZIAAG000957, Z01AG000957] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Muenter MD, 1998, ANN NEUROL, V43, P768, DOI 10.1002/ana.410430612; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324	5	3203	3289	5	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					841	841		10.1126/science.1090278	http://dx.doi.org/10.1126/science.1090278			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593171	Green Submitted			2022-12-01	WOS:000186258000041
J	Hacein-Bey-Abina, S; Von Kalle, C; Schmidt, M; McCcormack, MP; Wulffraat, N; Leboulch, P; Lim, A; Osborne, CS; Pawliuk, R; Morillon, E; Sorensen, R; Forster, A; Fraser, P; Cohen, JI; de Saint Basile, G; Alexander, I; Wintergerst, U; Frebourg, T; Aurias, A; Stoppa-Lyonnet, D; Romana, S; Radford-Weiss, I; Gross, F; Valensi, F; Delabesse, E; Macintyre, E; Sigaux, F; Soulier, J; Leiva, LE; Wissler, M; Prinz, C; Rabbitts, TH; Le Deist, F; Fischer, A; Cavazzana-Calvo, M				Hacein-Bey-Abina, S; Von Kalle, C; Schmidt, M; McCcormack, MP; Wulffraat, N; Leboulch, P; Lim, A; Osborne, CS; Pawliuk, R; Morillon, E; Sorensen, R; Forster, A; Fraser, P; Cohen, JI; de Saint Basile, G; Alexander, I; Wintergerst, U; Frebourg, T; Aurias, A; Stoppa-Lyonnet, D; Romana, S; Radford-Weiss, I; Gross, F; Valensi, F; Delabesse, E; Macintyre, E; Sigaux, F; Soulier, J; Leiva, LE; Wissler, M; Prinz, C; Rabbitts, TH; Le Deist, F; Fischer, A; Cavazzana-Calvo, M			LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; NONHUMAN-PRIMATES; TRANSGENIC MICE; PROTEIN RBTN2; HUMAN GENOME; GAMMA-CHAIN; LEUKEMIA; TRANSLOCATIONS; LYMPHOCYTES; DELTA	We have previously shown correction of X-linked severe combined immunodeficiency [SCID-X1, also known as gamma chain (gammac) deficiency] in 9 out of 10 patients by retrovirus-mediated gammac gene transfer into autologous CD34 bone marrow cells. However, almost 3 years after gene therapy, uncontrolled exponential clonal proliferation of mature T cells (with gammadelta+ or alphabeta+ T cell receptors) has occurred in the two youngest patients. Both patients' clones showed retrovirus vector integration in proximity to the LMO2 proto-oncogene promoter, leading to aberrant transcription and expression of LMO2. Thus, retrovirus vector insertion can trigger deregulated premalignant cell proliferation with unexpected frequency, most likely driven by retrovirus enhancer activity on the LMO2 gene promoter.	INSERM, U429, F-75743 Paris 15, France; Assistance Publ Hop Paris, Dept Biotherapie, F-75743 Paris, France; Univ Paris 05, Lab Cytogenet, F-75743 Paris 15, France; Univ Paris 05, Lab Cent Hematol, F-75743 Paris 15, France; Univ Paris 05, CNRS, Unite Rech Associee 1461, F-75743 Paris 15, France; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, F-75743 Paris 15, France; Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Med Ctr Utrecht, Wilhelmina Kinderziekenhuis, Utrecht, Netherlands; Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; INSERM, U277, F-75730 Paris, France; Babraham Inst, Lab Chromatin & Gene Express, Dev Genet Programme, Cambridge CB2 4AT, England; Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; Childrens Hosp, New Orleans, LA 70112 USA; NIAID, Med Virol Sect, Clin Invest Lab, Bethesda, MD 20892 USA; Childrens Hosp Westmead, Sydney, NSW 2145, Australia; Univ & Childrens Hosp, D-80337 Munich, Germany; CHU, Serv Genet, F-76183 Rouen, France; Fac Med & Pharm, INSERM 9906, Equipe Mixte, F-76183 Rouen, France; Inst Curie, INSERM, U434, Paris 15, France; Inst Curie, Dept Oncol Genet, Paris 15, France; Hop St Louis, INSERM, U462, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; MRC Laboratory Molecular Biology; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fischer, A (corresponding author), INSERM, U429, F-75743 Paris 15, France.		Wilson, Matthew H/K-3193-2013; Osborne, Cameron/N-1398-2017; DELABESSE, Eric/I-5221-2016; Fraser, Peter/B-7549-2009; Frebourg, Thierry/AAK-8390-2020; Rabbitts, Terence/D-6262-2016; de Saint Basile, Genevieve/G-9731-2017	Osborne, Cameron/0000-0003-4126-2499; DELABESSE, Eric/0000-0002-0928-0753; Macintyre-Davi, Elizabeth Anne/0000-0003-0520-0493; Wintergerst, Uwe/0000-0002-0785-0337; Rabbitts, Terence/0000-0002-4982-2609; McCormack, Matthew/0000-0003-1536-5611; de Saint Basile, Genevieve/0000-0002-1913-5269; Romana, Serge Pierrick/0000-0003-3435-239X; Alexander, Ian E/0000-0002-6213-5627; Fraser, Peter/0000-0002-0041-1227	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000430, ZIAAI000430] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; AURIAS A, UNPUB; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125; FISCH P, 1992, ONCOGENE, V7, P2389; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; GARCIA IS, 1991, ONCOGENE, V6, P577; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; HaceinBey S, 1996, BLOOD, V87, P3108, DOI 10.1182/blood.V87.8.3108.bloodjournal8783108; Kamps WA, 1999, BLOOD, V94, P1226; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; LARSON RC, 1994, ONCOGENE, V9, P3675; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Lim A, 2002, J IMMUNOL METHODS, V261, P177, DOI 10.1016/S0022-1759(02)00004-2; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; NEALE GAM, 1995, BLOOD, V86, P3060; Neale Geoffrey A. M., 1997, Leukemia (Basingstoke), V11, P289; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PRINTZ M, 1995, GENE THER, V2, P143; Rabbitts TH, 2001, ONCOGENE, V20, P5763, DOI 10.1038/sj.onc.1204597; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Schmidt M. K., UNPUB; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Song X, 2002, P NATL ACAD SCI USA, V99, P6269, DOI 10.1073/pnas.092112199; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; VANIN EF, 1994, J VIROL, V68, P4241, DOI 10.1128/JVI.68.7.4241-4250.1994; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; [No title captured]	38	2650	2820	2	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					415	419		10.1126/science.1088547	http://dx.doi.org/10.1126/science.1088547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14564000				2022-12-01	WOS:000185963200033
J	O'Riordan, M; Moors, MA; Portnoy, DA				O'Riordan, M; Moors, MA; Portnoy, DA			Listeria intracellular growth and virulence require host-derived lipoic acid	SCIENCE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; ESCHERICHIA-COLI; LIPB GENES; MONOCYTOGENES; PROTEIN; IDENTIFICATION; ANTIOXIDANT; METABOLISM; SECRETION; BIOLOGY	Listeria monocytogenes is a Gram-positive intracytosolic pathogen that causes severe disease in pregnant and immunocompromised individuals. We found that L. monocytogenes lacking the lipoate protein ligase LplA1 was defective for growth specifically in the host cytosol and was less virulent in animals by a factor of 300. A major target for LplA1, the E2 subunit of pyruvate dehydrogenase (PDH), lacked a critical lipoyl modi. cation when the DeltalplA1 strain was grown intracellularly, which suggests that abortive growth was due to loss of PDH function. Thus, the use of host-derived lipoic acid may be a critical process for in vivo replication of bacterial pathogens.	Univ Calif Berkeley, Sch Publ Hlth, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Wake Forest University; Wake Forest Baptist Medical Center	O'Riordan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.		O'Riordan, Mary/D-8227-2011	O'Riordan, Mary/0000-0001-6014-4637	NIAID NIH HHS [R37 AI029619, AI29619, R01 AI27655, R01 AI027655] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029619, R01AI027655, R37AI029619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BROOKFIELD DE, 1991, FEBS LETT, V295, P13, DOI 10.1016/0014-5793(91)81373-G; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; CAMILLI A, 1989, P NATL ACAD SCI USA, V86, P5522, DOI 10.1073/pnas.86.14.5522; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; DUBENSKY T, COMMUNICATION; Gao HC, 2002, J BACTERIOL, V184, P2780, DOI 10.1128/JB.184.10.2780-2788.2002; Glaser P, 2001, SCIENCE, V294, P849; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.3.CO;2-B; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MORRIS TW, 1995, J BACTERIOL, V177, P1; MOULDER JW, 1985, MICROBIOL REV, V49, P298, DOI 10.1128/MMBR.49.3.298-337.1985; O'Riordan M, 2002, TRENDS MICROBIOL, V10, P361, DOI 10.1016/S0966-842X(02)02401-0; ORIORDAN M, UNPUB; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; Stein A, 2000, J BACTERIOL, V182, P2119, DOI 10.1128/JB.182.8.2119-2124.2000	22	100	127	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					462	464		10.1126/science.1088170	http://dx.doi.org/10.1126/science.1088170			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14564012				2022-12-01	WOS:000185963200048
J	Hurlstone, AFL; Haramis, APG; Wienholds, E; Begthel, H; Korving, J; van Eeden, F; Cuppen, E; Zivkovic, D; Plasterk, RHA; Clevers, H				Hurlstone, AFL; Haramis, APG; Wienholds, E; Begthel, H; Korving, J; van Eeden, F; Cuppen, E; Zivkovic, D; Plasterk, RHA; Clevers, H			The Wnt/beta-catenin pathway regulates cardiac valve formation	NATURE			English	Article							BETA-CATENIN; COLORECTAL-CANCER; CUSHION FORMATION; ZEBRAFISH; GENE; TRANSFORMATION; APC; SPECIFICATION; PHENOTYPE; MUTATION	Truncation of the tumour suppressor adenomatous polyposis coli (Apc) constitutively activates the Wnt/beta-catenin signalling pathway(1). Apc has a role in development: for example, embryos of mice with truncated Apc do not complete gastrulation(2). To understand this role more fully, we examined the effect of truncated Apc on zebrafish development. Here we show that, in contrast to mice, zebrafish do complete gastrulation. However, mutant hearts fail to loop and form excessive endocardial cushions. Conversely, overexpression of Apc or Dickkopf 1 (Dkk1), a secreted Wnt inhibitor(3), blocks cushion formation. In wild-type hearts, nuclear beta-catenin, the hallmark of activated canonical Wnt signalling(4), accumulates only in valve-forming cells, where it can activate a Tcf reporter. In mutant hearts, all cells display nuclear beta-catenin and Tcf reporter activity, while valve markers are markedly upregulated. Concomitantly, proliferation and epithelial-mesenchymal transition, normally restricted to endocardial cushions, occur throughout the endocardium. Our findings identify a novel role for Wnt/beta-catenin signalling in determining endocardial cell fate.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Van Eeden, Freek/E-6198-2010; Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Hurlstone, Adam/0000-0001-5260-9457				Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; IWAMOTO R, 2003, P NATL ACAD SCI; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kim RY, 2001, DEV BIOL, V235, P449, DOI 10.1006/dbio.2001.0284; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; van de Water S, 2001, DEVELOPMENT, V128, P3877; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M, 1995, ZEBRAFISH BOOK; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8	24	316	334	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2003	425	6958					633	637		10.1038/nature02028	http://dx.doi.org/10.1038/nature02028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534590				2022-12-01	WOS:000185801000041
J	Verschure, PFMJ; Voegtlin, T; Douglas, RJ				Verschure, PFMJ; Voegtlin, T; Douglas, RJ			Environmentally mediated synergy between perception and behaviour in mobile robots	NATURE			English	Article							PLASTICITY; CORTEX	The notion that behaviour influences perception seems self-evident, but the mechanism of their interaction is not known. Perception and behaviour are usually considered to be separate processes. In this view, perceptual learning constructs compact representations of sensory events, reflecting their statistical properties(1,2), independently of behavioural relevance(3,4). Behavioural learning(5,6), however, forms associations between perception and action, organized by reinforcement(7,8), without regard for the construction of perception. It is generally assumed that the interaction between these two processes is internal to the agent, and can be explained solely in terms of the neuronal substrate(9). Here we show, instead, that perception and behaviour can interact synergistically via the environment. Using simulated and real mobile robots, we demonstrate that perceptual learning directly supports behavioural learning and so promotes a progressive structuring of behaviour. This structuring leads to a systematic bias in input sampling, which directly affects the organization of the perceptual system. This external, environmentally mediated feedback matches the perceptual system to the emerging behavioural structure, so that the behaviour is stabilized.	Univ Swiss Fed Inst Technol ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Verschure, PFMJ (corresponding author), Univ Swiss Fed Inst Technol ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland.		verschure, paul/E-1677-2011; Verschure, Paul/AAR-2340-2021	Verschure, Paul/0000-0003-3643-9544				Arkin R. C., 1998, BEHAV BASED ROBOTICS; Barto A, 1998, REINFORCEMENT LEARNI, V1st; Bell AJ, 1999, PHILOS T ROY SOC B, V354, P2013, DOI 10.1098/rstb.1999.0540; CLANCEY WJ, 1996, SITUATED COGNITION H; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Kalman R.E., 1960, T ASME J BASIC ENG, V82, P35, DOI DOI 10.1115/1.3662552; LAVOND DG, 1993, ANNU REV PSYCHOL, V44, P317, DOI 10.1146/annurev.ps.44.020193.001533; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mackintosh NJ., 1974, PSYCHOL ANIMAL LEARN; Massaro DW, 1997, PERCEIVING TALKING F; MCFARLAND D, 1993, INTELLIGENT BEHAV AN; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MONDADA F, 1993, EXPT ROBOTICS, V3, P501; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1177/0269881120954052, DOI 10.1101/GR.110528.110]; Sanchez-Montanes MA, 2000, NEURAL COMPUT, V12, P519, DOI 10.1162/089976600300015682; Scheier C, 1999, UNDERSTANDING INTELL; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Squire LR., 1999, MEMORY MIND MOL; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Thorndike E, 1898, PSYCHOL REV SER MO S, V2, P1, DOI [DOI 10.1037/H0092987, DOI 10.1037/0003-066X.53.10.1125]; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Verschure P. F. M. J., 1992, Robotics and Autonomous Systems, V9, P181, DOI 10.1016/0921-8890(92)90054-3; VERSCHURE PFM, 1992, ANIMALS ANIMATS, P210; Verschure PFMJ, 2003, COGNITIVE SCI, V27, P561, DOI 10.1016/S0364-0213(03)00034-X; Verschure PFMJ, 1998, NEURAL NETWORKS, V11, P1531, DOI 10.1016/S0893-6080(98)00029-X	28	139	140	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2003	425	6958					620	624		10.1038/nature02024	http://dx.doi.org/10.1038/nature02024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729XU	14534588				2022-12-01	WOS:000185801000038
J	Chen, Y; Deng, LB; Maeno-Hikichi, Y; Lai, MZ; Chang, SH; Chen, G; Zhang, JF				Chen, Y; Deng, LB; Maeno-Hikichi, Y; Lai, MZ; Chang, SH; Chen, G; Zhang, JF			Formation of an endophilin-Ca2+ channel complex is critical for clathrin-mediated synaptic vesicle endocytosis	CELL			English	Article							NEURONAL CA2+ CHANNELS; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; PROTEIN-INTERACTION; SH3 DOMAIN; CELL; EXOCYTOSIS; SRC; SYNAPTOTAGMIN	A tight balance between synaptic vesicle exocytosis and endocytosis is fundamental to maintaining synaptic structure and function. Calcium influx through voltage-gated Ca2+ channels is crucial in regulating synaptic vesicle exocytosis. However, much less is known about how Ca2+ regulates vesicle endocytosis or how the endocytic machinery becomes enriched at the nerve terminal. We report here a direct interaction between voltage-gated Ca2+ channels and endophilin, a key regulator of clathrin-mediated synaptic vesicle endocytosis. Formation of the endophlin-Ca2+ channel complex is Ca2+ dependent. The primary Ca2+ binding domain resides within endophilin and regulates both endophilin-Ca2+ channel and endophilin-dynamin complexes. Introduction into hippocampal neurons of a dominant-negative endophilin construct, which constitutively binds to Ca2+ channels, significantly reduces endocytosis-mediated uptake of FM 4-64 dye without abolishing exocytosis. These results suggest an important role for Ca2+ channels in coordinating synaptic vesicle recycling by directly coupling to both exocytotic and endocytic machineries.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, JF (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.		Chen, Yuan/D-1462-2011	Chen, Yuan/0000-0002-9412-4623; Chen JNU, Gong/0000-0002-1857-3670	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039355] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39355] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Huttner WB, 2002, TRENDS CELL BIOL, V12, P155, DOI 10.1016/S0962-8924(02)02252-3; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Mayer BJ, 2001, J CELL SCI, V114, P1253; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Teng HB, 2000, J NEUROSCI, V20, P7986; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yoshihara M, 2003, CURR OPIN NEUROBIOL, V13, P315, DOI 10.1016/S0959-4388(03)00063-1; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000	54	91	95	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 3	2003	115	1					37	48		10.1016/S0092-8674(03)00726-8	http://dx.doi.org/10.1016/S0092-8674(03)00726-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532001	Bronze			2022-12-01	WOS:000185815500007
J	Lund, E; Guttinger, S; Calado, A; Dahlberg, JE; Kutay, U				Lund, E; Guttinger, S; Calado, A; Dahlberg, JE; Kutay, U			Nuclear export of microRNA precursors	SCIENCE			English	Article							RNA-INTERFERENCE; TRANSPORT; DICER; MATURATION	MicroRNAs (miRNAs), which function as regulators of gene expression in eukaryotes, are processed from larger transcripts by sequential action of nuclear and cytoplasmic ribonuclease III-like endonucleases. We show that Exportin-5 (Exp5) mediates efficient nuclear export of short miRNA precursors (pre-miRNAs) and that its depletion by RNA interference results in reduced miRNA levels. Exp5 binds correctly processed pre-miRNAs directly and specifically, in a Ran guanosine triphosphate-dependent manner, but interacts only weakly with extended pre-miRNAs that yield incorrect miRNAs when processed by Dicer in vitro. Thus, Exp5 is key to miRNA biogenesis and may help coordinate nuclear and cytoplasmic processing steps.	Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	University of Wisconsin System; University of Wisconsin Madison; Swiss Federal Institutes of Technology Domain; ETH Zurich	Dahlberg, JE (corresponding author), Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA.	dahlberg@wisc.edu; ulrike.kutay@bc.biol.ethz.ch	Calado, Ângelo Miguel Silva/Y-2296-2019	Calado, Ângelo Miguel Silva/0000-0003-0182-2615	NIGMS NIH HHS [GM-30220] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030220, R37GM030220] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee D, 2002, BIOESSAYS, V24, P119, DOI 10.1002/bies.10046; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Grimm C, 1997, EMBO J, V16, P793, DOI 10.1093/emboj/16.4.793; Gwizdek C, 2003, J BIOL CHEM, V278, P5505, DOI 10.1074/jbc.C200668200; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kidner CA, 2003, TRENDS GENET, V19, P13, DOI 10.1016/S0168-9525(02)00011-2; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; LUND E, UNPUB; Moss EG, 2002, CURR BIOL, V12, pR688, DOI 10.1016/S0960-9822(02)01206-X; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; TERNS MP, 1992, MOL CELL BIOL, V12, P3032, DOI 10.1128/MCB.12.7.3032; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	29	1888	2079	5	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					95	98		10.1126/science.1090599	http://dx.doi.org/10.1126/science.1090599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14631048				2022-12-01	WOS:000187710600042
J	Rosegrant, MW; Cline, SA				Rosegrant, MW; Cline, SA			Global food security: Challenges and policies	SCIENCE			English	Article							AGRICULTURE; POVERTY; INDIA	Global food security will remain a worldwide concern for the next 50 years and beyond. Recently, crop yield has fallen in many areas because of declining investments in research and infrastructure, as well as increasing water scarcity. Climate change and HIV/AIDS are also crucial factors affecting food security in many regions. Although agroecological approaches offer some promise for improving yields, food security in developing countries could be substantially improved by increased investment and policy reforms.	Int Food Policy Res Inst, Washington, DC 20006 USA	CGIAR; International Food Policy Research Institute (IFPRI)	Rosegrant, MW (corresponding author), Int Food Policy Res Inst, 2033 K St NW, Washington, DC 20006 USA.		Zhong, Hong Lin/C-2633-2012					Adams R.M, 1999, CHOICES, V14, P22; Alston JM, 2000, 113 IFPRI; BARGHOUTI SM, 2001, SUSTAIN DEV INT, V1, P127; Boserup E., 1965, CONDITIONS AGR GROWT; Brown L. R., 1994, FULL HOUSE REASSESSI; Bruinsma J, 2003, WORLD AGR 2015 2030; BYERLEE D, 2000, ACCESSING MODERN SCI; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Ceccarelli Salvatore, 1996, P99; Clark Colin, 1970, STARVATION PLENTY; Croppenstedt A, 2000, ECON DEV CULT CHANGE, V48, P475, DOI 10.1086/452607; Downing ET, 1993, RENEWABLE ENERGY, V3, P491, DOI [10.1016/0960-1481(93)90115-W, DOI 10.1016/0960-1481(93)90115-W]; Ehrlich P.R., 1990, POPULATION EXPLOSION; Evans L., 1998, FEEDING 10 BILLION P; Fan S.G., 2002, GROWTH INEQUALITY PO; Fan SG, 2000, AM J AGR ECON, V82, P1038, DOI 10.1111/0002-9092.00101; *FOOD AGR POL RES, 2003, US WORLD AGR OUTL 20; GAIHA R, 1994, DESIGN POVERTY ALEVI; Haddad L., 2001, Journal of International Development, V13, P487, DOI 10.1002/jid.799; IFAD, 1995, STAT WORLD RUR POV P; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 IMP; Kassouf AL, 1996, ECON DEV CULT CHANGE, V44, P817, DOI 10.1086/452246; KOMEGAY J, 1996, PARTICIPATORY PLANT, P151; LIPTON M, 1998, SUCCESS ANTIPOVERTY; Malthus TR, 2003, ESSAY PRINCIPLE POPU; Meadows D. H., 1992, LIMITS CONFRONTING G; *ORG EC COOP DEV, 2003, AGR OUTL 2003 2008; OWEIS T, 1999, 7 INT WAT MAN I; Pretty J., 1999, ENVIRON DEV SUSTAIN, V1, P253, DOI DOI 10.1016/j.jaridenv.2014.01.016; PRETTY JN, 1995, WORLD DEV, V23, P1247, DOI 10.1016/0305-750X(95)00046-F; Rosegrant M.W., 2002, INT MODEL POLICY ANA; Rosegrant MW., 2002, INT FOOD POLICY RES, V1, P32; Simon JL, 1998, ULTIMATE RESOURCE; SINGH RP, 1993, ECON POLIT WEEKLY, V28, pA9; *UN FAO, 2000, CROPS DROPS; *UN FAO, 2001, COMM WORLD FOOD SEC; *UNAIDS, 2003, JOINT UN PROGR HIV A; *USDA, 2003, WAOB20031 USDA; *W AFR RIC DEV ASS, CONS FORM RAP DISS N; Witcover J., 2001, GLOBAL FOOD PROJECTI; *WORLD BANK, 1990, POV WORLD DEV IND; World Bank, 1996, POV RED WORLD BANK P; *WORLD BANK GROUP, 2003, MILL DEV GOALS GOALS	43	501	535	13	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1917	1919		10.1126/science.1092958	http://dx.doi.org/10.1126/science.1092958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671289	Green Submitted			2022-12-01	WOS:000187174000044
J	Roszak, AW; Howard, TD; Southall, J; Gardiner, AT; Law, CJ; Isaacs, NW; Cogdell, RJ				Roszak, AW; Howard, TD; Southall, J; Gardiner, AT; Law, CJ; Isaacs, NW; Cogdell, RJ			Crystal structure of the RC-LH1 core complex from Rhodopseudomonas palustris	SCIENCE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; LIGHT-HARVESTING COMPLEX; CYTOCHROME BC(1) COMPLEX; RHODOBACTER-SPHAEROIDES; PUFX PROTEIN; RHODOSPIRILLUM-RUBRUM; ALPHA-POLYPEPTIDE; RESOLUTION; CAPSULATUS; BACTERIA	The crystal structure at 4.8 angstrom resolution of the reaction center-light harvesting 1 (RC-LH1) core complex from Rhodopseudomonas palustris shows the reaction center surrounded by an oval LH1 complex that consists of 15 pairs of transmembrane helical alpha- and beta-apoproteins and their coordinated bacteriochlorophylls. Complete closure of the RC by the LH1 is prevented by a single transmembrane helix, out of register with the array of inner LH1 alpha-apoproteins. This break, located next to the binding site in the reaction center for the secondary electron acceptor ubiquinone (UQ(B)), may provide a portal through which UQ(B) can transfer electrons to cytochrome b/c(1).	Univ Glasgow, Inst Biomed & Life Sci, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Isaacs, NW (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland.		Gardiner, Alastair T/N-8385-2017; Law, Christopher/E-7174-2011	Southall, June/0000-0002-5496-1531				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15248, DOI 10.1021/bi00046a033; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15235, DOI 10.1021/bi00046a032; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; Cogdell RJ, 1996, PHOTOSYNTH RES, V48, P55, DOI 10.1007/BF00040996; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Frese RN, 2000, P NATL ACAD SCI USA, V97, P5197, DOI 10.1073/pnas.090083797; Fritzsch G, 2002, ACTA CRYSTALLOGR D, V58, P1660, DOI 10.1107/S0907444902014178; GALL A, 1994, THESIS U GLASGOW UK; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; McAuley KE, 2000, BIOCHEMISTRY-US, V39, P15032, DOI 10.1021/bi000557r; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MCGLYNN P, 1994, FEBS LETT, V349, P349, DOI 10.1016/0014-5793(94)00701-2; McGlynn P, 1996, J BIOL CHEM, V271, P3285, DOI 10.1074/jbc.271.6.3285; Moser CC, 2003, ADV PROTEIN CHEM, V63, P71; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Parkes-Loach PS, 2001, BIOCHEMISTRY-US, V40, P5593, DOI 10.1021/bi002580i; Recchia PA, 1998, BIOCHEMISTRY-US, V37, P11055, DOI 10.1021/bi980657l; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; Walz T, 1997, J MOL BIOL, V265, P107, DOI 10.1006/jmbi.1996.0714	29	561	604	6	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1969	1972		10.1126/science.1088892	http://dx.doi.org/10.1126/science.1088892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671305				2022-12-01	WOS:000187174000062
J	Gao, WT; Tamin, A; Soloff, A; D'Aiuto, L; Nwanegbo, E; Robbins, PD; Bellini, WJ; Barratt-Boyes, S; Gambotto, A				Gao, WT; Tamin, A; Soloff, A; D'Aiuto, L; Nwanegbo, E; Robbins, PD; Bellini, WJ; Barratt-Boyes, S; Gambotto, A			Effects of a SARS-associated coronavirus vaccine in monkeys	LANCET			English	Article							VIRUS	The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus. Here, we have investigated the ability of adenoviral delivery of codon-optimised SARS-CoV strain Urbani structural antigens spike protein S1 fragment, membrane protein, and nucleocapsid protein to induce virus-specific broad immunity in rhesus macaques. We immunised rhesus macaques intramuscularly with a combination of the three Ads-SARS-CoV vectors or a control vector and gave a booster vaccination on day 28. The vaccinated animals all had antibody responses against spike protein S1 fragment and T-cell responses against the nucleocapsid protein. All vaccinated animals showed strong neutralising antibody responses to SARS-CoV infection in vitro. These results show that an adenoviral-based vaccine can induce strong SARS-CoV-specific immune responses in the monkey, and hold promise for development of a protective vaccine against the SARS causal agent.	Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Div Infect Dis, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gambotto, A (corresponding author), Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Suite 412,300 Technol Dr, Pittsburgh, PA 15219 USA.			Soloff, Adam/0000-0002-1467-8168; Barratt Boyes, Simon/0000-0002-8869-4945; D'Aiuto, Leonardo/0000-0002-7102-2093	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066949] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL066949, U01 HL66949-01S1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anton IM, 1996, VIRUS RES, V46, P111, DOI 10.1016/S0168-1702(96)01390-1; BROWN K, IN PRESS J IMMUNOL; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5	5	210	246	0	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1895	1896		10.1016/S0140-6736(03)14962-8	http://dx.doi.org/10.1016/S0140-6736(03)14962-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667748	Bronze, Green Published			2022-12-01	WOS:000187011600012
J	Battin, TJ; Kaplan, LA; Newbold, JD; Hansen, CME				Battin, TJ; Kaplan, LA; Newbold, JD; Hansen, CME			Contributions of microbial biofilms to ecosystem processes in stream mesocosms	NATURE			English	Article							MASS-TRANSPORT; DEPOSITION; NITROGEN; SIZE	In many aquatic ecosystems, most microbes live in matrix-enclosed biofilms(1-3) and contribute substantially to energy flow and nutrient cycling. Little is known, however, about the coupling of structure and dynamics of these biofilms to ecosystem function(2). Here we show that microbial biofilms changed the physical and chemical microhabitat and contributed to ecosystem processes in 30-m-long stream mesocosms. Biofilm growth increased hydrodynamic transient storage-streamwater detained in quiescent zones, which is a major physical template for ecological processes in streams(4,5) - by 300% and the retention of suspended particles by 120%. In addition, by enhancing the relative uptake of organic molecules of lower bioavailability, the interplay of biofilm microarchitecture and mass transfer changed their downstream linkage. As living zones of transient storage, biofilms bring hydrodynamic retention and biochemical processing into close spatial proximity and influence biogeochemical processes and patterns in streams. Thus, biofilms are highly efficient and successful ecological communities that may also contribute to the influence that headwater streams have on rivers, estuaries and even oceans(6,7) through longitudinal linkages of local biogeochemical and hydrodynamic processes.	Univ Vienna, IECB, Dept Limnol, A-1090 Vienna, Austria; Stroud Water Res Ctr, Avondale, PA 19311 USA; Univ Innsbruck, Inst Limnol & Zool, A-6020 Innsbruck, Austria	University of Vienna; University of Innsbruck	Battin, TJ (corresponding author), Univ Vienna, IECB, Dept Limnol, Waehringer Guertel 18, A-1090 Vienna, Austria.	tomba@pflaphy.pph.univie.ac.at	BAttin, Tom/H-7971-2012					Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Battin TJ, 2003, APPL ENVIRON MICROB, V69, P5443, DOI 10.1128/AEM.69.9.5443-5452.2003; Cheng XH, 2001, ANAL CHEM, V73, P458, DOI 10.1021/ac001059r; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DRURY WJ, 1993, WATER RES, V27, P1119, DOI 10.1016/0043-1354(93)90003-Z; GANTZER CJ, 1988, WATER RES, V22, P709, DOI 10.1016/0043-1354(88)90182-0; Gomi T, 2002, BIOSCIENCE, V52, P905, DOI 10.1641/0006-3568(2002)052[0905:UPADLO]2.0.CO;2; Grady Jr C.L., 2011, BIOL WASTEWATER TREA; Jones J.B., 2000, STREAMS GROUND WATER; Kaplan L.A., 2003, AQUATIC ECOSYSTEMS I, P97; KIM BK, 1990, WATER RESOUR RES, V26, P505, DOI 10.1029/WR026i003p00505; KUGAPRASATHAM S, 1992, WATER RES, V26, P1629, DOI 10.1016/0043-1354(92)90162-W; Lawrence JR, 1998, J MICROBIOL METH, V32, P253, DOI 10.1016/S0167-7012(98)00027-X; Minshall GW, 2000, J N AM BENTHOL SOC, V19, P1, DOI 10.2307/1468278; MULHOLLAND PJ, 1994, OECOLOGIA, V98, P40, DOI 10.1007/BF00326088; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; Packman AI, 2000, WATER RESOUR RES, V36, P2351, DOI 10.1029/2000WR900059; Palmer RJ, 1997, TRENDS MICROBIOL, V5, P435, DOI 10.1016/S0966-842X(97)01142-6; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Picioreanu C, 2000, BIOTECHNOL BIOENG, V68, P355, DOI 10.1002/(SICI)1097-0290(20000520)68:4<355::AID-BIT1>3.0.CO;2-A; RUNKLE RL, 1998, 984018 US GEOL SURV; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Thomas SA, 2001, LIMNOL OCEANOGR, V46, P1415, DOI 10.4319/lo.2001.46.6.1415; Yang XM, 2000, J MICROBIOL METH, V39, P109, DOI 10.1016/S0167-7012(99)00097-4	24	510	521	11	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					439	442		10.1038/nature02152	http://dx.doi.org/10.1038/nature02152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647381				2022-12-01	WOS:000186800800037
J	Michael, TP; Salome, PA; Yu, HJ; Spencer, TR; Sharp, EL; McPeek, MA; Alonso, JM; Ecker, JR; McClung, CR				Michael, TP; Salome, PA; Yu, HJ; Spencer, TR; Sharp, EL; McPeek, MA; Alonso, JM; Ecker, JR; McClung, CR			Enhanced fitness conferred by naturally occurring variation in the circadian clock	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; ABERRANT EXPRESSION; GENE; LIGHT; RHYTHMS; PACEMAKER; RESPONSES; PLANTS; TIME	Natural variation in clock parameters is necessary for the circadian clock to contribute to organismal fitness over a broad geographic range. Considerable variation is evident in the period, phase, and amplitude of 150 Arabidopsis accessions, and the period length is correlated with the day length at the latitude of origin, implying the adaptive significance of correctly regulated circadian timing. Quantitative trait loci analysis of recombinant inbred lines indicates that multiple loci interact to determine period, phase, and amplitude. The loss-of-function analysis of each member of the ARABIDOPSIS PSEUDO-RESPONSE REGULATOR family suggests that they are candidates for clock quantitative trait loci.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Dartmouth College; Salk Institute	McClung, CR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	mcclung@dartmouth.edu	Alonso, Jose M/K-6826-2014; Salome, Patrice/E-5702-2017; McPeek, Mark/AAE-2784-2022; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895; Michael, Todd/0000-0001-6272-2875; McClung, C. Robertson/0000-0002-7875-3614				Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Borevitz JO, 2002, GENETICS, V160, P683; CLARKE JH, 1995, MOL GEN GENET, V248, P278, DOI 10.1007/BF02191594; Costa R, 1998, CURR OPIN NEUROBIOL, V8, P659, DOI 10.1016/S0959-4388(98)80096-2; Daido H, 2002, J THEOR BIOL, V217, P425, DOI 10.1006/jtbi.2002.3050; DeCoursey PJ, 2000, J COMP PHYSIOL A, V186, P169, DOI 10.1007/s003590050017; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Matsushika A, 2002, PLANT CELL PHYSIOL, V43, P833, DOI 10.1093/pcp/pcf118; MCCLUNG CR, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0044; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Miyashita NT, 1999, GENETICS, V152, P1723; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; Sato E, 2002, PLANT CELL PHYSIOL, V43, P1374, DOI 10.1093/pcp/pcf166; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Somers DE, 1998, DEVELOPMENT, V125, P485; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; Weinig C, 2003, MOL ECOL, V12, P1153, DOI 10.1046/j.1365-294X.2003.01787.x; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	30	330	339	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1049	1053		10.1126/science.1082971	http://dx.doi.org/10.1126/science.1082971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605371				2022-12-01	WOS:000186396300050
J	Walvoord, MA; Phillips, FM; Stonestrom, DA; Evans, RD; Hartsough, PC; Newman, BD; Striegl, RG				Walvoord, MA; Phillips, FM; Stonestrom, DA; Evans, RD; Hartsough, PC; Newman, BD; Striegl, RG			A reservoir of nitrate beneath desert soils	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; GLOBAL PATTERNS; NITROGEN-CYCLE; WATER; IMPACTS; STATES	A large reservoir of bioavailable nitrogen (up to -10(4) kilograms of nitrogen per hectare, as nitrate) has been previously overlooked in studies of global nitrogen distribution. The reservoir has been accumulating in subsoil zones of arid regions throughout the Holocene. Consideration of the subsoil reservoir raises estimates of vadose-zone nitrogen inventories by 14 to 71% for warm deserts and arid shrublands worldwide and by 3 to 16% globally. Subsoil nitrate accumulation indicates long-term leaching from desert soils, impelling further evaluation of nutrient dynamics in xeric ecosystems. Evidence that subsoil accumulations are readily mobilized raises concern about groundwater contamination after land-use or climate change.	US Geol Survey, Lakewood, CO 80225 USA; New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; Univ Nevada, Grad Program Hydrol Sci, Reno, NV 89557 USA; Desert Res Inst, Reno, NV 89512 USA; Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA	United States Department of the Interior; United States Geological Survey; New Mexico Institute of Mining Technology; United States Department of the Interior; United States Geological Survey; Washington State University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; United States Department of Energy (DOE); Los Alamos National Laboratory	Walvoord, MA (corresponding author), US Geol Survey, Lakewood, CO 80225 USA.	walvoord@usgs.gov	Evans, Raymond D/A-8829-2010; Stonestrom, David/E-9125-2011; Hartsough, Peter C./B-6104-2008; Walvoord, Michelle/AAQ-1137-2020	Evans, Raymond D/0000-0002-0446-2806; Stonestrom, David/0000-0001-7883-3385; Walvoord, Michelle/0000-0003-4269-8366; Hartsough, Peter/0000-0001-7888-8028				Ainsworth CC, 2000, VADOSE ZONE SCIENCE AND TECHNOLOGY SOLUTIONS, VOLS I AND II, P829; [Anonymous], [No title captured]; BORING LR, 1988, BIOGEOCHEMISTRY, V6, P119, DOI 10.1007/BF00003034; BOWDEN WB, 1986, BIOGEOCHEMISTRY, V2, P249, DOI 10.1007/BF02180161; BOYCE JS, 1976, FARM RANCH HOME Q, V22, P2; Canter LW., 1997, NITRATES GROUNDWATER; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; EVANS RD, 1994, OECOLOGIA, V99, P233, DOI 10.1007/BF00627735; EVANS RD, 1993, OECOLOGIA, V94, P314, DOI 10.1007/BF00317104; EVANS RML, UNPUB; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gebauer RLE, 2000, ECOLOGY, V81, P1415, DOI 10.1890/0012-9658(2000)081[1415:WANUPF]2.0.CO;2; GUTIERREZ JR, 1987, ECOLOGY, V68, P2032, DOI 10.2307/1939894; Hartsough P, 2001, GEOPHYS RES LETT, V28, P2955, DOI 10.1029/2000GL011823; HESS JW, 1977, PUBLICATION U NEVADA, V32; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; KLEIN JM, 1979, 7960 US GEOL SURV; LAJTHA K, 1987, BIOGEOCHEMISTRY, V4, P265, DOI 10.1007/BF02187370; McMahon P.B., 2003, WATER MOVEMENT THICK, DOI [10.3133/wri034171, DOI 10.3133/WRI034171]; NEWMAN B, UNPUB; Nolan BT, 2000, ENVIRON SCI TECHNOL, V34, P1156, DOI 10.1021/es9907663; PETERJOHN WT, 1990, BIOGEOCHEMISTRY, V10, P67; PHILLIPS FM, 1994, SOIL SCI SOC AM J, V58, P15, DOI 10.2136/sssaj1994.03615995005800010003x; POST WM, 1985, NATURE, V317, P613, DOI 10.1038/317613a0; RICE RC, 1989, GROUND WATER, V27, P813, DOI 10.1111/j.1745-6584.1989.tb01045.x; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SCHMIDT S, UNPUB; Stonestrom D.A., 2003, 03104 US GEOL SURV; Van Devender T. R., 1987, N AM ADJACENT OCEANS, P323; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Walvoord MA, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000824; Walvoord MA, 2002, THESIS NEW MEXICO I; West NE, 1978, NITROGEN DESERT ECOS; ZINKE PJ, 1984, TM8857 ORNL	34	264	277	3	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1021	1024		10.1126/science.1086435	http://dx.doi.org/10.1126/science.1086435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605364				2022-12-01	WOS:000186396300040
J	Hinds, BJ; Chopra, N; Rantell, T; Andrews, R; Gavalas, V; Bachas, LG				Hinds, BJ; Chopra, N; Rantell, T; Andrews, R; Gavalas, V; Bachas, LG			Aligned multiwalled carbon nanotube membranes	SCIENCE			English	Article							ARRAYS	An array of aligned carbon nanotubes (CNTs) was incorporated across a polymer film to form a well-ordered nanoporous membrane structure. This membrane structure was confirmed by electron microscopy, anisotropic electrical conductivity, gas flow, and ionic transport studies. The measured nitrogen permeance was consistent with the flux calculated by Knudsen diffusion through nanometer-scale tubes of the observed microstructure. Data on Ru(NH3)(6)(3+) transport across the membrane in aqueous solution also indicated transport through aligned CNT cores of the observed microstructure. The lengths of the nanotubes within the polymer film were reduced by selective electrochemical oxidation, allowing for tunable pore lengths. Oxidative trimming processes resulted in carboxylate end groups that were readily functionalized at the entrance to each CNT inner core. Membranes with CNT tips that were functionalized with biotin showed a reduction in Ru(NH3)(6)(3+) flux by a factor of 15 when bound with streptavidin, thereby demonstrating the ability to gate molecular transport through CNT cores for potential applications in chemical separations and sensing.	Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Ctr Appl Energy Res, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; University of Kentucky	Hinds, BJ (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.		Nitin, Chopra/F-8236-2011; Bachas, Leonidas G/G-2479-2015	Bachas, Leonidas/0000-0002-3308-6264				Ago H, 2000, APPL PHYS LETT, V77, P79, DOI 10.1063/1.126883; Andrews R, 1999, CHEM PHYS LETT, V303, P467, DOI 10.1016/S0009-2614(99)00282-1; Asefa T, 1999, NATURE, V402, P867, DOI 10.1038/47229; Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903; Casavant MJ, 2003, J APPL PHYS, V93, P2153, DOI 10.1063/1.1536732; Cheung CL, 2002, J PHYS CHEM B, V106, P2429, DOI 10.1021/jp0142278; Hamon MA, 2002, APPL PHYS A-MATER, V74, P333, DOI 10.1007/s003390201281; Huang SM, 2002, J PHYS CHEM B, V106, P3543, DOI 10.1021/jp014047y; Ito T, 2003, ELECTROCHEM SOLID ST, V6, pC4, DOI 10.1149/1.1526779; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Kanzow H, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125402; Klein E, 2000, J MEMBRANE SCI, V179, P1, DOI 10.1016/S0376-7388(00)00514-7; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Merkulov VI, 2002, APPL PHYS LETT, V80, P4816, DOI 10.1063/1.1487920; Miller SA, 2002, J ELECTROANAL CHEM, V522, P66, DOI 10.1016/S0022-0728(02)00648-4; Nguyen CV, 2002, NANO LETT, V2, P1079, DOI 10.1021/nl025689f; Pages X, 2001, SEP PURIF TECHNOL, V25, P399, DOI 10.1016/S1383-5866(01)00068-5; Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500; Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105; Steinle ED, 2002, ANAL CHEM, V74, P2416, DOI 10.1021/ac020024j; Sun L, 2000, J AM CHEM SOC, V122, P12340, DOI 10.1021/ja002429w; Thurn-Albrecht T, 2000, ADV MATER, V12, P787, DOI 10.1002/(SICI)1521-4095(200006)12:11<787::AID-ADMA787>3.0.CO;2-1; WIPF DO, 1988, ANAL CHEM, V60, P306, DOI 10.1021/ac00155a006; Zhang ZJ, 2000, APPL PHYS LETT, V77, P3764, DOI 10.1063/1.1330751	24	1128	1185	16	830	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					62	65		10.1126/science.1092048	http://dx.doi.org/10.1126/science.1092048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14645855				2022-12-01	WOS:000187710600031
J	Lyuksyutova, AI; Lu, CC; Milanesio, N; King, LA; Guo, NN; Wang, YS; Nathans, J; Tessier-Lavigne, M; Zou, YM				Lyuksyutova, AI; Lu, CC; Milanesio, N; King, LA; Guo, NN; Wang, YS; Nathans, J; Tessier-Lavigne, M; Zou, YM			Anterior-posterior guidance of commissural Axons by Wnt-frizzled signaling	SCIENCE			English	Article							SONIC HEDGEHOG; SPINAL-CORD; FLOOR PLATE; CHEMOATTRACTANT; MECHANISMS; NETRIN-1; RECEPTOR	Commissural neurons in the mammalian dorsal spinal cord send axons ventrally toward the floor plate, where they cross the midline and turn anteriorly toward the brain; a gradient of chemoattractant(s) inside the spinal cord controls this turning. In rodents, several Wnt proteins stimulate the extension of commissural axons after midline crossing (postcrossing). We found that Wnt4 messenger RNA is expressed in a decreasing anterior-to-posterior gradient in the floor plate, and that a directed source of Wnt4 protein attracted postcrossing commissural axons. Commissural axons in mice lacking the Wnt receptor Frizzled3 displayed anterior-posterior guidance defects after midline crossing. Thus, Wnt-Frizzled signaling guides commissural axons along the anterior-posterior axis of the spinal cord.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University	Zou, YM (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	yzou@bsd.uchicago.edu		Nathans, Jeremy/0000-0001-8106-5460	NINDS NIH HHS [R01 NS047484] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Liu AP, 2000, MECH DEVELOP, V91, P409, DOI 10.1016/S0925-4773(99)00308-1; LYUKSYUTOVA AI, UNPUB; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang YS, 2002, J NEUROSCI, V22, P8563; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	16	439	447	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1984	1988		10.1126/science.1089610	http://dx.doi.org/10.1126/science.1089610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671310				2022-12-01	WOS:000187174000067
J	Nef, S; Verma-Kurvari, S; Merenmies, J; Vassalli, JD; Efstratiadis, A; Accili, D; Parada, LF				Nef, S; Verma-Kurvari, S; Merenmies, J; Vassalli, JD; Efstratiadis, A; Accili, D; Parada, LF			Testis determination requires insulin receptor family function in mice	NATURE			English	Article							SEX DETERMINATION; SRY EXPRESSION; GENE; REVERSAL; PROLIFERATION; LACKING	In mice, gonads are formed shortly before embryonic day 10.5 by the thickening of the mesonephros and consist of somatic cells and migratory primordial germ cells(1). The male sex-determining process is set in motion by the sex-determining region of the Y chromosome (Sry), which triggers differentiation of the Sertoli cell lineage. In turn, Sertoli cells function as organizing centres and direct differentiation of the testis. In the absence of Sry expression, neither XX nor XY gonads develop testes(2), and alterations in Sry expression are often associated with abnormal sexual differentiation(3-8). The molecular signalling mechanisms by which Sry specifies the male pathway and models the undifferentiated gonad are unknown. Here we show that the insulin receptor tyrosine kinase family, comprising Ir, Igf1r and Irr, is required for the appearance of male gonads and thus for male sexual differentiation. XY mice that are mutant for all three receptors develop ovaries and show a completely female phenotype. Reduced expression of both Sry and the early testis-specific marker Sox9 indicates that the insulin signalling pathway is required for male sex determination.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Geneva, Dept Morphol, Ctr Med Univ, CH-1211 Geneva 4, Switzerland; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Geneva; Columbia University; Columbia University; Columbia University	Parada, LF (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Nef, Serge/AAV-6445-2020; Parada, luis F/B-9400-2014	Nef, Serge/0000-0001-5462-0676; 				Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Albrecht KH, 2003, GENETICS, V164, P277; Burgoyne PS, 1993, GONADAL DEV FUNCTION, P17; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; Capel B, 2000, MECH DEVELOP, V92, P89, DOI 10.1016/S0925-4773(99)00327-5; Clarkson MJ, 2002, TRENDS ENDOCRIN MET, V13, P106, DOI 10.1016/S1043-2760(01)00541-0; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; LEE CH, 1994, DEV BIOL, V165, P442, DOI 10.1006/dbio.1994.1266; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Scherer G, 1999, CELL MOL LIFE SCI, V55, P821, DOI 10.1007/s000180050335; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmahl J, 2003, DEV BIOL, V258, P264, DOI 10.1016/S0012-1606(03)00122-2; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Washburn LL, 2001, GENETICS, V158, P1675	27	202	210	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					291	295		10.1038/nature02059	http://dx.doi.org/10.1038/nature02059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628051				2022-12-01	WOS:000186660800044
J	Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S				Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S			Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines	LANCET			English	Article							DENDRITIC CELLS; RECONSTITUTION; ANTIGEN	Adoptive transfer of CMV-specific T cells offers the potential for reconstitution of viral immunity after allogeneic transplantation. However, the logistics of producing virus-specific T-cell clones has limited the application of cellular therapies. We treated 16 patients for CMV infection with polyclonal CMV-specific T-cell lines generated by short-term culture. Massive in-vivo expansions of CMV-specific cytotoxic T lymphocytes were observed, resulting in reconstitution of viral immunity. In eight cases antiviral drugs were not required, and subsequent episodes of reactivation occurred in only two patients. Our findings indicate that application of CMV-specific cell lines is both feasible and effective in a clinical environment.	UCL Royal Free & UCL Med Sch, Dept Haematol, London WC1E 6HX, England; Univ Birmingham, CR UK Inst Canc Studies, Birmingham, W Midlands, England; Publ Hlth Lab Serv, Dept Virol, Manchester, Lancs, England	University of London; University College London; University of Birmingham	Peggs, KS (corresponding author), UCL Royal Free & UCL Med Sch, Dept Haematol, London WC1E 6HX, England.	kpeggs@hotmail.com	Mackinnon, Stephen/C-5559-2008; Wilson, Matthew H/K-3193-2013; Moss, Paul/D-1728-2009; PEGGS, Karl/B-3869-2009; Pizzey, Arnold/E-6301-2015	Moss, Paul/0000-0002-6895-1967; Pizzey, Arnold/0000-0003-1850-1121				Chakrabarti S, 2002, BLOOD, V99, P4357, DOI 10.1182/blood.V99.12.4357; Cwynarski K, 2001, BLOOD, V97, P1232, DOI 10.1182/blood.V97.5.1232; Peggs K, 2002, BLOOD, V99, P213, DOI 10.1182/blood.V99.1.213; Peggs K, 2001, BLOOD, V97, P994, DOI 10.1182/blood.V97.4.994; RIDDELL SR, 1992, SCIENCE, V257, P238	5	377	388	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2003	362	9393					1375	1377		10.1016/S0140-6736(03)14634-X	http://dx.doi.org/10.1016/S0140-6736(03)14634-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585640				2022-12-01	WOS:000186143300012
J	Yu, XC; Chini, CCS; He, M; Mer, G; Chen, JJ				Yu, XC; Chini, CCS; He, M; Mer, G; Chen, JJ			The BRCT domain is a phospho-protein binding domain	SCIENCE			English	Article							DNA-DAMAGE; CHECKPOINT; REPAIR; FHA	The carboxyl-terminal domain (BRCT) of the Breast Cancer Gene 1 (BRCA1) protein is an evolutionarily conserved module that exists in a large number of proteins from prokaryotes to eukaryotes. Although most BRCT domain-containing proteins participate in DNA-damage checkpoint or DNA-repair pathways, or both, the function of the BRCT domain is not fully understood. We show that the BRCA1 BRCT domain directly interacts with phosphorylated BRCA1-Associated Carboxyl-terminal Helicase (BACH1). This specific interaction between BRCA1 and phosphorylated BACH1 is cell cycle regulated and is required for DNA damage-induced checkpoint control during the transition from G(2) to M phase of the cell cycle. Further, we show that two other BRCT domains interact with their respective physiological partners in a phosphorylation-dependent manner. Thirteen additional BRCT domains also preferentially bind phospho-peptides rather than nonphosphorylated control peptides. These data imply that the BRCT domain is a phospho-protein binding domain involved in cell cycle control.	Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Chen, JJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA.		Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578	NATIONAL CANCER INSTITUTE [R01CA089239, R01CA092312] Funding Source: NIH RePORTER; NCI NIH HHS [CA89239, CA92312] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen YM, 1996, CANCER RES, V56, P3168; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612	15	657	668	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					639	642		10.1126/science.1088753	http://dx.doi.org/10.1126/science.1088753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576433				2022-12-01	WOS:000186119900058
J	Nobrega, MA; Ovcharenko, I; Afzal, V; Rubin, EM				Nobrega, MA; Ovcharenko, I; Afzal, V; Rubin, EM			Scanning human gene deserts for long-range enhancers	SCIENCE			English	Article							DROSOPHILA DACHSHUND; EXPRESSION		US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nobrega, MA (corresponding author), US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA.				NHLBI NIH HHS [HL66728] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066728] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Caubit X, 1999, DEV DYNAM, V214, P66, DOI 10.1002/(SICI)1097-0177(199901)214:1<66::AID-DVDY7>3.0.CO;2-7; Davis RJ, 1999, DEV GENES EVOL, V209, P526, DOI 10.1007/s004270050285; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Machon O, 2002, NEUROSCIENCE, V112, P951, DOI 10.1016/S0306-4522(02)00053-2	6	464	484	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					413	413		10.1126/science.1088328	http://dx.doi.org/10.1126/science.1088328			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14563999	Green Submitted			2022-12-01	WOS:000185963200032
J	Pearson, BJ; Doe, CQ				Pearson, BJ; Doe, CQ			Regulation of neuroblast competence in Drosophila	NATURE			English	Article							CELL-FATE DETERMINATION; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTORS; CEREBRAL-CORTEX; RETINA; CNS; PROJECTIONS; SEQUENCE; LINEAGES; BINDING	Individual neural progenitors generate different cell types in a reproducible order in the retina(1-3), cerebral cortex(4-6) and probably in the spinal cord(7). It is unknown how neural progenitors change over time to generate different cell types. It has been proposed that progenitors undergo progressive restriction(8) or transit through distinct competence states(9,10); however, the underlying molecular mechanisms remain unclear. Here we investigate neural progenitor competence and temporal identity using an in vivo genetic system-Drosophila neuroblasts-where the Hunchback transcription factor is necessary and sufficient to specify early-born cell types(11). We show that neuroblasts gradually lose competence to generate early-born fates in response to Hunchback, similar to progressive restriction models(8), and that competence to acquire early-born fates is present in mitotic precursors but is lost in post-mitotic neurons. These results match those observed in vertebrate systems, and establish Drosophila neuroblasts as a model system for the molecular genetic analysis of neural progenitor competence and plasticity.	Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci & Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci & Mol Biol, Eugene, OR 97403 USA.			Pearson, Bret/0000-0002-3473-901X				ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BUENZOW DE, 1995, DEV BIOL, V170, P338, DOI 10.1006/dbio.1995.1219; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Desai AR, 2000, DEVELOPMENT, V127, P2863; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Landgraf M, 1997, J NEUROSCI, V17, P9642; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MCCONNELL SK, 1989, TRENDS NEUROSCI, V12, P342, DOI 10.1016/0166-2236(89)90041-6; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rapaport DH, 2001, J NEUROBIOL, V49, P129, DOI 10.1002/neu.1070; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; Schmid A, 1999, DEVELOPMENT, V126, P4653; Skeath JB, 1998, DEVELOPMENT, V125, P1857; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Yang XH, 1997, GENE DEV, V11, P1396, DOI 10.1101/gad.11.11.1396; ZHANG CC, 1992, P NATL ACAD SCI USA, V89, P7511, DOI 10.1073/pnas.89.16.7511; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	23	160	162	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2003	425	6958					624	628		10.1038/nature01910	http://dx.doi.org/10.1038/nature01910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534589				2022-12-01	WOS:000185801000039
J	Winter, Y; Lopez, J; von Helversen, O				Winter, Y; Lopez, J; von Helversen, O			Ultraviolet vision in a bat	NATURE			English	Article							PHOTORECEPTORS; SENSITIVITY; LIGHT	Most mammals, with the exception of primates, have dichromatic vision and correspondingly limited colour perception(1). Ultraviolet vision was discovered in mammals only a decade ago(2), and in the few rodents and marsupials where it has been found, ultraviolet light is detected by an independent photoreceptor(2,3). Bats orient primarily by echolocation, but they also use vision. Here we show that a phyllostomid flower bat, Glossophaga soricina, is colour-blind but sensitive to ultraviolet light down to a wavelength of 310 nm. Behavioural experiments revealed a spectral-sensitivity function with maxima at 510 nm (green) and above 365 nm (ultraviolet). A test for colour vision was negative. Chromatic adaptation had the same threshold-elevating effects on ultraviolet and visible test lights, indicating that the same photoreceptor is responsible for both response peaks (ultraviolet and green). Thus, excitation of the beta-band of the visual pigment is the most likely cause of ultraviolet sensitivity. This is a mechanism for ultraviolet vision that has not previously been demonstrated in intact mammalian visual systems.	Univ Munich, Dept Biol, D-80333 Munich, Germany; Max Planck Res Ctr Ornithol, D-82305 Seewiesen, Germany; Univ San Carlos, Escuela Biol, Guatemala City 01012, Guatemala; Univ Erlangen Nurnberg, Inst Zool, D-91058 Erlangen, Germany	University of Munich; Max Planck Society; Universidad de San Carlos de Guatemala; University of Erlangen Nuremberg	Winter, Y (corresponding author), Univ Munich, Dept Biol, Luisenstr 14, D-80333 Munich, Germany.	winter@zi.biologie.uni-muenchen.de	Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Winter, York/0000-0002-7828-1872				Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Biedinger N, 1993, TROP SUBTROP PFLANZE, V86, P1; CHASE J, 1983, ANIM BEHAV, V31, P526, DOI 10.1016/S0003-3472(83)80075-X; Douglas R.H., 1999, P95; Dyer AG, 1999, J COMP PHYSIOL A, V185, P445, DOI 10.1007/s003590050405; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; GRISWOLD MS, 1992, VISION RES, V32, P1739, DOI 10.1016/0042-6989(92)90166-G; JACOBS GH, 1992, AM ZOOL, V32, P544; JACOBS GH, 1994, VISION RES, V34, P1433, DOI 10.1016/0042-6989(94)90144-9; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; KIRSCHFELD K, 1982, PROC R SOC SER B-BIO, V216, P71, DOI 10.1098/rspb.1982.0061; MORTON RA, 1972, HDB SENSORY PHYSIOLO, V7, P33; NEUMEYER C, 1988, FARBENSEHEN GOLDFISC; REMY M, 1989, BEHAV NEUROSCI, V103, P170, DOI 10.1037/0735-7044.103.1.170; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; SUTHERS R, 1969, BIOL BULL, V137, P535, DOI 10.2307/1540174; VONCAMPENHAUSE C, 1986, NATURWISSENSCHAFTEN, V73, P674; Winter Y, 1999, J EXP BIOL, V202, P1917	19	103	107	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2003	425	6958					612	614		10.1038/nature01971	http://dx.doi.org/10.1038/nature01971			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534585				2022-12-01	WOS:000185801000035
J	Sharma, MR; Koc, EC; Datta, PP; Booth, TM; Spremulli, LL; Agrawal, RK				Sharma, MR; Koc, EC; Datta, PP; Booth, TM; Spremulli, LL; Agrawal, RK			Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins	CELL			English	Article							COLI 70S RIBOSOME; 3-DIMENSIONAL CRYOELECTRON MICROSCOPY; TRANSFER-RNA; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; COMPARATIVE SEQUENCE; TRANSLATION SYSTEM; CRYSTAL-STRUCTURE; MESSENGER-RNA	The mitochondrial ribosome is responsible for the biosynthesis of protein components crucial to the generation of ATP in the eukaryotic cell. Because the protein:RNA ratio in the mitochondrial ribosome (similar to69:similar to31) is the inverse of that of its prokaryotic counterpart (similar to33:similar to67), it was thought that the additional and/or larger proteins of the mitochondrial ribosome must compensate for the shortened rRNAs. Here, we present a three-dimensional cryo-electron microscopic map of the mammalian mitochondrial 55S ribosome carrying a tRNA at its P site, and we find that instead, many of the proteins occupy new positions in the ribosome. Furthermore, unlike cytoplasmic ribosomes, the mitochondrial ribosome possesses inter-subunit bridges composed largely of proteins; it has a gatelike structure at its mRNA entrance, perhaps involved in recruiting unique mitochondrial mRNAs; and it has a polypeptide exit tunnel that allows access to the solvent before the exit site, suggesting a unique nascent-polypeptide exit mechanism.	New York State Dept Hlth, Wadsworth Ctr, Div Mol Med, Albany, NY 12201 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA	State University of New York (SUNY) System; Wadsworth Center; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Agrawal, RK (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Mol Med, Empire State Plaza, Albany, NY 12201 USA.	agrawal@wadsworth.org			NIGMS NIH HHS [GM32734, R01 GM061576, GM61576] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734, R01GM061576] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Frank J, 2000, METHOD ENZYMOL, V317, P276; FRANK J, 2001, S QUANT BIOL, V66, P67; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Gray MW, 2001, GENOME BIOL, V2; Hanada T, 2001, GENES CELLS, V6, P1019, DOI 10.1046/j.1365-2443.2001.00491.x; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Mears JA, 2002, J MOL BIOL, V321, P215, DOI 10.1016/S0022-2836(02)00568-5; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; O'Brien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; OBRIEN TW, 1990, BIOCHIM BIOPHYS ACTA, V1050, P174, DOI 10.1016/0167-4781(90)90162-U; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; OJALA DK, 1980, NATURE, V287, P79, DOI 10.1038/287079a0; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Patel VB, 2001, J BIOL CHEM, V276, P6739, DOI 10.1074/jbc.M005781200; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; REMME J, 1989, EUR J BIOCHEM, V183, P281, DOI 10.1111/j.1432-1033.1989.tb14925.x; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2000, STRUCTURE, V8, P937, DOI 10.1016/S0969-2126(00)00185-4; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wittmann-Liebold B., 1985, STRUCTURE FUNCTION G, P326; WOLSTENHOLME D, 1992, ANIMAL MITOCHONDRIAL, P173; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	54	274	287	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2003	115	1					97	108		10.1016/S0092-8674(03)00762-1	http://dx.doi.org/10.1016/S0092-8674(03)00762-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532006	Bronze, Green Published			2022-12-01	WOS:000185815500012
J	Meyers, CD; Carr, MC; Park, S; Brunzell, JD				Meyers, CD; Carr, MC; Park, S; Brunzell, JD			Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED-RELEASE NIACIN; FULMINANT HEPATIC-FAILURE; CORONARY-ARTERY-DISEASE; LIPOPROTEIN LP(A); SERUM-CHOLESTEROL; MESO-INOSITOL; EFFICACY; SAFETY; THERAPY; NIASPAN	Background: Nicotinic acid is an effective treatment for dyslipidemia, but the content of over-the-counter niacin is not federally regulated. As a result, patients may use preparations of over-the-counter niacin that do not contain free nicotinic acid. Objective: To characterize the types, costs, and free nicotinic acid content of over-the-counter niacin preparations and to review literature on the use of over-the-counter niacin for dyslipidemia. Data Sources: Commonly used over-the-counter niacin preparations (500-mg tablets or capsules) from the 3 categories of immediate-release, sustained-release, and no-flush were purchased at health food stores and pharmacies and from Internet-based vitamin companies. Pertinent literature on the use of over-the-counter niacin was obtained by. searching PubMed. Measurements: For each preparation studied, the monthly cost of therapy (at 2000 mg/d) and the free nicotinic acid content (quantified by high-performance liquid chromatography) were reported. Data Synthesis: On average, immediate-release niacin preparations cost $7.10 per month, sustained-release preparations cost $9.75 per month, and no-flush preparations cost $21.70 per month. The average content of free nicotinic acid was 520.4 mg for immediate-release niacin, 502.6 mg for sustained-release niacin, and 0 for no-flush niacin. Conclusions: No-flush preparations of over-the-counter niacin contain no free nicotinic acid and should not be used to treat dyslipidemia. Over-the-counter sustained-release niacin contains free nicotinic acid, but some brands are hepatotoxic. Immediate-release niacin contains free nicotinic acid and is the least expensive form of over-the-counter niacin.	Univ Washington, Sch Med, Seattle, WA USA	University of Washington; University of Washington Seattle	Meyers, CD (corresponding author), Vet Affairs Med Ctr, 5901 E 7th St 11-111I, Long Beach, CA 90822 USA.	daniel.meyers@med.va.gov			NCRR NIH HHS [K23 RR16067] Funding Source: Medline; NHLBI NIH HHS [HL30086] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABOUELENEIN AM, 1983, NUTR REP INT, V28, P899; AGUSTI R, 1978, REV INVEST CLIN, V30, P327; ALDERMAN JD, 1989, AM J CARDIOL, V64, P725, DOI 10.1016/0002-9149(89)90754-6; ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Altschul R, 1964, NIACIN VASCULAR DISO; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Aronov DM, 1996, ARCH FAM MED, V5, P567, DOI 10.1001/archfami.5.10.567; Azen SP, 1996, CIRCULATION, V93, P34, DOI 10.1161/01.CIR.93.1.34; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Capuzzi D M, 2000, Curr Atheroscler Rep, V2, P64, DOI 10.1007/s11883-000-0096-y; Capuzzi DM, 1998, AM J CARDIOL, V82, p74U, DOI 10.1016/S0002-9149(98)00731-0; CARLSON LA, 1989, J INTERN MED, V226, P271, DOI 10.1111/j.1365-2796.1989.tb01393.x; CARLSON LA, 1968, ACTA MED SCAND, V183, P423; Chojnowska-Jezierska J, 1998, INT J CLIN PHARM TH, V36, P326; Cohn G, 2001, Curr Cardiol Rep, V3, P416; DALTON TA, 1992, AM J MED, V93, P102, DOI 10.1016/0002-9343(92)90689-9; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; ETCHASON JA, 1991, MAYO CLIN PROC, V66, P23, DOI 10.1016/S0025-6196(12)61171-9; FISCHER DJ, 1991, WESTERN J MED, V155, P410; GAUT ZN, 1971, METABOLISM, V20, P1031, DOI 10.1016/0026-0495(71)90026-6; GIBBONS LW, 1995, AM J MED, V99, P378, DOI 10.1016/S0002-9343(99)80185-5; GRAY DR, 1994, ANN INTERN MED, V121, P252, DOI 10.7326/0003-4819-121-4-199408150-00003; Grundy SM, 2002, ARCH INTERN MED, V162, P1568, DOI 10.1001/archinte.162.14.1568; GURAKAR A, 1985, ATHEROSCLEROSIS, V57, P293, DOI 10.1016/0021-9150(85)90041-3; HARTHON J G, 1964, Arzneimittelforschung, V14, P1170; HARTHON L, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1859; HENKIN Y, 1991, AM J MED, V91, P239, DOI 10.1016/0002-9343(91)90122-E; *I MED US STAND CO, 2000, PAN FOL OTH B VIT CH; KAHN SE, 1989, DIABETES, V38, P562, DOI 10.2337/diabetes.38.5.562; KEENAN JM, 1991, ARCH INTERN MED, V151, P1424, DOI 10.1001/archinte.151.7.1424; Knopp RH, 1998, METABOLISM, V47, P1097, DOI 10.1016/S0026-0495(98)90284-0; KNOPP RH, 1985, METABOLISM, V34, P642, DOI 10.1016/0026-0495(85)90092-7; KRUSE W, 1979, EUR J CLIN PHARMACOL, V16, P11, DOI 10.1007/BF00644960; MCKENNEY JM, 1994, JAMA-J AM MED ASSOC, V271, P672, DOI 10.1001/jama.271.9.672; MIYAUCHI Y, 1993, INT J VITAM NUTR RES, V63, P145; MULLIN GE, 1989, ANN INTERN MED, V111, P253, DOI 10.7326/0003-4819-111-3-253; PARSONS WB, 1961, ARCH INTERN MED, V107, P653, DOI 10.1001/archinte.1961.03620050019003; RADER JI, 1992, AM J MED, V92, P77, DOI 10.1016/0002-9343(92)90018-7; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; SIFTON DW, 2002, DRUG TOPICS RED BOOK; SOMMER H, 1965, ARZNEI-FORSCHUNG, V15, P1337; Spies TD, 1938, J AMER MED ASSOC, V110, P622, DOI 10.1001/jama.1938.02790090004002; SVEDMYR N, 1969, CLIN PHARMACOL THER, V10, P559; WAHLBERG G, 1990, J INTERN MED, V228, P151, DOI 10.1111/j.1365-2796.1990.tb00209.x; Ziliotto G R, 1977, Arch Sci Med (Torino), V134, P359; 1998, ALTERN MED REV, V3, P222	48	46	54	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					996	1002		10.7326/0003-4819-139-12-200312160-00009	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678919				2022-12-01	WOS:000187443200005
J	Dimitrov, DS				Dimitrov, DS			The secret life of ACE2 as a receptor for the SARS virus	CELL			English	Editorial Material							FUNCTIONAL-CHARACTERIZATION; CORONAVIRUS	The membrane-associated carboxypeptidase angiotensin-converting enzyme 2 (ACE2) is an essential regulator of heart function. Now, Li at al. identify and characterize an unexpected second function of ACE2 as a partner of the SARS-CoV spike glycoprotein in mediating virus entry and cell fusion.	NIH, NCI Frederick, CCR, LECB,Human Immunovirol & Computat Biol Grp, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Dimitrov, DS (corresponding author), NIH, NCI Frederick, CCR, LECB,Human Immunovirol & Computat Biol Grp, Ft Detrick, MD 21702 USA.							Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	8	99	105	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					652	653		10.1016/S0092-8674(03)00976-0	http://dx.doi.org/10.1016/S0092-8674(03)00976-0			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675530	Green Published, Bronze			2022-12-01	WOS:000187366100005
J	Mas, P; Kim, WY; Somers, DE; Kay, SA				Mas, P; Kim, WY; Somers, DE; Kay, SA			Targeted degradation of TOC1 by ZTL modulates circadian function in Arabidopsis thaliana	NATURE			English	Article							CLOCK; PROTEIN; PERIOD; RHYTHMS; DOMAINS; OXYGEN; SLIMB; LIGHT; TIME; SCF	The underlying mechanism of circadian rhythmicity appears to be conserved among organisms, and is based on negative transcriptional feedback loops forming a cellular oscillator ( or 'clock')(1,2). Circadian changes in protein stability, phosphorylation and subcellular localization also contribute to the generation and maintenance of this clock(1,2). In plants, several genes have been shown to be closely associated with the circadian system(3,4). However, the molecular mechanisms proposed to regulate the plant clock are mostly based on regulation at the transcriptional level(3,4). Here we provide genetic and molecular evidence for a role of ZEITLUPE (ZTL)(5-7) in the targeted degradation of TIMING OF CAB EXPRESSION 1 (TOC1)(8,9) in Arabidopsis thaliana (thale cress). The physical interaction of TOC1 with ZTL is abolished by the ztl-1 mutation, resulting in constitutive levels of TOC1 protein expression. The dark-dependent degradation of TOC1 protein requires functional ZTL, and is prevented by inhibiting the proteosome pathway. Our results show that the TOC1 - ZTL interaction is important in the control of TOC1 protein stability, and is probably responsible for the regulation of circadian period by the clock.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Ohio State Univ, Dept Plant Biol, Ctr Plant Biotechnol, Columbus, OH 43210 USA	Scripps Research Institute; University System of Ohio; Ohio State University	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Mas, Paloma/B-8215-2016; Somers, David E/A-9209-2010; Kay, Steve A/F-6025-2011	Mas, Paloma/0000-0002-3780-8041; Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	30	407	444	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					567	570		10.1038/nature02163	http://dx.doi.org/10.1038/nature02163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654842				2022-12-01	WOS:000186944300041
J	Brindle, P; Emberson, J; Lampe, F; Walker, M; Whincup, P; Fahey, T; Ebrahim, S				Brindle, P; Emberson, J; Lampe, F; Walker, M; Whincup, P; Fahey, T; Ebrahim, S			Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUAL PATIENT DATA; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; FOLLOW-UP; POPULATION; VALIDATION; RECOMMENDATIONS; STATEMENT; TRENDS	Objective To establish the predictive accuracy of the Framingham risk score for coronary heart disease in a representative British population. Design Prospective cohort study. Setting 24 towns in the United Kingdom. Participants 6643 British men aged 40-59 years and free from cardiovascular disease at entry into the British regional heart study. Main outcome measures Comparison of observed 10 year coronary heart disease mortality and event rates with predicted rates for each individual, using the relevant Framingham risk equation. Results Of 6643 men, 2.8% (95% confidence interval 2.4% to 3.2%) died from coronary heart disease compared with 4.1% predicted (relative overestimation 47%, P<0.0001). A fatal or non-fatal coronary heart disease event occurred in 10.2% (9.5% to 10.9%) of the men compared with 16.0% predicted (relative overestimation 57%, P<0.0001). These relative degrees of overestimation were similar at all levels of coronary heart disease risk, so that overestimation of absolute risk was greatest for those at highest risk. A simple adjustment provided an improved level of accuracy. In a "high risk score" approach, most cases occur in the low risk group. In this case, 84% of the deaths from coronary heart disease and non-fatal events occurred in the 93% of men classified at low risk (<30% in 10 years) by the Framingham score. Conclusion Guidelines for the primary prevention of coronary heart disease advocate offering preventive measures to individuals at high risk. Currently recommended risk scoring methods derived from the Framingham study significantly overestimate the absolute coronary risk assigned to individuals in the United Kingdom.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England; Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland	University of Bristol; University of London; University College London; UCL Medical School; St Georges University London; University of Dundee	Brindle, P (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	peter.brindle@bristol.ac.uk	Fahey, Tom/C-9367-2012; Lampe, Fiona/I-5826-2019	Fahey, Tom/0000-0002-5896-5783; Lampe, Fiona/0000-0001-6851-5471; Emberson, Jonathan/0000-0001-7792-9422; Whincup, Peter/0000-0002-5589-4107				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Brindle P, 2002, BRIT MED J, V325, P56, DOI 10.1136/bmj.325.7355.56; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Fodor JG, 2000, CAN MED ASSOC J, V162, P1441; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Hense H, 2003, EUR HEART J, V3, P1; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAURIER D, 1994, J CLIN EPIDEMIOL, V47, P1353, DOI 10.1016/0895-4356(94)90079-5; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MANTEL N, 1959, J NATL CANCER I, V22, P719; Menotti A, 2000, EUR HEART J, V21, P365, DOI 10.1053/euhj.1999.1864; Packard CJ, 1998, CIRCULATION, V97, P1440; PETERSON S, 2002, CHRISTIAN SCI M 0328, P1; Pocock SJ, 2001, BMJ-BRIT MED J, V323, P75, DOI 10.1136/bmj.323.7304.75; Ramachandran S, 2000, BRIT MED J, V320, P676, DOI 10.1136/bmj.320.7236.676; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; SHAPER AG, 1984, BRIT HEART J, V51, P595, DOI 10.1136/hrt.51.6.595; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Vanderpump MPJ, 1996, THYROID, V6, P155; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Wood D, 1998, HEART, V80, pS1	32	323	345	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2003	327	7426					1267	1270A		10.1136/bmj.327.7426.1267	http://dx.doi.org/10.1136/bmj.327.7426.1267			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644971	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000186948800020
J	Wang, XC; Wu, YC; Fadok, VA; Lee, MC; Gengyo-Ando, K; Cheng, LC; Ledwich, D; Hsu, PK; Chen, JY; Chou, BK; Henson, P; Mitani, S; Xue, D				Wang, XC; Wu, YC; Fadok, VA; Lee, MC; Gengyo-Ando, K; Cheng, LC; Ledwich, D; Hsu, PK; Chen, JY; Chou, BK; Henson, P; Mitani, S; Xue, D			Cell corpse engulfment mediated by C-elegans phosphatidylserine receptor through CED-5 and CED-12	SCIENCE			English	Article							CRKII/DOCK180/RAC PATHWAY; APOPTOTIC CELLS; GENERAL FEATURE; PHAGOCYTOSIS; CLEARANCE; MIGRATION; EXPOSURE; MACROPHAGES; ASYMMETRY	During apoptosis, phosphatidylserine, which is normally restricted to the inner lea. et of the plasma membrane, is exposed on the surface of apoptotic cells and has been suggested to act as an "eat-me" signal to trigger phagocytosis. It is unclear how phagocytes recognize phosphatidylserine. Recently, a putative phosphatidylserine receptor (PSR) was identified and proposed to mediate recognition of phosphatidylserine and phagocytosis. We report that psr-1, the Caenorhabditis elegans homolog of PSR, is important for cell corpse engulfment. In vitro PSR-1 binds preferentially phosphatidylserine or cells with exposed phosphatidylserine. In C. elegans, PSR-1 acts in the same cell corpse engulfment pathway mediated by intracellular signaling molecules CED-2 ( homologous to the human CrkII protein), CED-5 (DOCK180), CED-10 (Rac GTPase), and CED-12 (ELMO), possibly through direct interaction with CED-5 and CED-12. Our findings suggest that PSR-1 is likely an upstream receptor for the signaling pathway containing CED-2, CED-5, CED-10, and CED-12 proteins and plays an important role in recognizing phosphatidylserine during phagocytosis.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10617, Taiwan; Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; National Taiwan University; National Jewish Health; Tokyo Women's Medical University	Wu, YC (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	yichun@ntu.edu.tw; ding.xue@colorado.edu	Wu, Yi-Chun/F-7934-2012; Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019	Wu, Yi-Chun/0000-0002-8621-4098; XUE, DING/0000-0002-8429-8136				Ashman RF, 1995, IMMUNOL LETT, V48, P159, DOI 10.1016/0165-2478(95)02471-9; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; CHENG L, UNPUB; ELLIS RE, 1991, GENETICS, V129, P79; FADOK V, UNPUB; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shiratsuchi A, 1998, BIOCHEM BIOPH RES CO, V246, P549, DOI 10.1006/bbrc.1998.8663; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; vandenEijnde SM, 1997, CYTOMETRY, V29, P313, DOI 10.1002/(SICI)1097-0320(19971201)29:4<313::AID-CYTO8>3.0.CO;2-A; VandenEijnde SM, 1997, CELL DEATH DIFFER, V4, P311, DOI 10.1038/sj.cdd.4400241; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; WANG X, UNPUB; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	28	157	174	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1563	1566		10.1126/science.1087641	http://dx.doi.org/10.1126/science.1087641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645848	Green Published			2022-12-01	WOS:000186802200043
J	Barrenas, ML; Bratthall, A; Dahlgren, J				Barrenas, ML; Bratthall, A; Dahlgren, J			The thrifty phenotype hypothesis and hearing problems	BRITISH MEDICAL JOURNAL			English	Article							GROWTH; EAR		Univ Gothenburg, Inst Hlth Woman & Child, Dept Pediat, Goteborg Pediat Growth Res Ctr, S-41685 Gothenburg, Sweden	University of Gothenburg	Barrenas, ML (corresponding author), Univ Gothenburg, Inst Hlth Woman & Child, Dept Pediat, Goteborg Pediat Growth Res Ctr, S-41685 Gothenburg, Sweden.		Dahlgren, Jovanna/J-8558-2015	Andersson Barrenas, Marie-Louise/0000-0002-7051-1178				Barrenas ML, 2000, HEARING RES, V144, P21, DOI 10.1016/S0378-5955(00)00040-X; BJORNTORP P, 1995, METABOLISM S2, V44, pS38; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241	5	18	19	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 22	2003	327	7425					1199	1200		10.1136/bmj.327.7425.1199	http://dx.doi.org/10.1136/bmj.327.7425.1199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747BB	14630755	Green Published, Bronze			2022-12-01	WOS:000186784300018
J	Chen, CC; Lamping, KG; Nuno, DW; Barresi, R; Prouty, SJ; Lavoie, JL; Cribbs, LL; England, SK; Sigmund, CD; Weiss, RM; Williamson, RA; Hill, JA; Campbell, KP				Chen, CC; Lamping, KG; Nuno, DW; Barresi, R; Prouty, SJ; Lavoie, JL; Cribbs, LL; England, SK; Sigmund, CD; Weiss, RM; Williamson, RA; Hill, JA; Campbell, KP			Abnormal coronary function in mice deficient in alpha(1H) T-type Ca2+ channels	SCIENCE			English	Article							CALCIUM CHANNELS; VENTRICULAR MYOCYTES; SINOATRIAL NODE; SMOOTH-MUSCLE; GENE FAMILY; EXPRESSION; CURRENTS; ALPHA-1H; CELLS; SUBUNIT	Calcium ion (Ca2+) influx through voltage-gated Ca2+ channels is important for the regulation of vascular tone. Activation of L-type Ca2+ channels initiates muscle contraction; however, the role of T-type Ca2+ channels (T-channels) is not clear. We show that mice deficient in the alpha(1H) T-type Ca2+ channel (alpha(1) 3.2-null) have constitutively constricted coronary arterioles and focal myocardial fibrosis. Coronary arteries isolated from alpha(1) 3.2-null arteries showed normal contractile responses, but reduced relaxation in response to acetylcholine and nitroprusside. Furthermore, acute blockade of T-channels with Ni2+ prevented relaxation of wild-type coronary arteries. Thus, Ca2+ influx through alpha(1H) T-type Ca2+ channels is essential for normal relaxation of coronary arteries.	Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Vet Adm Med Ctr, Iowa City, IA 52242 USA; Loyola Univ, Med Ctr, Cardiovasc Inst, Maywood, IL 60153 USA; Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Loyola University Chicago; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA.		Sigmund, Curt D./W-1611-2019; Barresi, Rita/AAB-9569-2022; Chen, Chien-Chang/D-2023-2015; Lavoie, Julie/F-2288-2013	Sigmund, Curt D./0000-0002-1453-0921; Barresi, Rita/0000-0001-7351-959X; Chen, Chien-Chang/0000-0001-8850-4278; Lavoie, Julie/0000-0001-6316-2769; Campbell, Kevin/0000-0003-2066-5889				Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Bohn G, 2000, FEBS LETT, V481, P73, DOI 10.1016/S0014-5793(00)01979-7; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Guo W, 1998, J MOL CELL CARDIOL, V30, P1095, DOI 10.1006/jmcc.1998.0675; Gustafsson F, 2001, AM J PHYSIOL-HEART C, V280, pH582, DOI 10.1152/ajpheart.2001.280.2.H582; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hansen PB, 2001, CIRC RES, V89, P630, DOI 10.1161/hh1901.097126; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Lamping KG, 2000, AM J PHYSIOL-HEART C, V279, pH1906, DOI 10.1152/ajpheart.2000.279.4.H1906; Lee JH, 1999, J NEUROSCI, V19, P1912; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI200113310; NELSON MT, 1995, AM J PHYSIOL, V268, P799; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Perez-Reyes E, 1998, J BIOENERG BIOMEMBR, V30, P313, DOI 10.1023/A:1021981420839; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Schrier AD, 2001, AM J PHYSIOL-CELL PH, V280, pC265, DOI 10.1152/ajpcell.2001.280.2.C265; SEN L, 1994, CIRC RES, V75, P149, DOI 10.1161/01.RES.75.1.149; Son WY, 2002, DEV GROWTH DIFFER, V44, P181, DOI 10.1046/j.1440-169X.2002.00633.x; Talley EM, 1999, J NEUROSCI, V19, P1895	24	270	282	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1416	1418		10.1126/science.1089268	http://dx.doi.org/10.1126/science.1089268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631046				2022-12-01	WOS:000186683500058
J	Wood, E; Hogg, RS; Yip, B; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG				Wood, E; Hogg, RS; Yip, B; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG			Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4(+) cell count is 0.200 to 0.350 X 10(9) cells/L	ANNALS OF INTERNAL MEDICINE			English	Article							SOCIETY-USA PANEL; BASE-LINE; UPDATED RECOMMENDATIONS; DISEASE PROGRESSION; VIRAL LOAD; AIDS; TOXICITY; TRIAL; RNA	Background: The safety of delaying highly active antiretroviral therapy (HAART) in HIV-infected patients is uncertain when the CD4(+) cell count declines below 0.350 x 10(9) cells/L. Objective: To evaluate the effect of baseline CD4(+) cell count and adherence to HAART on survival rates. Design: Prospective observational study. Setting: Province-wide Canadian HlV/AIDS treatment program. Patients: 1422 HIV-infected persons initiating HAART between 1 August 1996 and 31 July 2000 and followed through 31 March 2002. Measurements: Patients were stratified by baseline CD4+ cell count and adherence level. Cumulative mortality rates were evaluated by using Kaplan-Meier methods and Cox regression-estimated adjusted relative hazards. Results: Kaplan-Meier analyses showed no survival benefit of starting HAART at a CD4(+) count of 0.200 x 10(9) cells/L or greater among adherent patients. Adjusted analysis showed that compared with adherent patients who initiated HAART at a CD4+ cell count of 0.350 x 10(9) cells/L or greater, nonadherent patients who initiated HAART when the CD4+ cell count was 0.200 to 0.349 x 109 cells/L had statistically elevated mortality rates (adjusted relative hazard, 2.56 [95% Cl, 1.36 to 4.84]; P = 0.004). However, compared with adherent patients who initiated HAART at a CD4(+) cell count of 0.350 x 109 cells/L or greater, adherent patients who initiated HAART when the CD4(+) cell count was 0.200 to 0.349 x 10(9) cells/L had statistically similar mortality rates (adjusted relative hazard, 0.82 [Cl, 0.45 to 1.49]; P > 0.2). Conclusions: Delaying HAART until the CD4(+) cell count falls to 0.200 x 10(9) cells/L does not increase the mortality rate in HIV-infected patients with good medication adherence. Mortality rates increase if HAART is initiated below 0.200 x 10(9) cells/L. Also, nonadherent patients have higher mortality rates than adherent patients with similar CD4(+) cell counts. Above a CD4(+) cell count of 0.200 x 10(9) cells/L, medication adherence is the critical determinant of survival, not the CD4(+) cell count at which HAART is begun.	Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Montaner, JSG (corresponding author), Univ British Columbia, St Pauls Hosp, AIDS Res Program, 667-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@hivnet.ubc.ca	Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488				Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; COX DR, 1972, J R STAT SOC B, V34, P187; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; FERRER E, 2003, 10 C RETR OPP INF BO; Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386; Grant LA, 2001, AIDS, V15, P2101, DOI 10.1097/00002030-200111090-00005; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Heath KV, 2001, AIDS, V15, P231, DOI 10.1097/00002030-200101260-00013; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; PALELLA F, 2002, 9 C RETR OPP INF SEA; Palepu A, 2001, AIDS, V15, P423, DOI 10.1097/00002030-200102160-00021; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phair JP, 2002, AIDS, V16, P2455, DOI 10.1097/00002030-200212060-00011; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; STERLING T, 2003, 10 C RETR OPP INF BO; Sterling TR, 2003, CLIN INFECT DIS, V36, P812, DOI 10.1086/367934; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; *US PUBL HLTH SERV, GUID US ANT AG HIV I; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009; WOOD E, 2003, IN PRESS J INFECT DI; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; 2001, HIV MED, V2, P276	33	303	306	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2003	139	10					810	816		10.7326/0003-4819-139-10-200311180-00008	http://dx.doi.org/10.7326/0003-4819-139-10-200311180-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744ZV	14623618				2022-12-01	WOS:000186663500004
J	Herzig, S; Hedrick, S; Morantte, I; Koo, SH; Galimi, F; Montminy, M				Herzig, S; Hedrick, S; Morantte, I; Koo, SH; Galimi, F; Montminy, M			CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma	NATURE			English	Article							GENE-EXPRESSION; RESPONSIVE ACTIVATOR; PROMOTER ANALYSIS; PROTEIN; GLUCONEOGENESIS; REVEALS; LIVER; HES-1	Fasting triggers a series of hormonal cues that promote energy balance by inducing glucose output and lipid breakdown in the liver(1). In response to pancreatic glucagon and adrenal cortisol, the cAMP-responsive transcription factor CREB activates gluconeogenic and fatty acid oxidation programmes by stimulating expression of the nuclear hormone receptor coactivator PGC-1 (refs 2-5). In parallel, fasting also suppresses lipid storage and synthesis ( lipogenic) pathways(1), but the underlying mechanism is unknown. Here we show that mice deficient in CREB activity have a fatty liver phenotype and display elevated expression of the nuclear hormone receptor PPAR-gamma, a key regulator of lipogenic genes(6,7). CREB inhibits hepatic PPAR-gamma expression in the fasted state by stimulating the expression of the Hairy Enhancer of Split (HES-1) gene, a transcriptional repressor that is shown here to be a mediator of fasting lipid metabolism in vivo. The coordinate induction of PGC-1 and repression of PPAR-gamma by CREB during fasting provides a molecular rationale for the antagonism between insulin and counter-regulatory hormones, and indicates a potential role for CREB antagonists as therapeutic agents in enhancing insulin sensitivity in the liver.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Galimi, Francesco/J-4238-2012; Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879; Herzig, Stephan/0000-0003-3950-3652				Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	27	234	250	0	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					190	193		10.1038/nature02110	http://dx.doi.org/10.1038/nature02110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614508				2022-12-01	WOS:000186517200046
J	Swingler, GH; Volmink, J; Ioannidis, JPA				Swingler, GH; Volmink, J; Ioannidis, JPA			Number of published systematic reviews and global burden of disease: database analysis	BRITISH MEDICAL JOURNAL			English	Article									Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece; Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa; Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of Ioannina; University of Cape Town; University of Cape Town	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece.		Ioannidis, John P. A./G-9836-2011					Alderson P, 2000, BRIT MED J, V320, P376, DOI 10.1136/bmj.320.7231.376; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008; Murray CJL., 1996, GLOBAL BURDEN DIS CO	5	75	79	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 8	2003	327	7423					1083	1084		10.1136/bmj.327.7423.1083	http://dx.doi.org/10.1136/bmj.327.7423.1083			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742QW	14604930	Green Published, Bronze			2022-12-01	WOS:000186530400019
J	Raitakari, OT; Juonala, M; Kahonen, M; Taittonen, L; Laitinen, T; Maki-Torkko, N; Jarvisalo, MJ; Uhari, M; Jokinen, E; Ronnemaa, T; Akerblom, HK; Viikari, JSA				Raitakari, OT; Juonala, M; Kahonen, M; Taittonen, L; Laitinen, T; Maki-Torkko, N; Jarvisalo, MJ; Uhari, M; Jokinen, E; Ronnemaa, T; Akerblom, HK; Viikari, JSA			Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood - The Cardiovascular Risk in Young Finns Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; WALL THICKNESS; PRECLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; SERUM-CHOLESTEROL; FOLLOW-UP; CHILDREN; MEN; ASSOCIATION	Context Exposure to cardiovascular risk factors during childhood and adolescence may be associated with the development of atherosclerosis later in life. Objective To study the relationship between cardiovascular risk factors measured in childhood and adolescence and common carotid artery intima-media thickness (IMT), a marker of preclinical atherosclerosis, measured in adulthood. Design, Setting, and Participants Population-based, prospective cohort study conducted at 5 centers in Finland among 2229 white adults aged 24 to 39 years who were examined in childhood and adolescence at ages 3 to 18 years in 1980 and reexamined 21 years later, between September 2001 and January 2002. Main Outcome Measures Association between cardiovascular risk variables (levels of low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides; LDL-C/HDL-C ratio; systolic and diastolic blood pressure; body mass index; smoking) measured in childhood and adulthood and common carotid artery IMT measured in adulthood. Results In multivariable models adjusted for age and sex, IMT in adulthood was significantly associated with childhood LDL-C levels (P=.001), systolic blood pressure (P<.001), body mass index (P=.007), and smoking (P=.02), and with adult systolic blood pressure (P<.001), body mass index (P<.001), and smoking (P=.004). The number of risk factors measured in 12- to 18-year-old adolescents, including high levels (ie, extreme age- and sex-specific 80th percentile) of LDL-C, systolic blood pressure, body mass index, and cigarette smoking, were directly related to carotid IMT measured in young adults at ages 33 through 39 years (P<.001 for both men and women), and remained significant after adjustment for contemporaneous risk variables. The number of risk factors measured at ages 3 to 9 years demonstrated a weak direct relationship with carotid IMT at ages 24 to 30 years in men (P=.02) but not in women (P=.63). Conclusions Risk factor profile assessed in 12- to 18-year-old adolescents predicts adult common carotid artery IMT independently of contemporaneous risk factors. These findings suggest that exposure to cardiovascular risk factors early in life may induce changes in arteries that contribute to the development of atherosclerosis.	Univ Turku, Turku PET Ctr, FIN-20500 Turku, Finland; Univ Turku, Dept Clin Physiol, FIN-20500 Turku, Finland; Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20500 Turku, Finland; Univ Turku, Dept Med, FIN-20500 Turku, Finland; Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; Univ Oulu, Dept Paediat, Oulu, Finland; Univ Kuopio, Dept Clin Physiol, FIN-70211 Kuopio, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	University of Turku; University of Turku; University of Turku; University of Turku; Tampere University; University of Oulu; University of Eastern Finland; University of Helsinki	Raitakari, OT (corresponding author), Univ Turku, Turku PET Ctr, POB 52, FIN-20500 Turku, Finland.	olli.raitakari@utu.fi	Raitakari, Olli/AAQ-7389-2021	Juonala, Markus/0000-0001-9498-364X; Kahonen, Mika/0000-0002-4510-7341				AKERBLOM HK, 1985, ACTA PAEDIATR SCAND, P49; Allan PL, 1997, STROKE, V28, P348, DOI 10.1161/01.STR.28.2.348; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; CRAVEN TE, 1990, CIRCULATION, V82, P1230, DOI 10.1161/01.CIR.82.4.1230; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaziano JM, 1998, NEW ENGL J MED, V338, P1690, DOI 10.1056/NEJM199806043382310; HAAPANEN A, 1989, CIRCULATION, V80, P10, DOI 10.1161/01.CIR.80.1.10; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Kanters SDJM, 1997, STROKE, V28, P665, DOI 10.1161/01.STR.28.3.665; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; LAPINLEIMU H, 1995, LANCET, V345, P471, DOI 10.1016/S0140-6736(95)90580-4; MAHONEY LT, 1991, ANN NY ACAD SCI, V623, P120, DOI 10.1111/j.1749-6632.1991.tb43723.x; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; Obarzanek E, 2001, PEDIATRICS, V107, P256, DOI 10.1542/peds.107.2.256; PAUCIULLO P, 1994, ARTERIOSCLER THROMB, V14, P1075, DOI 10.1161/01.ATV.14.7.1075; POLI A, 1988, ATHEROSCLEROSIS, V70, P253, DOI 10.1016/0021-9150(88)90176-1; Porkka KVK, 1997, AM J EPIDEMIOL, V146, P64, DOI 10.1093/oxfordjournals.aje.a009192; PORKKA KVK, 1994, AM J EPIDEMIOL, V140, P1096, DOI 10.1093/oxfordjournals.aje.a117210; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; VIIKARI J, 1991, ANN MED, V23, P53, DOI 10.3109/07853899109147931; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968	32	1275	1315	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2003	290	17					2277	2283		10.1001/jama.290.17.2277	http://dx.doi.org/10.1001/jama.290.17.2277			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PZ	14600186	Bronze			2022-12-01	WOS:000186356800022
J	Yagi, H; Furutani, Y; Hamada, H; Sasaki, T; Asakawa, S; Minoshima, S; Ichida, F; Joo, K; Kimura, M; Imamura, S; Kamatani, N; Momma, K; Takao, A; Nakazawa, M; Shimizu, N; Matsuoka, R				Yagi, H; Furutani, Y; Hamada, H; Sasaki, T; Asakawa, S; Minoshima, S; Ichida, F; Joo, K; Kimura, M; Imamura, S; Kamatani, N; Momma, K; Takao, A; Nakazawa, M; Shimizu, N; Matsuoka, R			Role of TBX1 in human del22q11.2 syndrome	LANCET			English	Article							T-BOX GENE; DELETION; DEFECTS; MUTANT; FGF8; ARCH	Background Del22q11.2 syndrome is the most frequent known chromosomal microdeletion syndrome, with an incidence of 1 in 4000-5000 livebirths. It is characterised by a 3-Mb deletion on chromosome 22q11.2, cardiac abnormalities, T-cell deficits, cleft palate facial anomalies, and hypocalcaemia. At least 30 genes have been mapped to the deleted region. However, the association of these genes with the cause of this syndrome is not clearly understood. Methods To test for the chromosomal deletion at 22q11.2, we did fluorescence in-situ hybridisation analysis with ten probes on 22q11.2 in 235 unrelated patients with clinically diagnosed del22q11.2 syndrome. To investigate mutations in the coding sequence of TBX1, we also did genetic analysis in 13 patients from ten families who have the 22q11.2 syndrome phenotype but no detectable deletion of 22q11.2. Findings 96% (225 of 235) of patients had a defined 1.5-3-Mb deletion at 22q11.2. We identified three mutations of TBX1 in two unrelated patients without the 22q11.2 deletion-one with sporadic conotruncal anomaly face syndrome/velocardiofacial syndrome and one with sporadic DiGeorge's syndrome-and in three patients from a family with conotruncal anomaly face syndrome/velocardiofacial syndrome. We did not record these three mutations in 555 healthy controls (1110 chromosomes; p<0.0001). Interpretation Our results suggest that the TBX1 mutation is responsible for five major phenotypes in del22q11.2 syndrome. Therefore, we conclude that TBX1 is a major genetic determinant of the del22q11.2 syndrome.	Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Div Genom Med,Shinjuku Ku, Tokyo, Japan; Tokyo Womens Med Univ, Heart Inst Japan, Shinjuku Ku, Tokyo, Japan; Chiba Univ, Grad Sch Med, Dept Paediat, Chiba, Japan; Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; Toyama Med & Pharmaceut Univ, Dept Paediat, Toyama, Japan; Kyushu Welf Pens Hosp, Dept Paediat, Fukuoka, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Chiba University; Keio University; University of Toyama	Matsuoka, R (corresponding author), Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Div Genom Med,Shinjuku Ku, 8-1 Kawada Cho, Tokyo, Japan.	rumiko@imcir.twmu.ac.jp	Sasaki, Takashi/AAD-1461-2019	Yagi, Hisato/0000-0003-1460-4043; Sasaki, Takashi/0000-0002-6275-046X				Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; BURN J, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P559; Conti E, 2003, EUR J HUM GENET, V11, P349, DOI 10.1038/sj.ejhg.5200956; FIREMAN P, 1965, J PEDIATR-US, V67, P907; Frank DU, 2002, DEVELOPMENT, V129, P4591; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kinouchi A, 1976, SHONIKA PEDIAT JPN, V17, P84; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; MATSUOKA R, 1994, AM J MED GENET, V53, P285, DOI 10.1002/ajmg.1320530314; Matsuoka R, 1998, HUM GENET, V103, P70, DOI 10.1007/s004390050786; Matsuoka R, 2000, ETIOLOGY MORPHOGENES, P341; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Paxton C, 2002, GENE, V283, P117, DOI 10.1016/S0378-1119(01)00878-2; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; SHPRINTZEN RJ, 1994, J MED GENET, V31, P423, DOI 10.1136/jmg.31.5.423-b; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; TAKAO A, 1980, ETIOLOGY MORPHOGENES, P253; Vitelli F, 2002, DEVELOPMENT, V129, P4605; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 1998, AM J MED GENET, V78, P319, DOI 10.1002/(SICI)1096-8628(19980724)78:4<319::AID-AJMG3>3.3.CO;2-K; Yamagishi Hiroyuki, 2002, Keio Journal of Medicine, V51, P77; YOSHIDA MC, 1986, JPN J CANCER RES, V77, P1059	30	570	606	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2003	362	9393					1366	1373		10.1016/S0140-6736(03)14632-6	http://dx.doi.org/10.1016/S0140-6736(03)14632-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585638				2022-12-01	WOS:000186143300010
J	Allsop, DJ; West, SA				Allsop, DJ; West, SA			Changing sex at the same relative body size - Similar forces may select for gender switching across taxa in all animals with this facility	NATURE			English	Editorial Material							AGE		Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Allsop, DJ (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	david.allsop@ed.ac.uk	West, Stuart A/M-3608-2014	West, Stuart A/0000-0003-2152-3153				Allsop DJ, 2003, J EVOLUTION BIOL, V16, P921, DOI 10.1046/j.1420-9101.2003.00590.x; CHARNOV E L, 1982; Charnov EL, 2000, EVOL ECOL RES, V2, P1067; Charnov Eric L., 1993, P1; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Gemmill AW, 1999, J EVOLUTION BIOL, V12, P1148, DOI 10.1046/j.1420-9101.1999.00117.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; LEIGH EG, 1976, P NATL ACAD SCI USA, V73, P3655, DOI DOI 10.1111/J.1420-9101.2006.01156.X; WEST PA, 1985, J ROY SOC HEALTH, V1, P15	10	53	55	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2003	425	6960					783	784		10.1038/425783a	http://dx.doi.org/10.1038/425783a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574399	Green Submitted			2022-12-01	WOS:000186118500032
J	Ashton, CM; Souchek, J; Petersen, NJ; Menke, TJ; Collins, TC; Kizer, KW; Wright, SM; Wray, NP				Ashton, CM; Souchek, J; Petersen, NJ; Menke, TJ; Collins, TC; Kizer, KW; Wright, SM; Wray, NP			Hospital use and survival among Veterans Affairs beneficiaries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE SYSTEM; QUALITY; VA; ADMISSIONS; OUTCOMES; IMPACT; RATES	BACKGROUND: Initiatives to reduce hospital care were part of the reorganization of the Department of Veterans Affairs (VA) medical care system undertaken in the mid-1990s. We examined changes in the use of VA health services and survival from 1994 through 1998 among VA beneficiaries with serious chronic diseases. We postulated that if access to hospital care was reduced too much, or if decreased hospital use was not offset by improvements in ambulatory care, urgent care visits would increase or survival rates would fall. METHODS: We tracked changes in risk-adjusted VA bed-day rates, rates of medical visits, rates of visits for testing and consultation, and rates of urgent care visits per patient-year among VA beneficiaries in nine disease cohorts (a total of 342,300 beneficiaries). Trends in non-VA hospital use by VA beneficiaries 65 years of age or older who were enrolled in fee-for-service Medicare were also studied. VA and Medicare vital-status data were used to calculate one-year survival rates. RESULTS: From 1994 through 1998, VA bed-day rates fell by 50 percent, rates of medical-clinic visits and visits for testing and consultation increased moderately, and rates of urgent care visits fell by 35 percent. The sharp decline in the use of VA hospitals was not compensated for by increases in the use of Medicare-reimbursed non-VA hospital care by veterans eligible for both VA care and Medicare, and the use of non-VA hospitals actually declined in four cohorts. The survival rates were essentially unchanged over the study period. CONCLUSIONS: The marked decline in VA hospital use from 1994 through 1998 did not curtail access to needed services and was not associated with serious consequences for chronically ill VA beneficiaries.	Vet Affairs Med Ctr, Ctr Qual Care & Utilizat Studies, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Vet Hlth Adm Headquarters, Washington, DC USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ashton, CM (corresponding author), Vet Affairs Med Ctr, Ctr Qual Care & Utilizat Studies, 152,2002 Holcombe Blvd, Houston, TX 77030 USA.	carol.ashton@med.va.gov						Ashton CM, 1999, NEW ENGL J MED, V340, P32, DOI 10.1056/NEJM199901073400106; ASHTON CM, 1994, MED CARE, V32, P447, DOI 10.1097/00005650-199405000-00004; BLUMENTHAL D, 1995, HEALTH SERV RES, V30, P253; BOOTH BM, 1991, MED CARE, V29, pAS40; COX DR, 1972, J R STAT SOC B, V34, P187; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Forrest CB, 1996, J FAM PRACTICE, V43, P40; GARG R, 1995, JAMA-J AM MED ASSOC, V274, P462; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th, DOI DOI 10.1002/9780470973394; GRAVES EJ, 1997, VITAL HLTH STAT 13, V128; Iglehart JK, 1996, NEW ENGL J MED, V335, P1407, DOI 10.1056/NEJM199610313351821; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; Kizer KW, 1999, AM J MED QUAL, V14, P3, DOI 10.1177/106286069901400103; Kizer KW, 1997, HOSP HEALTH SERV ADM, V42, P283; Kizer KW, 2001, HLTH INFORMAT SER, P79; LUFT HS, 1990, JAMA-J AM MED ASSOC, V263, P2899, DOI 10.1001/jama.263.21.2899; Menke TJ, 1998, MED CARE, V36, P1126, DOI 10.1097/00005650-199808000-00003; MILLER MG, 1994, JAMA-J AM MED ASSOC, V271, P1493, DOI 10.1001/jama.271.19.1493; NAJI S, 1994, BRIT MED J, V308, P1208; *NAT CTR HLTH STAT, 2002, PROV TABL BIRTHS MAR, V47; Page WF, 1996, ANN EPIDEMIOL, V6, P102, DOI 10.1016/1047-2797(95)00126-3; POPOVIC JR, 2000, VITAL HLTH STAT 13, V148; Smith CB, 1996, MED CARE, V34, P85, DOI 10.1097/00005650-199601000-00007; SNEDECOR GW, 1980, STATISTICAL METHODS, P288; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; *VET HLTH ADM OFF, 1997, VET EQ RES ALL SYST; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Wilson NJ, 1997, HEALTH AFFAIR, V16, P200, DOI 10.1377/hlthaff.16.4.200; Wray NP, 1999, HEALTH SERV RES, V34, P777; Wray NP, 1997, MED CARE, V35, P768, DOI 10.1097/00005650-199708000-00003; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	31	75	76	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2003	349	17					1637	1646		10.1056/NEJMsa003299	http://dx.doi.org/10.1056/NEJMsa003299			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734ZT	14573736				2022-12-01	WOS:000186088400010
J	Seminara, SB; Messager, S; Chatzidaki, EE; Thresher, RR; Acierno, JS; Shagoury, JK; Bo-Abbas, Y; Kuohung, W; Schwinof, KM; Hendrick, AG; Zahn, D; Dixon, J; Kaiser, UB; Slaugenhaupt, SA; Gusella, JF; O'Rahilly, S; Carlton, MBL; Crowley, WF; Aparicio, SAJR; Colledge, WH				Seminara, SB; Messager, S; Chatzidaki, EE; Thresher, RR; Acierno, JS; Shagoury, JK; Bo-Abbas, Y; Kuohung, W; Schwinof, KM; Hendrick, AG; Zahn, D; Dixon, J; Kaiser, UB; Slaugenhaupt, SA; Gusella, JF; O'Rahilly, S; Carlton, MBL; Crowley, WF; Aparicio, SAJR; Colledge, WH			The GPR54 gene as a regulator of puberty	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; LUTEINIZING-HORMONE; KALLMANNS-SYNDROME; MENSTRUAL-CYCLE; GNRH RECEPTOR; KISS-1; MEN	BACKGROUND: Puberty, a complex biologic process involving sexual development, accelerated linear growth, and adrenal maturation, is initiated when gonadotropin-releasing hormone begins to be secreted by the hypothalamus. We conducted studies in humans and mice to identify the genetic factors that determine the onset of puberty. METHODS: We used complementary genetic approaches in humans and in mice. A consanguineous family with members who lacked pubertal development (idiopathic hypogonadotropic hypogonadism) was examined for mutations in a candidate gene, GPR54, which encodes a G protein-coupled receptor. Functional differences between wild-type and mutant GPR54 were examined in vitro. In parallel, a Gpr54-deficient mouse model was created and phenotyped. Responsiveness to exogenous gonadotropin-releasing hormone was assessed in both the humans and the mice. RESULTS: Affected patients in the index pedigree were homozygous for an L148S mutation in GPR54, and an unrelated proband with idiopathic hypogonadotropic hypogonadism was determined to have two separate mutations, R331X and X399R. The in vitro transfection of COS-7 cells with mutant constructs demonstrated a significantly decreased accumulation of inositol phosphate. The patient carrying the compound heterozygous mutations (R331X and X399R) had attenuated secretion of endogenous gonadotropin-releasing hormone and a left-shifted dose-response curve for gonadotropin-releasing hormone as compared with six patients who had idiopathic hypogonadotropic hypogonadism without GPR54 mutations. The Gpr54-deficient mice had isolated hypogonadotropic hypogonadism (small testes in male mice and a delay in vaginal opening and an absence of follicular maturation in female mice), but they showed responsiveness to both exogenous gonadotropins and gonadotropin-releasing hormone and had normal levels of gonadotropin-releasing hormone in the hypothalamus. CONCLUSIONS: Mutations in GPR54, a G protein-coupled receptor gene, cause autosomal recessive idiopathic hypogonadotropic hypogonadism in humans and mice, suggesting that this receptor is essential for normal gonadotropin-releasing hormone physiology and for puberty.	Paradigm Therapeut, Cambridge CB4 0WA, England; Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Inst Human Genet, Boston, MA USA; Univ Cambridge, Dept Physiol, Cambridge, England; Univ Cambridge, Dept Oncol, Cambridge, England; Univ Cambridge, Dept Clin Biochem, Cambridge, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Kuwait Univ, Fac Med, Al Jabriyah, Kuwait	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Kuwait University	Colledge, WH (corresponding author), Paradigm Therapeut, 214 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WA, England.		Oka, Yoshitaka/C-9670-2010; O'Rahilly, Stephen/ABF-6509-2020; Colledge, William/X-4976-2019	Oka, Yoshitaka/0000-0002-3482-3051; O'Rahilly, Stephen/0000-0003-2199-4449; Colledge, William/0000-0002-9603-4429; Hendrick, Alan/0000-0002-8604-0462; Kuohung, Wendy/0000-0003-1764-2264; Aparicio, Samuel/0000-0002-0487-9599; Acierno, James/0000-0002-5301-4970	NCRR NIH HHS [3M01 RR01066-22S2] Funding Source: Medline; NICHD NIH HHS [5R01 HD15788-17, R01 HD015788, U54 HD28138-13, R01 HD043341, T32 HD40135, U54 HD028138, U54 HD029164] Funding Source: Medline; NIGMS NIH HHS [GM61354] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040135, U54HD028138, R01HD043341, R01HD015788] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD029164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acierno JS, 2003, J CLIN ENDOCR METAB, V88, P2947, DOI 10.1210/jc.2003-030423; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bedecarrats GY, 2003, J CLIN ENDOCR METAB, V88, P834, DOI 10.1210/jc.2002-020806; Bo-Abbas Y, 2003, J CLIN ENDOCR METAB, V88, P2730, DOI 10.1210/jc.2002-021948; CAMERON JL, 1985, BIOL REPROD, V33, P147, DOI 10.1095/biolreprod33.1.147; CARATY A, 1995, ENDOCRINOLOGY, V136, P3452, DOI 10.1210/en.136.8.3452; COLLINS TJ, 1981, NEUROBIOL AGING, V2, P125, DOI 10.1016/0197-4580(81)90010-5; CROWLEY WF, 1980, J CLIN ENDOCR METAB, V51, P173, DOI 10.1210/jcem-51-1-173; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; FILICORI M, 1986, J CLIN ENDOCR METAB, V62, P1136, DOI 10.1210/jcem-62-6-1136; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; HOFFMAN AR, 1982, NEW ENGL J MED, V307, P1237, DOI 10.1056/NEJM198211113072003; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1997, INT J CANCER, V71, P1035, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.0.CO;2-B; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LEE JH, 1997, JNCI-J NATL CANCER I, V89, P1549; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEGOUIS R, 1993, P NATL ACAD SCI USA, V90, P2461, DOI 10.1073/pnas.90.6.2461; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; MCDOWELL IFW, 1982, J ENDOCRINOL, V95, P331, DOI 10.1677/joe.0.0950331; MCDOWELL IFW, 1982, J ENDOCRINOL, V95, P321, DOI 10.1677/joe.0.0950321; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; SANTEN RJ, 1973, J CLIN INVEST, V52, P2617, DOI 10.1172/JCI107454; SANTORO N, 1986, ENDOCR REV, V7, P11, DOI 10.1210/edrv-7-1-11; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; SPRATT DI, 1987, J CLIN ENDOCR METAB, V64, P283, DOI 10.1210/jcem-64-2-283; SPRATT DI, 1988, AM J PHYSIOL, V254, pE658, DOI 10.1152/ajpendo.1988.254.5.E658; *UCSC, 2002, UCSC GEN BROWS; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; WHITCOMB RW, 1990, J CLIN ENDOCR METAB, V70, P3, DOI 10.1210/jcem-70-1-3; WIEMANN JN, 1989, ENDOCRINOLOGY, V124, P1760, DOI 10.1210/endo-124-4-1760	37	1855	1933	5	106	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2003	349	17					1614	U8		10.1056/NEJMoa035322	http://dx.doi.org/10.1056/NEJMoa035322			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZT	14573733				2022-12-01	WOS:000186088400006
J	Hemingway, H; Shipley, M; Britton, A; Page, M; Macfarlane, P; Marmot, M				Hemingway, H; Shipley, M; Britton, A; Page, M; Macfarlane, P; Marmot, M			Prognosis of angina with and without a diagnosis: 11 year follow up in the Whitehall II prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABNORMALITIES; MORTALITY; SYMPTOMS	Objective To investigate the prognosis of angina among people with and without diagnosis by a doctor and an abnormal cardiovascular test result. Design Prospective cohort study with a median follow up of 11 years. Setting 20 civil service departments originally located in London. Participants 10 308 civil servants aged 35-55 years at baseline. Main outcome measures Recurrent reports of angina; quality of life (SF-36 physical functioning); non-fatal myocardial infarction; death from any cause (n = 344). Results 1158 (11.4%) participants developed angina, and 813 (70%) had no evidence of diagnosis by a doctor at the time of the initial report. Participants without a diagnosis had an increased risk of impaired physical functioning (age and sex adjusted odds ratio of 2.36 (95% confidence interval 1.91 to 2.90)) compared with those who had neither angina nor myocardial infarction throughout follow up. Among reported cases of angina without a diagnosis, the 15.5% with an abnormality on a study electrocardiogram had an increased risk of death (hazard ratio 2.37 (1.16 to 4.87)). These effects were similar in magnitude to those in participants with a diagnosis of angina. Conclusion Undiagnosed angina was common and had an adverse impact on prognosis comparable to that of diagnosed angina, particularly among people with electrocardiographic abnormalities. Efforts to improve prognosis among people with angina should take account of this submerged clinical iceberg.	UCL, Sch Med, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, London WC1E 6BT, England; Univ Glasgow, Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland	University of London; University College London; UCL Medical School; Royal Infirmary of Edinburgh; University of Glasgow	Hemingway, H (corresponding author), UCL, Sch Med, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, London WC1E 6BT, England.	h.hemingway@public-health.ucl.ac.uk	Hemingway, Harry/C-1219-2009; Marmot, M G/Y-3920-2019; Greiver, Michelle/N-8764-2015	Hemingway, Harry/0000-0003-2279-0624; Marmot, M G/0000-0002-2431-6419; Greiver, Michelle/0000-0001-8957-0285	AHRQ HHS [5 R01 HS06516] Funding Source: Medline; Medical Research Council [G19/35, G8802774, G0100222] Funding Source: Medline; NHLBI NIH HHS [2R01 HL36310] Funding Source: Medline; NIA NIH HHS [R01 AG13196-02] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Hemingway H, 2000, J EPIDEMIOL COMMUN H, V54, P510, DOI 10.1136/jech.54.7.510; Lampe FC, 1999, J CLIN EPIDEMIOL, V52, P73, DOI 10.1016/S0895-4356(98)00146-2; Lampe FC, 2001, AM J EPIDEMIOL, V153, P1173, DOI 10.1093/aje/153.12.1173; LAST JM, 1963, LANCET, P28; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Rose G.A., 1982, CARDIOVASCULAR SURVE; Stafford M, 1998, J EPIDEMIOL COMMUN H, V52, P353, DOI 10.1136/jech.52.6.353; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583	13	47	50	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2003	327	7420					895	898		10.1136/bmj.327.7420.895	http://dx.doi.org/10.1136/bmj.327.7420.895			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734RV	14563744	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000186072100016
J	Ueshima, R; Asami, T				Ueshima, R; Asami, T			Single-gene speciation by left-right reversal - A land-snail species of polyphyletic origin results from chirality constraints on mating.	NATURE			English	Editorial Material							SYMPATRIC SPECIATION; PARTULA-SUTURALIS; POLYMORPHISM; EVOLUTION; COIL		Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Shinshu Univ, Dept Biol, Matsumoto, Nagano 3608621, Japan; Japan Sci & Technol, PRESTO, Kawaguchi 3320012, Japan	University of Tokyo; Shinshu University; Japan Science & Technology Agency (JST)	Ueshima, R (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	asami99@gipac.shinshu-u.ac.jp						Asami T, 1998, AM NAT, V152, P225, DOI 10.1086/286163; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; GITTENBERGER E, 1988, EVOLUTION, V42, P826, DOI 10.1111/j.1558-5646.1988.tb02502.x; Harrison RG, 1998, ENDLESS FORMS, P19; JOHNSON MS, 1990, EVOLUTION, V44, P459, DOI 10.1111/j.1558-5646.1990.tb05215.x; JOHNSON MS, 1982, HEREDITY, V49, P145, DOI 10.1038/hdy.1982.80; LIPTON CS, 1979, MALACOLOGIA, V19, P129; Muller H., 1942, BIOL S, V6, P71; ORR HA, 1991, EVOLUTION, V45, P764, DOI 10.1111/j.1558-5646.1991.tb04345.x; VANHATENBURG FHO, 1996, HEREDITY, V76, P278; VERMEIJ GJ, 1975, NATURE, V254, P419, DOI 10.1038/254419a0	12	130	138	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2003	425	6959					679	679		10.1038/425679a	http://dx.doi.org/10.1038/425679a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562091	Bronze			2022-12-01	WOS:000185924500029
J	Lewin, MR; Bouyer, DH; Walker, DH; Musher, DM				Lewin, MR; Bouyer, DH; Walker, DH; Musher, DM			Rickettsia sibirica infection in members of scientific expeditions to northern Asia	LANCET			English	Article							INNER-MONGOLIA	The risk of acquiring North Asian tick typhus (infection by Rickettsia sibirica) during travel to regions of Asia where this disease is endemic is unknown. We investigated prospectively 13 paleontologists on expedition to Mongolia. Four paleontologists had acute illness characterised by fever, rash, headache, and lymphadenoparthy. All had IgM and IgG antibodies to R sibirica. Paleontologists with no illness and people who went on expeditions in other parts of the world did not have antibodies to R sibirica. Only two of the four infected persons were aware of tick bites. Travellers to regions endemic for R sibirica are at risk of contracting North Asian tick typhus even in the absence of recognised tick-bites.	Univ Calif San Francisco, Fresno, CA USA; Univ Texas, Med Branch, Galveston, TX 77550 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine	Lewin, MR (corresponding author), Dept Emergency Med, Room 275,445 S Cedar Ave, Fresno, CA 93702 USA.	aplysia99@yahoo.com		Lewin, Matthew/0000-0003-4480-9891				ANTONOV NI, 1936, DALNEVOST MED ZH, V5, P77; Lankester T, 1997, LANCET, V349, P656, DOI 10.1016/S0140-6736(05)61613-3; LIU QH, 1990, ANN NY ACAD SCI, V590, P237, DOI 10.1111/j.1749-6632.1990.tb42225.x; LIU QH, 1995, EPIDEMIOL INFECT, V115, P177, DOI 10.1017/S0950268800058246; Lyskovtsev MM, 1968, MISCELLANEOUS PUBLIC, V6, P42	5	18	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2003	362	9391					1201	1202		10.1016/S0140-6736(03)14515-1	http://dx.doi.org/10.1016/S0140-6736(03)14515-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CW	14568744				2022-12-01	WOS:000185924100014
J	Mukhopadhyay, S; Kim, BS; Chipman, PR; Rossmann, MG; Kuhn, RJ				Mukhopadhyay, S; Kim, BS; Chipman, PR; Rossmann, MG; Kuhn, RJ			Structure of West Nile virus	SCIENCE			English	Article							ENVELOPE GLYCOPROTEIN; DENGUE VIRUS; ENCEPHALITIS		Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuhn, RJ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	kuhnr@purdue.edu	Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Chipman, Paul/0000-0003-3652-4087	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045976] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 45976] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0	6	283	306	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					248	248		10.1126/science.1089316	http://dx.doi.org/10.1126/science.1089316			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	14551429				2022-12-01	WOS:000185825900031
J	Wai, SN; Lindmark, B; Soderblom, T; Takade, A; Westermark, M; Oscarsson, J; Jass, J; Richter-Dahlfors, A; Mizunoe, Y; Uhlin, BE				Wai, SN; Lindmark, B; Soderblom, T; Takade, A; Westermark, M; Oscarsson, J; Jass, J; Richter-Dahlfors, A; Mizunoe, Y; Uhlin, BE			Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin	CELL			English	Article							HEAT-LABILE ENTEROTOXIN; OUTER-MEMBRANE VESICLES; ESCHERICHIA-COLI; SECRETORY PATHWAY; PROTEIN SECRETION; CRYSTAL-STRUCTURE; HEMOLYSIN-E; IN-VITRO; SHEA; EXPRESSION	The ClyA protein is a pore-forming cytotoxin expressed by Escherichia coli and some other enterobacteria. It confers cytotoxic activity toward mammalian cells, but it has remained unknown how ClyA is surface exposed and exported from bacterial cells. Outer-membrane vesicles (OMVs) released from the bacteria were shown to contain ClyA protein. ClyA formed oligomeric pore assemblies in the OMVs, and the cytotoxic activity toward mammalian cells was considerably higher than that of ClyA protein purified from the bacterial periplasm. The redox status of ClyA correlated with its ability to form the oligomeric pore assemblies. In bacterial cells with a defective periplasmic disulphide oxidoreductase system, the ClyA protein was phenotypically expressed in a constitutive manner. The results define a vesicle-mediated transport mechanism in bacteria, and our findings show that the localization of proteins to OMVs directly may contribute to the activation and delivery of pathogenic effector proteins.	Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Kyushu Univ, Fac Med Sci, Dept Bacteriol, Fukuoka 8128582, Japan	Umea University; Karolinska Institutet; Kyushu University	Wai, SN (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.	sun.nyunt.wai@molbiol.umu.se	Jass, Jana/D-1617-2013; Uhlin, Bernt Eric/AAO-6292-2021	Jass, Jana/0000-0001-7957-0310; Uhlin, Bernt Eric/0000-0002-2991-8072; Richter-Dahlfors, Agneta/0000-0002-5479-7591; Wai, Sun Nyunt/0000-0003-4793-4671				AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Atkins A, 2000, J BIOL CHEM, V275, P41150, DOI 10.1074/jbc.M005420200; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chen LY, 1996, J BIOL CHEM, V271, P2703, DOI 10.1074/jbc.271.5.2703; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; del Castillo FJ, 2001, FEMS MICROBIOL LETT, V204, P281, DOI 10.1016/S0378-1097(01)00413-X; delCastillo FJ, 1997, MOL MICROBIOL, V25, P107, DOI 10.1046/j.1365-2958.1997.4391813.x; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Green J, 1997, MICROBIOL-SGM, V143, P3785, DOI 10.1099/00221287-143-12-3785; Henderson IR, 2000, TRENDS MICROBIOL, V8, P529, DOI 10.1016/S0966-842X(00)01853-9; HENNING U, 1979, ANAL BIOCHEM, V97, P153, DOI 10.1016/0003-2697(79)90339-7; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadurugamuwa JL, 1998, ANTIMICROB AGENTS CH, V42, P1476, DOI 10.1128/AAC.42.6.1476; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; KORONAKIS V, 1991, EMBO J, V10, P3263, DOI 10.1002/j.1460-2075.1991.tb04890.x; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai XH, 2000, INFECT IMMUN, V68, P4363, DOI 10.1128/IAI.68.7.4363-4367.2000; LARSSON S, 1986, AM J PHYSIOL, V251, pC455, DOI 10.1152/ajpcell.1986.251.3.C455; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Oscarsson J, 2002, INT J MED MICROBIOL, V291, P625, DOI 10.1078/1438-4221-00176; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Oscarsson J, 1996, MOL MICROBIOL, V20, P191, DOI 10.1111/j.1365-2958.1996.tb02500.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; UHLIN BE, 1994, J CELL BIOCH S A, V18, P71; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; WHITTAM TS, 1988, J INFECT DIS, V157, P1124, DOI 10.1093/infdis/157.6.1124; Xia Y, 2000, EMBO J, V19, P1450, DOI 10.1093/emboj/19.7.1450	48	349	364	6	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2003	115	1					25	35		10.1016/S0092-8674(03)00754-2	http://dx.doi.org/10.1016/S0092-8674(03)00754-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730ED	14532000	Bronze			2022-12-01	WOS:000185815500006
J	Mazel, CH; Cronin, TW; Caldwell, RL; Marshall, NJ				Mazel, CH; Cronin, TW; Caldwell, RL; Marshall, NJ			Fluorescent enhancement of signaling in a mantis shrimp	SCIENCE			English	Article									Phys Sci Inc, Andover, MA 01810 USA; Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	Physical Sciences Inc.; University System of Maryland; University of Maryland Baltimore County; University of California System; University of California Berkeley; University of Queensland	Mazel, CH (corresponding author), Phys Sci Inc, 20 New England Business Ctr, Andover, MA 01810 USA.			Marshall, Justin/0000-0001-9006-6713				Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; Cronin TW, 2000, PHILOS T ROY SOC B, V355, P1263, DOI 10.1098/rstb.2000.0680; Lythgoe J.N., 1979, ECOLOGY VISION; Mathger LM, 2001, J EXP BIOL, V204, P2103; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P390, DOI 10.4319/lo.2003.48.1_part_2.0390	5	68	69	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					51	51		10.1126/science.1089803	http://dx.doi.org/10.1126/science.1089803			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14615546				2022-12-01	WOS:000187710600027
J	Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF				Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF			Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							FLEXIBLE SIGMOIDOSCOPY; ASYMPTOMATIC ADULTS; SOCIETY GUIDELINES; COLONOSCOPY; ADENOMAS; RECOMMENDATIONS; PREVENTION; POLYPS; UPDATE	Background: Colonoscopic screening for colorectal cancer has been suggested because sigmoidoscopy misses nearly half of persons with advanced proximal neoplasia. Objective: To create a clinical index to stratify risk for advanced proximal neoplasia and to identify a subgroup with very low risk in which screening sigmoidoscopy alone might suffice. Design: Cross-sectional study. Setting: A company-based program of screening colonoscopy for colorectal cancer. Patients: Consecutive persons 50 years of age or older undergoing first-time screening colonoscopy between September 1995 and June 2001. Measurements: A clinical index with 3 variables was created from information on the first 1994 persons. Points were assigned to categories of age, sex, and distal findings. Risk for advanced proximal neoplasia (defined as an adenoma 1 cm or larger or one with villous histology, severe dysplasia, or cancer) was measured for each score. The index was tested on the next 1031 persons from the same screening program. Results: Of 1994 persons, 67 (3.4%) had advanced proximal neoplasia. A low-risk subgroup comprising 37% of the cohort had scores of 0 or 1 and a risk of 0.68% (95% CI, 0.22% to 1.57%). Among the validation group of 1031 persons, risk for advanced proximal neoplasia in the low-risk subgroup (comprising 47% of the cohort) was 0.4% (upper confidence limit of 1.49%). Application of this index detected 92% of persons with advanced proximal neoplasms and, if applied following screening sigmoidoscopy, could reduce the need for colonoscopy by 40%. The marginal benefit of colonoscopy among low-risk persons was small: To detect 7 additional persons with advanced proximal neoplasia, 1217 additional colonoscopies would be required. Conclusions: This clinical index stratifies the risk for advanced proximal neoplasia and identifies a subgroup at very low risk. If it is validated in other cohorts or groups, the index could be used to tailor endoscopic screening for colorectal cancer.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Univ N Carolina, Chapel Hill, NC USA; Eli Lilly & Co, Indianapolis, IN 46285 USA; Indianapolis Gastroenterol Res Fdn, Indianapolis, IN 46285 USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of North Carolina; University of North Carolina Chapel Hill; Eli Lilly; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Imperiale, TF (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073	NIDDK NIH HHS [K24 DK 02756] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 2000, JNCI-J NATL CANCER I, V92, P513, DOI 10.1093/jnci/92.7.513; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; Fletcher RH, 1999, GASTROENTEROLOGY, V117, P486, DOI 10.1053/gast.1999.0029900486; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Levin Theodore R, 2002, Gastrointest Endosc Clin N Am, V12, P23, DOI 10.1016/S1052-5157(03)00055-2; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Lewis JD, 1999, ANN INTERN MED, V130, P525, DOI 10.7326/0003-4819-130-6-199903160-00017; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; RUTTIMANN UE, 1994, CRIT CARE CLIN, V10, P19, DOI 10.1016/S0749-0704(18)30142-8; Schoen RE, 1998, GASTROENTEROLOGY, V115, P533, DOI 10.1016/S0016-5085(98)70132-5; SELBY JV, 1994, GASTROENTEROLOGY, V106, P1702, DOI 10.1016/0016-5085(94)90429-4; Sherrick RC, 2000, NEW ENGL J MED, V343, P1651; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0	29	132	139	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					959	965		10.7326/0003-4819-139-12-200312160-00005	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678915				2022-12-01	WOS:000187443200001
J	Rigotti, NA				Rigotti, NA			Commentary: Putting the research into practice	BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING CESSATION; PATCH; TRIAL		Harvard Univ, Sch Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Rigotti, NA (corresponding author), Harvard Univ, Sch Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA.							Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Fiore MC., 2000, TREATING TOBACCO USE; Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; *US DEP HHS, DHHS PUBL; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	8	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1395	1396		10.1136/bmj.327.7428.1395	http://dx.doi.org/10.1136/bmj.327.7428.1395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670890	Green Published			2022-12-01	WOS:000187417900028
J	Ceci, M; Gaviraghi, C; Gorrini, C; Sala, LA; Offenhauser, N; Marchisio, PC; Biffo, S				Ceci, M; Gaviraghi, C; Gorrini, C; Sala, LA; Offenhauser, N; Marchisio, PC; Biffo, S			Release of eIF6 (p27(BBP)) from the 60S subunit allows 80S ribosome assembly	NATURE			English	Article							TRANSLATION INITIATION-FACTOR; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; CLONING; RACK1; RECEPTOR; HOMOLOG; BINDING; CELLS	The assembly of 80S ribosomes requires joining of the 40S and 60S subunits, which is triggered by the formation of an initiation complex on the 40S subunit(1). This event is rate-limiting for translation(2), and depends on external stimuli(3) and the status of the cell(4). Here we show that 60S subunits are activated by release of eIF6 (also termed p27(BBP))(5,6). In the cytoplasm, eIF6 is bound to free 60S but not to 80S. Furthermore, eIF6 interacts in the cytoplasm with RACK1(7), a receptor for activated protein kinase C (PKC). RACK1 is a major component of translating ribosomes, which harbour significant amounts of PKC. Loading 60S subunits with eIF6 caused a dose-dependent translational block and impairment of 80S formation, which were reversed by expression of RACK1 and stimulation of PKC in vivo and in vitro. PKC stimulation led to eIF6 phosphorylation, and mutation of a serine residue in the carboxy terminus of eIF6 impaired RACK1/PKC-mediated translational rescue. We propose that eIF6 release regulates subunit joining, and that RACK1 provides a physical and functional link between PKC signalling and ribosome activation.	DIBIT HSR, Mol Histol Unit, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, Sch Med, I-20132 Milan, Italy; Firc Inst Mol Oncol, I-20100 Milan, Italy; Univ Eastern Piedmont Amedeo Avogadro, Dept Sci & Adv Technol, I-15100 Alessandria, Italy	Vita-Salute San Raffaele University; IFOM - FIRC Institute of Molecular Oncology; University of Eastern Piedmont Amedeo Avogadro	Biffo, S (corresponding author), DIBIT HSR, Mol Histol Unit, I-20132 Milan, Italy.	biffo.stefano@hsr.it		Ceci, Marcello/0000-0002-5066-1590; biffo, stefano/0000-0002-3780-1050; Gorrini, Chiara/0000-0002-5239-6671; Offenhauser, Nina/0000-0002-3316-3047				Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Chantrel Y, 1998, GENETICS, V148, P559; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Ho JHN, 2000, RNA, V6, P1625, DOI 10.1017/S1355838200001291; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Nadano D, 2000, JPN J CANCER RES, V91, P802, DOI 10.1111/j.1349-7006.2000.tb01017.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Proud CG, 2001, BIOCHEM SOC T, V29, P541, DOI 10.1042/BST0290541; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; SPROTT SC, 1991, ANAL BIOCHEM, V194, P407, DOI 10.1016/0003-2697(91)90249-S; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Wood LC, 1999, J BIOL CHEM, V274, P11653, DOI 10.1074/jbc.274.17.11653	27	317	328	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					579	584		10.1038/nature02160	http://dx.doi.org/10.1038/nature02160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654845				2022-12-01	WOS:000186944300044
J	Wikramanayake, AH; Hong, M; Lee, PN; Pang, K; Byrum, CA; Bince, JM; Xu, RH; Martindale, MQ				Wikramanayake, AH; Hong, M; Lee, PN; Pang, K; Byrum, CA; Bince, JM; Xu, RH; Martindale, MQ			An ancient role for nuclear beta-catenin in the evolution of axial polarity and germ layer segregation	NATURE			English	Article							SIGNAL-TRANSDUCTION; XENOPUS EMBRYOS; CELL FATES; SPECIFICATION; ENDODERM; LOCALIZATION; HYPOTHESES; INDUCTION; LITHIUM	The human oncogene beta-catenin is a bifunctional protein with critical roles in both cell adhesion and transcriptional regulation in the Wnt pathway(1-3). Wnt/beta-catenin signalling has been implicated in developmental processes as diverse as elaboration of embryonic polarity(2-6), formation of germ layers(4-8), neural patterning, spindle orientation and gap junction communication(2), but the ancestral function of beta-catenin remains unclear. In many animal embryos, activation of beta-catenin signalling occurs in blastomeres that mark the site of gastrulation and endomesoderm formation(5-10), raising the possibility that asymmetric activation of beta-catenin signalling specified embryonic polarity and segregated germ layers in the common ancestor of bilaterally symmetrical animals. To test whether nuclear translocation of beta-catenin is involved in axial identity and/or germ layer formation in 'pre-bilaterians', we examined the in vivo distribution, stability and function of beta-catenin protein in embryos of the sea anemone Nematostella vectensis (Cnidaria, Anthozoa). Here we show that N. vectensis beta-catenin is differentially stabilized along the oral-aboral axis, translocated into nuclei in cells at the site of gastrulation and used to specify entoderm, indicating an evolutionarily ancient role for this protein in early pattern formation.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Univ Hawaii, Pacific Biomed Res Ctr, Kewalo Marine Lab, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System	Wikramanayake, AH (corresponding author), Univ Hawaii Manoa, Dept Zool, 2538 McCarthy Mall, Honolulu, HI 96822 USA.	athula@hawaii.edu; mqmartin@hawaii.edu		Byrum, Christine/0000-0002-6653-7922				Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Ding YN, 2002, TRENDS BIOCHEM SCI, V27, P327, DOI 10.1016/S0968-0004(02)02137-0; FREEMAN G, 1982, DEV BIOL, V94, P142, DOI 10.1016/0012-1606(82)90077-X; Goldstein B, 1997, BIOESSAYS, V19, P105, DOI 10.1002/bies.950190205; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Imai K, 2000, DEVELOPMENT, V127, P3009; Kao KR, 1998, BIOL CELL, V90, P585, DOI 10.1016/S0248-4900(99)80016-1; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Logan CY, 1999, DEVELOPMENT, V126, P345; Mao CA, 1996, DEVELOPMENT, V122, P1489; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Miyawaki K, 2003, DEV GROWTH DIFFER, V45, P121; Montross WT, 2000, J CELL SCI, V113, P1759; Polakis P, 2000, GENE DEV, V14, P1837; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Weitzel HE, 2002, DEV BIOL, V247, P479; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	30	235	240	1	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					446	450		10.1038/nature02113	http://dx.doi.org/10.1038/nature02113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647383				2022-12-01	WOS:000186800800039
J	Sijen, T; Plasterk, RHA				Sijen, T; Plasterk, RHA			Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi	NATURE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; GENE; INTERFERENCE; HELICASE; HOMOLOG; RDE-1	Transposable elements are stretches of DNA that can move and multiply within the genome of an organism. The Caenorhabditis elegans genome contains multiple Tc1 transposons that jump in somatic cells, but are silenced in the germ line(1-3). Many mutants that have lost this silencing have also lost the ability to execute RNA interference (RNAi)(2,3), a process whereby genes are suppressed by exposure to homologous double-stranded RNA ( dsRNA). Here we show how RNAi causes transposon silencing in the nematode germ line. We find evidence for transposon-derived dsRNAs, in particular to the terminal inverted repeats, and show that these RNAs may derive from read-through transcription of entire transposable elements. Small interfering RNAs of Tc1 were detected. When a germline-expressed reporter gene is fused to a stretch of Tc1 sequence, this transgene is silenced in a manner dependent on functional mutator genes (mut-7, mut-16 and pk732). These results indicate that RNAi surveillance is triggered by fortuitous read-through transcription of dispersed Tc1 copies, which can form dsRNA as a result of 'snap-back' of the terminal inverted repeats. RNAi mediated by this dsRNA silences transposase gene expression.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl						Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aroian RV, 1997, EMBO J, V16, P1541, DOI 10.1093/emboj/16.7.1541; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; EMMONS SW, 1983, CELL, V32, P55, DOI 10.1016/0092-8674(83)90496-8; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer SEJ, 2003, GENETICS, V164, P127; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Praitis V, 2001, GENETICS, V157, P1217; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Sijen T, 1996, PLANT CELL, V8, P2277, DOI 10.1105/tpc.8.12.2277; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI [10.1016/S0960-9822(03)00539-6, 10.1016/s0960-9822(03)00539-6]; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Vos JC, 1996, GENE DEV, V10, P755, DOI 10.1101/gad.10.6.755; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	30	337	364	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					310	314		10.1038/nature02107	http://dx.doi.org/10.1038/nature02107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628056				2022-12-01	WOS:000186660800049
J	Prahlad, V; Pilgrim, D; Goodwin, EB				Prahlad, V; Pilgrim, D; Goodwin, EB			Roles for mating and environment in C. elegans sex determination	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; NEMATODE	In Caenorhabditis elegans the two sexes, hermaphrodites and males, are thought to be irreversibly determined at fertilization by the ratio of X chromosomes to sets of autosomes: XX embryos develop as hermaphrodites and XO embryos as males. We show instead that both sex and genotype of C. elegans can be altered postembryonically and that this. exibility requires sexual reproduction. When grown in specific bacterial metabolites, some XX larvae generated by mating males and hermaphrodites develop as males and lose one X chromosome. However, XX larvae produced by hermaphrodite self-fertilization show no such changes. We propose that sexual reproduction increases developmental. exibility of progeny, allowing for better adaptation to changing environments.	Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Alberta, Ctr Biol Sci, CW 405, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Alberta	Goodwin, EB (corresponding author), Univ Wisconsin, Dept Genet, 445 Henry Mall, Madison, WI 53706 USA.	goodwin@wisc.edu	; Pilgrim, David/A-2676-2014	Prahlad, Veena/0000-0002-0413-6074; Pilgrim, David/0000-0001-7820-7915	NIGMS NIH HHS [GM51836] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051836] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; BRENNER S, 1974, GENETICS, V77, P71; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Carmi I, 1998, NATURE, V396, P168, DOI 10.1038/24164; Chasnov JR, 2002, GENETICS, V160, P983; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; DONIACH T, 1986, GENETICS, V114, P53; Edgley ML, 2001, MOL GENET GENOMICS, V266, P385, DOI 10.1007/s004380100523; HODGKIN J, 1992, BIOESSAYS, V14, P253, DOI 10.1002/bies.950140409; KELLY WB, COMMUNICATION; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; Maynard-Smith J., 1978, MODELS ECOLOGY; NELSON GA, 1978, DEV BIOL, V66, P386, DOI 10.1016/0012-1606(78)90247-6; PERRY MD, 1993, GENE DEV, V7, P216, DOI 10.1101/gad.7.2.216; Pigliucci M, 1998, CURR OPIN PLANT BIOL, V1, P87, DOI 10.1016/S1369-5266(98)80133-7; PRAHLAD V, UNPUB; Stewart AD, 2002, GENETICS, V160, P975; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	21	22	26	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1046	1049		10.1126/science.1087946	http://dx.doi.org/10.1126/science.1087946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605370				2022-12-01	WOS:000186396300049
J	Chen, WG; Chang, Q; Lin, YX; Meissner, A; West, AE; Griffith, EC; Jaenisch, R; Greenberg, ME				Chen, WG; Chang, Q; Lin, YX; Meissner, A; West, AE; Griffith, EC; Jaenisch, R; Greenberg, ME			Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2	SCIENCE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; HISTONE DEACETYLASE; SIGNALING PATHWAY; MESSENGER-RNAS; EXPRESSION; MUTATIONS; NEURONS; CELLS; GENE	Mutations in MeCP2, which encodes a protein that has been proposed to function as a global transcriptional repressor, are the cause of Rett syndrome (RTT), an X-linked progressive neurological disorder. Although the selective inactivation of MeCP2 in neurons is sufficient to confer a Rett-like phenotype in mice, the specific functions of MeCP2 in postmitotic neurons are not known. We find that MeCP2 binds selectively to BDNF promoter III and functions to repress expression of the BDNF gene. Membrane depolarization triggers the calcium-dependent phosphorylation and release of MeCP2 from BDNF promoter III, thereby facilitating transcription. These studies indicate that MeCP2 plays a key role in the control of neuronal activity-dependent gene regulation and suggest that the deregulation of this process may underlie the pathology of RTT.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.			Chen, Wen/0000-0003-0853-7526; /0000-0002-7002-1275; Griffith, Eric/0000-0003-0428-3215	NICHD NIH HHS [HD 18655] Funding Source: Medline; NINDS NIH HHS [NS28829] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen W., UNPUB; Chen WG, 2003, J NEUROSCI, V23, P2572; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 2001, HUM MOL GENET, V10, P1085, DOI 10.1093/hmg/10.10.1085; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298	37	944	988	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					885	889		10.1126/science.1086446	http://dx.doi.org/10.1126/science.1086446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593183				2022-12-01	WOS:000186258000055
J	Wernet, MF; Labhart, T; Baumann, F; Mazzoni, EO; Pichaud, F; Desplan, C				Wernet, MF; Labhart, T; Baumann, F; Mazzoni, EO; Pichaud, F; Desplan, C			Homothorax switches function of Drosophila photoreceptors from color to polarized light sensors	CELL			English	Article							MARGINAL OMMATIDIA; OPTIC LOBE; CELL FATES; EYE; RHODOPSIN; GENES; R7; ENCODES; PROTEIN; DIFFERENTIATION	Different classes of photoreceptors (PRs) allow animals to perceive various types of visual information. In the Drosophila eye, the outer PRs of each ommatidium are involved in motion detection while the inner PRs mediate color vision. In addition, flies use a specialized class of inner PRs in the "dorsal rim area" of the eye (DRA) to detect the e-vector of polarized light, allowing them to exploit skylight polarization for orientation. We show that homothorax is both necessary and sufficient for inner PRs to adopt the polarization-sensitive DRA fate instead of the color-sensitive default state. Homothorax increases rhabdomere size and uncouples R7-R8 communication to allow both cells to express the same opsin rather than different ones as required for color vision. Homothorax expression is induced by the iroquois complex and the wingless (wg) pathway. However, crucial wg pathway components are not required, suggesting that additional signals are involved.	NYU, Dept Biol, New York, NY 10003 USA; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	New York University; University of Zurich	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413; Pichaud, Franck/0000-0002-8393-716X; mazzoni, esteban/0000-0001-8994-681X	NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER; MRC [MC_U122673973] Funding Source: UKRI; Medical Research Council [MC_U122673973] Funding Source: Medline; NEI NIH HHS [R01 EY13010] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennan CA, 2000, CELL MOL LIFE SCI, V57, P195, DOI 10.1007/PL00000684; CAMPOSORTEGA JA, 1979, ROUX ARCH DEV BIOL, V186, P27, DOI 10.1007/BF00848106; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRANCESCHINI N, 1971, KYBERNETIK, V8, P1, DOI 10.1007/BF00270828; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; KIRSCHFE.K, 1968, KYBERNETIK, V5, P47, DOI 10.1007/BF00272694; KIRSCHFELD K, 1977, BIOPHYS STRUCT MECH, V3, P191, DOI 10.1007/BF00535818; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Labhart T, 2000, NATURWISSENSCHAFTEN, V87, P133, DOI 10.1007/s001140050691; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; LABHART T, 1988, NATURE, V331, P435, DOI 10.1038/331435a0; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Pichaud F, 2001, DEVELOPMENT, V128, P815; Pichaud F, 2000, MECH DEVELOP, V96, P15, DOI 10.1016/S0925-4773(00)00372-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; ROSSEL S, 1986, NATURE, V323, P128, DOI 10.1038/323128a0; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; TOMLINSON A, 2003, IN PRESS DEV CELL; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; VONPHILIPSBORN A, 1990, J COMP PHYSIOL A, V167, P737, DOI 10.1007/BF00189764; WADA S, 1974, Z MORPHOL TIERE, V77, P87, DOI 10.1007/BF00374212; WEHNER R, 1994, FORTS ZOOL, V39, P103; WOLF R, 1980, J COMP PHYSIOL, V139, P177, DOI 10.1007/BF00657080; WOLFF T, 2000, DROSOPHILA PROTOCOLS, P201; Wolff Tanya, 1993, P1277; WUNDERER H, 1982, INT J INSECT MORPHOL, V11, P25, DOI 10.1016/0020-7322(82)90035-6; XU T, 1993, DEVELOPMENT, V117, P1223; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	50	146	151	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					267	279		10.1016/S0092-8674(03)00848-1	http://dx.doi.org/10.1016/S0092-8674(03)00848-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636555	Bronze			2022-12-01	WOS:000186415000007
J	Martina, BEE; Haagmans, BL; Kuiken, T; Fouchier, RAM; Rimmelzwaan, GF; van Amerongen, G; Peiris, JSM; Lim, W; Osterhaus, ADME				Martina, BEE; Haagmans, BL; Kuiken, T; Fouchier, RAM; Rimmelzwaan, GF; van Amerongen, G; Peiris, JSM; Lim, W; Osterhaus, ADME			SARS virus infection of cats and ferrets	NATURE			English	Article							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS		Erasmus Med Ctr, Inst Virol, NL-3015 GE Rotterdam, Netherlands; Queen Mary Hosp, Dept Pathol & Microbiol, Hong Kong, Hong Kong, Peoples R China; Govt Virus Unit, Kowloon, Hong Kong, Peoples R China	Erasmus University Rotterdam; Erasmus MC; University of Hong Kong	Martina, BEE (corresponding author), Erasmus Med Ctr, Inst Virol, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014; Haagmans, Bart/E-9791-2015	Fouchier, Ron A/0000-0001-8095-2869; Haagmans, Bart/0000-0001-6221-2015; Osterhaus, Albert/0000-0002-6074-1172				Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2	5	421	455	57	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					915	915		10.1038/425915a	http://dx.doi.org/10.1038/425915a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586458	Green Published, Bronze			2022-12-01	WOS:000186230600030
J	Khot, UN; Jia, G; Moliterno, DJ; Lincoff, AM; Khot, MB; Harrington, RA; Topol, EJ				Khot, UN; Jia, G; Moliterno, DJ; Lincoff, AM; Khot, MB; Harrington, RA; Topol, EJ			Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes - The enduring value of Killip classification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLATELET GLYCOPROTEIN IIB/IIIA; ACUTE ISCHEMIC SYNDROMES; UNSTABLE ANGINA; RISK STRATIFICATION; SEGMENT ELEVATION; DOPPLER-ECHOCARDIOGRAPHY; CARDIAC AUSCULTATION; CARDIOGENIC-SHOCK; EJECTION FRACTION	Context In acute myocardial infarction, the presence and severity of heart failure at the time of initial presentation have been formally categorized by the Killip classification. Although well studied in ST-elevation myocardial infarction, the prognostic importance of Killip classification in non-ST-elevation acute coronary syndromes is not well established. Objectives To determine the prognostic importance of physical examination for heart failure analyzed according to Killip classification in non-ST-elevation acute coronary syndromes and to understand its predictive value relative to other variables. Design, Setting, and Patients From April 2001 to September 2003, We analyzed information from 26090 patients with non-ST-elevation acute coronary syndromes enrolled in the GUSTO IIb, PURSUIT, PARAGON A, and PARAGON B trials. Demographic information was categorized by Killip class. Killip classes III and IV were combined into 1 category. Multivariate Cox proportional hazard models were developed to determine the prognostic importance of Killip classification in comparison with other variables. Main Outcome Measure Association between Killip classification and all-cause mortality at 30 days and 6 months. Results Patients in Killip class II (n =2513) and III/IV (n =390) were older than those in Killip class I (n =23 187), with higher rates of diabetes, prior myocardial infarction, ST depression, and elevated cardiac enzymes (all P<.001). Higher Killip class was associated with higher mortality at 30 days (2.8% in Killip class I vs 8.8% in class II vs 14.4% in class III/IV; P<.001) and 6 months (5.0% vs 14.7% vs 23.0%, respectively; P<.001). Patients with Killip class II, III, or IV constituted 11% of the overall population but accounted for approximately 30% of the deaths at both time points. In multivariate analysis, Killip class III/IV was the most powerful predictor of mortality at 30 days (hazard ratio [HR], 2.35; 95% confidence interval [CI], 1.69-3.26; P<.001) and 6 months (HR, 2.12; 95% Cl, 1.63-2.75; P<.001). Killip class 11 was predictive of mortality at 30 days (HR, 1.73; 95% Cl, 1.44-2.09; P<.001) and 6 months (HR, 1.52; 95% Cl, 1.31-1.76; P<.001). Five factors-age, Killip classification, heart rate, systolic blood pressure, and ST depression-provided more than 70% of the prognostic information for 30-day and 6-month mortality. Conclusions Killip classification is a powerful independent predictor of all-cause mortality in patients with non-ST-elevation acute coronary syndromes. Age, Killip classification, heart rate, systolic blood pressure, and ST depression should receive particular attention in the initial assessment of these patients.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Duke Clin Res Inst, Durham, NC USA	Cleveland Clinic Foundation; Duke University	Khot, UN (corresponding author), Indiana Heart Phys, 112 N 17th Ave,Suite 300, Beech Grove, IN 46107 USA.			Topol, Eric/0000-0002-1478-4729				Alexander JH, 2000, JAMA-J AM MED ASSOC, V283, P347, DOI 10.1001/jama.283.3.347; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; Bazzino O, 1999, AM HEART J, V137, P322, DOI 10.1053/hj.1999.v137.93029; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Braunwald E, 1994, UNSTABLE ANGINA DIAG; BROWN KA, 1991, J AM COLL CARDIOL, V17, P1053, DOI 10.1016/0735-1097(91)90829-X; CHATTERJEE K, 2002, TXB CARDIOVASCULAR M, P273; COL NF, 1994, AM J CARDIOL, V73, P149, DOI 10.1016/0002-9149(94)90206-2; Collinson J, 2000, EUR HEART J, V21, P1450, DOI 10.1053/euhj.1999.1995; Coronado BE, 1997, J AM COLL CARDIOL, V29, P1490, DOI 10.1016/S0735-1097(97)00077-6; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; de Sa EL, 2002, MEDICINE, V81, P434, DOI 10.1097/00005792-200211000-00004; DeGeare VS, 2001, AM J CARDIOL, V87, P1035, DOI 10.1016/S0002-9149(01)01457-6; Diderholm E, 2002, AM HEART J, V143, P760, DOI 10.1067/mhj.2002.121733; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Gigli G, 2002, Eur J Echocardiogr, V3, P59, DOI 10.1053/euje.2001.0119; Harrington RA, 2002, CIRCULATION, V105, P316; Holmes DR, 1999, CIRCULATION, V100, P2067, DOI 10.1161/01.CIR.100.20.2067; JAFFE WM, 1988, CIRCULATION, V78, P267, DOI 10.1161/01.CIR.78.2.267; Katz DA, 1996, JAMA-J AM MED ASSOC, V276, P1568; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; LAUNBJERG J, 1992, CARDIOLOGY, V80, P375, DOI 10.1159/000175028; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Mangione S, 1999, AM J RESP CRIT CARE, V159, P1119, DOI 10.1164/ajrccm.159.4.9806083; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; Moller JE, 2001, J AM SOC ECHOCARDIOG, V14, P757, DOI 10.1067/mje.2001.113367; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Neskovic AN, 1999, AM HEART J, V137, P361, DOI 10.1053/hj.1999.v137.89744; NICOD P, 1988, AM J CARDIOL, V61, P1165, DOI 10.1016/0002-9149(88)91148-4; Roe MT, 2000, CIRCULATION, V102, P1101, DOI 10.1161/01.CIR.102.10.1101; Rott D, 1997, AM J CARDIOL, V80, P859, DOI 10.1016/S0002-9149(97)00536-5; Savonitto S, 2002, J AM COLL CARDIOL, V39, P22, DOI 10.1016/S0735-1097(01)01706-5; Schneiderman H, 2001, AM J MED, V110, P233, DOI 10.1016/S0002-9343(00)00736-1; Seres L, 1999, AM J CARDIOL, V84, P963, DOI 10.1016/S0002-9149(99)00481-6; Solomon DH, 2001, J AM COLL CARDIOL, V38, P969, DOI 10.1016/S0735-1097(01)01503-0; Tavel ME, 1996, CIRCULATION, V93, P1250, DOI 10.1161/01.CIR.93.6.1250; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol E, 1998, CIRCULATION, V97, P2386; Topol EJ, 1996, NEW ENGL J MED, V335, P775; WARNOWICZ MA, 1983, CIRCULATION, V67, P330, DOI 10.1161/01.CIR.67.2.330	41	154	165	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2003	290	16					2174	2181		10.1001/jama.290.16.2174	http://dx.doi.org/10.1001/jama.290.16.2174			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CB	14570953	Bronze			2022-12-01	WOS:000186036700027
J	Vasan, RS; Sullivan, LM; D'Agostino, RB; Roubenoff, R; Harris, T; Sawyer, DB; Levy, D; Wilson, PWF				Vasan, RS; Sullivan, LM; D'Agostino, RB; Roubenoff, R; Harris, T; Sawyer, DB; Levy, D; Wilson, PWF			Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							DILATED CARDIOMYOPATHY; BODY-COMPOSITION; TRANSGENIC MICE; OLDER WOMEN; WALL STRESS; HYPERTROPHY; HORMONE; OVEREXPRESSION; DISEASE; EPIDEMIOLOGY	Background: several experimental investigations have emphasized the favorable effects of insulin-like growth factor I (IGF-1) on left ventricular remodeling, partly through its antiapoptotic effects. Cross-sectional clinical studies have reported that low serum IGF-I levels in patients with heart failure correlate with cachexia and severity of ventricular dysfunction. it is unclear whether low serum IGF-I is a risk factor for heart failure. Objective: To prospectively study the association between serum IGF-I level and the incidence of congestive heart failure. Design: Community-based, prospective cohort study. Setting: Framingham, Massachusetts. Participants: 717 elderly individuals (mean age, 78.4 years; 67% women) who did not have myocardial infarction and congestive heart failure at baseline. Measurement: Incidence of a first episode of congestive heart failure on follow-up. Results: During follow-up (mean, 5.2 years), 56 participants (35 women) developed congestive heart failure. In multivarlable Cox regression models adjusting for established risk factors at baseline, there was a 27% decrease in risk for heart failure for every 1 standard. deviation increment in log IGF-I. Individuals with serum IGF-I level at or above the median value (140 mug/L) had half the risk for heart failure (hazard ratio, 0.49 [95% Cl, 0.26 to 0.92]) of those with serum IGF-I levels below the median. These comparisons were maintained in analyses adjusting for the occurrence of a myocardial infarction on follow-up. Conclusions: In our prospective, community-based investigation, serum IGF-I level was inversely related to the risk for congestive heart failure in elderly people without a previous myocardial infarction. Additional investigations are warranted to confirm these findings.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Boston, MA 02215 USA; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; NHLBI, Bethesda, MD 20892 USA; NIA, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Wilson, Peter W.F./J-2455-2016	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Roubenoff, Ronenn/0000-0002-3959-3179; Sullivan, Lisa/0000-0003-0726-7149	NHLBI NIH HHS [N01-HC-25195, 1K24 HL04334] Funding Source: Medline; NIA NIH HHS [AG15797] Funding Source: Medline; NIDDK NIH HHS [DK02120] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG015797] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMBLER GR, 1993, CARDIOVASC RES, V27, P1368, DOI 10.1093/cvr/27.7.1368; Anker SD, 2001, J AM COLL CARDIOL, V38, P443, DOI 10.1016/S0735-1097(01)01385-7; Anversa P, 1996, CARDIOVASC RES, V32, P484, DOI 10.1016/S0008-6363(96)00036-3; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Benbassat CA, 1997, J CLIN ENDOCR METAB, V82, P1484, DOI 10.1210/jc.82.5.1484; Bruch C, 2002, AM HEART J, V144, P538, DOI 10.1067/mhj.2002.123572; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Cox DR., 1984, ANAL SURVIVAL DATA; Cupples LA, 1987, FRAMINGHAM STUDY EPI; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Donath MY, 1998, J CLIN ENDOCR METAB, V83, P3177, DOI 10.1210/jc.83.9.3177; DUERR RL, 1995, J CLIN INVEST, V95, P619, DOI 10.1172/JCI117706; GoodmanGruen D, 1997, AM J EPIDEMIOL, V145, P970, DOI 10.1093/oxfordjournals.aje.a009065; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Harris TB, 1997, J AM GERIATR SOC, V45, P133, DOI 10.1111/j.1532-5415.1997.tb04497.x; HINTZ RL, 1988, HORM METAB RES, V20, P344, DOI 10.1055/s-2007-1010832; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Khan AS, 2002, CARDIOVASC RES, V54, P25, DOI 10.1016/S0008-6363(01)00533-8; Lee WL, 1999, ENDOCRINOLOGY, V140, P4831, DOI 10.1210/en.140.10.4831; Leri A, 1999, CIRC RES, V84, P752; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; Niebauer J, 1998, J AM COLL CARDIOL, V32, P393, DOI 10.1016/S0735-1097(98)00226-5; Osterziel KJ, 1998, LANCET, V351, P1233, DOI 10.1016/S0140-6736(97)11329-0; Parkhouse WS, 2000, MECH AGEING DEV, V113, P75, DOI 10.1016/S0047-6374(99)00103-7; Redaelli G, 1998, CIRC RES, V82, P594, DOI 10.1161/01.RES.82.5.594; Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036; Serneri GGN, 1999, CIRC RES, V85, P57; Tai BC, 2001, STAT MED, V20, P661, DOI 10.1002/sim.711; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Vecchione C, 2001, HYPERTENSION, V37, P1480, DOI 10.1161/01.HYP.37.6.1480; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Wang PH, 2001, CIRC RES, V88, P552, DOI 10.1161/01.RES.88.6.552; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75	38	218	226	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2003	139	8					642	648		10.7326/0003-4819-139-8-200310210-00007	http://dx.doi.org/10.7326/0003-4819-139-8-200310210-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734DW	14568852				2022-12-01	WOS:000186040800002
J	Wilcken, NRC; Stockler, MTR				Wilcken, NRC; Stockler, MTR			Fulvestrant: spreading the word, but not too thinly	LANCET			English	Editorial Material							ADVANCED BREAST-CANCER; POSTMENOPAUSAL WOMEN; ANASTROZOLE		Westmead Hosp, NSW Breast Canc Inst, Sydney, NSW, Australia; Westmead Hosp, Dept Med Oncol, Sydney, NSW, Australia; NHMRC Clin Trials Ctr, Sydney, NSW, Australia; Sydney Canc Ctr, RPA & Concord Hosp, Sydney, NSW, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Wilcken, NRC (corresponding author), Westmead Hosp, NSW Breast Canc Inst, Sydney, NSW, Australia.	nicholasw@westgate.wh.usyd.edu.au	Stockler, Martin R/N-3859-2016	Stockler, Martin R/0000-0003-3793-8724				[Anonymous], 1988, LANCET, V2, P349; *ASTR, 2002, FASL FULV INJ HORM T; Fletcher RH, 2003, LANCET, V361, P10, DOI 10.1016/S0140-6736(03)12185-X; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Mauriac L, 2003, EUR J CANCER, V39, P1228, DOI 10.1016/S0959-8049(03)00199-0; Osborne CK, 2002, J CLIN ONCOL, V20, P3386, DOI 10.1200/JCO.2002.10.058; STOCKLER M, 1993, MED J AUSTRALIA, V159, P291, DOI 10.5694/j.1326-5377.1993.tb137859.x; Tannock IF, 1996, J NATL CANCER I, V88, P206, DOI 10.1093/jnci/88.3-4.206	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2003	362	9392					1254	1254		10.1016/S0140-6736(03)14616-8	http://dx.doi.org/10.1016/S0140-6736(03)14616-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575967				2022-12-01	WOS:000186036900006
J	Colavita, A; Tessier-Lavigne, M				Colavita, A; Tessier-Lavigne, M			A neurexin-related protein, BAM-2, terminates axonal branches in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; NEURONS	Neuronal axons connect to multiple target cells through the formation of collateral branches, but the mechanisms that regulate this process are largely unknown. We show that BAM-2, a neurexin-related transmembrane protein, is required for development of VC motoneuron branches in the worm Caenorhabditis elegans. Expression analysis and ectopic expression experiments suggest that BAM-2 functions as a branch termination cue and reveal a mechanism for selective control of branches that sprout off a primary axon.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Tessier-Lavigne, M (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com		Colavita, Antonio/0000-0001-9391-5282				Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; LI C, 1990, NEURON, V4, P681, DOI 10.1016/0896-6273(90)90195-L; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; OLSEN PT, COMMUNICATION; PELES E, COMMUNICATION; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; TAKAO I, 2002, GENE EXPR PATTERNS, V2, P235; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	18	24	35	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					293	296		10.1126/science.1089163	http://dx.doi.org/10.1126/science.1089163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	14551437				2022-12-01	WOS:000185825900044
J	Whitfield, CW; Cziko, AM; Robinson, GE				Whitfield, CW; Cziko, AM; Robinson, GE			Gene expression profiles in the brain predict behavior in individual honey bees	SCIENCE			English	Article							MICROARRAYS; GENOMICS	We show that the age-related transition by adult honey bees from hive work to foraging is associated with changes in messenger RNA abundance in the brain for 39% of similar to5500 genes tested. This result, discovered using a highly replicated experimental design involving 72 microarrays, demonstrates more extensive genomic plasticity in the adult brain than has yet been shown. Experimental manipulations that uncouple behavior and age revealed that messenger RNA changes were primarily associated with behavior. Individual brain messenger RNA profiles correctly predicted the behavior of 57 out of 60 bees, indicating a robust association between brain gene expression in the individual and naturally occurring behavioral plasticity.	Univ Illinois, Dept Entomol, 320 Morrill Hall,505 S Goodwin Ave, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall,505 S Goodwin Ave, Urbana, IL 61801 USA.	generobi@life.uiuc.edu						Alcock J., 2001, ANIMAL BEHAV EVOLUTI; Becker JB, 1992, BEHAV ENDOCRINOLOGY; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; CASH AC, UNPUB; Cavallaro S, 2002, NEUROCHEM RES, V27, P1201, DOI 10.1023/A:1020933627597; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Etter PD, 2002, BIOESSAYS, V24, P494, DOI 10.1002/bies.10109; Gibson G, 2002, MOL ECOL, V11, P17, DOI 10.1046/j.0962-1083.2001.01425.x; Greenspan RJ, 1997, CURR OPIN NEUROBIOL, V7, P805, DOI 10.1016/S0959-4388(97)80139-0; Hofmann HA, 2000, J NEUROSCI, V20, P4740, DOI 10.1523/JNEUROSCI.20-12-04740.2000; Korol DL, 1998, AM J CLIN NUTR, V67, p764S, DOI 10.1093/ajcn/67.4.764S; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Mong JA, 2003, P NATL ACAD SCI USA, V100, P318, DOI 10.1073/pnas.262663799; Oster G.F., 1978, Monographs in Population Biology, pi; Robinson GE, 2002, AM NAT, V160, pS160, DOI 10.1086/342901; Robinson GE, 2002, GENES BRAIN BEHAV, V1, P197, DOI 10.1034/j.1601-183X.2002.10401.x; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Sun MK, 2002, TRENDS PHARMACOL SCI, V23, P83, DOI 10.1016/S0165-6147(02)01899-0; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Townsend JP, 2002, GENOME BIOL, V3; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Winston M. L., 1987, BIOL HONEY BEE; 2003, NATURE NEUROSCI, V6, P647	27	445	468	0	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					296	299		10.1126/science.1086807	http://dx.doi.org/10.1126/science.1086807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	14551438				2022-12-01	WOS:000185825900045
J	Anderson, RM; Latorre-Esteves, M; Neves, AR; Lavu, S; Medvedik, O; Taylor, C; Howitz, KT; Santos, H; Sinclair, DA				Anderson, RM; Latorre-Esteves, M; Neves, AR; Lavu, S; Medvedik, O; Taylor, C; Howitz, KT; Santos, H; Sinclair, DA			Yeast life-span extension by calorie restriction is independent of NAD fluctuation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN SIR2; NICOTINAMIDE; REGULATOR; LONGEVITY; STRESS	Calorie restriction (CR) slows aging in numerous species. In the yeast Saccharomyces cerevisiae, this effect requires Sir2, a conserved NAD(+)-dependent deacetylase. We report that CR reduces nuclear NAD(+) levels in vivo. Moreover, the activity of Sir2 and its human homologue SIRT1 are not affected by physiological alterations in the NAD(+): NADH ratio. These data implicate alternate mechanisms of Sir2 regulation by CR.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; Biomol Res Labs Inc, Plymouth Meeting, PA 19462 USA	Harvard University; Harvard Medical School; Universidade Nova de Lisboa	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	David_Sinclair@hms.harvard.edu	Latorre-Esteves, Magda/GMW-6353-2022; Neves, Ana/B-9476-2008; Santos, Helena/B-9141-2011	Neves, Ana/0000-0003-4896-9585; Santos, Helena/0000-0002-8050-9485; Sinclair, David/0000-0002-9936-436X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG019972, R01AG019719, R01AG028730, P01AG027916] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG019719, R37 AG028730, R01 AG019972, R01 AG028730, P01 AG027916] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; ANDERSON RW, UNPUB; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; PAINE PL, 1975, J CELL BIOL, V66, P652, DOI 10.1083/jcb.66.3.652; Penfound T, 1999, J BACTERIOL, V181, P648, DOI 10.1128/JB.181.2.648-655.1999; Sandmeier JJ, 2002, GENETICS, V160, P877; Shama S, 1998, EXP CELL RES, V245, P379, DOI 10.1006/excr.1998.4279; Sies H, 1982, METABOLIC COMPARTMEN; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Swiecilo A, 2000, ACTA BIOCHIM POL, V47, P355; UNKEFER CJ, 1984, J BIOL CHEM, V259, P2311; Wei YM, 2001, BIOCHEMISTRY-US, V40, P11279, DOI 10.1021/bi011085z; Zhang QH, 2002, SCIENCE, V295, P1895	23	125	133	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2124	2126		10.1126/science.1088697	http://dx.doi.org/10.1126/science.1088697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14605207	Green Accepted			2022-12-01	WOS:000187385200045
J	Boulware, LE; Jaar, BG; Tarver-Carr, ME; Brancati, FL; Powe, NR				Boulware, LE; Jaar, BG; Tarver-Carr, ME; Brancati, FL; Powe, NR			Screening for proteinuria in US adults - A cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							3RD NATIONAL-HEALTH; PERCUTANEOUS RENAL BIOPSY; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; FOLLOW-UP; MULTIFACTORIAL INTERVENTION; MEDICATION ADHERENCE	Context Chronic kidney disease is a growing public health problem. Screening for early identification could improve health but could also lead to unnecessary harms and excess costs. Objective To assess the value of periodic, population-based dipstick screening for early detection of urine protein in adults with neither hypertension nor diabetes and in adults with hypertension. Design, Setting, and Population Cost-effectiveness analysis using a Markov decision analytic model to compare a strategy of annual screening with no screening (usual care) for proteinuria at age 50 years followed by treatment with an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II-receptor blocker (ARB). Main Outcome Measure Cost per quality-adjusted life-year (QALY). Results For persons with neither hypertension nor diabetes, the cost-effectiveness ratio for screening vs no screening (usual care) was unfavorable ($282 818 per QALY; incremental cost of $616 and a gain of 0.0022 QALYs per person). However, screening such persons beginning at age 60 years yielded a more favorable ratio ($53 372 per QALY). For persons with hypertension, the ratio was highly favorable ($18621 per QALY; incremental cost of $476 and a gain of 0.03 QALYs per person). Cost-effectiveness was mediated by both chronic kidney disease progression and death prevention benefits of ACE inhibitor and ARB therapy. Influential parameters that might make screening for the general population more cost-effective include a greater incidence of proteinuria, age at screening ($53 372 per QALY for persons beginning screening at age 60 years), or lower frequency of screening (every 10 years: $80700 per QALY at age 50 years; $6195 per QALY at age 60 years; and $5486 per QALY at age 70 years). Conclusions Early detection of urine protein to slow progression of chronic kidney disease and decrease mortality is not cost-effective unless selectively directed toward high-risk groups (older persons and persons with hypertension) or conducted at an infrequent interval of 10 years.	Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boulware, LE (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-635, Baltimore, MD 21205 USA.	lboulwa@jhmi.edu	Jaar, Bernard/B-1917-2009	Boulware, Ebony/0000-0002-8650-4212; Jaar, Bernard/0000-0003-1210-7115	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059616] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; American Diabetes Association, 2003, DIABETES CARE, V26, pS80, DOI DOI 10.2337/DIACARE.26.2007.S80; Barat I, 2001, BRIT J CLIN PHARMACO, V51, P615, DOI 10.1046/j.0306-5251.2001.01401.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cabana MD, 2000, ARCH PEDIAT ADOL MED, V154, P685, DOI 10.1001/archpedi.154.7.685; CAREL RS, 1987, CLIN CHEM, V33, P2106; CHANG P, PHARM MARKET SHARE D; CHERRY DK, 2002, NATL AMBULATORY MED; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Clause SL, 2002, ANN PHARMACOTHER, V36, P1505; Coon P, 2002, DIABETES CARE, V25, P2224, DOI 10.2337/diacare.25.12.2224; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; *CTR MED MED SERV, 2003 CLIN DIAGN LAB; *CTR MED MED SERV, 2000 MED PROV AN REV; *CTR MED MED SERV, 2003 NAT PHYS FRE; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; de Wit GA, 2002, NEPHROL DIAL TRANSPL, V17, P86, DOI 10.1093/ndt/17.1.86; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Erlinger TP, 2000, J AM GERIATR SOC, V48, P1486, DOI 10.1111/jgs.2000.48.11.1486; Farber HJ, 2003, J ASTHMA, V40, P17, DOI 10.1081/JAS-120017203; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Fuiano G, 2000, AM J KIDNEY DIS, V35, P448, DOI 10.1016/S0272-6386(00)70197-1; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; *IMS HLTH, ANG ANT DAT IMPR; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; JAMES GP, 1978, CLIN CHEM, V24, P1934; JEE SH, 2003, 43 ANN C CARD DIS EP; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; Kiberd BA, 1995, BRIT MED J, V311, P1595, DOI 10.1136/bmj.311.7020.1595; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KLEIN R, 1995, DIABETES, V44, P916, DOI 10.2337/diabetes.44.8.916; KUTNER NG, 1991, AM J NEPHROL, V11, P334, DOI 10.1159/000168333; LEBOVITZ HE, 1994, KIDNEY INT, V45, pS150; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lipscomb J, 1996, COST EFFECTIVENESS H, P214; Lonn E, 2002, J AM COLL CARDIOL, V40, P693, DOI 10.1016/S0735-1097(02)02035-1; LUCE BR, 1996, COST EFFECTIVENESS H, P176; MADAIO MP, 1990, KIDNEY INT, V38, P529, DOI 10.1038/ki.1990.236; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manninen D L, 1991, Clin Transpl, P193; Markell MS, 1997, AM J KIDNEY DIS, V29, P881, DOI 10.1016/S0272-6386(97)90462-5; MARTIN TL, 1995, DIABETES CARE, V18, P1124, DOI 10.2337/diacare.18.8.1124; Marwah DS, 1996, AM J KIDNEY DIS, V28, P47, DOI 10.1016/S0272-6386(96)90129-8; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; *MED EC CO, 2001, 2001 DRUG TOP RED BO; Mehta SS, 1999, AM J HYPERTENS, V12, P333, DOI 10.1016/S0895-7061(00)86958-7; MENDELSSOHN DC, 1995, AM J KIDNEY DIS, V26, P580, DOI 10.1016/0272-6386(95)90592-8; Merkus MP, 1997, AM J KIDNEY DIS, V29, P584, DOI 10.1016/S0272-6386(97)90342-5; Molitch ME, 2003, DIABETES CARE, V26, pS94, DOI [10.2337/diacare.26.2007.s94, DOI 10.2337/DIACARE.26.2007.S94]; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Nass K, 1999, AM J KIDNEY DIS, V34, P955, DOI 10.1016/S0272-6386(99)70058-2; *NAT KIDN FDN, 2000, NAT KIDN FDN CLIN PR; Nelson CR, 2000, HYPERTENSION, V36, P600, DOI 10.1161/01.HYP.36.4.600; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Ni H, 2003, AM HEART J, V146, P121, DOI 10.1016/S0002-8703(02)94800-3; Nosadini R, 2000, DIABETES, V49, P476, DOI 10.2337/diabetes.49.3.476; *OFF AN EP NCHS, CDC WOND 1999 COMPR; Okosun IS, 2000, ANN EPIDEMIOL, V10, P263, DOI 10.1016/S1047-2797(00)00045-4; Palmer AJ, 2000, DIABETOLOGIA, V43, P13, DOI 10.1007/s001250050003; PARRISH AE, 1992, CLIN NEPHROL, V38, P135; Patel RP, 2002, ANN PHARMACOTHER, V36, P40, DOI 10.1345/aph.1A046; Rachmani R, 2000, DIABETES RES CLIN PR, V49, P187, DOI 10.1016/S0168-8227(00)00155-8; Raiz L, 1997, J Health Soc Policy, V8, P67, DOI 10.1300/J045v08n04_05; RALSTON SH, 1988, ANN RHEUM DIS, V47, P759, DOI 10.1136/ard.47.9.759; Ramsey SD, 2001, MED CARE, V39, P979, DOI 10.1097/00005650-200109000-00008; RASGON S, 1993, AM J KIDNEY DIS, V22, P403, DOI 10.1016/S0272-6386(12)70143-9; Renal Physicians Association, 2001, Clin Nephrol, V56, P179; Ruggenenti P, 1998, BRIT MED J, V316, P504, DOI 10.1136/bmj.316.7130.504; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Schoenfeld ER, 2001, OPHTHALMOLOGY, V108, P563, DOI 10.1016/S0161-6420(00)00600-X; SHAW ST, 1985, JAMA-J AM MED ASSOC, V253, P1596, DOI 10.1001/jama.253.11.1596; Speirs C, 1998, BRIT J CLIN PHARMACO, V46, P63, DOI 10.1046/j.1365-2125.1998.00031.x; Stratta P, 1996, AM J KIDNEY DIS, V27, P631, DOI 10.1016/S0272-6386(96)90096-7; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; *THOMPS MICR, 2003, MICR HLTH CAR SER, P116; Torffvit O, 2001, J DIABETES COMPLICAT, V15, P307, DOI 10.1016/S1056-8727(01)00176-3; *US DEP HHS, 2000, DET DIS PAT CHRON RE; *US DEP LAB, 2002, NAT COMP SURV 2001; *US REN DAT SYST, USRDS 2002 ANN DAT R; van Manen JG, 2001, PERITON DIALYSIS INT, V21, P595; Vargas CM, 2000, AM J EPIDEMIOL, V152, P272, DOI 10.1093/aje/152.3.272; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Voyaki SM, 2001, J HYPERTENS, V19, P511, DOI 10.1097/00004872-200103000-00020; Wang PS, 2002, J GEN INTERN MED, V17, P504, DOI 10.1046/j.1525-1497.2002.00406.x; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; WOOLHANDLER S, 1989, JAMA-J AM MED ASSOC, V262, P1214, DOI 10.1001/jama.262.9.1214; Wyatt RJ, 1998, J AM SOC NEPHROL, V9, P853; Yusuf HR, 1998, PREV MED, V27, P1, DOI 10.1006/pmed.1997.0268; Yusuf S, 2000, NEW ENGL J MED, V342, P145	107	279	295	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3101	3114		10.1001/jama.290.23.3101	http://dx.doi.org/10.1001/jama.290.23.3101			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	753ZB	14679273	Bronze			2022-12-01	WOS:000187277300029
J	Inoki, K; Zhu, TQ; Guan, KL				Inoki, K; Zhu, TQ; Guan, KL			TSC2 mediates cellular energy response to control cell growth and survival	CELL			English	Article							ACTIVATED PROTEIN-KINASE; P70 S6 KINASE; TUMOR-SUPPRESSOR GENE; TUBEROUS-SCLEROSIS; MAMMALIAN TARGET; RAPAMYCIN; MTOR; PHOSPHORYLATION; INSULIN; COMPLEX	Mutations in either the TSC1 or TSC2 tumor suppressor gene are responsible for Tuberous Sclerosis Complex. The gene products of TSC1 and TSC2 form a functional complex and inhibit the phosphorylation of S6K and 4EBP1, two key regulators of translation. Here, we describe that TSC2 is regulated by cellular energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. Phosphorylation of TSC2 by AMPK is required for translation regulation and cell size control in response to energy deprivation. Furthermore, TSC2 and its phosphorylation by AMPK protect cells from energy deprivation-induced apoptosis. These observations demonstrate a model where TSC2 functions as a key player in regulation of the common mTOR pathway of protein synthesis, cell growth, and viability in response to cellular energy levels.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022; INOKI, KEN/A-1202-2007					Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.tb20498.x; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kenerson HL, 2002, CANCER RES, V62, P5645; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Krause U, 2002, EUR J BIOCHEM, V269, P3751, DOI 10.1046/j.1432-1033.2002.03074.x; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	2861	2980	10	221	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					577	590		10.1016/S0092-8674(03)00929-2	http://dx.doi.org/10.1016/S0092-8674(03)00929-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651849	Bronze			2022-12-01	WOS:000186885600008
J	Imaizumi, T; Tran, HG; Swartz, TE; Briggs, WR; Kay, SA				Imaizumi, T; Tran, HG; Swartz, TE; Briggs, WR; Kay, SA			FKF1 is essential for photoperiodic-specific light signalling in Arabidopsis	NATURE			English	Article							CIRCADIAN CLOCK; PHOTORECEPTOR PHOTOTROPIN; PROTEIN; PLANTS; NPH1; PURIFICATION; TRANSDUCTION; RECEPTORS; MEDIATE; DOMAINS	Adaptation to seasonal change is a crucial component of an organism's survival strategy. To monitor seasonal variation, organisms have developed the capacity to measure day length ( photoperiodism). Day-length assessment involves the photoperiodic control of flowering in Arabidopsis thaliana, whereby the coincidence of light and high expression of CONSTANS ( CO) induces the expression of FLOWERING LOCUS T (FT), leading to flowering in long-day conditions(1). Although controlling CO expression is clearly a key step in day-length discrimination, the mechanism that generates day-length-dependent CO expression remains unknown. Here we show that the clock-controlled FLAVIN-BINDING, KELCH REPEAT, F-BOX (FKF1)(2) protein has an essential role in generating the diurnal CO peak and that this function is dependent on light. We show that a recombinant FKF1 LIGHT, OXYGEN OR VOLTAGE ( LOV)(3) domain binds the chromophore flavin mononucleotide and undergoes light-induced photochemistry, indicating that FKF1 may function as a photoperiodic blue-light receptor. It is likely that the circadian control of FKF1 expression and the light regulation of FKF1 function coincide to control the daytime CO waveform precisely, which in turn is crucial for day-length discrimination by Arabidopsis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA	Scripps Research Institute; Carnegie Institution for Science	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; CARRINGTON JC, 1991, PLANT CELL, V3, P953, DOI 10.1105/tpc.3.9.953; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yanovsky MJ, 2001, J BIOL RHYTHM, V16, P523, DOI 10.1177/074873001129002213	28	413	460	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					302	306		10.1038/nature02090	http://dx.doi.org/10.1038/nature02090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628054				2022-12-01	WOS:000186660800047
J	Silk, JB; Alberts, SC; Altmann, J				Silk, JB; Alberts, SC; Altmann, J			Social bonds of female baboons enhance infant survival	SCIENCE			English	Article							NONHUMAN-PRIMATES; ENVIRONMENT; EVOLUTION; MONKEYS; STRESS	Among nonhuman primates, females often form strong bonds with kin and other group members. These relationships are thought to have adaptive value for females, but direct effects of sociality on fitness have never been demonstrated. We present 16 years of behavioral data from a well-studied population of wild baboons, which demonstrate that sociality of adult females is positively associated with infant survival, an important component of variation in female lifetime fitness. The effects of sociality on infant survival are independent of the effects of dominance rank, group membership, and environmental conditions. Our results are consistent with the evidence that social support has beneficial effects on human health and well-being across the life span. For humans and other primates, sociality has adaptive value.	Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; Brookfield Zoo, Dept Conservat Biol, Brookfield, IL 60513 USA	University of California System; University of California Los Angeles; Duke University; Princeton University	Silk, JB (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA.							ALBERTS SC, IN PRESS PRIMATE SEA; Altmann J, 2003, OFFSPRING, P140; AURELLI F, 2000, NATURAL CONFLICT RES, P193; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cacioppo JT, 2000, INT J PSYCHOPHYSIOL, V35, P143, DOI 10.1016/S0167-8760(99)00049-5; CHENEY D, 1986, SCIENCE, V234, P1361, DOI 10.1126/science.3538419; Clutton-Brock Timothy H., 1988, REPROD SUCCESS STUDI; COHEN S, 1992, PSYCHOL SCI, V3, P301, DOI 10.1111/j.1467-9280.1992.tb00677.x; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; Cords M., 1997, MACHIAVELLIAN INTELL, P24, DOI [10.1017/CBO9780511525636.003, DOI 10.1017/CBO9780511525636.003]; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Gardner W, 2000, HDB PSYCHOPHYSIOLOGY, P643; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; LEFEVRE JA, 1992, PHYSIOL BEHAV, V52, P603, DOI 10.1016/0031-9384(92)90354-5; Melnick D.J., 1987, P121; Palombit RA, 1999, EVOL ANTHROPOL, V7, P117, DOI 10.1002/(SICI)1520-6505(1999)7:4<117::AID-EVAN2>3.0.CO;2-O; SALTZMAN W, 1991, PHYSIOL BEHAV, V50, P271, DOI 10.1016/0031-9384(91)90066-W; Sapolsky RM, 1997, ARCH GEN PSYCHIAT, V54, P1137; Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; SHIVELY CA, 1989, ATHEROSCLEROSIS, V77, P69, DOI 10.1016/0021-9150(89)90011-7; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; SILK JB, IN PRESS ANIM BEHAV; Smuts BB., 1985, SEX FRIENDSHIP BABOO; *STATA, 2003, STATA 8 0; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	30	692	703	3	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1231	1234		10.1126/science.1088580	http://dx.doi.org/10.1126/science.1088580			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	742XW	14615543				2022-12-01	WOS:000186544300060
J	Navarro-Gonzalez, R; Rainey, FA; Molina, P; Bagaley, DR; Hollen, BJ; de la Rosa, J'; Small, AM; Quinn, RC; Grunthaner, FJ; Caceres, L; Gomez-Silva, B; McKay, CP				Navarro-Gonzalez, R; Rainey, FA; Molina, P; Bagaley, DR; Hollen, BJ; de la Rosa, J'; Small, AM; Quinn, RC; Grunthaner, FJ; Caceres, L; Gomez-Silva, B; McKay, CP			Mars-like soils in the Atacama Desert, Chile, and the dry limit of microbial life	SCIENCE			English	Article								The Viking missions showed the martian soil to be lifeless and depleted in organic material and indicated the presence of one or more reactive oxidants. Here we report the presence of Mars-like soils in the extreme arid region of the Atacama Desert. Samples from this region had organic species only at trace levels and extremely low levels of culturable bacteria. Two samples from the extreme arid region were tested for DNA and none was recovered. Incubation experiments, patterned after the Viking labeled-release experiment but with separate biological and nonbiological isomers, show active decomposition of organic species in these soils by nonbiological processes.	Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estudios Planetarios, Mexico City 04510, DF, Mexico; Univ Paris 12, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Univ Paris 07, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; NASA, Div Space Sci, Ames Res Ctr, Moffett Field, CA 94035 USA; NASA, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Antofagasta, Fac Ingn, Inst Desierto, Antofagasta, Chile; Univ Antofagasta, Fac Ingn, Dept Ingn Quim, Antofagasta, Chile; Univ Antofagasta, Fac Ciencias Salud, Inst Desierto, Antofagasta, Chile; Univ Antofagasta, Fac Ciencias Salud, Dept Biomed, Unidad Bioquim, Antofagasta, Chile	Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Louisiana State University System; Louisiana State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Universidad de Antofagasta; Universidad de Antofagasta; Universidad de Antofagasta; Universidad de Antofagasta	Navarro-Gonzalez, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estudios Planetarios, Circuito Exterior,Ciudad Univ,Apartado Postal 70-, Mexico City 04510, DF, Mexico.		Rainey, Fred A/C-8767-2013; GOMEZ-SILVA, BENITO/J-8324-2017; Rainey, Fred/AAG-7996-2019; Gómez-Silva, Benito/AAT-8215-2020; De la Rosa, José/A-3573-2010; Navarro-González, Rafael/D-1748-2009	Rainey, Fred A/0000-0001-9129-6844; Gómez-Silva, Benito/0000-0002-7611-9943; Navarro-González, Rafael/0000-0002-6078-7621; Grunthaner, Frank/0000-0003-2397-6658; Caceres, Luis/0000-0001-7359-2148				ARROYO MTK, 1988, ANN MO BOT GARD, V75, P55, DOI 10.2307/2399466; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Levin G. V., 1977, Journal of Geophysical Research, V82, P4663, DOI 10.1029/JS082i028p04663; McKay CP, 1998, PLANET SPACE SCI, V46, P769, DOI 10.1016/S0032-0633(98)00011-7; MCKAY CP, 2003, ASTROBIOLOGY, V3, P293; Miller A, 1976, WORLD SURVEY CLIMATO, V12, P113; Oyama V. I., 1977, Journal of Geophysical Research, V82, P4669, DOI 10.1029/JS082i028p04669; PLUMB RC, 1989, NATURE, V338, P633, DOI 10.1038/338633a0	9	392	404	6	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1018	1021		10.1126/science.1089143	http://dx.doi.org/10.1126/science.1089143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605363				2022-12-01	WOS:000186396300039
J	Busino, L; Donzelli, M; Chiesa, M; Guardavaccaro, D; Ganoth, D; Dorrello, NV; Hershko, A; Pagano, M; Draetta, GF				Busino, L; Donzelli, M; Chiesa, M; Guardavaccaro, D; Ganoth, D; Dorrello, NV; Hershko, A; Pagano, M; Draetta, GF			Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage	NATURE			English	Article							KAPPA-B-ALPHA; UBIQUITIN LIGASE; PHOSPHORYLATION; DESTRUCTION; CHECKPOINT; PROTEOLYSIS; COMPLEX; IDENTIFICATION; PROGRESSION; CATENIN	The Cdc25A phosphatase is essential for cell-cycle progression because of its function in dephosphorylating cyclin-dependent kinases. In response to DNA damage or stalled replication, the ATM and ATR protein kinases activate the checkpoint kinases Chk1 and Chk2, which leads to hyperphosphorylation of Cdc25A(1-3). These events stimulate the ubiquitin-mediated proteolysis of Cdc25A(1,4,5) and contribute to delaying cell-cycle progression, thereby preventing genomic instability(1-7). Here we report that beta-TrCP is the F-box protein that targets phosphorylated Cdc25A for degradation by the Skp1/Cul1/F-box protein complex. Downregulation of beta-TrCP1 and beta-TrCP2 expression by short interfering RNAs causes an accumulation of Cdc25A in cells progressing through S phase and prevents the degradation of Cdc25A induced by ionizing radiation, indicating that beta-TrCP may function in the intra-S-phase checkpoint. Consistent with this hypothesis, suppression of beta-TrCP expression results in radioresistant DNA synthesis in response to DNA damage - a phenotype indicative of a defect in the intra-S-phase checkpoint that is associated with an inability to regulate Cdc25A properly. Our results show that beta-TrCP has a crucial role in mediating the response to DNA damage through Cdc25A degradation.	European Inst Oncol, I-20141 Milan, Italy; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Inst Canc, New York, NY 10016 USA; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel	IRCCS European Institute of Oncology (IEO); New York University; New York University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Donzelli, M (corresponding author), European Inst Oncol, 435 Via Ripamonti, I-20141 Milan, Italy.	mdonzell@ieo.it	Donzelli, Maddalena/ABD-3774-2020	pagano, michele/0000-0003-3210-2442; Guardavaccaro, Daniele/0000-0002-4517-1765; DONZELLI, MADDALENA/0000-0002-4045-0802	Telethon [E.0865] Funding Source: Medline	Telethon(Fondazione Telethon)		Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clucas C, 2002, EMBO J, V21, P665, DOI 10.1093/emboj/21.4.665; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Spruck CH, 2002, CELL CYCLE, V1, P248, DOI 10.4161/cc.1.4.132; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	28	351	370	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					87	91		10.1038/nature02082	http://dx.doi.org/10.1038/nature02082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603323				2022-12-01	WOS:000186370800047
J	Shattuck, TM; Valimaki, S; Obara, T; Gaz, RD; Clark, OH; Shoback, D; Wierman, ME; Tojo, K; Robbins, CM; Carpten, JD; Farnebo, LO; Larsson, C; Arnold, A				Shattuck, TM; Valimaki, S; Obara, T; Gaz, RD; Clark, OH; Shoback, D; Wierman, ME; Tojo, K; Robbins, CM; Carpten, JD; Farnebo, LO; Larsson, C; Arnold, A			Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JAW TUMOR SYNDROME; HEREDITARY HYPERPARATHYROIDISM; SUPPRESSOR GENES; RETINOBLASTOMA; DIAGNOSIS; MANAGEMENT; HISTORY; CANCER; BRCA2	BACKGROUND: We looked for mutations of the HRPT2 gene, which encodes the parafibromin protein, in sporadic parathyroid carcinoma because germ-line inactivating HRPT2 mutations have been found in a type of familial hyperparathyroidism -- hyperparathyroidism-jaw tumor (HPT-JT) syndrome -- that carries an increased risk of parathyroid cancer. METHODS: We directly sequenced the full coding and flanking splice-junctional regions of the HRPT2 gene in 21 parathyroid carcinomas from 15 patients who had no known family history of primary hyperparathyroidism or the HPT-JT syndrome at presentation. We also sought to confirm the somatic nature of the identified mutations and tested the carcinomas for tumor-specific loss of heterozygosity at HRPT2. RESULTS: Parathyroid carcinomas from 10 of the 15 patients had HRPT2 mutations, all of which were predicted to inactivate the encoded parafibromin protein. Two distinct HRPT2 mutations were found in tumors from five patients, and biallelic inactivation as a result of a mutation and loss of heterozygosity was found in one tumor. At least one HRPT2 mutation was demonstrably somatic in carcinomas from six patients. Unexpectedly, HRPT2 mutations in the parathyroid carcinomas of three patients were identified as germ-line mutations. CONCLUSIONS: Sporadic parathyroid carcinomas frequently have HRPT2 mutations that are likely to be of pathogenetic importance. Certain patients with apparently sporadic parathyroid carcinoma carry germ-line mutations in HRPT2 and may have the HPT-JT syndrome or a phenotypic variant.	Univ Connecticut, Sch Med, Ctr Mol Med, Farmington, CT 06030 USA; Univ Connecticut, Sch Med, Div Endocrinol & Metab, Farmington, CT 06030 USA; Karolinska Hosp, Dept Mol Med, S-10401 Stockholm, Sweden; Karolinska Hosp, Dept Surg Sci, S-10401 Stockholm, Sweden; Tokyo Womens Med Univ, Dept Endocrine Surg, Sinjuku Ku, Tokyo, Japan; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Vet Affairs Med Ctr, Endocrine Res Unit, San Francisco, CA 94143 USA; Univ Colorado, Vet Affairs Med Ctr, Div Endocrinol, Denver, CO 80202 USA; Jikei Univ, Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Tokyo, Japan; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	University of Connecticut; University of Connecticut; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Tokyo Women's Medical University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jikei University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Arnold, A (corresponding author), Univ Connecticut, Sch Med, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	catharina.larsson@cmm.ki.se; molecularmedicine@uchc.edu						Agarwal SK, 1998, CANCER GENET CYTOGEN, V106, P30, DOI 10.1016/S0165-4608(98)00049-1; ANDERSON BJ, 1983, SURGERY, V94, P906; Arnold A, 2002, J BONE MINER RES, V17, pN30; BONDESON L, 1993, AM J SURG PATHOL, V17, P820, DOI 10.1097/00000478-199308000-00007; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; COSTA J, 2003, J ENDOCR GENET, V3, P57; CRYNS VL, 1994, NEW ENGL J MED, V330, P757, DOI 10.1056/NEJM199403173301105; Dotzenrath C, 1996, J CLIN ENDOCR METAB, V81, P3194, DOI 10.1210/jc.81.9.3194; EVERSOLE LR, 1985, ORAL SURG ORAL MED O, V60, P505, DOI 10.1016/0030-4220(85)90239-7; FITKO R, 1990, HUM PATHOL, V21, P234, DOI 10.1016/0046-8177(90)90136-S; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; Haven CJ, 2000, J CLIN ENDOCR METAB, V85, P1449, DOI 10.1210/jc.85.4.1449; Imanishi Y, 1999, J BONE MINER RES, V14, pS421; JACKSON CE, 1990, SURGERY, V108, P1006; KENNETT S, 1971, ORAL SURG ORAL MED O, V31, P502, DOI 10.1016/0030-4220(71)90347-1; Kytola S, 2000, AM J PATHOL, V157, P579, DOI 10.1016/S0002-9440(10)64568-3; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Marx SJ, 2002, J BONE MINER RES, V17, pN37; Marx SJ, 2001, NEW ENGL J MED, V344, P696; Marx SJ, 2001, NEW ENGL J MED, V344, P240; Pearce SHS, 1996, CLIN ENDOCRINOL, V45, P195, DOI 10.1046/j.1365-2265.1996.d01-1561.x; ROTH SI, 1962, ARCH PATHOL, V73, P495; SANDELIN K, 1991, SURGERY, V110, P978; SANDELIN K, 1992, WORLD J SURG, V16, P724, DOI 10.1007/BF02067369; SCHANTZ A, 1973, CANCER-AM CANCER SOC, V31, P600, DOI 10.1002/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0; Shane E, 2001, J CLIN ENDOCR METAB, V86, P485, DOI 10.1210/jc.86.2.485; Shattuck TM, 2003, CLIN ENDOCRINOL, V59, P180, DOI 10.1046/j.1365-2265.2003.01814.x; Shattuck TM, 2002, J CLIN ENDOCR METAB, V87, P3911, DOI 10.1210/jc.87.8.3911; Simonds WF, 2002, MEDICINE, V81, P1, DOI 10.1097/00005792-200201000-00001; SZABO J, 1995, AM J HUM GENET, V56, P944; Teh BT, 1996, J CLIN ENDOCR METAB, V81, P4204, DOI 10.1210/jc.81.12.4204; VETTO JT, 1993, SURGERY, V114, P882; WANG CA, 1985, AM J SURG, V149, P522, DOI 10.1016/S0002-9610(85)80050-7; Wassif WS, 1999, CLIN ENDOCRINOL, V50, P191, DOI 10.1046/j.1365-2265.1999.00633.x	34	384	400	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2003	349	18					1722	1729		10.1056/NEJMoa031237	http://dx.doi.org/10.1056/NEJMoa031237			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	737FJ	14585940				2022-12-01	WOS:000186219500006
J	Panageas, KS; Schrag, D; Riedel, E; Bach, PB; Begg, CB				Panageas, KS; Schrag, D; Riedel, E; Bach, PB; Begg, CB			The effect of clustering of outcomes on the association of procedure volume and surgical outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							NEW-YORK-STATE; HOSPITAL VOLUME; SURGEON VOLUME; RADICAL PROSTATECTOMY; CANCER RESECTION; BREAST-CANCER; COLON-CANCER; MORTALITY; SURVIVAL; MODELS	Background: A large body of literature documents associations between the volume of cases a hospital or surgeon treats and clinical outcomes. Most of these studies have used conventional statistical methods that do not recognize the fact that hospitals or surgeons with similar volumes may have very different outcomes because of systematic differences in processes of care, a phenomenon that exaggerates the true statistical significance of the effect of volume on outcome. Objective: To describe methods to assess the degree of this "clustering" of outcomes and to explore the impact of available statistical techniques that correct for clustering. Design: Reanalysis of 3 previously published volume-outcome studies. Setting: Medicare beneficiaries 65 years of age or older undergoing surgery for colon, prostate, or rectal cancer in the population defined by the Surveillance, Epidemiology, and End Results cancer registries during 1992 to 1996. Patients: 3 data sets were analyzed to assess the impact of surgeon volume on outcomes: 1) 24 166 colectomies performed by 2682 surgeons, 2) 10 737 prostatectomies performed by 999 surgeons, and 3) 2603 rectal resections performed by 1141 surgeons. Measurements: Volume-outcome trends were analyzed by a conventional method (logistic regression) and corrected for clustering. Two widely used statistical methods for analyzing clustered data, a random-effects model and generalized estimating equations, were used and compared, and the degree of clustering was presented graphically. Results: Substantial clustering was observed in the analyses involving morbidity end points. The 2 statistical techniques produced noticeably different results in some analyses. Conclusions: The presence of clustering represents variations in outcomes among providers with similar volumes. Thus, in volume-outcome studies, the degree of clustering of outcomes should be characterized because it may provide insight into variations in quality of care.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Begg, CB (corresponding author), Mem Sloan Kettering Canc Ctr, 307 E 63rd St 3rd Floor, New York, NY 10021 USA.	beggc@mskcc.org		Schrag, Deborah/0000-0002-4334-5717	NATIONAL CANCER INSTITUTE [R01CA090226, K07CA083950, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [CA83950, CA08748, CA90226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM MED ASS, 1999, CURR PROC TERM; ASHBY M, 1992, STAT MED, V11, P67, DOI 10.1002/sim.4780110108; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Begg CB, 2003, J CLIN ONCOL, V21, P393, DOI 10.1200/JCO.2003.11.022; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Choti M A, 1998, J Gastrointest Surg, V2, P11, DOI 10.1016/S1091-255X(98)80098-X; Dimick JB, 2001, ANN THORAC SURG, V72, P334, DOI 10.1016/S0003-4975(01)02781-3; DONNER A, 1987, STAT MED, V6, P43, DOI 10.1002/sim.4780060106; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Glasgow RE, 1999, ARCH SURG-CHICAGO, V134, P30, DOI 10.1001/archsurg.134.1.30; Glasgow RE, 1996, WESTERN J MED, V165, P294; GREEN SB, 1995, AM J EPIDEMIOL, V142, P587, DOI 10.1093/oxfordjournals.aje.a117679; Greenfield S, 2002, ANN INTERN MED, V136, P111, DOI 10.7326/0003-4819-136-2-200201150-00008; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HANNAN EL, 1994, ANN THORAC SURG, V58, P1852, DOI 10.1016/0003-4975(94)91726-4; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169; Kee F, 1999, BRIT MED J, V318, P1381, DOI 10.1136/bmj.318.7195.1381; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Polednak AP, 1999, AM J PUBLIC HEALTH, V89, P946, DOI 10.2105/AJPH.89.6.946; POTOSKY AL, 1993, MED CARE, V31, P732; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Schrag D, 2003, J SURG ONCOL, V83, P68, DOI 10.1002/jso.10244; Schrag D, 2002, ANN SURG, V236, P583, DOI 10.1097/00000658-200211000-00008; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; *WHO, 1990, INT CLASS DIS ONC; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950	42	275	276	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2003	139	8					658	665		10.7326/0003-4819-139-8-200310210-00009	http://dx.doi.org/10.7326/0003-4819-139-8-200310210-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734DW	14568854				2022-12-01	WOS:000186040800004
J	Dahan, M; Levi, S; Luccardini, C; Rostaing, P; Riveau, B; Triller, A				Dahan, M; Levi, S; Luccardini, C; Rostaing, P; Riveau, B; Triller, A			Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking	SCIENCE			English	Article							LATERAL MOVEMENTS; IN-VIVO; SYNAPSES; GEPHYRIN; MEMBRANE; MICROSCOPY; NEURONS	Semiconductor quantum dots (QDs) are nanometer-sized fluorescent probes suitable for advanced biological imaging. We used QDs to track individual glycine receptors (GlyRs) and analyze their lateral dynamics in the neuronal membrane of living cells for periods ranging from milliseconds to minutes. We characterized multiple diffusion domains in relation to the synaptic, perisynaptic, or extrasynaptic GlyR localization. The entry of GlyRs into the synapse by diffusion was observed and further confirmed by electron microscopy imaging of QD-tagged receptors.	Ecole Normale Super, CNRS, UMR 8552, Lab Kastler Brossel, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Ecole Normale Super, INSERM, U497, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Dahan, M (corresponding author), Ecole Normale Super, CNRS, UMR 8552, Lab Kastler Brossel, 24 Rue Lhomond, F-75005 Paris, France.		Dahan, Maxime/F-1740-2010; LEVI, SABINE/AAX-5607-2020	Levi, Sabine/0000-0002-9927-0945; TRILLER, Antoine/0000-0002-7530-1233; Dahan, Maxime/0000-0002-4943-2491				Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Empedocles S, 1999, ACCOUNTS CHEM RES, V32, P389, DOI 10.1021/ar9501939; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Gready JE, 1997, PROTEIN SCI, V6, P983, DOI 10.1002/pro.5560060504; Harms GS, 2001, BIOPHYS J, V80, P2396, DOI 10.1016/S0006-3495(01)76209-1; HARVEY K, 2002, RECEPTOR ION CHANNEL, pCH8; HURTLEY SM, 2003, SCIENCE, V300; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Rasmussen H, 2002, MOL CELL NEUROSCI, V19, P201, DOI 10.1006/mcne.2001.1074; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHRODER S, 1991, BIOCHEMISTRY-US, V30, P42, DOI 10.1021/bi00215a007; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764	25	1219	1283	2	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					442	445		10.1126/science.1088525	http://dx.doi.org/10.1126/science.1088525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14564008				2022-12-01	WOS:000185963200042
J	Tumbar, T; Guasch, G; Greco, V; Blanpain, C; Lowry, WE; Rendl, M; Fuchs, E				Tumbar, T; Guasch, G; Greco, V; Blanpain, C; Lowry, WE; Rendl, M; Fuchs, E			Defining the epithelial stem cell niche in skin	SCIENCE			English	Article							GROWTH-FACTOR-BETA; LABEL-RETAINING CELLS; HAIR FOLLICLE BULGE; SELF-RENEWAL; WNT; GENE; EXPRESSION; EPIDERMIS; MICE; PROLIFERATION	Many adult regenerative cells divide infrequently but have high proliferative capacity. We developed a strategy to fluorescently label slow-cycling cells in a cell type-specific fashion. We used this method to purify the label-retaining cells (LRCs) that mark the skin stem cell (SC) niche. We found that these cells rarely divide within their niche but change properties abruptly when stimulated to exit. We determined their transcriptional pro. le, which, when compared to progeny and other SCs, defines the niche. Many of the > 100 messenger RNAs preferentially expressed in the niche encode surface receptors and secreted proteins, enabling LRCs to signal and respond to their environment.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Blanpain, Cedric/ABD-8392-2021; Tumbar, Tudorita/A-1916-2014	Rendl, Michael/0000-0001-6326-620X; Guasch, Geraldine/0000-0001-7362-9318; Tumbar, Tudorita/0000-0002-2273-1889	NIAMS NIH HHS [R01 AR063663, R01 AR050452, R01 AR050452-04] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663, R01AR050452] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P168, DOI 10.1046/j.1523-1747.2003.12003.x; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Garcion E, 2001, DEVELOPMENT, V128, P2485; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Ito M, 2001, J INVEST DERMATOL, V116, P956, DOI 10.1046/j.0022-202x.2001.01369.x; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; POTTEN CS, 1988, J CELL SCI, P45; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sander G, 2000, J INVEST DERMATOL, V115, P753, DOI 10.1046/j.1523-1747.2000.00122.x; Sette C, 2000, INT J DEV BIOL, V44, P599; Soma Y, 2002, ARCH DERMATOL RES, V293, P609, DOI 10.1007/s00403-001-0279-6; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	33	1487	1572	6	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					359	363		10.1126/science.1092436	http://dx.doi.org/10.1126/science.1092436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14671312	Green Accepted			2022-12-01	WOS:000188111800040
J	Metivier, R; Penot, G; Hubner, MR; Reid, G; Brand, H; Kos, M; Gannon, F				Metivier, R; Penot, G; Hubner, MR; Reid, G; Brand, H; Kos, M; Gannon, F			Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter	CELL			English	Article							RNA-POLYMERASE-II; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; COACTIVATOR COMPLEXES; HISTONE MODIFICATIONS; CHROMATIN STRUCTURE; DISTINCT PATTERNS; NUCLEAR RECEPTORS; GENE-EXPRESSION	Transcriptional activation of a gene involves an orchestrated recruitment of components of the basal transcription machinery and intermediate factors, concomitant with an alteration in local chromatin structure generated by posttranslational modifications of histone tails and nucleosome remodeling. We provide here a comprehensive picture of events resulting in transcriptional activation of a gene, through evaluating the estrogen receptor-alpha (NR3A1) target pS2 gene promoter in MCF-7 cells. This description integrates chromatin remodeling with a kinetic evaluation of cyclical networks of association of 46 transcription factors with the promoter, as determined by chromatin immunoprecipitation assays. We define the concept of a "transcriptional clock" that directs and achieves the sequential and combinatorial assembly of a transcriptionally productive complex on a promoter. Furthermore, the unanticipated findings of key roles for histone deacetylases and nucleosome-remodeling complexes in limiting transcription implies that transcriptional activation is a cyclical process that requires both activating and repressive epigenetic processes.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Metivier, R (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	raphael.metivier@embl-heidelberg.de; frank.gannon@embo.org	Gannon, Frank/G-1194-2015; Kos, Martin/E-2534-2011; jia, xu/A-8386-2016	Kos, Martin/0000-0002-3337-9681; Reid, George/0000-0002-0298-693X				Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Emerson BM, 2002, CELL, V109, P267, DOI 10.1016/S0092-8674(02)00740-7; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2002, J CELL SCI, V115, P689; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Ogbourne S, 1998, BIOCHEM J, V331, P1; ONATE SA, 1995, SCIENCE, V270, P1354; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Sabbah M, 1998, BIOCHEM J, V336, P639, DOI 10.1042/bj3360639; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Vermeulen W, 2002, MOL CELL, V10, P1264, DOI 10.1016/S1097-2765(02)00795-5; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; WAMMACK A, 2001, J BIOL CHEM, V276, P45939; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; WOLFFE AP, 1992, CHROMATIN STRUCTURE; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu SY, 1999, J BIOL CHEM, V274, P23480, DOI 10.1074/jbc.274.33.23480; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961	74	1208	1240	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					751	763		10.1016/S0092-8674(03)00934-6	http://dx.doi.org/10.1016/S0092-8674(03)00934-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675539	Bronze			2022-12-01	WOS:000187366100014
J	Povich, MS; Raymond, JC; Jones, GH; Uzzo, M; Ko, YK; Feldman, PD; Smith, PL; Marsden, BG; Woods, TN				Povich, MS; Raymond, JC; Jones, GH; Uzzo, M; Ko, YK; Feldman, PD; Smith, PL; Marsden, BG; Woods, TN			Doubly ionized carbon observed in the plasma tail of comet Kudo-Fujikawa	SCIENCE			English	Article							BETA-PICTORIS; SOLAR; DUST; CO	Comet C/2002 X5 (Kudo-Fujikawa) was observed near its perihelion of 0.19 astronomical unit by the Ultraviolet Coronagraph Spectrometer aboard the Solar and Heliospheric Observatory spacecraft. Images of the comet reconstructed from high-resolution spectra reveal a quasi-spherical cloud of neutral hydrogen and a variable tail of C+ and C2+ that disconnects from the comet and subsequently regenerates. The high abundance of C2+ and C+, at least 24% relative to water, cannot be explained by photodissociation of carbon monoxide and is instead attributed to the evaporation and subsequent photoionization of atomic carbon from organic refractory compounds present in the cometary dust grains. This result serves to strengthen the connection between comets and the material from which the Solar System formed.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; University of Colorado System; University of Colorado Boulder	Povich, MS (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.		Jones, Geraint H./C-1682-2008	Jones, Geraint H./0000-0002-5859-1136				ALFVEN H, 1957, TELLUS, V9, P92, DOI 10.1111/j.2153-3490.1957.tb01855.x; Bouret JC, 2002, ASTRON ASTROPHYS, V390, P1049, DOI 10.1051/0004-6361:20020741; BOUT M, 2003, B AM ASTRON SOC, V35, P988; Brandt JC, 2000, ICARUS, V148, P52, DOI 10.1006/icar.2000.6484; COMBI MR, 1988, ASTROPHYS J, V327, P1026, DOI 10.1086/166260; Curdt W, 2001, ASTRON ASTROPHYS, V375, P591, DOI 10.1051/0004-6361:20010364; DiSanti MA, 2001, ICARUS, V153, P361, DOI 10.1006/icar.2001.6695; Feldman PD, 2002, ASTROPHYS J, V576, pL91, DOI 10.1086/343089; GOMBOSI TI, 1996, J GEOPHYS RES, V101, P15223; Greenberg JM, 1999, SPACE SCI REV, V90, P149, DOI 10.1023/A:1005298014670; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Kohl JL, 1995, SOL PHYS, V162, P313, DOI 10.1007/BF00733433; LAMY PL, 1988, ICARUS, V76, P100, DOI 10.1016/0019-1035(88)90142-X; NAKANO S, 2002, 8032 INT ASTR UN; Raymond JC, 2002, ASTROPHYS J, V564, P1054, DOI 10.1086/324545; Sheeley NR, 1999, J GEOPHYS RES-SPACE, V104, P24739, DOI 10.1029/1999JA900308; Verner DA, 1996, ASTROPHYS J, V465, P487, DOI 10.1086/177435; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; WATANABE J, 2002, 8033 INT ASTR UN; Woods TN, 1998, P SOC PHOTO-OPT INS, V3442, P180, DOI 10.1117/12.330255; Yi Y, 1996, J GEOPHYS RES-SPACE, V101, P27585, DOI 10.1029/96JA02235	21	24	24	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1949	1952		10.1126/science.1092142	http://dx.doi.org/10.1126/science.1092142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671299				2022-12-01	WOS:000187174000056
J	Coltman, DW; O'Donoghue, P; Jorgenson, JT; Hogg, JT; Strobeck, C; Festa-Bianchet, M				Coltman, DW; O'Donoghue, P; Jorgenson, JT; Hogg, JT; Strobeck, C; Festa-Bianchet, M			Undesirable evolutionary consequences of trophy hunting	NATURE			English	Article							DEER CERVUS-ELAPHUS; POPULATION-DYNAMICS; BIGHORN SHEEP; CONSERVATION; REPRODUCTION; MANAGEMENT; SELECTION; SIZE; RAMS	Phenotype- based selective harvests, including trophy hunting, can have important implications for sustainable wildlife management if they target heritable traits(1 - 3). Here we show that in an evolutionary response to sport hunting of bighorn trophy rams ( Ovis canadensis) body weight and horn size have declined significantly over time. We used quantitative genetic analyses, based on a partly genetically reconstructed pedigree from a 30- year study of a wild population in which trophy hunting targeted rams with rapidly growing horns(4), to explore the evolutionary response to hunter selection on ram weight and horn size. Both traits were highly heritable, and trophy- harvested rams were of significantly higher genetic ' breeding value' for weight and horn size than rams that were not harvested. Rams of high breeding value were also shot at an early age, and thus did not achieve high reproductive success(5). Declines in mean breeding values for weight and horn size therefore occurred in response to unrestricted trophy hunting, resulting in the production of smaller- horned, lighter rams, and fewer trophies.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Alberta Dept Sustainable Dev, Fish & Wildlife Div, Canmore, AB T0L 0M0, Canada; Montana Conservat Sci Inst, Missoula, MT 59803 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Sheffield; University of Alberta; University of Sherbrooke	Coltman, DW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Coltman, David W/A-4453-2012; Strobeck, Curtis/E-9998-2011	Coltman, David W/0000-0002-1268-2307; Festa-Bianchet, Marco/0000-0002-2352-3379				Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Clutton-Brock TH, 2002, NATURE, V415, P633, DOI 10.1038/415633a; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Coltman DW, 2002, P ROY SOC B-BIOL SCI, V269, P165, DOI 10.1098/rspb.2001.1851; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; CRAWFORD AM, 1995, GENETICS, V140, P703; Festa-Bianchet M, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P191; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; FESTABIANCHET M, IN PRESS BEHAV ECOL; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; GROENEVELD E, 1992, ARCH ANIM BREED, V15, P399; GROENEVELD E, 1995, USERS GUIDE REML VCE; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hogg JT, 1997, BEHAV ECOL SOCIOBIOL, V41, P33, DOI 10.1007/s002650050361; JACHMANN H, 1995, AFR J ECOL, V33, P230, DOI 10.1111/j.1365-2028.1995.tb00800.x; JORGENSON JT, 1993, J WILDLIFE MANAGE, V57, P429, DOI 10.2307/3809267; Jorgenson JT, 1998, J WILDLIFE MANAGE, V62, P1011, DOI 10.2307/3802554; Langvatn R, 1999, WILDLIFE BIOL, V5, P213; Laurian C, 2000, J APPL ECOL, V37, P515, DOI 10.1046/j.1365-2664.2000.00520.x; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lynch M., 1998, AM J HUM GENET; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Slate J, 1998, ANIM GENET, V29, P307, DOI 10.1046/j.1365-2052.1998.00347.x; THELEN TH, 1991, J WILDLIFE MANAGE, V55, P243, DOI 10.2307/3809146; [No title captured]	30	543	553	9	608	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					655	658		10.1038/nature02177	http://dx.doi.org/10.1038/nature02177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668862				2022-12-01	WOS:000187132800039
J	Yokoyama, K; Doi, Y; Yamane, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T; Kato, H; Arakawa, Y				Yokoyama, K; Doi, Y; Yamane, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T; Kato, H; Arakawa, Y			Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa	LANCET			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; AMINOGLYCOSIDE ANTIBIOTICS; MICROMONOSPORA-PURPUREA; GENTAMICIN; ARBEKACIN; BACTERIA; TRENDS; DNA	Background Bacteria develop resistance to aminoglycosides by producing aminoglycoside-modifying enzymes such as acetyltransferase, phosphorylase, and adenyltransferase. These enzymes, however, cannot confer consistent resistance to various aminoglycosides because of their substrate specificity. Notwithstanding, a Pseudomonas aeruginosa strain AR-2 showing high-level resistance (minimum inhibitory concentration >1024 mg/L) to various aminoglycosides was isolated clinically. We aimed to clone and characterise the genetic determinant of this resistance. Methods We used conventional methods for DNA manipulation, susceptibility testing, and gene analyses to clone and characterise the genetic determinant of the resistance seen. PCR detection of the gene was also done on a stock of P aeruginosa strains that were isolated clinically since 1997. Findings An aminoglycoside-resistance gene, designated rmtA, was identified in P aeruginosa AR-2. The Escherichia coli transformant and transconjugant harbouring the rmtA gene showed very high-level resistance to various aminoglycosides, including amikacin, tobramycin, isepamicin, arbekacin, kanamycin, and gentamicin. The 756-bp nucleotide rmtA gene encoded a protein, RmtA. This protein showed considerable similarity to the 16S rRNA methylases of aminoglycoside-producing actinomycetes, which protect bacterial 16S rRNA from intrinsic aminoglycosides by methylation. Incorporation of radiolabelled methyl groups into the 30S ribosome was detected in the presence of RmtA. Of 1113 clinically isolated P aeruginosa strains, nine carried the rmtA gene, as shown by PCR analyses. Interpretation Our findings strongly suggest intergeneric lateral gene transfer of 16S rRNA methylase gene from some aminoglycoside-producing microorganisms to P aeruginosa. Further dissemination of the rmtA gene in nosocomial bacteria could be a matter of concern in the future.	Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan	National Institute of Infectious Diseases (NIID)	Arakawa, Y (corresponding author), Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, 4-7-1 Gakuen, Tokyo 2080011, Japan.		Arakawa, Yoshichika/P-5997-2015; Yagi, Tetsuya/J-3303-2012	Doi, Yohei/0000-0002-9620-2525				Arakawa Y, 2000, EMERG INFECT DIS, V6, P572, DOI 10.3201/eid0606.000604; Bootsma HJ, 2000, MOL MICROBIOL, V36, P93, DOI 10.1046/j.1365-2958.2000.01828.x; *DNA DAT BANK JAP, DDBJ HOM SEARCH SYST; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Gonzalez-Zorn B, 2003, LANCET INFECT DIS, V3, P67, DOI 10.1016/S1473-3099(03)00510-3; INOUE M, 1994, DRUG EXP CLIN RES, V20, P233; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; KELEMEN GH, 1991, GENE, V98, P53, DOI 10.1016/0378-1119(91)90103-I; Kondo S., 1999, J Infect Chemother, V5, P1, DOI 10.1007/s101560050001; Kurokawa H, 1999, LANCET, V354, P955, DOI 10.1016/S0140-6736(05)75707-X; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; *NAT COMM CLIN LAB, 2002, M100S12 NCCLS; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PRICE KE, 1986, AM J MED, V80, P182, DOI 10.1016/0002-9343(86)90499-7; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SKEGGS PA, 1985, MOL GEN GENET, V200, P415, DOI 10.1007/BF00425725; Tacconelli E, 2002, EMERG INFECT DIS, V8, P220, DOI 10.3201/eid0802.010121; TANAKA N, 1983, ANTIMICROB AGENTS CH, V24, P797, DOI 10.1128/AAC.24.5.797; THOMPSON J, 1985, MOL GEN GENET, V201, P168, DOI 10.1007/BF00425655; THORNSBERRY C, 1980, ANTIMICROB AGENTS CH, V18, P338, DOI 10.1128/AAC.18.2.338; Umezawa H, 1979, Jpn J Antibiot, V32 Suppl, pS1; Watanabe T, 1997, J ANTIMICROB CHEMOTH, V39, P471, DOI 10.1093/jac/39.4.471; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975	25	168	242	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1888	1893		10.1016/S0140-6736(03)14959-8	http://dx.doi.org/10.1016/S0140-6736(03)14959-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667745				2022-12-01	WOS:000187011600009
J	Shibata, Y; Branicky, R; Landaverde, IO; Hekimi, S				Shibata, Y; Branicky, R; Landaverde, IO; Hekimi, S			Redox regulation of germline and vulval development in Caenorhabditis elegans	SCIENCE			English	Article							LIVED CLK-1 MUTANTS; C-ELEGANS; TRANSFER PROTEIN; GENE; ABETALIPOPROTEINEMIA; MUTATIONS; KINASE	In vitro studies have indicated that reactive oxygen species (ROS) and the oxidation of signaling molecules are important mediators of signal transduction. We have identified two pathways by which the altered redox chemistry of the clk-1 mutants of Caenorhabditis elegans acts in vivo on germline development. One pathway depends on the oxidation of an analog of vertebrate low density lipoprotein (LDL) and acts on the germline through the Ack-related tyrosine kinase (ARK-1) kinase and inositol trisphosphate (IP3) signaling. The other pathway is the oncogenic ras signaling pathway, whose action on germline as well as vulval development appears to be modulated by cytoplasmic ROS.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Shibata, Yukimasa/H-8467-2017					ALLEVA R, 1995, P NATL ACAD SCI USA, V92, P9388, DOI 10.1073/pnas.92.20.9388; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Branicky R, 2001, GENETICS, V159, P997; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ernster L., 1993, CLIN INVESTIGATOR, V71, P60; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Guo ZM, 2001, ARTERIOSCL THROM VAS, V21, P1131, DOI 10.1161/hq0701.092092; Hihi AK, 2002, J BIOL CHEM, V277, P2202, DOI 10.1074/jbc.M109034200; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jacobs D, 1998, GENETICS, V149, P1809; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Miyadera H, 2002, FEBS LETT, V512, P33, DOI 10.1016/S0014-5793(02)02282-2; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Morey M, 2001, DEV BIOL, V238, P145, DOI 10.1006/dbio.2001.0389; Segrest JP, 2001, J LIPID RES, V42, P1346; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHIBATA Y, UNPUB; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; WONG A, 1995, GENETICS, V139, P1247	26	96	120	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1779	1782		10.1126/science.1087167	http://dx.doi.org/10.1126/science.1087167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657502				2022-12-01	WOS:000186970100052
J	Wang, HR; Zhang, Y; Ozdamar, B; Ogunjimi, AA; Alexandrova, E; Thomsen, GH; Wrana, JL				Wang, HR; Zhang, Y; Ozdamar, B; Ogunjimi, AA; Alexandrova, E; Thomsen, GH; Wrana, JL			Regulation of cell polarity and protrusion formation by targeting RhoA for degradation	SCIENCE			English	Article							PROTEIN-KINASE-C; E3 UBIQUITIN LIGASE; CAENORHABDITIS-ELEGANS; FAMILY GTPASES; COMPLEX; CDC42; SMURF2; TRANSFORMATION; CYTOSKELETON; ADHESION	The Rho family of small guanosine triphosphatases regulates actin cytoskeleton dynamics that underlie cellular functions such as cell shape changes, migration, and polarity. We found that Smurf1, a HECT domain E3 ubiquitin ligase, regulated cell polarity and protrusive activity and was required to maintain the transformed morphology and motility of a tumor cell. Atypical protein kinase C zeta (PKCzeta), an effector of the Cdc42/Rac1-PAR6 polarity complex, recruited Smurf1 to cellular protrusions, where it controlled the local level of RhoA. Smurf1 thus links the polarity complex to degradation of RhoA in lamellipodia and filopodia to prevent RhoA signaling during dynamic membrane movements.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M56 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M56 1X5, Canada.		Wrana, Jeffrey/F-8857-2013	Wang, Hong-Rui/0000-0002-2916-8849	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032429] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD032429, R01 HD032429-07, R01 HD032429-06, HD32429] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Gomes JE, 2002, CURR BIOL, V12, pR444, DOI 10.1016/S0960-9822(02)00939-9; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hall A, 1999, BRIT J CANCER, V80, P25; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hung TJ, 1999, DEVELOPMENT, V126, P127; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; WANG H, UNPUB; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	34	429	443	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1775	1779		10.1126/science.1090772	http://dx.doi.org/10.1126/science.1090772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657501				2022-12-01	WOS:000186970100051
J	Chim, SSC; Tsui, SKW; Chan, KCA; Au, TCC; Hung, ECW; Tong, YK; Chiu, RWK; Ng, EKO; Chan, PKS; Chu, CM; Sung, JJY; Tam, JS; Fung, KP; Waye, MMY; Lee, CY; Yuen, KY; Lo, YMD				Chim, SSC; Tsui, SKW; Chan, KCA; Au, TCC; Hung, ECW; Tong, YK; Chiu, RWK; Ng, EKO; Chan, PKS; Chu, CM; Sung, JJY; Tam, JS; Fung, KP; Waye, MMY; Lee, CY; Yuen, KY; Lo, YMD		CUHK Molecular SARS Res Grp	Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong	LANCET			English	Article								Severe acute respiratory syndrome (SARS) is a global health concern. In Hong Kong, two major outbreaks, one hospital based and the other in the Amoy Gardens apartments, were identified. The frequency of diarrhoea, admission to intensive care, and mortality differed significantly between the two outbreaks. We did genomic sequencing for viral isolates from five Amoy Gardens patients. The virus sequence was identical in four of these five patients. The sequence data from one hospital case and the four identical community cases had only three nucleotide differences. Alterations in the SARS coronavirus genome are unlikely to have caused the distinctive clinical features of the Amoy Gardens patients, and these results highlight the importance of non-viral genomic factors in this outbreak.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Biochem, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; United Christian Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; United Christian Hospital; University of Hong Kong	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Room 38023,F Clin Sci Bldg,30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Ng, Enders/T-3881-2019; Chan, K.C. Allen/M-2930-2013; Wong, Chi Hang/C-6909-2015; Wong, Chi Hang/ABE-8673-2021; Chan, Martin/B-3588-2009; Lo, Yuk Ming Dennis/D-4468-2011; Chan, Paul KS/J-9360-2013; Sung, Joseph J. Y./R-3203-2018; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Fung, Kwok Pui/R-9708-2018; Chim, Stephen SC/O-6271-2016; Tsui, Stephen Kwok-Wing/E-4385-2015; Ng, Enders K.O./F-2787-2010	Ng, Enders/0000-0002-6955-0030; Chan, K.C. Allen/0000-0003-1780-1691; Wong, Chi Hang/0000-0003-4157-6287; Wong, Chi Hang/0000-0003-4157-6287; Chan, Martin/0000-0002-1568-1596; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, Paul KS/0000-0002-6360-4608; Sung, Joseph J. Y./0000-0003-3125-5199; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Fung, Kwok Pui/0000-0001-6214-5123; Chim, Stephen SC/0000-0002-2152-7050; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Ng, Enders K.O./0000-0002-6955-0030; Yuen, Kwok-yung/0000-0002-2083-1552; Ng, Enders Kai-on/0000-0002-5293-3529; Chan, Anna/0000-0003-2176-5734				Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952	4	41	49	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1807	1808		10.1016/S0140-6736(03)14901-X	http://dx.doi.org/10.1016/S0140-6736(03)14901-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654320	Green Published, Bronze			2022-12-01	WOS:000186872900013
J	Marshall, T				Marshall, T			Coronary heart disease prevention: insights from modelling incremental cost effectiveness	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; RISK; METAANALYSIS; ASPIRIN; STATINS	Objective To determine which treatments for preventing coronary heart disease should be offered to which patients by assessing their incremental cost effectiveness. Design Modelling study Data sources Cost estimates (for NHS) and estimates of effectiveness obtained for aspirin, antihypertensive drugs, statins and clopidogrel. Data synthesis Treatment effects were assumed to be independent, and cost per coronary event prevented was calculated for treatments individually and in combination across patients at a range of coronary risks. Results ne most cost effective preventive treatments are aspirin, initial antihypertensive treatment (bendrofluazide and atenolol), and intensive andhypertensive treatment (bendrofluazide, atenolol and enalapril), whereas simvastatin and clopidogrel are the least cost effective (cost per coronary event prevented in a patient at 10% coronary risk over five years is pound3500 for aspirin, pound12500 for initial antihypertensives, pound18300 for intensive antihypertensives, pound60000 for clopidogrel, and pound61400 for simvastatin). Aspirin in a patient at 5% five year coronary risk costs less than a fifth as much per event prevented (pound7900) as simvastatin in a patient at 30% five year risk (pound40800). Discussion A cost effective prevention strategy would offer aspirin and initial antihypertensive treatment to all patients at greater than 7.5% five year coronary risk before offering statins or clopidogrel to patients at greater than 15% five year coronary risk. Incremental cost effectiveness analysis of treatments produces robust, practical cost effectiveness rankings that can be used to inform treatment guidelines.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Partners Healthcare, 1620 Tremont St, Boston, MA 02120 USA.	T.P.Marshall@bham.ac.uk		Marshall, Tom/0000-0001-9277-5214				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; *BRIT MED ASS ROYA, 2002, 44 BMA RPS; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, P1; CASPOZ JM, 2002, NEW ENGL J MED, V346, P1800; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Department of Health, 2000, NAT SERV FRAM COR HE, P1; Ebrahim S, 1999, Health Technol Assess, V3, pi; EBRAHIM S, 1999, HEALTH TECHNOL ASSES, V3, P1; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; HANKEY GJ, 2000, COCHRANE DB SYST REV, V2; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Marshall T, 2002, BMJ-BRIT MED J, V325, P197, DOI 10.1136/bmj.325.7357.197; *NAT I CLIN EXC, 2001, NICE TECHN GUID MAN; Neal B, 2000, LANCET, V356, P1955; Netten A., 2001, UNIT COSTS HLTH SOCI; *PRESCR PRIC AUTH, 2002, DRUG TAR; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; *STAT OFF, 2000, HLTH SURV ENGL 1998; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wood D, 1998, HEART, V80, pS1; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3	27	40	43	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2003	327	7426					1264	1267		10.1136/bmj.327.7426.1264	http://dx.doi.org/10.1136/bmj.327.7426.1264			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644970	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000186948800019
J	Hungate, BA; Dukes, JS; Shaw, MR; Luo, YQ; Field, CB				Hungate, BA; Dukes, JS; Shaw, MR; Luo, YQ; Field, CB			Nitrogen and climate change	SCIENCE			English	Editorial Material							CO2; DEPOSITION; RESPONSES; STORAGE; WORLD		No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Northern Arizona University; Northern Arizona University; Carnegie Institution for Science; University of Oklahoma System; University of Oklahoma - Norman	Hungate, BA (corresponding author), No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA.	bruce.hungate@nau.edu	Hungate, Bruce/F-8991-2011; Dukes, Jeffrey/AAD-8791-2019; Dukes, Jeffrey S/C-9765-2009	Hungate, Bruce/0000-0002-7337-1887; Dukes, Jeffrey S/0000-0001-9482-7743				Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hungate BA, 1999, CARBON DIOXIDE ENV S, P265, DOI DOI 10.1016/B978-012460370-7/50011-5; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; RASTETTER EB, 1992, WATER AIR SOIL POLL, V64, P327, DOI 10.1007/BF00477109; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486	11	595	655	7	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1512	1513		10.1126/science.1091390	http://dx.doi.org/10.1126/science.1091390			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645831				2022-12-01	WOS:000186802200024
J	Ruefli-Brasse, AA; French, DM; Dixit, VM				Ruefli-Brasse, AA; French, DM; Dixit, VM			Regulation of NF-kappa B-dependent lymphocyte activation and development by paracaspase	SCIENCE			English	Article							MALT LYMPHOMA; MARGINAL-ZONE; IMMUNE-RESPONSES; BCL10; CARMA1; CELLS; PROLIFERATION; PROTEINS	Paracaspase (MALT1), a member of an evolutionarily conserved superfamily of caspase-like proteins, has been shown to bind and colocalize with the protein Bcl10 in vitro and, because of this association, has been suggested to be involved in the CARMA1-Bcl10 pathway of antigen-induced nuclear factor kappaB (NF-kappaB) activation. We demonstrate that primary T and B lymphocytes from para-caspase-deficient mice are defective in antigen-receptor-induced NF-kappaB activation, cytokine production, and proliferation. Paracaspase acts downstream of Bcl10 to induce NF-kappaB activation and is required for the normal development of B cells, indicating that paracaspase provides the missing link between Bcl10 and activation of the IkappaB kinase complex.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Bertoni Francesco, 2002, Hematol J, V3, P10, DOI 10.1038/sj.thj.6200146; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; RUEFLIBRASSE AA, UNPUB; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vega F, 2001, ADV ANAT PATHOL, V8, P313, DOI 10.1097/00125480-200111000-00001; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	18	291	315	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1581	1584		10.1126/science.1090769	http://dx.doi.org/10.1126/science.1090769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14576442				2022-12-01	WOS:000186802200049
J	Stroebel, D; Choquet, Y; Popot, JL; Picot, D				Stroebel, D; Choquet, Y; Popot, JL; Picot, D			An atypical haem in the cytochrome b(6)f complex	NATURE			English	Article							ELECTRON-TRANSFER; BC(1) COMPLEX; CRYSTAL-STRUCTURE; CHLOROPHYLL-A; BF COMPLEX; CHLOROPLAST; PROTEIN; SPINACH; SUBUNIT; DOMAIN	Photosystems I and II ( PSI and II) are reaction centres that capture light energy in order to drive oxygenic photosynthesis; however, they can only do so by interacting with the multisubunit cytochrome b(6)f complex. This complex receives electrons from PSII and passes them to PSI, pumping protons across the membrane and powering the Q-cycle. Unlike the mitochondrial and bacterial homologue cytochrome bc(1), cytochrome b(6)f can switch to a cyclic mode of electron transfer around PSI using an unknown pathway. Here we present the X-ray structure at 3.1 Angstrom of cytochrome b(6)f from the alga Chlamydomonas reinhardtii. The structure bears similarities to cytochrome bc(1) but also exhibits some unique features, such as binding chlorophyll, beta-carotene and an unexpected haem sharing a quinone site. This haem is atypical as it is covalently bound by one thioether linkage and has no axial amino acid ligand. This haem may be the missing link in oxygenic photosynthesis.	Univ Paris 07, CNRS, UMR 7099, Lab Physicochim Mol Membranes Biol, F-75005 Paris, France; Inst Biol Physicochim, CNRS, UPR 1261, Lab Physiol Membranaire & Mol Chloroplaste, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Picot, D (corresponding author), Univ Paris 07, CNRS, UMR 7099, Lab Physicochim Mol Membranes Biol, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	Jean-Luc.Popot@ibpc.fr; Daniel.Picot@ibpc.fr	Choquet, Yves/M-5533-2019; Choquet, Yves/ABE-3084-2020	Choquet, Yves/0000-0003-4760-3397; Picot, Daniel/0000-0002-1375-1490				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Breyton C, 1997, J BIOL CHEM, V272, P21892, DOI 10.1074/jbc.272.35.21892; Breyton C, 2000, BBA-BIOENERGETICS, V1459, P467, DOI 10.1016/S0005-2728(00)00185-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Choquet Y, 2003, PLANT CELL, V15, P1443, DOI 10.1105/tpc.011692; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Finazzi G, 2002, BIOCHEMISTRY-US, V41, P7475, DOI 10.1021/bi025714w; Hart SE, 2003, BIOCHEMISTRY-US, V42, P4829, DOI 10.1021/bi020674h; Hirst J, 2001, BIOCHEMISTRY-US, V40, P1274, DOI 10.1021/bi002090q; HOFLE G, 1984, LIEBIGS ANN CHEM, P1883; HOPE AB, 1993, BIOCHIM BIOPHYS ACTA, V1143, P1, DOI 10.1016/0005-2728(93)90210-7; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; HURT E, 1981, EUR J BIOCHEM, V117, P591; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JOLIOT P, 1988, BIOCHIM BIOPHYS ACTA, V933, P319, DOI 10.1016/0005-2728(88)90039-4; Joliot P, 1998, BIOCHEMISTRY-US, V37, P10404, DOI 10.1021/bi980546m; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LAVERGNE J, 1983, BIOCHIM BIOPHYS ACTA, V725, P25, DOI 10.1016/0005-2728(83)90220-7; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MUKAI K, 1989, EUR J BIOCHEM, V178, P649, DOI 10.1111/j.1432-1033.1989.tb14494.x; MURAKAMI S, 1970, J CELL BIOL, V47, P332, DOI 10.1083/jcb.47.2.332; NITSCHKE W, 1987, BIOCHIM BIOPHYS ACTA, V892, P314, DOI 10.1016/0005-2728(87)90235-0; Peterman EJG, 1998, BIOPHYS J, V75, P389, DOI 10.1016/S0006-3495(98)77523-X; Pierre Y, 1997, J BIOL CHEM, V272, P21901, DOI 10.1074/jbc.272.35.21901; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Pond AE, 1999, BIOCHEMISTRY-US, V38, P7601, DOI 10.1021/bi9825448; Sainz G, 2000, BIOCHEMISTRY-US, V39, P9164, DOI 10.1021/bi0004596; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Schoepp B, 2000, J BIOL CHEM, V275, P5275, DOI 10.1074/jbc.275.8.5275; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yan JS, 2001, BBA-BIOENERGETICS, V1506, P182, DOI 10.1016/S0005-2728(01)00212-2; Yu J, 1998, J BIOL CHEM, V273, P8860, DOI 10.1074/jbc.273.15.8860; Zhang HM, 1999, J BIOL CHEM, V274, P1581, DOI 10.1074/jbc.274.3.1581; Zhang HM, 2003, P NATL ACAD SCI USA, V100, P5160, DOI 10.1073/pnas.0931431100; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zito F, 1998, BIOCHEMISTRY-US, V37, P10395, DOI 10.1021/bi980238o	51	512	548	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					413	418		10.1038/nature02155	http://dx.doi.org/10.1038/nature02155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647374				2022-12-01	WOS:000186800800030
J	Yamaguchi, S; Isejima, H; Matsuo, T; Okura, R; Yagita, K; Kobayashi, M; Okamura, H				Yamaguchi, S; Isejima, H; Matsuo, T; Okura, R; Yagita, K; Kobayashi, M; Okamura, H			Synchronization of cellular clocks in the suprachiasmatic nucleus	SCIENCE			English	Article							CIRCADIAN-RHYTHMS; MPER1 GENE; MOUSE; TETRODOTOXIN	Individual cellular clocks in the suprachiasmatic nucleus (SCN), the circadian center, are integrated into a stable and robust pacemaker with a period length of about 24 hours. We used real-time analysis of gene expression to show synchronized rhythms of clock gene transcription across hundreds of neurons within the mammalian SCN in organotypic slice culture. Differentially phased neuronal clocks are topographically arranged across the SCN. A protein synthesis inhibitor set all cell clocks to the same initial phase and, after withdrawal, intrinsic interactions among cell clocks reestablished the stable program of gene expression across the assemblage. Na+-dependent action potentials contributed to establishing cellular synchrony and maintaining spontaneous oscillation across the SCN.	Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci, Kobe, Hyogo 6500017, Japan; Yamaguchi Univ, Dept Phys Informat & Biol, Yamaguchi 7538512, Japan; Tohoku Inst Technol, Dept Elect, Sendai, Miyagi 9828577, Japan	Kobe University; Yamaguchi University; Tohoku Institute Technology	Okamura, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci, Kobe, Hyogo 6500017, Japan.	okamurah@kobe-u.ac.jp	MATSUO, Takuya/I-7493-2014	Ookura, Ryusuke/0000-0002-6045-9193; Okamura, Hitoshi/0000-0002-3013-4881				Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Asai M, 2001, CURR BIOL, V11, P1524, DOI 10.1016/S0960-9822(01)00445-6; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; Honma S, 2000, NEUROSCI LETT, V294, P113, DOI 10.1016/S0304-3940(00)01558-5; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1985, J NEUROSCI, V5, P2771; SHIBATA S, 1993, BRAIN RES, V606, P259, DOI 10.1016/0006-8993(93)90993-W; TOMINAGA K, 1994, NEUROSCIENCE, V59, P1025, DOI 10.1016/0306-4522(94)90303-4; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yamaguchi S, 2001, NATURE, V409, P684, DOI 10.1038/35055628	21	692	701	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1408	1412		10.1126/science.1089287	http://dx.doi.org/10.1126/science.1089287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631044				2022-12-01	WOS:000186683500056
J	Krack, P; Batir, A; Van Blercom, N; Chabardes, S; Fraix, V; Ardouin, C; Koudsie, A; Limousin, PD; Benazzouz, A; LeBas, JF; Benabid, AL; Pollak, P				Krack, P; Batir, A; Van Blercom, N; Chabardes, S; Fraix, V; Ardouin, C; Koudsie, A; Limousin, PD; Benazzouz, A; LeBas, JF; Benabid, AL; Pollak, P			Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-BRAIN-STIMULATION; RATING-SCALE; POSTEROVENTRAL PALLIDOTOMY; UNILATERAL PALLIDOTOMY; GLOBUS-PALLIDUS; MOTOR FUNCTION; LEVODOPA; FLUCTUATIONS; DEPRESSION; SPECTRUM	Background: Although the short-term benefits of bilateral stimulation of the subthalamic nucleus in patients with advanced Parkinson's disease have been well documented, the long-term outcomes of the procedure are unknown. Methods: We conducted a five-year prospective study of the first 49 consecutive patients whom we treated with bilateral stimulation of the subthalamic nucleus. Patients were assessed at one, three, and five years with levodopa (on medication) and without levodopa (off medication), with use of the Unified Parkinson's Disease Rating Scale. Seven patients did not complete the study: three died, and four were lost to follow-up. Results: As compared with base line, the patients' scores at five years for motor function while off medication improved by 54 percent (P<0.001) and those for activities of daily living improved by 49 percent (P<0.001). Speech was the only motor function for which off-medication scores did not improve. The scores for motor function on medication did not improve one year after surgery, except for the dyskinesia scores. On-medication akinesia, speech, postural stability, and freezing of gait worsened between year 1 and year 5 (P<0.001 for all comparisons). At five years, the dose of dopaminergic treatment and the duration and severity of levodopa-induced dyskinesia were reduced, as compared with base line (P<0.001 for each comparison). The average scores for cognitive performance remained unchanged, but dementia developed in three patients after three years. Mean depression scores remained unchanged. Severe adverse events included a large intracerebral hemorrhage in one patient. One patient committed suicide. Conclusions: Patients with advanced Parkinson's disease who were treated with bilateral stimulation of the subthalamic nucleus had marked improvements over five years in motor function while off medication and in dyskinesia while on medication. There was no control group, but worsening of akinesia, speech, postural stability, freezing of gait, and cognitive function between the first and the fifth year is consistent with the natural history of Parkinson's disease.	Univ Grenoble 1, Dept Clin & Biol Neurosci, Grenoble, France; Univ Grenoble 1, Dept Magnet Resonance Imaging, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Krack, P (corresponding author), CHU Grenoble, Dept Neurol, Dept Clin & Biol Neurosci, BP 217, F-38043 Grenoble 9, France.	paul.krack@ujf-grenoble.fr	FRAIX, VALERIE/AAC-3616-2019; Benazzouz, Abdelhamid/E-5050-2016; Benabid, Alim L/Q-3506-2017	Krack, Paul/0000-0002-3508-7295				Albanese A, 2001, MOVEMENT DISORD, V16, P197, DOI 10.1002/mds.1069; Alkhani A, 2001, J NEUROSURG, V94, P43, DOI 10.3171/jns.2001.94.1.0043; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18; BONNET AM, 1987, NEUROLOGY, V37, P1539, DOI 10.1212/WNL.37.9.1539; De Bie RMA, 2002, MOVEMENT DISORD, V17, P533, DOI 10.1002/mds.10090; Doshi PK, 2002, MOVEMENT DISORD, V17, P1084, DOI 10.1002/mds.10198; Durif F, 2002, MOVEMENT DISORD, V17, P803, DOI 10.1002/mds.10128; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fine J, 2000, NEW ENGL J MED, V342, P1708, DOI 10.1056/NEJM200006083422304; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Funkiewiez A, 2003, MOVEMENT DISORD, V18, P524, DOI 10.1002/mds.10441; Ghika J, 1998, J NEUROSURG, V89, P713, DOI 10.3171/jns.1998.89.5.0713; Ghika J, 1999, J NEUROSURG, V91, P313, DOI 10.3171/jns.1999.91.2.0313; Goetz CG, 2002, MOVEMENT DISORD, V17, P283, DOI 10.1002/mds.10024; Goetz CG, 2000, NEUROLOGY, V54, P710, DOI 10.1212/WNL.54.3.710; GREENE P, 1993, ADV NEUROL, V60, P703; Hariz GM, 2003, MOVEMENT DISORD, V18, P373, DOI 10.1002/mds.10386; Hariz MI, 2001, J NEUROSURG, V94, P552, DOI 10.3171/jns.2001.94.4.0552; Hoehn MM, 1969, 3 S PARK DIS, P274; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; Jahanshahi M, 2000, BRAIN, V123, P1142, DOI 10.1093/brain/123.6.1142; KLAWANS HL, 1986, MOVEMENT DISORD, V3, P187; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; Krack P, 1997, LANCET, V350, P1676, DOI 10.1016/S0140-6736(05)64273-0; Krack P, 1999, BRAIN, V122, P1133, DOI 10.1093/brain/122.6.1133; Kumar R, 1998, NEUROLOGY, V51, P850, DOI 10.1212/WNL.51.3.850; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARKHAM CH, 1986, ANN NEUROL, V19, P365, DOI 10.1002/ana.410190410; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Oh MY, 2002, NEUROSURGERY, V50, P1268; Pahwa R, 2003, J NEUROSURG, V99, P71, DOI 10.3171/jns.2003.99.1.0071; Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411; Rehncrona S, 2003, MOVEMENT DISORD, V18, P163, DOI 10.1002/mds.10309; RICHARDS M, 1994, MOVEMENT DISORD, V9, P89, DOI 10.1002/mds.870090114; RILEY DE, 1993, NEUROLOGY, V43, P1459, DOI 10.1212/WNL.43.8.1459; Romito LM, 2002, MOVEMENT DISORD, V17, P1371, DOI 10.1002/mds.10265; SCHMIDT R, 1994, NEUROLOGY, V44, P964, DOI 10.1212/WNL.44.5.964; Schwab R.S., 1969, 3 S PARKINSONS DIS, P152; Speelman JD, 1998, MOVEMENT DISORD, V13, P103; Valldeoriola F, 2002, J NEUROL, V249, P1671, DOI 10.1007/s00415-002-0897-8; Zhang H, 2003, NEUROSURGERY, V52, P89, DOI 10.1227/01.NEU.0000038933.95427.AE	46	1547	1579	1	188	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2003	349	20					1925	1934		10.1056/NEJMoa035275	http://dx.doi.org/10.1056/NEJMoa035275			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742EA	14614167	Green Published, Bronze			2022-12-01	WOS:000186502400007
J	Lei, M; Podell, ER; Baumann, P; Cech, TR				Lei, M; Podell, ER; Baumann, P; Cech, TR			DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA	NATURE			English	Article							END-BINDING-PROTEIN; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; DOMAIN; PROTECTION; SEQUENCE	Telomeres, specialized protein-DNA complexes that cap the ends of linear chromosomes, are essential for protecting chromosomes from degradation and end-to-end fusions(1,2). The Pot1 (protection of telomeres 1) protein is a widely distributed eukaryotic end-capping protein, having been identified in fission yeast, microsporidia, plants and animals(3,4). Schizosaccharomyces pombe Pot1p is essential for telomere maintenance(3), and human POT1 has been implicated in telomerase regulation(5,6). Pot1 binds telomeric single-stranded DNA (ssDNA) with exceptionally high sequence specificity(7), the molecular basis of which has been unknown. Here we describe the 1.9-Angstrom-resolution crystal structure of the amino-terminal DNA-binding domain of S. pombe Pot1p complexed with ssDNA. The protein adopts an oligonucleotide/oligosaccharide-binding (OB) fold(8) with two loops that protrude to form a clamp for ssDNA binding. The structure explains the sequence specificity of binding: in the context of the Pot1 protein, DNA self-recognition involving base-stacking and unusual G-T base pairs compacts the DNA. Any sequence change disrupts the ability of the DNA to form this structure, preventing it from contacting the array of protein hydrogen-bonding groups. The structure also explains how Pot1p avoids binding the vast excess of RNA in the nucleus.	Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Stowers Institute for Medical Research	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Baumann, Peter/0000-0003-4892-1485				Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Cervantes RB, 2002, CURR OPIN CELL BIOL, V14, P351, DOI 10.1016/S0955-0674(02)00325-3; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Classen S, 2003, BIOCHEMISTRY-US, V42, P9269, DOI 10.1021/bi0273718; Classen S, 2001, J MOL BIOL, V314, P1113, DOI 10.1006/jmbi.2000.5191; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lei M, 2002, BIOCHEMISTRY-US, V41, P14560, DOI 10.1021/bi026674z; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NICHOLLS A, 1991, J COMPUT CHEM, V270, P26184; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Peersen OB, 2002, NAT STRUCT BIOL, V9, P182, DOI 10.1038/nsb761; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506	30	172	182	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					198	203		10.1038/nature02092	http://dx.doi.org/10.1038/nature02092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614509				2022-12-01	WOS:000186517200048
J	Pearce, EL; Mullen, AC; Martins, GA; Krawczyk, CM; Hutchins, AS; Zediak, VP; Banica, M; DiCioccio, CB; Gross, DA; Mao, C; Shen, H; Cereb, N; Yang, SY; Lindsten, T; Rossant, J; Hunter, CA; Reiner, SL				Pearce, EL; Mullen, AC; Martins, GA; Krawczyk, CM; Hutchins, AS; Zediak, VP; Banica, M; DiCioccio, CB; Gross, DA; Mao, C; Shen, H; Cereb, N; Yang, SY; Lindsten, T; Rossant, J; Hunter, CA; Reiner, SL			Control of effector CD8(+) T cell function by the transcription factor Eomesodermin	SCIENCE			English	Article							LINEAGE COMMITMENT; BET; GENE; MEMORY; DIFFERENTIATION; INDUCTION; FOXP3; CD4	Activated CD8(+) T cells play a critical role in host defense against viruses, intracellular microbes, and tumors. It is not clear if a key regulatory transcription factor unites the effector functions of CD8(+) T cells. We now show that Eomesodermin (Eomes), a paralogue of T-bet, is induced in effector CD8(+) T cells in vitro and in vivo. Ectopic expression of Eomes was sufficient to invoke attributes of effector CD8(+) T cells, including interferon-gamma (IFN-gamma), perforin, and granzyme B. Loss-of-function analysis suggests Eomes may also be necessary for full effector differentiation of CD8(+) T cells. We suggest that Eomesodermin is likely to complement the actions of T-bet and act as a key regulatory gene in the development of cell-mediated immunity.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Ctr Genet Polymorphism, Ossining, NY 10562 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Hunter, Christopher/H-1970-2011	Mao, Chai-An/0000-0002-9700-6964; Mullen, Alan/0000-0002-4096-3106	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-042370] Funding Source: Medline; NIGMS NIH HHS [GM-07229] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CEREB N, UNPUB; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horton AC, 2002, J EXP ZOOL, V294, P112, DOI 10.1002/jez.10151; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; MAO C, UNPUB; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; REINER SL, UNPUB; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yi CH, 1999, GENOMICS, V55, P10, DOI 10.1006/geno.1998.5632; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	21	740	759	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1041	1043		10.1126/science.1090148	http://dx.doi.org/10.1126/science.1090148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605368				2022-12-01	WOS:000186396300047
J	Billas, IML; Iwema, T; Garnier, JM; Mitschler, A; Rochel, N; Moras, D				Billas, IML; Iwema, T; Garnier, JM; Mitschler, A; Rochel, N; Moras, D			Structural adaptability in the ligand-binding pocket of the ecdysone hormone receptor	NATURE			English	Article							CRYSTAL-STRUCTURE; NUCLEAR RECEPTOR; HETERODIMERIC COMPLEX; DOMAIN; ALPHA; ACTIVATION; REVEALS; INSECT; BETA; ECR	The ecdysteroid hormones coordinate the major stages of insect development, notably moulting and metamorphosis, by binding to the ecdysone receptor (EcR); a ligand-inducible nuclear transcription factor(1,2). To bind either ligand or DNA, EcR must form a heterodimer with ultraspiracle (USP), the homologue of retinoid-X receptor(3-5). Here we report the crystal structures of the ligand-binding domains of the moth Heliothis virescens EcR - USP heterodimer in complex with the ecdysteroid ponasterone A and with a non-steroidal, lepidopteran-specific agonist BYI06830 used in agrochemical pest control. The two structures of EcR - USP emphasize the universality of heterodimerization as a general mechanism common to both vertebrates and invertebrates. Comparison of the EcR structures in complex with steroidal and non-steroidal ligands reveals radically different and only partially overlapping ligand-binding pockets that could not be predicted by molecular modelling and docking studies(6,7). These findings offer new perspectives for the design of insect-specific, environmentally safe insecticides. The concept of a ligand-dependent binding pocket in EcR provides an insight into the moulding of nuclear receptors to their ligand, and has potential applications for human nuclear receptors.	Univ Strasbourg 1, IGBMC, Dept Biol & Genom Struct, CNRS,INSERM, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Moras, D (corresponding author), Univ Strasbourg 1, IGBMC, Dept Biol & Genom Struct, CNRS,INSERM, Parc Innovat BP10142, F-67404 Illkirch Graffenstaden, France.	moras@igbmc.u-strasbg.fr	Rochel, Natacha/A-5718-2016; Billas, Isabelle M.L./I-2790-2016	Rochel, Natacha/0000-0002-3573-5889; Billas, Isabelle M.L./0000-0003-2323-4208				Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Baker KD, 2000, INSECT BIOCHEM MOLEC, V30, P1037, DOI 10.1016/S0965-1748(00)00075-8; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clayton GM, 2001, P NATL ACAD SCI USA, V98, P1549, DOI 10.1073/pnas.041611298; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Farnegardh M, 2003, J BIOL CHEM, V278, P38821, DOI 10.1074/jbc.M304842200; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Greiner EF, 1996, P NATL ACAD SCI USA, V93, P10105, DOI 10.1073/pnas.93.19.10105; HENRICH VC, 1995, INSECT BIOCHEM MOLEC, V25, P881, DOI 10.1016/0965-1748(95)00030-Y; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kasuya A, 2003, J MOL MODEL, V9, P58, DOI 10.1007/s00894-002-0113-x; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kumar MB, 2002, P NATL ACAD SCI USA, V99, P14710, DOI 10.1073/pnas.222278999; MOHAMMEDALI AK, 1995, CAN J CHEM, V73, P550, DOI 10.1139/v95-071; Potier N, 2003, PROTEIN SCI, V12, P725, DOI 10.1110/ps.0232503; Riddiford LM, 2001, VITAM HORM, V60, P1; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Toya T, 2002, BIOCHEM BIOPH RES CO, V292, P1087, DOI 10.1006/bbrc.2002.6771; Wurtz JM, 2000, PROTEIN SCI, V9, P1073, DOI 10.1110/ps.9.6.1073; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F	30	191	200	6	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					91	96		10.1038/nature02112	http://dx.doi.org/10.1038/nature02112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14595375				2022-12-01	WOS:000186370800048
J	Rose, CR; Blum, R; Pichler, B; Lepier, A; Kafitz, KW; Konnerth, A				Rose, CR; Blum, R; Pichler, B; Lepier, A; Kafitz, KW; Konnerth, A			Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells	NATURE			English	Article							NERVOUS-SYSTEM; TYROSINE KINASE; FULL-LENGTH; RECEPTOR; TRANSDUCTION; PROTEIN; BDNF; ACTIVATION; ASTROCYTES; INHIBITOR	The neurotrophin receptor TrkB is essential for normal function of the mammalian brain(1-3). It is expressed in three splice variants. Full-length receptors (TrkB(FL)) possess an intracellular tyrosine kinase domain and are considered as those TrkB receptors that mediate the crucial effects of brain-derived neurotrophic factor (BDNF) or neurotrophin 4/5 (NT- 4/5). By contrast, truncated receptors (TrkB-T1 and TrkB-T2) lack tyrosine kinase activity and have not been reported to elicit rapid intracellular signalling(4). Here we show that astrocytes predominately express TrkB-T1 and respond to brief application of BDNF by releasing calcium from intracellular stores. The calcium transients are insensitive to the tyrosine kinase blocker K-252a and persist in mutant mice lacking TrkB(FL). By contrast, neurons produce rapid BDNF-evoked signals through TrkB(FL) and the Na(v)1.9 channel(5,6). Expression of antisense TrkB messenger RNA strongly reduces BDNF-evoked calcium signals in glia. Thus, our results show that, unexpectedly, TrkB-T1 has a direct signalling role in mediating inositol-1,4,5-trisphosphate-dependent calcium release; in addition, they identify a previously unknown mechanism of neurotrophin action in the brain.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Rose, CR (corresponding author), Univ Munich, Inst Physiol, D-80336 Munich, Germany.		Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854				BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Baxter GT, 1997, J NEUROSCI, V17, P2683; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Climent E, 2000, NEUROSCI LETT, V288, P53, DOI 10.1016/S0304-3940(00)01207-6; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; HELMS JB, 1995, FEBS LETT, V369, P84, DOI 10.1016/0014-5793(95)00620-O; Idestrup CP, 1998, NEUROSCIENCE, V86, P913, DOI 10.1016/S0306-4522(98)00128-6; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kryl D, 2000, BIOCHEM BIOPH RES CO, V279, P925, DOI 10.1006/bbrc.2000.4058; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Newman E A, 2001, Prog Brain Res, V132, P241; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI DOI 10.1007/978-3-642-59524-0_3; ROBACK JD, 1995, EUR J NEUROSCI, V7, P849, DOI 10.1111/j.1460-9568.1995.tb01072.x; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99	30	281	289	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					74	78		10.1038/nature01983	http://dx.doi.org/10.1038/nature01983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603320				2022-12-01	WOS:000186370800044
J	Behr, E; Wood, DA; Wright, M; Syrris, P; Sheppard, MN; Casey, A; Davies, MJ; McKenna, W				Behr, E; Wood, DA; Wright, M; Syrris, P; Sheppard, MN; Casey, A; Davies, MJ; McKenna, W		SADS Steering Grp	Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome	LANCET			English	Article							LONG-QT SYNDROME	4.1% of sudden cardiac deaths in the 16-64 age-group are unexplained. In this group, cardiac pathological findings are normal and toxicological tests are negative; termed sudden arrythmic death syndrome (SADS). We searched for evidence of inherited cardiac disease in cases of SADS. Of 147 first-degree relatives of 32 people who died of SADS, 109 (74%) underwent cardiological assessment. Seven (22%) of the 32 families were diagnosed with inherited cardiac disease: four with long QT syndrome; one with non-structural cardiac electrophysiological disease; one with myotonic dystrophy; and one with hypertrophic cardiomyopathy. Families of people who die of SADS should be offered assessment in centres with experience of inherited cardiac disease.	Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Univ London Imperial Coll Sci Technol & Med, Imperial Coll Sch Med, Natl Heart & Lung Inst, London, England	St Georges University London; Imperial College London	McKenna, W (corresponding author), Natl Heart Hosp, 16-18 Westmoreland St, London W1G 8PH, England.		McKenna, William J/C-3243-2008; Sheppard, Mary N/AAB-3364-2019; SYRRIS, PETROS/C-1703-2008	McKenna, William J/0000-0001-7994-2460; Sheppard, Mary N/0000-0003-2724-3881; SYRRIS, PETROS/0000-0002-2363-8758; Behr, Elijah/0000-0002-8731-2853				Bowker TJ, 2003, QJM-INT J MED, V96, P269, DOI 10.1093/qjmed/hcg038; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8	5	216	222	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 1	2003	362	9394					1457	1459		10.1016/S0140-6736(03)14692-2	http://dx.doi.org/10.1016/S0140-6736(03)14692-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602442				2022-12-01	WOS:000186356600014
J	Merikangas, KR; Risch, N				Merikangas, KR; Risch, N			Genomic priorities and public health	SCIENCE			English	Article							GENETIC EPIDEMIOLOGY; ADOLESCENT SMOKING; DIABETES-MELLITUS; ALZHEIMER-DISEASE; COMPLEX TRAITS; FAMILY-HISTORY; LIFE-STYLE; STRATEGIES; CANCER; RISK	Given the continuing difficulty of identifying genes for complex disorders in a robust, replicable manner, and the extensive resources devoted to this effort, it is becoming increasingly important to analyze the relative benefits of genomics research for public health applications and for the understanding of disease pathogenesis. To establish priorities for genetics research, we review and evaluate several characteristics of selected exemplary complex diseases, including phenotypic accuracy, knowledge of specific and nonspecific genetic and environmental risk factors, and population prevalence and impact. We propose that complex diseases with the strongest evidence for genetic etiology, limited ability to modify exposure or risk factors, and high public health impact should have the highest priority for genetics research.	NIMH, Sec Dev Genet Epidemiol, Mood & Anxiety Disorders Progrma, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Kaiser Permanente, Div Res, Oakland, CA 94612 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Stanford University; Kaiser Permanente	Merikangas, KR (corresponding author), NIMH, Sec Dev Genet Epidemiol, Mood & Anxiety Disorders Progrma, NIH,Dept Hlth & Human Serv, 15K N Dr,Mail Stop Code 2670, Bethesda, MD 20892 USA.	kathleen.merikangas@nih.gov		Merikangas, Kathkeen/0000-0002-4667-2414	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002804, ZIAMH002804] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; *AM CANC SOC, 2003, CANC FACTS FIG 2003; [Anonymous], 2002, WORLD HLTH REP 2002; Avenevoli S, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1360-0443.98.s1.2.x; Baird P, 2001, Community Genet, V4, P77, DOI 10.1159/000051161; Baird PA, 2002, PERSPECT BIOL MED, V45, P516, DOI 10.1353/pbm.2002.0061; BOOMSMA DI, 1994, ADDICTION, V89, P219, DOI 10.1111/j.1360-0443.1994.tb00881.x; Breslau N, 2001, ARCH GEN PSYCHIAT, V58, P810, DOI 10.1001/archpsyc.58.9.810; Calabrese EJ, 1997, ENVIRON HEALTH PERSP, V105, P1354, DOI 10.2307/3433755; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; *CDC, 2001, SURV EP AIDS SURV SP; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; GOLDMAN D, 1993, RECENT DEV ALCOHOLIS, V2; Goldner EM, 2002, CAN J PSYCHIAT, V47, P833, DOI 10.1177/070674370204700904; Gottesman I.I., 1972, SCHIZOPHRENIA GENETI; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; HANLEY AJG, 1995, INT J EPIDEMIOL, V24, P255, DOI 10.1093/ije/24.2.255; Harrison TA, 2003, AM J PREV MED, V24, P152, DOI 10.1016/S0749-3797(02)00588-3; Hendrie HC, 1998, AM J GERIAT PSYCHIAT, V6, pS3, DOI 10.1097/00019442-199821001-00002; Ishibe N, 1997, CANCER CAUSE CONTROL, V8, P504, DOI 10.1023/A:1018421724776; Kenny S.J., 1995, NIH PUBLICATION, P47; Khoury MJ, 2003, GENET MED, V5, P261, DOI 10.1097/01.GIM.0000076977.90682.A5; Khoury MJ, 1996, AM J PUBLIC HEALTH, V86, P1717, DOI 10.2105/AJPH.86.12.1717; KIDD K, COMMUNICATION; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lantz PM, 2000, TOB CONTROL, V9, P47, DOI 10.1136/tc.9.1.47; Little J, 2003, AM J EPIDEMIOL, V157, P667, DOI 10.1093/aje/kwg048; MERIKANGAS KR, 1990, PSYCHOL MED, V20, P11, DOI 10.1017/S0033291700013192; MERIKANGAS KR, UNPUB AM J EPIDEMIOL; Newschaffer CJ, 2002, EPIDEMIOL REV, V24, P137, DOI 10.1093/epirev/mxf010; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Pollitt RJ, 2001, J INHERIT METAB DIS, V24, P299, DOI 10.1023/A:1010339606265; RAVUSSIN E, 1994, DIABETES CARE, V17, P1067, DOI 10.2337/diacare.17.9.1067; REWERS M, 1995, NIH PUBLICATION, P179; Rich SS, 2002, DIABETES, V51, pS288, DOI 10.2337/diabetes.51.2007.S288; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; ROSE G, 1997, STRATEGY PREVENTIVE; Rose JS, 1999, MERRILL PALMER QUART, V45, P62; Sadovnick AD, 2002, CLIN NEUROL NEUROSUR, V104, P199, DOI 10.1016/S0303-8467(02)00038-0; SHAPER AG, 1991, ACTA PAEDIATR SCAND, P73; Shostak S, 2003, SOC SCI MED, V56, P2327, DOI 10.1016/S0277-9536(02)00231-9; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Slooter AJC, 1997, EPIDEMIOL REV, V19, P107, DOI 10.1093/oxfordjournals.epirev.a017933; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668; Susser M, 1998, J EPIDEMIOL COMMUN H, V52, P608, DOI 10.1136/jech.52.10.608; Trevisan R, 1998, NEPHROL DIAL TRANSPL, V13, P2, DOI 10.1093/ndt/13.suppl_8.2	51	185	190	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					599	601		10.1126/science.1091468	http://dx.doi.org/10.1126/science.1091468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	735MV	14576422				2022-12-01	WOS:000186119900045
J	Van Laere, AS; Nguyen, M; Braunschweig, M; Nezer, C; Collette, C; Moreau, L; Archibald, AL; Haley, CS; Buys, N; Tally, M; Andersson, G; Georges, M; Andersson, L				Van Laere, AS; Nguyen, M; Braunschweig, M; Nezer, C; Collette, C; Moreau, L; Archibald, AL; Haley, CS; Buys, N; Tally, M; Andersson, G; Georges, M; Andersson, L			A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; INCREASED OVULATION RATE; GENETIC DISSECTION; IDENTIFICATION; DELETION; MASS; PHENOTYPE; SKELETAL; ELEMENT; CATTLE	Most traits and disorders have a multifactorial background indicating that they are controlled by environmental factors as well as an unknown number of quantitative trait loci (QTLs)(1,2). The identification of mutations underlying QTLs is a challenge because each locus explains only a fraction of the phenotypic variation(3,4). A paternally expressed QTL affecting muscle growth, fat deposition and size of the heart in pigs maps to the IGF2 (insulin-like growth factor 2) region(5,6). Here we show that this QTL is caused by a nucleotide substitution in intron 3 of IGF2. The mutation occurs in an evolutionarily conserved CpG island that is hypomethylated in skeletal muscle. The mutation abrogates in vitro interaction with a nuclear factor, probably a repressor, and pigs inheriting the mutation from their sire have a threefold increase in IGF2 messenger RNA expression in postnatal muscle. Our study establishes a causal relationship between a single-base-pair substitution in a non-coding region and a QTL effect. The result supports the long-held view that regulatory mutations are important for controlling phenotypic variation(7).	Swedish Univ Agr Sci, Dept Anim Breeding & Genet, BMC, SE-75124 Uppsala, Sweden; Uppsala Univ, Dept Med Biochem & Microbiol, BMC, SE-75124 Uppsala, Sweden; Univ Liege, Fac Vet Med, Dept Genet, B-4000 Liege, Belgium; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Gentec, B-9255 Buggenhout, Belgium; Tally Consulting, SE-11458 Stockholm, Sweden	Swedish University of Agricultural Sciences; Uppsala University; University of Liege; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Georges, M (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, BMC, Box 597, SE-75124 Uppsala, Sweden.		Haley, Chris S/F-3110-2013; Van+Laere, Anne-Sophie/ADZ-7821-2022; Andersson, Goran/AAK-6564-2020	Andersson, Goran/0000-0001-5131-3144; Buys, Nadine/0000-0002-7313-3088; Georges, Michel/0000-0003-4124-2375; Haley, Chris/0000-0002-9811-0210; Archibald, Alan/0000-0001-9213-1830				Amarger V, 2002, MAMM GENOME, V13, P388, DOI 10.1007/s00335-001-3059-x; Anderson SI, 2000, MAMM GENOME, V11, P811, DOI 10.1007/s003350010155; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Darvasi A, 2002, TRENDS GENET, V18, P489, DOI 10.1016/S0168-9525(02)02767-1; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; ENGEMANN S, 2002, METHODS MOL BIOL, V181; Evans GJ, 2003, GENETICS, V164, P621; Florini JR, 1995, DIABETES REV, V3, P73; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Giuffra E, 2000, GENETICS, V154, P1785; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Greally JM, 1997, MAMM GENOME, V8, P805, DOI 10.1007/s003359900583; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; HALEY CS, 1994, GENETICS, V136, P1195; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Kashuk C, 2002, GENOME RES, V12, P333, DOI 10.1101/gr.211202; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Mulsant P, 2001, P NATL ACAD SCI USA, V98, P5104, DOI 10.1073/pnas.091577598; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nezer C, 2003, GENETICS, V165, P277; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769	29	672	724	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					832	836		10.1038/nature02064	http://dx.doi.org/10.1038/nature02064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574411				2022-12-01	WOS:000186118500044
J	Loya, WM; Pregitzer, KS; Karberg, NJ; King, JS; Giardina, CP				Loya, WM; Pregitzer, KS; Karberg, NJ; King, JS; Giardina, CP			Reduction of soil carbon formation by tropospheric ozone under increased carbon dioxide levels	NATURE			English	Article							GROWTH; TREES; ALLOCATION; PLANTS; ASPEN	In the Northern Hemisphere, ozone levels in the troposphere have increased by 35 per cent over the past century(1), with detrimental impacts on forest(2,3) and agricultural(4) productivity, even when forest productivity has been stimulated by increased carbon dioxide levels'. In addition to reducing productivity, increased tropospheric ozone levels could alter terrestrial carbon cycling by lowering the quantity and quality of carbon inputs to soils. However, the influence of elevated ozone levels on soil carbon formation and decomposition are unknown. Here we examine the effects of elevated ozone levels on the formation rates of total and decay-resistant acid-insoluble soil carbon under conditions of elevated carbon dioxide levels in experimental aspen (Populus tremuloides) stands and mixed aspen-birch (Betula papyrifera) stands. With ambient concentrations of ozone and carbon dioxide both raised by 50 per cent, we find that the formation rates of total and acid-insoluble soil carbon are reduced by 50 per cent relative to the amounts entering the soil when the forests were exposed to increased carbon dioxide alone. Our results suggest that, in a world with elevated atmospheric carbon dioxide concentrations, global-scale reductions in plant productivity due to elevated ozone levels will also lower soil carbon formation rates significantly.	Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; US Forest Serv, USDA, N Cent Res Stn, Houghton, MI 49931 USA	Michigan Technological University; United States Department of Agriculture (USDA); United States Forest Service	Loya, WM (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.		Giardina, Christian P/C-3120-2011	Giardina, Christian P/0000-0002-3431-5073				Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; CHAMEIDES WL, 1994, SCIENCE, V264, P74, DOI 10.1126/science.264.5155.74; COLEMAN MD, 1995, TREE PHYSIOL, V15, P593, DOI 10.1093/treephys/15.9.593; DICKSON RE, 2000, NC214 USDA; Findlay S, 1996, ECOL APPL, V6, P269, DOI 10.2307/2269570; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; *IPCC SECR, 2001, IPCC CLIM CHANG 2001; King JS, 2001, OECOLOGIA, V128, P237, DOI 10.1007/s004420100656; Larson JL, 2002, SOIL SCI SOC AM J, V66, P1848, DOI 10.2136/sssaj2002.1848; Leavitt SW, 1996, RADIOCARBON, V38, P231, DOI 10.1017/S0033822200017604; MCLAUGHLIN SB, 1995, NATURE, V374, P252, DOI 10.1038/374252a0; Paul EA, 1997, SOIL SCI SOC AM J, V61, P1058, DOI 10.2136/sssaj1997.03615995006100040011x; Percy KE, 2002, NATURE, V420, P403, DOI 10.1038/nature01028; Phillips RL, 2002, OECOLOGIA, V131, P236, DOI 10.1007/s00442-002-0868-x; *US EPA, LAT FIND NAT AIR QUA	15	105	113	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					705	707		10.1038/nature02047	http://dx.doi.org/10.1038/nature02047			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562100				2022-12-01	WOS:000185924500038
J	Ashida, H; Saito, Y; Kojima, C; Kobayashi, K; Ogasawara, N; Yokota, A				Ashida, H; Saito, Y; Kojima, C; Kobayashi, K; Ogasawara, N; Yokota, A			A functional link between RuBisCO-like protein of Bacillus and photosynthetic RuBisCO	SCIENCE			English	Article							METHIONINE SALVAGE PATHWAY; COMPLETE GENOME SEQUENCE; RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CHLOROBIUM-TEPIDUM; ARCHAEON; SITE	The genomes of several nonphotosynthetic bacteria, such as Bacillus subtilis, and some Archaea include genes for proteins with sequence homology to the large subunit of ribulose bisphosphate carboxylase/oxygenase (RuBisCO). We found that such a RuBisCO-like protein (RLP) from B. subtilis catalyzed the 2,3-diketo-5-methylthiopentyl-1-phosphate enolase reaction in the methionine salvage pathway. A growth-defective mutant, in which the gene for this RLP had been disrupted, was rescued by the gene for RuBisCO from the photosynthetic bacterium Rhodospirillum rubrum. Thus, the photosynthetic RuBisCO from R. rubrum retains the ability to function in the methionine salvage pathway in B. subtilis.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Res Inst Innovat Technol Earth, Plant Mol Physiol Lab, Kyoto 6190292, Japan	Nara Institute of Science & Technology; Research Institute of Innovative Technology for the Earth	Yokota, A (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.	yokota@bs.aist-nara.ac.jp	Kojima, Chojiro/AFV-4592-2022; Ogasawara, Naotake/B-7971-2011; Saito, Yohtaro/C-9838-2017	Saito, Yohtaro/0000-0002-1024-5154; Kojima, Chojiro/0000-0003-2723-8249				Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; ASHIDA H, UNPUB; Avigad G, 1975, Methods Enzymol, V41, P27; CHEN YR, 1995, J BIOL CHEM, V270, P11741, DOI 10.1074/jbc.270.20.11741; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Dai Y, 2001, BIOCHEMISTRY-US, V40, P6379, DOI 10.1021/bi010110y; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; FURFINE ES, 1988, J BIOL CHEM, V263, P9598; GRUNDY JF, 2002, BACILLUS SUBTILIS IT, P245; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hartman H, 1998, ORIGINS LIFE EVOL B, V28, P515, DOI 10.1023/A:1006548904157; Heilbronn J, 1999, J BACTERIOL, V181, P1739, DOI 10.1128/JB.181.6.1739-1747.1999; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; LARSON EM, 1995, BIOCHEMISTRY-US, V34, P4531, DOI 10.1021/bi00014a005; Moszer I, 1999, CURR OPIN MICROBIOL, V2, P524, DOI 10.1016/S1369-5274(99)00011-9; Murphy BA, 2002, J BACTERIOL, V184, P2314, DOI 10.1128/JB.184.8.2314-2318.2002; MYERS RW, 1993, J BIOL CHEM, V268, P24785; Roy Harry, 2000, VVolume 9, P53; Sekowska A, 2001, BMC Microbiol, V1, P15, DOI 10.1186/1471-2180-1-15; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147	29	143	155	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					286	290		10.1126/science.1086997	http://dx.doi.org/10.1126/science.1086997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	14551435				2022-12-01	WOS:000185825900042
J	Sparen, P; Vagero, D; Shestov, DB; Plavinskaja, S; Parfenova, N; Hoptiar, V; Paturot, D; Galanti, MR				Sparen, P; Vagero, D; Shestov, DB; Plavinskaja, S; Parfenova, N; Hoptiar, V; Paturot, D; Galanti, MR			Long term mortality after severe starvation during the siege of Leningrad: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; WOMEN BORN 1915-29; ANOREXIA-NERVOSA; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; PRENATAL EXPOSURE; EATING-DISORDERS; DUTCH FAMINE; SWEDISH MEN; RISK	Objective To determine whether starvation during periods of increased growth after birth has long term health consequences. Design Analysis of cardiovascular risk factors and mortality in a longitudinal follow up after the 1941-4 siege of Leningrad. Mortality measured from 1975 to the end of 1999. Setting St Petersburg, Russia (formerly Leningrad). Participants 5000 men born 1916-35 who lived in Leningrad, randomly selected to take part in health examinations in 1975-7. Of the 3905 men who participated, a third had experienced the siege. Main outcome measures Relative risk of ischaemic heart disease and mortality from stroke by siege exposure. Odds ratios and means for several cardiovascular risk factors. Results Three to six decades after the siege, in men who experienced the siege around the age of puberty blood pressure was raised (mean difference in systolic 3.3 mm Hg, in diastolic 1.3 mm Hg) as was mortality from ischaemic heart disease (relative risk 1.39, 95% confidence interval 1.07 to 1.79) and stroke (1.67, 1.15 to 2.43), including haemorrhagic stroke (1.71, 0.90 to 3.22). The effect on mortality was partly mediated via blood pressure but not by any other measured biological, behavioural, or social factor. Conclusions Starvation, or accompanying chronic stress, particularly at the onset of or during puberty, may increase vulnerability to later cardiovascular disease.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Stockholm Univ, Karolinska Inst, CHESS, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden; Russian Acad Med Sci, Inst Expt Med, St Petersburg, Russia; Univ Coll, Sodertorns Hgsk, Huddinge, Sweden; Karolinska Hosp, Dept Med, Clin Epidemiol Unit, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Sodertorn University; Karolinska Institutet; Karolinska University Hospital	Sparen, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.		Parfenova, Nina/E-6672-2014	Parfenova, Nina/0000-0002-1236-3058; Sparen, Par/0000-0002-5184-8971				ABERNATHY JR, 1988, AM J CARDIOL, V61, P1071, DOI 10.1016/0002-9149(88)90128-2; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ANTONOV AN, 1947, J PEDIATR, V30, P250, DOI 10.1016/S0022-3476(47)80160-X; Beevor Anthony, 1998, STALINGRAD; Bohlooly-Y M, 2001, ENDOCRINOLOGY, V142, P3317, DOI 10.1210/en.142.8.3317; Breslow NE, 1987, STAT METHODS CANC RE, VII; BROZEK J, 1948, JAMA-J AM MED ASSOC, V137, P1569, DOI 10.1001/jama.1948.02890520001001; Bygren LO, 2000, AM J HUM BIOL, V12, P447, DOI 10.1002/1520-6300(200007/08)12:4&lt;447::AID-AJHB3&gt;3.0.CO;2-M; COOKE RA, 1995, BRIT J HOSP MED, V54, P313; DESIMONE GD, 1994, BRIT HEART J, V71, P287; FORSDAHL A, 1977, BRIT J PREV SOC MED, V31, P91; GARNETT ES, 1969, LANCET, V1, P914; Holdaway I M, 1999, Pituitary, V2, P29, DOI 10.1023/A:1009965803750; Hypponen E, 2001, BRIT MED J, V323, P1033, DOI 10.1136/bmj.323.7320.1033; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; Kermack WO, 1934, LANCET, V1, P698; Keys A, 1950, BIOL HUMAN STARVATIO; KREIPE RE, 1992, PEDIATR ANN, V21, P760; LEON D, 2001, FETAL ORIGINS CARDIO; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; MARSHALL WA, 1986, HUMAN GROWTH COMPREH, P171; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; NELSON MJ, 1992, AM J EPIDEMIOL, V136, P633, DOI 10.1093/oxfordjournals.aje.a116543; PAVLOV DV, 1965, LENINGRAD 1941 BLOCK; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein Z., 1975, FAMINE HUM DEV DUTCH; Stoving RK, 1999, J PSYCHIATR RES, V33, P139, DOI 10.1016/S0022-3956(98)00049-1; Swenne I, 2000, ACTA PAEDIATR, V89, P447, DOI 10.1080/080352500750028177; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	33	93	99	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 3	2004	328	7430					11	14A		10.1136/bmj.37942.603970.9A	http://dx.doi.org/10.1136/bmj.37942.603970.9A			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761QG	14660443	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000187919000013
J	DeBusk, RF				DeBusk, RF			Sexual activity in patients with angina	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ERECTILE DYSFUNCTION; SILDENAFIL CITRATE; PHYSICAL EXERTION; EFFICACY; RISK		Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Stanford University	DeBusk, RF (corresponding author), Stanford Univ, Sch Med, Dept Med, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.							*AHCPR, 1994, AHCPR PUBL; Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; *AM HEART ASS, 2000, EM CARD CAR ADV CARD; American Heart Association, 2003, HEART DIS STROK STAT; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; Conti CR, 1999, AM J CARDIOL, V83, p29C; DeBusk R, 2000, AM J CARDIOL, V86, P175, DOI 10.1016/S0002-9149(00)00896-1; DEBUSK RF, 1986, NEW ENGL J MED, V314, P161, DOI 10.1056/NEJM198601163140307; DeBusk RF, 2002, JAMA-J AM MED ASSOC, V287, P2359, DOI 10.1001/jama.287.18.2359; DeBusk RF, 2000, AM J CARDIOL, V86, p51F; FROELICHER VF, 1980, CARDIOLOGY, V66, P223, DOI 10.1159/000170869; Kloner RA, 2003, AM J CARDIOL, V92, p37M, DOI 10.1016/S0002-9149(03)00074-2; LAUMANN EO, 1994, SOCIAL ORG SEXUALITY, P77; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; POLLOCK ML, 1995, HEART DIS REHABILITA; Porst H, 2001, INT J IMPOT RES, V13, P192, DOI 10.1038/sj.ijir.3900713; Webb DJ, 2000, J AM COLL CARDIOL, V36, P25, DOI 10.1016/S0735-1097(00)00705-1	19	26	27	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3129	3132		10.1001/jama.290.23.3129	http://dx.doi.org/10.1001/jama.290.23.3129			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679276				2022-12-01	WOS:000187277300032
J	Houck, O				Houck, O			Tales from a troubled marriage: Science and law in environmental policy	SCIENCE			English	Article							CLEAN-AIR ACT	Early environmental policy depended on science, with mixed results. Newer approaches continue to rely on science to identify problems and solve them, but use other mechanisms to set standards and legal obligations. Given the important role that science continues to play, however, several cautionary tales are in order concerning "scientific management," "good science," the lure of money, and the tension between objectivity and involvement in important issues of our time.	Tulane Univ, Sch Law, New Orleans, LA 70118 USA	Tulane University	Houck, O (corresponding author), Tulane Univ, Sch Law, 6329 Freret St, New Orleans, LA 70118 USA.							Adler RW, 1999, HARVARD ENVIRON LAW, V23, P203; ADLER RW, 1993, CLEAN WATER ACT 20 Y; BABICH A, 2003, ENV FORUM        MAY, P36; BEAN MJ, 1999, ENV FORUM        JAN, P26; BEEMAN P, 1994, DES MOINES REGI 0307, P1; *BNA, 1990, BNA ENV REP CURR DEV, V21, P1485; *BNA, 1993, BNA ENV REP CURR DEV, V24, P878; Breyer S., 1993, BREAKING VICIOUS CIR; BRIDGES T, 1990, WASHINGTON POST 0624, pH2; COGLIANESE G, SHIFTING SANDS LIMIT; *EPA, 1989, WAT QUAL IMPR STUD; GREER L, 2002, ENV FORUM        JAN, P28; HARR JONATHAN, 1995, CIVIL ACTION; HOUCK O, 2002, CLEAN WATER ACT TMDL, P173; Houck OA, 1994, MISS LJ, V63, P403; HOUCK OA, 1991, ENV LAW REGIST, V21, P10551; Houck Oliver, 1991, ENV L REP, V21, P10; Houck Oliver A., 1993, U COLO L REV, V64, P277; Houck OliverA., 2002, CLEAN WATER ACT TMDL; HOWARD P, 1990, HOUSTON POST    1024, pA2; JACKSON DZ, 2003, BOSTON GLOBE    0620, pA15; KURLANSKY M, 1997, COD, P122; Lambrecht Bill, 2003, ST LOUIS POST D 1106, pA1; LATIN H, 1991, ENV L, V21, P1647; Limbaugh Rush, 1992, WAY THINGS OUGGHT BE, V160; MILLER H, 2003, NY TIMES        0807; PERCIVAL R, 2003, ENV REGULATION LAW S, P333; REITZE A, 2001, ENVIRON LAW, V21, P1550; REUKIN AC, 2003, NY TIMES        0619, pA1; REVKIN AC, 2003, NY TIMES        0829, pA11; RODGERS WH, 1992, ENV LAW, V1; RODGERS WH, 1992, ENV LAW, V2; SCHOENBROD D, 1983, UCLA LAW REV, V30, P740; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; TYSON JL, 1994, CHRISTIAN SCI M 0314, P11; TYSON JL, 1979, BATON ROUGE MOR 0525, pB1; WAGAR WE, 1995, COLUMBIA LAW REV, V95, P1613; WILL G, 1998, TIMES PICAYUNE  0223, pB7; 2003, BNA DAILY ENV   1030, pA14; 1986, FED REG, V51, P40572	40	33	34	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1926	1929		10.1126/science.1093758	http://dx.doi.org/10.1126/science.1093758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671294				2022-12-01	WOS:000187174000049
J	Kawaguchi, Y; Kovacs, JJ; McLaurin, A; Vance, JM; Ito, A; Yao, TP				Kawaguchi, Y; Kovacs, JJ; McLaurin, A; Vance, JM; Ito, A; Yao, TP			The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress	CELL			English	Article							HISTONE DEACETYLASES; IN-VIVO; PROTEASOME; DISEASE; MICROTUBULES; DEGRADATION; INHIBITOR; TUBULIN; BODIES; DOMAIN	The efficient clearance of cytotoxic misfolded protein aggregates is critical for cell survival. Misfolded protein aggregates are transported and removed from the cytoplasm by dynein motors via the microtubule network to a novel organelle termed the aggresome where they are processed. However, the means by which dynein motors recognize misfolded protein cargo, and the cellular factors that regulate aggresome formation, remain unknown. We have discovered that HDAC6, a microtubule-associated deacetylase, is a component of the aggresome. We demonstrate that HDAC6 has the capacity to bind both polyubiquitinated misfolded proteins and dynein motors, thereby acting to recruit misfolded protein cargo to dynein motors for transport to aggresomes. Indeed, cells deficient in HDAC6 fail to clear misfolded protein aggregates from the cytoplasm, cannot form aggresomes properly, and are hypersensitive to the accumulation of misfolded proteins. These findings identify HDAC6 as a crucial player in the cellular management of misfolded protein-induced stress.	Duke Univ, Dept Pharmcol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Dept Med, Durham, NC 27710 USA; Duke Univ, Ctr Human Genet, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Yao, TP (corresponding author), Duke Univ, Dept Pharmcol & Canc Biol, Durham, NC 27710 USA.		Ito, Akihiro/A-6100-2015		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39764] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Tran PB, 1999, TRENDS NEUROSCI, V22, P194, DOI 10.1016/S0166-2236(99)01409-5; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	26	1144	1196	1	72	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					727	738		10.1016/S0092-8674(03)00939-5	http://dx.doi.org/10.1016/S0092-8674(03)00939-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675537	Bronze			2022-12-01	WOS:000187366100012
J	Salter, MG; Franklin, KA; Whitelam, GC				Salter, MG; Franklin, KA; Whitelam, GC			Gating of the rapid shade-avoidance response by the circadian clock in plants	NATURE			English	Article							APRR1/TOC1 QUINTET; PHYTOCHROME-A; ARABIDOPSIS; PERCEPTION; EXPRESSION; SIGNAL; PATTERNS; GENE	The phytochromes are a family of plant photoreceptor proteins that control several adaptive developmental strategies(1,2). For example, the phytochromes perceive far- red light ( wavelengths between 700 and 800 nm) reflected or scattered from the leaves of nearby vegetation. This provides an early warning of potential shading, and triggers a series of ' shade- avoidance' responses, such as a rapid increase in elongation(3), by which the plant attempts to overgrow its neighbours(3). Other, less immediate, responses include accelerated flowering and early production of seeds. However, little is known about the molecular events that connect light perception with increased growth in shade avoidance. Here we show that the circadian clock gates this rapid shade- avoidance response. It is most apparent around dusk and is accompanied by altered expression of several genes. One of these rapidly responsive genes encodes a basic helix - loop - helix protein, PIL1, previously shown to interact with the clock protein TOC1 ( ref. 4). Furthermore PIL1 and TOC1 are both required for the accelerated growth associated with the shade- avoidance response.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Whitelam, GC (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	gcw1@le.ac.uk						Botto JF, 2002, PLANT CELL ENVIRON, V25, P53, DOI 10.1046/j.0016-8025.2001.00812.x; Carabelli M, 1996, P NATL ACAD SCI USA, V93, P3530, DOI 10.1073/pnas.93.8.3530; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Hall A, 2001, PLANT PHYSIOL, V127, P1808, DOI 10.1104/pp.010294; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; KENDRICK RE, 1999, PHOTOMORPHOGENESIS P; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; MORGAN DC, 1980, PLANTA, V150, P95, DOI 10.1007/BF00582351; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078	20	236	258	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					680	683		10.1038/nature02174	http://dx.doi.org/10.1038/nature02174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668869				2022-12-01	WOS:000187132800046
J	Sesso, HD; Buring, JE; Rifai, N; Blake, GJ; Gaziano, JM; Ridker, PM				Sesso, HD; Buring, JE; Rifai, N; Blake, GJ; Gaziano, JM; Ridker, PM			C-reactive protein and the risk of developing hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; INFLAMMATION; HEALTH; COHORT; ATHEROSCLEROSIS; INTERLEUKIN-6; ASSOCIATION; EXPRESSION; PREVENTION	Context Although it has been hypothesized that hypertension is in part an inflammatory disorder, clinical data linking inflammation with incident hypertension are scarce. Objective To examine whether C-reactive protein levels, a marker of systemic inflammation, are associated with incident hypertension. Design, Setting, and Participants A prospective cohort study that began in 1992 of 20525 female US health professionals aged 45 years or older who provided baseline blood samples with initially normal levels of blood pressure (BP) (systolic BP <140 mm Hg and diastolic BP <90 mm Hg, and no history of hypertension or antihypertensive medications) and then followed up for a median of 7.8 years for the development of incident hypertension. Plasma C-reactive protein levels were measured and baseline coronary risk factors were collected. Main Outcome Measure Incident hypertension, defined as either a new physician diagnosis, the initiation of anti hypertensive treatment, or self-reported systolic BP of at least 140 mm Hg or a diastolic BP of at least 90 mm Hg. Results During follow-up, 5365 women developed incident hypertension. In crude models, the relative risks (RRs) and 95% confidence intervals (Cis) of developing hypertension from the lowest (referent) to the highest levels of baseline C-reactive protein were 1.00, 1.25 (95% CI, 1.14-1.40)', 1.51 (95% Cl, 1.35-1.68), 1.90 (95% Cl, 1 ' 72-2.11), and 2.50 (95% Cl, 2.27-2.75) (linear trend P<.001). In fully adjusted models for coronary risk factors, the RRs and 95% Cis were 1.00, 1.07 (95% Cl, 0.95-1.20), 1.17 (95% Cl, 1.04-1.31), 1.30 (95% Cl, 1.17-1.45), and 1.52 (95% Cl, 1.36-1.69) (linear trend P<.001). C-reactive protein was significantly associated with an increased risk of developing hypertension in all prespecified subgroups evaluated, including those with very low levels of baseline BP, as well as those with no traditional coronary risk factors. Similar results were found when treating C-reactive protein as a continuous variable and controlling for baseline BP. Conclusion C- reactive protein levels are associated with future development of hypertension, which suggests that hypertension is in part an inflammatory disorder.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Dept Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Sesso, HD (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	hsesso@hsph.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; DAWSON S, 1992, ATHEROSCLEROSIS, V95, P105, DOI 10.1016/0021-9150(92)90014-8; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Engstrom G, 2002, ARTERIOSCL THROM VAS, V22, P2054, DOI 10.1161/01.ATV.0000041842.43905.F3; Ford ES, 2000, J CLIN EPIDEMIOL, V53, P95, DOI 10.1016/S0895-4356(99)00143-2; GILES WH, 1995, AM J PREV MED, V11, P163, DOI 10.1016/S0749-3797(18)30468-9; Klag M J, 1993, Ann Epidemiol, V3, P442; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Liuzzo G, 2001, Rays, V26, P221; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; Ockene IS, 2001, CLIN CHEM, V47, P444; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Poli KA, 2000, CIRCULATION, V101, P264, DOI 10.1161/01.CIR.101.3.264; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Skoog T, 2002, EUR HEART J, V23, P376, DOI 10.1053/euhj.2001.2805; Srikumar N, 2002, AM J HYPERTENS, V15, P683, DOI 10.1016/S0895-7061(02)02952-7; TODD ME, 1992, CAN J PHYSIOL PHARM, V70, P536, DOI 10.1139/y92-069; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Verma S, 2001, Cardiol Rev, V9, P250, DOI 10.1097/00045415-200109000-00003; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Wang CH, 2003, CIRCULATION, V107, P1783, DOI 10.1161/01.CIR.0000061916.95736.E5; Yamada S, 2001, AM J EPIDEMIOL, V153, P1183, DOI 10.1093/aje/153.12.1183; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	37	751	795	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2945	2951		10.1001/jama.290.22.2945	http://dx.doi.org/10.1001/jama.290.22.2945			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665655	Bronze			2022-12-01	WOS:000187112700025
J	De Cock, KM; Marum, E; Mbori-Ngacha, D				De Cock, KM; Marum, E; Mbori-Ngacha, D			A serostatus-based approach to HIV/AIDS prevention and care in Africa	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; PUBLIC-HEALTH; HIV EPIDEMIC; RURAL UGANDA; TRANSMISSION; TUBERCULOSIS; PREVALENCE; DISEASE; AIDS		Univ Kenya, Nairobi, Kenya; US Ctr Dis Control & Prevent Kenya, Nairobi, Kenya		De Cock, KM (corresponding author), POB 30137, Nairobi, Kenya.		Abrams, William R/A-5782-2008					Ammann AJ, 2003, BRIT MED J, V326, P1342, DOI 10.1136/bmj.326.7403.1342; BRATTEGAARD K, 1993, AIDS, V7, P883, DOI 10.1097/00002030-199306000-00019; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Cantwell MF, 1997, INT J TUBERC LUNG D, V1, P205; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Clinton WJ, 2003, NEW ENGL J MED, V348, P1800, DOI 10.1056/NEJMsb023052; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Frankish H, 2003, LANCET, V362, P297, DOI 10.1016/S0140-6736(03)14007-X; Gayle HD, 2003, NEW ENGL J MED, V348, P1802, DOI 10.1056/NEJMsb030352; Grant AD, 2001, AM J TROP MED HYG, V65, P810, DOI 10.4269/ajtmh.2001.65.810; Gruskin S, 2002, LANCET, V360, P1880, DOI 10.1016/S0140-6736(02)11780-6; *HLTH CAN, 2002, TRANSM HIV MOTH CHIL, P2; *I MED, 1999, RED ODDS PREV PER TR; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Joesoef MR, 2003, INT J STD AIDS, V14, P193, DOI 10.1258/095646203762869214; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; MARUM E, 2002, 14 INT AIDS C BARC S; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; Stetler HC, 1997, AIDS, V11, P369, DOI 10.1097/00002030-199703110-00015; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer EM, 2001, OBSTET GYNECOL, V98, P1104, DOI 10.1016/S0029-7844(01)01631-3; Talbot EA, 2003, INT J TUBERC LUNG D, V7, P710; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; *UNAIDS, 2003, FOLL UP 2001 UN SPEC; *US CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1013; *US CDCP, 1998, MMWR-MORBID MORTAL W, V47, pRR12; Vetter KM, 1996, PEDIATR INFECT DIS J, V15, P438, DOI 10.1097/00006454-199605000-00011; World Health Organization (WHO), 2003, RIGHT KNOW NEW APPR; 2003, LANCET, V361, P539; 2003, NY TIMES        0809	33	100	102	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1847	1849		10.1016/S0140-6736(03)14906-9	http://dx.doi.org/10.1016/S0140-6736(03)14906-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654325				2022-12-01	WOS:000186872900026
J	Liao, JC; Beal, DN; Lauder, GV; Triantafyllou, MS				Liao, JC; Beal, DN; Lauder, GV; Triantafyllou, MS			Fish exploiting vortices decrease muscle activity	SCIENCE			English	Article							HYDRODYNAMIC FUNCTION; ONCORHYNCHUS-MYKISS; SWIMMING SPEEDS; LOCOMOTION; SCHOOLS; TROUT; PROPULSION; SALMON; SLOW	Fishes moving through turbulent flows or in formation are regularly exposed to vortices. Although animals living in fluid environments commonly capture energy from vortices, experimental data on the hydrodynamics and neural control of interactions between fish and vortices are lacking. We used quantitative flow visualization and electromyography to show that trout will adopt a novel mode of locomotion to slalom in between experimentally generated vortices by activating only their anterior axial muscles. Reduced muscle activity during vortex exploitation compared with the activity of fishes engaged in undulatory swimming suggests a decrease in the cost of locomotion and provides a mechanism to understand the patterns of fish distributions in schools and riverine environments.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; MIT, Dept Ocean Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Liao, JC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.							ABRAHAMS MV, 1987, ENVIRON BIOL FISH, V20, P79, DOI 10.1007/BF00002028; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Anderson J.M, 1996, THESIS MIT; Belyayev V., 1969, PROBLEMS ICHTHYOLOGY, V9, P578; BOSE N, 1990, PROC R SOC SER B-BIO, V240, P591, DOI 10.1098/rspb.1990.0054; BREDER C. M., 1965, ZOOLOGICA NEW YORK, V50, P97; BREDER CM, 1976, FISH B-NOAA, V74, P471; Drucker EG, 1999, J EXP BIOL, V202, P2393; Drucker EG, 2002, INTEGR COMP BIOL, V42, P243, DOI 10.1093/icb/42.2.243; FAUSCH KD, 1993, CAN J FISH AQUAT SCI, V50, P1198, DOI 10.1139/f93-136; GOLPALKRISHNAN R, 1994, J FLUID MECH, V274, P1, DOI DOI 10.1017/S0022112094002016; Hammond L, 1998, J EXP BIOL, V201, P1659; HARTWELL SI, 1978, T AM FISH SOC, V107, P793, DOI 10.1577/1548-8659(1978)107<793:SPOJMB>2.0.CO;2; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1111/j.1095-8649.1998.tb00986.x; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; JAYNE BC, 1994, J COMP PHYSIOL A, V175, P123; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; McGlinchey SM, 2001, COMP BIOCHEM PHYS A, V129, P727, DOI 10.1016/S1095-6433(01)00334-8; Nauen JC, 2002, J EXP BIOL, V205, P1709; PARTRIDGE BL, 1979, NATURE, V279, P418, DOI 10.1038/279418a0; Pavlov D.S., 2000, Journal of Ichthyology, V40, pS232; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; Streitlien K, 1996, AIAA J, V34, P2315, DOI 10.2514/3.13396; Webb Paul W., 1998, P3; Webb PW, 1998, J EXP BIOL, V201, P2403; WEIHS D, 1973, NATURE, V241, P290, DOI 10.1038/241290a0; WU TY, 1975, SWIMMING FLYING NATU, V2; Zdravkovich MM, 1997, FLOW CIRCULAR CYLIND, V2	28	539	565	8	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1566	1569		10.1126/science.1088295	http://dx.doi.org/10.1126/science.1088295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645849				2022-12-01	WOS:000186802200044
J	Wang, LJ; Fan, C; Topol, SE; Topol, EJ; Wang, Q				Wang, LJ; Fan, C; Topol, SE; Topol, EJ; Wang, Q			Mutation of MEF2A in an inherited disorder with features of coronary artery disease	SCIENCE			English	Article							HEART-DISEASE; MOUSE EMBRYOGENESIS; LINKAGE ANALYSIS; EXPRESSION; CHROMOSOME-2; LINEAGES; SUGGESTS; LOCUS; DEATH	The early genetic pathway(s) triggering the pathogenesis of coronary artery disease (CAD) and myocardial infarction (MI) remain largely unknown. Here, we describe an autosomal dominant form of CAD/MI (adCAD1) that is caused by the deletion of seven amino acids in transcription factor MEF2A. The deletion disrupts nuclear localization of MEF2A, reduces MEF2A-mediated transcription activation, and abolishes synergistic activation by MEF2A and by the transcription factor GATA-1 through a dominant-negative mechanism. The MEF2A protein demonstrates strong expression in the endothelium of coronary arteries. These results identify a pathogenic gene for a familial vascular disease with features of CAD and implicate the MEF2A signaling pathway in the pathogenesis of CAD/MI.	Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Ctr Mol Genet, Dept Mol Cardiol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.			Topol, Eric/0000-0002-1478-4729	NHLBI NIH HHS [R01 HL65630, R01 HL065630, R01 HL066251, R01 HL66251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251, R01HL065630] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Borghi S, 2001, J CELL SCI, V114, P4477; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mao ZX, 1996, J BIOL CHEM, V271, P14371, DOI 10.1074/jbc.271.24.14371; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; WANG Q, 2000, TXB CARDIOVASCULAR M, V3, P1	18	265	308	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1578	1581		10.1126/science.1088477	http://dx.doi.org/10.1126/science.1088477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645853	Green Accepted			2022-12-01	WOS:000186802200048
J	Relman, DA				Relman, DA			Shedding light on microbial detection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Stanford University	Relman, DA (corresponding author), Stanford Univ, Med Ctr, Stanford, CA 94305 USA.			Relman, David A./0000-0001-8331-1354				Kovacs GTA, 2003, P IEEE, V91, P915, DOI 10.1109/JPROC.2003.813580; McFadden P, 2002, SCIENCE, V297, P2075, DOI 10.1126/science.297.5589.2075; Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920	3	14	18	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2162	2163		10.1056/NEJMcibr035737	http://dx.doi.org/10.1056/NEJMcibr035737			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645646				2022-12-01	WOS:000186779700014
J	Nejentsev, S; Guja, C; McCormack, R; Cooper, J; Howson, JMM; Nutland, S; Rance, H; Walker, N; Undlien, D; Ronningen, KS; Tuomilehto-Wolf, E; Tuomilehto, J; Ionescu-Tirgoviste, C; Gale, EAM; Bingley, PJ; Gillespie, KM; Savage, DA; Carson, DJ; Patterson, CC; Maxwell, AP; Todd, JA				Nejentsev, S; Guja, C; McCormack, R; Cooper, J; Howson, JMM; Nutland, S; Rance, H; Walker, N; Undlien, D; Ronningen, KS; Tuomilehto-Wolf, E; Tuomilehto, J; Ionescu-Tirgoviste, C; Gale, EAM; Bingley, PJ; Gillespie, KM; Savage, DA; Carson, DJ; Patterson, CC; Maxwell, AP; Todd, JA			Association of intercellular adhesion molecule-1 gene with type 1 diabetes	LANCET			English	Article								Intercellular adhesion molecule-1 (ICAM-1) functions via its ligands, the leucocyte integrins, in adhesion of immune cells to endothelial cells and in T cell activation. The third immunoglobulin-like extracellular domain binds integrin Mac-1 and contains a common non-conservative aminoacid polymorphism, G241R. Phenotypically, ICAM-1 has been associated with type I diabetes, a T-cell-mediated autoimmune disease. We assessed two independent datasets, and noted that R241 was associated with lower risk of type I diabetes than is G241 (3695 families, relative risk 0.91, p=0-03; 446 families, 0.60, p=0.006). Our data indicate an aetiological role for ICAM-1 in type I diabetes, which needs to be confirmed In future genetic and functional experiments.	Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 2XY, England; Inst Diabet Nutr & Metab Dis N Paulescu, Diabet Clin, Bucharest, Romania; Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland; Univ Oslo, Ulleval Univ Hosp, Inst Med Genet, Oslo, Norway; Norwegian Inst Publ Hlth, Div Epidemiol, Lab Mol Epidemiol, Oslo, Norway; Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Univ Bristol, Div Med, Diabet & Metab Unit, Bristol, Avon, England; Queens Univ Belfast, Dept Child Hlth, Belfast BT7 1NN, Antrim, North Ireland; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland; Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AD, Antrim, North Ireland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Queens University Belfast; University of Oslo; Norwegian Institute of Public Health (NIPH); Finland National Institute for Health & Welfare; University of Helsinki; University of Bristol; Queens University Belfast; Queens University Belfast; Belfast City Hospital	Nejentsev, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.		Todd, John A/A-3542-2010; Guja, Cristian/K-2334-2019	Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688; Maxwell, Alexander P./0000-0002-6110-7253; Howson, Joanna/0000-0001-7618-0050				Camacho SA, 2001, NAT IMMUNOL, V2, P523, DOI 10.1038/88720; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cox NJ, 2001, AM J HUM GENET, V69, P820, DOI 10.1086/323501; Douek IF, 2002, DIABETOLOGIA, V45, P495, DOI 10.1007/s00125-002-0790-0; Kristiansen OP, 2000, IMMUNOGENETICS, V52, P107, DOI 10.1007/s002510000258; Weinberg CR, 2000, AM J EPIDEMIOL, V152, P197, DOI 10.1093/aje/152.3.197	6	31	32	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1723	1724		10.1016/S0140-6736(03)14847-7	http://dx.doi.org/10.1016/S0140-6736(03)14847-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643123				2022-12-01	WOS:000186767700013
J	Bergman, TJ; Beehner, JC; Cheney, DL; Seyfarth, RM				Bergman, TJ; Beehner, JC; Cheney, DL; Seyfarth, RM			Hierarchical classification by rank and kinship in baboons	SCIENCE			English	Article							FEMALE BABOONS; SOCIAL RELATIONSHIPS; DOMINANCE RELATIONS; PAPIO-CYNOCEPHALUS; JAPANESE MACAQUES; BONNET MACAQUES; KIN; RECOGNITION; INDIVIDUALS; MONKEYS	Humans routinely classify others according to both their individual attributes, such as social status or wealth, and membership in higher order groups, such as families or castes. They also recognize that people's individual attributes may be influenced and regulated by their group affiliations. It is not known whether such rule-governed, hierarchical classifications are specific to humans or might also occur in nonlinguistic species. Here we show that baboons recognize that a dominance hierarchy can be subdivided into family groups. In playback experiments, baboons respond more strongly to call sequences mimicking dominance rank reversals between families than within families, indicating that they classify others simultaneously according to both individual rank and kinship. The selective pressures imposed by complex societies may therefore have favored cognitive skills that constitute an evolutionary precursor to some components of human cognition.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Bergman, TJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.		Seyfarth, Robert/AAX-9474-2020; Beehner, Jacinta/E-8467-2012; Bergman, Thore J/B-8196-2008	Beehner, Jacinta/0000-0001-6566-6872; Bergman, Thore J/0000-0002-9615-5001	NIMH NIH HHS [MH62249] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062249] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AURELI F, 1992, ANIM BEHAV, V44, P283, DOI 10.1016/0003-3472(92)90034-7; BERGMAN TL, UNPUB; Bernstein I.S., 1991, P6; Chapais B, 2001, INT J PRIMATOL, V22, P203, DOI 10.1023/A:1005619430744; CHAPAIS B, 1988, BEHAVIOUR, V104, P41, DOI 10.1163/156853988X00593; Cheney D.L., 1990, MONKEYS SEE WORLD IN; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHENEY DL, 1995, J COMP PSYCHOL, V109, P134, DOI 10.1037/0735-7036.109.2.134; DASSER V, 1988, ANIM BEHAV, V36, P225, DOI 10.1016/S0003-3472(88)80265-3; EHARDT CL, 1986, INT J PRIMATOL, V7, P157, DOI 10.1007/BF02692316; Gouzoules S., 1987, P299; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HAUSFATER G, 1982, SCIENCE, V217, P752, DOI 10.1126/science.217.4561.752; Jackendoff Ray, 2002, FDN LANGUAGE BRAIN M; MACUDA T, 1995, J EXP PSYCHOL ANIM B, V21, P20, DOI 10.1037/0097-7403.21.1.20; Pinker S., 1995, LANGUAGE INSTINCT; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; SAMUELS A, 1987, ANIM BEHAV, V35, P785, DOI 10.1016/S0003-3472(87)80115-X; Schusterman RJ, 1998, ANIM BEHAV, V55, P1087, DOI 10.1006/anbe.1997.0654; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; SILK JB, IN PRESS ANIM BEHAV; SILK JB, 2002, INT J PRIMATOL, V17, P445; Sinha A, 1998, PHILOS T ROY SOC B, V353, P619, DOI 10.1098/rstb.1998.0230; Walters J.R., 1987, P306	26	267	271	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1234	1236		10.1126/science.1087513	http://dx.doi.org/10.1126/science.1087513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615544				2022-12-01	WOS:000186544300061
J	Kenet, T; Bibitchkov, D; Tsodyks, M; Grinvald, A; Arieli, A				Kenet, T; Bibitchkov, D; Tsodyks, M; Grinvald, A; Arieli, A			Spontaneously emerging cortical representations of visual attributes	NATURE			English	Article							OBLIQUE CONTOURS; ONGOING ACTIVITY; IN-VIVO; CORTEX; VARIABILITY; RESPONSES; DYNAMICS; CELLS; SYNCHRONIZATION; CIRCUITS	Spontaneous cortical activity - ongoing activity in the absence of intentional sensory input - has been studied extensively(1), using methods ranging from EEG (electroencephalography)(2-4), through voltage sensitive dye imaging(5-7), down to recordings from single neurons(8,9). Ongoing cortical activity has been shown to play a critical role in development(10-14), and must also be essential for processing sensory perception, because it modulates stimulus-evoked activity(5,15,16), and is correlated with behaviour(17). Yet its role in the processing of external information and its relationship to internal representations of sensory attributes remains unknown. Using voltage sensitive dye imaging, we previously established a close link between ongoing activity in the visual cortex of anaesthetized cats and the spontaneous firing of a single neuron(6). Here we report that such activity encompasses a set of dynamically switching cortical states, many of which correspond closely to orientation maps. When such an orientation state emerged spontaneously, it spanned several hypercolumns and was often followed by a state corresponding to a proximal orientation. We suggest that dynamically switching cortical states could represent the brain's internal context, and therefore reflect or influence memory, perception and behaviour.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kenet, T (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, 513 Parnassus Ave,Box 0732, San Francisco, CA 94143 USA.		tsodyks, misha/J-4430-2013; GRINVALD, AMIRAM/AAH-9919-2019	Tsodyks, Misha/0000-0002-5661-4349				Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Chiu CY, 2002, NEURON, V35, P1123, DOI 10.1016/S0896-6273(02)00867-X; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P19, DOI 10.1016/0013-4694(66)90137-4; Elul R, 1971, Int Rev Neurobiol, V15, P227; Ernst UA, 2001, NAT NEUROSCI, V4, P431, DOI 10.1038/86089; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kisley MA, 1999, J NEUROSCI, V19, P10451; Kohonen T., 2000, SELF ORG MAPS; Lestienne R, 2001, PROG NEUROBIOL, V65, P545, DOI 10.1016/S0301-0082(01)00019-3; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; McCormick DA, 1999, SCIENCE, V285, P541, DOI 10.1126/science.285.5427.541; NODA H, 1970, BRAIN RES, V18, P513, DOI 10.1016/0006-8993(70)90134-4; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Scherrer J, 1976, Prog Brain Res, V45, P309, DOI 10.1016/S0079-6123(08)60996-6; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sur M, 1999, J NEUROBIOL, V41, P33, DOI 10.1002/(SICI)1097-4695(199910)41:1<33::AID-NEU6>3.0.CO;2-1; Thompson I, 1997, CURR BIOL, V7, pR324, DOI 10.1016/S0960-9822(06)00150-3; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Wang G, 2003, NEUROSCI LETT, V338, P77, DOI 10.1016/S0304-3940(02)01355-1	30	614	619	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					954	956		10.1038/nature02078	http://dx.doi.org/10.1038/nature02078			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586468				2022-12-01	WOS:000186230600040
J	Witmer, LM; Chatterjee, S; Franzosa, J; Rowe, T				Witmer, LM; Chatterjee, S; Franzosa, J; Rowe, T			Neuroanatomy of flying reptiles and implications for flight, posture and behaviour	NATURE			English	Article							PIGEONS	Comparison of birds and pterosaurs, the two archosaurian flyers, sheds light on adaptation to an aerial lifestyle. The neurological basis of control holds particular interest in that flight demands on sensory integration, equilibrium, and muscular coordination are acute(1-8). Here we compare the brain and vestibular apparatus in two pterosaurs based on high-resolution computed tomographic (CT) scans from which we constructed digital endocasts. Although general neural organization resembles birds, pterosaurs had smaller brains relative to body mass than do birds. This difference probably has more to do with phylogeny than flight, in that birds evolved from nonavian theropods that had already established trends for greater encephalization(5,9). Orientation of the osseous labyrinth relative to the long axis of the skull was different in these two pterosaur species, suggesting very different head postures and reflecting differing behaviours. Their enlarged semicircular canals reflect a highly refined organ of equilibrium, which is concordant with pterosaurs being visually based, aerial predators. Their enormous cerebellar floccular lobes may suggest neural integration of extensive sensory information from the wing, further enhancing eye- and neck-based reflex mechanisms for stabilizing gaze.	Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; Texas Tech Univ Museum, Lubbock, TX 79409 USA; Univ Texas, Jackson Sch Geosci, Austin, TX 78712 USA	University System of Ohio; Ohio University; Texas Tech University System; Texas Tech University; University of Texas System; University of Texas Austin	Witmer, LM (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	witmerL@ohio.edu						Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; BLANKS RHI, 1972, AM J PHYSIOL, V223, P55, DOI 10.1152/ajplegacy.1972.223.1.55; Brochu CA, 2001, J PALEONTOL, V75, P1185, DOI 10.1666/0022-3360(2001)075<1185:PAFDIA>2.0.CO;2; BUTLER AB, 1996, COMP VERTEBRATE NEUR, P514; CHATTERJEE S, IN PRESS GEOL SOC AM; de Beer G. R., 1947, Proceedings of the Linnean Society of London, V159, P125; Duijm M., 1951, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V54C, P202; Duijm M., 1951, P KONINKL NEDERL A C, V54, P260; Edinger T, 1941, AM J SCI, V239, P665, DOI 10.2475/ajs.239.9.665; EDINGER T, 1927, Z ANAT ENTWICKLUNGS, V82, P105; ERICHSEN JT, 1989, BRAIN BEHAV EVOLUT, V33, P268, DOI 10.1159/000115935; Hopson J.A., 1979, P39; HURLBURT GR, 1996, THESIS U TORONTO, P250; Jerison H.J., 1973, EVOLUTION BRAIN INTE, P482; JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019; Kellner Alexander Wilhelm Armin, 1996, American Museum Novitates, V3175, P1; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; LEBEDKIN S, 1924, ANAT ANZEIGER, V58, P447; Newton E.T., 1888, PHILOS T R SOC B, V179, P503; Proctor N. S., 1993, MANUAL ORNITHOLOGY A, V340; Romer A.S., 1956, OSTEOLOGY REPTILES; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Tischlinger H., 2002, ARCHAEOPTERYX, V20, P1; TURKEWITSCH B. G., 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P551, DOI 10.1007/BF02118934; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P., 1991, ILLUSTRATED ENCY PTE, P192; WHARTON DS, 2002, THESIS U BRISTOL, P343; Winship IR, 2003, J COMP NEUROL, V456, P127, DOI 10.1002/cne.10507	31	197	204	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					950	953		10.1038/nature02048	http://dx.doi.org/10.1038/nature02048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586467	Green Published			2022-12-01	WOS:000186230600039
J	Schwarz, DS; Hutvagner, G; Du, T; Xu, ZS; Aronin, N; Zamore, PD				Schwarz, DS; Hutvagner, G; Du, T; Xu, ZS; Aronin, N; Zamore, PD			Asymmetry in the assembly of the RNAi enzyme complex	CELL			English	Article							DOUBLE-STRANDED-RNA; SHORT-INTERFERING RNAS; MESSENGER-RNA; GENE-EXPRESSION; HAIRPIN RNAS; C-ELEGANS; DROSOPHILA; SIRNAS; DICER; MICRORNAS	A key step in RNA interference (RNAi) is assembly of the RISC, the protein-siRNA complex that mediates target RNA cleavage. Here, we show that the two strands of an siRNA duplex are not equally eligible for assembly into RISC. Rather, both the absolute and relative stabilities of the base pairs at the 5' ends of the two siRNA strands determine the degree to which each strand participates in the RNAi pathway. siRNA duplexes can be functionally asymmetric, with only one of the two strands able to trigger RNAi. Asymmetry is the hallmark of a related class of small, single-stranded, noncoding RNAs, microRNAs (miRNAs). We suggest that single-stranded miRNAs are initially generated as siRNA-like duplexes whose structures predestine one strand to enter the RISC and the other strand to be destroyed. Thus, the common step of RISC assembly is an unexpected source of asymmetry for both siRNA function and miRNA biogenesis.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Lazare Res Bldg,364 Plantat St, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Hutvagner, Gyorgy/0000-0002-7231-9446; Zamore, Phillip/0000-0002-4505-9618	NIGMS NIH HHS [GM62862-01, GM65236-01] Funding Source: Medline; NINDS NIH HHS [R01 NS38194, R21 NS44952-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862, R01GM065236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038194, R21NS044952] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Boutla A, 2001, CURR BIOL, V11, P1776, DOI 10.1016/S0960-9822(01)00541-3; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Crow JP, 1997, J NEUROCHEM, V69, P1936; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE SK, 1993, LAND DEGRAD REHABIL, V4, P1, DOI 10.1002/ldr.3400040102; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; TURNER DH, 1987, J AM CHEM SOC, V109, P3783, DOI 10.1021/ja00246a047; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; ZUKER M, 2003, NUCLEIC ACIDS RES, V31, P1	71	1986	2317	6	272	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2003	115	2					199	208		10.1016/S0092-8674(03)00759-1	http://dx.doi.org/10.1016/S0092-8674(03)00759-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567917	Bronze			2022-12-01	WOS:000186039200011
J	Ghaemmaghami, S; Huh, W; Bower, K; Howson, RW; Belle, A; Dephoure, N; O'Shea, EK; Weissman, JS				Ghaemmaghami, S; Huh, W; Bower, K; Howson, RW; Belle, A; Dephoure, N; O'Shea, EK; Weissman, JS			Global analysis of protein expression in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; GENE DELETION; GENOME; IDENTIFICATION; ORGANIZATION	The availability of complete genomic sequences and technologies that allow comprehensive analysis of global expression profiles of messenger RNA(1-3) have greatly expanded our ability to monitor the internal state of a cell. Yet biological systems ultimately need to be explained in terms of the activity, regulation and modification of proteins-and the ubiquitous occurrence of posttranscriptional regulation makes mRNA an imperfect proxy for such information. To facilitate global protein analyses, we have created a Saccharomyces cerevisiae fusion library where each open reading frame is tagged with a high-affinity epitope and expressed from its natural chromosomal location. Through immunodetection of the common tag, we obtain a census of proteins expressed during log-phase growth and measurements of their absolute levels. We find that about 80% of the proteome is expressed during normal growth conditions, and, using additional sequence information, we systematically identify misannotated genes. The abundance of proteins ranges from fewer than 50 to more than 10(6) molecules per cell. Many of these molecules, including essential proteins and most transcription factors, are present at levels that are not readily detectable by other proteomic techniques nor predictable by mRNA levels or codon bias measurements.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jsw1@itsa.ucsf.edu	Huh, Won-Ki/AAQ-6767-2021; Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657; Ghaemmaghami, Sina/0000-0002-8696-2950; Weissman, Jonathan/0000-0003-2445-670X				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Das S, 1997, NATURE, V385, P29, DOI 10.1038/385029a0; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goffeau A, 2000, FEBS LETT, V480, P37, DOI 10.1016/S0014-5793(00)01775-0; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harrison PM, 2002, NUCLEIC ACIDS RES, V30, P1083, DOI 10.1093/nar/30.5.1083; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kowalczuk M, 1999, YEAST, V15, P1031, DOI 10.1002/(SICI)1097-0061(199908)15:11<1031::AID-YEA431>3.0.CO;2-G; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang CT, 2000, NUCLEIC ACIDS RES, V28, P2804, DOI 10.1093/nar/28.14.2804	29	2870	6773	7	583	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2003	425	6959					737	741		10.1038/nature02046	http://dx.doi.org/10.1038/nature02046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562106				2022-12-01	WOS:000185924500046
J	Jones, JM; Datta, P; Srinivasula, SM; Ji, WZ; Gupta, S; Zhang, ZJ; Davies, E; Hajnoczky, G; Saunders, TL; Van Keuren, ML; Fernandes-Alnemri, T; Meisler, MH; Alnemri, ES				Jones, JM; Datta, P; Srinivasula, SM; Ji, WZ; Gupta, S; Zhang, ZJ; Davies, E; Hajnoczky, G; Saunders, TL; Van Keuren, ML; Fernandes-Alnemri, T; Meisler, MH; Alnemri, ES			Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice	NATURE			English	Article							APOPTOSIS-INDUCING FACTOR; SERINE-PROTEASE; REGULATES APOPTOSIS; CASPASE ACTIVITY; CHROMOSOME 2P13; CELL-DEATH; INHIBITOR; OMI/HTRA2; SEQUENCE; XIAP	The mouse mutant mnd2 (motor neuron degeneration 2) exhibits muscle wasting, neurodegeneration, involution of the spleen and thymus, and death by 40 days of age(1,2). Degeneration of striatal neurons, with astrogliosis and microglia activation, begins at around 3 weeks of age, and other neurons are affected at later stages'. Here we have identified the mnd2 mutation as the missense mutation Ser276Cys in the protease domain of the nuclear-encoded mitochondrial serine protease Omi (also known as HtrA2 or Prss25). Protease activity of Omi is greatly reduced in tissues of mnd2 mice but is restored in mice rescued by a bacterial artificial chromosome transgene containing the wildtype Omi gene. Deletion of the PDZ domain partially restores protease activity to the inactive recombinant Omi protein carrying the Ser276Cys mutation, suggesting that the mutation impairs substrate access or binding to the active site pocket. Loss of Omi protease activity increases the susceptibility of mitochondria to induction of the permeability transition, and increases the sensitivity of mouse embryonic fibroblasts to stress-induced cell death. The neurodegeneration and juvenile lethality in mnd2 mice result from this defect in mitochondrial Omi protease.	Thomas Jefferson Univ Hosp, Ctr Apoptosis Res, Philadelphia, PA 19107 USA; Thomas Jefferson Univ Hosp, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ Hosp, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Biomed Res Core Facil, Transgen Anim Model Core, Ann Arbor, MI 48109 USA	Jefferson University; Jefferson University; Jefferson University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Alnemri, ES (corresponding author), Thomas Jefferson Univ Hosp, Ctr Apoptosis Res, Philadelphia, PA 19107 USA.		gupta, sanjeev/B-2824-2008; Alnemri, Emad S/B-4526-2010; Gupta, Sanjeev/AAG-9749-2020	gupta, sanjeev/0000-0002-4691-6853; Gupta, Sanjeev/0000-0002-4691-6853; Saunders, Thom/0000-0003-2015-101X				Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jang KH, 1996, J MICROBIOL BIOTECHN, V6, P36; Jang W, 1999, GENOME RES, V9, P53; Jang W, 1997, BIOCHEM BIOPH RES CO, V231, P344, DOI 10.1006/bbrc.1997.6095; Jang WH, 1997, GENOMICS, V40, P506, DOI 10.1006/geno.1996.4593; Ji WZ, 2001, MAMM GENOME, V12, P456, DOI 10.1007/s003350020032; JONES JM, 1993, GENOMICS, V16, P669, DOI 10.1006/geno.1993.1246; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Maurizi MR, 2002, NAT STRUCT BIOL, V9, P410, DOI 10.1038/nsb0602-410; Rathke-Hartlieb S, 2002, EXP NEUROL, V175, P87, DOI 10.1006/exnr.2002.7868; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Van Dyck L, 1999, CELL MOL LIFE SCI, V56, P825, DOI 10.1007/s000180050029; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Weber JS, 1998, GENOMICS, V54, P107, DOI 10.1006/geno.1998.5496; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903	29	297	309	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					721	727		10.1038/nature02052	http://dx.doi.org/10.1038/nature02052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14534547	Green Published			2022-12-01	WOS:000185924500043
J	de Waal, A; Whiteside, A				de Waal, A; Whiteside, A			New variant famine: AIDS and food crisis in southern Africa	LANCET			English	Article							MORTALITY	Southern Africa is undergoing a food crisis of surprising scale and novelty. The familiar culprits of drought and mismanagement of national strategies are implicated. However, this crisis is distinct from conventional drought-induced food shortages with respect to those vulnerable to starvation, and the course of impoverishment and recovery. We propose that these new aspects to the food crisis can be attributed largely to the HIV/AIDS epidemic in the region. We present evidence that we are facing a new variant famine. We have used frameworks drawn from famine theory to examine the implications. HIV/AIDS has created a new category of highly vulnerable households-namely, those with Ill adults or those whose adults have died. The general burden of care in both AIDS-affected and non-AIDS-affected households has reduced the viability of farming livelihoods. The sensitivity of rural communities to external shocks such as drought has increased, and their resilience has declined. The prospects for a sharp decline into severe famine are increased, and possibilities for recovery reduced.	Univ Natal, Hlth Econ & HIV AIDS Res Div, ZA-4041 Durban, South Africa; UN Econ Commiss Africa, Commiss HIV AIDS & Governance Africa, Addis Ababa, Ethiopia	University of Kwazulu Natal; UN Economic Commission for Africa (UNECA)	Whiteside, A (corresponding author), Univ Natal, Hlth Econ & HIV AIDS Res Div, ZA-4041 Durban, South Africa.							[Anonymous], 1992, AIDS AFRICA; Barnett T., 2002, AIDS 21 CENTURY DIS; Baylies C, 2002, DEV CHANGE, V33, P611, DOI 10.1111/1467-7660.00272; CALDWELL JC, 1977, DROUGHT AFRICA, V2; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; DAVIES S, 1995, ADAPTABLE LIVELIHOOD; de Waal A., 1989, FAMINE KILLS DARFUR; DEVEREUX S, 2002, IDS B, V33, P88; DEWAAL A, 1990, DEV CHANGE, V21, P469, DOI 10.1111/j.1467-7660.1990.tb00384.x; DEWAAL A, 1989, POP STUD-J DEMOG, V43, P5, DOI 10.1080/0032472031000143826; Dyson T., 2002, FAMINE DEMOGRAPHY PE; Eldridge C, 2002, IDS BULL-I DEV STUD, V33, P79, DOI 10.1111/j.1759-5436.2002.tb00047.x; HADDAD L, 2001, 112 INT FOOD POL RES; KWARAMBA P, 1998, 19 EC ADV PROJ; Macintyre Kate, 2002, FAMINE DEMOGRAPHY PE; ROSEN S, 2002, SHIFTING BURDEN HIV; Rugalema G., 2000, Review of African Political Economy, P537, DOI 10.1080/03056240008704488; *SAV CHILDR FUND, 2002, HARARE           MAR; Semba RD, 1999, BRIT J NUTR, V81, P181, DOI 10.1017/S0007114599000379; Sen A., 1981, POVERTY FAMINES ESSA; *SO AFR DEV COMM, 2003, UNPUB VULN ASS COMM; STANECKI K, 2003, M EMP EV DEM SOC IMP; SWIFT J, 1993, IDS BULL-I DEV STUD, V24, P1, DOI 10.1111/j.1759-5436.1993.mp24004001.x; *UN ADM COMM COORD, 1998, SCN NEWS, V17, P3; *UNICEF USAID UNAI, 2002, CHILDR BRINK 2002 JO; WATKINS SC, 1985, POPUL DEV REV, V11, P647, DOI 10.2307/1973458; WEBB D, 1999, SAFAIDS NEWS; World Development Movement, 2002, STRUCT DAM CAUS CONS	28	212	214	0	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 11	2003	362	9391					1234	1237		10.1016/S0140-6736(03)14548-5	http://dx.doi.org/10.1016/S0140-6736(03)14548-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732CW	14568749				2022-12-01	WOS:000185924100028
J	Multani, DS; Briggs, SP; Chamberlin, MA; Blakeslee, JJ; Murphy, AS; Johal, GS				Multani, DS; Briggs, SP; Chamberlin, MA; Blakeslee, JJ; Murphy, AS; Johal, GS			Loss of an MDR transporter in compact stalks of maize br2 and sorghum dw3 mutants	SCIENCE			English	Article							GENES	Agriculturally advantageous reduction in plant height is usually achieved by blocking the action or production of gibberellins. Here, we describe a different dwarfing mechanism found in maize brachytic2 (br2) mutants characterized by compact lower stalk internodes. The height reduction in these plants results from the loss of a P-glycoprotein that modulates polar auxin transport in the maize stalk. The sorghum ortholog of br2 is dwarf3 (dw3), an unstable mutant of long-standing commercial interest and concern. A direct duplication within the dw3 gene is responsible for its mutant nature and also for its instability, because it facilitates unequal crossing-over at the locus.	Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; Pioneer HiBred Int Inc, Johnston, IA 50131 USA; Diversa Corp, San Diego, CA 92121 USA; Purdue Univ, Dept Hort, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; DuPont; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Johal, GS (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	gjohal@purdue.edu	Blakeslee, Joshua/G-4420-2011; Johal, Guri/F-5056-2017	Johal, Guri/0000-0001-8101-8410; Multani, Dilbag/0000-0003-2343-4613				Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Karper RE, 1932, AM NAT, V66, P511, DOI 10.1086/280457; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Langham, 1940, MAIZE GENET COOP NEW, V14, P21; Leng ER, 1951, MAIZE GENET NEWSL, V25, P31; Mullet JE, 2002, CURR OPIN PLANT BIOL, V5, P118, DOI 10.1016/S1369-5266(02)00232-7; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Noh B, 2003, NATURE, V423, P999, DOI 10.1038/nature01716; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; PARKER KE, 1990, PLANT PHYSIOL, V94, P1763, DOI 10.1104/pp.94.4.1763; QUINBY JR, 1954, AGRON J, V46, P211, DOI 10.2134/agronj1954.00021962004600050007x; QUINBY JR, 1963, GRAIN SORGH RES UT C, V3, P18; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623; STEIN OL, 1955, AM J BOT, V42, P885, DOI 10.2307/2485286; TARTOF KD, 1988, GENETICS, V120, P1; Vogler H, 2003, CURR OPIN PLANT BIOL, V6, P51, DOI 10.1016/S1369-5266(02)00013-4	17	346	391	12	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2003	302	5642					81	84		10.1126/science.1086072	http://dx.doi.org/10.1126/science.1086072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727UD	14526073				2022-12-01	WOS:000185678500038
J	Davies, AG; Pierce-Shimomura, JT; Kim, H; VanHoven, MK; Thiele, TR; Bonci, A; Bargmann, CI; McIntire, SL				Davies, AG; Pierce-Shimomura, JT; Kim, H; VanHoven, MK; Thiele, TR; Bonci, A; Bargmann, CI; McIntire, SL			A central role of the BK potassium channel in behavioral responses to ethanol in C-elegans	CELL			English	Article							CA2+-ACTIVATED K+ CHANNELS; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; LARGE-CONDUCTANCE; MULTIPLE ASPECTS; GENE; NEURONS; SENSITIVITY; SEROTONIN; CURRENTS	The activities of many neuronal proteins are modulated by ethanol, but the fundamental mechanisms underlying behavioral effects of ethanol remain unclear. To identify mechanisms responsible for intoxication, we screened for Caenorhabditis elegans mutants with altered behavioral responses to ethanol. We found that slo-1 mutants, which were previously recognized as having slightly uncoordinated movement, are highly resistant to ethanol in two behavioral assays. Numerous loss-of-function slo-1 alleles emerged from our screens, indicating that slo-1 has a central role in ethanol responses. slo-1 encodes the BK potassium channel. Electrophysiological analysis shows that ethanol activates the channel in vivo, which would inhibit neuronal activity. Moreover, behaviors of slo-1 gain-of-function mutants resemble those of ethanol-intoxicated animals. These results demonstrate that selective activation of BK channels is responsible for acute intoxicating effects of ethanol in C. elegans. BK channel activation may explain a variety of behavioral responses to ethanol in invertebrate and vertebrate systems.	Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, Program Neurosci, Emeryville, CA 94608 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, Program Biomed Sci, Emeryville, CA 94608 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	McIntire, SL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA.	slm@itsa.ucsf.edu	Davies, Andrew G/AAY-3567-2020	Kim, Hongkyun/0000-0002-4879-7122; VanHoven, Miri/0000-0001-7714-1555; Bargmann, Cornelia/0000-0002-8484-0618; Thiele, Tod/0000-0003-2628-8359				ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; DIAMOND IF, 2002, DIS NERVOUS SYSTEM C, P1814; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Dopico AM, 1998, J PHARMACOL EXP THER, V284, P258; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gruss M, 2001, EUR J NEUROSCI, V14, P1246, DOI 10.1046/j.0953-816x.2001.01754.x; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hallam S, 2000, DEVELOPMENT, V127, P4239; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jin YS, 1999, J NEUROSCI, V19, P539; Jospin M, 2002, J PHYSIOL-LONDON, V544, P373, DOI 10.1113/jphysiol.2002.022293; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nickell WT, 2002, J MEMBRANE BIOL, V189, P55, DOI 10.1007/s00232-002-1004-x; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shioi G, 2001, GENETICS, V157, P1611; Spanagel R, 2002, J NEUROSCI, V22, P8676; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	44	260	272	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					655	666		10.1016/S0092-8674(03)00979-6	http://dx.doi.org/10.1016/S0092-8674(03)00979-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675531	Bronze			2022-12-01	WOS:000187366100006
J	Li, MY; Brooks, CL; Wu-Baer, F; Chen, DL; Baer, R; Gu, W				Li, MY; Brooks, CL; Wu-Baer, F; Chen, DL; Baer, R; Gu, W			Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2	SCIENCE			English	Article							UBIQUITIN-PROTEIN LIGASE; RING-FINGER DOMAIN; NUCLEAR EXPORT; MDM2-DEPENDENT UBIQUITINATION; DEGRADATION; STABILITY; PROMOTES	Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.			Brooks, Christopher/0000-0003-3487-6644				Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li M., UNPUB; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Parant JM, 2003, HUM MUTAT, V21, P321, DOI 10.1002/humu.10186; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	31	606	619	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1972	1975		10.1126/science.1091362	http://dx.doi.org/10.1126/science.1091362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671306				2022-12-01	WOS:000187174000063
J	Mascie-Taylor, CGN; Karim, E				Mascie-Taylor, CGN; Karim, E			The burden of chronic disease	SCIENCE			English	Article							HUMAN HOOKWORM INFECTIONS; PUBLIC-HEALTH IMPORTANCE; RESISTANCE; PYRANTEL; REGION	The shift from acute infectious and deficiency diseases to chronic noncommunicable diseases is not a simple transition but a complex and dynamic epidemiological process, with some diseases disappearing and others appearing or reemerging. The unabated pandemic of childhood and adulthood obesity and concomitant comorbidities are affecting both rich and poor nations, while infectious diseases remain an important public health problem, particularly in developing countries. More attention should be given to the high burden of disease associated with soil-transmitted helminths and schistosomiasis, which until recently was not considered a priority even though regular drug treatment is obtainable at relatively little cost. In developing countries, the pressing requirement is to provide an accessible and good quality health-care system, whereas industrialized countries have a major need for greater public health education and the promotion of healthy life-styles.	Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England; Hlth & Life Sci Partnership, London EC1V 9HL, England	University of Cambridge	Mascie-Taylor, CGN (corresponding author), Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England.	nmt1@cam.ac.uk						*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P881; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Cioli D, 2000, CURR OPIN INFECT DIS, V13, P659, DOI 10.1097/00001432-200012000-00014; COOPER E, 1991, T ROY SOC TROP MED H, V85, P168, DOI 10.1016/0035-9203(91)90009-N; Crompton DWT, 2000, PARASITOLOGY, V121, pS39, DOI 10.1017/S0031182000006454; Geerts S, 2001, TROP MED INT HEALTH, V6, P915, DOI 10.1046/j.1365-3156.2001.00774.x; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Guyatt H, 2002, WORLD CL PARASITES, V2, P75; Horton J, 2003, TRENDS PARASITOL, V19, P405, DOI 10.1016/S1471-4922(03)00171-5; MONTRESSOR A, 2002, HELMINTH CONTROL SCH; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Reynoldson JA, 1997, ACTA TROP, V68, P301, DOI 10.1016/S0001-706X(97)00106-X; *RI DEP HLTH, OB CONTR PROGR; Sacko M, 1999, T ROY SOC TROP MED H, V93, P195, DOI 10.1016/S0035-9203(99)90306-1; SAVIOLI L, 2002, T R SOC TROP MED HYG, V86, P353; Smith RD, 2003, B WORLD HEALTH ORGAN, V81, P475; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; STOLL NR, 1947, J PARASITOL, V33, P1; United Nations Development Program, HUM DEV REP; *WHO, HLTH ALL 21 CENT; Yokogawa M., 1985, Ascariasis and its public health significance, P265	23	73	81	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1921	1922		10.1126/science.1092488	http://dx.doi.org/10.1126/science.1092488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671291				2022-12-01	WOS:000187174000046
J	Potuschak, T; Lechner, E; Parmentier, Y; Yanagisawa, S; Grava, S; Koncz, C; Genschik, P				Potuschak, T; Lechner, E; Parmentier, Y; Yanagisawa, S; Grava, S; Koncz, C; Genschik, P			EIN3-dependent regulation of plant ethylene hormone signaling by two Arabidopsis F box proteins: EBF1 and EBF2	CELL			English	Article							SCF UBIQUITIN-LIGASE; RESPONSE PATHWAY; AUX/IAA PROTEINS; AUXIN RESPONSE; DEGRADATION; TRANSDUCTION; THALIANA; ETHYLENE-INSENSITIVE3; IDENTIFICATION; PROTEOLYSIS	The plant hormone ethylene regulates a wide range of developmental processes and the response of plants to stress and pathogens. Genetic studies in Arabidopsis led to a partial elucidation of the mechanisms of ethylene action. Ethylene signal transduction initiates with ethylene binding at a family of ethylene receptors and terminates in a transcription cascade involving the EIN3/EIL and ERF families of plant-specific transcription factors. Here, we identify two Arabidopsis F box proteins called EBF1 and EBF2 that interact physically with EIN3/EIL transcription factors. EBF1 overexpression results in plants insensitive to ethylene. In contrast, plants carrying the ebf1 and ebf2 mutations display a constitutive ethylene response and accumulate the EIN3 protein in the absence of the hormone. Our work places EBF1 and EBF2 within the genetic framework of the ethylene-response pathway and supports a model in which ethylene action depends on EIN3 protein stabilization.	CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Okayama Univ, Res Inst Bioresources, Kurashiki, Okayama 7100046, Japan; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Okayama University; Max Planck Society	Genschik, P (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.			GENSCHIK, Pascal/0000-0002-4107-5071; Potuschak, Thomas/0000-0002-2632-4981				Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], 2002, ARABIDOPSIS BOOK; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KIPREOS ET, 2000, IN PRESS GENOME BIOL; Lechner E, 2002, J BIOL CHEM, V277, P50069, DOI 10.1074/jbc.M204254200; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; ROMAN G, 1995, GENETICS, V139, P1393; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Smalle J, 1997, P NATL ACAD SCI USA, V94, P2756, DOI 10.1073/pnas.94.6.2756; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; ZUO J, 2002, PLANT J, V24, P265	41	515	573	6	113	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					679	689		10.1016/S0092-8674(03)00968-1	http://dx.doi.org/10.1016/S0092-8674(03)00968-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675533	Bronze			2022-12-01	WOS:000187366100008
J	Varaldi, J; Fouillet, P; Ravallec, M; Lopez-Ferber, M; Bouletreau, M; Fleury, F				Varaldi, J; Fouillet, P; Ravallec, M; Lopez-Ferber, M; Bouletreau, M; Fleury, F			Infectious behavior in a parasitoid	SCIENCE			English	Article							SUPERPARASITISM		Univ Lyon 1, Lab Biometrie & Biol Evolut, CNRS, UMR 5558, F-69622 Villeurbanne, France; Univ Montpellier 2, INRA, Lab Pathol Comparee, CNRS,UMR 5087, F-30380 St Christol Les Ales, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Montpellier	Varaldi, J (corresponding author), Univ Lyon 1, Lab Biometrie & Biol Evolut, CNRS, UMR 5558, 43 Bld 11 Novembre 1918, F-69622 Villeurbanne, France.	varaldi@biomserv.univ-lyon1.fr	Lopez-Ferber, Miguel/F-5465-2012	Lopez-Ferber, Miguel/0000-0002-3850-1703; varaldi, julien/0000-0002-2100-1542				Allemand R, 2002, ANN SOC ENTOMOL FR, V38, P319, DOI 10.1080/00379271.2002.10697346; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; Vinson SB, 1998, J INSECT PHYSIOL, V44, P703, DOI 10.1016/S0022-1910(98)00003-1	4	62	65	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1930	1930		10.1126/science.1088798	http://dx.doi.org/10.1126/science.1088798			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14564013				2022-12-01	WOS:000187174000050
J	Tanaka, M; Vitek, CR; Pascual, FB; Bisgard, KM; Tate, JE; Murphy, TV				Tanaka, M; Vitek, CR; Pascual, FB; Bisgard, KM; Tate, JE; Murphy, TV			Trends in pertussis among infants in the United States, 1980-1999	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUNG INFANTS; EPIDEMIOLOGIC FEATURES; CHANGING EPIDEMIOLOGY; NEONATAL PERTUSSIS; VACCINE; ADULTS; IMMUNIZATION; DIAGNOSIS; CHILDREN	Context Reported cases of pertussis among adolescents and adults have increased since the 1980s, despite increasingly high rates of vaccination among infants and children. However, severe pertussis morbidity and mortality occur primarily among infants. Objective To describe the trends and characteristics of reported cases of pertussis among infants younger than 12 months in the United States from 1980 to 1999. Design, Setting, and Participants Cases of pertussis in infants younger than 12 months in the United States reported to the National Notifiable Disease Surveillance System of the Centers for Disease Control and Prevention between 1980 and 1999, and detailed case data from the Supplementary Pertussis Surveillance System. Main Outcome Measures incidence and demographic and clinical characteristics of cases. Results The incidence of reported cases of pertussis among infants increased 49% in the 1990s compared with the incidence in the 1980s (19798 vs 12550 cases reported; 51.1 cases vs 34.2 cases per 100000 infant population, respectively), increases in the incidence of cases and the number of deaths among infants during the 1990s primarily were among those aged 4 months or younger, contrasting with a stable incidence of cases among infants aged 5 months or older. The proportion of cases confirmed by bacterial culture was higher in the 1990s than in the 1980s (50% and 33%, respectively); the proportion of hospitalized cases was unchanged (67% vs 68%, respectively). Receipt of fewer doses of vaccine was associated with hospitalization, when,cases were stratified by age in months. Conclusions The incidence of reported cases of pertussis among infants increased in the 1990s compared with the 1980s. The limited age group affected, the increased rate of bacteriologic confirmation, and the unchanged severity of illness suggest that an increase in infant pertussis has occurred apart from any change in reporting. Strategies are needed to prevent the morbidity and mortality from pertussis among infants too young to be fully vaccinated, according to the current recommended schedules of vaccination in the United States.	Ctr Dis Control & Prevent MS 61, Bacterial Vaccine Preventable Dis Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Tanaka, M (corresponding author), Ctr Dis Control & Prevent MS 61, Bacterial Vaccine Preventable Dis Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd, Atlanta, GA 30333 USA.							Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; BASS JW, 1989, PEDIATR INFECT DIS J, V8, P352, DOI 10.1097/00006454-198906000-00004; BEITER A, 1993, OBSTET GYNECOL, V82, P691; BISGARD K, 2002, MANUAL SURVEILLANCE; Bisgard Kristine M., 2001, Pediatric Research, V49, p110A; BROOKSALER F, 1967, AM J DIS CHILD, V114, P389, DOI 10.1001/archpedi.1967.02090250087005; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P11; *CDCP, NAT IMM PROGR IMM CO; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P73; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; CHRISTIE CDC, 1989, AM J DIS CHILD, V143, P1199, DOI 10.1001/archpedi.1989.02150220097027; De Serres G, 2000, Can Commun Dis Rep, V26, P1; EDWARDS KM, 1993, JAMA-J AM MED ASSOC, V269, P53, DOI 10.1001/jama.269.1.53; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; FEIGIN RD, 1992, TXB PEDIAT INFECT DI, P1208; FINE PEM, 1986, INT J EPIDEMIOL, V15, P237, DOI 10.1093/ije/15.2.237; GAN VN, 1990, AM J DIS CHILD, V144, P1130, DOI 10.1001/archpedi.1990.02150340076027; Grimprel E, 1999, LANCET, V354, P1699, DOI 10.1016/S0140-6736(99)01576-7; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; HEININGER U, 1992, EUR J PEDIATR, V151, P342, DOI 10.1007/BF02113254; Hoppe JE, 2000, PEDIATR INFECT DIS J, V19, P244, DOI 10.1097/00006454-200003000-00014; Izurieta HS, 1996, CLIN INFECT DIS, V22, P503, DOI 10.1093/clinids/22.3.503; Juretzko P, 2002, CLIN INFECT DIS, V35, P162, DOI 10.1086/341027; KAUFMAN S, 1960, AMA J DIS CHILD, V99, P417, DOI 10.1001/archpedi.1960.02070030419003; Keitel WA, 1999, CLIN INFECT DIS, V28, pS118, DOI 10.1086/515064; Muller FMC, 1997, J CLIN MICROBIOL, V35, P2435; *NAT BUR CENS, ANN TIM SER STAT POP; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; ONORATO IM, 1992, JAMA-J AM MED ASSOC, V267, P2745, DOI 10.1001/jama.267.20.2745; Simpson DM, 2001, AM J PREV MED, V20, P6, DOI 10.1016/S0749-3797(01)00286-0; SOTOMAYOR J, 1985, AM J DIS CHILD, V139, P724, DOI 10.1001/archpedi.1985.02140090086039; SUTTER RW, 1992, JAMA-J AM MED ASSOC, V267, P386, DOI 10.1001/jama.267.3.386; Sweden Ad Hoc Group for the Study of Pertussis Vaccines, 1988, Lancet, Vi, P955; *US DHHS, 2000, HLTH PEOPL 2010, V1, pCH14; *US PHS, ANN REP SURG GEN PUB; *US PHS, 1953, REP INC SEL NOT DIS, P240; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Wharton M, 1990, MMWR Recomm Rep, V39, P1; WHARTON M, 2002, MANUAL SURVEILLANCE	40	262	272	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2968	2975		10.1001/jama.290.22.2968	http://dx.doi.org/10.1001/jama.290.22.2968			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665658	Bronze			2022-12-01	WOS:000187112700028
J	Calsbeek, R; Smith, TB				Calsbeek, R; Smith, TB			Ocean currents mediate evolution in island lizards	NATURE			English	Article							LOCOMOTOR PERFORMANCE; ANOLIS; SPECIATION; RADIATIONS; MORPHOLOGY	Islands are considered to be natural laboratories in which to examine evolution because of the implicit assumption that limited gene flow allows tests of evolutionary processes in isolated replicates(1). Here we show that this well-accepted idea requires re-examination. Island inundation during hurricanes can have devastating effects on lizard populations in the Bahamas(2,3). After severe storms, islands may be recolonized by overwater dispersal of lizards from neighbouring islands(3). High levels of gene flow may homogenize genes responsible for divergence, and are widely viewed as a constraining force on evolution(4,5). Ultimately, the magnitude of gene flow determines the extent to which populations diverge from one another, and whether or not they eventually form new species(6,7). We show that patterns of gene flow among island populations of Anolis lizards are best explained by prevailing ocean currents, and that over-water dispersal has evolutionary consequences. Across islands, divergence in fitness-related morphology decreases with increasing gene flow(5). Results suggest that over-water dispersal after hurricanes constrains adaptive diversification in Anolis lizards, and that it may have an important but previously undocumented role in this classical example of adaptive radiation.	Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90065 USA	University of California System; University of California Los Angeles	Calsbeek, R (corresponding author), Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90065 USA.	calsbeek@ucla.edu		Calsbeek, Ryan/0000-0002-9236-4092				BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Batchelet E., 1981, CIRCULAR STAT BIOL, V1st; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; CALSBEEK R, UNPUB AM NAT; CASGRAIN P, 2001, R PACKAGE MULTIVARIA; Endler J.A., 1977, Monographs in Population Biology, pi; Georges TM, 1996, NATURE, V379, P434, DOI 10.1038/379434a0; Irschick DJ, 1998, EVOLUTION, V52, P219, DOI 10.1111/j.1558-5646.1998.tb05155.x; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1006/bijl.1996.0052; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; KINDER TH, 1985, MAR GEOL, V68, P25, DOI 10.1016/0025-3227(85)90004-0; Lee TN, 1996, J PHYS OCEANOGR, V26, P962, DOI 10.1175/1520-0485(1996)026<0962:MOOWBC>2.0.CO;2; LIGHTY RG, 1979, NATURE, V278, P281, DOI 10.1038/278281b0; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOSOS JB, 1989, J EXP BIOL, V145, P23; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; Mayr E, 1963, ANIMAL SPECIES EVOLU; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER A, 1984, OECOLOGIA, V63, P289, DOI 10.1007/BF00390655; Schoener T.W., 1983, P491; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18	30	109	112	0	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					552	555		10.1038/nature02143	http://dx.doi.org/10.1038/nature02143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654839				2022-12-01	WOS:000186944300037
J	Conboy, IM; Conboy, MJ; Smythe, GM; Rando, TA				Conboy, IM; Conboy, MJ; Smythe, GM; Rando, TA			Notch-mediated restoration of regenerative potential to aged muscle	SCIENCE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; DIFFERENTIATION; MYOGENESIS; NUMBERS; FIBERS	A hallmark of aging is diminished regenerative potential of tissues, but the mechanism of this decline is unknown. Analysis of injured muscle revealed that, with age, resident precursor cells ( satellite cells) had a markedly impaired propensity to proliferate and to produce myoblasts necessary for muscle regeneration. This was due to insufficient up-regulation of the Notch ligand Delta and, thus, diminished activation of Notch in aged, regenerating muscle. Inhibition of Notch impaired regeneration of young muscle, whereas forced activation of Notch restored regenerative potential to old muscle. Thus, Notch signaling is a key determinant of muscle regenerative potential that declines with age.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Serv Neurol, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.			Smythe, Gayle/0000-0002-4967-209X; Rando, Thomas/0000-0001-5843-8564	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [F31NR005902] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS36409] Funding Source: Medline; NINR NIH HHS [NRSA-AG05902] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cossu G, 1996, TRENDS GENET, V12, P218, DOI 10.1016/0168-9525(96)10025-1; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Goldring K, 2002, J PATHOL, V197, P457, DOI 10.1002/path.1157; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Kojika S, 2001, EXP HEMATOL, V29, P1041, DOI 10.1016/S0301-472X(01)00676-2; Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Partridge TA, 2002, GENE THER, V9, P752, DOI 10.1038/sj.gt.3301764; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Shawber C, 1996, DEVELOPMENT, V122, P3765; Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	21	777	815	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1575	1577		10.1126/science.1087573	http://dx.doi.org/10.1126/science.1087573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645852				2022-12-01	WOS:000186802200047
J	Manel, N; Kim, FJ; Kinet, S; Taylor, N; Sitbon, M; Battini, JL				Manel, N; Kim, FJ; Kinet, S; Taylor, N; Sitbon, M; Battini, JL			The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV	CELL			English	Article							T-CELL LEUKEMIA; HAMSTER OVARY CELLS; VIRUS TYPE-I; SYNCYTIUM FORMATION; SURFACE EXPRESSION; HUMAN ERYTHROCYTES; BINDING-PROTEIN; LYMPHOCYTES; RETROVIRUS; ACTIVATION	The human T cell leukemia virus (HTLV) is associated with leukemia and neurological syndromes. The physiopathological effects of HTLV envelopes are unclear and the identity of the receptor, present on all vertebrate cell lines, has been elusive. We show that the receptor binding domains of both HTLV-1 and -2 envelope glycoproteins inhibit glucose transport by interacting with GLUT-1, the ubiquitous vertebrate glucose transporter. Receptor binding and HTLV envelope-driven infection are selectively inhibited when glucose transport or GLUT-1 expression are blocked by cytochalasin B or siRNAs, respectively. Furthermore, ectopic expression of GLUT-1, but not the related transporter GLUT-3, restores HTLV infection abrogated by either GLUT-1 siRNAs or interfering HTLV envelope glycoproteins. Therefore, GLUT-1 is a receptor for HTLV. Perturbations in glucose metabolism resulting from interactions of HTLV envelope glycoproteins with GLUT-1 are likely to contribute to HTLV-associated disorders.	Inst Genet Mol Montpellier, CNRS UMR 5535, IFR 122, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Sitbon, M (corresponding author), Inst Genet Mol Montpellier, CNRS UMR 5535, IFR 122, F-34293 Montpellier 5, France.		Manel, Nicolas/E-2128-2011; Sitbon, Marc/A-6771-2010; Taylor, Naomi/H-4016-2014	Manel, Nicolas/0000-0002-1481-4430; Sitbon, Marc/0000-0003-3616-2338; kinet, sandrina/0000-0003-0699-108X; Battini, Jean-Luc/0000-0002-5884-9934				Akaoka H, 2001, VIRUS RES, V78, P57, DOI 10.1016/S0168-1702(01)00284-2; ASANO T, 1992, BIOCHEM J, V288, P189, DOI 10.1042/bj2880189; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; BATTINI JL, 1995, J VIROL, V69, P713, DOI 10.1128/JVI.69.2.713-719.1995; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Cavrois M, 1996, ONCOGENE, V12, P2419; CHAKRABARTI R, 1994, J IMMUNOL, V152, P2660; Concha II, 1997, BLOOD, V89, P4190, DOI 10.1182/blood.V89.11.4190; Daenke S, 1999, J GEN VIROL, V80, P1429, DOI 10.1099/0022-1317-80-6-1429; Daenke S, 2000, J CELL SCI, V113, P37; DENESVRE C, 1995, J VIROL, V69, P4149, DOI 10.1128/JVI.69.7.4149-4157.1995; Denesvre C, 1996, J VIROL, V70, P4380, DOI 10.1128/JVI.70.7.4380-4386.1996; Derse D, 2003, SCIENCE, V299, P1670, DOI 10.1126/science.1083218; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; Feuer G, 1996, J VIROL, V70, P4038, DOI 10.1128/JVI.70.6.4038-4044.1996; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GESSAIN A, 1985, LANCET, V2, P407; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; HARRISON SA, 1990, J BIOL CHEM, V265, P5793; Hildreth JEK, 1997, J VIROL, V71, P1173, DOI 10.1128/JVI.71.2.1173-1180.1997; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; KASINRERK W, 1992, J IMMUNOL, V149, P847; Kim FJ, 2000, J BIOL CHEM, V275, P23417, DOI 10.1074/jbc.C901002199; Kim FJ, 2003, J VIROL, V77, P963, DOI 10.1128/JVI.77.2.963-969.2003; KIM FJ, 2003, IN PRESS VIROLOGY; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Korgun ET, 2002, BLOOD CELL MOL DIS, V28, P152, DOI 10.1006/bcmd.2002.0504; Manel N, 2003, BLOOD, V101, P1913, DOI 10.1182/blood-2002-09-2681; MANTYCH G, 1991, BIOCHEM BIOPH RES CO, V180, P367, DOI 10.1016/S0006-291X(05)81302-6; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Nath MD, 2003, BLOOD, V101, P3085, DOI 10.1182/blood-2002-07-2277; OSAME M, 1986, LANCET, V1, P1031; Overbaugh J, 2001, MICROBIOL MOL BIOL R, V65, P371, DOI 10.1128/MMBR.65.3.371-389.2001; PICHARD L, 1990, DRUG METAB DISPOS, V18, P595; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rodrigues P, 1999, J VIROL, V73, P3789, DOI 10.1128/JVI.73.5.3789-3799.1999; Rosenberg AR, 1998, J VIROL, V72, P7609, DOI 10.1128/JVI.72.9.7609-7614.1998; SIEGEL GJ, 1998, CIRCULATION ENERGY M, pCH5; Slattery JP, 1999, GENOME RES, V9, P525; Sutton RE, 1996, J VIROL, V70, P7322, DOI 10.1128/JVI.70.10.7322-7326.1996; Tailor CS, 2003, CURR TOP MICROBIOL, V281, P29; Trejo SR, 2000, VIROLOGY, V268, P41, DOI 10.1006/viro.2000.0143; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765	56	299	319	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					449	459		10.1016/S0092-8674(03)00881-X	http://dx.doi.org/10.1016/S0092-8674(03)00881-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622599	Bronze			2022-12-01	WOS:000186627100011
J	Zhao, GQ; Zhang, YF; Hoon, MA; Chandrashekar, J; Erlenbach, I; Ryba, NJP; Zuker, CS				Zhao, GQ; Zhang, YF; Hoon, MA; Chandrashekar, J; Erlenbach, I; Ryba, NJP; Zuker, CS			The receptors for mammalian sweet and umami taste	CELL			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PHOSPHOLIPASE-C; GENE-EXPRESSION; CHORDA TYMPANI; BITTER TASTE; RESPONSES; CELLS; MICE; IDENTIFICATION; FAMILY	Sweet and umami (the taste of monosodium glutamate) are the main attractive taste modalities in humans. T1Rs are candidate mammalian taste receptors that combine to assemble two heteromeric G-protein-coupled receptor complexes: T1R1+3, an umami sensor, and T1R2+3, a sweet receptor. We now report the behavioral and physiological characterization of T1R1, T1R2, and T1R3 knockout mice. We demonstrate that sweet and umami taste are strictly dependent on T1R-receptors, and show that selective elimination of T1R-subunits differentially abolishes detection and perception of these two taste modalities. To examine the basis of sweet tastant recognition and coding, we engineered animals expressing either the human T1R2-receptor (hT1R2), or a modified opioid-receptor (RASSL) in sweet cells. Expression of hT1R2 in mice generates animals with humanized sweet taste preferences, while expression of RASSL drives strong attraction to a synthetic opiate, demonstrating that sweet cells trigger dedicated behavioral outputs, but their tastant selectivity is determined by the nature of the receptors.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ryba, NJP (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	nr13k@nih.gov; charles@flyeye.ucsd.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abaffy T, 2003, AM J PHYSIOL-CELL PH, V284, pC1420, DOI 10.1152/ajpcell.00556.2002; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 2000, J NUTR, V130, p935S, DOI 10.1093/jn/130.4.935S; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 1998, ANN NY ACAD SCI, V855, P398, DOI 10.1111/j.1749-6632.1998.tb10598.x; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Gossen Manfred, 1994, Current Opinion in Biotechnology, V5, P516, DOI 10.1016/0958-1669(94)90067-1; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Mody SM, 2000, MOL PHARMACOL, V57, P13; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ninomiya Y, 1999, J NEUROPHYSIOL, V81, P3087, DOI 10.1152/jn.1999.81.6.3087; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; SCHIFFMAN SS, 1981, PHARMACOL BIOCHEM BE, V15, P377, DOI 10.1016/0091-3057(81)90266-5; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	40	895	955	8	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					255	266		10.1016/S0092-8674(03)00844-4	http://dx.doi.org/10.1016/S0092-8674(03)00844-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636554	Bronze			2022-12-01	WOS:000186415000006
J	Liotta, LA; Ferrari, M; Petricoin, E				Liotta, LA; Ferrari, M; Petricoin, E			Written in blood	NATURE			English	Article									NCI, Bethesda, MD 20892 USA; Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Internal Med, Columbus, OH 43210 USA; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; US Food & Drug Administration (FDA)	Liotta, LA (corresponding author), NCI, 10 Ctr Dr, Bethesda, MD 20892 USA.							Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Liu J, 2002, DIS MARKERS, V18, P175, DOI 10.1155/2002/874157; Mehta AI, 2003, DIS MARKERS, V19, P1; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200	5	410	450	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					905	905		10.1038/425905a	http://dx.doi.org/10.1038/425905a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586448	Green Published, Bronze			2022-12-01	WOS:000186230600022
J	Nelson, KB				Nelson, KB			Can we prevent cerebral palsy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CESAREAN-SECTION; BIRTH-WEIGHT; RISK-FACTORS; INFANTS; STROKE; INTRAPARTUM; DELIVERY; TRENDS		NINDS, Neuroepidemiol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Nelson, KB (corresponding author), NINDS, Neuroepidemiol Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002863] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrew M E, 2001, Hematology Am Soc Hematol Educ Program, P358; Clark SL, 2003, AM J OBSTET GYNECOL, V188, P628, DOI 10.1067/mob.2003.204; Golomb MR, 2001, ANN NEUROL, V50, P163, DOI 10.1002/ana.1078; GRANT A, 1989, LANCET, V2, P1233; Grether JK, 1998, JAMA-J AM MED ASSOC, V279, P118; Grether JK, 2003, ARCH PEDIAT ADOL MED, V157, P26, DOI 10.1001/archpedi.157.1.26; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Jackson N, 2001, BEST PRACT RES CL OB, V15, P49, DOI 10.1053/beog.2000.0148; Lanska DJ, 2000, STROKE, V31, P1274, DOI 10.1161/01.STR.31.6.1274; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097/00008480-200112000-00002; MacDorman MF, 2002, PEDIATRICS, V110, P1037, DOI 10.1542/peds.110.6.1037; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; PETTERSON B, 1993, BRIT MED J, V307, P1239, DOI 10.1136/bmj.307.6914.1239; Ros HS, 2002, AM J OBSTET GYNECOL, V186, P198, DOI 10.1067/mob.2002.119177; SHY KK, 1990, NEW ENGL J MED, V322, P588, DOI 10.1056/NEJM199003013220904; STANLEY F, 2000, CLIN DEV MED, V151; Surman G, 2003, DEV MED CHILD NEUROL, V45, P456, DOI 10.1017/S0012162203000859; THACKER SB, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000063; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x; Willoughby RE, 2002, CLIN PERINATOL, V29, P603, DOI 10.1016/S0095-5108(02)00058-1; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220	25	131	137	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2003	349	18					1765	1769		10.1056/NEJMsb035364	http://dx.doi.org/10.1056/NEJMsb035364			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	737FJ	14585946				2022-12-01	WOS:000186219500013
J	Duyk, G				Duyk, G			Attrition and translation	SCIENCE			English	Article							DRUG DEVELOPMENT; UNITED-STATES	The recently published NIH Roadmap proposes that public-sector science should place increased emphasis on the development of new therapeutics and diagnostics based on the fruits of fundamental research. Such "translational research" activities, traditionally the province of the private sector, have long been compromised by high rates of attrition (failure during the course of preclinical or clinical development of therapeutics). Attrition has led to growing financial costs, as well as opportunity costs. The new focus offers a way to reverse these trends, especially if the scientific community can improve on its ability to reconcile molecular genetic research with integrative organ- and organism-based research.	Exelixis Inc, San Francisco, CA 94083 USA	Exelixis, Inc.	Duyk, G (corresponding author), Exelixis Inc, 170 Harbor Way, San Francisco, CA 94083 USA.							*BILL MEL GAT FDN, GLOB HLTH PROGR; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P286, DOI 10.1067/mcp.2001.115132; DIMASI JA, 1991, CLIN PHARMACOL THER, V50, P471, DOI 10.1038/clpt.1991.172; DiMasi Joseph A., 1996, Am J Ther, V3, P647, DOI 10.1097/00045391-199609000-00008; Eisenberg RS, 2003, SCIENCE, V299, P1018, DOI 10.1126/science.1081790; FALK M, 2003, STATUS FUTURE INTEGR; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; KAITIN KI, 2003, TUFTS CTR STUDY DRUG, V5; *LEHM BROTH, 2001, FRUITS GEN DRUG PIP; Malakoff D, 2003, SCIENCE, V300, P1635; MCCLELLAN MB, 2003, COMMUNICATION   0609; MILNE CP, 2002, PHARMACOECONOMICS S3, V20; Wellcome Trust, 2003, SHAR DAT LARG SCAL B; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	16	72	74	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					603	605		10.1126/science.1090521	http://dx.doi.org/10.1126/science.1090521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576424				2022-12-01	WOS:000186119900047
J	Baumgart, T; Hess, ST; Webb, WW				Baumgart, T; Hess, ST; Webb, WW			Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension	NATURE			English	Article							GIANT PHOSPHOLIPID-VESICLES; INTRAMEMBRANE DOMAINS; MEMBRANES; SHAPE; FISSION; TRANSITIONS; MONOLAYERS; DYNAMICS	Lipid bilayer membranes - ubiquitous in biological systems and closely associated with cell function - exhibit rich shape-transition behaviour, including bud formation(1) and vesicle fission(2). Membranes formed from multiple lipid components can laterally separate into coexisting liquid phases, or domains, with distinct compositions. This process, which may resemble raft formation in cell membranes, has been directly observed in giant unilamellar vesicles(3,4). Detailed theoretical frameworks(5-11) link the elasticity of domains and their boundary properties to the shape adopted by membranes and the formation of particular domain patterns, but it has been difficult to experimentally probe and validate these theories. Here we show that high-resolution fluorescence imaging using two dyes preferentially labelling different fluid phases directly provides a correlation between domain composition and local membrane curvature. Using freely suspended membranes of giant unilamellar vesicles, we are able to optically resolve curvature and line tension interactions of circular, stripe and ring domains. We observe long-range domain ordering in the form of locally parallel stripes and hexagonal arrays of circular domains, curvature-dependent domain sorting, and membrane fission into separate vesicles at domain boundaries. By analysing our observations using available membrane theory, we are able to provide experimental estimates of boundary tension between fluid bilayer domains.	Cornell Univ, Ithaca, NY 14853 USA; NICHHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Webb, WW (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.		Webb, Watt W./B-5905-2011					ANDELMAN D, 1992, EUROPHYS LETT, V19, P57, DOI 10.1209/0295-5075/19/1/010; ANDELMAN D, 1987, J CHEM PHYS, V86, P3673, DOI 10.1063/1.451970; BARZIV R, 1994, PHYS REV LETT, V73, P1392, DOI 10.1103/PhysRevLett.73.1392; BENVEGNU DJ, 1992, J PHYS CHEM-US, V96, P6820, DOI 10.1021/j100195a053; Chen CM, 1997, PHYS REV LETT, V79, P1579, DOI 10.1103/PhysRevLett.79.1579; Debregeas G, 1998, SCIENCE, V279, P1704, DOI 10.1126/science.279.5357.1704; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; DOBEREINER HG, 1993, BIOPHYS J, V65, P1396; DUWE HP, 1990, PHYSICA A, V163, P410, DOI 10.1016/0378-4371(90)90349-W; HELFRICH W, 1984, NUOVO CIMENTO D, V3, P137, DOI 10.1007/BF02452208; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; JENKINS JT, 1977, J MATH BIOL, V4, P149, DOI 10.1007/BF00275981; Jiang Y, 2000, PHYS REV E, V61, pR57, DOI 10.1103/PhysRevE.61.R57; Julicher F, 1996, PHYS REV E, V53, P2670, DOI 10.1103/PhysRevE.53.2670; KAS J, 1991, BIOPHYS J, V60, P825, DOI 10.1016/S0006-3495(91)82117-8; Kumar PBS, 2001, PHYS REV LETT, V86, P3911, DOI 10.1103/PhysRevLett.86.3911; LEIBLER S, 1987, J PHYS-PARIS, V48, P2013, DOI 10.1051/jphys:0198700480110201300; LIPOWSKY R, 1992, J PHYS II, V2, P1825, DOI 10.1051/jp2:1992238; Lipowsky R, 2003, J PHYS-CONDENS MAT, V15, pS31, DOI 10.1088/0953-8984/15/1/304; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mukherjee S, 2000, TRAFFIC, V1, P203, DOI 10.1034/j.1600-0854.2000.010302.x; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; SCHNEIDER MB, 1984, J PHYS-PARIS, V45, P1457, DOI 10.1051/jphys:019840045090145700; SEIFERT U, 1993, PHYS REV LETT, V70, P1335, DOI 10.1103/PhysRevLett.70.1335; SEUL M, 1995, SCIENCE, V267, P476, DOI 10.1126/science.267.5197.476; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; Wintz W, 1996, EUROPHYS LETT, V33, P403, DOI 10.1209/epl/i1996-00353-8	29	1225	1249	8	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					821	824		10.1038/nature02013	http://dx.doi.org/10.1038/nature02013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14574408				2022-12-01	WOS:000186118500041
J	Lee, S; Sowa, ME; Watanabe, YH; Sigler, PB; Chiu, W; Yoshida, M; Tsai, FTF				Lee, S; Sowa, ME; Watanabe, YH; Sigler, PB; Chiu, W; Yoshida, M; Tsai, FTF			The structure of clpB: A molecular chaperone that rescues proteins from an aggregated state	CELL			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; HSP100 CHAPERONE; LEUCINE-ZIPPER; BINDING; ATPASE; DNAK; TRANSLOCATION; SOFTWARE; SYSTEM	Molecular chaperones assist protein folding by facilitating their "forward" folding and preventing aggregation. However, once aggregates have formed, these chaperones cannot facilitate protein disaggregation. Bacterial ClpB and its eukaryotic homolog Hsp104 are essential proteins of the heat-shock response, which have the remarkable capacity to rescue stress-damaged proteins from an aggregated state. We have determined the structure of Thermus thermophilus ClpB (TClpB) using a combination of X-ray crystallography and cryo-electron microscopy (cryo-EM). Our single-particle reconstruction shows that TClpB forms a two-tiered hexameric ring. The ClpB/Hsp104-linker consists of an 85 Angstrom long and mobile coiled coil that is located on the outside of the hexamer. Our mutagenesis and biochemical data show that both the relative position and motion of this coiled coil are critical for chaperone function. Taken together, we propose a mechanism by which an ATP-driven conformational change is coupled to a large coiled-coil motion, which is indispensable for protein disaggregation.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Baylor College of Medicine; Tokyo Institute of Technology; Yale University; Howard Hughes Medical Institute; Yale University	Tsai, FTF (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	ftsai@bcm.tmc.edu			NCRR NIH HHS [P41RR02250] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Clarke AK, 2000, J BACTERIOL, V182, P7092, DOI 10.1128/JB.182.24.7092-7096.2000; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1991, MOL REPLACEMENT, P91; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Li JZ, 2002, J MOL BIOL, V318, P1127, DOI 10.1016/S0022-2836(02)00188-2; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK SK, 1993, J BIOL CHEM, V268, P20170; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Stiggall D L, 1979, Methods Enzymol, V55, P308; Tek V, 2002, PROTEIN SCI, V11, P1192, DOI 10.1110/ps.4860102; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	53	348	355	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2003	115	2					229	240		10.1016/S0092-8674(03)00807-9	http://dx.doi.org/10.1016/S0092-8674(03)00807-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567920	Bronze			2022-12-01	WOS:000186039200014
J	Walmsley, MJ; Ooi, SKT; Reynolds, LF; Smith, SH; Ruf, S; Mathiot, A; Vanes, L; Williams, DA; Cancro, MP; Tybulewicz, VLJ				Walmsley, MJ; Ooi, SKT; Reynolds, LF; Smith, SH; Ruf, S; Mathiot, A; Vanes, L; Williams, DA; Cancro, MP; Tybulewicz, VLJ			Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling	SCIENCE			English	Article							RECEPTOR RESPONSES; B-1 CELLS; BAFF-R; ACTIVATION; EXPRESSION; SELECTION; KINASE	The Rac1 guanosine triphosphatase (GTPase) has been implicated in multiple cellular functions, including actin dynamics, proliferation, apoptosis, adhesion, and migration resulting from signaling by multiple receptors, including the B cell antigen receptor (BCR). We used conditional gene targeting to generate mice with specific Rac1 deficiency in the B cell lineage. In the absence of both Rac1 and the highly related Rac2, B cell development was almost completely blocked. Both GTPases were required to transduce BCR signals leading to proliferation, survival and upregulation of BAFF-R, a receptor for BAFF, a key survival molecule required for B cell development and maintenance.	Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol, Cincinnati, OH 45229 USA	MRC National Institute for Medical Research; University of Pennsylvania; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Tybulewicz, VLJ (corresponding author), Natl Inst Med Res, Div Immune Cell Biol, Ridgeway,Mill Hill, London NW7 1AA, England.	vtybule@nimr.mrc.ac.uk		Tybulewicz, Victor/0000-0003-2439-0798; Cancro, Michael/0000-0002-8659-3227; Ooi, Steen/0000-0003-4198-9014	NIAID NIH HHS [R01 AI054488] Funding Source: Medline; NIDDK NIH HHS [R01 DK62757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amanna IJ, 2003, J IMMUNOL, V170, P4593, DOI 10.4049/jimmunol.170.9.4593; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Grill B, 2002, BLOOD, V100, P3183, DOI 10.1182/blood-2002-01-0154; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Lentz VM, 1998, J IMMUNOL, V160, P3743; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Nosaka Y, 2001, BIOCHEM BIOPH RES CO, V285, P675, DOI 10.1006/bbrc.2001.5222; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; WALMSLEY MJ, UNPUB; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	26	208	211	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2003	302	5644					459	462		10.1126/science.1089709	http://dx.doi.org/10.1126/science.1089709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	14564011				2022-12-01	WOS:000185963200047
J	Scholefield, JH; Moss, S				Scholefield, JH; Moss, S			Screening sigmoidoscopy for colorectal cancer	LANCET			English	Editorial Material							DEBATE; COSTS		Univ Nottingham Hosp, Div GI Surg, Nottingham NG7 2UH, England; Canc Screening Evaluat Unit, Surrey, England	University of Nottingham	Scholefield, JH (corresponding author), Univ Nottingham Hosp, Div GI Surg, Nottingham NG7 2UH, England.	john.scholefield@nottingham.ac.uk						Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2003, GUT, V52, P321, DOI 10.1136/gut.52.3.321; Cronin KA, 1998, J NATL CANCER I, V90, P498, DOI 10.1093/jnci/90.7.498; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Lund JN, 2001, GUT, V49, P91, DOI 10.1136/gut.49.1.91; Macafee DAL, 2003, GUT, V52, P323, DOI 10.1136/gut.52.3.323; MILBURN A, 2002, BRIT CANC C LOND NOV; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Schoen RE, 2003, JAMA-J AM MED ASSOC, V290, P41, DOI 10.1001/jama.290.1.41; Steele RJC, 2001, J MED SCREEN, V8, P197, DOI 10.1136/jms.8.4.197; WHYNES DK, 1992, J EPIDEMIOL COMMUN H, V46, P577, DOI 10.1136/jech.46.6.577	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2003	362	9391					1167	1168		10.1016/S0140-6736(03)14553-9	http://dx.doi.org/10.1016/S0140-6736(03)14553-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CW	14568733				2022-12-01	WOS:000185924100003
J	Jepson, PD; Arbelo, M; Deaville, R; Patterson, IAP; Castro, P; Baker, JR; Degollada, E; Ross, HM; Herraez, P; Pocknell, AM; Rodriguez, F; Howie, FE; Espinosa, A; Reid, RJ; Jaber, JR; Martin, V; Cunningham, AA; Fernandez, A				Jepson, PD; Arbelo, M; Deaville, R; Patterson, IAP; Castro, P; Baker, JR; Degollada, E; Ross, HM; Herraez, P; Pocknell, AM; Rodriguez, F; Howie, FE; Espinosa, A; Reid, RJ; Jaber, JR; Martin, V; Cunningham, AA; Fernandez, A			Gas-bubble lesions in stranded cetaceans - Was sonar responsible for a spate of whale deaths after an Atlantic military exercise?	NATURE			English	Editorial Material							COLLAPSE; GROWTH		Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Las Palmas de Gran Canaria, Sch Vet, Inst Anim Hlth, Histol & Pathol Unit, Las Palmas Gran Canaria, Spain; SAC Vet Sci Div Inverness, Wildlife Unit, Inverness IV2 4JZ, Scotland; Univ Liverpool, Dept Vet Pathol, Wirral CH64 7TE, Merseyside, England; SAC Vet Sci Div Edinburgh, Penicuik EH26 0QE, Midlothian, Scotland	Zoological Society of London; Universidad de Las Palmas de Gran Canaria; Scottish Agricultural College; University of Liverpool; Scottish Agricultural College	Jepson, PD (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.		Arbelo, Manuel/D-6789-2013; Langhamer, Olivia/J-3425-2012; Fernandez, Antonio/G-3448-2015; Castro, Pedro Luis/ABF-6635-2021; Cunningham, Andrew A/E-7536-2010; Jepson, Paul D/G-1840-2013; Rodriguez Guisado, Francisco/L-6874-2014	Arbelo, Manuel/0000-0002-1623-5010; Fernandez, Antonio/0000-0001-5281-0521; Castro, Pedro Luis/0000-0002-0395-899X; Herraez, Pedro/0000-0001-9316-2882; Rodriguez Guisado, Francisco/0000-0002-4968-5333				Crum LA, 1996, J ACOUST SOC AM, V99, P2898, DOI 10.1121/1.414859; FALKE KJ, 1985, SCIENCE, V229, P556, DOI 10.1126/science.4023700; Francis T. J. R., 2003, BENNETT ELLIOTTS PHY, P530; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; HARRISON R. J., 1956, PROC ZOOL SOC LONDON, V126, P205; Houser DS, 2001, J THEOR BIOL, V213, P183, DOI 10.1006/jtbi.2001.2415; Knight B, 1996, FORENSIC PATHOLOGY; Ponganis P. J., 2003, BENNETT ELLIOTTS PHY, P211; RIDGWAY SH, 1982, SCIENCE, V216, P651, DOI 10.1126/science.216.4546.651; RIDGWAY SH, 1979, SCIENCE, V206, P1182, DOI 10.1126/science.505001; SIMMONDS MP, 1991, NATURE, V351, P448, DOI 10.1038/351448a0; *USN, 2001, JOINT INT REP BAH MA	12	304	323	4	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2003	425	6958					575	576		10.1038/425575a	http://dx.doi.org/10.1038/425575a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534575				2022-12-01	WOS:000185801000025
J	Stelfox, HT; Bates, DW; Redelmeier, DA				Stelfox, HT; Bates, DW; Redelmeier, DA			Safety of patients isolated for infection control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ADVERSE; EVENTS; STOP; CARE	Context Hospital infection control policies that use patient isolation prevent nosocomial transmission of infectious diseases, but may inadvertently lead to patient neglect and errors. Objective To examine the quality of medical care received by patients isolated for infection control. Design, Setting, and Patients We identified consecutive adults who were isolated for methicillin-resistant Staphylococcus aureus colonization or infection at 2 large North American teaching hospitals: a general cohort (patients admitted with all diagnoses between January 1, 1999, and January 1, 2000; n = 78); and a disease-specific cohort (patients admitted with a diagnosis of congestive heart failure between January 1, 1999, and July 1, 2002; n = 72). Two matched controls were selected for each isolated patient (n = 156 general cohort controls and n = 144 disease-specific cohort controls). Main Outcome Measures Quality-of-care measures encompassing processes, outcomes, and satisfaction. Adjustments for study cohort and patient demographic, hospital, and clinical characteristics were conducted using multivariable regression. Results Isolated and control patients generally had similar baseline characteristics; however, isolated patients were twice as likely as control patients to experience adverse events during their hospitalization (31 vs 15 adverse events per 1000 days; P<.001). This difference in adverse events reflected preventable events (20 vs 3 adverse events per 1000 days; P<.001) as opposed to nonpreventable events (11 vs 12 adverse events per 1000 days; P=.98). Isolated patients were also more likely to formally complain to the hospital about their care than control patients (8% vs 1%; P<.001), to have their vital signs not recorded as ordered (51% vs 31%; P<.001), and more likely to have days with no physician progress note (26% vs 13%; P<.001). No differences in hospital mortality were observed for the 2 groups (17% vs 10%; P=16). Conclusion Compared with controls, patients isolated for infection control precautions experience more preventable adverse events, express greater dissatisfaction with their treatment, and have less documented care.	Brigham & Womens Hosp, Div Gen Med, Boston, MA 02120 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON, Canada; Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; Partners HealthCare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Partners Healthcare System	Stelfox, HT (corresponding author), Brigham & Womens Hosp, Div Gen Med, 1620 Tremont St, Boston, MA 02120 USA.	stelfox@fas.harvard.edu		Stelfox, Henry/0000-0003-1231-1490	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS011534] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Brown L H, 1997, Prehosp Emerg Care, V1, P145, DOI 10.1080/10903129708958808; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Centers for Disease Control and Prevention, SEV AC RESP SYNDR SA; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Gawande AA, 2003, NEW ENGL J MED, V348, P229, DOI 10.1056/NEJMsa021721; Harvard Medical Practice study, 1990, PAT DOCT LAW STUD ME, VI; HICKSON G, 1997, LAW CONTEMP PROBL, V27, P8; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; HIGGINS L, 2001, J GEN INTERN MED S1, V16, P200; Kirkland KB, 1999, LANCET, V354, P1177, DOI 10.1016/S0140-6736(99)04196-3; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Knowles H E, 1993, Nurs Times, V89, P53; Kohn L, 2000, ERR IS HUMAN BUILDIN; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krumholz HM, 2000, CIRCULATION, V101, pE122, DOI 10.1161/01.CIR.101.12.e122; Krumholz HM, 2000, CIRCULATION, V101, P1483; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Montecalvo MA, 1999, ANN INTERN MED, V131, P269, DOI 10.7326/0003-4819-131-4-199908170-00006; Nettleman M D, 1994, Clin Perform Qual Health Care, V2, P67; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; Ostrowsky BE, 2001, NEW ENGL J MED, V344, P1427, DOI 10.1056/NEJM200105103441903; Peel RK, 1997, BRIT MED J, V315, P58; Perrow C., 1984, NORMAL ACCIDENTS LIV; Pichert J W, 1999, Jt Comm J Qual Improv, V25, P288; Reason J, 1997, MANAGING RISKS ORG A; Reason J., 1990, HUMAN ERROR; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Sobie J M, 2000, J Emerg Nurs, V26, P549, DOI 10.1067/men.2000.110891; Teare EL, 1997, BRIT MED J, V314, P665, DOI 10.1136/bmj.314.7081.665; WEICK KE, 1987, CALIF MANAGE REV, V29, P112, DOI 10.2307/41165243; World Health Organization, HOSP INF CONTR GUID; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	404	405	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2003	290	14					1899	1905		10.1001/jama.290.14.1899	http://dx.doi.org/10.1001/jama.290.14.1899			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729CB	14532319	Bronze			2022-12-01	WOS:000185752600031
J	Kmietowicz, Z				Kmietowicz, Z			Information for patients: Getting professional help	BRITISH MEDICAL JOURNAL			English	Article									BMJ Publishing Grp, London WC1H 9JR, England	BMJ Publishing Group Ltd	Kmietowicz, Z (corresponding author), BMJ Publishing Grp, London WC1H 9JR, England.								0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1396	1396		10.1136/bmj.327.7428.1396	http://dx.doi.org/10.1136/bmj.327.7428.1396			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670891	Green Published			2022-12-01	WOS:000187417900029
J	Birnbaum, K; Shasha, DE; Wang, JY; Jung, JW; Lambert, GM; Galbraith, DW; Benfey, PN				Birnbaum, K; Shasha, DE; Wang, JY; Jung, JW; Lambert, GM; Galbraith, DW; Benfey, PN			A gene expression map of the Arabidopsis root	SCIENCE			English	Article							LASER CAPTURE MICRODISSECTION; COMPUTATIONAL ANALYSIS; CHROMOSOMAL DOMAINS; DIFFERENTIATION; REVEALS; PHLOEM; CELLS	A global map of gene expression within an organ can identify genes with coordinated expression in localized domains, thereby relating gene activity to cell fate and tissue specialization. Here, we present localization of expression of more than 22,000 genes in the Arabidopsis root. Gene expression was mapped to 15 different zones of the root that correspond to cell types and tissues at progressive developmental stages. Patterns of gene expression traverse traditional anatomical boundaries and show cassettes of hormonal response. Chromosomal clustering defined some coregulated genes. This expression map correlates groups of genes to specific cell fates and should serve to guide reverse genetics.	Duke Univ, Dept Biol, Durham, NC 27708 USA; NYU, Dept Biol, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	Duke University; New York University; New York University; University of Arizona	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Box 91000, Durham, NC 27708 USA.		Galbraith, David/AAG-8891-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020716] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 F32 GM20716-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano T, 2002, PLANT J, V32, P401, DOI 10.1046/j.1365-313X.2002.01423.x; BENFEY PN, 1994, TRENDS GENET, V10, P84, DOI 10.1016/0168-9525(94)90230-5; Berleth T, 2000, CURR OPIN PLANT BIOL, V3, P406, DOI 10.1016/S1369-5266(00)00104-7; BIRNBAUM K, UNPUB; BONKE M, IN PRESS NATURE; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lin Y, 2001, DEVELOPMENT, V128, P3697; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Milioni D, 2002, PLANT CELL, V14, P2813, DOI 10.1105/tpc.005231; Murdock LL, 2002, J AGR FOOD CHEM, V50, P6605, DOI 10.1021/jf020192c; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	21	920	957	6	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1956	1960		10.1126/science.1090022	http://dx.doi.org/10.1126/science.1090022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671301				2022-12-01	WOS:000187174000058
J	Gunjan, A; Verreault, A				Gunjan, A; Verreault, A			A Rad53 kinase-dependent surveillsnce mechanism 3that regulates histone protein levels6 in S. cerevisiae	CELL			English	Article							STALLED REPLICATION FORKS; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PATHWAYS; PHASE CHECKPOINT; BUDDING YEAST; MESSENGER-RNA; CHROMATIN; DAMAGE; PROGRESSION	Rad53 and Mec1 are protein kinases required for DNA replication and recovery from DNA damage in Saccharomyces cerevisiae. Here, we show that rad53, but not mec1 mutants, are extremely sensitive to histone overexpression, as Rad53 is required for degradation of excess histones. Consequently, excess histones accumulate in rad53 mutants, resulting in slow growth, DNA damage sensitivity, and chromosome loss phenotypes that are significantly suppressed by a reduction in histone gene dosage. Rad53 monitors excess histones by associating with them in a dynamic complex that is modulated by its kinase activity. Our results argue that Rad53 contributes to genome stability independently of Mec1 by preventing the damaging effects of excess histones both during normal cell cycle progression and in response to DNA damage.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Verreault, A (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.			Gunjan, Akash/0000-0001-8478-3978				Berloco M, 2001, P NATL ACAD SCI USA, V98, P12126, DOI 10.1073/pnas.211428798; BONNER WM, 1988, BIOCHEMISTRY-US, V27, P6542, DOI 10.1021/bi00417a052; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Fay DS, 1997, CURR GENET, V31, P97, DOI 10.1007/s002940050181; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HAAS A, 1990, J BIOL CHEM, V265, P21664; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Holmes SG, 2001, YEAST, V18, P291, DOI 10.1002/1097-0061(20010315)18:4<291::AID-YEA668>3.0.CO;2-V; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Klein HL, 2001, GENETICS, V159, P1501; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Melo JA, 2001, GENE DEV, V15, P2809; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PICKART CM, 1988, J BIOL CHEM, V263, P15076; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Steger DJ, 1999, METHODS, V19, P410, DOI 10.1006/meth.1999.0877; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Sutton A, 2001, GENETICS, V158, P587; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Beekvelt CA, 2001, NUCLEIC ACIDS RES, V29, P5001, DOI 10.1093/nar/29.24.5001; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	47	237	242	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					537	549		10.1016/S0092-8674(03)00896-1	http://dx.doi.org/10.1016/S0092-8674(03)00896-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651846	Bronze			2022-12-01	WOS:000186885600005
J	Wilcock, GK				Wilcock, GK			Dementia with Lewy bodies	LANCET			English	Editorial Material							INTERNATIONAL WORKSHOP; CONSENSUS CRITERIA; ALZHEIMERS-DISEASE; POPULATION; DIAGNOSIS; PREVALENCE; OLDER		Univ Bristol, Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England	University of Bristol	Wilcock, GK (corresponding author), Univ Bristol, Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England.							American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; HANSEN L, 1990, NEUROLOGY, V40, P1; McKeith IG, 2000, NEUROLOGY, V54, P1050, DOI 10.1212/WNL.54.5.1050; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; Perry R H, 1989, Lancet, V1, P166; PERRY RH, 1990, J NEUROL SCI, V95, P119, DOI 10.1016/0022-510X(90)90236-G; Rahkonen T, 2003, J NEUROL NEUROSUR PS, V74, P720, DOI 10.1136/jnnp.74.6.720; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Yamada T, 2002, PSYCHIAT CLIN NEUROS, V56, P71, DOI 10.1046/j.1440-1819.2002.00931.x; Yamada T, 2001, PSYCHIAT CLIN NEUROS, V55, P21, DOI 10.1046/j.1440-1819.2001.00779.x	11	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1689	1690		10.1016/S0140-6736(03)14883-0	http://dx.doi.org/10.1016/S0140-6736(03)14883-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643115				2022-12-01	WOS:000186767700005
J	Matamala, R; Gonzalez-Meler, MA; Jastrow, JD; Norby, RJ; Schlesinger, WH				Matamala, R; Gonzalez-Meler, MA; Jastrow, JD; Norby, RJ; Schlesinger, WH			Impacts of fine root turnover on forest NPP and soil C sequestration potential	SCIENCE			English	Article							ELEVATED ATMOSPHERIC CO2; CARBON STORAGE; ECOSYSTEMS; BIOMASS; ENRICHMENT; MORTALITY; DYNAMICS; PATTERNS	Estimates of forest net primary production (NPP) demand accurate estimates of root production and turnover. We assessed root turnover with the use of an isotope tracer in two forest free-air carbon dioxide enrichment experiments. Growth at elevated carbon dioxide did not accelerate root turnover in either the pine or the hardwood forest. Turnover of fine root carbon varied from 1.2 to 9 years, depending on root diameter and dominant tree species. These long turnover times suggest that root production and turnover in forests have been overestimated and that sequestration of anthropogenic atmospheric carbon in forest soils may be lower than currently estimated.	Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Oak Ridge National Laboratory; Duke University	Matamala, R (corresponding author), Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA.		Norby, Richard J/C-1773-2012; Jastrow, Julie D./AAX-1631-2020	Norby, Richard J/0000-0002-0238-9828; Jastrow, Julie D./0000-0001-7069-4560; Gonzalez-Meler, Miquel/0000-0001-5388-7969				ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Ellsworth DS, 1999, PLANT CELL ENVIRON, V22, P461, DOI 10.1046/j.1365-3040.1999.00433.x; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; GRIER CC, 1981, CAN J FOREST RES, V11, P155, DOI 10.1139/x81-021; HENDRICK RL, 1993, NATURE, V361, P59, DOI 10.1038/361059a0; Hendricks JJ, 1997, OECOLOGIA, V112, P300, DOI 10.1007/s004420050312; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; JASTROW JD, UNPUB; Langley JA, 2002, OECOLOGIA, V131, P542, DOI 10.1007/s00442-002-0932-6; Luo YQ, 2003, GLOBAL CHANGE BIOL, V9, P1118, DOI 10.1046/j.1365-2486.2003.00642.x; Matamala R, 2000, GLOB CHANGE BIOL, V6, P967, DOI 10.1046/j.1365-2486.2000.00374.x; MILCHUNAS DG, 1992, ECOLOGY, V73, P593, DOI 10.2307/1940765; Norby RJ, 2002, ECOL APPL, V12, P1261, DOI 10.1890/1051-0761(2002)012[1261:NPPOAC]2.0.CO;2; NORBY RJ, UNPUB; Pataki DE, 2003, BIOSCIENCE, V53, P805, DOI 10.1641/0006-3568(2003)053[0805:TCIEFU]2.0.CO;2; Pritchard SG, 2001, GLOBAL CHANGE BIOL, V7, P829, DOI 10.1046/j.1354-1013.2001.00457.x; SANTANTONIO D, 1987, CAN J FOREST RES, V17, P900, DOI 10.1139/x87-141; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Schoettle A.W., 1994, ECOL BULL, V43, P136, DOI DOI 10.2307/20113137	23	359	408	13	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1385	1387		10.1126/science.1089543	http://dx.doi.org/10.1126/science.1089543			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631037				2022-12-01	WOS:000186683500049
J	Stocking, MA				Stocking, MA			Tropical soils and food security: The next 50 years	SCIENCE			English	Article							QUALITY; FERTILITY; SYSTEMS; EROSION; TOOL	An appreciation of the dynamism of the links between soil resources and society provides a platform for examining food security over the next 50 years. Interventions to reverse declining trends in food security must recognize the variable resilience and sensitivity of major tropical soil types. In most agroecosystems, declining crop yield is exponentially related to loss of soil quality. For the majority smallholder (subsistence) farmers, investments to reverse degradation are primarily driven by private benefit, socially or financially. "Tragedy of the commons" scenarios can be averted by pragmatic local solutions that help farmers to help themselves.	Univ E Anglia, Sch Dev Studies, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Stocking, MA (corresponding author), Univ E Anglia, Sch Dev Studies, Norwich NR4 7TJ, Norfolk, England.							Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; Boardman J, 2003, ENVIRON SCI POLICY, V6, P1, DOI 10.1016/S1462-9011(02)00120-X; Brookfield H., 2001, EXPLORING AGRODIVERS; *CIMMYT, 2003, GLOB WARM THREAT FOO; CROSSON P, 1995, SOIL EROSION ITS ON; Doran J. W., 1996, SSSA SPECIAL PUBLICA, V49; Dorward P, 2003, AGR SYST, V75, P97, DOI 10.1016/S0308-521X(02)00034-3; *FAO COMM WORLD FO, 2001, IMP HIV AIDS FOOD SE; Food and Agriculture Organization of the United Nations (FAO), SPEC PROGR FOOD SEC; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gordon Prain, 1999, BIOL CULTURAL DIVERS; GYASI EA, 2002, CULTIVATING BIODIVER, P245; HHIEMSTRA W, 1992, LET FARMERS JUDGE EX; *INT FOOD POL RES, 2002, REACH SUST FOOD SEC; KAHLHURA F, 2003, AGR BIODIVERSITY SMA; Karlen DL, 2003, GEODERMA, V114, P145, DOI 10.1016/S0016-7061(03)00039-9; KIOME RM, 1995, GLOBAL ENVIRON CHANG, V5, P281, DOI 10.1016/0959-3780(95)00063-T; LAL R, 1994, SOIL EROSION RES MET; Lutz E., 1994, 8 WORLD BANK; Mausback M.J., 1998, SOIL QUALITY AGR SUS, P33; MAZZUCATO V, 2000, TROPICAL RESOURCE MA, V32; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Pretty Jules, 1995, REGENERATING AGR POL; Renwick A, 2002, PHILOS T ROY SOC A, V360, P1721, DOI 10.1098/rsta.2002.1028; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanchez PA, 2003, GEODERMA, V114, P157, DOI 10.1016/S0016-7061(03)00040-5; Scherr S J, 1995, 14 INT FOOD POL RES; Seybold CA, 1998, ADV SOIL S, P387; Stocking M., 1988, Soil Technology, V1, P289, DOI 10.1016/0933-3630(88)90028-1; Stocking M., 2003, ENCY SOIL SCI; Stocking M., 2000, ENV SCI ENV MANAGEME, P287; STOCKING M, 1999, PUBLICATION AGL MISC, P91; STOCKING M, 2002, SUSTAINABLE USE MANA, V1, P178; Stocking M.A., 2001, HDB FIELD ASSESSMENT, DOI [10.4324/9781849776219, DOI 10.4324/9781849776219]; Swift MJ, 1999, NATURE RESOUR, V35, P12; SWIFT MJ, 1998, CARBON NUTR DYNAMICS, P59; Tengberg A, 1998, ADV GEOECOL, V31, P355; Tengberg A, 2001, RESPONSE TO LAND DEGRADATION, P171; TENGBERG A, 1998, EXPT AGR, V34, P55; *UN DEV PROGR, 2001, ANN REP 2001; *UN DEV PROGR, 2003, MILL DEV GOALS; Versteeg MN, 1998, AGR SYST, V56, P269, DOI 10.1016/S0308-521X(97)00041-3; Whitbread AM, 2000, SOIL TILL RES, V54, P63, DOI 10.1016/S0167-1987(99)00112-9; *WORLD FOOD PROGR, WORLD FOOD PROGR GOA; World Health Organization, 1999, WORLD HLTH REP 1999; 2003, DAILY NEWS      0617	46	155	170	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1356	1359		10.1126/science.1088579	http://dx.doi.org/10.1126/science.1088579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631030				2022-12-01	WOS:000186683500040
J	Svensson, M; Gustafsson, F; Galatius, S; Hildebrandt, PR; Atar, D				Svensson, M; Gustafsson, F; Galatius, S; Hildebrandt, PR; Atar, D			Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study	BRITISH MEDICAL JOURNAL			English	Article									Aker Univ Hosp, Div Cardiol, Oslo, Norway; Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark	University of Oslo	Atar, D (corresponding author), Aker Univ Hosp, Div Cardiol, Oslo, Norway.			Gustafsson, Finn/0000-0003-2144-341X				GALATIUS S, 2002, AM HEART J S, V144, pS2; GREENBERG B, 2002, J CARDIOVASC PHARM, V38, P59; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Remme WJ, 2002, EUR J HEART FAIL, V4, P11, DOI 10.1016/S1388-9842(01)00231-8	5	53	58	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 15	2003	327	7424					1141	1142		10.1136/bmj.327.7424.1141	http://dx.doi.org/10.1136/bmj.327.7424.1141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744HL	14615339	Bronze, Green Published			2022-12-01	WOS:000186622100020
J	Kaksonen, M; Sun, Y; Drubin, DG				Kaksonen, M; Sun, Y; Drubin, DG			A pathway for association of receptors, adaptors, and actin during endocytic internalization	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; CLATHRIN-COATED PITS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; IN-VIVO; MEDIATED ENDOCYTOSIS; FILAMENT TURNOVER; ARP2/3 COMPLEX; CYTOSKELETON; DYNAMICS	In budding yeast, many proteins involved in endocytic internalization, including adaptors and actin cytoskeletal proteins, are localized to cortical patches of differing protein composition. Using multicolor real-time fluorescence microscopy and particle tracking algorithms, we define an early endocytic pathway wherein an invariant sequence of changes in cortical patch protein composition correlates with changes in patch motility. Three Arp2/3 activators each showed a distinct behavior, suggesting distinct patch-related endocytic functions. Actin polymerization occurs late in the endocytic pathway and is required both for endocytic internalization and for patch disassembly. In cells lacking the highly conserved endocytic protein Sla2p, patch motility was arrested and actin comet tails associated with endocytic patch complexes. Fluorescence recovery after photobleaching of the actin comet tails revealed that endocytic complexes are nucleation sites for rapid actin polymerization. Attention is now focused on the mechanisms by which the order and timing of events in this endocytic pathway are achieved.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Drubin, DG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall, Berkeley, CA 94720 USA.			Sun, Yidi/0000-0002-2157-1983; Kaksonen, Marko/0000-0003-3645-7689	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042759, R01GM050399, R37GM042759] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50399, GM42759] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Carlsson AE, 2002, BIOPHYS J, V82, P2333, DOI 10.1016/S0006-3495(02)75579-3; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551; Engqvist-Goldstein AEY, 1999, J CELL BIOL, V147, P1503, DOI 10.1083/jcb.147.7.1503; ENGQVISTGOLDSTE.AE, 2003, IN PRESS ANN REV CEL; Geli MI, 1998, J CELL SCI, V111, P1031; Goode BL, 2001, CURR OPIN MICROBIOL, V4, P703, DOI 10.1016/S1369-5274(01)00272-7; Gourlay CW, 2003, J CELL SCI, V116, P2551, DOI 10.1242/jcs.00454; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; Howard JP, 2002, J CELL BIOL, V157, P315, DOI 10.1083/jcb.200110027; KARPOVA TS, 1995, J CELL BIOL, V131, P1483, DOI 10.1083/jcb.131.6.1483; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Mulholland J, 1999, MOL BIOL CELL, V10, P799, DOI 10.1091/mbc.10.3.799; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Smith MG, 2001, J CELL SCI, V114, P1505; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K; Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Warren DT, 2002, J CELL SCI, V115, P1703; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759	44	516	523	4	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					475	487		10.1016/S0092-8674(03)00883-3	http://dx.doi.org/10.1016/S0092-8674(03)00883-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622601	Bronze			2022-12-01	WOS:000186627100013
J	Bonke, M; Thitamadee, S; Mahonen, AP; Hauser, MT; Helariutta, Y				Bonke, M; Thitamadee, S; Mahonen, AP; Hauser, MT; Helariutta, Y			APL regulates vascular tissue identity in Arabidopsis	NATURE			English	Article							RADIAL ORGANIZATION; PATTERN-FORMATION; SIEVE ELEMENTS; ROOT; DIFFERENTIATION; CELL; MORPHOGENESIS; TRAFFICKING; MUTATIONS; PHLOEM	Vascular plants have a long-distance transport system consisting of two tissue types with elongated cell files, phloem and xylem(1). Phloem has two basic cell types, enucleate sieve elements and companion cells. Xylem has various lignified cell types, such as tracheary elements, the differentiation of which involves deposition of elaborate cell wall thickenings and programmed cell death(1-4). Until now, little has been known about the genetic control of phloem-xylem patterning. Here we identify the ALTERED PHLOEM DEVELOPMENT (APL) gene, which encodes a MYB coiled-coil-type transcription factor that is required for phloem identity in Arabidopsis. Phloem is established through asymmetric cell divisions and subsequent differentiation. We show that both processes are impaired by a recessive apl mutation. This is associated with the formation of cells that have xylem characteristics in the position of phloem. The APL expression profile is consistent with a key role in phloem development. Ectopic APL expression in the vascular bundle inhibits xylem development. Our studies suggest that APL has a dual role both in promoting phloem differentiation and in repressing xylem differentiation during vascular development.	Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, FIN-00014 Helsinki, Finland; BOKU Univ Nat Resources & Appl Life Sci Vienna, Ctr Appl Genet, A-1190 Vienna, Austria	University of Helsinki; University of Natural Resources & Life Sciences, Vienna	Helariutta, Y (corresponding author), Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, POB 56, FIN-00014 Helsinki, Finland.		Helariutta, Yrjo/AAE-8149-2020; Mähönen, Ari Pekka/B-9764-2015; Hauser, Marie-Theres/J-6029-2013	Helariutta, Yrjo/0000-0002-7287-8459; Mähönen, Ari Pekka/0000-0001-6051-866X; Hauser, Marie-Theres/0000-0001-8938-2460				ALONI R, 1987, ANNU REV PLANT PHYS, V38, P179, DOI 10.1146/annurev.pp.38.060187.001143; Baum SF, 2002, AM J BOT, V89, P908, DOI 10.3732/ajb.89.6.908; Carland FM, 1999, PLANT CELL, V11, P2123, DOI 10.1105/tpc.11.11.2123; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kuhn C, 1997, SCIENCE, V275, P1298, DOI 10.1126/science.275.5304.1298; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lin Y, 2001, DEVELOPMENT, V128, P3697; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; McCann M, 1997, TRENDS PLANT SCI, V2, P333, DOI 10.1016/S1360-1385(97)84620-1; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Oparka KJ, 1999, PLANT CELL, V11, P739, DOI 10.1105/tpc.11.4.739; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; TORRESRUIZ RA, 1994, DEVELOPMENT, V120, P2967; WAITES R, 1995, DEVELOPMENT, V121, P2143; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; Ye ZH, 2002, ANNU REV PLANT BIOL, V53, P183, DOI 10.1146/annurev.arplant.53.100301.135245; Yoshimura T, 1996, PLANT CELL PHYSIOL, V37, P1167, DOI 10.1093/oxfordjournals.pcp.a029068	25	322	352	7	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					181	186		10.1038/nature02100	http://dx.doi.org/10.1038/nature02100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614507				2022-12-01	WOS:000186517200044
J	Freckleton, RP; Sutherland, WJ; Watkinson, AR				Freckleton, RP; Sutherland, WJ; Watkinson, AR			Deciding the future of GM crops in Europe	SCIENCE			English	Editorial Material							HERBICIDE-TOLERANT CROPS; BIODIVERSITY		Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia; University of East Anglia; University of East Anglia	Freckleton, RP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Freckleton, Rob P/B-6455-2013; Sutherland, William/B-1291-2013; Watkinson, Andrew R/N-1649-2013	Freckleton, Robert/0000-0002-8338-864X; Sutherland, William/0000-0002-6498-0437				Brooks DR, 2003, PHILOS T R SOC B, V358, P1847, DOI 10.1098/rstb.2003.1407; *CAB OFF, 2003, STRAT UN FIELD WORK; Campbell S, 2003, NATURE, V425, P559, DOI 10.1038/425559b; Champion GT, 2003, PHILOS T ROY SOC B, V358, P1801, DOI 10.1098/rstb.2003.1405; Dewar AM, 2003, P ROY SOC B-BIOL SCI, V270, P335, DOI 10.1098/rspb.2002.2248; Firbank LG, 2003, J APPL ECOL, V40, P2, DOI 10.1046/j.1365-2664.2003.00787.x; FRECKLETON RP, IN PRESS P R SOC B; *GM SCI REV PAN, 2003, 1 DEP TRAD IND GM SC; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1833, DOI 10.1098/rstb.2003.1401; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1819, DOI 10.1098/rstb.2003.1402; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Roy DB, 2003, PHILOS T ROY SOC B, V358, P1879, DOI 10.1098/rstb.2003.1404; Squire GR, 2003, PHILOS T R SOC B, V358, P1779, DOI 10.1098/rstb.2003.1403; Watkinson AR, 2000, SCIENCE, V289, P1554, DOI 10.1126/science.289.5484.1554; [No title captured]	17	19	20	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					994	996		10.1126/science.1092671	http://dx.doi.org/10.1126/science.1092671			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605355				2022-12-01	WOS:000186396300030
J	Miller, AI; Foote, M				Miller, AI; Foote, M			Increased longevities of post-Paleozoic marine genera after mass extinctions	SCIENCE			English	Article							TAXONOMIC DIVERSITY; FOSSIL RECORD; END; RECOVERY; ORIGINATION; COMPONENTS; EVOLUTION	Cohorts of marine taxa that originated during recoveries from mass extinctions were commonly more widespread spatially than those originating at other times. Coupled with the recognition of a correlation between the geographic ranges and temporal longevities of marine taxa, this observation predicts that recovery taxa were unusually long-lived geologically. We analyzed this possibility by assessing the longevities of marine genus cohorts that originated in successive substages throughout the Phanerozoic. Results confirm that several mass extinction recovery cohorts were significantly longer lived than other cohorts, but this effect was limited to the post-Paleozoic, suggesting differences in the dynamics of Paleozoic versus post-Paleozoic diversification.	Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Cincinnati; University of Chicago	Miller, AI (corresponding author), Univ Cincinnati, Dept Geol, POB 210013, Cincinnati, OH 45221 USA.							Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Droser ML, 2000, GEOLOGY, V28, P675, DOI 10.1130/0091-7613(2000)28<675:DOTAES>2.0.CO;2; Erwin DH, 1998, SCIENCE, V279, P1324, DOI 10.1126/science.279.5355.1324; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kirchner JW, 2002, NATURE, V415, P65, DOI 10.1038/415065a; MARKOV AV, 2002, PALEONTOL J, V36, P121; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; RAUP DM, 1985, PALEOBIOLOGY, V11, P42, DOI 10.1017/S0094837300011386; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; RAUP DM, 1991, PALEOBIOLOGY, V17, P37, DOI 10.1017/S0094837300010332; Rodland DL, 2001, PALAIOS, V16, P95, DOI 10.2307/3515554; SCHUBERT JK, 1992, GEOLOGY, V20, P883, DOI 10.1130/0091-7613(1992)020<0883:ETSAPM>2.3.CO;2; Sepkoski, 2002, B AM PALEONTOL, V363, P1; SHEEHAN P M, 1975, Paleobiology, V1, P205; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318	25	41	44	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1030	1032		10.1126/science.1089719	http://dx.doi.org/10.1126/science.1089719			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605366				2022-12-01	WOS:000186396300043
J	Goldfine, AB; Kahn, CR				Goldfine, AB; Kahn, CR			Adiponectin: linking the fat cell to insulin sensitivity	LANCET			English	Editorial Material							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; RESISTANCE; OXIDATION; GENE		Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.	C.Ronald.Kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Goldfine, Allison/0000-0002-0345-1048				Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mora S, 2002, DIABETES-METAB RES, V18, P345, DOI 10.1002/dmrr.321; Musi N, 2003, BIOCHEM SOC T, V31, P191, DOI 10.1042/bst0310191; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Ukkola O, 2003, METABOLISM, V52, P881, DOI 10.1016/S0026-0495(03)00074-X; Vasseur F, 2003, INT CONGR SER, V1253, P37, DOI 10.1007/s11892-003-0039-4; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	19	89	94	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2003	362	9394					1431	1432		10.1016/S0140-6736(03)14727-7	http://dx.doi.org/10.1016/S0140-6736(03)14727-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602433				2022-12-01	WOS:000186356600005
J	Thompson, T; Barbour, R; Schwartz, L				Thompson, T; Barbour, R; Schwartz, L			Adherence to advance directives in critical care decision making: vignette study	BRITISH MEDICAL JOURNAL			English	Article							PROFESSIONALS; ATTITUDES; VIEWS	Objective To explore health professionals' decision making in a critical care scenario when there is an advance directive. Design Qualitative study. Setting Scotland. Participants Interviewees (n = 12) comprising general practitioners, hospital specialists, and nurses, and six focus groups (n = 34 participants) comprising general practitioners, geriatricians (consultants and specialist registrars), hospital nurses, and hospice nurses. Results When presented with an advance directive that applied to the same hypothetical scenario, health professionals came to divergent conclusions as to the "right thing to do' " Arguments opposing treatment centred on the supremacy of autonomy as an ethical principle. Other arguments were that the decision to treat was consistent with the terms of the advance directive, or that, notwithstanding the advance directive, the patients quality of life was sufficient to warrant treatment. Conclusion Advance directives are open to widely varying interpretation. Some of this variability is related to the ambiguity of the directive's terminology whereas some is related to the willingness of health professionals to make subjective value judgments concerning quality of life.	Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Dundee, Sch Nursing & Midwifery, Dundee DD1 4HJ, Scotland; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ Glasgow, Dept Gen Practice, Glasgow G12 8QQ, Lanark, Scotland	University of Bristol; University of Dundee; McMaster University; University of Glasgow	Thompson, T (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.			Schwartz, Lisa/0000-0002-4959-225X				Barbour RS, 2000, FAM PRACT, V17, P83, DOI 10.1093/fampra/17.1.83; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; *BRIT MED ASS, 1999, WITHH WITHDR LIF PRO; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; Collins K, 1999, BRIT J GEN PRACT, V49, P641; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; DAVIDSON KW, 1989, JAMA-J AM MED ASSOC, V262, P2415, DOI 10.1001/jama.262.17.2415; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Docker C, 2000, BMJ-BRIT MED J, V320, P54; DOWNIE RS, 2000, CLIN JUDGEMENT; DOWNIE RS, 1994, HLTH RESPECT, P51; DOWNIE RS, 1994, HLTH RESPECT, P141; Hojat M, 2001, ACAD MED, V76, P669, DOI 10.1097/00001888-200107000-00001; *HOUS LORDS, 1994, REP SEL COMM MED ETH, V1, P54; Ikonomidis S, 1999, J MED ETHICS, V25, P522, DOI 10.1136/jme.25.6.522; KELNER M, 1993, CAN MED ASSOC J, V148, P1331; Mallik M, 1997, J ADV NURS, V25, P130, DOI 10.1046/j.1365-2648.1997.1997025130.x; MCLEAN S, 2000, ETHICS LAW INTENSIVE, P68; MUHR T, 1997, ATLAS SHORT USERS GU; NEUBERGER J, 1999, DYING WELL GUIDE ENA; Ritchie Jane., 2002, ANAL QUALITATIVE DAT, P187, DOI DOI 10.4324/9780203413081_CHAPTER_9; SOMMERVILLE A, 1995, BRIT MED J, V310, P1663; Swartz R, 1998, Adv Ren Replace Ther, V5, P109; Thompson TDB, 2003, PALLIATIVE MED, V17, P403, DOI 10.1191/0269216303pm784oa	24	60	60	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2003	327	7422					1011	1014		10.1136/bmj.327.7422.1011	http://dx.doi.org/10.1136/bmj.327.7422.1011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738NE	14593032	Bronze, Green Published			2022-12-01	WOS:000186294100016
J	Collins, NC; Thordal-Christensen, H; Lipka, V; Bau, S; Kombrink, E; Qiu, JL; Huckelhoven, R; Stein, M; Freialdenhoven, A; Somerville, SC; Schulze-Lefert, P				Collins, NC; Thordal-Christensen, H; Lipka, V; Bau, S; Kombrink, E; Qiu, JL; Huckelhoven, R; Stein, M; Freialdenhoven, A; Somerville, SC; Schulze-Lefert, P			SNARE-protein-mediated disease resistance at the plant cell wall	NATURE			English	Article							POWDERY MILDEW FUNGUS; PAPILLA FORMATION; BARLEY; COMPLEX; GENES; SPECIFICITY; IDENTIFICATION; SYNTAXIN; FUSION; HORDEI	Failure of pathogenic fungi to breach the plant cell wall constitutes a major component of immunity of non-host plant species species outside the pathogen host range - and accounts for a proportion of aborted infection attempts on 'susceptible' host plants (basal resistance)(1-4). Neither form of penetration resistance is understood at the molecular level. We developed a screen for penetration ( pen) mutants of Arabidopsis, which are disabled in non-host penetration resistance against barley powdery mildew, Blumeria graminis f. sp. hordei, and we isolated the PEN1 gene. We also isolated barley ROR2 (ref. 2), which is required for basal penetration resistance against B. g. hordei. The genes encode functionally homologous syntaxins, demonstrating a mechanistic link between non-host resistance and basal penetration resistance in monocotyledons and dicotyledons. We show that resistance in barley requires a SNAP-25 (synaptosome-associated protein, molecular mass 25 kDa) homologue capable of forming a binary SNAP receptor ( SNARE) complex with ROR2. Genetic control of vesicle behaviour at penetration sites, and plasma membrane location of PEN1/ROR2, is consistent with a proposed involvement of SNARE-complex-mediated exocytosis and/or homotypic vesicle fusion events in resistance. Functions associated with SNARE-dependent penetration resistance are dispensable for immunity mediated by race-specific resistance (R) genes, highlighting fundamental differences between these two resistance forms.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Riso Natl Lab, Plant Res Dept, DK-4000 Roskilde, Denmark; Univ Giessen, Inst Phytopathol & Appl Zool, D-35392 Giessen, Germany; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA	Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Technical University of Denmark; Justus Liebig University Giessen; Carnegie Institution for Science	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.		Schulze-Lefert, Paul/B-6707-2011; Bruening, Stefan/B-8505-2011; Thordal-Christensen, Hans/F-6281-2014; Schulze-Lefert, Paul/A-7746-2008; Huckelhoven, Ralph/H-6676-2013; Lipka, Volker/C-5874-2009	Thordal-Christensen, Hans/0000-0001-8813-0157; Huckelhoven, Ralph/0000-0001-5632-5451; Qiu, Jin-Long/0000-0001-8054-2552; Stein, Monica/0000-0002-1926-4212				Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Betz WJ, 2000, NAT NEUROSCI, V3, P636, DOI 10.1038/76579; Blatt MR, 2002, NEW PHYTOL, V153, P405, DOI 10.1046/j.0028-646X.2001.00341.x; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hoogkamp TJH, 1998, PHYTOPATHOLOGY, V88, P856, DOI 10.1094/PHYTO.1998.88.8.856; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JOHNSON LEB, 1982, CAN J BOT, V60, P1068, DOI 10.1139/b82-137; KOGA H, 1990, CAN J BOT, V68, P2344, DOI 10.1139/b90-299; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; SNYDER BA, 1990, SCIENCE, V248, P1637, DOI 10.1126/science.248.4963.1637; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Yu Y, 2000, THEOR APPL GENET, V101, P1093, DOI 10.1007/s001220051584	24	694	732	4	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					973	977		10.1038/nature02076	http://dx.doi.org/10.1038/nature02076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586469				2022-12-01	WOS:000186230600044
J	Horne-Badovinac, S; Rebagliati, M; Stainier, DYR				Horne-Badovinac, S; Rebagliati, M; Stainier, DYR			A cellular framework for gut-looping morphogenesis in zebrafish	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; RIGHT AXIS FORMATION; ENDODERM FORMATION; HEART; PATHWAYS; PROTEIN; GENES; LIVER; ROLES; SOUL	Many vertebrate organs adopt asymmetric positions with respect to the midline, but little is known about the cellular changes and tissue movements that occur downstream of left-right gene expression to produce this asymmetry. Here, we provide evidence that the looping of the zebrafish gut results from the asymmetric migration of the neighboring lateral plate mesoderm (LPM). Mutations that disrupt the epithelial structure of the LPM perturb this asymmetric migration and inhibit gut looping. Asymmetric LPM migration still occurs when the endoderm is ablated from the gut-looping region, suggesting that the LPM can autonomously provide a motive force for gut displacement. Finally, reducing left-sided Nodal activity randomizes the pattern of LPM migration and gut looping. These results reveal a cellular framework for the regulation of organ laterality by asymmetrically expressed genes.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026				Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Burdine RD, 2000, GENE DEV, V14, P763; Campione M, 1999, DEVELOPMENT, V126, P1225; Chen JN, 1997, DEVELOPMENT, V124, P4373; Chin AJ, 2000, DEV BIOL, V227, P403, DOI 10.1006/dbio.2000.9924; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Kikuchi Y, 2000, GENE DEV, V14, P1279; Liang JO, 2000, DEVELOPMENT, V127, P5101; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527	21	105	108	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					662	665		10.1126/science.1085397	http://dx.doi.org/10.1126/science.1085397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576439				2022-12-01	WOS:000186119900064
J	Victora, CG; Barros, FC; Lima, RC; Horta, BL; Wells, J				Victora, CG; Barros, FC; Lima, RC; Horta, BL; Wells, J			Anthropometry and body composition of 18 year old men according to duration of breast feeding: birth cohort study from Brazil	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OVERWEIGHT	Objective To assess the association between duration of breast feeding and measures of adiposity in adolescence. Design Population based birth cohort study. Setting Pelotas, a city of 320 000 inhabitants in a relatively developed area in southern Brazil. Participants All newborn infants in the city's hospitals were enrolled in 1982; 78.8% (2250) of all male participants were located at age 18 years when enrolling in the national army. Main outcome measures Weight, height, sitting height, subscapular and triceps skinfolds, and body composition (body fat, lean mass). Results Neither the duration of total breast feeding nor that of predominant breast feeding (breast milk plus non-nutritive fluids) showed consistent associations with anthropometric or body composition indices. After adjustment for confounding factors, the only significant associations were a greater than 50% reduction in obesity among participants breast fed for three to five months compared with all other breastfeeding categories (P = 0.007) and a linear decreasing trend in obesity with increasing duration of predominant breast feeding (P = 0.03). Similar significant effects were not observed for other measures of adiposity. Borderline direct associations also occurred between total duration of breast feeding and adult height (P = 0.06). Conclusions The significant reduction in obesity among children breast fed for three to five months is difficult to interpret, as no a priori hypothesis existed regarding a protective effect of intermediate duration of breast feeding. The findings indicate that, in this population, breast feeding has no marked protective effect against adolescent adiposity.	Univ Fed Pelotas, Post Grad Programme Epidemiol, BR-96001970 Pelotas, RS, Brazil; PAHO WHO, Latin Amer Ctr Perinatol & Human Dev, Montevideo, Uruguay; Univ Catolica Pelotas, Fac Med, Pelotas, RS, Brazil; Univ London, Inst Child Hlth, London WC1N 1EH, England	Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; University of London; University College London	Victora, CG (corresponding author), Univ Fed Pelotas, Post Grad Programme Epidemiol, CP 464, BR-96001970 Pelotas, RS, Brazil.	cvictora@terra.com.br	Victora, Cesar G/D-4476-2013; Barros, Fernando C/D-4857-2013; Victora, Cesar Gomes/Y-2455-2019; Wells, Jonathan/A-4604-2009; Horta, Bernardo/A-7604-2008	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Wells, Jonathan/0000-0003-0411-8025; Horta, Bernardo/0000-0001-9843-412X				BARROS FC, 1990, PAEDIATR PERINAT EP, V4, P267; Beral V, 2003, LANCET, V361, P177, DOI 10.1016/S0140-6736(03)12209-X; BLOCK G, 1989, J NUTR EDUC, V21, P199; Butte NE, 2001, PEDIATR CLIN N AM, V48, P189, DOI 10.1016/S0031-3955(05)70293-5; Dewey Kathryn G, 2003, J Hum Lact, V19, P9; Dietz WH, 2001, JAMA-J AM MED ASSOC, V285, P2506, DOI 10.1001/jama.285.19.2506; Elliott KG, 1997, OBES RES, V5, P538, DOI 10.1002/j.1550-8528.1997.tb00574.x; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; Hediger ML, 2001, JAMA-J AM MED ASSOC, V285, P2453, DOI 10.1001/jama.285.19.2453; KRAMER MS, 1981, J PEDIATR-US, V98, P883, DOI 10.1016/S0022-3476(81)80579-3; Tulldahl J, 1999, OBES RES, V7, P431, DOI 10.1002/j.1550-8528.1999.tb00430.x; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; VICTORA CG, 2003, IN PRESS CAD SAUDE P; *WHO DIV DIARRH AC, 1991, IND ASS BREAST FEED; *WHO EXP COMM NUTR, 1995, WHO TECHN REP SER, V854	15	99	110	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2003	327	7420					901	904		10.1136/bmj.327.7420.901	http://dx.doi.org/10.1136/bmj.327.7420.901			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734RV	14563746	Bronze, Green Published			2022-12-01	WOS:000186072100018
J	Hu, QD; Ang, BT; Karsak, M; Hu, WP; Cui, XY; Duka, T; Takeda, Y; Chia, W; Sankar, N; Ng, YK; Ling, EA; Maciag, T; Small, D; Trifonova, R; Kopan, R; Okano, H; Nakafuku, M; Chiba, S; Hirai, H; Aster, JC; Schachner, M; Pallen, CJ; Watanabe, K; Xiao, ZC				Hu, QD; Ang, BT; Karsak, M; Hu, WP; Cui, XY; Duka, T; Takeda, Y; Chia, W; Sankar, N; Ng, YK; Ling, EA; Maciag, T; Small, D; Trifonova, R; Kopan, R; Okano, H; Nakafuku, M; Chiba, S; Hirai, H; Aster, JC; Schachner, M; Pallen, CJ; Watanabe, K; Xiao, ZC			F3/contactin acts as a functional ligand for notch during oligodendrocyte maturation	CELL			English	Article							ADHESION MOLECULE; NEURITE OUTGROWTH; FYN KINASE; RECEPTOR; EXPRESSION; CELLS; CONTACTIN; MOUSE; DIFFERENTIATION; F3	Axon-derived molecules are temporally and spatially required as positive or negative signals to coordinate oligodendrocyte differentiation. Increasing evidence suggests that, in addition to the inhibitory Jagged1/ Notch1 signaling cascade, other pathways act via Notch to mediate oligodendrocyte differentiation. The GPI-linked neural cell recognition molecule F3/contactin is clustered during development at the paranodal region, a vital site for axoglial interaction. Here, we show that F3/contactin acts as a functional ligand of Notch. This trans-extracellular interaction triggers gamma-secre-tase-dependent nuclear translocation of the Notch intracellular domain. F3/Notch signaling promotes oligodendrocyte precursor cell differentiation and upregulates the myelin-related protein MAG in OLN-93 cells. This can be blocked by dominant negative Notch1, Notch2, and two Deltex1 mutants lacking the RING-H2 finger motif, but not by dominant-negative RBP-J or Hes1 antisense oligonucleotides. Expression of constitutively active Notch1 or Notch2 does not upregulate MAG. Thus, F3/contactin specifically initiates a Notch/Deltex1 signaling pathway that promotes oligodendrocyte maturation and myelination.	Tokyo Metropolitan Inst Gerontol, Dept Cell Recognit, Tokyo 1730015, Japan; Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore; Natl Univ Singapore, Dept Anat, Singapore 117597, Singapore; Natl Inst Neurosci, Dept Neurosurg, Singapore 306433, Singapore; Univ Hamburg, Zentrum Mol Neurobiol, D-20251 Hamburg, Germany; Singapore Gen Hosp, Dept Obstet & Gynecol, Singapore 169608, Singapore; Natl Canc Ctr, Singapore 169610, Singapore; Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04469 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Div Dermatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; Univ Tokyo, Dept Cell Therapy Transplantat Med & Hematol, Tokyo 1138655, Japan; Univ Tokyo, Dept Oncol, Tokyo 1138655, Japan; Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 1M9, Canada	Tokyo Metropolitan Institute of Gerontology; Singapore General Hospital; National University of Singapore; National Neuroscience Institute (NNI); University of Hamburg; University Medical Center Hamburg-Eppendorf; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Maine Medical Center; Washington University (WUSTL); Washington University (WUSTL); Keio University; University of Tokyo; University of Tokyo; University of Tokyo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of British Columbia	Xiao, ZC (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Cell Recognit, Tokyo 1730015, Japan.		Okano, Hideyuki/I-7584-2019; Kopan, Raphael/AAF-1357-2022; xiao, zhicheng/A-1529-2011; Nakafuku, Masato/J-3068-2013; Kopan, Raphael/AFG-3275-2022	Kopan, Raphael/0000-0002-0350-2730; Pallen, Catherine/0000-0002-3576-5295; Nakafuku, Masato/0000-0001-7783-9005	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032348, R01HL035627] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 15555] Funding Source: Medline; NHLBI NIH HHS [HL32348, HL35627] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; BOGLER O, 1997, CURRENT PROTOCOLS NE, DOI UNSP 3.4.1-3.4.9; COLELLO RJ, 1998, CURRENT PROTOCOLS NE, DOI UNSP 3.12.7-3.12.10; Dale JK, 2003, BIOESSAYS, V25, P200, DOI 10.1002/bies.10253; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.0.CO;2-N; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Girault JA, 2002, CURR OPIN NEUROBIOL, V12, P476, DOI 10.1016/S0959-4388(02)00370-7; HEMANN C, 1994, DNA CELL BIOL, V13, P437, DOI 10.1089/dna.1994.13.437; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holm J, 1996, EUR J NEUROSCI, V8, P1613, DOI 10.1111/j.1460-9568.1996.tb01306.x; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jack C, 2001, MOL BRAIN RES, V87, P166, DOI 10.1016/S0169-328X(01)00010-9; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kabos P, 2002, J BIOL CHEM, V277, P8763, DOI 10.1074/jbc.C100758200; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kato H, 1997, DEVELOPMENT, V124, P4133; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kishi N, 2001, INT J DEV NEUROSCI, V19, P21, DOI 10.1016/S0736-5748(00)00071-X; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Koch T, 1997, GLIA, V19, P199, DOI 10.1002/(SICI)1098-1136(199703)19:3<199::AID-GLIA3>3.0.CO;2-V; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Matsuno K, 2002, DEVELOPMENT, V129, P1049; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Revest JM, 1999, ADV EXP MED BIOL, V468, P309; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shimazaki K, 1998, NEUROSCI LETT, V245, P117, DOI 10.1016/S0304-3940(98)00179-7; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; TSIOTRA PC, 1993, GENOMICS, V18, P562, DOI 10.1016/S0888-7543(05)80357-X; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707	44	289	302	3	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 17	2003	115	2					163	175		10.1016/S0092-8674(03)00810-9	http://dx.doi.org/10.1016/S0092-8674(03)00810-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567914	Bronze			2022-12-01	WOS:000186039200008
J	Biju, SD; Bossuyt, F				Biju, SD; Bossuyt, F			New frog family from India reveals an ancient biogeographical link with the Seychelles	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MADAGASCAN; AMPHIBIA	About 96% of the more than 4,800 living anuran species(1) belong to the Neobatrachia or advanced frogs(2-4). Because of the extremely poor representation of these animals in the Mesozoic fossil record, hypotheses on their early evolution have to rely largely on extant taxa(5-7). Here we report the discovery of a burrowing frog from India that is noticeably distinct from known taxa in all anuran families. Phylogenetic analyses of 2.8 kilobases of mitochondrial and nuclear DNA unambiguously designate this frog as the sister taxon of Sooglossidae, a family exclusively occurring on two granitic islands of the Seychelles archipelago(8). Furthermore, molecular clock analyses(9) uncover the branch leading to both taxa as an ancient split in the crown-group Neobatrachia. Our discovery discloses a lineage that may have been more diverse on Indo-Madagascar in the Cretaceous period, but now only comprises four species on the Seychelles and a sole survivor in India. Because of its very distinct morphology and an inferred origin that is earlier than several neobatrachian families(10), we recognize this frog as a new family.	Free Univ Brussels, Dept Biol, Unit Ecol & Systemat, B-1050 Brussels, Belgium; Trop Bot Garden & Res Inst, Thiruvananthapuram 695562, Kerala, India	Universite Libre de Bruxelles; Vrije Universiteit Brussel; KSCSTE-Jawaharlal Nehru Tropical Botanic Garden & Research Institute (JNTBGRI)	Bossuyt, F (corresponding author), Free Univ Brussels, Dept Biol, Unit Ecol & Systemat, Pleinlaan 2, B-1050 Brussels, Belgium.	fbossuyt@vub.ac.be		Bossuyt, Franky/0000-0001-6804-9271				Avise JC, 1999, P NATL ACAD SCI USA, V96, P7358, DOI 10.1073/pnas.96.13.7358; BENTON MJ, 1997, VERTEBRATE PALAEONTO, P1; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; COFFIN MF, 1992, AAPG MEMOIR, V53, P207; Duellman WE, 1986, BIOL AMPHIBIANS, P1; Feller AE, 1998, MOL PHYLOGENET EVOL, V9, P509, DOI 10.1006/mpev.1998.0500; Ford Linda S., 1993, Herpetological Monographs, V7, P94, DOI 10.2307/1466954; FROST DR, 2002, AMPHIBIAN SPECIES WO; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; HAY JM, 1995, MOL BIOL EVOL, V12, P928; Hay WW, 1999, GEOL S AM S, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Krause DW, 2001, NATURE, V412, P497, DOI 10.1038/35087649; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Lemmon AR, 2002, P NATL ACAD SCI USA, V99, P10516, DOI 10.1073/pnas.162224399; Lynch J. D., 1971, Misc Publs Mus nat Hist Univ Kansas, VNo. 53, P1; NUSSBAUM RA, 1980, HERPETOLOGICA, V36, P1; NUSSBAUM RA, 1979, CARYOLOGIA, V32, P279, DOI 10.1080/00087114.1979.10796793; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruvinsky I, 1996, MOL PHYLOGENET EVOL, V5, P533, DOI 10.1006/mpev.1996.0048; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; SPINAR Z V, 1985, Amphibia-Reptilia, V6, P363, DOI 10.1163/156853885X00353; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; TYLER MJ, 1985, HERPETOLOGICA, V41, P173; Wilkinson M, 2002, MOL PHYLOGENET EVOL, V23, P401, DOI 10.1016/S1055-7903(02)00031-3	28	246	267	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2003	425	6959					711	714		10.1038/nature02019	http://dx.doi.org/10.1038/nature02019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562102				2022-12-01	WOS:000185924500040
J	Peter, BJ; Kent, HM; Mills, IG; Vallis, Y; Butler, PJG; Evans, PR; McMahon, HT				Peter, BJ; Kent, HM; Mills, IG; Vallis, Y; Butler, PJG; Evans, PR; McMahon, HT			BAR domains as sensors of membrane curvature: The amphiphysin BAR structure	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEIN; SYNAPTIC VESICLE ENDOCYTOSIS; CLATHRIN-MEDIATED ENDOCYTOSIS; ADP-RIBOSYLATION FACTORS; ACTIN CYTOSKELETON; DROSOPHILA AMPHIPHYSIN; LYSOPHOSPHATIDIC ACID; TERMINAL DOMAIN; SH3 DOMAIN; BINDING	The BAR (Bin/amphiphysin/Rvs) domain is the most conserved feature in amphiphysins from yeast to human and is also found in endophilins and nadrins. We solved the structure of the Drosophila amphiphysin BAR domain. It is a crescent-shaped dimer that binds preferentially to highly curved negatively charged membranes. With its N-terminal amphipathic helix and BAR domain (N-BAR), amphiphysin can drive membrane curvature in vitro and in vivo. The structure is similar to that of arfaptin2, which we find also binds and tubulates membranes. From this, we predict that BAR domains are in many protein families, including sorting nexins, centaurins, and oligophrenins. The universal and minimal BAR domain is a dimerization, membrane-binding, and curvature-sensing module.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Evans, PR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	pre@mrc-lmb.cam.ac.uk; hmm@mrc-lmb.cam.ac.uk	Mills, Ian/AAK-9292-2020; Peter, Brian/AAZ-7323-2020	Mills, Ian/0000-0001-5347-5083; 				Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Billuart P, 1998, PATHOL BIOL, V46, P678; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Harada A, 2000, J BIOL CHEM, V275, P36885, DOI 10.1074/jbc.M004069200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leventis PA, 2001, TRAFFIC, V2, P839; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; PETER BJ, UNPUB; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Spitzenberger F, 2003, J BIOL CHEM, V278, P26166, DOI 10.1074/jbc.M213222200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zelhof AC, 2001, DEVELOPMENT, V128, P5005; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x	46	1272	1306	0	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					495	499		10.1126/science.1092586	http://dx.doi.org/10.1126/science.1092586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14645856				2022-12-01	WOS:000188316400030
J	McMichael, AJ; Butler, CD; Folke, C				McMichael, AJ; Butler, CD; Folke, C			New visions for addressing sustainability	SCIENCE			English	Article							POPULATION; GROWTH	Attaining sustainability will require concerted interactive efforts among disciplines, many of which have not yet recognized, and internalized, the relevance of environmental issues to their main intellectual discourse. The inability of key scientific disciplines to engage interactively is an obstacle to the actual attainment of sustainability. For example, in the list of Millennium Development Goals from the United Nations World Summit on Sustainable Development, Johannesburg, 2002, the seventh of the eight goals, to "ensure environmental sustainability," is presented separately from the parallel goals of reducing fertility and poverty, improving gains in equity, improving material conditions, and enhancing population health. A more integrated and consilient approach to sustainability is urgently needed.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	Australian National University; Stockholm University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	Folke, Carl/Z-1545-2019	Butler, Colin/0000-0002-2942-5294; Folke, Carl/0000-0002-4050-3281				ABERNETHY V, 1993, POPULATION POLITICS; Aguirre A.A., 2002, CONSERVATION MED ECO; Andre C, 1998, J ECON BEHAV ORGAN, V34, P1, DOI 10.1016/S0167-2681(97)00045-0; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Arthur WB, 1999, SCIENCE, V284, P107, DOI 10.1126/science.284.5411.107; Berkes F., 2003, NAVIGATING SOCIAL EC; BERKMAN LF, 2001, SOCIAL EPIDEMIOLOGY; Butler C, 2000, ECOSYST HEALTH, V6, P171, DOI 10.1046/j.1526-0992.2000.006003171.x; Butler CD, 2000, GLOBAL CHANGE HUMAN, V1, P156, DOI DOI 10.1023/A:1010029222095; COHEN JE, 1995, SCIENCE, V269, P341, DOI 10.1126/science.7618100; COSTANZA R, 1997, DEV ECOLOGICAL EC; DAILY GC, 1992, BIOSCIENCE, V42, P761, DOI 10.2307/1311995; DEMENY P, 1988, POPUL DEV REV, V14, P213, DOI 10.2307/2808097; EASTERLIN RA, 1971, AM ECON REV, V61, P399; Levin S., 1999, FRAGILE DOMINION; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Maler KG, 2000, EUR ECON REV, V44, P645, DOI 10.1016/S0014-2921(00)00043-X; MCINTOSH RJ, 2000, WAY WIND BLOWS; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; National Research Council, 1999, OUR COMM JOURN TRANS; Ostrom E., 2002, DRAMA COMMONS, DOI 10.17226/10287; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Raven PH, 2002, SCIENCE, V297, P954, DOI 10.1126/science.297.5583.954; Redman C.L., 1999, HUMAN IMPACT ANCIENT; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; STERN PC, 1993, SCIENCE, V260, P1897, DOI 10.1126/science.260.5116.1897; Westley F., 2002, PANARCHY UNDERSTANDI, P103; WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203	29	136	144	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1919	1920						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671290				2022-12-01	WOS:000187174000045
J	Greenberg, AJ; Moran, JR; Coyne, JA; Wu, CI				Greenberg, AJ; Moran, JR; Coyne, JA; Wu, CI			Ecological adaptation during incipient speciation revealed by precise gene replacement	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; SEXUAL ISOLATION; HYDROCARBON POLYMORPHISM; REPRODUCTIVE ISOLATION; DESATURASE GENE; COLD TOLERANCE; EVOLUTION; TEMPERATURE; POPULATIONS; STARVATION	To understand the role of adaptation in speciation, one must characterize the ecologically relevant phenotypic effects of naturally occurring alleles at loci potentially causing reproductive isolation. The desaturase2 gene of Drosophila melanogaster is such a locus. Two geographically differentiated ds2 alleles underlie a pheromonal difference between the Zimbabwe and Cosmopolitan races. We used a site-directed gene replacement technique to introduce an allele of ds2 from the Zimbabwe population into Cosmopolitan flies. We show that the Cosmopolitan allele confers resistance to cold as well as susceptibility to starvation when the entire genetic background is otherwise identical. We conclude that ecological adaptation likely accompanies sexual isolation between the two behavioral races of D. melanogaster.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Wu, CI (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.			Greenberg, Anthony/0000-0003-3296-5811				Cossins AR, 1994, TEMPERATURE ADAPTATI; Coyne JA, 1996, GENETICS, V143, P353; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; Coyne JA, 1999, GENET RES, V73, P189, DOI 10.1017/S0016672398003723; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Doi M, 2001, P NATL ACAD SCI USA, V98, P6714, DOI 10.1073/pnas.091421598; Fang S, 2002, GENETICS, V162, P781; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI [10.1111/j.1558-5646.1997.tb03965.x, 10.2307/2411047]; Hollocher H, 1997, GENETICS, V147, P1191; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Karan D, 2000, J THERM BIOL, V25, P345, DOI 10.1016/S0306-4565(99)00106-0; KIMURA MT, 1988, EVOLUTION, V42, P1288, DOI 10.1111/j.1558-5646.1988.tb04188.x; Knipple DC, 2002, GENETICS, V162, P1737; LAURIEAHLBERG CC, 1987, GENETICS, V115, P129; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Ohtsu T, 1998, EUR J BIOCHEM, V252, P608, DOI 10.1046/j.1432-1327.1998.2520608.x; Parkash R, 2000, EVOL ECOL RES, V2, P685; PARTRIDGE L, 1994, EVOLUTION, V48, P1269, DOI [10.2307/2410384, 10.1111/j.1558-5646.1994.tb05311.x]; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2001, GENETICS, V157, P1307; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; WU CI, 1995, P NATL ACAD SCI USA, V92, P2519, DOI 10.1073/pnas.92.7.2519; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	37	132	136	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1754	1757		10.1126/science.1090432	http://dx.doi.org/10.1126/science.1090432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657496				2022-12-01	WOS:000186970100045
J	Outeiro, TF; Lindquist, S				Outeiro, TF; Lindquist, S			Yeast cells provide insight into alpha-synuclein biology and pathobiology	SCIENCE			English	Article							PARKINSONS-DISEASE; PHOSPHOLIPASE-D; MEMBRANE INTERACTIONS; PROTEIN AGGREGATION; BINDING PROTEINS; FATTY-ACIDS; MUTATIONS; SYSTEM; NEURODEGENERATION; OLIGOMERIZATION	Alpha-synuclein is implicated in several neurodegenerative disorders, such as Parkinson's disease and multiple system atrophy, yet its functions remain obscure. When expressed in yeast, alpha-synuclein associated with the plasma membrane in a highly selective manner, before forming cytoplasmic inclusions through a concentration-dependent, nucleated process. Alpha-synuclein inhibited phospholipase D, induced lipid droplet accumulation, and affected vesicle trafficking. This readily manipulable system provides an opportunity to dissect the molecular pathways underlying normal alpha-synuclein biology and the pathogenic consequences of its misfolding.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727	NINDS NIH HHS [NS044829-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS044829] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Gasser T, 2001, J NEUROL, V248, P833, DOI 10.1007/s004150170066; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rudge SA, 2001, GENETICS, V158, P1431; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389	30	587	608	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1772	1775		10.1126/science.1090439	http://dx.doi.org/10.1126/science.1090439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657500	Green Accepted			2022-12-01	WOS:000186970100050
J	Bigay, J; Gounon, P; Robineau, S; Antonny, B				Bigay, J; Gounon, P; Robineau, S; Antonny, B			Lipid packing sensed by ArfGAP1 couples COPI coat disassembly to membrane bilayer curvature	NATURE			English	Article							ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; GOLGI MEMBRANES; BINDING PROTEIN; VESICLES; COMPLEX; LIPOSOMES; FACTOR-1; NUCLEOTIDE; TRANSPORT	Protein coats deform flat lipid membranes into buds and capture membrane proteins to form transport vesicles(1-3). The assembly/ disassembly cycle of the COPI coat on Golgi membranes is coupled to the GTP/GDP cycle of the small G protein Arf1. At the heart of this coupling is the specific interaction of membrane-bound Arf1 - GTP with coatomer, a complex of seven proteins that forms the building unit of the COPI coat(4-7). Although COPI coat disassembly requires the catalysis of GTP hydrolysis in Arf1 by a specific GTPase-activating protein (ArfGAP1)(8-10), the precise timing of this reaction during COPI vesicle formation is not known. Using time-resolved assays for COPI dynamics on liposomes of controlled size, we show that the rate of ArfGAP1-catalysed GTP hydrolysis in Arf1 and the rate of COPI disassembly increase over two orders of magnitude as the curvature of the lipid bilayer increases and approaches that of a typical transport vesicle. This leads to a model for COPI dynamics in which GTP hydrolysis in Arf1 is organized temporally and spatially according to the changes in lipid packing induced by the coat.	CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Nice, Ctr Commun Microscopie Appl, F-06103 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Antonny, B (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.		Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; Joelle, BIGAY/0000-0002-7487-3416				Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Nickel W, 2001, METHOD ENZYMOL, V329, P388; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stamnes M, 1998, P NATL ACAD SCI USA, V95, P13676, DOI 10.1073/pnas.95.23.13676; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; YANG NC, 1969, MOL PHOTOCHEM, V1, P159; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	30	249	253	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					563	566		10.1038/nature02108	http://dx.doi.org/10.1038/nature02108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654841				2022-12-01	WOS:000186944300040
J	Kappelman, J; Rasmussen, DT; Sanders, WJ; Feseha, M; Bown, T; Copeland, P; Crabaugh, J; Fleagle, J; Glantz, M; Gordon, A; Jacobs, B; Maga, M; Muldoon, K; Pan, A; Pyne, L; Richmond, B; Ryan, T; Seiffert, ER; Sen, S; Todd, L; Wiemann, MC; Winkler, A				Kappelman, J; Rasmussen, DT; Sanders, WJ; Feseha, M; Bown, T; Copeland, P; Crabaugh, J; Fleagle, J; Glantz, M; Gordon, A; Jacobs, B; Maga, M; Muldoon, K; Pan, A; Pyne, L; Richmond, B; Ryan, T; Seiffert, ER; Sen, S; Todd, L; Wiemann, MC; Winkler, A			Oligocene mammals from Ethiopia and faunal exchange between Afro-Arabia and Eurasia	NATURE			English	Article							FLOOD VOLCANISM; MIOCENE; PROBOSCIDEANS; HIGHLANDS; MOROCCO; YEMEN	Afro-Arabian mammalian communities underwent a marked transition near the Oligocene/Miocene boundary at approximately 24 million years (Myr) ago. Although it is well documented that the endemic paenungulate taxa were replaced by migrants from the Northern Hemisphere, the timing and evolutionary dynamics of this transition have long been a mystery because faunas from about 32 to 24 Myr ago are largely unknown(1). Here we report a late Oligocene fossil assemblage from Ethiopia, which constrains the migration to postdate 27 Myr ago, and yields new insight into the indigenous faunal dynamics that preceded this event. The fauna is composed of large paenungulate herbivores and reveals not only which earlier taxa persisted into the late Oligocene epoch but also demonstrates that one group, the Proboscidea, underwent a marked diversification. When Eurasian immigrants entered Afro-Arabia, a pattern of winners and losers among the endemics emerged: less diverse taxa such as arsinoitheres became extinct, moderately species-rich groups such as hyracoids continued into the Miocene with reduced diversity, whereas the proboscideans successfully carried their adaptive radiation out of Afro-Arabia and across the world.	Univ Texas, Dept Anthropol, Austin, TX 78712 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Houston, Dept Geosci, Houston, TX 77204 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA; So Methodist Univ, Dept Geol Sci, Dallas, TX 75275 USA; George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA; Museum Natl Hist Nat, Lab Paleontol, F-75005 Paris, France; Forest Serv, Ctr Wood Anat Res, USDA, Forest Prod Lab, Madison, WI 53705 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Houston System; University of Houston; University of Wyoming; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Colorado State University; Southern Methodist University; George Washington University; Duke University; Museum National d'Histoire Naturelle (MNHN); United States Department of Agriculture (USDA); United States Forest Service; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kappelman, J (corresponding author), Univ Texas, Dept Anthropol, Austin, TX 78712 USA.		Gordon, Adam/AAB-9006-2019; Copeland, Pete/A-9823-2008	Gordon, Adam/0000-0002-1807-4644; PAN, AARON/0000-0002-3286-3105; Maga, A. Murat/0000-0002-7921-9018				Andrews CW, 1906, DESCRIPTIVE CATALOGU, P1; Baker J, 1996, EARTH PLANET SC LETT, V138, P39, DOI 10.1016/0012-821X(95)00229-6; BOSCHETTO HB, 1992, J HUM EVOL, V22, P47, DOI 10.1016/0047-2484(92)90029-9; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Coppens Y., 1978, P336; Court N, 1995, J VERTEBR PALEONTOL, V15, P650, DOI 10.1080/02724634.1995.10011254; FESEHA M, 2001, SEQUENCE STRATIGRAPH; Gheerbrant E, 2002, ACTA PALAEONTOL POL, V47, P493; Gheerbrant E, 1996, NATURE, V383, P68, DOI 10.1038/383068a0; Harris J.M., 1978, P315; Hofmann C, 1997, NATURE, V389, P838, DOI 10.1038/39853; Maglio V.J., 1978, P603; MURDOCK TG, 1944, MINERAL INVESTIGATIO, V19; PICKFORD M, 1986, COMPTES RENDUS ACD S, V19, P1305; Pickford M., 1986, MUNCHNER GEOWISS ABH, V8, P1; Rasmussen D.T., 1988, Journal of Vertebrate Paleontology, V8, P67; RASMUSSEN DT, 1989, EVOLUTION PERISSODAC, P57; Rochette P, 1998, EARTH PLANET SC LETT, V164, P497, DOI 10.1016/S0012-821X(98)00241-6; Sanders WJ, 2002, J VERTEBR PALEONTOL, V22, P388, DOI 10.1671/0272-4634(2002)022[0388:NPFTEM]2.0.CO;2; SHOSHANI J, 2001, 8 INT THER C JOH, P128; Spell TL, 1996, GEOL SOC AM BULL, V108, P1549, DOI 10.1130/0016-7606(1996)108<1549:CTRJVF>2.3.CO;2; Tanner L.G., 1978, P279; TASSY P, 1985, MEMOIRES SCI TERRE U, V8534, P1; Thomas H, 1999, FOSSIL VERTEBRATES OF ARABIA, P430; Ukstins IA, 2002, EARTH PLANET SC LETT, V198, P289, DOI 10.1016/S0012-821X(02)00525-3; Wight A.W.R., 1980, GEOLOGY LIBYA, P309; YEMANE K, 1987, J AFR EARTH SCI, V6, P91, DOI 10.1016/0899-5362(87)90110-2; YEMANE K, 1987, PALAEOGEOGR PALAEOCL, V60, P123, DOI 10.1016/0031-0182(87)90028-9; YEMANE K, 1985, NATURE, V318, P653, DOI 10.1038/318653a0	29	105	112	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					549	552		10.1038/nature02102	http://dx.doi.org/10.1038/nature02102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654838	Green Published			2022-12-01	WOS:000186944300036
J	Lin, M; Storer, B; Martin, PJ; Tseng, L; Gooley, T; Chen, P; Hansen, JA				Lin, M; Storer, B; Martin, PJ; Tseng, L; Gooley, T; Chen, P; Hansen, JA			Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; SINGLE NUCLEOTIDE POLYMORPHISMS; GENE POLYMORPHISMS; TNF-ALPHA; INTERFERON-GAMMA; IL-10 PRODUCTION; T-CELLS; CD4(+); ASSOCIATE; SIBLINGS	BACKGROUND: Polymorphisms in cytokine genes can influence immune responses, inflammation, and tissue injury and may affect the outcome of hematopoietic stem-cell transplantation. METHODS: We analyzed single-nucleotide polymorphisms in the genes for interleukin-1(beta), interleukin-1-receptor antagonist, interleukin-6, interleukin-10 (IL10), and tumor necrosis factor (alpha) in 570 transplant recipients and their HLA-identical sibling donors. Genotypes were tested for an association with graft-versus-host disease (GVHD) by multivariable analysis. A second cohort of 423 transplant recipients was independently analyzed for the genotype associations identified in the first cohort. RESULTS: The recipient's IL10 promoter region genotype was significantly associated with the risk of acute GVHD in the first cohort. Analysis of all 993 transplant recipients showed that, as compared with the C/C genotype, the IL10 -592A/A genotype was associated with a decreased risk of grade III or IV acute GVHD (hazard ratio, 0.4; 95 percent confidence interval, 0.2 to 0.9; P=0.02) and death in remission (hazard ratio, 0.6; 95 percent confidence interval, 0.3 to 1.0; P=0.05). A haplotype analysis showed that the IL10 -592A allele was a specific marker for a promoter haplotype, T-C-A-T-A, defined by five polymorphisms at positions -3575, -2763, -1082, -819, and -592, respectively. CONCLUSIONS: Among recipients of hematopoietic cells from an HLA-identical sibling, the IL10 -592A allele is a marker of a favorable outcome after transplantation.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Sch Med, Seattle, WA USA; Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; Natl Taiwan Univ, Canc Res Ctr, Taipei 10764, Taiwan	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Hansen, JA (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,D2-100,POB 19024, Seattle, WA 98109 USA.			TSENG, LI-HUI/0000-0002-8308-6772; Chen, Pei-Jer/0000-0001-8316-3785	NATIONAL CANCER INSTITUTE [P01CA018029, P30CA015704, P01CA018221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484] Funding Source: NIH RePORTER; NCI NIH HHS [CA18221, CA18029, CA15704] Funding Source: Medline; NIAID NIH HHS [AI49213, AI33484] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen PK, 2012, STAT MODELS BASED CO; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; BEATTY PG, 1985, NEW ENGL J MED, V313, P765, DOI 10.1056/NEJM198509263131301; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Blazar BR, 1998, TRANSPLANTATION, V66, P1220, DOI 10.1097/00007890-199811150-00018; BLAZAR BR, 1995, BLOOD, V85, P842, DOI 10.1182/blood.V85.3.842.bloodjournal853842; Cavet J, 1999, BLOOD, V94, P3941, DOI 10.1182/blood.V94.11.3941.423k10_3941_3946; Cavet J, 2001, BLOOD, V98, P1594, DOI 10.1182/blood.V98.5.1594; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Cullup H, 2001, BRIT J HAEMATOL, V113, P807, DOI 10.1046/j.1365-2141.2001.02811.x; DING L, 1993, J IMMUNOL, V151, P1224; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; HANSEN JA, 1992, MANUAL CLIN LAB IMMU, P850; HARTL DL, 1997, PRINCIPLES POPULATIO, P71; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Holler E, 2000, BONE MARROW TRANSPL, V25, P237, DOI 10.1038/sj.bmt.1702126; Keijsers Vivian, 1997, Arthritis and Rheumatism, V40, pS179; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Krenger W, 1997, TRANSPLANTATION, V64, P553, DOI 10.1097/00007890-199708270-00001; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Lin MT, 2001, BLOOD, V98, P3172, DOI 10.1182/blood.V98.10.3172; MORISHIMA Y, 1989, BLOOD, V74, P2252, DOI 10.1182/blood.V74.6.2252.2252; PERREAULT C, 1990, BLOOD, V76, P1269; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sasazuki T, 1999, NEW ENGL J MED, V340, P402; SMITH SR, 1995, TRANSPLANTATION, V59, P890, DOI 10.1097/00007890-199503270-00016; Socie G, 2001, TRANSPLANTATION, V72, P699, DOI 10.1097/00007890-200108270-00024; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Takahashi H, 2000, BONE MARROW TRANSPL, V26, P1317, DOI 10.1038/sj.bmt.1702724; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Tegoshi H, 2002, HUM IMMUNOL, V63, P121, DOI 10.1016/S0198-8859(01)00363-9; Tseng LH, 2002, J IMMUNOL METHODS, V267, P151, DOI 10.1016/S0022-1759(02)00165-5; Tseng LH, 2002, TISSUE ANTIGENS, V59, P280, DOI 10.1034/j.1399-0039.2002.590405.x; Tseng LH, 2001, TISSUE ANTIGENS, V57, P318, DOI 10.1034/j.1399-0039.2001.057004318.x; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Zeller JC, 1999, J IMMUNOL, V163, P3684	40	297	316	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2201	2210		10.1056/NEJMoa022060	http://dx.doi.org/10.1056/NEJMoa022060			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657427	Bronze			2022-12-01	WOS:000186921700006
J	Hansen, H; Groce, N				Hansen, H; Groce, N			Human immunodeficiency virus and quarantine in Cuba	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AIDS; HIV		Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Hansen, H (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.		Chesters, Heather/C-6089-2009	Groce, Nora/0000-0002-7885-7042				Avila JP, 1996, BIOMED PHARMACOTHER, V50, P216, DOI 10.1016/0753-3322(96)87661-X; BAYER R, 1989, NEW ENGL J MED, V320, P1022, DOI 10.1056/NEJM198904133201529; Burr C, 1997, LANCET, V350, P647, DOI 10.1016/S0140-6736(05)63342-9; CASTILLO OG, 2003, TOURISM DEV LOCOMOTI; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; FEINSILVER JM, 1989, LAT AM RES REV, V24, P1; Hansen H, 2001, Med Anthropol, V19, P259; KEYS S, 1997, AIDS WKLY PLUS  0901, P21; PEREZSTABLE EJ, 1991, AM J PUBLIC HEALTH, V81, P563, DOI 10.2105/AJPH.81.5.563; SANTANA S, 1991, INT J HEALTH SERV, V21, P511, DOI 10.2190/PPF0-X27G-LF4X-XEYC; SCHEPERHUGHES N, 1994, SOC SCI MED, V39, P991, DOI 10.1016/0277-9536(94)90210-0; SCHEPERHUGHES N, 1993, LANCET, V342, P965, DOI 10.1016/0140-6736(93)92006-F; Swanson J M, 1995, J Assoc Nurses AIDS Care, V6, P33, DOI 10.1016/S1055-3290(05)80027-5; *UNAIDS, 2003, FACT SHEET CUB; Waitzkin H, 1997, J FAM PRACTICE, V45, P250	15	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2875	2875		10.1001/jama.290.21.2875	http://dx.doi.org/10.1001/jama.290.21.2875			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	748QP	14657076	Bronze			2022-12-01	WOS:000186872800034
J	Courchamp, F; Woodroffe, R; Roemer, G				Courchamp, F; Woodroffe, R; Roemer, G			Removing protected populations to save endangered species	SCIENCE			English	Article									New Mexico State Univ, Dept Fishery & Wildlife Sci, Las Cruces, NM 88003 USA; Univ Paris 11, F-91405 Orsay, France; Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	New Mexico State University; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis	Roemer, G (corresponding author), New Mexico State Univ, Dept Fishery & Wildlife Sci, Las Cruces, NM 88003 USA.		Courchamp, Franck/ABE-7204-2020; burke, daniel/D-3668-2009	Courchamp, Franck/0000-0001-7605-4548; 				COONAN T, 2003, ISLAND FOX CAPTIVE B; ROEMER G, IN PRESS FOXES JACKA; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; *US NAT PARK SERV, 2003, SANT CRUZ ISL PRIM R	4	75	77	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1532	1532		10.1126/science.1089492	http://dx.doi.org/10.1126/science.1089492			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645839				2022-12-01	WOS:000186802200032
J	Bertrand, V; Hudson, C; Caillol, D; Popovici, C; Lemaire, P				Bertrand, V; Hudson, C; Caillol, D; Popovici, C; Lemaire, P			Neural tissue in ascidian embryos is induced by FGF9/16/20, acting via a combination of maternal GATA and Ets transcription factors	CELL			English	Article							CHORDATE CIONA-INTESTINALIS; FIBROBLAST-GROWTH-FACTOR; XENOPUS EMBRYOS; NERVOUS-SYSTEM; HOMEOBOX GENE; CELL FATE; EXPRESSION; INDUCTION; SPECIFICATION; NOTOCHORD	In chordates, formation of neural tissue from ectodermal cells requires an induction. The molecular nature of the inducer remains controversial in vertebrates. Here, using the early neural marker Otx as an entry point, we dissected the neural induction pathway in the simple embryos of Ciona intestinalis. We first isolated the regulatory element driving Otx expression in the prospective neural tissue, showed that this element directly responds to FGF signaling and that FGF9/16/20 acts as an endogenous neural inducer. Binding site analysis and gene loss of function established that FGF9/16/20 induces neural tissue in the ectoderm via a synergy between two maternal response factors. Ets1/2 mediates general FGF responsiveness, while the restricted activity of GATAa targets the neural program to the ectoderm. Thus, our study identifies an endogenous FGF neural inducer and its early downstream gene cascade. It also reveals a role for GATA factors in FGF signaling.	Univ Mediterranee, AP Marseille, CNRS, INSERM,Lab Genet & Physiol Dev,IBDM, F-13288 Marseille 9, France; CNRS, UPMC, Stn Zool, Unite Biol Dev,UMR 7009, F-06230 Villefranche Sur Mer, France; INSERM, Mol Oncol Lab, U119, IFR 57, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bertrand, V (corresponding author), Univ Mediterranee, AP Marseille, CNRS, INSERM,Lab Genet & Physiol Dev,IBDM, Parc Sci Luminy,Case 907, F-13288 Marseille 9, France.		Lemaire, Patrick/B-5560-2012; Lemaire, Patrick/D-4237-2009; POPOVICI, Cornel/A-2027-2009; Lemaire, Patrick/P-8228-2019; Hudson, Clare/X-7618-2019	Lemaire, Patrick/0000-0003-4925-2009; POPOVICI, Cornel/0000-0001-8226-3127; Lemaire, Patrick/0000-0003-4925-2009; Hudson, Clare/0000-0003-1585-8328; Bertrand, Vincent/0000-0002-9036-2544				Akanuma T, 2002, DEV GENES EVOL, V212, P459, DOI 10.1007/s00427-002-0264-x; Corbo JC, 1998, DEV BIOL, V203, P358, DOI 10.1006/dbio.1998.9067; Corbo JC, 1997, DEVELOPMENT, V124, P589; D'Ambrosio P, 2003, DEV DYNAM, V226, P145, DOI 10.1002/dvdy.10216; Darras S, 2001, DEV BIOL, V236, P271, DOI 10.1006/dbio.2001.0339; Darras S, 1997, DEVELOPMENT, V124, P4275; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Garcia-Garcia MJ, 1999, DEVELOPMENT, V126, P3523; Hardcastle Z, 2000, CURR BIOL, V10, P1511, DOI 10.1016/S0960-9822(00)00825-3; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; HIKOSAKA A, 1994, DEV BIOL, V166, P763, DOI 10.1006/dbio.1994.1354; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; Hudson C, 2003, DEVELOPMENT, V130, P147, DOI 10.1242/dev.00200; Hudson C, 2001, MECH DEVELOP, V100, P189, DOI 10.1016/S0925-4773(00)00528-1; Imai KS, 2002, DEVELOPMENT, V129, P1729; Inazawa T, 1998, J PHYSIOL-LONDON, V511, P347, DOI 10.1111/j.1469-7793.1998.347bh.x; Jiang YM, 1996, DEV BIOL, V174, P258, DOI 10.1006/dbio.1996.0071; Kawachi K, 2003, J BIOL CHEM, V278, P5473, DOI 10.1074/jbc.M211054200; KELLEY C, 1994, DEV BIOL, V165, P193, DOI 10.1006/dbio.1994.1246; Koga C, 1999, BIOCHEM BIOPH RES CO, V261, P756, DOI 10.1006/bbrc.1999.1039; Launay C, 1996, DEVELOPMENT, V122, P869; Lemaire P, 2002, DEV BIOL, V252, P151, DOI 10.1006/dbio.2002.0861; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Locascio A, 1999, DEVELOPMENT, V126, P4737; Miya T, 2003, DEV BIOL, V261, P25, DOI 10.1016/S0012-1606(03)00246-X; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; NEAVE B, 1995, MECH DEVELOP, V51, P169, DOI 10.1016/0925-4773(95)00351-7; Nishida H, 2002, BIOESSAYS, V24, P613, DOI 10.1002/bies.10099; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Partington GA, 1997, DEV BIOL, V181, P144, DOI 10.1006/dbio.1996.8432; Ristoratore F, 1999, DEVELOPMENT, V126, P5149; Satou Y, 2002, DEV GENES EVOL, V212, P432, DOI 10.1007/s00427-002-0266-8; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Satou Y, 2001, GENESIS, V30, P103, DOI 10.1002/gene.1040; Sheng GJ, 1999, MECH DEVELOP, V87, P213, DOI 10.1016/S0925-4773(99)00150-1; Shibata K, 1998, BIOCHEM BIOPH RES CO, V252, P241, DOI 10.1006/bbrc.1998.9490; Song JW, 1996, DEV DYNAM, V206, P427, DOI 10.1002/(SICI)1097-0177(199608)206:4<427::AID-AJA8>3.0.CO;2-K; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Wada S, 1996, MECH DEVELOP, V60, P59, DOI 10.1016/S0925-4773(96)00600-4; Wada S, 2002, DEV DYNAM, V225, P46, DOI 10.1002/dvdy.10135; Wada S, 1999, MECH DEVELOP, V82, P67, DOI 10.1016/S0925-4773(99)00012-X; WHITTAKER JR, 1973, P NATL ACAD SCI USA, V70, P2096, DOI 10.1073/pnas.70.7.2096; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Xu RH, 1997, MOL CELL BIOL, V17, P436, DOI 10.1128/MCB.17.1.436; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10642, DOI 10.1073/pnas.88.23.10642	53	203	204	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					615	627		10.1016/S0092-8674(03)00928-0	http://dx.doi.org/10.1016/S0092-8674(03)00928-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651852	Bronze			2022-12-01	WOS:000186885600011
J	Miao, L; Vanderlinde, O; Stewart, M; Roberts, TM				Miao, L; Vanderlinde, O; Stewart, M; Roberts, TM			Retraction in amoeboid cell motility powered by cytoskeletal dynamics	SCIENCE			English	Article							PROTEIN MSP CYTOSKELETON; ACTIN-BASED MOTILITY; HEAVY-CHAIN GENE; NEMATODE SPERM; ASCARIS SPERM; BODY; DEPOLYMERIZATION; TRANSLOCATION; NUCLEATION; MECHANISM	Cells crawl by coupling protrusion of their leading edge with retraction of their cell body. Protrusion is generated by the polymerization and bundling of. laments, but the mechanism of retraction is less clear. We have reconstituted retraction in vitro by adding Yersinia tyrosine phosphatase to the major sperm protein-based motility apparatus assembled from Ascaris sperm extracts. Retraction in vitro parallels that observed in vivo and is generated primarily by disassembly and rearrangement of the cytoskeleton. Therefore, cytoskeletal dynamics alone, unassisted by conventional motors, are able to generate both of these central components of amoeboid locomotion.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	State University System of Florida; Florida State University; MRC Laboratory Molecular Biology	Roberts, TM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	roberts@bio.fsu.edu		Miao, Long/0000-0002-0562-6681	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029994] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37GM29994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson KI, 1996, J CELL BIOL, V134, P1209, DOI 10.1083/jcb.134.5.1209; Berg, 2018, RANDOM WALKS BIOL; Bottino D, 2002, J CELL SCI, V115, P367; Bray D., 2001, CELL MOVEMENTS MOL M; Bullock TL, 1998, NAT STRUCT BIOL, V5, P184, DOI 10.1038/nsb0398-184; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Carlier MF, 2003, BIOESSAYS, V25, P336, DOI 10.1002/bies.10257; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Feringa BL, 2000, NATURE, V408, P151, DOI 10.1038/35041665; HUXLEY HE, 1973, NATURE, V244, P445, DOI 10.1038/243445a0; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; Italiano JE, 1999, J CELL BIOL, V146, P1087, DOI 10.1083/jcb.146.5.1087; KING KL, 1994, CELL MOTIL CYTOSKEL, V27, P193, DOI 10.1002/cm.970270302; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; LeClaire LL, 2003, J CELL SCI, V116, P2655, DOI 10.1242/jcs.00469; LI Y, 1992, ANNU REV MATER SCI, V22, P243; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; Roberts TM, 1998, J CELL BIOL, V140, P367, DOI 10.1083/jcb.140.2.367; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Theriot JA, 1996, CELL, V84, P1, DOI 10.1016/S0092-8674(00)80068-9; Uchida KSK, 2003, J CELL SCI, V116, P51, DOI 10.1242/jcs.00195; WATERMANSTORER CM, 1995, J CELL BIOL, V130, P1161, DOI 10.1083/jcb.130.5.1161	26	49	53	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1405	1407		10.1126/science.1089129	http://dx.doi.org/10.1126/science.1089129			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631043				2022-12-01	WOS:000186683500055
J	Roberts, DL; Solow, AR				Roberts, DL; Solow, AR			Flightless birds - When did the dodo become extinct?	NATURE			English	Editorial Material									Royal Bot Gardens, Richmond TW9 3AE, Surrey, England; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Royal Botanic Gardens, Kew; Woods Hole Oceanographic Institution	Roberts, DL (corresponding author), Royal Bot Gardens, Richmond TW9 3AE, Surrey, England.			Roberts, David/0000-0001-6788-2691				Cheke A.S., 1987, P5, DOI 10.1017/CBO9780511735769.003; COOKE P, 1980, BIOMETRIKA, V67, P257; Fuller E., 2002, DODO BRIEF HIST	3	117	125	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					245	245		10.1038/426245a	http://dx.doi.org/10.1038/426245a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628039				2022-12-01	WOS:000186660800031
J	Smith, RJ; Muir, RDJ; Walpole, MJ; Balmford, A; Leader-Williams, N				Smith, RJ; Muir, RDJ; Walpole, MJ; Balmford, A; Leader-Williams, N			Governance and the loss of biodiversity	NATURE			English	Article							CONSERVATION; COSTS	Most of the world's biodiversity occurs within developing countries that require donor support to build their conservation capacity(1). Unfortunately, some of these countries experience high levels of political corruption(2), which may limit the success of conservation projects by reducing effective funding levels and distorting priorities(3). We investigated whether changes in three well surveyed and widespread components of biodiversity were associated with national governance scores and other socioeconomic measures. Here we show that governance scores were correlated with changes in total forest cover, but not with changes in natural forest cover. We found strong associations between governance scores and changes in the numbers of African elephants and black rhinoceroses, and these socio-economic factors explained observed patterns better than any others. Finally, we show that countries rich in species and identified as containing priority areas for conservation have lower governance scores than other nations. These results stress the need for conservationists to develop and implement policies that reduce the effects of political corruption and, in this regard, we question the universal applicability of an influential approach to conservation that seeks to ban international trade in endangered species.	Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England; Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England	University of Kent; University of Cambridge	Smith, RJ (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England.	R.J.Smith@kent.ac.uk	Smith, Robert J/D-9660-2011	Smith, Robert J/0000-0003-1599-9171; Balmford, Andrew/0000-0002-0144-3589				Archabald K, 2001, ENVIRON CONSERV, V28, P135, DOI 10.1017/S0376892901000145; Azfar O, 2001, ANN AM ACAD POLIT SS, V573, P42, DOI 10.1177/0002716201573001003; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barnes R., 1999, AFRICAN ELEPHANT DAT; BARNES RFW, 1995, BIOL CONSERV, V71, P125, DOI 10.1016/0006-3207(94)00014-H; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Didia DO, 1997, GLOBAL ENVIRON CHANG, V7, P63, DOI 10.1016/S0959-3780(96)00024-6; Emslie, 1999, AFRICAN RHINO STATUS; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hughey KFD, 2003, CONSERV BIOL, V17, P93, DOI 10.1046/j.1523-1739.2003.01317.x; International Institute for Environment and Development, 1994, WHOS ED OV COMM APPR; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James A. N., 1999, GLOBAL REV PROTECTED; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; Kaufmann D, 1997, FOREIGN POLICY, P114, DOI 10.2307/1149337; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Leakey R., 2001, WILDLIFE WARS MY BAT; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYERS N, 1992, PRIMARY SOURCE TROPI; Oldfield S., 2002, TRADE WILDLIFE REGUL; Robertson JMY, 2001, ORYX, V35, P26, DOI 10.1046/j.1365-3008.2001.00149.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Transparency International, 2002, CORR PERC IND 2002; Walpole MJ, 2001, NATURE, V413, P771, DOI 10.1038/35101762; Whitten T, 2001, CONSERV BIOL, V15, P1, DOI 10.1046/j.1523-1739.2001.01_01.x; *WORLD WID FUND NA, 1999, LIV PLAN CAMP CALL A	30	268	278	2	162	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					67	70		10.1038/nature02025	http://dx.doi.org/10.1038/nature02025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603318				2022-12-01	WOS:000186370800042
J	Gilg, O; Hanski, I; Sittler, B				Gilg, O; Hanski, I; Sittler, B			Cyclic dynamics in a simple vertebrate predator-prey community	SCIENCE			English	Article							DICROSTONYX-GROENLANDICUS; POPULATION-CYCLES; RODENT DYNAMICS; LEMMINGS; MODEL	The collared lemming in the high-Arctic tundra in Greenland is preyed upon by four species of predators that show marked differences in the numbers of lemmings each consumes and in the dependence of their dynamics on lemming density. A predator-prey model based on the field-estimated predator responses robustly predicts 4-year periodicity in lemming dynamics, in agreement with long-term empirical data. There is no indication in the field that food or space limits lemming population growth, nor is there need in the model to consider those factors. The cyclic dynamics are driven by a 1-year delay in the numerical response of the stoat and stabilized by strongly density-dependent predation by the arctic fox, the snowy owl, and the long-tailed skua.	Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, FIN-00014 Helsinki, Finland; INRA, IRD, Equipe Biol & Gest Pullulat, CBGP, F-34988 Montferrier Sur Lez, Lez, France; Univ Freiburg, Inst Landespflege, D-79085 Freiburg, Germany	University of Helsinki; INRAE; Institut de Recherche pour le Developpement (IRD); University of Freiburg	Gilg, O (corresponding author), Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, POB 65, FIN-00014 Helsinki, Finland.	olivier.gilg@libertysurf.fr	GILG, Olivier/C-2588-2008	GILG, Olivier/0000-0002-9083-4492				ANDERSSON M, 1976, J ANIM ECOL, V45, P537, DOI 10.2307/3890; Batzli G.O., 1980, ARCTIC ECOSYSTEM COA, P335, DOI DOI 10.1575/1912/222; Berg T.B., 2003, THESIS U COPENHAGEN; CHERNYAVSKII FB, 1975, MATERIALY EKOLOGII M, P13; CHERNYAVSKY FB, 1981, ECOLOGY BIRDS MAMMAL; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; DUNAEVA T N, 1978, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V83, P18; DUNAEVA TN, 1948, P I GEOGRAPHY ACAD S, V51, P78; FITZGERALD BM, 1977, J ANIM ECOL, V46, P367, DOI 10.2307/3818; Gilg O, 2002, OIKOS, V99, P499, DOI 10.1034/j.1600-0706.2002.11989.x; GILG O, 2002, THESIS U FRANCHE COM; HANSKI I, 1995, ECOLOGY, V76, P840, DOI 10.2307/1939349; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HENRY GHR, 1990, CAN J BOT, V68, P2660, DOI 10.1139/b90-336; Klemola T, 2003, ADV ECOL RES, V33, P75, DOI 10.1016/S0065-2504(03)33010-7; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; MIKKELSEN PS, 1994, NORDOST GRONLAND 190; Millar JS, 2001, ECOSCIENCE, V8, P145, DOI 10.1080/11956860.2001.11682639; Oli MK, 2003, TRENDS ECOL EVOL, V18, P105, DOI 10.1016/S0169-5347(03)00005-3; SITTLER B, 1995, ANN ZOOL FENN, V32, P79; Sittler B, 2000, ARCTIC, V53, P53; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; Turchin P, 2001, ECOL LETT, V4, P267, DOI 10.1046/j.1461-0248.2001.00204.x; Turchin P, 2000, NATURE, V405, P562, DOI 10.1038/35014595; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	27	234	245	6	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					866	868		10.1126/science.1087509	http://dx.doi.org/10.1126/science.1087509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593179				2022-12-01	WOS:000186258000049
J	Kubori, T; Galan, JE				Kubori, T; Galan, JE			Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation	CELL			English	Article							III SECRETION SYSTEM; YERSINIA-ENTEROCOLITICA; BACTERIAL TOXIN; HOST-CELLS; TYPHIMURIUM; CHAPERONE; IDENTIFICATION; YOPE; TRANSLOCATION; GENES	Salmonella enterica invasion of host cells requires the reversible activation of the Rho-family GTPases Cdc42 and Rac1 by the bacterially encoded GEF SopE and the GAP SptP, which exert their function at different times during infection and are delivered into host cells by a type III secretion system. We found that SopE and SptP are delivered in equivalent amounts early during infection. However, SopE is rapidly degraded through a proteosome-mediated pathway, while SptP exhibits much slower degradation kinetics. The half-lives of these effector proteins are determined by their secretion and translocation domains. Chimeric protein analysis indicated that delivery of SptP into host cells by the SopE secretion and translocation domain drastically shortened its half-life. Conversely, delivery of SopE by the SptP secretion and translocation signals significantly increased its half-life, resulting in persistent actin cytoskeleton rearrangements. This regulatory mechanism constitutes a remarkable example of a pathogen's adaptation to modulate cellular functions.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Kubori, Tomoko/AAH-3609-2019	Kubori, Tomoko/0000-0003-1098-6021	NIAID NIH HHS [AI30492] Funding Source: Medline; NIGMS NIH HHS [GM52543] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030492, R29AI030492, R01AI030492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052543] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	40	217	224	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					333	342		10.1016/S0092-8674(03)00849-3	http://dx.doi.org/10.1016/S0092-8674(03)00849-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636560	Bronze			2022-12-01	WOS:000186415000012
J	Zoghbi, HY				Zoghbi, HY			Postnatal neurodevelopmental disorders: Meeting at the synapse?	SCIENCE			English	Article							LINKED MENTAL-RETARDATION; CPG-BINDING PROTEIN-2; RETT-SYNDROME BRAIN; AUTISTIC DISORDER; MECP2 MUTATIONS; DNA METHYLATION; PROXIMAL 15Q; ANGELMAN-SYNDROME; INFANTILE-AUTISM; SYNDROME GENE	We often think of neurodevelopmental disorders as beginning before birth, and many certainly do. A handful, however, strike many months after birth, following a period of apparently normal growth and development. Autism and Rett syndrome are two such disorders, and here I consider some of their similarities at the phenotypic and pathogenic levels. I propose that both disorders result from disruption of postnatal or experience-dependent synaptic plasticity.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu		Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040301] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 40301] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Armstrong DD, 1999, PEDIATR NEUROL, V20, P125, DOI 10.1016/S0887-8994(98)00124-6; Armstrong J, 2001, ANN NEUROL, V50, P692, DOI 10.1002/ana.1272; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAILEY A, 1993, LANCET, V341, P1225, DOI 10.1016/0140-6736(93)91065-T; BAKER P, 1994, J AUTISM DEV DISORD, V24, P529, DOI 10.1007/BF02172133; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; BAUMAN ML, 1995, NEUROPEDIATRICS, V26, P105, DOI 10.1055/s-2007-979737; Beaudet Arthur L., 2002, Genetics in Medicine, V4, P399, DOI 10.1097/00125817-200209000-00013; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bolton PF, 2001, AM J MED GENET, V105, P675, DOI 10.1002/ajmg.1551; Boyar FZ, 2001, CLIN GENET, V60, P421, DOI 10.1034/j.1399-0004.2001.600604.x; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHENG SD, 1994, AM J HUM GENET, V55, P753; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Cook EH, 1997, AM J HUM GENET, V60, P928; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GLAZE DG, 1987, ARCH NEUROL-CHICAGO, V44, P1053, DOI 10.1001/archneur.1987.00520220051016; Gurrieri F, 1999, NEUROLOGY, V52, P1694, DOI 10.1212/WNL.52.8.1694; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hardan AY, 2001, J CHILD NEUROL, V16, P421, DOI 10.2310/7010.2001.7113; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hoffbuhr K, 2001, NEUROLOGY, V56, P1486, DOI 10.1212/WNL.56.11.1486; HOTOPF M, 1995, J AUTISM DEV DISORD, V25, P41, DOI 10.1007/BF02178166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; JELLINGER K, 1986, AM J MED GENET, V24, P259; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kanner L, 1943, NERV CHILD, V2, P217; Kashiwagi A, 2003, J HUM GENET, V48, P194, DOI 10.1007/s10038-003-0009-3; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Klauck SM, 2002, AM J HUM GENET, V70, P1034, DOI 10.1086/339553; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Konstantareas MM, 1999, J AUTISM DEV DISORD, V29, P275, DOI 10.1023/A:1022155201662; Laan LAEM, 2002, EPILEPSIA, V43, P1590, DOI 10.1046/j.1528-1157.2002.30802.x; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Luna B, 2002, NEUROLOGY, V59, P834, DOI 10.1212/WNL.59.6.834; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; NIELSEN JB, 1990, ARCH NEUROL-CHICAGO, V47, P982, DOI 10.1001/archneur.1990.00530090054013; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; PICKLES A, 1995, AM J HUM GENET, V57, P717; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; Rett A, 1966, Wien Med Wochenschr, V116, P723; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Silva AE, 2002, ARQ NEURO-PSIQUIAT, V60, P290, DOI 10.1590/S0004-282X2002000200021; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Thomas JA, 2003, AM J MED GENET A, V119A, P111, DOI 10.1002/ajmg.a.10176; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; VERMA NP, 1986, ELECTROEN CLIN NEURO, V64, P394, DOI 10.1016/0013-4694(86)90072-6; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; Wilson S, 2003, DEV MED CHILD NEUROL, V45, P508, DOI 10.1111/j.1469-8749.2003.tb00950.x; Winnepenninckx B, 2002, HUM MUTAT, V20, P249, DOI 10.1002/humu.10130; Wolpert CM, 2000, AM J MED GENET, V96, P365, DOI 10.1002/1096-8628(20000612)96:3<365::AID-AJMG25>3.0.CO;2-X	81	506	528	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					826	830		10.1126/science.1089071	http://dx.doi.org/10.1126/science.1089071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593168				2022-12-01	WOS:000186258000038
J	Dasen, JS; Liu, JP; Jessell, TM				Dasen, JS; Liu, JP; Jessell, TM			Motor neuron columnar fate imposed by sequential phases of Hox-c activity	NATURE			English	Article							SPINAL-CORD; HOMEODOMAIN PROTEIN; SUBTYPE IDENTITY; HOMEOTIC TRANSFORMATIONS; TRANSCRIPTIONAL CODES; POSITIONAL IDENTITY; GENES; EXPRESSION; MICE; SPECIFICATION	The organization of neurons into columns is a prominent feature of central nervous systemstructure and function. In many regions of the central nervous system the grouping of neurons into columns links cell-body position to axonal trajectory, thus contributing to the establishment of topographic neural maps. This link is prominent in the developing spinal cord, where columnar sets of motor neurons innervate distinct targets in the periphery. We show here that sequential phases of Hox-c protein expression and activity control the columnar differentiation of spinal motor neurons. Hox expression in neural progenitors is established by graded fibroblast growth factor signalling and translated into a distinct motor neuron Hox pattern. Motor neuron columnar fate then emerges through cell autonomous repressor and activator functions of Hox proteins. Hox proteins also direct the expression of genes that establish motor topographic projections, thus implicating Hox proteins as critical determinants of spinal motor neuron identity and organization.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	Columbia University; Howard Hughes Medical Institute; University of Virginia	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, 701 W 168th St, New York, NY 10032 USA.							Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 2000, GENESIS, V27, P6, DOI 10.1002/1526-968X(200005)27:1<6::AID-GENE20>3.3.CO;2-F; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Cooper KL, 2003, DEV BIOL, V253, P200, DOI 10.1016/S0012-1606(02)00018-0; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Ensini M, 1998, DEVELOPMENT, V125, P969; Gabay L, 1997, DEVELOPMENT, V124, P3535; Garcia-Gasca A, 2000, DEV DYNAM, V219, P261, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1048>3.0.CO;2-3; Goddard JM, 1996, DEVELOPMENT, V122, P3217; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; HOLLYDAY M, 1990, J COMP NEUROL, V302, P575, DOI 10.1002/cne.903020313; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; Rossel M, 1999, DEVELOPMENT, V126, P5027; Sanders TA, 2002, J NEUROSCI, V22, P10742; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Tiret L, 1998, DEVELOPMENT, V125, P279; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wahba GM, 2001, DEV BIOL, V231, P87, DOI 10.1006/dbio.2000.0130; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358	49	260	266	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					926	933		10.1038/nature02051	http://dx.doi.org/10.1038/nature02051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586461				2022-12-01	WOS:000186230600033
J	Matsushita, K; Morrell, CN; Cambien, B; Yang, SX; Yamakuchi, M; Bao, C; Hara, MR; Quick, RA; Cao, W; O'Rourke, B; Lowenstein, JM; Pevsner, J; Wagner, DD; Lowenstein, CJ				Matsushita, K; Morrell, CN; Cambien, B; Yang, SX; Yamakuchi, M; Bao, C; Hara, MR; Quick, RA; Cao, W; O'Rourke, B; Lowenstein, JM; Pevsner, J; Wagner, DD; Lowenstein, CJ			Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimdide-sensitive factor	CELL			English	Article							WEIBEL-PALADE BODIES; HUMAN-ENDOTHELIAL-CELLS; VON-WILLEBRAND-FACTOR; MEMBRANE-FUSION; TRANSPORT VESICLES; YEAST VACUOLES; KNOCKOUT MICE; P-SELECTIN; PROTEIN; NSF	Nitric oxide (NO) inhibits vascular inflammation, but the molecular basis for its anti-inflammatory properties is unknown. We show that NO inhibits exocytosis of Weibel-Palade bodies, endothelial granules that mediate vascular inflammation and thrombosis, by regulating the activity of N-ethylmaleimide-sensitive factor (NSF). NO inhibits NSF disassembly of soluble NSF attachment protein receptor (SNARE) complexes by nitrosylating critical cysteine residues of NSF. NO may regulate exocytosis in a variety of physiological processes, including vascular inflammation, neuro-transmission, thrombosis, and cytotoxic T lymphocyte cell killing.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Brandeis University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lowenstein, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.			Lowenstein, Charles/0000-0003-0485-7514; Cambien, Beatrice/0000-0002-6914-0525; O'Rourke, Brian/0000-0002-5548-4853	NCRR NIH HHS [T32 RR007002, RR07002] Funding Source: Medline; NHLBI NIH HHS [R01 HL074061, R01 HL063706, R01 HL078635-04, P01 HL56091, P01 HL065608-050003, R37 HL41002, R01 HL074061-04, P01 HL065608, HL074945, P01 HL056091, R37 HL041002, R01 HL63706-04, R01 HL078635, K08 HL074945, P01 HL056091-100003, P01 HL65608] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007002] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074945, P01HL065608, R01HL063706, P01HL056091, R01HL074061, R01HL078635, R37HL041002] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andre P, 2000, BLOOD, V96, P3322, DOI 10.1182/blood.V96.10.3322.h8003322_3322_3328; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BONFANTI R, 1989, BLOOD, V73, P1109; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Huber D, 2002, BLOOD, V99, P3637, DOI 10.1182/blood.V99.10.3637; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAFFREY SR, 2001, SCI STKE; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Littleton JT, 1995, INVERTEBR NEUROSCI, V1, P3, DOI 10.1007/BF02331827; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Qian ZP, 2001, CIRCULATION, V104, P2369, DOI 10.1161/hc4401.098471; RADOMSKI MW, 1993, THROMB HAEMOSTASIS, V70, P36; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Ruggeri ZM, 1997, J CLIN INVEST, V100, pS41; Saura M, 1999, IMMUNITY, V10, P21, DOI 10.1016/S1074-7613(00)80003-5; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; WAGNER DD, 1993, THROMB HAEMOSTASIS, V70, P105; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247	51	357	378	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 17	2003	115	2					139	150		10.1016/S0092-8674(03)00803-1	http://dx.doi.org/10.1016/S0092-8674(03)00803-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	734DD	14567912	Green Accepted, Bronze			2022-12-01	WOS:000186039200006
J	Huh, WK; Falvo, JV; Gerke, LC; Carroll, AS; Howson, RW; Weissman, JS; O'Shea, EK				Huh, WK; Falvo, JV; Gerke, LC; Carroll, AS; Howson, RW; Weissman, JS; O'Shea, EK			Global analysis of protein localization in budding yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; SUBCELLULAR-LOCALIZATION; FLUORESCENT PROTEIN; MASS-SPECTROMETRY; GENE DELETION; CELL-WALL; SCALE; ORGANIZATION; PHOSPHATASE; EXPRESSION	A fundamental goal of cell biology is to define the functions of proteins in the context of compartments that organize them in the cellular environment. Here we describe the construction and analysis of a collection of yeast strains expressing full-length, chromosomally tagged green fluorescent protein fusion proteins. We classify these proteins, representing 75% of the yeast proteome, into 22 distinct subcellular localization categories, and provide localization information for 70% of previously unlocalized proteins. Analysis of this high-resolution, high-coverage localization data set in the context of transcriptional, genetic, and protein-protein interaction data helps reveal the logic of transcriptional co-regulation, and provides a comprehensive view of interactions within and between organelles in eukaryotic cells.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	O'Shea, EK (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, 600 16th St, San Francisco, CA 94143 USA.		Huh, Won-Ki/AAQ-6767-2021	Weissman, Jonathan/0000-0003-2445-670X				Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; BHATTACHARYA S, 1995, P NATL ACAD SCI USA, V92, P2984, DOI 10.1073/pnas.92.7.2984; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DOLINSKI K, 2003, GENOME DATABASE; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hodges PE, 2002, NUCLEIC ACIDS RES, V30, P137, DOI 10.1093/nar/30.1.137; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; PELHAM HRB, 1988, EMBO J, V7, P1757, DOI 10.1002/j.1460-2075.1988.tb03005.x; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Taylor SW, 2003, TRENDS BIOTECHNOL, V21, P82, DOI 10.1016/S0167-7799(02)00037-9; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VANBERKEL MAA, 1994, FEBS LETT, V349, P135, DOI 10.1016/0014-5793(94)00631-8; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	48	3150	5240	11	395	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					686	691		10.1038/nature02026	http://dx.doi.org/10.1038/nature02026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562095				2022-12-01	WOS:000185924500033
J	Sollner, C; Burghammer, M; Busch-Nentwich, E; Berger, J; Schwarz, H; Riekel, C; Nicolson, T				Sollner, C; Burghammer, M; Busch-Nentwich, E; Berger, J; Schwarz, H; Riekel, C; Nicolson, T			Control of crystal size and lattice formation by starmaker in otolith biomineralization	SCIENCE			English	Article							EAR DEVELOPMENT; FISH OTOLITHS; MAJOR PROTEIN; ZEBRAFISH; MACROMOLECULES; DIMENSIONS; MUTATIONS; OTOCONIA; MATRIX; DSPP	The stone-like otoliths from the ears of teleost fishes are involved in balance and hearing and consist of calcium carbonate crystallites embedded in a protein framework. We report that a previously unknown gene, starmaker, is required in zebrafish for otolith morphogenesis. Reduction of starmaker activity by injection of modified antisense oligonucleotides causes a change in the crystal lattice structure and thus a change in otolith morphology. The expression pattern of starmaker, along with the presence of the protein on the growing otolith, suggest that the expression levels of starmaker control the shape of the otoliths.	Max Planck Inst Entwicklungsbiol, Microscopy Unit, D-72076 Tubingen, Germany; European Synchrotron Radiat Facil, F-38073 Grenoble, France	Max Planck Society; European Synchrotron Radiation Facility (ESRF)	Nicolson, T (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	nicolson@ohsu.edu						Bekele H, 1999, J AM CHEM SOC, V121, P7266, DOI 10.1021/ja991416j; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borelli G, 2001, CALCIFIED TISSUE INT, V69, P356, DOI 10.1007/s00223-001-2016-8; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; FAY RR, 1984, SCIENCE, V225, P951, DOI 10.1126/science.6474161; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hurle B, 2003, HUM MOL GENET, V12, P777, DOI 10.1093/hmg/ddg087; Lowenstam H.A., 1989, BIOMINERALISATION; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NEILSON JD, 1985, FISH B-NOAA, V83, P81; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Pisam M, 2002, CELL TISSUE RES, V310, P163, DOI 10.1007/s00441-002-0622-z; POPPER A, 1993, INNER EAR LATERAL LI, P99; POTE KG, 1993, BIOCHEMISTRY-US, V32, P5017, DOI 10.1021/bi00070a007; RADTKE RL, 1982, FISH B-NOAA, V80, P201; Riekel C, 2000, REP PROG PHYS, V63, P233, DOI 10.1088/0034-4885/63/3/201; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	27	228	231	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					282	286		10.1126/science.1088443	http://dx.doi.org/10.1126/science.1088443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	14551434				2022-12-01	WOS:000185825900041
J	Sears, MR; Greene, JM; Willan, AR; Wiecek, EM; Taylor, DR; Flannery, EM; Cowan, JO; Herbison, GP; Silva, PA; Poulton, R				Sears, MR; Greene, JM; Willan, AR; Wiecek, EM; Taylor, DR; Flannery, EM; Cowan, JO; Herbison, GP; Silva, PA; Poulton, R			A longitudinal, population-based, cohort study of childhood asthma followed to adulthood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; LUNG-FUNCTION; AIRWAY HYPERRESPONSIVENESS; NEW-ZEALAND; WHEEZING ILLNESS; BIRTH COHORT; ATOPY; PREVALENCE; CHILDREN; LIFE	BACKGROUND: The outcome of childhood asthma in adults has been described in high-risk cohorts, but few population-based studies have reported the risk factors for persistence and relapse. METHODS: We assessed children born from April 1972 through March 1973 in Dunedin, New Zealand, repeatedly from 9 to 26 years of age with questionnaires, pulmonary-function tests, bronchial-challenge testing, and allergy testing. RESULTS: By the age of 26 years, 51.4 percent of 613 study members with complete respiratory data had reported wheezing at more than one assessment. Eighty-nine study members (14.5 percent) had wheezing that persisted from childhood to 26 years of age, whereas 168 (27.4 percent) had remission, but 76 (12.4 percent) subsequently relapsed by the age of 26. Sensitization to house dust mites predicted the persistence of wheezing (odds ratio, 2.41; P=0.001) and relapse (odds ratio, 2.18; P=0.01), as did airway hyperresponsiveness (odds ratio for persistence, 3.00; P<0.001; odds ratio for relapse, 3.03; P<0.001). Female sex predicted the persistence of wheezing (odds ratio, 1.71; P=0.03), as did smoking at the age of 21 years (odds ratio, 1.84; P=0.01). The earlier the age at onset, the greater the risk of relapse (odds ratio, 0.89 per year of increase in the age at onset; P<0.001). Pulmonary function was consistently lower in those with persistent wheezing than in those without persistent wheezing. CONCLUSIONS: In an unselected birth cohort, more than one in four children had wheezing that persisted from childhood to adulthood or that relapsed after remission. The factors predicting persistence or relapse were sensitization to house dust mites, airway hyperresponsiveness, female sex, smoking, and early age at onset. These findings, together with persistently low lung function, suggest that outcomes in adult asthma may be determined primarily in early childhood.	McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Otago, Dunedin Multidisciplinary Hlth & Dev Res Unit, Dunedin, New Zealand	McMaster University; McMaster University; University of Otago; University of Otago	Sears, MR (corresponding author), McMaster Univ & St Josephs Healthcare, Firestone Inst Resp Hlth, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.			Herbison, Graham Peter/0000-0002-5684-024X				Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; BRONNIMANN S, 1986, CHEST, V90, P480, DOI 10.1378/chest.90.4.480; BURNEY PGJ, 1987, CHEST, V91, P79; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; Downs SH, 2001, ARCH DIS CHILD, V84, P20, DOI 10.1136/adc.84.1.20; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Grol MH, 1996, ALLERGY, V51, P855; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; JENKINS MA, 1994, BRIT MED J, V309, P90, DOI 10.1136/bmj.309.6947.90; JONES DT, 1987, BRIT J DIS CHEST, V81, P332, DOI 10.1016/0007-0971(87)90181-1; Lowe L, 2002, LANCET, V359, P1904, DOI 10.1016/S0140-6736(02)08781-0; Oswald H, 1997, PEDIATR PULM, V23, P14, DOI 10.1002/(SICI)1099-0496(199701)23:1<14::AID-PPUL2>3.0.CO;2-P; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Rhodes HL, 2001, J ALLERGY CLIN IMMUN, V108, P720, DOI 10.1067/mai.2001.119151; Rhodes HL, 2002, AM J RESP CRIT CARE, V165, P176, DOI 10.1164/ajrccm.165.2.2104032; SEARS MR, 1986, THORAX, V41, P283, DOI 10.1136/thx.41.4.283; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; Sears MR, 1996, ARCH DIS CHILD, V75, P392, DOI 10.1136/adc.75.5.392; Sears MR, 1997, EUR RESPIR J, V10, P51, DOI 10.1183/09031936.97.10010051; SEARS MR, 1994, BRIT MED J, V309, P72, DOI 10.1136/bmj.309.6947.72; Silva, 1996, CHILD ADULT DUNEDIN; SINCLAIR SW, 1980, NEW ZEAL MED J, V91, P1; Strachan DP, 1996, BRIT MED J, V312, P1195; Strachan DP, 1996, AM J RESP CRIT CARE, V154, P1629, DOI 10.1164/ajrccm.154.6.8970346; Ulrik CS, 1999, EUR RESPIR J, V13, P904, DOI 10.1034/j.1399-3003.1999.13d35.x; Ulrik CS, 1996, RESP MED, V90, P623, DOI 10.1016/S0954-6111(96)90021-9; Xuan W, 2000, AM J RESP CRIT CARE, V161, P1820, DOI 10.1164/ajrccm.161.6.9809118; Xuan W, 2002, THORAX, V57, P104, DOI 10.1136/thorax.57.2.104	28	912	932	1	60	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2003	349	15					1414	1422		10.1056/NEJMoa022363	http://dx.doi.org/10.1056/NEJMoa022363			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JF	14534334				2022-12-01	WOS:000185769500004
J	Pereira, G; Schiebel, E				Pereira, G; Schiebel, E			Separase regulates INCENP-Aurora B anaphase spindle function through Cdc14	SCIENCE			English	Article							CENTROMERE PROTEIN; PHOSPHATASE CDC14; MITOTIC EXIT; CLEAVAGE; KINASE; LOCALIZATION; KINETOCHORE; MITOSIS; COHESIN; COMPLEX	The inner centromere-like protein ( INCENP) forms a complex with the evolutionarily conserved family of Aurora B kinases. The INCENP-Aurora complex helps coordinate chromosome segregation, spindle behavior, and cytokinesis during mitosis. INCENP-Aurora associates with kinetochores in metaphase and with spindle microtubules in anaphase, yet the trigger for this abrupt transfer is unknown. Here we show that the conserved phosphatase Cdc14 regulated the yeast INCENP-Aurora complex, Sli15-Ipl1. Cdc14 dephosphorylated Sli15 and thereby directed the complex to spindles. Activation of Cdc14 by separase was sufficient for Sli15 dephosphorylation and relocalization. Cdc14 not only regulates mitotic exit but also modulates spindle midzone assembly through Sli15-Ipl1.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England	University of Manchester; Paterson Institute for Cancer Research	Schiebel, E (corresponding author), Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	eschiebel@picr.man.ac.uk	Pereira, Gislene/D-4024-2014					Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Jin QW, 2000, J CELL SCI, V113, P1903; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; PEREIRA G, UNPUB; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	22	209	216	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2120	2124		10.1126/science.1091936	http://dx.doi.org/10.1126/science.1091936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14605209				2022-12-01	WOS:000187385200044
J	Beaugrand, G; Brander, KM; Lindley, JA; Souissi, S; Reid, PC				Beaugrand, G; Brander, KM; Lindley, JA; Souissi, S; Reid, PC			Plankton effect on cod recruitment in the North Sea	NATURE			English	Article							MATCH MISMATCH HYPOTHESIS; LARVAL FISH; GADUS-MORHUA; ATLANTIC COD; DEPENDENT MORTALITY; GROWTH; VARIABILITY; ZOOPLANKTON; ABUNDANCE; SURVIVAL	The Atlantic cod ( Gadus morhua L.) has been overexploited in the North Sea since the late 1960s and great concern has been expressed about the decline in cod biomass and recruitment(1). Here we show that, in addition to the effects of overfishing(1), fluctuations in plankton have resulted in long- term changes in cod recruitment in the North Sea ( bottom- up control). Survival of larval cod is shown to depend on three key biological parameters of their prey: the mean size of prey, seasonal timing and abundance. We suggest a mechanism, involving the match/ mismatch hypothesis(2), by which variability in temperature affects larval cod survival and conclude that rising temperature since the mid- 1980s has modified the plankton ecosystem in a way that reduces the survival of young cod.	Univ Sci & Technol Lille, Stn Marine, CNRS, UMR ELICO 8013, F-62930 Wimereux, France; Sir Alister Hardy Fdn Ocean Sci, The Lab, Plymouth PL1 2PB, Devon, England; ICES, DK-1261 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Beaugrand, G (corresponding author), Univ Sci & Technol Lille, Stn Marine, CNRS, UMR ELICO 8013, BP 80, F-62930 Wimereux, France.		Brander, Keith/AAN-6278-2021; Souissi, Sami/C-5146-2018	Souissi, Sami/0000-0002-6720-0096; BEAUGRAND, GREGORY/0000-0002-0712-5223				Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BOLLENS SM, 1992, J PLANKTON RES, V14, P1279, DOI 10.1093/plankt/14.9.1279; Brander K, 2000, OCEANOL ACTA, V23, P485, DOI 10.1016/S0399-1784(00)00133-X; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; CUSHING DH, 1984, J CONSEIL, V41, P159; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; CUSHING DH, 1997, SCI RECR FISH POP; Gallego A, 1997, J FISH BIOL, V51, P121, DOI 10.1111/j.1095-8649.1997.tb06096.x; Gotceitas V, 1996, MAR ECOL PROG SER, V130, P29, DOI 10.3354/meps130029; *ICES COOP RES REP, 2001, WORKSH GAD STOCKS N; *ICES COOP RES REP, 2002, REP ICES ADV COMM FI; Letcher BH, 1996, CAN J FISH AQUAT SCI, V53, P787, DOI 10.1139/cjfas-53-4-787; Mauchline, 1998, BIOL CALANOID COPEPO; Mauchline J, 1969, Adv. mar. Biol., V7, P1; Munk P, 1997, J FISH BIOL, V51, P340, DOI 10.1111/j.1095-8649.1997.tb06107.x; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; PEPIN P, 1993, CAN J FISH AQUAT SCI, V50, P2166, DOI 10.1139/f93-242; PETERS H, 1983, BIOL IMPLICATION BOD; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Pope JG, 1996, ICES J MAR SCI, V53, P1157, DOI 10.1006/jmsc.1996.0141; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rothschild BJ, 1998, J PLANKTON RES, V20, P1721, DOI 10.1093/plankt/20.9.1721; Shepherd JG, 1999, ICES J MAR SCI, V56, P584, DOI 10.1006/jmsc.1999.0498; Swain DP, 2003, FISH RES, V59, P327, DOI 10.1016/S0165-7836(02)00027-9; THORISSON K, 1989, RAP PROCES, V191, P264; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; WARNER AJ, 1994, PROG OCEANOGR, V34, P237, DOI 10.1016/0079-6611(94)90011-6	30	899	926	7	357	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					661	664		10.1038/nature02164	http://dx.doi.org/10.1038/nature02164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668864				2022-12-01	WOS:000187132800041
J	Loewe, L; Textor, V; Scherer, S				Loewe, L; Textor, V; Scherer, S			High deleterious genomic mutation rate in stationary phase of Escherichia coli	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-STRESS; ADAPTIVE MUTATION; FITNESS; DNA; POPULATIONS; EVOLUTION; BACTERIA; RECOMBINATION; HYPERMUTATION	In natural habitats, bacteria spend most of their time in some form of growth arrest. Little is known about deleterious mutations in such stages, and consequently there is limited understanding of what evolutionary events occur. In a deleterious mutation accumulation experiment in prolonged stationary phase of Escherichia coli, about 0.03 slightly deleterious mutations were observed per genome per day. This is over an order of magnitude higher than extrapolations from fast-growing cells, but in line with inferences from observations in adaptive stationary phase mutation experiments. These findings may affect understanding of bacterial evolution and the emergence of bacterial pathogenicity.	Tech Univ Munich, Dept Biosci, Microbial Ecol Grp, D-85354 Freising Weihenstephan, Germany	Technical University of Munich	Loewe, L (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Ashworth Labs, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Scherer, Siegfried/I-1320-2013	Scherer, Siegfried/0000-0002-0394-9890				Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Bull HJ, 2000, GENETICS, V156, P925; Bull HJ, 2000, GENETICS, V154, P1427; Bull HJ, 2001, P NATL ACAD SCI USA, V98, P8334, DOI 10.1073/pnas.151009798; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Drake JW, 1998, GENETICS, V148, P1667; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Finkel SE, 2000, BACTERIAL STRESS RESPONSES, P231; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Funchain P, 2000, GENETICS, V154, P959; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Keightley PD, 1998, GENETICS, V150, P1283; Keightley PD, 1999, GENETICS, V153, P515; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MATIN A, 1989, ANNU REV MICROBIOL, V43, P293, DOI 10.1146/annurev.mi.43.100189.001453; Morita RY, 1997, BACTERIA OLIGOTROPHI; MUKAI T, 1964, GENETICS, V50, P1; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Rosche WA, 1999, P NATL ACAD SCI USA, V96, P6862, DOI 10.1073/pnas.96.12.6862; Rosenberg SM, 1998, GENETICS, V148, P1559; RYAN FJ, 1963, J GEN MICROBIOL, V30, P193, DOI 10.1099/00221287-30-2-193; RYAN FJ, 1961, Z VEREBUNGSL, V92, P38, DOI 10.1007/BF01854099; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Szafraniec K, 2001, P NATL ACAD SCI USA, V98, P1107, DOI 10.1073/pnas.021390798; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; Townsend JP, 2003, GENETICS, V164, P13; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; Zeyl C, 2001, GENETICS, V157, P53	32	60	62	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1558	1560		10.1126/science.1087911	http://dx.doi.org/10.1126/science.1087911			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645846	Green Submitted			2022-12-01	WOS:000186802200041
J	Sowell, ER; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW; Peterson, BS				Sowell, ER; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW; Peterson, BS			Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder	LANCET			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; CEREBRAL GLUCOSE-METABOLISM; DEFICIT/HYPERACTIVITY DISORDER; TOURETTE SYNDROME; BRAIN METABOLISM; BLOOD-FLOW; MRI; CORTEX; GIRLS; FMRI	Background Results of structural brain imaging studies of patients with attention-deficit hyperactivity disorder have shown subtle reductions in total brain volume and in volumes of the right frontal lobe and caudate nucleus. Although various conventional volumetric and voxel-based methods of image analysis have been used in these studies, regional brain size and grey-matter abnormalities have not yet been mapped over the entire cortical surface in patients with this disorder. We aimed to map these features in patients with attention-deficit hyperactivity disorder. Methods We used high-resolution MRI and surface-based, computational image analytic techniques to map regional brain size and grey-matter abnormalities at the cortical surface in a group of 27 children and adolescents with attention-deficit hyperactivity disorder and 46 controls, who were group-matched by age and sex. Findings Abnormal morphology was noted in the frontal cortices of patients with attention-deficit hyperactivity disorder, with reduced regional brain size localised mainly to inferior portions of dorsal prefrontal cortices bilaterally. Brain size was also reduced in anterior temporal cortices bilaterally. Prominent increases in grey matter were recorded in large portions of the posterior temporal and inferior parietal cortices bilaterally. Interpretation The frontal, temporal, and parietal regions are heteromodal association cortices that constitute a distributed neural system, which subserves attention and behavioural inhibition. We have identified region-specific anatomical abnormalities in cortical components of attentional systems, which may help better account for the symptoms of attention-deficit hyperactivity disorder.	Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute	Sowell, ER (corresponding author), Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, 710 Westwood Plaza,Room 4-238, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	NCRR NIH HHS [P41 RR13642] Funding Source: Medline; NIMH NIH HHS [MH59239, K01 MH01733, MH01232] Funding Source: Medline; NINDS NIH HHS [NS3753] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001733, K08MH001232, R01MH059239] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Baumgardner TL, 1996, NEUROLOGY, V47, P477, DOI 10.1212/WNL.47.2.477; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Castellanos FX, 2001, ARCH GEN PSYCHIAT, V58, P289, DOI 10.1001/archpsyc.58.3.289; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; Ernst M, 1997, J AM ACAD CHILD PSY, V36, P1399, DOI 10.1097/00004583-199710000-00022; ERNST M, 1994, J AM ACAD CHILD PSY, V33, P858, DOI 10.1097/00004583-199407000-00012; Evans AC, 1996, AUTOMATIC 3D REGIONA; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; FUSTER JM, 1997, PREFRONTAL CORTEX; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P440; Langleben DD, 2001, NUCL MED COMMUN, V22, P1333, DOI 10.1097/00006231-200112000-00009; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Overmeyer S, 2001, PSYCHOL MED, V31, P1425, DOI 10.1017/S0033291701004706; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Peterson BS, 1998, ARCH GEN PSYCHIAT, V55, P326, DOI 10.1001/archpsyc.55.4.326; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; Spalletta G, 2001, J NEURAL TRANSM, V108, P1203, DOI 10.1007/s007020170010; Thompson Paul M, 2001, Inf Process Med Imaging, V2082, P488; THOMPSON PM, 2003, P 19 C MED RECH IPSE; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; ZAMETKIN AJ, 1993, ARCH GEN PSYCHIAT, V50, P333; ZAMETKIN AJ, 1990, NEW ENGL J MED, V323, P1361, DOI 10.1056/NEJM199011153232001	43	387	401	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1699	1707		10.1016/S0140-6736(03)14842-8	http://dx.doi.org/10.1016/S0140-6736(03)14842-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	746VE	14643117				2022-12-01	WOS:000186767700007
J	Reinhardt, D; Pesce, ER; Stieger, P; Mandel, T; Baltensperger, K; Bennett, M; Traas, J; Friml, J; Kuhlemeier, C				Reinhardt, D; Pesce, ER; Stieger, P; Mandel, T; Baltensperger, K; Bennett, M; Traas, J; Friml, J; Kuhlemeier, C			Regulation of phyllotaxis by polar auxin transport	NATURE			English	Article							ARABIDOPSIS GENE MONOPTEROS; GNOM ARF-GEF; VASCULAR DEVELOPMENT; PATTERN-FORMATION; EMBRYOGENESIS; LOCALIZATION; MERISTEM; CARRIER; EMBRYO; PIN1	The regular arrangement of leaves around a plant's stem, called phyllotaxis, has for centuries attracted the attention of philosophers, mathematicians and natural scientists; however, to date, studies of phyllotaxis have been largely theoretical. Leaves and flowers are formed from the shoot apical meristem, triggered by the plant hormone auxin. Auxin is transported through plant tissues by specific cellular influx and efflux carrier proteins. Here we show that proteins involved in auxin transport regulate phyllotaxis. Our data indicate that auxin is transported upwards into the meristem through the epidermis and the outermost meristem cell layer. Existing leaf primordia act as sinks, redistributing auxin and creating its heterogeneous distribution in the meristem. Auxin accumulation occurs only at certain minimal distances from existing primordia, defining the position of future primordia. This model for phyllotaxis accounts for its reiterative nature, as well as its regularity and stability.	Univ Bern, Inst Plant Physiol, CH-3013 Bern, Switzerland; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; INRA, Biol Cellulaire Lab, F-78026 Versailles, France; Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England; Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland	University of Bern; Eberhard Karls University of Tubingen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Nottingham; University of Bern	Kuhlemeier, C (corresponding author), Univ Bern, Inst Plant Physiol, Altenbergrain 21, CH-3013 Bern, Switzerland.		Friml, Jiri/D-9511-2012; Traas, Jan/AAZ-7004-2020; Reinhardt, Didier/M-8508-2014; Bennett, Malcolm/G-4004-2010	Friml, Jiri/0000-0002-8302-7596; Traas, Jan/0000-0001-5107-1472; Reinhardt, Didier/0000-0003-3495-6783; Bennett, Malcolm/0000-0003-0475-390X				Aida M, 2002, DEVELOPMENT, V129, P3965; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Green PB, 1996, SEMIN CELL DEV BIOL, V7, P903, DOI 10.1006/scdb.1996.0110; Hadfi K, 1998, DEVELOPMENT, V125, P879; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Jean R., 1994, PHYLLOTAXIS SYSTEMAT; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kuhlemeier C, 2001, TRENDS PLANT SCI, V6, P187, DOI 10.1016/S1360-1385(01)01894-5; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Lomax Terri L., 1995, P509; Lynn K, 1999, DEVELOPMENT, V126, P469; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Meinhardt H., 1984, Positional controls in plant development, P1; MITCHISON GJ, 1977, SCIENCE, V196, P270, DOI 10.1126/science.196.4287.270; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Parry G, 2001, J PLANT GROWTH REGUL, V20, P217, DOI 10.1007/s003440010030; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; REINHARDT D, 2002, MERISTEMATIC TISSUES, P172; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SACHS T, 1981, ADV BOT RES, V9, P151, DOI 10.1016/S0065-2296(08)60351-1; Schoute JC., 1913, RECL TRAV BOT EERL, V10, P153; Schwabe W. W., 1984, Positional controls in plant development, P403; SNOW M, 1962, PHILOS T ROY SOC B, V244, P483, DOI 10.1098/rstb.1962.0003; Steeves TA, 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Stieger PA, 2002, PLANT J, V32, P509, DOI 10.1046/j.1365-313X.2002.01448.x; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Vernoux T, 2000, DEVELOPMENT, V127, P5157; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N	43	1075	1141	12	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					255	260		10.1038/nature02081	http://dx.doi.org/10.1038/nature02081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628043				2022-12-01	WOS:000186660800035
J	Tootle, TL; Silver, SJ; Davies, EL; Newman, V; Latek, RR; Mills, IA; Selengut, JD; Parlikar, BEW; Rebay, I				Tootle, TL; Silver, SJ; Davies, EL; Newman, V; Latek, RR; Mills, IA; Selengut, JD; Parlikar, BEW; Rebay, I			The transcription factor Eyes absent is a protein tyrosine phosphatase	NATURE			English	Article							P-TYPE ATPASE; SIGNALING PATHWAY; DROSOPHILA; PHOSPHORYLATION; SUPERFAMILY; REVEALS; COMPLEX; DOMAIN; EYA; PERVANADATE	Post-translational modifications provide sensitive and flexible mechanisms to dynamically modulate protein function in response to specific signalling inputs(1). In the case of transcription factors, changes in phosphorylation state can influence protein stability, conformation, subcellular localization, cofactor interactions, transactivation potential and transcriptional output(1). Here we show that the evolutionarily conserved transcription factor Eyes absent (Eya)(2,3) belongs to the phosphatase subgroup of the haloacid dehalogenase (HAD) superfamily(4,5), and propose a function for it as a non-thiol-based protein tyrosine phosphatase. Experiments performed in cultured Drosophila cells and in vitro indicate that Eyes absent has intrinsic protein tyrosine phosphatase activity and can autocatalytically dephosphorylate itself. Confirming the biological significance of this function, mutations that disrupt the phosphatase active site severely compromise the ability of Eyes absent to promote eye specification and development in Drosophila. Given the functional importance of phosphorylation-dependent modulation of transcription factor activity, this evidence for a nuclear transcriptional coactivator with intrinsic phosphatase activity suggests an unanticipated method of fine-tuning transcriptional regulation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Inst Genom Res, Rockville, MD 20850 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); J. Craig Venter Institute	Rebay, I (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Tootle, Tina/AAE-1220-2019	Tootle, Tina/0000-0002-1515-9538				Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Bui QT, 2000, GENETICS, V155, P709; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cohen J, 1997, BIOCHEM J, V327, P391, DOI 10.1042/bj3270391; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01252-3; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; IMBERT V, 1994, BIOCHEM J, V297, P163, DOI 10.1042/bj2970163; Kim SS, 2002, STRUCTURE, V10, P787, DOI 10.1016/S0969-2126(02)00769-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Selengut JD, 2000, BIOCHEMISTRY-US, V39, P8315, DOI 10.1021/bi0005052; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Tootle TL, 2003, DEVELOPMENT, V130, P845, DOI 10.1242/dev.00312; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917	28	202	213	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					299	302		10.1038/nature02097	http://dx.doi.org/10.1038/nature02097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628053				2022-12-01	WOS:000186660800046
J	Neuman, KC; Abbondanzieri, EA; Landick, R; Gelles, J; Block, SM				Neuman, KC; Abbondanzieri, EA; Landick, R; Gelles, J; Block, SM			Ubiquitous transcriptional pausing is independent of RNA polymerase backtracking	CELL			English	Article							ESCHERICHIA-COLI; SINGLE-MOLECULE; CHAIN ELONGATION; STRUCTURAL BASIS; DNA-POLYMERASE; II ELONGATION; TERMINATION; MECHANISM; COMPLEX; ARREST	RNA polymerase (RNAP) transcribes DNA discontinuously, with periods of rapid nucleotide addition punctuated by frequent pauses. We investigated the mechanism of transcription by measuring the effect of both hindering and assisting forces on the translocation of single Escherichia coli transcription elongation complexes, using an optical trapping apparatus that allows for the detection of pauses as short as one second. We found that the vast majority of pauses are brief (1-6 s at 21degreesC, 1 mM NTPs), and that the probability of pausing at any particular position on a DNA template is low and fairly constant. Neither the probability nor the duration of these ubiquitous pauses was affected by hindering or assisting loads, establishing that they do not result from the backtracking of RNAP along the DNA template. We propose instead that they are caused by a structural rearrangement within the enzyme.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison; Brandeis University	Block, SM (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.	sblock@stanford.edu	Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671	NIGMS NIH HHS [R01 GM057035-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; CHAMBERLIN MJ, 1994, HARVEY LECT, V88, P1992; Chan CL, 1997, J MOL BIOL, V268, P37, DOI 10.1006/jmbi.1997.0934; CHAN CL, 1994, TRANSCRIPTION MECHAN, P297; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Erie DA, 2002, BBA-GENE STRUCT EXPR, V1577, P224, DOI 10.1016/S0167-4781(02)00454-2; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; Maier B, 2000, P NATL ACAD SCI USA, V97, P12002, DOI 10.1073/pnas.97.22.12002; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Press W., 1992, NUMERICAL RECIPES, V2nd; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REISBIG RR, 1981, BIOCHEMISTRY-US, V20, P1907, DOI 10.1021/bi00510a029; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; Santangelo TJ, 2003, GENE DEV, V17, P1281, DOI 10.1101/gad.1082103; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Sokal Robert R., 1969, BIOMETRY; THEISSEN G, 1990, ANAL BIOCHEM, V189, P254, DOI 10.1016/0003-2697(90)90117-R; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Toulme F, 1999, EMBO J, V18, P5052, DOI 10.1093/emboj/18.18.5052; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; WINKLER ME, 1981, BIOCHEMISTRY-US, V20, P3738, DOI 10.1021/bi00516a011; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	64	257	264	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					437	447		10.1016/S0092-8674(03)00845-6	http://dx.doi.org/10.1016/S0092-8674(03)00845-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622598	Bronze			2022-12-01	WOS:000186627100010
J	Kitano, H				Kitano, H			Cancer robustness - Tumour tactics	NATURE			English	Editorial Material							SYSTEMS		Sony Comp Sci Labs Inc, Shinagawa Ku, Tokyo 1410022, Japan	Sony Corporation	Kitano, H (corresponding author), Sony Comp Sci Labs Inc, Shinagawa Ku, 3-14-13 Higashi Gotanda, Tokyo 1410022, Japan.							Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537	3	107	114	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					125	125		10.1038/426125a	http://dx.doi.org/10.1038/426125a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614483	Bronze			2022-12-01	WOS:000186517200021
J	Waren, A; Bengtson, S; Goffredi, SK; Van Dover, CL				Waren, A; Bengtson, S; Goffredi, SK; Van Dover, CL			A hot-vent gastropod with iron sulfide dermal sclerites	SCIENCE			English	Article							OCEAN		Swedish Museum Nat Hist, SE-10405 Stockholm, Sweden; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	Swedish Museum of Natural History; Monterey Bay Aquarium Research Institute; William & Mary	Waren, A (corresponding author), Swedish Museum Nat Hist, Box 50007, SE-10405 Stockholm, Sweden.			Van Dover, Cindy/0000-0001-9845-8391; Bengtson, Stefan/0000-0003-0206-5791				Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Ip YK, 1997, J COMP PHYSIOL B, V167, P213, DOI 10.1007/s003600050067; Lowenstam H.A., 1989, BIOMINERALISATION; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Waren A, 2001, VELIGER, V44, P116; YI Q, 1989, FOSSILS STRATA, V24, P1; Zbinden M, 2003, DEEP-SEA RES PT I, V50, P269, DOI 10.1016/S0967-0637(02)00161-9	7	82	87	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1007	1007		10.1126/science.1087696	http://dx.doi.org/10.1126/science.1087696			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605361				2022-12-01	WOS:000186396300036
J	Muller, W; Fricke, H; Halliday, AN; McCulloch, MT; Wartho, JA				Muller, W; Fricke, H; Halliday, AN; McCulloch, MT; Wartho, JA			Origin and migration of the Alpine Iceman	SCIENCE			English	Article							ISOTOPES; CLIMATE; VALLEY	The Alpine Iceman provides a unique window into the Neolithic-Copper Age of Europe. We compared the radiogenic (strontium and lead) and stable (oxygen and carbon) isotope composition of the Iceman's teeth and bones, as well as Ar-40/Ar-39 mica ages from his intestine, to local geology and hydrology, and we inferred his habitat and range from childhood to adult life. The Iceman's origin can be restricted to a few valleys within similar to60 kilometers south(east) of the discovery site. His migration during adulthood is indicated by contrasting isotopic compositions of enamel, bones, and intestinal content. This demonstrates that the Alpine valleys of central Europe were permanently inhabited during the terminal Neolithic.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA; ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; Curtin Univ Technol, Dept Appl Geol, Perth, WA 6845, Australia	Australian National University; Colorado College; Swiss Federal Institutes of Technology Domain; ETH Zurich; Curtin University	Muller, W (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	wolfgang.mueller@anu.edu.au	Wartho, Jo-Anne/B-5169-2016; McCulloch, Malcolm T/C-3651-2009	McCulloch, Malcolm T/0000-0003-1538-1558; Muller, Wolfgang/0000-0001-5368-8011				Bereuter TL, 1997, CHEM-EUR J, V3, P1032, DOI 10.1002/chem.19970030708; Budd P, 2001, ROY SOC CH, P311, DOI 10.1039/9781847551696-00311; DICKSON JH, 1996, P R SOC LONDON B, V263; FLECKINGER A, 1999, FASCINATION NEOLITHI; GABER O, 1999, GLETSCHERMUMIE KUPFE, V1, P39; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hoogewerff J, 2001, J ARCHAEOL SCI, V28, P983, DOI 10.1006/jasc.2001.0659; HORN P, COMMUNICATION; Humer G., 1995, NIEDERSCHLAGSISOTOPE, V52; Kralik C, 1996, MAN IN ICE, V3, P283; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Longinelli A, 2003, J HYDROL, V270, P75; McDermott F, 1999, QUATERNARY SCI REV, V18, P1021, DOI 10.1016/S0277-3791(98)00107-3; Oeggl K, 2000, MAN IN ICE, V4, P163; Oeggl K, 2000, MAN IN ICE, V4, P89; PATE FD, 1994, J ARCHAEOL METHOD TH, V1, P161, DOI DOI 10.1007/BF02231415; PRINOTHFORNWAGNER R, 1994, NUCL INSTRUM METH B, V92, P282, DOI 10.1016/0168-583X(94)96020-8; ROZANSKI K, 1993, CLIMATE CHANGE CONTI; SEIDLER H, 1992, SCIENCE, V258, P455, DOI 10.1126/science.1411539; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Spindler K., 1994, MAN ICE PRESERVED BO; Spotl C, 2002, J SEDIMENT RES, V72, P793, DOI 10.1306/041102720793; THOMAS MG, 2001, IC 2001 BOZ BOLZ IT; Thoni M, 1999, SCHWEIZ MINER PETROG, V79, P209; VANWAES HJM, 2001, KINDERZAHNMEDIZIN FA, V17; WINIGER J, 1998, BR ARCHAEOL REP INT, V701, P246	26	165	167	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					862	866		10.1126/science.1089837	http://dx.doi.org/10.1126/science.1089837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593178				2022-12-01	WOS:000186258000048
J	Hoang, QQ; Sicheri, F; Howard, AJ; Yang, DSC				Hoang, QQ; Sicheri, F; Howard, AJ; Yang, DSC			Bone recognition mechanism of porcine osteocalcin from crystal structure	NATURE			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; PROTEIN	Osteocalcin is the most abundant noncollagenous protein in bone(1), and its concentration in serum is closely linked to bone metabolism and serves as a biological marker for the clinical assessment of bone disease(2). Although its precise mechanism of action is unclear, osteocalcin influences bone mineralization(3,4), in part through its ability to bind with high affinity to the mineral component of bone, hydroxyapatite(5). In addition to binding to hydroxyapatite, osteocalcin functions in cell signalling and the recruitment of osteoclasts(6) and osteoblasts(7), which have active roles in bone resorption and deposition, respectively. Here we present the X-ray crystal structure of porcine osteocalcin at 2.0 Angstrom resolution, which reveals a negatively charged protein surface that coordinates five calcium ions in a spatial orientation that is complementary to calcium ions in a hydroxyapatite crystal lattice. On the basis of our findings, we propose a model of osteocalcin binding to hydroxyapatite and draw parallels with other proteins that engage crystal lattices.	McMaster Univ, Fac Hlth Sci, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; Microstar Biotech Inc, Flamborough, ON L9H 7H9, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Illinois Institute of Technology	Yang, DSC (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Biochem, Hamilton, ON L8N 3Z5, Canada.	yang@mcmaster.ca	Sicheri, Frank/F-8856-2013; ID, IMCACAT/D-5867-2014					ATKINSON RA, 1995, EUR J BIOCHEM, V232, P515, DOI 10.1111/j.1432-1033.1995.515zz.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bodine PVN, 1999, BONE, V25, P535, DOI 10.1016/S8756-3282(99)00213-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; CHENU C, 1994, J CELL BIOL, V127, P1149, DOI 10.1083/jcb.127.4.1149; COLOMBO G, 1993, J BONE MINER RES, V8, P733; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dowd TL, 2003, BIOCHEMISTRY-US, V42, P7769, DOI 10.1021/bi034470s; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1; HAUSCHKA PV, 1978, DEV BIOL, V65, P426, DOI 10.1016/0012-1606(78)90038-6; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; HOHM L, 1993, J MOL BIOL, V233, P123; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0; Klein C., 1999, MANUAL MINERALOGY, V21st; Laue TM, 1992, BIOCH POLYM SCI; MUNDY GR, 1983, CALCIFIED TISSUE INT, V35, P164, DOI 10.1007/BF02405025; ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASTOUREAU P, 1993, J BONE MINER RES, V8, P1417; POSER JW, 1979, J BIOL CHEM, V254, P431; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X	30	405	419	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2003	425	6961					977	980		10.1038/nature02079	http://dx.doi.org/10.1038/nature02079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586470				2022-12-01	WOS:000186230600045
J	Hanczyc, MM; Fujikawa, SM; Szostak, JW				Hanczyc, MM; Fujikawa, SM; Szostak, JW			Experimental models of primitive cellular compartments: Encapsulation, growth, and division	SCIENCE			English	Article							MURCHISON CARBONACEOUS CHONDRITE; LARGE UNILAMELLAR VESICLES; FATTY-ACID MEMBRANES; MONTMORILLONITE CATALYSIS; SIZE DISTRIBUTION; EXTRUSION; SURFACE; RNA; POLYMERIZATION; COMPONENTS	The clay montmorillonite is known to catalyze the polymerization of RNA from activated ribonucleotides. Here we report that montmorillonite accelerates the spontaneous conversion of fatty acid micelles into vesicles. Clay particles often become encapsulated in these vesicles, thus providing a pathway for the prebiotic encapsulation of catalytically active surfaces within membrane vesicles. In addition, RNA adsorbed to clay can be encapsulated within vesicles. Once formed, such vesicles can grow by incorporating fatty acid supplied as micelles and can divide without dilution of their contents by extrusion through small pores. These processes mediate vesicle replication through cycles of growth and division. The formation, growth, and division of the earliest cells may have occurred in response to similar interactions with mineral particles and inputs of material and energy.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.			Hanczyc, Martin/0000-0002-5453-2139	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Apel CL, 2002, BBA-BIOMEMBRANES, V1559, P1, DOI 10.1016/S0005-2736(01)00400-X; Aranda-Espinoza H, 1999, SCIENCE, V285, P394, DOI 10.1126/science.285.5426.394; Berclaz N, 2001, J PHYS CHEM B, V105, P1056, DOI 10.1021/jp001298i; Blochliger E, 1998, J PHYS CHEM B, V102, P10383, DOI 10.1021/jp981234w; CLERC SG, 1994, BIOPHYS J, V67, P475, DOI 10.1016/S0006-3495(94)80503-X; DEAMER DW, 1985, NATURE, V317, P792, DOI 10.1038/317792a0; DEAMER DW, 1989, ORIGINS LIFE EVOL B, V19, P21, DOI 10.1007/BF01808285; Dworkin JP, 2001, P NATL ACAD SCI USA, V98, P815, DOI 10.1073/pnas.98.3.815; Ertem G, 1997, J AM CHEM SOC, V119, P7197, DOI 10.1021/ja970422h; FERRIS JP, 1993, J AM CHEM SOC, V115, P12270, DOI 10.1021/ja00079a006; FERRIS JP, 1992, SCIENCE, V257, P1387, DOI 10.1126/science.1529338; Franchi M, 2003, ORIGINS LIFE EVOL B, V33, P1, DOI 10.1023/A:1023982008714; Frisken BJ, 2000, LANGMUIR, V16, P928, DOI 10.1021/la9905113; GEBICKI JM, 1973, NATURE, V243, P232, DOI 10.1038/243232a0; GEBICKI JM, 1976, CHEM PHYS LIPIDS, V16, P142, DOI 10.1016/0009-3084(76)90006-2; HAINES TH, 1983, P NATL ACAD SCI-BIOL, V80, P160, DOI 10.1073/pnas.80.1.160; HARGREAVES WR, 1978, BIOCHEMISTRY-US, V17, P3759, DOI 10.1021/bi00611a014; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hunter DG, 1998, BIOPHYS J, V74, P2996, DOI 10.1016/S0006-3495(98)78006-3; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Korgel BA, 1998, BIOPHYS J, V74, P3264, DOI 10.1016/S0006-3495(98)78033-6; Malinin VS, 2001, BIOCHEMISTRY-US, V40, P8292, DOI 10.1021/bi010570r; MAYER L, 1986, BIOCHIM BIOPHYS ACTA, V858, P61; McCollom TM, 1999, ORIGINS LIFE EVOL B, V29, P153, DOI 10.1023/A:1006592502746; Monnard PA, 2002, ASTROBIOLOGY, V2, P139, DOI 10.1089/15311070260192237; MUI BLS, 1995, BIOPHYS J, V69, P930, DOI 10.1016/S0006-3495(95)79967-2; NAYER R, 1989, BIOCHIM BIOPHYS ACTA, V986, P200; Ramos L, 1999, SCIENCE, V286, P2325, DOI 10.1126/science.286.5448.2325; Rushdi AI, 2001, ORIGINS LIFE EVOL B, V31, P103, DOI 10.1023/A:1006702503954; SMITH R, 1973, P NATL ACAD SCI USA, V70, P289, DOI 10.1073/pnas.70.2.289; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Traikia M, 2002, BIOPHYS J, V83, P1443, DOI 10.1016/S0006-3495(02)73915-5; WALDE P, 1994, J AM CHEM SOC, V116, P11649, DOI 10.1021/ja00105a004	34	575	592	10	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					618	622		10.1126/science.1089904	http://dx.doi.org/10.1126/science.1089904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576428	Green Accepted			2022-12-01	WOS:000186119900051
J	King, MC; Marks, JH; Mandell, JB				King, MC; Marks, JH; Mandell, JB		New York Breast Canc Study Grp	Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2	SCIENCE			English	Article							ASHKENAZI JEWISH CARRIERS; FAMILY-HISTORY; PENETRANCE; WOMEN; PREVALENCE; FREQUENCY; SERIES; OOPHORECTOMY; INDIVIDUALS; MASTECTOMY	Risks of breast and ovarian cancer were determined for Ashkenazi Jewish women with inherited mutations in the tumor suppressor genes BRCA1 and BRCA2. We selected 1008 index cases, regardless of family history of cancer, and carried out molecular analysis across entire families. The lifetime risk of breast cancer among female mutation carriers was 82%, similar to risks in families with many cases. Risks appear to be increasing with time: Breast cancer risk by age 50 among mutation carriers born before 1940 was 24%, but among those born after 1940 it was 67%. Lifetime risks of ovarian cancer were 54% for BRCA1 and 23% for BRCA2 mutation carriers. Physical exercise and lack of obesity in adolescence were associated with significantly delayed breast cancer onset.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Sarah Lawrence Coll, Grad Program Human Genet, Bronxville, NY 10708 USA; Albert Einstein Coll Med, Montefiore Med Ctr, Bronx, NY USA; Beth Israel Med Ctr, New York, NY 10003 USA; Columbia Univ, Columbia Presbyterian Med Ctr, New York, NY 10027 USA; Englewood Hosp & Med Ctr, Englewood, NJ 07631 USA; Greenwich Hosp, Yale Canc Ctr, Greenwich, CT 06830 USA; Hackensack Univ, Med Ctr, Hackensack, NJ 07601 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NYU, Med Ctr, New York, NY 10016 USA; N Shore Univ Hosp, Manhasset, NY 11030 USA; Stamford Hosp, Bennett Canc Ctr, Stamford, CT 06902 USA; Strang Canc Prevent Ctr, New York, NY USA; Univ Washington, Seattle, WA 98195 USA; White Plains Hosp Ctr, White Plains, NY 10601 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Sarah Lawrence College; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Columbia University; NewYork-Presbyterian Hospital; Englewood Hospital & Medical Center; Hackensack University Medical Center; Memorial Sloan Kettering Cancer Center; New York University; Northwell Health; North Shore University Hospital; Stamford Hospital; University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.			Robson, Mark/0000-0002-3109-1692; King, Mary-Claire/0000-0001-9426-1743; Walsh, Tom/0000-0002-8875-0310; Norton, Larry/0000-0003-3701-9250				Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Begg CB, 2002, J NATL CANCER I, V94, P1221; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Carpenter CL, 2003, INT J CANCER, V106, P96, DOI 10.1002/ijc.11186; Colditz GA, 1996, J NATL CANCER I, V88, P365, DOI 10.1093/jnci/88.6.365; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Foulkes WD, 2002, J MED GENET, V39, P407, DOI 10.1136/jmg.39.6.407; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Narod SA, 2002, NAT REV CANCER, V2, P113, DOI 10.1038/nrc726; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Ries LAG, 2002, SEER CANC STAT REV 1; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Satagopan JM, 2002, CLIN CANCER RES, V8, P3776; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.20.5.1260; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241	27	1587	1645	2	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					643	646		10.1126/science.1088759	http://dx.doi.org/10.1126/science.1088759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576434				2022-12-01	WOS:000186119900059
J	Brennan, M; Penn, MS; Van Lente, F; Nambi, V; Shishehbor, MH; Aviles, RJ; Goormastic, M; Pepoy, ML; McErlean, ES; Topol, EJ; Nissen, SE; Hazen, SL				Brennan, M; Penn, MS; Van Lente, F; Nambi, V; Shishehbor, MH; Aviles, RJ; Goormastic, M; Pepoy, ML; McErlean, ES; Topol, EJ; Nissen, SE; Hazen, SL			Prognostic value of myeloperoxidase in patients with chest pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; UNSTABLE ANGINA-PECTORIS; C-REACTIVE PROTEIN; TROPONIN-I; INFLAMMATION; ATHEROSCLEROSIS; NEUTROPHIL; INHIBITOR; LESIONS; SERUM	BACKGROUND: Inflammation is linked to adverse outcomes in acute coronary syndromes. Myeloperoxidase, an abundant leukocyte enzyme, is elevated in culprit lesions that have fissured or ruptured in patients with sudden death from cardiac causes. Numerous lines of evidence suggest mechanistic links between myeloperoxidase and both inflammation and cardiovascular disease. METHODS: We assessed the value of plasma levels of myeloperoxidase as a predictor of the risk of cardiovascular events in 604 sequential patients presenting to the emergency department with chest pain. RESULTS: Initial plasma myeloperoxidase levels predicted the risk of myocardial infarction, even in patients who are negative for troponin T (<0.1 ng per milliliter) at base line (P<0.001). Myeloperoxidase levels at presentation also predicted the risk of major adverse cardiac events (myocardial infarction, the need for revascularization, or death) within 30 days and 6 months after presentation (P<0.001). In patients without evidence of myocardial necrosis (defined as those who were negative for troponin T), the base-line myeloperoxidase levels independently predicted the risk of major adverse coronary events at 30 days (unadjusted 2nd, 3rd, and 4th quartile odds ratios, 2.2 [95 percent confidence interval, 1.1 to 4.6], 4.2 [95 percent confidence interval, 2.1 to 8.4], and 4.1 [95 percent confidence interval, 2.0 to 8.4], respectively) and at 6 months. CONCLUSIONS: A single initial measurement of plasma myeloperoxidase independently predicts the early risk of myocardial infarction, as well as the risk of major adverse cardiac events in the ensuing 30-day and 6-month periods. Myeloperoxidase levels, in contrast to troponin T, creatine kinase MB isoform, and C-reactive protein levels, identified patients at risk for cardiac events in the absence of myocardial necrosis, highlighting its potential usefulness for risk stratification among patients who present with chest pain.	Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Internal Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave,NC10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Topol, Eric/0000-0002-1478-4729	NATIONAL CANCER INSTITUTE [F32CA096348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018390] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070621, R01HL061878, R01HL062526] Funding Source: NIH RePORTER; NCI NIH HHS [CA96348] Funding Source: Medline; NCRR NIH HHS [M01 RR018390] Funding Source: Medline; NHLBI NIH HHS [HL61878, HL70621, HL62526] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Agner K., 1972, STRUCTURE FUNCTION O, P329; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Biasucci L M, 2001, Ital Heart J, V2, P164; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; deServi S, 1996, AM J CARDIOL, V78, P564, DOI 10.1016/S0002-9149(96)00367-0; DINERMAN JL, 1990, J AM COLL CARDIOL, V15, P1559, DOI 10.1016/0735-1097(90)92826-N; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; KLEBANOFF SJ, 1984, METHOD ENZYMOL, V105, P399; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; McErlean ES, 2000, AM J CARDIOL, V85, P421, DOI 10.1016/S0002-9149(99)00766-3; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Sabatine MS, 2002, CIRCULATION, V105, P1760, DOI 10.1161/01.CIR.0000015464.18023.0A; Schmitt D, 1999, BIOCHEMISTRY-US, V38, P16904, DOI 10.1021/bi991623w; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shabani F, 1998, FREE RADICAL RES, V28, P115, DOI 10.3109/10715769809065797; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136	25	798	882	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2003	349	17					1595	1604		10.1056/NEJMoa035003	http://dx.doi.org/10.1056/NEJMoa035003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZT	14573731	Bronze			2022-12-01	WOS:000186088400004
J	Strom, BL; Schinnar, R; Apter, AJ; Margolis, DJ; Lautenbach, E; Hennessy, S; Bilker, WB; Pettitt, D				Strom, BL; Schinnar, R; Apter, AJ; Margolis, DJ; Lautenbach, E; Hennessy, S; Bilker, WB; Pettitt, D			Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK FACTOR; SELECTION; DATABASE; ALLERGY; SENSITIVITY; PREVALENCE; VALIDATION; CELECOXIB; PROFILE; ATOPY	BACKGROUND: The safety of sulfonamide nonantibiotics is unclear in patients with prior allergic reactions to sulfonamide antibiotics. METHODS: We conducted a retrospective cohort study using the General Practice Research Database in the United Kingdom, examining the risk of allergic reactions within 30 days after the receipt of a sulfonamide nonantibiotic. Patients with evidence of prior hypersensitivity after the receipt of a sulfonamide antibiotic were compared with those without such evidence. Similar analyses were also performed with the use of penicillins instead of sulfonamides, to determine whether any risk was specific to sulfonamide cross-reactivity. RESULTS: Of 969 patients with an allergic reaction after a sulfonamide antibiotic, 96 (9.9 percent) had an allergic reaction after subsequently receiving a sulfonamide nonantibiotic. Of 19,257 who had no allergic reaction after a sulfonamide antibiotic, 315 (1.6 percent) had an allergic reaction after receiving a sulfonamide nonantibiotic (adjusted odds ratio, 2.8; 95 percent confidence interval, 2.1 to 3.7). However, the risk of allergic reactions was even greater after the receipt of a penicillin among patients with a prior hypersensitivity reaction to a sulfonamide antibiotic, as compared with patients with no such history (adjusted odds ratio, 3.9; 95 percent confidence interval, 3.5 to 4.3). Furthermore, among those with a prior hypersensitivity reaction after the receipt of a sulfonamide antibiotic, the risk of an allergic reaction after the subsequent receipt of a sulfonamide nonantibiotic was lower than the risk of an allergic reaction after the subsequent receipt of a penicillin (adjusted odds ratio, 0.7; 95 percent confidence interval, 0.5 to 0.9). Finally, the risk of an allergic reaction after the receipt of a sulfonamide nonantibiotic was lower among patients with a history of hypersensitivity to sulfonamide antibiotics than among patients with a history of hypersensitivity to penicillins (adjusted odds ratio, 0.6; 95 percent confidence interval, 0.5 to 0.8). CONCLUSIONS: There is an association between hypersensitivity after the receipt of sulfonamide antibiotics and a subsequent allergic reaction after the receipt of a sulfonamide nonantibiotic, but this association appears to be due to a predisposition to allergic reactions rather than to cross-reactivity with sulfonamide-based drugs.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA; Pfizer, Dept Outcomes Res, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pfizer	Strom, BL (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, 824 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.		Bilker, Warren/AAS-3515-2021					ADKINSON NF, 1984, J ALLERGY CLIN IMMUN, V74, P567, DOI 10.1016/0091-6749(84)90108-8; BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358; BRETZA JA, 1982, WISC MED J, V81, P21; Cribb AE, 1996, ADVERSE DRUG REACT T, V15, P9; Demoly P, 2001, CURR OPIN ALLERGY CL, V1, P305, DOI 10.1097/01.all.0000011031.16814.e0; DITTO AM, 2002, PATTERSONS ALLERGIC, P295; ENRIGHT T, 1989, ANN ALLERGY, V62, P302; Garcia Rodriguez L A, 2000, PHARMACOEPIDEM DR S, P375; GREENBERGER PA, 2002, PATTERSONS ALLERGIC, P335; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; HANSBROUGH JR, 1987, J ALLERGY CLIN IMMUN, V80, P538, DOI 10.1016/0091-6749(87)90004-2; HOIGNE R, 1993, MONOGR ALLERGY, V31, P147; Holtzer CD, 1998, PHARMACOTHERAPY, V18, P831; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Hosoya T, 2000, Radiat Med, V18, P39; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Knowles S, 2001, DRUG SAFETY, V24, P239, DOI 10.2165/00002018-200124040-00001; LANDOR M, 1993, ANN ALLERGY, V70, P196; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; LIEBERMAN P, 1997, ALLERGIC DIS DIAGNOS, P289; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Margolis DJ, 2002, ANN EPIDEMIOL, V12, P321, DOI 10.1016/S1047-2797(01)00255-1; MAURIHELLWEG D, 1995, J IMMUNOL, V155, P462; Park J, 2000, Can J Clin Pharmacol, V7, P38; Pastorello EA, 1998, ALLERGY, V53, P880, DOI 10.1111/j.1398-9995.1998.tb03995.x; Patterson R, 1999, CLIN THER, V21, P2065, DOI 10.1016/S0149-2918(00)87238-0; ROBINS JM, 1986, AM J EPIDEMIOL, V123, P392, DOI 10.1093/oxfordjournals.aje.a114254; RYTEL MW, 1963, JAMA-J AM MED ASSOC, V186, P894; Sanchez-Borges N, 2000, ANN ALLERG ASTHMA IM, V84, P101, DOI 10.1016/S1081-1206(10)62748-2; *SAS I, 2000, SAS VERS 8 0; SMITH JW, 1966, NEW ENGL J MED, V274, P998, DOI 10.1056/NEJM196605052741804	35	212	216	0	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2003	349	17					1628	U9		10.1056/NEJMoa022963	http://dx.doi.org/10.1056/NEJMoa022963			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZT	14573734				2022-12-01	WOS:000186088400007
J	Chitnis, V; Chitnis, S; Patil, S; Chitnis, D				Chitnis, V; Chitnis, S; Patil, S; Chitnis, D			Solar disinfection of infectious biomedical waste: a new approach for developing countries	LANCET			English	Article							DRINKING-WATER	Poor developing countries cannot afford expensive technologies such as incineration for management of infectious biomedical waste. We assessed solar heating as an alternative technology. We immersed simulated infectious waste with added challenge bacteria in water in a box-type solar cooker, which was left in the sun for 6 h. In 24 sets of observations, the amount of viable bacteria was reduced by about 7 log. We also tested infectious medical waste with a heavy load of bacteria (10(8)-10(9)/g) from our hospital's burn U nit for solar heat disinfection in 20 experiments. Our results showed a similar 7 log reduction in the amount of viable bacteria. Solar heating thus seems to be a cheap method to disinfect infectious medical waste in less economically developed countries.	Choithram Hosp & Res Ctr, Dept Microbiol, Indore 452001, Madhya Pradesh, India; Devi Ahilya Vishwavidyalaya, Sch Life Sci, Dept Microbiol, Indore, Madhya Pradesh, India	Devi Ahilya University	Chitnis, V (corresponding author), Choithram Hosp & Res Ctr, Dept Microbiol & Immunol, Indore 452001, Madhya Pradesh, India.							Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; GRAHAM W, 1983, TOPLEY WILSONS PRINC, P70; Reed RH, 2000, LETT APPL MICROBIOL, V30, P432, DOI [10.1046/j.1472-765x.2000.00741.x, 10.1046/j.1472-765X.2000.00741.x]; Rijal GK, 2001, WATER SCI TECHNOL, V43, P155, DOI 10.2166/wst.2001.0728; *UNICEF REG OFF MI, 1984, SOL DIS DRINK WAT OR	5	10	10	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1285	1286		10.1016/S0140-6736(03)14610-7	http://dx.doi.org/10.1016/S0140-6736(03)14610-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575975				2022-12-01	WOS:000186036900014
J	Bogan, JS; Hendon, N; McKee, AE; Tsao, TS; Lodish, HF				Bogan, JS; Hendon, N; McKee, AE; Tsao, TS; Lodish, HF			Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking	NATURE			English	Article							3T3-L1 ADIPOCYTES; INSULIN; PROTEINS; CELLS; COMPARTMENTS; INTERACTS; MEMBRANE; DOMAIN; GENE; P47	Insulin stimulates glucose uptake in fat and muscle by mobilizing the GLUT4 glucose transporter. GLUT4 is sequestered intracellularly in the absence of insulin, and is redistributed to the plasma membrane within minutes of insulin stimulation(1,2). But the trafficking mechanisms that control GLUT4 sequestration have remained elusive. Here we describe a functional screen to identify proteins that modulate GLUT4 distribution, and identify TUG as a putative tether, containing a UBX domain, for GLUT4. In truncated form, TUG acts in a dominant-negative manner to inhibit insulin-stimulated GLUT4 redistribution in Chinese hamster ovary cells and 3T3-L1 adipocytes. Full-length TUG forms a complex specifically with GLUT4; in 3T3-L1 adipocytes, this complex is present in unstimulated cells and is largely disassembled by insulin. Endogenous TUG is localized with the insulin-mobilizable pool of GLUT4 in unstimulated 3T3-L1 adipocytes, and is not mobilized to the plasma membrane by insulin. Distinct regions of TUG are required to bind GLUT4 and to retain GLUT4 intracellularly in transfected, non-adipose cells. Our data suggest that TUG traps endocytosed GLUT4 and tethers it intracellularly, and that insulin mobilizes this pool of retained GLUT4 by releasing this tether.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Dept Med, Diabet Unit, Boston, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Bogan, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,Box 208020, New Haven, CT 06520 USA.		Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466; Tsao, Tsu-Shuen/0000-0002-1041-9687				Becker K, 1997, FEBS LETT, V412, P102, DOI 10.1016/S0014-5793(97)00758-8; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Holman GD, 2001, TRENDS CELL BIOL, V11, P173, DOI 10.1016/S0962-8924(01)01953-5; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Ladanyi M, 2001, ONCOGENE, V20, P48, DOI 10.1038/sj.onc.1204074; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; Wright DA, 1996, J BIOL CHEM, V271, P31037, DOI 10.1074/jbc.271.49.31037; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864	22	143	148	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					727	733		10.1038/nature01989	http://dx.doi.org/10.1038/nature01989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14562105				2022-12-01	WOS:000185924500044
J	Pui, CH; Sandlund, JT; Pei, DQ; Rivera, GK; Howard, SC; Ribeiro, RC; Rubnitz, JE; Razzouk, BI; Hudson, MM; Cheng, C; Raimondi, SC; Behm, FG; Downing, JR; Relling, MV; Evans, WE				Pui, CH; Sandlund, JT; Pei, DQ; Rivera, GK; Howard, SC; Ribeiro, RC; Rubnitz, JE; Razzouk, BI; Hudson, MM; Cheng, C; Raimondi, SC; Behm, FG; Downing, JR; Relling, MV; Evans, WE			Results of therapy for acute lymphoblastic leukemia in black and white children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PEDIATRIC-ONCOLOGY-GROUP; CENTRAL-NERVOUS-SYSTEM; CANCER SURVIVAL; RACIAL-DIFFERENCES; CHILDHOOD-CANCER; LUMBAR PUNCTURE; TRIALS; RISK; INTENSIFICATION; DIAGNOSIS	Context Treatment results for acute lymphoblastic leukemia (ALL) clearly have improved over the past decade, but black children have not fared as well as white children in large national trials. Objective To compare the clinical outcomes of therapy for black and white children with ALL treated at a single institution. Design, Setting, and Patients A retrospective analysis of 412 children and adolescents (68 black, 338 white, and 6 other race) with newly diagnosed ALL who were treated consecutively at a pediatric cancer center in Memphis, Tenn. Patients were enrolled from December 1991 to July 1998 in successive Total Therapy studies regardless of race, ethnicity, or ability to pay and received risk-directed therapy according to stringent criteria. Interventions All patients received the same intensive, remission-induction therapy followed by 120 weeks of risk-assigned postremission therapy that included reinduction treatment, pulses of high-dose methotrexate, and early intensification of intrathecal chemotherapy. Main Outcome Measures Event-free and overall survival rates for black and white children were estimated by the method of Kaplan and Meier and compared with the Mantel-Haenszel test and by Cox proportional hazards regression analysis, adjusting for known prognostic factors. Results The 68 black children were significantly more likely than the 338 white children to have higher-risk prognostic features, including an initial leukocyte count greater than 100 X 10(3)/muL, a T-cell immunophenotype, and the t(1;19) chromosomal translocation with E2A-PBX1 fusion, and were less likely to have hyperdiploid blast cells, a favorable prognostic factor in childhood ALL. However, the clinical outcomes for these 2 cohorts were not significantly different: 5-year event-free and overall survival rates were 80.7% (95% confidence interval [CI], 70.3%-91.1%) and 86.2% (95% Cl, 77.2%-95.2%) for black children vs 79.4% (95% CI, 74.7%-84.1%) and 85.0% (95% Cl, 80.9%-89.1%) for white children. Ten-year results also were comparable, but the Cls were wide because of the small numbers of patients who had been followed up for 10 years or more. The lack of a racial effect on the long-term outcome of therapy was still apparent in a multivariate Cox regression analysis, adjusting for sex, age, presenting leukocyte count, leukemic cell DNA index, immunophenotype, and central nervous system status. Conclusion With equal access to effective antileukemic therapy, black and white children with ALL can expect the same high rate of cure.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org	Relling, Mary/N-5032-2018; Raimondi, Susana C/N-8166-2018; Downing, James R./N-8102-2018; Howard, Scott C/K-3401-2013; Evans, William E./C-2069-2012; Pui, Ching-Hon/N-8076-2018; Cheng, Cheng/N-8075-2018; Hudson, Melissa M/N-4441-2018	Howard, Scott C/0000-0003-2244-1686; Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658; Hudson, Melissa M/0000-0001-6984-2407; Razzouk, Bassem/0000-0003-0536-6135	NCI NIH HHS [CA-21765, CA-51001, CA-36401, CA-78224] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036401, R29CA051001, R01CA078224, P30CA021765, R37CA036401, R01CA051001] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agresti A., 2019, INTRO CATEGORICAL DA; Bach PB, 2002, JAMA-J AM MED ASSOC, V287, P2106, DOI 10.1001/jama.287.16.2106; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Clarke M, 2003, J CLIN ONCOL, V21, P1798, DOI 10.1200/JCO.2003.08.047; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; FALLETTA JM, 1984, PROG CANCER RES THER, V27, P191; Gajjar A, 2000, BLOOD, V96, P3381; Gaynon PS, 2000, LEUKEMIA, V14, P2223, DOI 10.1038/sj.leu.2401939; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Gustafsson G, 2000, LEUKEMIA, V14, P2267, DOI 10.1038/sj.leu.2401961; HOWARD J, 1992, CANCER, V69, P2349, DOI 10.1002/1097-0142(19920501)69:9&lt;2349::AID-CNCR2820690925&gt;3.0.CO;2-7; Howard SC, 2002, JAMA-J AM MED ASSOC, V288, P2001, DOI 10.1001/jama.288.16.2001; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI, P169; KALWINSKY DK, 1985, LEUKEMIA RES, V9, P817, DOI 10.1016/0145-2126(85)90300-5; MAHMOUD HH, 1993, NEW ENGL J MED, V329, P314, DOI 10.1056/NEJM199307293290504; Maloney KW, 2000, LEUKEMIA, V14, P2276, DOI 10.1038/sj.leu.2401965; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Matherly LH, 1997, BLOOD, V90, P578, DOI 10.1182/blood.V90.2.578.578_578_589; NOVAKOVIC B, 1994, MED PEDIATR ONCOL, V23, P480, DOI 10.1002/mpo.2950230606; PINKEL D, 1993, LEUKEMIA, V7, pS146; Pollock BH, 2000, J CLIN ONCOL, V18, P813, DOI 10.1200/JCO.2000.18.4.813; Pui CH, 2000, LEUKEMIA, V14, P2286, DOI 10.1038/sj.leu.2401938; PUI CH, 1988, J CLIN ONCOL, V6, P56, DOI 10.1200/JCO.1988.6.1.56; PUI CH, 1995, JAMA-J AM MED ASSOC, V273, P633, DOI 10.1001/jama.273.8.633; Pui CH, 2003, J CLIN ONCOL, V21, P179, DOI 10.1200/JCO.2003.10.032; PUI CH, 1992, LEUKEMIA, V6, P150; PUI CH, 1986, BLOOD, V67, P1688; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; PUI CH, 1995, NEW ENGL J MED, V332, P1618, DOI 10.1056/NEJM199506153322407; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; PUI CH, IN PRESS N ENGL J ME; RAGLAND KE, 1991, AM J EPIDEMIOL, V133, P672; REAMAN GH, 1984, PROG CANCER RES THER, V27, P163; Relling MV, 2003, BLOOD, V101, P3862, DOI 10.1182/blood-2002-08-2405; RIES LA, 1999, PUBLICATION NIH; Ries LAG, 1999, SEER CANC STAT REV 1; SATHER H, 1984, PROG CANCER RES THER, V27, P179; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; WALTERS TR, 1972, CANCER, V29, P210, DOI 10.1002/1097-0142(197201)29:1<210::AID-CNCR2820290131>3.0.CO;2-U; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	43	130	134	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2003	290	15					2001	2007		10.1001/jama.290.15.2001	http://dx.doi.org/10.1001/jama.290.15.2001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732CX	14559953				2022-12-01	WOS:000185924200023
J	McIntire, JJ; Umetsu, SE; Macaubas, C; Hoyte, EG; Cinnioglu, C; Cavalli-Sforza, LL; Barsh, GS; Hallmayer, JF; Underhill, PA; Risch, NJ; Freeman, GJ; DeKruyff, RH; Umetsu, DT				McIntire, JJ; Umetsu, SE; Macaubas, C; Hoyte, EG; Cinnioglu, C; Cavalli-Sforza, LL; Barsh, GS; Hallmayer, JF; Underhill, PA; Risch, NJ; Freeman, GJ; DeKruyff, RH; Umetsu, DT			Hepatitis A virus link to atopic disease	NATURE			English	Editorial Material							HAY-FEVER; INFECTION; MARKERS		Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute	McIntire, JJ (corresponding author), Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.		Jones, Jennifer/C-8691-2015; Freeman, Gordon/AAC-5380-2019	Jones, Jennifer/0000-0002-9488-7719; Freeman, Gordon/0000-0002-7210-5616				Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bower WA, 2000, J INFECT DIS, V182, P12, DOI 10.1086/315701; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Silberstein E, 2003, J VIROL, V77, P8765, DOI 10.1128/JVI.77.16.8765-8774.2003; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259	10	166	185	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2003	425	6958					576	576		10.1038/425576a	http://dx.doi.org/10.1038/425576a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14534576				2022-12-01	WOS:000185801000026
J	Yoshimura, T; Yasuo, S; Watanabe, M; Iigo, M; Yamamura, T; Hirunagi, K; Ebihara, S				Yoshimura, T; Yasuo, S; Watanabe, M; Iigo, M; Yamamura, T; Hirunagi, K; Ebihara, S			Light-induced hormone conversion of T-4 to T-3 regulates photoperiodic response of gonads in birds	NATURE			English	Article							CIRCADIAN CLOCK GENES; JAPANESE-QUAIL; ELECTRICAL-STIMULATION; GONADOTROPHIN RELEASE; TUBERAL HYPOTHALAMUS; TESTICULAR GROWTH; THYROIDECTOMY; EXPRESSION; THYROXINE; RHYTHMICITY	Reproduction of many temperate zone birds is under photoperiodic control. The Japanese quail is an excellent model for studying the mechanism of photoperiodic time measurement because of its distinct and marked response to changing photoperiods. Studies on this animal have suggested that the mediobasal hypothalamus (MBH) is an important centre controlling photoperiodic time measurement(1-8). Here we report that expression in the MBH of the gene encoding type 2 iodothyronine deiodinase (Dio2), which catalyses the intracellular deiodination of thyroxine (T-4) prohormone to the active 3,5,3'-triiodothyronine (T-3), is induced by light in Japanese quail. Intracerebroventricular administration of T-3 mimics the photoperiodic response, whereas the Dio2 inhibitor iopanoic acid prevents gonadal growth. These findings demonstrate that light-induced Dio2 expression in the MBH may be involved in the photoperiodic response of gonads in Japanese quail.	Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Nagoya Univ Museum, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Utsunomiya Univ, Fac Agr, Dept Appl Biol Chem, Utsunomiya, Tochigi 3218505, Japan	Nagoya University; Nagoya University; Utsunomiya University	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.		Iigo, Masayuki/I-7110-2013; Yoshimura, Takashi/C-8306-2012	Yoshimura, Takashi/0000-0001-7018-9652; Iigo, Masayuki/0000-0001-8251-4141				Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Chopra I J, 1978, Recent Prog Horm Res, V34, P521; DAVIES DT, 1975, PROC R SOC SER B-BIO, V191, P303, DOI 10.1098/rspb.1975.0130; DAWSON A, 1993, J ENDOCRINOL, V139, P51, DOI 10.1677/joe.0.1390051; Dawson A, 1998, GEN COMP ENDOCR, V110, P196, DOI 10.1006/gcen.1998.7065; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dawson A., 2001, P141; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P829, DOI 10.1007/BF00691015; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P837, DOI 10.1007/BF00691016; FOLLETT BK, 1969, NATURE, V223, P968, DOI 10.1038/223968b0; FOLLETT BK, 1985, J ENDOCRINOL, V107, P211, DOI 10.1677/joe.0.1070211; FOLLETT BK, 1984, J EXP ZOOL, V232, P573, DOI 10.1002/jez.1402320325; IKUTA K, 1987, GEN COMP ENDOCR, V65, P99, DOI 10.1016/0016-6480(87)90228-0; JUSS TS, 1993, AVIAN ENDOCRINOLOGY, P47; KONISHI H, 1987, J COMP PHYSIOL A, V161, P315, DOI 10.1007/BF00615251; Kuenzel W., 1988, STEREOTAXIC ATLAS BR; Leonard JL., 1986, THYROID HORMONE META, P189; MEDDLE SL, 1995, J COMP PHYSIOL A, V176, P79; Meddle SL, 1997, J NEUROSCI, V17, P8909; NICHOLS DH, 1985, CLIN OBSTET GYNECOL, V28, P375, DOI 10.1097/00003081-198528020-00015; OHTA M, 1984, J COMP PHYSIOL, V154, P583, DOI 10.1007/BF00610171; OHTA M, 1987, GEN COMP ENDOCR, V68, P286, DOI 10.1016/0016-6480(87)90040-2; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; SHARP PJ, 1969, NEUROENDOCRINOLOGY, V5, P205, DOI 10.1159/000121861; SILVER R, 1988, CELL TISSUE RES, V253, P189; TAGAWA M, 1987, GEN COMP ENDOCR, V68, P129, DOI 10.1016/0016-6480(87)90068-2; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7	28	367	383	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					178	181		10.1038/nature02117	http://dx.doi.org/10.1038/nature02117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614506				2022-12-01	WOS:000186517200043
